id subject predicate object category relation description has_attribute source uuid:13000c2a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:130040aa-d20a-11ec-8377-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:13006a58-d20a-11ec-8377-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:13008fb0-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine targets GPCR (Prostaglandin E2 receptor EP1 subtype) DrugCentral uuid:1300b4fe-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.707']} DrugCentral uuid:1300e186-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine targets Ion channel (5-hydroxytryptamine receptor 3A) DrugCentral uuid:130106e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:1301305a-d20a-11ec-8377-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:4 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobupivacaine targets Ion channel (Potassium voltage-gated channel subfamily A member 5) DrugCentral uuid:130159ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:130159ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:130189e2-d20a-11ec-8377-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:6 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nitrendipine is blocker of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1301b372-d20a-11ec-8377-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:6 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1301dd02-d20a-11ec-8377-0242ac110003 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:6 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1302067e-d20a-11ec-8377-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:6 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:13023360-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:6 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:13025ce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:6 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 (S)-nitrendipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:13028216-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:13 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levdobutamine is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:1302a732-d20a-11ec-8377-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:21 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminopterin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1302d0ae-d20a-11ec-8377-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:21 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminopterin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1302f994-d20a-11ec-8377-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:21 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminopterin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:13032266-d20a-11ec-8377-0242ac110003 UniProtKB:P48760 biolink:molecularly_interacts_with DrugCentral:21 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminopterin targets Enzyme (Folylpoly-gamma-glutamate synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:13034be2-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:21 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminopterin is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:130374be-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:24 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutanoic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:13039d9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:24 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutanoic acid targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:1303c662-d20a-11ec-8377-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:24 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutanoic acid targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:1303f0a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:24 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutanoic acid targets Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:13041b1c-d20a-11ec-8377-0242ac110003 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:25 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azacitidine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13044402-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:25 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azacitidine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:130468ba-d20a-11ec-8377-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:26 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorouracil is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:13048dc2-d20a-11ec-8377-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:26 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorouracil targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:1304b23e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96J66 biolink:molecularly_interacts_with DrugCentral:26 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorouracil targets Transporter (ATP-binding cassette sub-family C member 11) DrugCentral uuid:1304d6ec-d20a-11ec-8377-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:26 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorouracil targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1304ffaa-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8F0 biolink:molecularly_interacts_with DrugCentral:26 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorouracil targets Enzyme (Uracil phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:130528f4-d20a-11ec-8377-0242ac110003 UniProtKB:O26232 biolink:molecularly_interacts_with DrugCentral:27 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azaribine targets Enzyme (Orotidine 5'-phosphate decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:130551e4-d20a-11ec-8377-0242ac110003 UniProtKB:P03962 biolink:molecularly_interacts_with DrugCentral:27 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azaribine targets Enzyme (Orotidine 5'-phosphate decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:13057b42-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:30 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxsalen targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1305a41e-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:30 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxsalen targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:1305cee4-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:30 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxsalen targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1305f7b6-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:30 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxsalen targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:13062074-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:30 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxsalen targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:13064946-d20a-11ec-8377-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:34 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abacavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.276']} DrugCentral uuid:130672e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:34 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abacavir is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:13069bb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:34 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abacavir targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1306c484-d20a-11ec-8377-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:35 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abarelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.49']} DrugCentral uuid:1306f698-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:1306f698-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:1306f698-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:130746e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:130746e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:130746e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:130746e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:130746e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:130746e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:130746e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:38 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acamprosate is antagonist of Ion channel (Glutamate [NMDA] receptor) DrugCentral uuid:1307aa52-d20a-11ec-8377-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose is inhibitor of Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.697']} DrugCentral uuid:1307d626-d20a-11ec-8377-0242ac110003 UniProtKB:P04746 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose is inhibitor of Enzyme (Pancreatic alpha-amylase) DrugCentral uuid:1307fac0-d20a-11ec-8377-0242ac110003 UniProtKB:P04745 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Alpha-amylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:13082392-d20a-11ec-8377-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:13084d40-d20a-11ec-8377-0242ac110003 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:13087608-d20a-11ec-8377-0242ac110003 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:13089ef8-d20a-11ec-8377-0242ac110003 UniProtKB:P94451 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Alpha-amylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1308c888-d20a-11ec-8377-0242ac110003 UniProtKB:P53051 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Oligo-1,6-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:1308f146-d20a-11ec-8377-0242ac110003 UniProtKB:P00690 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Pancreatic alpha-amylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:13091a04-d20a-11ec-8377-0242ac110003 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:39 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acarbose targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.609']} DrugCentral uuid:130942f4-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:40 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acebutolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:13096ce8-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:40 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acebutolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:130995b0-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:40 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acebutolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1309be78-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:43 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclofenac targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1309e722-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:43 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclofenac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:130a10bc-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:43 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclofenac targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.227']} DrugCentral uuid:130a3998-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:43 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:130a5e0a-d20a-11ec-8377-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:44 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acediasulfone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:130a86aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q4Z710 biolink:molecularly_interacts_with DrugCentral:44 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acediasulfone targets Unclassified (Dihydropteroate synthetase, putative) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:130aafe0-d20a-11ec-8377-0242ac110003 UniProtKB:A0A113T0T6 biolink:molecularly_interacts_with DrugCentral:44 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acediasulfone targets Unclassified (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:130ad88a-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:47 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acemetacin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:130afe64-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:47 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acemetacin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:130b231c-d20a-11ec-8377-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:47 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acemetacin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:130b4df6-d20a-11ec-8377-0242ac110003 UniProtKB:Q6TEK4 biolink:molecularly_interacts_with DrugCentral:48 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acenocoumarol is inhibitor of Unclassified (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:130b76be-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:48 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acenocoumarol is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.114']} DrugCentral uuid:130b9f90-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:49 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acefylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.56']} DrugCentral uuid:130bc92a-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:50 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceprometazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:130bee96-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:130c174a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol is opener of Ion channel (Transient receptor potential cation channel subfamily V member 1) DrugCentral uuid:130c3be4-d20a-11ec-8377-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:130c607e-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:130c89aa-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:130cb254-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:130cdb08-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:130d03d0-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:130d2f4a-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:130d5812-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:130d80da-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:130daa56-d20a-11ec-8377-0242ac110003 UniProtKB:P20292 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Cytosolic other (Arachidonate 5-lipoxygenase-activating protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:130dd3a0-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.547']} DrugCentral uuid:130dfc7c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:130e2562-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:130e4ea2-d20a-11ec-8377-0242ac110003 UniProtKB:P02144 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol targets Unclassified (Myoglobin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:130e7760-d20a-11ec-8377-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:52 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paracetamol is agonist of GPCR (Cannabinoid receptor 1) DrugCentral uuid:130e9bdc-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:54 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetanilide targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:130ec4b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9VTU8 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2, isoform A; LD26647p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:130eee8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9V396 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 1; GH09688p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:130f1760-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:130f4064-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:130f6940-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:130f92bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:130fbb8e-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:130fe532-d20a-11ec-8377-0242ac110003 UniProtKB:P29972 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Transporter (Aquaporin-1) DrugCentral uuid:131009a4-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:131032d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.27']} DrugCentral uuid:13105b8e-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:13108442-d20a-11ec-8377-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1310ad0a-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:1310d8ac-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:13110318-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:13112be0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1311553e-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:13117dfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERQ8 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1311a6c4-d20a-11ec-8377-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1311cf96-d20a-11ec-8377-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1311f8cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:13122194-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:13124a52-d20a-11ec-8377-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.09']} DrugCentral uuid:13127338-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:13129e4e-d20a-11ec-8377-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1312c8ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1312f196-d20a-11ec-8377-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:13131a54-d20a-11ec-8377-0242ac110003 UniProtKB:P29029 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Endochitinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:131343c6-d20a-11ec-8377-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.13']} DrugCentral uuid:13136c70-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1313952e-d20a-11ec-8377-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1313bde2-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:1313e718-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:131410da-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:131439a2-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:13146396-d20a-11ec-8377-0242ac110003 UniProtKB:P00921 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1314b7b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1314b7b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1314b7b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1314b7b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1314b7b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1314b7b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1314b7b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1314b7b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1314b7b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1314b7b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1314b7b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1314b7b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:131567b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:131567b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:131567b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:131567b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1315b7be-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:1315b7be-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:1315ebbc-d20a-11ec-8377-0242ac110003 UniProtKB:P46510 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:1316147a-d20a-11ec-8377-0242ac110003 UniProtKB:Q3SZX4 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.08']} DrugCentral uuid:13163e82-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.56']} DrugCentral uuid:1316675e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HVB9 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:131691c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.37']} DrugCentral uuid:1316bbfa-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:1316e620-d20a-11ec-8377-0242ac110003 UniProtKB:O75493 biolink:molecularly_interacts_with DrugCentral:56 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetazolamide targets Enzyme (Carbonic anhydrase-related protein 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:13171302-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:57 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohexamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.639']} DrugCentral uuid:13171302-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:57 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohexamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.639']} DrugCentral uuid:13174700-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:58 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohydroxamic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:13177810-d20a-11ec-8377-0242ac110003 UniProtKB:Q03284 biolink:molecularly_interacts_with DrugCentral:58 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohydroxamic acid is inhibitor of Enzyme (Bacterial urease) DrugCentral uuid:13177810-d20a-11ec-8377-0242ac110003 UniProtKB:Q03284 biolink:molecularly_interacts_with DrugCentral:58 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohydroxamic acid is inhibitor of Enzyme (Bacterial urease) DrugCentral uuid:13177810-d20a-11ec-8377-0242ac110003 UniProtKB:Q03284 biolink:molecularly_interacts_with DrugCentral:58 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohydroxamic acid is inhibitor of Enzyme (Bacterial urease) DrugCentral uuid:1317b000-d20a-11ec-8377-0242ac110003 UniProtKB:P07374 biolink:molecularly_interacts_with DrugCentral:58 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohydroxamic acid targets Enzyme (Urease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:1317d882-d20a-11ec-8377-0242ac110003 UniProtKB:Q0PXQ5 biolink:molecularly_interacts_with DrugCentral:58 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetohydroxamic acid targets Enzyme (Urease subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:13180140-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:59 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetophenazine is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:131828d2-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:59 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetophenazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:13185492-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:13187d96-d20a-11ec-8377-0242ac110003 UniProtKB:P08473 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril is inhibitor of Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1318a6f4-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1318d00c-d20a-11ec-8377-0242ac110003 UniProtKB:P07861 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1318f88e-d20a-11ec-8377-0242ac110003 UniProtKB:P08049 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:13192106-d20a-11ec-8377-0242ac110003 UniProtKB:P19621 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:131949d8-d20a-11ec-8377-0242ac110003 UniProtKB:P42892 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril targets Enzyme (Endothelin-converting enzyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:13197246-d20a-11ec-8377-0242ac110003 UniProtKB:P00800 biolink:molecularly_interacts_with DrugCentral:60 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racecadotril targets Enzyme (Thermolysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:13199ae6-d20a-11ec-8377-0242ac110003 UniProtKB:P23141 biolink:molecularly_interacts_with DrugCentral:62 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetoxolone targets Enzyme (Liver carboxylesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1319c35e-d20a-11ec-8377-0242ac110003 UniProtKB:P14061 biolink:molecularly_interacts_with DrugCentral:62 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetoxolone targets Enzyme (Estradiol 17-beta-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:1319ed66-d20a-11ec-8377-0242ac110003 UniProtKB:P37059 biolink:molecularly_interacts_with DrugCentral:62 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetoxolone targets Enzyme (Estradiol 17-beta-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:131a1606-d20a-11ec-8377-0242ac110003 UniProtKB:P80365 biolink:molecularly_interacts_with DrugCentral:62 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:131a3eb0-d20a-11ec-8377-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:62 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:131a6746-d20a-11ec-8377-0242ac110003 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:62 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetoxolone targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:131a9176-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:131ab9f8-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:131ae2ac-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:131b0c6e-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:131b359a-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:131b5e1c-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:131b86b2-d20a-11ec-8377-0242ac110003 UniProtKB:P58154 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Unclassified (Acetylcholine-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:131baf48-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:131bda9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:131c0718-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:131c0718-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:131c3ed6-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:131c3ed6-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:131c775c-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:131c775c-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:131caf38-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:131caf38-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:131ce782-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:131ce782-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:131d2080-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:131d2080-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:131d63c4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:131d63c4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:131d63c4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:131d63c4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:131d63c4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:131dbfd6-d20a-11ec-8377-0242ac110003 UniProtKB:H6TY12 biolink:molecularly_interacts_with DrugCentral:65 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcholine targets Ion channel (Nicotinic acetylcholine receptor alpha8 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:131de8b2-d20a-11ec-8377-0242ac110003 UniProtKB:P99999 biolink:molecularly_interacts_with DrugCentral:66 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcysteine targets Enzyme (Cytochrome c) DrugCentral uuid:131e0d06-d20a-11ec-8377-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:66 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcysteine targets Secreted (Vascular endothelial growth factor A) DrugCentral uuid:131e3218-d20a-11ec-8377-0242ac110003 UniProtKB:P04179 biolink:molecularly_interacts_with DrugCentral:66 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcysteine targets Enzyme (Superoxide dismutase [Mn], mitochondrial) DrugCentral uuid:131e569e-d20a-11ec-8377-0242ac110003 UniProtKB:P48637 biolink:molecularly_interacts_with DrugCentral:66 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcysteine is modulator of Enzyme (Glutathione synthetase) DrugCentral uuid:131e7b2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPY5 biolink:molecularly_interacts_with DrugCentral:66 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylcysteine is modulator of Transporter (Cystine/glutamate transporter) DrugCentral uuid:131ebb48-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:131ebb48-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:131ebb48-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:131ebb48-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:131ebb48-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:131ebb48-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:131ebb48-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:131ebb48-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:67 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetyldigitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:131f25ba-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:73 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acepromazine is antagonist of GPCR (D(1A) dopamine receptor) DrugCentral uuid:131f4a4a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:73 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acepromazine is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:131f6f84-d20a-11ec-8377-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:73 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acepromazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:131f982e-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:131fc0f6-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:131fe96e-d20a-11ec-8377-0242ac110003 UniProtKB:P60045 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid targets Enzyme (Acidic phospholipase A2 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:132012d6-d20a-11ec-8377-0242ac110003 UniProtKB:P19440 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid targets Enzyme (Gamma-glutamyltranspeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:13203b58-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:132063da-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:13208c66-d20a-11ec-8377-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1320b574-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid is blocker of Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1320ddf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:74 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylsalicylic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:13210786-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:76 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acipimox is agonist of GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:132130ee-d20a-11ec-8377-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:78 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acitretin is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) DrugCentral uuid:132155ce-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:78 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acitretin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:13217e50-d20a-11ec-8377-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:78 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acitretin is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) DrugCentral uuid:1321a2c2-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:78 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acitretin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:1321cba8-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:80 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclarubicin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.152']} DrugCentral uuid:1321f47a-d20a-11ec-8377-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:80 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclarubicin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:13221d24-d20a-11ec-8377-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:80 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclarubicin is inhibitor of Enzyme (DNA topoisomerase 1) DrugCentral uuid:132245b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:80 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclarubicin is inhibitor of Enzyme (DNA topoisomerase II) DrugCentral uuid:132245b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:80 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclarubicin is inhibitor of Enzyme (DNA topoisomerase II) DrugCentral uuid:1322841c-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:1322841c-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:1322841c-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:1322841c-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:1322841c-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:81 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclatonium is agonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:1322cf76-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:82 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acrivastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:1322f3f2-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:82 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acrivastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:13231ec2-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:82 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acrivastine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1323473a-d20a-11ec-8377-0242ac110003 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.04']} DrugCentral uuid:13236fc6-d20a-11ec-8377-0242ac110003 UniProtKB:P09250 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir targets Kinase (Thymidine kinase) DrugCentral uuid:1323944c-d20a-11ec-8377-0242ac110003 UniProtKB:P9WP01 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1323bd96-d20a-11ec-8377-0242ac110003 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1323e640-d20a-11ec-8377-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:13240ac6-d20a-11ec-8377-0242ac110003 UniProtKB:P09252 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:13242f2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir is inhibitor of Kinase (Thymidine kinase) DrugCentral uuid:13245422-d20a-11ec-8377-0242ac110003 UniProtKB:P04407 biolink:molecularly_interacts_with DrugCentral:85 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acyclovir is inhibitor of Kinase (Thymidine kinase) DrugCentral uuid:132479ac-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:87 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adapalene targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1324a224-d20a-11ec-8377-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:87 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adapalene targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1324cb50-d20a-11ec-8377-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:87 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adapalene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:1324f62a-d20a-11ec-8377-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:87 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adapalene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:13251ee8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:88 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adefovir dipivoxil is inhibitor of Polyprotein (Protein P) DrugCentral uuid:1325433c-d20a-11ec-8377-0242ac110003 UniProtKB:P54098 biolink:molecularly_interacts_with DrugCentral:88 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adefovir dipivoxil targets Enzyme (DNA polymerase subunit gamma-1) DrugCentral uuid:132567cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:88 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adefovir dipivoxil targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:13259120-d20a-11ec-8377-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:89 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenine targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1325c58c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1325c58c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1325c58c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1325c58c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:89 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenine targets Kinase (Phosphatidylinositol 4-kinase, PI4K) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:13260fd8-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:13263968-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.509']} DrugCentral uuid:132661f4-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:13268a6c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine is agonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1326b438-d20a-11ec-8377-0242ac110003 UniProtKB:P55263 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Kinase (Adenosine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1326dc9c-d20a-11ec-8377-0242ac110003 UniProtKB:P00813 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.602']} DrugCentral uuid:1327053c-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.29']} DrugCentral uuid:13272ddc-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:132757ee-d20a-11ec-8377-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:13278098-d20a-11ec-8377-0242ac110003 UniProtKB:Q9TVW2 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Kinase (Adenosine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1327a942-d20a-11ec-8377-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1327d1d8-d20a-11ec-8377-0242ac110003 UniProtKB:P23526 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Enzyme (Adenosylhomocysteinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.796']} DrugCentral uuid:1327ff78-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1327ff78-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:13283330-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BTU6 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine is inhibitor of Kinase (Phosphatidylinositol 4-kinase type 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:13285bc6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCG2 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine is inhibitor of Kinase (Phosphatidylinositol 4-kinase type 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:13288696-d20a-11ec-8377-0242ac110003 UniProtKB:P04406 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Enzyme (Glyceraldehyde-3-phosphate dehydrogenase liver) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1328bbd4-d20a-11ec-8377-0242ac110003 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1328bbd4-d20a-11ec-8377-0242ac110003 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1328bbd4-d20a-11ec-8377-0242ac110003 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1328bbd4-d20a-11ec-8377-0242ac110003 UniProtKB:P31322 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Kinase (cAMP-dependent protein kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1329065c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TEK3 biolink:molecularly_interacts_with DrugCentral:90 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine targets Enzyme (Histone-lysine N-methyltransferase, H3 lysine-79 specific) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:13293078-d20a-11ec-8377-0242ac110003 UniProtKB:P49652 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1329590e-d20a-11ec-8377-0242ac110003 UniProtKB:P51575 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Ion channel (P2X purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:13298208-d20a-11ec-8377-0242ac110003 UniProtKB:P51582 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1329abe8-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1329d578-d20a-11ec-8377-0242ac110003 UniProtKB:P47900 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1329fde6-d20a-11ec-8377-0242ac110003 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:132a265e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96G91 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets GPCR (P2Y purinoceptor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:132a4ed6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:132a78e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BPV8 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of GPCR (P2Y purinoceptor 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:132aa17e-d20a-11ec-8377-0242ac110003 UniProtKB:P41148 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Membrane other (Endoplasmin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:132ac9ec-d20a-11ec-8377-0242ac110003 UniProtKB:P49137 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Kinase (MAP kinase-activated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:132af318-d20a-11ec-8377-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:132b1c08-d20a-11ec-8377-0242ac110003 UniProtKB:Q99571 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Ion channel (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:132b44b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13304 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:132b6d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.836']} DrugCentral uuid:132b9660-d20a-11ec-8377-0242ac110003 UniProtKB:Q12931 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Unclassified (Heat shock protein 75 kDa, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:132bbeec-d20a-11ec-8377-0242ac110003 UniProtKB:P29410 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Kinase (Adenylate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.05']} DrugCentral uuid:132be7a0-d20a-11ec-8377-0242ac110003 UniProtKB:P11142 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Unclassified (Heat shock cognate 71 kDa protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:132c1018-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMV8 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Unclassified (Heat shock 70 kDa protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:132c3a84-d20a-11ec-8377-0242ac110003 UniProtKB:Q7TN37 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:132c646e-d20a-11ec-8377-0242ac110003 UniProtKB:P49653 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:132c8cfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJX6 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:132cb5ae-d20a-11ec-8377-0242ac110003 UniProtKB:O35811 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:132cde9e-d20a-11ec-8377-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:132d0720-d20a-11ec-8377-0242ac110003 UniProtKB:P51579 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:132d2fac-d20a-11ec-8377-0242ac110003 UniProtKB:P51578 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:132d5838-d20a-11ec-8377-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate is agonist of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:132d815a-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:91 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine triphosphate targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:132da9f0-d20a-11ec-8377-0242ac110003 UniProtKB:P09467 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (Fructose-1,6-bisphosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:132dd27c-d20a-11ec-8377-0242ac110003 UniProtKB:P00636 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (Fructose-1,6-bisphosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:132dfaf4-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:132e2786-d20a-11ec-8377-0242ac110003 UniProtKB:O94759 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Ion channel (Transient receptor potential cation channel subfamily M member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:132e5044-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:132e78d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:132ea5b2-d20a-11ec-8377-0242ac110003 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:132ea5b2-d20a-11ec-8377-0242ac110003 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:132ed9ba-d20a-11ec-8377-0242ac110003 UniProtKB:P00338 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (L-lactate dehydrogenase A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.19']} DrugCentral uuid:132f025a-d20a-11ec-8377-0242ac110003 UniProtKB:P0A9J4 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (Ketopantoate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.2']} DrugCentral uuid:132f2b04-d20a-11ec-8377-0242ac110003 UniProtKB:P29410 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Kinase (Adenylate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:132f555c-d20a-11ec-8377-0242ac110003 UniProtKB:O43598 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (2'-deoxynucleoside 5'-phosphate N-hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:132f7e88-d20a-11ec-8377-0242ac110003 UniProtKB:O35820 biolink:molecularly_interacts_with DrugCentral:92 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adenosine phosphate targets Enzyme (2'-deoxynucleoside 5'-phosphate N-hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:132fa71e-d20a-11ec-8377-0242ac110003 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam targets Transporter (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:13300286-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:13300286-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:13300286-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:13300286-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:13300286-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:13300286-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:13300286-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:13300286-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:13300286-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:13300286-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:13300286-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:13300286-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:13300286-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:93 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adinazolam is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:13309d5e-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:94 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adiphenine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1330d594-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:1330d594-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:1330d594-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:1330d594-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:1330d594-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:94 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adiphenine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:13312b70-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1331541a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:133180c0-d20a-11ec-8377-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:133180c0-d20a-11ec-8377-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:1331be46-d20a-11ec-8377-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:1331be46-d20a-11ec-8377-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:1331be46-d20a-11ec-8377-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:1331fd2a-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:133225f2-d20a-11ec-8377-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:13324f0a-d20a-11ec-8377-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:99 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 agomelatine is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:133277b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:100 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ajmaline is inhibitor of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:13329c12-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:100 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ajmaline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1332c584-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:100 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ajmaline is inhibitor of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:1332ee74-d20a-11ec-8377-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:100 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ajmaline is inhibitor of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:133316ec-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:101 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alacepril is inhibitor of Enzyme (Angiotensin-converting enzyme) DrugCentral uuid:13333f78-d20a-11ec-8377-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alatrofloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:13333f78-d20a-11ec-8377-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alatrofloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:133372d6-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alatrofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:133372d6-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alatrofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:1333a4ea-d20a-11ec-8377-0242ac110003 UniProtKB:P50719 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole targets Structural (Tubulin alpha chain) DrugCentral uuid:1333d168-d20a-11ec-8377-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:1333d168-d20a-11ec-8377-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:1333d168-d20a-11ec-8377-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:13342118-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:13342118-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:13342118-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:13342118-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:13342118-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:13342118-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:13342118-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:13347fbe-d20a-11ec-8377-0242ac110003 UniProtKB:P50719 biolink:molecularly_interacts_with DrugCentral:104 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albendazole sulfoxide targets Structural (Tubulin alpha chain) DrugCentral uuid:1334a430-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salbutamol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.613']} DrugCentral uuid:1334cd48-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salbutamol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:1334f5de-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salbutamol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.94']} DrugCentral uuid:13351e92-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salbutamol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1335471e-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:107 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:13356e1a-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:107 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alclofenac targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:1335928c-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:1335bb22-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1335e3a4-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:13360ca8-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:13363552-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.721']} DrugCentral uuid:13365f46-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.959']} DrugCentral uuid:133687aa-d20a-11ec-8377-0242ac110003 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1336b82e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets Ion channel (Acetylcholine receptor) DrugCentral uuid:1336b82e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets Ion channel (Acetylcholine receptor) DrugCentral uuid:1336b82e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets Ion channel (Acetylcholine receptor) DrugCentral uuid:1336f3c0-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.347']} DrugCentral uuid:1336f3c0-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.347']} DrugCentral uuid:13372836-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldosterone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:133753c4-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldosterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:13377c5a-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldosterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1337a4d2-d20a-11ec-8377-0242ac110003 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldosterone targets Transcription factor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.37']} DrugCentral uuid:1337cdcc-d20a-11ec-8377-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alendronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:1337f784-d20a-11ec-8377-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alendronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:13382010-d20a-11ec-8377-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alendronic acid targets Enzyme (Protein farnesyltransferase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:1338487e-d20a-11ec-8377-0242ac110003 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alendronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:13387178-d20a-11ec-8377-0242ac110003 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alendronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:13389a0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NR96 biolink:molecularly_interacts_with DrugCentral:113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alexidine targets Membrane receptor (Toll-like receptor 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1338c29a-d20a-11ec-8377-0242ac110003 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alexidine targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1338eb12-d20a-11ec-8377-0242ac110003 UniProtKB:Q932Y6 biolink:molecularly_interacts_with DrugCentral:113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alexidine targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:13391628-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WUK0 biolink:molecularly_interacts_with DrugCentral:113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alexidine is inhibitor of Enzyme (Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.97']} DrugCentral uuid:133941ca-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:13396a42-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.951']} DrugCentral uuid:133992ba-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:1339bbdc-d20a-11ec-8377-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1339efe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:1339efe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:1339efe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:1339efe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:133a3b7a-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfuzosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:133a63fc-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfuzosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:133a8c9c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfuzosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:133ab514-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfuzosin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:133ade9a-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfuzosin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:133b06ea-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfuzosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:133b2f58-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfuzosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:133b57c6-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.61']} DrugCentral uuid:133b80e8-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.678']} DrugCentral uuid:133baa1e-d20a-11ec-8377-0242ac110003 UniProtKB:P00797 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren is inhibitor of Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:133bd26e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9TSZ1 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:133bfad2-d20a-11ec-8377-0242ac110003 UniProtKB:Q6DLS0 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:133c2430-d20a-11ec-8377-0242ac110003 UniProtKB:P08424 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:133c4ca8-d20a-11ec-8377-0242ac110003 UniProtKB:P06281 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Renin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.35']} DrugCentral uuid:133c74ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q7M3D2 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:133c9d66-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:133cc8e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q6DLW5 biolink:molecularly_interacts_with DrugCentral:119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aliskiren targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:133cf446-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alizapride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:133d1ec6-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alizapride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:133d47f2-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alizapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:133d7074-d20a-11ec-8377-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 allopurinol is inhibitor of Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:133d9a18-d20a-11ec-8377-0242ac110003 UniProtKB:P00492 biolink:molecularly_interacts_with DrugCentral:124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 allopurinol targets Enzyme (Hypoxanthine-guanine phosphoribosyltransferase) DrugCentral uuid:133dbe80-d20a-11ec-8377-0242ac110003 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 allopurinol targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:133de77a-d20a-11ec-8377-0242ac110003 UniProtKB:P22985 biolink:molecularly_interacts_with DrugCentral:124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 allopurinol targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:133e1100-d20a-11ec-8377-0242ac110003 UniProtKB:Q9FBI2 biolink:molecularly_interacts_with DrugCentral:124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 allopurinol targets Unclassified (Shiga toxin subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:133e398c-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:128 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 almotriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:133e620e-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:128 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 almotriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:133e8bee-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:128 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 almotriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:133eb470-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alosetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:133edcf2-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alosetron targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:133f0588-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alosetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:133f2ea0-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alosetron targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.218']} DrugCentral uuid:133f5704-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:130 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfacalcidol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:133f7f86-d20a-11ec-8377-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:130 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfacalcidol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:133fa3e4-d20a-11ec-8377-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Transporter (Sodium- and chloride-dependent GABA transporter 1) DrugCentral uuid:133fd12a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:133fd12a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:133fd12a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13404a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13412e26-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:13412e26-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:13412e26-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alfaxalone targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:13416cf6-d20a-11ec-8377-0242ac110003 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Transporter (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:134195b4-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1341bf44-d20a-11ec-8377-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342218c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1342f3a0-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:13431c36-d20a-11ec-8377-0242ac110003 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem targets Unclassified (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:134344e0-d20a-11ec-8377-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpidem is partial agonist of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) DrugCentral uuid:13436984-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.85']} DrugCentral uuid:134391de-d20a-11ec-8377-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.457']} DrugCentral uuid:1343bae2-d20a-11ec-8377-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:1343e350-d20a-11ec-8377-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.61']} DrugCentral uuid:13441514-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:13441514-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:13441514-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:13445baa-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:13445baa-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:13445baa-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:1344a31c-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.161']} DrugCentral uuid:1344a31c-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.161']} DrugCentral uuid:1344a31c-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.161']} DrugCentral uuid:1344e994-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1344e994-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1344e994-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1345283c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:13455122-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:13457b20-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.86']} DrugCentral uuid:1345a488-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:1345cd0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q02769 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol targets Enzyme (Squalene synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1345f62c-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:13461eae-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:1346476c-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.678']} DrugCentral uuid:134670d4-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprenolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.658']} DrugCentral uuid:13469956-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1346c1ce-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1346ea1e-d20a-11ec-8377-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:134712dc-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:13473b54-d20a-11ec-8377-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:134763b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:13478c26-d20a-11ec-8377-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:1347b5f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1347de74-d20a-11ec-8377-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1348070a-d20a-11ec-8377-0242ac110003 UniProtKB:P32240 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:13482f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:134858d6-d20a-11ec-8377-0242ac110003 UniProtKB:P43114 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:1348814e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1348a9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1348d234-d20a-11ec-8377-0242ac110003 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1348fae8-d20a-11ec-8377-0242ac110003 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is activator of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:13492342-d20a-11ec-8377-0242ac110003 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:13494bc4-d20a-11ec-8377-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.35']} DrugCentral uuid:13497428-d20a-11ec-8377-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alprostadil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1349a06a-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:141 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 altretamine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:1349c8f6-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alvimopan is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:1349f1a0-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alvimopan targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:134a1b6c-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alvimopan targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:134a43ee-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alvimopan targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:134a6c84-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:134a9506-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:134abe00-d20a-11ec-8377-0242ac110003 UniProtKB:P63231 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is inhibitor of Ion channel (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:134afe9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:134afe9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:134afe9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:134afe9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:134afe9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:134afe9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:134afe9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:134b6e72-d20a-11ec-8377-0242ac110003 UniProtKB:Q20MD5 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:134b9708-d20a-11ec-8377-0242ac110003 UniProtKB:P05778 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:134bbf94-d20a-11ec-8377-0242ac110003 UniProtKB:P0DOF8 biolink:molecularly_interacts_with DrugCentral:144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:134be884-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambenonium is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:134c0cec-d20a-11ec-8377-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambenonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.34']} DrugCentral uuid:134c355a-d20a-11ec-8377-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambenonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:134c5dc8-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:147 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambroxol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.744']} DrugCentral uuid:134c86cc-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:147 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambroxol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.254']} DrugCentral uuid:134caf4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:147 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambroxol targets Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:134cd3c0-d20a-11ec-8377-0242ac110003 UniProtKB:P04062 biolink:molecularly_interacts_with DrugCentral:147 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambroxol targets Enzyme (Glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:134cfc38-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amcinonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:134d2ae6-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:134d2ae6-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:134d2ae6-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:134d76e0-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:134d76e0-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:134d76e0-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amidefrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:134db592-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifostine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.184']} DrugCentral uuid:134ddebe-d20a-11ec-8377-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifostine targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) DrugCentral uuid:134e031c-d20a-11ec-8377-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:157 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amikacin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.201']} DrugCentral uuid:134e2b9e-d20a-11ec-8377-0242ac110003 UniProtKB:P37088 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Ion channel (Amiloride-sensitive sodium channel subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:134e5402-d20a-11ec-8377-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:134e7e8c-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:134ea70e-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.408']} DrugCentral uuid:134ecf90-d20a-11ec-8377-0242ac110003 UniProtKB:P19634 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Transporter (Sodium/hydrogen exchanger 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:134ef934-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:134f21d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16515 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride is blocker of Ion channel (Acid-sensing ion channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:134f4a38-d20a-11ec-8377-0242ac110003 UniProtKB:P78348 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:134f7292-d20a-11ec-8377-0242ac110003 UniProtKB:O08590 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Enzyme (Membrane primary amine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:134f9c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:134fcc9c-d20a-11ec-8377-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:134fcc9c-d20a-11ec-8377-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:134fcc9c-d20a-11ec-8377-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:13500b94-d20a-11ec-8377-0242ac110003 UniProtKB:Q9W6Q1 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Transporter (Sodium/hydrogen exchanger) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:135035b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q14940 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride is inhibitor of Transporter (Sodium/hydrogen exchanger 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:13505e50-d20a-11ec-8377-0242ac110003 UniProtKB:P26431 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride is inhibitor of Transporter (Sodium/hydrogen exchanger 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:135087c2-d20a-11ec-8377-0242ac110003 UniProtKB:P50482 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Transporter (Sodium/hydrogen exchanger 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:1350b062-d20a-11ec-8377-0242ac110003 UniProtKB:P06869 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1350d9de-d20a-11ec-8377-0242ac110003 UniProtKB:P55926 biolink:molecularly_interacts_with DrugCentral:158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiloride targets Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:13510260-d20a-11ec-8377-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:160 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoacridine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:13512aba-d20a-11ec-8377-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:160 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoacridine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:13515346-d20a-11ec-8377-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:160 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoacridine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:13517c72-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:161 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amineptine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1351a4ea-d20a-11ec-8377-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminocaproic acid is inhibitor of Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1351cd76-d20a-11ec-8377-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminocaproic acid is inhibitor of Enzyme (Tissue-type plasminogen activator) DrugCentral uuid:1351f1f2-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoglutethimide is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:13521aba-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoglutethimide targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:13524350-d20a-11ec-8377-0242ac110003 UniProtKB:P05108 biolink:molecularly_interacts_with DrugCentral:164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoglutethimide is inhibitor of Enzyme (Cholesterol side-chain cleavage enzyme, mitochondrial) DrugCentral uuid:135267cc-d20a-11ec-8377-0242ac110003 UniProtKB:P22443 biolink:molecularly_interacts_with DrugCentral:164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoglutethimide targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:13529030-d20a-11ec-8377-0242ac110003 UniProtKB:P00189 biolink:molecularly_interacts_with DrugCentral:164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoglutethimide targets Enzyme (Cytochrome P450 11A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1352baa6-d20a-11ec-8377-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminohippuric acid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1352e332-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminohippuric acid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:13530bbe-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminophenazone targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:1353301c-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminophenazone targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:1353551a-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminophenazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:13537db0-d20a-11ec-8377-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminopicoline is inhibitor of Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1353a63c-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoquinuride targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1353ceb4-d20a-11ec-8377-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoquinuride targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:1353f786-d20a-11ec-8377-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoquinuride targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:13542012-d20a-11ec-8377-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminoquinuride targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:13544876-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:13547102-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:13549b32-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.112']} DrugCentral uuid:1354c3c8-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1354ec4a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.177']} DrugCentral uuid:13551580-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:13553de4-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1355665c-d20a-11ec-8377-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:13558eb6-d20a-11ec-8377-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1355b828-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1355e0aa-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:13560a58-d20a-11ec-8377-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:135632e4-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:13565c9c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.912']} DrugCentral uuid:13568532-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.647']} DrugCentral uuid:1356adbe-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.989']} DrugCentral uuid:1356d636-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.231']} DrugCentral uuid:1356ff4e-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.674']} DrugCentral uuid:135727f8-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.045']} DrugCentral uuid:13575084-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:13577906-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.387']} DrugCentral uuid:1357a25a-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.984']} DrugCentral uuid:1357cadc-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:1357f372-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.743']} DrugCentral uuid:13581c6c-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.168']} DrugCentral uuid:135848c2-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.296']} DrugCentral uuid:13587360-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.968']} DrugCentral uuid:13589cf0-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.498']} DrugCentral uuid:1358c5d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.701']} DrugCentral uuid:1358ee58-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.004']} DrugCentral uuid:135916da-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.207']} DrugCentral uuid:13593f70-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.176']} DrugCentral uuid:13596860-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.549']} DrugCentral uuid:135990d8-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:1359b932-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.284']} DrugCentral uuid:1359e1aa-d20a-11ec-8377-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.791']} DrugCentral uuid:135a0ca2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14534 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:135a370e-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.088']} DrugCentral uuid:135a5fa4-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.039']} DrugCentral uuid:135a8830-d20a-11ec-8377-0242ac110003 UniProtKB:P37268 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Squalene synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:135ab148-d20a-11ec-8377-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.368']} DrugCentral uuid:135ad9d4-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.191']} DrugCentral uuid:135b0256-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:135b2b46-d20a-11ec-8377-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:135b53b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.347']} DrugCentral uuid:135b7c22-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:135ba530-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.407']} DrugCentral uuid:135bcf42-d20a-11ec-8377-0242ac110003 UniProtKB:P30411 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.115']} DrugCentral uuid:135bfa8a-d20a-11ec-8377-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.879']} DrugCentral uuid:135c2474-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:135c4d00-d20a-11ec-8377-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.967']} DrugCentral uuid:135c771c-d20a-11ec-8377-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.943']} DrugCentral uuid:135ca0ac-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.932']} DrugCentral uuid:135cc94c-d20a-11ec-8377-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:135cf1c4-d20a-11ec-8377-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:135d1a8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Unclassified (THAP domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:135d4304-d20a-11ec-8377-0242ac110003 UniProtKB:P15389 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:135d6b7c-d20a-11ec-8377-0242ac110003 UniProtKB:O75151 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Lysine-specific demethylase PHF2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:135d9412-d20a-11ec-8377-0242ac110003 UniProtKB:P29375 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Lysine-specific demethylase 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:135dbffa-d20a-11ec-8377-0242ac110003 UniProtKB:Q6ZMT4 biolink:molecularly_interacts_with DrugCentral:176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amiodarone targets Enzyme (Lysine-specific demethylase 7A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:135de8ae-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.953']} DrugCentral uuid:135e1112-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.081']} DrugCentral uuid:135e3a5c-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:135e62e8-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.382']} DrugCentral uuid:135e8b6a-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:135eb3e2-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.758']} DrugCentral uuid:135edcfa-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.873']} DrugCentral uuid:135f057c-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.812']} DrugCentral uuid:135f2dea-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.625']} DrugCentral uuid:135f5658-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:135f80a6-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:135fa932-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amisulpride is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.495']} DrugCentral uuid:135fd1be-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:135ffa2c-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.051']} DrugCentral uuid:13602362-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.708']} DrugCentral uuid:13604be4-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.879']} DrugCentral uuid:13607470-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:13609dd8-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1360c6c8-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.367']} DrugCentral uuid:1360ef54-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.456']} DrugCentral uuid:136117d6-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:1361404e-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:13616b6e-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:136193e6-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1361bc68-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1361e59e-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:13620e16-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:136237a6-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:136260b4-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.686']} DrugCentral uuid:13628990-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1362b208-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1362da8a-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:136302ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:13632d0a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.83']} DrugCentral uuid:1363556e-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:13637dd2-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1363a62c-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:1363cf44-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1363f7bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.585']} DrugCentral uuid:13642020-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.066']} DrugCentral uuid:136448c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1364719c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:13649b54-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1364c408-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.252']} DrugCentral uuid:1364ec9e-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:136515de-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:13653e60-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:136566c4-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:1365900e-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.771']} DrugCentral uuid:1365b890-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:1365e0f4-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:13660958-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:13663220-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:13665a98-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:13668306-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1366ab6a-d20a-11ec-8377-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1366d4e6-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1366fd54-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:136726da-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:13674f66-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.854']} DrugCentral uuid:1367885a-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1367885a-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1367885a-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1367885a-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1367885a-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1367def4-d20a-11ec-8377-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptyline is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:13680820-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amitriptylinoxide targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:136831a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlexanox is inhibitor of Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:13685a46-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlexanox is inhibitor of Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:136882c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlexanox targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1368b964-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:1368b964-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:1368b964-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:1368b964-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlexanox is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:1368fafa-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.646']} DrugCentral uuid:1369237c-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.871']} DrugCentral uuid:13694ce4-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:136975e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:13699e60-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.583']} DrugCentral uuid:1369c6e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.358']} DrugCentral uuid:1369f022-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:136a189a-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:136a411c-d20a-11ec-8377-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:136a699e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:136a9112-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:136ab5ac-d20a-11ec-8377-0242ac110003 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:136ade38-d20a-11ec-8377-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:136b06a6-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.507']} DrugCentral uuid:136b2f8c-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:136b57e6-d20a-11ec-8377-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:136b8090-d20a-11ec-8377-0242ac110003 UniProtKB:Q8HY88 biolink:molecularly_interacts_with DrugCentral:183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amlodipine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:136ba9bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amodiaquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:136bd234-d20a-11ec-8377-0242ac110003 UniProtKB:P50135 biolink:molecularly_interacts_with DrugCentral:186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amodiaquine targets Enzyme (Histamine N-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:136bfbc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y251 biolink:molecularly_interacts_with DrugCentral:186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amodiaquine targets Enzyme (Heparanase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.28']} DrugCentral uuid:136c2450-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amodiaquine targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:136c4e1c-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.708']} DrugCentral uuid:136c787e-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:136ca0f6-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.307']} DrugCentral uuid:136cc964-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:136cee44-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.469']} DrugCentral uuid:136d16ee-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:136d40b0-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:136d6950-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.75']} DrugCentral uuid:136d929a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.182']} DrugCentral uuid:136dbb44-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:136de3da-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:136e0c66-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:136e37e0-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.593']} DrugCentral uuid:136e608a-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.734']} DrugCentral uuid:136e8916-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:136eb1a2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.542']} DrugCentral uuid:136eda60-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:136f02d8-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.423']} DrugCentral uuid:136f2bdc-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.616']} DrugCentral uuid:136f554e-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.211']} DrugCentral uuid:136f7dc6-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.336']} DrugCentral uuid:136fa63e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.365']} DrugCentral uuid:136fcec0-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:136ff8f0-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:137024ec-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.842']} DrugCentral uuid:13704d82-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:137075fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y345 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Transporter (Sodium- and chloride-dependent glycine transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.036']} DrugCentral uuid:13709ed6-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:1370c730-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.45']} DrugCentral uuid:1370ef94-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:13711820-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:13714160-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:137169d8-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:13719a0c-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:13719a0c-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:13719a0c-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxapine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1371f402-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:13721f40-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:137247ae-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1372704e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:1372abcc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1372abcc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1372abcc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1372abcc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1372abcc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1372abcc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1372abcc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amoxicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:13730ca2-d20a-11ec-8377-0242ac110003 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amperozide targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1373352e-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amperozide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:13735dba-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:13738204-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.753']} DrugCentral uuid:1373ad10-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:1373d48e-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:1373f8f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine is releasing agent of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.936']} DrugCentral uuid:13742178-d20a-11ec-8377-0242ac110003 UniProtKB:Q16568 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets Transcription factor (Cocaine- and amphetamine-regulated transcript protein) DrugCentral uuid:13744644-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:13746e94-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:13749720-d20a-11ec-8377-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1374bf84-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1374e8c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1375113c-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:13756cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13756cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13756cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13756cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13756cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13756cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13756cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13756cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13756cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13756cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13756cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13756cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13756cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13756cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13763260-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:13763260-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:13763260-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:13763260-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:13768580-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:13768580-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:13768580-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:1376c6e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amfetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:1376ef66-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:137713c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.09']} DrugCentral uuid:13773caa-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin targets Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:1377820a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1377820a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1377820a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1377820a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1377820a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1377820a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1377820a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1377e16e-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:137809f0-d20a-11ec-8377-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:13782e4e-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.172']} DrugCentral uuid:137856c6-d20a-11ec-8377-0242ac110003 UniProtKB:P07339 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir targets Enzyme (Cathepsin D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:13787fde-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:1378a93c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.44']} DrugCentral uuid:1378d1be-d20a-11ec-8377-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:1378fa36-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amprenavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:137924ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amrinone is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:13794e8c-d20a-11ec-8377-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amrinone targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:1379770e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amrinone is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:1379ab16-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:1379ab16-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:1379ab16-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:1379ab16-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:1379f67a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:137a1ee8-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:137a476a-d20a-11ec-8377-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:137a708c-d20a-11ec-8377-0242ac110003 UniProtKB:Q969P6 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Enzyme (DNA topoisomerase I, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:137a98d2-d20a-11ec-8377-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:137ac12c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:137aea9e-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:137b19ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:137b19ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amsacrine targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:137b4d5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anagrelide is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:137b75ea-d20a-11ec-8377-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anagrelide targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:137b9ee4-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anastrozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:137bc86a-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:213 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androisoxazole targets Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:137becbe-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenediol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:137c1522-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenediol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:137c3e08-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenediol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:137c664e-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenediol targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:137c8eb2-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenediol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.17']} DrugCentral uuid:137cb73e-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenediol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:137ce268-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenedione targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:137d0ae0-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenedione targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:137d33d0-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenedione targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:137d5e00-d20a-11ec-8377-0242ac110003 UniProtKB:P37058 biolink:molecularly_interacts_with DrugCentral:215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenedione targets Enzyme (Testosterone 17-beta-dehydrogenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:137d866e-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenedione targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:137daec8-d20a-11ec-8377-0242ac110003 UniProtKB:O54939 biolink:molecularly_interacts_with DrugCentral:215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstenedione targets Enzyme (Testosterone 17-beta-dehydrogenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:137dd736-d20a-11ec-8377-0242ac110003 UniProtKB:P05121 biolink:molecularly_interacts_with DrugCentral:217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anecortave targets Secreted (Plasminogen activator inhibitor 1) DrugCentral uuid:137dfc0c-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anhydrovinblastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:137e207e-d20a-11ec-8377-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anhydrovinblastine targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:137e44d2-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anhydrovinblastine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:137e6930-d20a-11ec-8377-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anhydrovinblastine targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:137e8d66-d20a-11ec-8377-0242ac110003 UniProtKB:P68371 biolink:molecularly_interacts_with DrugCentral:219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anhydrovinblastine targets Structural (Tubulin beta-4B chain) DrugCentral uuid:137eb2b4-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anileridine is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:137ed73a-d20a-11ec-8377-0242ac110003 UniProtKB:P38435 biolink:molecularly_interacts_with DrugCentral:222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anisindione is inhibitor of Enzyme (Vitamin K-dependent gamma-carboxylase) DrugCentral uuid:137efba2-d20a-11ec-8377-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anisindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:137f2424-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octatropine methylbromide is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:137f4968-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octatropine methylbromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:137f6dc6-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:224 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 antazoline is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:137f9224-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:224 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 antazoline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:137fba9c-d20a-11ec-8377-0242ac110003 UniProtKB:O75342 biolink:molecularly_interacts_with DrugCentral:226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dithranol targets Enzyme (Arachidonate 12-lipoxygenase, 12R-type) DrugCentral uuid:137fdf68-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BEG3 biolink:molecularly_interacts_with DrugCentral:226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dithranol targets Enzyme (5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:138007f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NXA8 biolink:molecularly_interacts_with DrugCentral:226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dithranol targets Enzyme (NAD-dependent protein deacylase sirtuin-5, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:138030b2-d20a-11ec-8377-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dithranol targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:13805948-d20a-11ec-8377-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dithranol targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:138083b4-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.34']} DrugCentral uuid:1380ac40-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:1380d4c2-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1380fd30-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:13812652-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:13814ede-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:13817882-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1381a26c-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1381caf8-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1381f38e-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:13821bfc-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1382460e-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:138271d8-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.91']} DrugCentral uuid:13829af0-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1382c368-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1382ec94-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.187']} DrugCentral uuid:1383150c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:13833d8e-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:138365fc-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:13838ed8-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:1383b746-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:1383dfe6-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:1384085e-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:13843432-d20a-11ec-8377-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:13845f8e-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:13848a0e-d20a-11ec-8377-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1384b326-d20a-11ec-8377-0242ac110003 UniProtKB:Q61616 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1384dba8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13850f88-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13850f88-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13850f88-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13850f88-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13858c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13858c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13858c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13858c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13858c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13858c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13858c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13858c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13858c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13858c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13858c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13858c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13858c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13858c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:13865636-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:13865636-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:13865636-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:13869984-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:13869984-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1386dcdc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1386dcdc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1386dcdc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1386dcdc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1386dcdc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:138739fc-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:138739fc-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:138739fc-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:13877a34-d20a-11ec-8377-0242ac110003 UniProtKB:P34949 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets Enzyme (Mannose-6-phosphate isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:1387a298-d20a-11ec-8377-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1387cbf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q00987 biolink:molecularly_interacts_with DrugCentral:228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apomorphine targets Nuclear other (E3 ubiquitin-protein ligase Mdm2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:1387f518-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apraclonidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:13881dae-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apraclonidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.938']} DrugCentral uuid:13884658-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apraclonidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13886f8e-d20a-11ec-8377-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apraclonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:13889fea-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apraclonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:13889fea-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apraclonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:13889fea-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apraclonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1388df00-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprepitant targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:138903cc-d20a-11ec-8377-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprepitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:13892c6c-d20a-11ec-8377-0242ac110003 UniProtKB:P29371 biolink:molecularly_interacts_with DrugCentral:230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprepitant targets GPCR (Neuromedin-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:13895584-d20a-11ec-8377-0242ac110003 UniProtKB:Q5DUB1 biolink:molecularly_interacts_with DrugCentral:230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprepitant targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:13897dde-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:1389a37c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:1389c7d0-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.757']} DrugCentral uuid:1389f048-d20a-11ec-8377-0242ac110003 UniProtKB:P25786 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine targets Enzyme (Proteasome subunit alpha type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:138a18c0-d20a-11ec-8377-0242ac110003 UniProtKB:P32418 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine targets Transporter (Sodium/calcium exchanger 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:138a41ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.359']} DrugCentral uuid:138a71f8-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine is inhibitor of Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['4.745']} DrugCentral uuid:138a71f8-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine is inhibitor of Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['4.745']} DrugCentral uuid:138a71f8-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprindine is inhibitor of Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['4.745']} DrugCentral uuid:138ab654-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:234 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aranidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:138ab654-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:234 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aranidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:138ae606-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arbutamine is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:138b0a78-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 argatroban is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:138b3318-d20a-11ec-8377-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 argatroban targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:138b5bae-d20a-11ec-8377-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 argatroban targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.06']} DrugCentral uuid:138b8502-d20a-11ec-8377-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 argatroban targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:138bad7a-d20a-11ec-8377-0242ac110003 UniProtKB:P00735 biolink:molecularly_interacts_with DrugCentral:239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 argatroban targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.02']} DrugCentral uuid:138bd5de-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.851']} DrugCentral uuid:138bfee2-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.788']} DrugCentral uuid:138c2778-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:138c5004-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole is partial agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.71']} DrugCentral uuid:138c7868-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.131']} DrugCentral uuid:138ca162-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:138cc9ee-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:138cf252-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:138d1ab6-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:138d44b4-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:138d6f98-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.444']} DrugCentral uuid:138d981a-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:138dc092-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.51']} DrugCentral uuid:138de9b4-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:138e1218-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:138e3a86-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.991']} DrugCentral uuid:138e62f4-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.53']} DrugCentral uuid:138e8bda-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.681']} DrugCentral uuid:138eb434-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:138edca2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.169']} DrugCentral uuid:138f05f6-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.455']} DrugCentral uuid:138f31c0-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:138f5d30-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.818']} DrugCentral uuid:138f883c-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.633']} DrugCentral uuid:138fb14a-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:138fd9c2-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1390023a-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.421']} DrugCentral uuid:13902ac6-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.492']} DrugCentral uuid:1390538e-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:13907d6e-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.202']} DrugCentral uuid:1390a5e6-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.463']} DrugCentral uuid:1390ce5e-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.906']} DrugCentral uuid:1390f942-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.097']} DrugCentral uuid:139124b2-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:13914d66-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:139176e2-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1391a054-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:1391c8e0-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1391f16c-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:13921a52-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:139242de-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:13926b4c-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:139293ce-d20a-11ec-8377-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1392bdc2-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1392e6a8-d20a-11ec-8377-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:1393104c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:139338c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:244 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arsenic trioxide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:13936218-d20a-11ec-8377-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:244 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arsenic trioxide is inhibitor of Enzyme (Thioredoxin reductase 1, cytoplasmic) DrugCentral uuid:1393866c-d20a-11ec-8377-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.312']} DrugCentral uuid:1393aeee-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.998']} DrugCentral uuid:1393d784-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:1394007e-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.698']} DrugCentral uuid:1394290a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.822']} DrugCentral uuid:13945196-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.741']} DrugCentral uuid:13947a2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.025']} DrugCentral uuid:1394a52e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.046']} DrugCentral uuid:1394d0c6-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.481']} DrugCentral uuid:1394f952-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:139521ca-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:13954b14-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.865']} DrugCentral uuid:13957396-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.359']} DrugCentral uuid:13959c4a-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.253']} DrugCentral uuid:1395c56c-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.126']} DrugCentral uuid:1395ee0c-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.027']} DrugCentral uuid:13961698-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.819']} DrugCentral uuid:13963f38-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.756']} DrugCentral uuid:13966a58-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:13969334-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.781']} DrugCentral uuid:1396bbc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1396e442-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:13970e5e-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:139737d0-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:139760e8-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:13978960-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.297']} DrugCentral uuid:1397b2aa-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.219']} DrugCentral uuid:1397db22-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.545']} DrugCentral uuid:139803ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.101']} DrugCentral uuid:13982c3a-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.784']} DrugCentral uuid:1398576e-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.671']} DrugCentral uuid:13988018-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:1398a89a-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:1398d1da-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.577']} DrugCentral uuid:1398fa52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:13991ea6-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:13994eda-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:13994eda-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:13994eda-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:13998e2c-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1399b6b8-d20a-11ec-8377-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1399df58-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.218']} DrugCentral uuid:139a0870-d20a-11ec-8377-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.065']} DrugCentral uuid:139a335e-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.701']} DrugCentral uuid:139a5bc2-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.546']} DrugCentral uuid:139a843a-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.883']} DrugCentral uuid:139aad16-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.002']} DrugCentral uuid:139ad598-d20a-11ec-8377-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:139afed8-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:139b275a-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:139b5086-d20a-11ec-8377-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.87']} DrugCentral uuid:139b7912-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.673']} DrugCentral uuid:139ba19e-d20a-11ec-8377-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.868']} DrugCentral uuid:139bca3e-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.733']} DrugCentral uuid:139bf450-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:139c1cd2-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:139c466c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:139c72e0-d20a-11ec-8377-0242ac110003 UniProtKB:P49355 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:139c72e0-d20a-11ec-8377-0242ac110003 UniProtKB:P49355 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:139ca6e8-d20a-11ec-8377-0242ac110003 UniProtKB:O75530 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Unclassified (Polycomb protein EED) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:139ccf60-d20a-11ec-8377-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:139cf7ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:139d20fa-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 astemizole is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['8.58']} DrugCentral uuid:139d4936-d20a-11ec-8377-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asulacrine targets Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:139d6d8a-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.629']} DrugCentral uuid:139d960c-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:139dbf9c-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.921']} DrugCentral uuid:139de7ec-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.921']} DrugCentral uuid:139e1082-d20a-11ec-8377-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.575']} DrugCentral uuid:139e390e-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:139e6212-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:139e8a94-d20a-11ec-8377-0242ac110003 UniProtKB:P22309 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Enzyme (UDP-glucuronosyltransferase 1-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.721']} DrugCentral uuid:139eb334-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:139edbc0-d20a-11ec-8377-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.27']} DrugCentral uuid:139f058c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:254 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atazanavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.12']} DrugCentral uuid:139f2e0e-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atenolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:139f56a4-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:139f7f26-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atenolol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:139fab04-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:139fd430-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.93']} DrugCentral uuid:139ffcc6-d20a-11ec-8377-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atenolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:13a02606-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:13a04e88-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:13a07714-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.69']} DrugCentral uuid:13a09fa0-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.97']} DrugCentral uuid:13a0c872-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:13a0f0f4-d20a-11ec-8377-0242ac110003 UniProtKB:P48051 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.282']} DrugCentral uuid:13a11958-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:13a141ee-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:13a16c28-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:13a1977a-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:13a1c402-d20a-11ec-8377-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.478']} DrugCentral uuid:13a1c402-d20a-11ec-8377-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.478']} DrugCentral uuid:13a1fc38-d20a-11ec-8377-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.845']} DrugCentral uuid:13a1fc38-d20a-11ec-8377-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.845']} DrugCentral uuid:13a2314e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13118 biolink:molecularly_interacts_with DrugCentral:256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atomoxetine targets Nuclear other (Krueppel-like factor 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:13a259b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:13a27e1a-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:13a2a700-d20a-11ec-8377-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:13a2d072-d20a-11ec-8377-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:13a2f8fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:13a32180-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:13a34c64-d20a-11ec-8377-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:13a374e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q1W675 biolink:molecularly_interacts_with DrugCentral:257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atorvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:13a39d36-d20a-11ec-8377-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atovaquone targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:13a3c59a-d20a-11ec-8377-0242ac110003 UniProtKB:P43264 biolink:molecularly_interacts_with DrugCentral:258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atovaquone targets Enzyme (Ubiquinol-cytochrome-c reductase complex core protein I, mitochondrial) DrugCentral uuid:13a3eb24-d20a-11ec-8377-0242ac110003 UniProtKB:Q02768 biolink:molecularly_interacts_with DrugCentral:258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atovaquone is inhibitor of Enzyme (Cytochrome b) DrugCentral uuid:13a40f6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q63707 biolink:molecularly_interacts_with DrugCentral:258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atovaquone targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:13a437e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q54A96 biolink:molecularly_interacts_with DrugCentral:258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atovaquone targets Enzyme (Dihydroorotate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:13a46054-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:13a4853e-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium is antagonist of Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:13a4adc0-d20a-11ec-8377-0242ac110003 UniProtKB:P70605 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:13a4de30-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:13a4de30-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:13a4de30-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:13a51eb8-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium is antagonist of Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:13a54758-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atracurium is antagonist of Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:13a56fbc-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:13a5983e-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:13a5c16a-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.276']} DrugCentral uuid:13a5e9d8-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.907']} DrugCentral uuid:13a61264-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:13a63adc-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.97']} DrugCentral uuid:13a663fe-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:13a68e06-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:13a6b688-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.29']} DrugCentral uuid:13a6e036-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:13a70b2e-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:13a733c4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:13a75c64-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.59']} DrugCentral uuid:13a785a4-d20a-11ec-8377-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:13a7ae1c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:13a7d7d4-d20a-11ec-8377-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:13a8007e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WMX0 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:13a8296e-d20a-11ec-8377-0242ac110003 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:13a851e6-d20a-11ec-8377-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:13a87a72-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.99']} DrugCentral uuid:13a8a2fe-d20a-11ec-8377-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:13a8dcf6-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:13a8dcf6-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:13a8dcf6-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:13a8dcf6-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:13a8dcf6-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:13a931b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atropine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.99']} DrugCentral uuid:13a962a2-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:13a962a2-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:13a962a2-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:13a9a9c4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:13a9a9c4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:13a9a9c4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:13a9ea24-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapropazone targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:13aa0e82-d20a-11ec-8377-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azapropazone targets Enzyme (Xanthine dehydrogenase/oxidase) DrugCentral uuid:13aa3326-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azasetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.268']} DrugCentral uuid:13aa5bbc-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azatadine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:13aa8010-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azatadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:13aaac7a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azathioprine targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:13aad0e2-d20a-11ec-8377-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azathioprine targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:13aaf536-d20a-11ec-8377-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azathioprine targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:13ab1994-d20a-11ec-8377-0242ac110003 UniProtKB:P63000 biolink:molecularly_interacts_with DrugCentral:269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azathioprine targets Enzyme (Ras-related C3 botulinum toxin substrate 1) DrugCentral uuid:13ab3e74-d20a-11ec-8377-0242ac110003 UniProtKB:P51580 biolink:molecularly_interacts_with DrugCentral:269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azathioprine targets Enzyme (Thiopurine S-methyltransferase) DrugCentral uuid:13ab62be-d20a-11ec-8377-0242ac110003 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelaic acid targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) DrugCentral uuid:13ab871c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:13abaf80-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:13abd442-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:13abfcc4-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:13ac2546-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:13ac4ddc-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.168']} DrugCentral uuid:13ac79c4-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:13aca296-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:13accb0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:13acf552-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:13ad21e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:13ad21e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azelnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:13ad5006-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azimilide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:13ad789c-d20a-11ec-8377-0242ac110003 UniProtKB:O08703 biolink:molecularly_interacts_with DrugCentral:274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azimilide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:13ada1be-d20a-11ec-8377-0242ac110003 UniProtKB:O70344 biolink:molecularly_interacts_with DrugCentral:274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azimilide targets Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:13adca22-d20a-11ec-8377-0242ac110003 UniProtKB:P97414 biolink:molecularly_interacts_with DrugCentral:274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azimilide is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:13adf36c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azithromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.39']} DrugCentral uuid:13ae1bda-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azithromycin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.7']} DrugCentral uuid:13ae46aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azithromycin targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:13ae7134-d20a-11ec-8377-0242ac110003 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azithromycin is agonist of GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:13aeacda-d20a-11ec-8377-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:13aeacda-d20a-11ec-8377-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:13aeacda-d20a-11ec-8377-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:13aeacda-d20a-11ec-8377-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:13aeacda-d20a-11ec-8377-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:13aeacda-d20a-11ec-8377-0242ac110003 UniProtKB:Q9X6W0 biolink:molecularly_interacts_with DrugCentral:277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azlocillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:13af0270-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.736']} DrugCentral uuid:13af2afc-d20a-11ec-8377-0242ac110003 UniProtKB:Q07806 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:13af5374-d20a-11ec-8377-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.317']} DrugCentral uuid:13af7c50-d20a-11ec-8377-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.317']} DrugCentral uuid:13afa4aa-d20a-11ec-8377-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:13afcd18-d20a-11ec-8377-0242ac110003 UniProtKB:A4ZYU9 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:13aff5fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q83TT7 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Unclassified (AmpC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:13b0209c-d20a-11ec-8377-0242ac110003 UniProtKB:Q3S5C3 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Transporter (Efflux transporter; SugE) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:13b0493c-d20a-11ec-8377-0242ac110003 UniProtKB:Q48435 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:13b0718c-d20a-11ec-8377-0242ac110003 UniProtKB:B2ZTR6 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:13b099e6-d20a-11ec-8377-0242ac110003 UniProtKB:D6NSM8 biolink:molecularly_interacts_with DrugCentral:279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aztreonam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:13b0da28-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:13b0da28-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:13b0da28-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:13b0da28-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:13b0da28-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:13b0da28-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:13b0da28-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacampicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:13b139c8-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacitracin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.269']} DrugCentral uuid:13b16222-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacitracin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.716']} DrugCentral uuid:13b18aae-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacitracin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.868']} DrugCentral uuid:13b1b466-d20a-11ec-8377-0242ac110003 UniProtKB:P60932 biolink:molecularly_interacts_with DrugCentral:281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bacitracin targets Unclassified (Undecaprenyl-diphosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:13b1e198-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z0U4 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets GPCR (GABA B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b1e198-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z0U4 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets GPCR (GABA B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2194c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen is agonist of GPCR (GABA-B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:13b2194c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen is agonist of GPCR (GABA-B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:13b24ce6-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b2afb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baclofen targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13b380d4-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 balsalazide is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:13b3a528-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 balsalazide is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:13b3cc06-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 balsalazide is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:13b3f064-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 balsalazide is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) DrugCentral uuid:13b4149a-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bambuterol targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:13b438e4-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bambuterol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:13b461e8-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bambuterol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.25']} DrugCentral uuid:13b48a60-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bambuterol is inhibitor of Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:13b4b2e2-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bambuterol targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:13b4db3c-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bamipine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:13b503dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 barnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:13b503dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 barnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:13b531fe-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.427']} DrugCentral uuid:13b55a58-d20a-11ec-8377-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:13b583ac-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:13b5ad46-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:13b5d67c-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:13b5feea-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:13b627d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:13b650ca-d20a-11ec-8377-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:13b67924-d20a-11ec-8377-0242ac110003 UniProtKB:Q86Y34 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate is agonist of GPCR (Probable G-protein coupled receptor 97) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:13b6a17e-d20a-11ec-8377-0242ac110003 UniProtKB:P04401 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Unclassified (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:13b6ca5a-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclometasone dipropionate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:13b6f2d2-d20a-11ec-8377-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:296 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belotecan is inhibitor of Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.561']} DrugCentral uuid:13b71b22-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benazepril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.51']} DrugCentral uuid:13b74372-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benazepril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:13b76d0c-d20a-11ec-8377-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benazepril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:13b79642-d20a-11ec-8377-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendamustine targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:13b7be7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendamustine targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:13b7e6e2-d20a-11ec-8377-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendamustine targets Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:13b80ff0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendamustine targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:13b83840-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendamustine targets Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:13b8609a-d20a-11ec-8377-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendamustine targets Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:13b888ea-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendroflumethiazide targets Enzyme (Carbonic anhydrase 2) DrugCentral uuid:13b8adb6-d20a-11ec-8377-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendroflumethiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['8.3']} DrugCentral uuid:13b8d5fc-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendroflumethiazide targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:13b8fa3c-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendroflumethiazide targets Enzyme (Carbonic anhydrase 4) DrugCentral uuid:13b91ea4-d20a-11ec-8377-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bendroflumethiazide targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:13b94500-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benoxaprofen is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:13b96940-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benoxaprofen targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:13b9919a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.57']} DrugCentral uuid:13b9ba08-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:13b9e320-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benperidol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:13ba0b7a-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:13ba33e8-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.18']} DrugCentral uuid:13ba5c56-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:13ba8532-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:13baadaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:13bad618-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.131']} DrugCentral uuid:13baffa8-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.105']} DrugCentral uuid:13bb2848-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.108']} DrugCentral uuid:13bb50b6-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.562']} DrugCentral uuid:13bb7a5a-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:13bba43a-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:13bbccbc-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:13bbf534-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.486']} DrugCentral uuid:13bc1d98-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:13bc4e6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:13bc4e6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:13bc4e6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:13bc8d0a-d20a-11ec-8377-0242ac110003 UniProtKB:P20711 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Enzyme (Aromatic-L-amino-acid decarboxylase) DrugCentral uuid:13bcb208-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:13bcdc10-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:13bd0bcc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:13bd0bcc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:13bd43bc-d20a-11ec-8377-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:13bd6c8e-d20a-11ec-8377-0242ac110003 UniProtKB:P03313 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Unclassified (Genome polyprotein [Cleaved into: P1; Capsid protein VP0) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:13bd9556-d20a-11ec-8377-0242ac110003 UniProtKB:P52789 biolink:molecularly_interacts_with DrugCentral:314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benserazide targets Kinase (Hexokinase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:13bdbdba-d20a-11ec-8377-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzarone targets Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:13bde60a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99504 biolink:molecularly_interacts_with DrugCentral:317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzarone targets Enzyme (Eyes absent homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:13be0ee6-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:13be3768-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:13be5ffe-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:13be886c-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:13beb242-d20a-11ec-8377-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:13bedaa6-d20a-11ec-8377-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:13bf02f6-d20a-11ec-8377-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.976']} DrugCentral uuid:13bf2b50-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.908']} DrugCentral uuid:13bf5526-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.711']} DrugCentral uuid:13bf7d6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:13bfa5e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:13bfce66-d20a-11ec-8377-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.32']} DrugCentral uuid:13bff738-d20a-11ec-8377-0242ac110003 UniProtKB:O00167 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (Eyes absent homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:13c01fba-d20a-11ec-8377-0242ac110003 UniProtKB:Q99504 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone targets Enzyme (Eyes absent homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:13c04832-d20a-11ec-8377-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzbromarone is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:13c070aa-d20a-11ec-8377-0242ac110003 UniProtKB:O15392 biolink:molecularly_interacts_with DrugCentral:321 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benziodarone targets Unclassified (Baculoviral IAP repeat-containing protein 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:13c09c24-d20a-11ec-8377-0242ac110003 UniProtKB:Q99504 biolink:molecularly_interacts_with DrugCentral:321 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benziodarone targets Enzyme (Eyes absent homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:13c0c488-d20a-11ec-8377-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:13c0e8e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:13c10d44-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:13c13350-d20a-11ec-8377-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:13c157ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:13c17c02-d20a-11ec-8377-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:13c1a0e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UI33 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 11 subunit alpha) DrugCentral uuid:13c1c590-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:13c1e9e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q01118 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 7 subunit alpha) DrugCentral uuid:13c20e2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['3.495']} DrugCentral uuid:13c2367e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzonatate targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:13c25c1c-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzphetamine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:13c28340-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzphetamine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:13c2a776-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzphetamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:13c2cbac-d20a-11ec-8377-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzphetamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:13c2f0be-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzquinamide is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:13c31918-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzquinamide is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:13c34190-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzquinamide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.445']} DrugCentral uuid:13c36a1c-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzquinamide targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.241']} DrugCentral uuid:13c39406-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzquinamide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.865']} DrugCentral uuid:13c3bc4c-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzquinamide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:13c3e4ba-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzquinamide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.264']} DrugCentral uuid:13c40d0a-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzthiazide targets Enzyme (Carbonic anhydrase 2) DrugCentral uuid:13c432da-d20a-11ec-8377-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzthiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['8.17']} DrugCentral uuid:13c45b0c-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzthiazide targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:13c47f42-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzthiazide targets Enzyme (Carbonic anhydrase 4) DrugCentral uuid:13c4a378-d20a-11ec-8377-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzthiazide targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:13c4c83a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:13c4f0a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:13c519e8-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:13c5424c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:13c56b14-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.157']} DrugCentral uuid:13c5938c-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:13c5bc18-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:13c5e468-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.888']} DrugCentral uuid:13c60f1a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:13c6377e-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.654']} DrugCentral uuid:13c65fec-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:13c68864-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.926']} DrugCentral uuid:13c6b186-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.636']} DrugCentral uuid:13c6db16-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.854']} DrugCentral uuid:13c703a2-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:13c72c10-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:13c75514-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:13c77d82-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:13c7a6e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.253']} DrugCentral uuid:13c7d0e8-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:13c7f960-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:13c821ba-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:13c84a1e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:13c872e6-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:13c89b5e-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:13c8c3c2-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:13c8ec58-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:13c91520-d20a-11ec-8377-0242ac110003 UniProtKB:Q695T7 biolink:molecularly_interacts_with DrugCentral:333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzatropine is inhibitor of Transporter (Sodium-dependent neutral amino acid transporter B(0)AT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:13c93d84-d20a-11ec-8377-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:335 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzyl benzoate targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:13c965ca-d20a-11ec-8377-0242ac110003 UniProtKB:P15304 biolink:molecularly_interacts_with DrugCentral:335 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzyl benzoate targets Enzyme (Hormone-sensitive lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:13c98e42-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepotastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:13c9b3ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:13c9d7ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:13ca0052-d20a-11ec-8377-0242ac110003 UniProtKB:O00555 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:13ca28ca-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.149']} DrugCentral uuid:13ca51f6-d20a-11ec-8377-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:13ca7a50-d20a-11ec-8377-0242ac110003 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:13caa28c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:13cacae6-d20a-11ec-8377-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:13cafb74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:13cafb74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:13cafb74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:13cb39fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z258 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil is gating inhibitor of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:13cb6366-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:13cb897c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bepridil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:13cbade4-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beraprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:13cbd65c-d20a-11ec-8377-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beraprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:13cbfec0-d20a-11ec-8377-0242ac110003 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beraprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:13cc27ec-d20a-11ec-8377-0242ac110003 UniProtKB:P43253 biolink:molecularly_interacts_with DrugCentral:343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beraprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:13cc5064-d20a-11ec-8377-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beraprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:13cc788c-d20a-11ec-8377-0242ac110003 UniProtKB:Q2Q167 biolink:molecularly_interacts_with DrugCentral:345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betacarotene targets Unclassified (Core protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:13cca1ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betahistine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:13cccabc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betahistine is inverse agonist of GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.523']} DrugCentral uuid:13ccf334-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:13cd1b66-d20a-11ec-8377-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone targets Cytosolic other (Annexin A1) DrugCentral uuid:13cd3fb0-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:13cd6666-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone benzoate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:13cd8c86-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone dipropionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:13cdb15c-d20a-11ec-8377-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone dipropionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:13cdd9d4-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone valerate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:13cdfeb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamipron targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:13ce2704-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamipron targets Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:13ce4f5e-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betaxolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:13ce7844-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betaxolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:13cea10c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betaxolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.98']} DrugCentral uuid:13cec95c-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betaxolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:13cef198-d20a-11ec-8377-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betaxolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.53']} DrugCentral uuid:13cf19f2-d20a-11ec-8377-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betaxolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.76']} DrugCentral uuid:13cf45b2-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:357 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betazole is agonist of GPCR (Histamine H2 receptor) DrugCentral uuid:13cf6a10-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:13cf936e-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:13cfbbb4-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:13cfe4ae-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bethanechol is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:13d00cf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bethanechol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.9']} DrugCentral uuid:13d03530-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VH27 biolink:molecularly_interacts_with DrugCentral:358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bethanechol targets GPCR (Muscarinic receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:13d05dda-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betanidine is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:13d0821a-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:360 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bevantolol is antagonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:13d0a646-d20a-11ec-8377-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:13d0cee6-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene is antagonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:13d0f7f4-d20a-11ec-8377-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:13d12076-d20a-11ec-8377-0242ac110003 UniProtKB:P28702 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:13d148da-d20a-11ec-8377-0242ac110003 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:13d17134-d20a-11ec-8377-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:13d19a6a-d20a-11ec-8377-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:13d1c2c4-d20a-11ec-8377-0242ac110003 UniProtKB:P28704 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Transcription factor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:13d1eb28-d20a-11ec-8377-0242ac110003 UniProtKB:P28705 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Transcription factor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:13d21396-d20a-11ec-8377-0242ac110003 UniProtKB:P28700 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Transcription factor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:13d23c2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q05343 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:13d2647c-d20a-11ec-8377-0242ac110003 UniProtKB:O43174 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Enzyme (Cytochrome P450 26A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:13d28e02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NR63 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Enzyme (Cytochrome P450 26B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:13d2b67a-d20a-11ec-8377-0242ac110003 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:13d2e0be-d20a-11ec-8377-0242ac110003 UniProtKB:Q13133 biolink:molecularly_interacts_with DrugCentral:361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bexarotene targets Nuclear other (Oxysterols receptor LXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:13d30904-d20a-11ec-8377-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezafibrate targets Enzyme (Lipoprotein lipase) DrugCentral uuid:13d32d62-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:13d355a8-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezafibrate targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.178']} DrugCentral uuid:13d37fba-d20a-11ec-8377-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezafibrate targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:13d3a800-d20a-11ec-8377-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezafibrate targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.48']} DrugCentral uuid:13d3d078-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezafibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:13d3f8f0-d20a-11ec-8377-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezafibrate is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) DrugCentral uuid:13d41db2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9X6V3 biolink:molecularly_interacts_with DrugCentral:365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biapenem targets Enzyme (Penicillin-binding protein 2) DrugCentral uuid:13d441ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biapenem targets Enzyme (Penicillin-binding protein 4) DrugCentral uuid:13d466aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9X6V7 biolink:molecularly_interacts_with DrugCentral:365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biapenem targets Enzyme (D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5) DrugCentral uuid:13d48ae0-d20a-11ec-8377-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biapenem targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:13d4b0e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q7CHG0 biolink:molecularly_interacts_with DrugCentral:365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biapenem targets Enzyme (D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6) DrugCentral uuid:13d4d810-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bicalutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:13d500a6-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bicalutamide targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:13d528e2-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bicalutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:13d551fa-d20a-11ec-8377-0242ac110003 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bicalutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:13d57a40-d20a-11ec-8377-0242ac110003 UniProtKB:P06186 biolink:molecularly_interacts_with DrugCentral:367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bicalutamide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:13d5a290-d20a-11ec-8377-0242ac110003 UniProtKB:Q63449 biolink:molecularly_interacts_with DrugCentral:367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bicalutamide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:13d5cb26-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y468 biolink:molecularly_interacts_with DrugCentral:369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bifemelane targets Unclassified (Lethal(3)malignant brain tumor-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:13d5f466-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bifonazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:13d61cb6-d20a-11ec-8377-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bifonazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:13d64524-d20a-11ec-8377-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bifonazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:13d66d60-d20a-11ec-8377-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bifonazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:13d698bc-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bimatoprost targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:13d6c10c-d20a-11ec-8377-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bimatoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:13d6e98e-d20a-11ec-8377-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biotin targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:13d71292-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.32']} DrugCentral uuid:13d73b8c-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:13d763f0-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:13d78d3a-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biperiden is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.62']} DrugCentral uuid:13d7b5f8-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biperiden targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.201']} DrugCentral uuid:13d7de5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biperiden targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:13d80292-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisacodyl targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.756']} DrugCentral uuid:13d82af6-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisacodyl targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.011']} DrugCentral uuid:13d855a8-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisacodyl targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:13d87df8-d20a-11ec-8377-0242ac110003 UniProtKB:P15559 biolink:molecularly_interacts_with DrugCentral:376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisantrene targets Enzyme (NAD(P)H dehydrogenase [quinone] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:13d8a666-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisoprolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:13d8cec0-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisoprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:13d8f7c4-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisoprolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:13d92032-d20a-11ec-8377-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:13d94882-d20a-11ec-8377-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:13d970fa-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bisulepine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:13d995a8-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bitolterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:13d9b9e8-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bivalirudin is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:13d9e242-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blonanserin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:13da0a92-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blonanserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:13da354e-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blonanserin is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.854']} DrugCentral uuid:13da5df8-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blonanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.092']} DrugCentral uuid:13da8670-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.815']} DrugCentral uuid:13daaede-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.345']} DrugCentral uuid:13dad828-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.014']} DrugCentral uuid:13db00a0-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.463']} DrugCentral uuid:13db2918-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.262']} DrugCentral uuid:13db515e-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:13db7a44-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:13dba3a2-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bopindolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.65']} DrugCentral uuid:13dbcc06-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:13dbf55a-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:13dc1dbe-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:13dc4622-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:13dc6e9a-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:13dc97bc-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:13dcc002-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:13dce866-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:13dd10c0-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:13dd396a-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.745']} DrugCentral uuid:13dd61c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q99460 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Cytosolic other (26S proteasome non-ATPase regulatory subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:13dd8a32-d20a-11ec-8377-0242ac110003 UniProtKB:P25786 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit alpha type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.208']} DrugCentral uuid:13ddb30e-d20a-11ec-8377-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:13dddd98-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:13de0930-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:13de3338-d20a-11ec-8377-0242ac110003 UniProtKB:P08311 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Cathepsin G) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:13de5cbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:13de85d6-d20a-11ec-8377-0242ac110003 UniProtKB:P23946 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Chymase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:13deae26-d20a-11ec-8377-0242ac110003 UniProtKB:P17538 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Chymotrypsinogen B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:13ded6a8-d20a-11ec-8377-0242ac110003 UniProtKB:P28062 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:13deff20-d20a-11ec-8377-0242ac110003 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:13df27c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:13df5042-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:13df78d8-d20a-11ec-8377-0242ac110003 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:13dfa25e-d20a-11ec-8377-0242ac110003 UniProtKB:P49721 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:13dfcbf8-d20a-11ec-8377-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib is inhibitor of Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:13dff470-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:13e01cd4-d20a-11ec-8377-0242ac110003 UniProtKB:A5PKW4 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Unclassified (PH and SEC7 domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:13e04d9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q04206 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Transcription factor (Nuclear factor NF-kappa-B complex) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:13e04d9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q04206 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Transcription factor (Nuclear factor NF-kappa-B complex) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:13e04d9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q04206 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Transcription factor (Nuclear factor NF-kappa-B complex) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:13e08c00-d20a-11ec-8377-0242ac110003 UniProtKB:P00766 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Alpha-chymotrypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:13e0b46e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IJT1 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:13e0ddc2-d20a-11ec-8377-0242ac110003 UniProtKB:P28063 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta type-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.78']} DrugCentral uuid:13e10630-d20a-11ec-8377-0242ac110003 UniProtKB:P28065 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta type-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:13e12e6c-d20a-11ec-8377-0242ac110003 UniProtKB:P40306 biolink:molecularly_interacts_with DrugCentral:391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bortezomib targets Enzyme (Proteasome subunit beta type-10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:13e156a8-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:13e17c1e-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:13e1a4a0-d20a-11ec-8377-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:13e1cd40-d20a-11ec-8377-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:13e1f59a-d20a-11ec-8377-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:13e21eb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q29010 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:13e246f8-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:13e26f0c-d20a-11ec-8377-0242ac110003 UniProtKB:P21451 biolink:molecularly_interacts_with DrugCentral:392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosentan targets GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:13e29734-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bretylium targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:13e2bbc4-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bretylium targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:13e2e022-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bretylium is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:13e30462-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.387']} DrugCentral uuid:13e32cb2-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.836']} DrugCentral uuid:13e356ec-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:13e37f5a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:13e3a930-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.469']} DrugCentral uuid:13e3d16c-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.073']} DrugCentral uuid:13e3fa5c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:13e423f6-d20a-11ec-8377-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:13e44c32-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:13e4748c-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:13e4a4fc-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13e4a4fc-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13e4a4fc-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13e4eb6a-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:13e4eb6a-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:13e4eb6a-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:13e52bd4-d20a-11ec-8377-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brimonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:13e5567c-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:13e57ee0-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:13e5a744-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:13e5d106-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:13e5f97e-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:13e621b0-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:13e64a14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13e672f0-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:13e69b4a-d20a-11ec-8377-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:13e6c3b8-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:13e6ec26-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:13e717f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:13e7405e-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:13e769d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:13e79306-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:13e7bb60-d20a-11ec-8377-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:13e7e3ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:13e80c46-d20a-11ec-8377-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:13e83536-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:13e85d86-d20a-11ec-8377-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:13e885ea-d20a-11ec-8377-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:13e8aee4-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:13e8d89c-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:13e90196-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:13e929fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:13e95272-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:13e97b4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:13e9a3b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:13e9cd56-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brinzolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:13e9f5b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:13ea1ec8-d20a-11ec-8377-0242ac110003 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brivudine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:13ea472c-d20a-11ec-8377-0242ac110003 UniProtKB:P06479 biolink:molecularly_interacts_with DrugCentral:397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13ea6f86-d20a-11ec-8377-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:13ea97d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:13eac396-d20a-11ec-8377-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:13eaebd2-d20a-11ec-8377-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:13eb140e-d20a-11ec-8377-0242ac110003 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:13eb3ce0-d20a-11ec-8377-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:13eb660c-d20a-11ec-8377-0242ac110003 UniProtKB:P00378 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.54']} DrugCentral uuid:13eb8e5c-d20a-11ec-8377-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:13ebb68e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8Z9J9 biolink:molecularly_interacts_with DrugCentral:398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodimoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:13ebe758-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:13ebe758-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:13ebe758-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:13ec1ee4-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromfenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:13ec4752-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromfenac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:13ec747a-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromfenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:13ec747a-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromfenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:13eca7ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromhexine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:13ecd028-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromhexine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.954']} DrugCentral uuid:13ecf878-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromhexine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.708']} DrugCentral uuid:13ed2136-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromhexine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:13ed4990-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.858']} DrugCentral uuid:13ed71e0-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:13ed9a30-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:13edc33e-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:13edeb98-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:13ee13de-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:13ee3c1a-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:13ee671c-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:13ee8f6c-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:13eeb7d0-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:13eee08e-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:13ef08d4-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:13ef321e-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:13ef5ba4-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:13ef84a8-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:13efad98-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:13efd5e8-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:13effe38-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:13f0285e-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:13f053f6-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:13f07f5c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.86']} DrugCentral uuid:13f0aaea-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.818']} DrugCentral uuid:13f0d420-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.708']} DrugCentral uuid:13f0fc98-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:13f124fc-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.16']} DrugCentral uuid:13f14d4c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:13f1766e-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:13f19eb4-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:13f1c6f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q7TSF2 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets Transporter (Vesicular glutamate transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:13f1f03a-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:13f223ca-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:13f223ca-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:13f223ca-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:13f271c2-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:13f271c2-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:13f271c2-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:13f271c2-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:13f271c2-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:13f2cc12-d20a-11ec-8377-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:13f2cc12-d20a-11ec-8377-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromocriptine targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:13f2fff2-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:404 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:13f32900-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:13f3515a-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromopride targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:13f37996-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:13f3a1f0-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:13f3cba8-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:13f3f3e4-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:13f41c2a-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:13f44484-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:13f46d56-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.119']} DrugCentral uuid:13f495c4-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.745']} DrugCentral uuid:13f4bf18-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.146']} DrugCentral uuid:13f4e754-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:13f51044-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.319']} DrugCentral uuid:13f5388a-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bromperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:13f560e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brompheniramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:13f5893e-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brompheniramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.218']} DrugCentral uuid:13f5ba58-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brompheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:13f5ba58-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brompheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:13f5ba58-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brompheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:13f5f900-d20a-11ec-8377-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:409 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brotizolam targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:13f62150-d20a-11ec-8377-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 broxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:13f64afe-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buclizine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:13f66f34-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:13f69374-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:13f6bbb0-d20a-11ec-8377-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:13f6e496-d20a-11ec-8377-0242ac110003 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Cytokine (Interferon gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.5']} DrugCentral uuid:13f70cf0-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:13f735b8-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:13f75df4-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.701']} DrugCentral uuid:13f787c0-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.963']} DrugCentral uuid:13f7b01a-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:13f7d874-d20a-11ec-8377-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:13f800c4-d20a-11ec-8377-0242ac110003 UniProtKB:P04401 biolink:molecularly_interacts_with DrugCentral:419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budesonide targets Unclassified (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:13f82964-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:13f86938-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:13f86938-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:13f86938-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:13f86938-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:13f86938-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:13f86938-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:13f86938-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 budipine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:13f8d44a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:13f8f89e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:13f92116-d20a-11ec-8377-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:13f94a92-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:13f96ec8-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:13f992f4-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets GPCR (Alpha-1D adrenergic receptor) DrugCentral uuid:13f9b860-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:13f9de3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:13fa0284-d20a-11ec-8377-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buflomedil targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:13fa2ad4-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufuralol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:13fa5338-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufuralol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:13fa7cf0-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufuralol targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:13faa14e-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufuralol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ks', 'has_quantitative_value': ['4.59']} DrugCentral uuid:13fac9b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bumetanide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:13faf1f8-d20a-11ec-8377-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bumetanide targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:13fb1ba6-d20a-11ec-8377-0242ac110003 UniProtKB:P55011 biolink:molecularly_interacts_with DrugCentral:427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bumetanide is inhibitor of Transporter (Solute carrier family 12 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:13fb4400-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bumetanide is agonist of GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:13fb6c3c-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bunazosin is antagonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:13fb9054-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bunazosin targets GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:13fbb55c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bunazosin is antagonist of GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:13fbd992-d20a-11ec-8377-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bunazosin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) DrugCentral uuid:13fbfe68-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.399']} DrugCentral uuid:13fc26d6-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.263']} DrugCentral uuid:13fc4fd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:13fc782a-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.585']} DrugCentral uuid:13fca07a-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:13fcc8f2-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.593']} DrugCentral uuid:13fcf28c-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:13fd1cbc-d20a-11ec-8377-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:13fd4520-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobunolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:13fd6d8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:13fd96b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:13fdbf82-d20a-11ec-8377-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.293']} DrugCentral uuid:13fde8ea-d20a-11ec-8377-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:13fe111c-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.514']} DrugCentral uuid:13fe39c6-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:13fe61f8-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.233']} DrugCentral uuid:13fe8a34-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:13feb284-d20a-11ec-8377-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:13fedd2c-d20a-11ec-8377-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:13ff0572-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z0V1 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine is blocker of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:13ff2dc2-d20a-11ec-8377-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:13ff5608-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupranolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:13ff7f2a-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupranolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:13ffa8c4-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupranolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:13ffd128-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.29']} DrugCentral uuid:13fffa0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1400225e-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.01']} DrugCentral uuid:14004ac2-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:14007308-d20a-11ec-8377-0242ac110003 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:14009cde-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.89']} DrugCentral uuid:1400c592-d20a-11ec-8377-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1400edf6-d20a-11ec-8377-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:14011646-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buprenorphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:14013f5e-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:140167ea-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:14019044-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.796']} DrugCentral uuid:1401b92a-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1401e2c4-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Enzyme (Cytochrome P450 2D6) DrugCentral uuid:140206fa-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:14023030-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:1402586c-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.846']} DrugCentral uuid:14028350-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:1402b17c-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1402b17c-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1402e8ae-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1402e8ae-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bupropion targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:14031cd4-d20a-11ec-8377-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buserelin targets GPCR (Lutropin-choriogonadotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.569']} DrugCentral uuid:14034538-d20a-11ec-8377-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buserelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.52']} DrugCentral uuid:14036d74-d20a-11ec-8377-0242ac110003 UniProtKB:Q01776 biolink:molecularly_interacts_with DrugCentral:436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buserelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:1403959c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1403be50-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:1403e6aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:14040f68-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:140437c2-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:140462c4-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:14048b00-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1404b346-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1404dc86-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.435']} DrugCentral uuid:14050508-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:14052d76-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:140555e4-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.277']} DrugCentral uuid:14057fce-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1405a922-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.471']} DrugCentral uuid:1405d17c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1405f9ea-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:14062488-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:14064f76-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:140677a8-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:14069fee-d20a-11ec-8377-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1406c91a-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1406f160-d20a-11ec-8377-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1407199c-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:140741d8-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:14076aa0-d20a-11ec-8377-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:140792e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1407bb54-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1407e39a-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:14080cc6-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:140840ba-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:140840ba-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:140840ba-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:140840ba-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:140892f4-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:140892f4-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:140892f4-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1408e114-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1408e114-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1408e114-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1408e114-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1408e114-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:14093f4c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:14093f4c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:14093f4c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:140985c4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:140985c4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:140985c4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buspirone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:1409c52a-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:438 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 busulfan targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.283']} DrugCentral uuid:1409f54a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secbutabarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1409f54a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secbutabarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1409f54a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secbutabarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:140a3618-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butalbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:140a3618-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butalbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:140a3618-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butalbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:140a6e4e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.864']} DrugCentral uuid:140a969e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.779']} DrugCentral uuid:140abf84-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.125']} DrugCentral uuid:140ae7fc-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.411']} DrugCentral uuid:140b10b0-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:140b3900-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.161']} DrugCentral uuid:140b6146-d20a-11ec-8377-0242ac110003 UniProtKB:Q4JEY0 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine is inhibitor of Enzyme (Squalene epoxidase) DrugCentral uuid:140b859a-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.805']} DrugCentral uuid:140bb16e-d20a-11ec-8377-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:140bdce8-d20a-11ec-8377-0242ac110003 UniProtKB:Q92206 biolink:molecularly_interacts_with DrugCentral:444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butenafine targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.347']} DrugCentral uuid:140c0650-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:450 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butoconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:140c2af4-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:454 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butorphanol is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:140c5380-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:454 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butorphanol is partial agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:140c7bee-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:454 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butorphanol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:140ca45c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:455 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butriptyline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.866']} DrugCentral uuid:140ccd06-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:455 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butriptyline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:140cf54c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:455 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.405']} DrugCentral uuid:140d1da6-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:140d41dc-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:140d6770-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:140d8db8-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine butylbromide targets GPCR (Muscarinic acetylcholine receptor M4) DrugCentral uuid:140db202-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:140dda70-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:140e0360-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:140e2ba6-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:140e540a-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:140e7c64-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:140ea540-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:140ecdae-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:140ef612-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:140f1e80-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:140f490a-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:140f71a0-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:140f9a0e-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:140fc3b2-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:140fecac-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:14101600-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:14103e5a-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabergoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:141066c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:461 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cadralazine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:14108b76-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:461 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cadralazine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1410b3e4-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:1410dc3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:14110498-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:14112f9a-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1411595c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:141181d4-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1411aa92-d20a-11ec-8377-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1411d2f6-d20a-11ec-8377-0242ac110003 UniProtKB:P00489 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets Enzyme (Glycogen phosphorylase, muscle form) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:1411fb5a-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:141223a0-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:14124c7c-d20a-11ec-8377-0242ac110003 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.54']} DrugCentral uuid:141274ea-d20a-11ec-8377-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:1412a140-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1412a140-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1412e07e-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:1412e07e-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:1412e07e-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:1412e07e-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:14132b4c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2T3 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets Enzyme (Guanine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:141353ba-d20a-11ec-8377-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:14137c46-d20a-11ec-8377-0242ac110003 UniProtKB:Q60614 biolink:molecularly_interacts_with DrugCentral:463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caffeine is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1413a52c-d20a-11ec-8377-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:464 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcifediol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:1413ca8e-d20a-11ec-8377-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:465 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcipotriene is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.51']} DrugCentral uuid:1413f2de-d20a-11ec-8377-0242ac110003 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) DrugCentral uuid:1414171e-d20a-11ec-8377-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:14143fc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q6VVX0 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Enzyme (Vitamin D 25-hydroxylase) DrugCentral uuid:141463ea-d20a-11ec-8377-0242ac110003 UniProtKB:P02774 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Secreted (Vitamin D-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:14148c62-d20a-11ec-8377-0242ac110003 UniProtKB:P13053 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:1414b4d0-d20a-11ec-8377-0242ac110003 UniProtKB:O42392 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.6']} DrugCentral uuid:1414de6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q28037 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:141506a6-d20a-11ec-8377-0242ac110003 UniProtKB:A3RGC1 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.15']} DrugCentral uuid:14153036-d20a-11ec-8377-0242ac110003 UniProtKB:Q9PTN2 biolink:molecularly_interacts_with DrugCentral:466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitriol targets Nuclear hormone receptor (Vitamin D3 receptor A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:141558fe-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camphor targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:14158176-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camphor is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:1415a9bc-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:1415d220-d20a-11ec-8377-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat is inhibitor of Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1415faca-d20a-11ec-8377-0242ac110003 UniProtKB:P06870 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Enzyme (Kallikrein-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:1416231a-d20a-11ec-8377-0242ac110003 UniProtKB:Q01177 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:14164b60-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:141673a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:14169d9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1416c5f4-d20a-11ec-8377-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1416ee4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q04756 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat targets Enzyme (Hepatocyte growth factor activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:14171716-d20a-11ec-8377-0242ac110003 UniProtKB:O15393 biolink:molecularly_interacts_with DrugCentral:471 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camostat is inhibitor of Enzyme (Transmembrane protease serine 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:14173fb6-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:472 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 camylofin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:14176824-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:14179088-d20a-11ec-8377-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1417b8f6-d20a-11ec-8377-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:1417e358-d20a-11ec-8377-0242ac110003 UniProtKB:P34976 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.19']} DrugCentral uuid:14180bf8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBT6 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Enzyme (DNULL polymerase kappa) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:14183466-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNA4 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Enzyme (DNULL polymerase iota) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:14185cc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y253 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Enzyme (DNULL polymerase eta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:1418865a-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1418aeaa-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1418d70e-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:1418fffe-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:14192876-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:14195102-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:14197970-d20a-11ec-8377-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.16']} DrugCentral uuid:1419a242-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1419ca88-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 candesartan cilexetil targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1419f300-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 canrenone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:141a1b46-d20a-11ec-8377-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capecitabine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:141a417a-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:141a6ab0-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:141a931e-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:141abb78-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:141ae454-d20a-11ec-8377-0242ac110003 UniProtKB:P00797 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:141b0dd0-d20a-11ec-8377-0242ac110003 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:141b362a-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:141b5e8e-d20a-11ec-8377-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:141b879c-d20a-11ec-8377-0242ac110003 UniProtKB:P44514 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Succinyl-diaminopimelate desuccinylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:141bb000-d20a-11ec-8377-0242ac110003 UniProtKB:Q79MP6 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:141bd936-d20a-11ec-8377-0242ac110003 UniProtKB:Q93T40 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Beta-lactamase II) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:141c0172-d20a-11ec-8377-0242ac110003 UniProtKB:Q9K2N0 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Unclassified (Beta-lactamase class B VIM-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:141c2dc8-d20a-11ec-8377-0242ac110003 UniProtKB:C7C422 biolink:molecularly_interacts_with DrugCentral:484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 captopril targets Enzyme (Beta-lactamase NDM-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.85']} DrugCentral uuid:141c5654-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caramiphen targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.81']} DrugCentral uuid:141c7eb8-d20a-11ec-8377-0242ac110003 UniProtKB:P42785 biolink:molecularly_interacts_with DrugCentral:486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caramiphen targets Enzyme (Lysosomal Pro-X carboxypeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:141ca780-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caramiphen targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:141ccfe4-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caramiphen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:141cf834-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caramiphen targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:141d2098-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carazolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.94']} DrugCentral uuid:141d496a-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carazolol is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:141d71c4-d20a-11ec-8377-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carazolol is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:141d9a3c-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carazolol is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:141dc2aa-d20a-11ec-8377-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carazolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:141decc6-d20a-11ec-8377-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carazolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:141e1520-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:141e3d34-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:141e657a-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:141e8de8-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.577']} DrugCentral uuid:141eb61a-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.097']} DrugCentral uuid:141ede56-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.18']} DrugCentral uuid:141f06b0-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:141f2f82-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:141f57f0-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:141f804a-d20a-11ec-8377-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:141fa8b8-d20a-11ec-8377-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:141fd536-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:141ffd9a-d20a-11ec-8377-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:142025ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.74']} DrugCentral uuid:14204e44-d20a-11ec-8377-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:14207ab8-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:14207ab8-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1420b2d0-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1420b2d0-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1420ebc4-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1420ebc4-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1421233c-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1421233c-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:14215ad2-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:14215ad2-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1421933a-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1421933a-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1421d6c4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1421d6c4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1421d6c4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1421d6c4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1421d6c4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:488 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbachol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:14222c50-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:1422507c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.495']} DrugCentral uuid:142278cc-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.125']} DrugCentral uuid:1422a14e-d20a-11ec-8377-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1422cb06-d20a-11ec-8377-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1422f34c-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:14231f48-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:14231f48-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:14231f48-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:14235ad0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:14235ad0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:14238f1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H461 biolink:molecularly_interacts_with DrugCentral:489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamazepine is allosteric modulator of GPCR (Frizzled-8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1423b778-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1423dfb4-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:142408a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:1424440e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1424440e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1424440e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1424440e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1424440e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1424440e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1424440e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1424a322-d20a-11ec-8377-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenoxolone is inhibitor of Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:1424cb5e-d20a-11ec-8377-0242ac110003 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:1424f3c2-d20a-11ec-8377-0242ac110003 UniProtKB:P51661 biolink:molecularly_interacts_with DrugCentral:493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbenoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:14251d52-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxyverine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.71']} DrugCentral uuid:142547e6-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxyverine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:142570ae-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxyverine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:14259926-d20a-11ec-8377-0242ac110003 UniProtKB:P42785 biolink:molecularly_interacts_with DrugCentral:494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxyverine targets Enzyme (Lysosomal Pro-X carboxypeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:1425c16c-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxyverine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:1425ea7a-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxyverine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:142613d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxyverine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:14263c28-d20a-11ec-8377-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbetocin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:1426645a-d20a-11ec-8377-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbetocin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.232']} DrugCentral uuid:14268d40-d20a-11ec-8377-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbetocin is agonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.149']} DrugCentral uuid:1426b5ae-d20a-11ec-8377-0242ac110003 UniProtKB:P20711 biolink:molecularly_interacts_with DrugCentral:496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbidopa is inhibitor of Enzyme (Aromatic-L-amino-acid decarboxylase) DrugCentral uuid:1426d9e4-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbidopa targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.168']} DrugCentral uuid:14270234-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbidopa targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.428']} DrugCentral uuid:14272b4c-d20a-11ec-8377-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbidopa targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:142753b0-d20a-11ec-8377-0242ac110003 UniProtKB:P22079 biolink:molecularly_interacts_with DrugCentral:497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbimazole targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:14277bf6-d20a-11ec-8377-0242ac110003 UniProtKB:P07202 biolink:molecularly_interacts_with DrugCentral:497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbimazole is inhibitor of Enzyme (Thyroid peroxidase) DrugCentral uuid:1427a040-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbinoxamine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:1427c5b6-d20a-11ec-8377-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:502 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carboprost is agonist of GPCR (Prostaglandin F2-alpha receptor) DrugCentral uuid:1427edf2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.602']} DrugCentral uuid:1427edf2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.602']} DrugCentral uuid:1428388e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1428388e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1428388e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1428388e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1428388e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1428388e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1428388e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carindacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14289720-d20a-11ec-8377-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:510 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carubicin targets Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:1428bb4c-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carmofur targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1428e4dc-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carmofur targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.213']} DrugCentral uuid:14290dae-d20a-11ec-8377-0242ac110003 UniProtKB:Q6P7S1 biolink:molecularly_interacts_with DrugCentral:511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carmofur targets Enzyme (Acid ceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:142935f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13510 biolink:molecularly_interacts_with DrugCentral:511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carmofur targets Enzyme (Acid ceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:14295e44-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6N5 biolink:molecularly_interacts_with DrugCentral:511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carmofur targets Unclassified (Sulfide:quinone oxidoreductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:14298748-d20a-11ec-8377-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:512 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carmustine is inhibitor of Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1429b0a6-d20a-11ec-8377-0242ac110003 UniProtKB:P50416 biolink:molecularly_interacts_with DrugCentral:513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocarnitine targets Enzyme (Carnitine O-palmitoyltransferase 1, liver isoform) DrugCentral uuid:1429d4e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q63704 biolink:molecularly_interacts_with DrugCentral:513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocarnitine targets Enzyme (Carnitine O-palmitoyltransferase 1, muscle isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:1429fd36-d20a-11ec-8377-0242ac110003 UniProtKB:P18886 biolink:molecularly_interacts_with DrugCentral:513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocarnitine targets Enzyme (Carnitine palmitoyltransferase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:142a2734-d20a-11ec-8377-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:515 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carperitide targets Enzyme (Atrial natriuretic peptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10']} DrugCentral uuid:142a4f7a-d20a-11ec-8377-0242ac110003 UniProtKB:P18910 biolink:molecularly_interacts_with DrugCentral:515 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carperitide targets Enzyme (Atrial natriuretic peptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:142a77a2-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:516 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfenazine is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:142a9bec-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:516 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfenazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:142ac112-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carpipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.06']} DrugCentral uuid:142ae976-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carpipramine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:142b11ee-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:518 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:142b3a34-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:518 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:142b62e8-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:518 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:142b8b38-d20a-11ec-8377-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:518 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carprofen targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:142bb37e-d20a-11ec-8377-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:518 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carprofen targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:142bdbd8-d20a-11ec-8377-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:518 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carprofen targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:142c04e6-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carteolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:142c2d4a-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carteolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:142c559a-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carumonam targets Enzyme (Peptidoglycan synthase FtsI) DrugCentral uuid:142c7a02-d20a-11ec-8377-0242ac110003 UniProtKB:Q92736 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol is inhibitor of Ion channel (Ryanodine receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:142ca590-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.742']} DrugCentral uuid:142ccf16-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:142cf798-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:142d1ff2-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.126']} DrugCentral uuid:142d489c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:142d718c-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:142d99e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:142dc3da-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.928']} DrugCentral uuid:142dec2a-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.273']} DrugCentral uuid:142e145c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.476']} DrugCentral uuid:142e3cb6-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.932']} DrugCentral uuid:142e66a0-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:142e8f04-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:142eb754-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.152']} DrugCentral uuid:142edfb8-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:142f088a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:142f30d0-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.708']} DrugCentral uuid:142f5920-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:142f8170-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:142faa74-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:142fd2f6-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.054']} DrugCentral uuid:142ffc0e-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1430258a-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1430512c-d20a-11ec-8377-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Ion channel (Potassium channel subfamily K member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:14307b84-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.706']} DrugCentral uuid:1430a3de-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1430ccba-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:1430f4f6-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:14311d5a-d20a-11ec-8377-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.09']} DrugCentral uuid:143145b4-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:14316ee0-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:14319730-d20a-11ec-8377-0242ac110003 UniProtKB:O00206 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Membrane receptor (Toll-like receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1431c066-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:522 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carvedilol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1431e898-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefacetrile targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:14320dbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:143231e0-d20a-11ec-8377-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:14327132-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14327132-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14327132-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14327132-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14327132-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14327132-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14327132-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaclor is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1432cfce-d20a-11ec-8377-0242ac110003 UniProtKB:P46059 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil targets Transporter (Solute carrier family 15 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.14']} DrugCentral uuid:14330f5c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14330f5c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14330f5c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14330f5c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14330f5c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14330f5c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14330f5c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefadroxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14336e66-d20a-11ec-8377-0242ac110003 UniProtKB:P46059 biolink:molecularly_interacts_with DrugCentral:527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole targets Transporter (Solute carrier family 15 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.09']} DrugCentral uuid:1433ae9e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1433ae9e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1433ae9e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1433ae9e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1433ae9e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1433ae9e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1433ae9e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefamandole nafate is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1434117c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:14344e62-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14344e62-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14344e62-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14344e62-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14344e62-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14344e62-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14344e62-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefazolin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1434ae48-d20a-11ec-8377-0242ac110003 UniProtKB:O54286 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir targets Enzyme (Pencillin binding protein 2a; Penicillin binding protein 2'; Penicillin binding protein, PBP2; Penicillin-binding protein 2; Penicillin-binding protein 2'; Peptidase) DrugCentral uuid:1434d274-d20a-11ec-8377-0242ac110003 UniProtKB:Q14TG6 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:1434f6a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:14353692-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14353692-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14353692-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14353692-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14353692-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14353692-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14353692-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143594b6-d20a-11ec-8377-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefdinir targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1435be6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14TG6 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:1435e29a-d20a-11ec-8377-0242ac110003 UniProtKB:Q54906 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil targets Enzyme (Penicillin-binding protein) DrugCentral uuid:14361de6-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14361de6-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14361de6-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14361de6-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14361de6-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14361de6-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14361de6-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefditoren pivoxil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1436938e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1436938e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1436938e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1436938e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1436938e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1436938e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1436938e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefepime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1436f2f2-d20a-11ec-8377-0242ac110003 UniProtKB:P42971 biolink:molecularly_interacts_with DrugCentral:536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefetamet pivoxil targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:14371714-d20a-11ec-8377-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefetamet pivoxil targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:14373b40-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:143764a8-d20a-11ec-8377-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1437a508-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1437a508-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1437a508-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1437a508-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1437a508-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1437a508-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1437a508-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1438035e-d20a-11ec-8377-0242ac110003 UniProtKB:P19174 biolink:molecularly_interacts_with DrugCentral:537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefixime targets Enzyme (1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:14384350-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14384350-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14384350-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14384350-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14384350-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14384350-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14384350-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmenoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1438a174-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:1438dd24-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1438dd24-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1438dd24-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1438dd24-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1438dd24-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1438dd24-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1438dd24-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14393b5c-d20a-11ec-8377-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:14396460-d20a-11ec-8377-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefmetazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:14398cc4-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:1439b500-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:1439da30-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:143a032a-d20a-11ec-8377-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:143a4272-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143a4272-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143a4272-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143a4272-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143a4272-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143a4272-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143a4272-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefonicid is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143aa118-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:143add90-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143add90-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143add90-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143add90-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143add90-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143add90-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143add90-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoperazone is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143b3d3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:143b791c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143b791c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143b791c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143b791c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143b791c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143b791c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143b791c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceforanide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143bd812-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotaxime is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:143c0076-d20a-11ec-8377-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotaxime is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.512']} DrugCentral uuid:143c28e4-d20a-11ec-8377-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotaxime is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.659']} DrugCentral uuid:143c512a-d20a-11ec-8377-0242ac110003 UniProtKB:B2ZTR6 biolink:molecularly_interacts_with DrugCentral:546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotaxime targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:143c79de-d20a-11ec-8377-0242ac110003 UniProtKB:D6NSM8 biolink:molecularly_interacts_with DrugCentral:546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotaxime targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:143ca242-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotaxime is inhibitor of Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.617']} DrugCentral uuid:143ccb6e-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:143cf3b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:143d1998-d20a-11ec-8377-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:143d41de-d20a-11ec-8377-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:143d6a2e-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:143d927e-d20a-11ec-8377-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:143dd2a2-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143dd2a2-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143dd2a2-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143dd2a2-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143dd2a2-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143dd2a2-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143dd2a2-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotetan is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143e30bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:143e5542-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:143e7d88-d20a-11ec-8377-0242ac110003 UniProtKB:P32241 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam targets GPCR (Vasoactive intestinal polypeptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:143ebcc6-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143ebcc6-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143ebcc6-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143ebcc6-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143ebcc6-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143ebcc6-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143ebcc6-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefotiam is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:143f23dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:143f4894-d20a-11ec-8377-0242ac110003 UniProtKB:P00808 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) DrugCentral uuid:143f6cc0-d20a-11ec-8377-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:143f95e2-d20a-11ec-8377-0242ac110003 UniProtKB:B2ZTR6 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:143fbe32-d20a-11ec-8377-0242ac110003 UniProtKB:D6NSM8 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:143fe682-d20a-11ec-8377-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:14402674-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14402674-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14402674-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14402674-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14402674-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14402674-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14402674-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefoxitin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14409d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14409d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14409d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14409d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14409d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14409d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14409d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefpiramide is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:144103fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefprozil targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:14412830-d20a-11ec-8377-0242ac110003 UniProtKB:P25098 biolink:molecularly_interacts_with DrugCentral:558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefsulodin targets Kinase (Beta-adrenergic receptor kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:14415116-d20a-11ec-8377-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefsulodin targets Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.522']} DrugCentral uuid:14417948-d20a-11ec-8377-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefsulodin targets Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.328']} DrugCentral uuid:1441a17a-d20a-11ec-8377-0242ac110003 UniProtKB:Q06124 biolink:molecularly_interacts_with DrugCentral:558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefsulodin targets Enzyme (Tyrosine-protein phosphatase non-receptor type 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1441c9b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y468 biolink:molecularly_interacts_with DrugCentral:558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefsulodin targets Unclassified (Lethal(3)malignant brain tumor-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:1441f260-d20a-11ec-8377-0242ac110003 UniProtKB:P29350 biolink:molecularly_interacts_with DrugCentral:558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefsulodin targets Enzyme (Protein-tyrosine phosphatase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:14421a9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q5A7N4 biolink:molecularly_interacts_with DrugCentral:558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefsulodin targets Unclassified (tRNA 2'-phosphotransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:14424332-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:559 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftazidime is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.261']} DrugCentral uuid:14426ba0-d20a-11ec-8377-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:559 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftazidime is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.534']} DrugCentral uuid:14429594-d20a-11ec-8377-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:559 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftazidime is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1442bdd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q1J5W5 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten targets Enzyme (Penicillin-binding protein) DrugCentral uuid:1442e31e-d20a-11ec-8377-0242ac110003 UniProtKB:Q60FU1 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:14431fdc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14431fdc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14431fdc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14431fdc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14431fdc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14431fdc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14431fdc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftibuten is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14437f90-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:1443a3b2-d20a-11ec-8377-0242ac110003 UniProtKB:P00808 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime targets Enzyme (Beta-lactamase) DrugCentral uuid:1443df80-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1443df80-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1443df80-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1443df80-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1443df80-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1443df80-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1443df80-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftizoxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14443e08-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftriaxone is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.142']} DrugCentral uuid:14446716-d20a-11ec-8377-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftriaxone is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.513']} DrugCentral uuid:14448f7a-d20a-11ec-8377-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftriaxone is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.744']} DrugCentral uuid:1444b7d4-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftriaxone is inhibitor of Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.213']} DrugCentral uuid:1444e006-d20a-11ec-8377-0242ac110003 UniProtKB:P14920 biolink:molecularly_interacts_with DrugCentral:564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftriaxone targets Enzyme (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:144508f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:14452d2c-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:14455586-d20a-11ec-8377-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:14457de0-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1445bddc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1445bddc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1445bddc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1445bddc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1445bddc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1445bddc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1445bddc-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:565 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14463578-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14463578-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14463578-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14463578-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14463578-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14463578-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14463578-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefuroxime axetil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:144697de-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1446c024-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1446e964-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.854']} DrugCentral uuid:144711dc-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.477']} DrugCentral uuid:14473a54-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:14476330-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:14478b9e-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.917']} DrugCentral uuid:1447b402-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1447dc66-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1448054c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.856']} DrugCentral uuid:14482da6-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:144855ec-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:14487e50-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:1448a74a-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1448cfa4-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1448f812-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1449208a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:1449495c-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:14497210-d20a-11ec-8377-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:14499ae2-d20a-11ec-8377-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.033']} DrugCentral uuid:1449c346-d20a-11ec-8377-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:1449eed4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:144a171a-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:144a3f92-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:144a67e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:144a9104-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:144ab936-d20a-11ec-8377-0242ac110003 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:144ae172-d20a-11ec-8377-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.32']} DrugCentral uuid:144b0a26-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.627']} DrugCentral uuid:144b3276-d20a-11ec-8377-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.29']} DrugCentral uuid:144b5ab2-d20a-11ec-8377-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:144b830c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8SPQ9 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Cyclooxygenase 2; Prostaglandin G/H synthase-2; Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:144bac74-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:144bd4a6-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:144bfcf6-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:144c2668-d20a-11ec-8377-0242ac110003 UniProtKB:P35355 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:144c4f4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:144c77a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8HZR1 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:144c9fee-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:144cc852-d20a-11ec-8377-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:144cf11a-d20a-11ec-8377-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:144d1992-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:144d4200-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:144d6a6e-d20a-11ec-8377-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:144d949e-d20a-11ec-8377-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:144dbcee-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:144de55c-d20a-11ec-8377-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:144e0ea6-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:144e37c8-d20a-11ec-8377-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:144e6022-d20a-11ec-8377-0242ac110003 UniProtKB:O78750 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:144e8912-d20a-11ec-8377-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:144eb180-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:144edaca-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:144f032e-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:144f2b88-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:144f54fa-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:144f7d54-d20a-11ec-8377-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:144fa586-d20a-11ec-8377-0242ac110003 UniProtKB:O78749 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Cytochrome c oxidase subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:144fcdb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:144ff6a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:14501f0c-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celecoxib targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:14504766-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celiprolol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:14506f98-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celiprolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:14509888-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 celiprolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1450c0ce-d20a-11ec-8377-0242ac110003 UniProtKB:P42971 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin targets Enzyme (Penicillin-binding protein 3) DrugCentral uuid:1450e4f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q16348 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin targets Transporter (Solute carrier family 15 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:1451253c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1451253c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1451253c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1451253c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1451253c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1451253c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1451253c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalexin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14519be8-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14519be8-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14519be8-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14519be8-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14519be8-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14519be8-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14519be8-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefaloglycin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1451fc1e-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1452245a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:14524886-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:14527130-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:145299a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSA0 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Transporter (Solute carrier family 22 member 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1452c20c-d20a-11ec-8377-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1452ea5c-d20a-11ec-8377-0242ac110003 UniProtKB:P35236 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin targets Enzyme (Tyrosine-protein phosphatase non-receptor type 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:14532e0e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14532e0e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14532e0e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14532e0e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14532e0e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14532e0e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14532e0e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefalotin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14538c1e-d20a-11ec-8377-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1453b4e6-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1453dd22-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:14540568-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:14542db8-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:14545662-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:14547e94-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1454a6d0-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:1454d01a-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1454f964-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:14551d7c-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:145545d6-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:14556ebc-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:145596f8-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1455bf20-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1455e752-d20a-11ec-8377-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:14560ffc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1456395a-d20a-11ec-8377-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:14566182-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:145689d2-d20a-11ec-8377-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1456b312-d20a-11ec-8377-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1456f30e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1456f30e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1456f30e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1456f30e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1456f30e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1456f30e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1456f30e-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefapirin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:145751b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:145775d6-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:14579e08-d20a-11ec-8377-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1457de40-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1457de40-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1457de40-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1457de40-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1457de40-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1457de40-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1457de40-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefradine is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:14583d54-d20a-11ec-8377-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cerivastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:14586194-d20a-11ec-8377-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cerivastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:14588bf6-d20a-11ec-8377-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cerivastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:1458b45a-d20a-11ec-8377-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:578 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cerulenin targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1458dc8c-d20a-11ec-8377-0242ac110003 UniProtKB:P00488 biolink:molecularly_interacts_with DrugCentral:578 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cerulenin targets Enzyme (Coagulation factor XIII A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:145904d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:578 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cerulenin targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:14592dae-d20a-11ec-8377-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceruletide is agonist of GPCR (Cholecystokinin receptor type A) DrugCentral uuid:14595248-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:581 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetirizine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:14597a98-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:581 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetirizine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:1459a2de-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:581 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetirizine targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1459cbce-d20a-11ec-8377-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetrorelix targets GPCR (Lutropin-choriogonadotropic hormone receptor) DrugCentral uuid:1459f004-d20a-11ec-8377-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetrorelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:145a1868-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cevimeline is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.638']} DrugCentral uuid:145a40a4-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cevimeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.983']} DrugCentral uuid:145a6b60-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cevimeline is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.319']} DrugCentral uuid:145a9388-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cevimeline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.883']} DrugCentral uuid:145abba6-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cevimeline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.201']} DrugCentral uuid:145ae504-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorambucil targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:145b0e62-d20a-11ec-8377-0242ac110003 UniProtKB:P07339 biolink:molecularly_interacts_with DrugCentral:588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorambucil targets Enzyme (Cathepsin D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.93']} DrugCentral uuid:145b36a8-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorambucil targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.026']} DrugCentral uuid:145b5ee4-d20a-11ec-8377-0242ac110003 UniProtKB:P14091 biolink:molecularly_interacts_with DrugCentral:588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorambucil targets Enzyme (Cathepsin E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.78']} DrugCentral uuid:145b87fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q13443 biolink:molecularly_interacts_with DrugCentral:588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorambucil targets Enzyme (Disintegrin and metalloproteinase domain-containing protein 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:145bb042-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:589 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloramphenicol targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:145bd892-d20a-11ec-8377-0242ac110003 UniProtKB:P62580 biolink:molecularly_interacts_with DrugCentral:589 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloramphenicol targets Enzyme (Chloramphenicol acetyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.89']} DrugCentral uuid:145c018c-d20a-11ec-8377-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:589 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloramphenicol targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:145c2b3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q88N29 biolink:molecularly_interacts_with DrugCentral:589 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloramphenicol targets Unclassified (Probable HTH-type transcriptional regulator TtgR) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.88']} DrugCentral uuid:145c54a2-d20a-11ec-8377-0242ac110003 UniProtKB:P10415 biolink:molecularly_interacts_with DrugCentral:593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorcyclizine targets Cytosolic other (Apoptosis regulator Bcl-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.22']} DrugCentral uuid:145c7d06-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.682']} DrugCentral uuid:145ca574-d20a-11ec-8377-0242ac110003 UniProtKB:P34981 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:145cce64-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:145cf6b4-d20a-11ec-8377-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:145d1f2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:145d4786-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:145d7076-d20a-11ec-8377-0242ac110003 UniProtKB:P21761 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:145da0aa-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:145da0aa-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:145da0aa-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:145de83a-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:145de83a-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:145de83a-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:145e3182-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:145e3182-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:145e3182-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:145e77d2-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:145e77d2-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:145e77d2-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:145ebec2-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:145ebec2-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:145ebec2-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:145f38d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:146022a8-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:146022a8-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:146022a8-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:146022a8-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:146022a8-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:146022a8-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1460870c-d20a-11ec-8377-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1460870c-d20a-11ec-8377-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1460be8e-d20a-11ec-8377-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1460be8e-d20a-11ec-8377-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlordiazepoxide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1460f304-d20a-11ec-8377-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:14611bea-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:14614430-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:14616c80-d20a-11ec-8377-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:146194ee-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1461bfb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1461e818-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:14621068-d20a-11ec-8377-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1462389a-d20a-11ec-8377-0242ac110003 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:14626130-d20a-11ec-8377-0242ac110003 UniProtKB:O15056 biolink:molecularly_interacts_with DrugCentral:597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorhexidine targets Enzyme (Synaptojanin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1462896c-d20a-11ec-8377-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlormadinone targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1462b194-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlormadinone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.764']} DrugCentral uuid:1462da8e-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlormadinone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:146302ca-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlormadinone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:14632b24-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlormadinone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.163']} DrugCentral uuid:14635b30-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomethiazole targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:14635b30-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomethiazole targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:14635b30-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomethiazole targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:14639794-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroprocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:1463bbf2-d20a-11ec-8377-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:606 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloropyramine targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1463e46a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:14640cec-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1464358c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:14645e72-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:146486d6-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1464b0e8-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1464d960-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:146501ce-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:14652a50-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:146553f4-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:14657c58-d20a-11ec-8377-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1465a4bc-d20a-11ec-8377-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1465cd02-d20a-11ec-8377-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1465f5b6-d20a-11ec-8377-0242ac110003 UniProtKB:P05227 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Cytosolic other (Histidine-rich protein PFHRP-II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:14661dfc-d20a-11ec-8377-0242ac110003 UniProtKB:P02752 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Unclassified (Riboflavin-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:14664656-d20a-11ec-8377-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:14666ea6-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:14669796-d20a-11ec-8377-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1466bffa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N6S8 biolink:molecularly_interacts_with DrugCentral:607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroquine targets Enzyme (Cysteine proteinase falcipain 2a) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1466e836-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorothiazide targets Enzyme (Carbonic anhydrase 2) DrugCentral uuid:14670c80-d20a-11ec-8377-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['5.43']} DrugCentral uuid:14673750-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorotrianisene targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:14675e24-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorotrianisene is modulator of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:1467826e-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroxine targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1467aad2-d20a-11ec-8377-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroxine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1467d3a4-d20a-11ec-8377-0242ac110003 UniProtKB:P18054 biolink:molecularly_interacts_with DrugCentral:611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroxine targets Enzyme (Arachidonate 12-lipoxygenase, 12S-type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1467fbfe-d20a-11ec-8377-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroxine targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:1468246c-d20a-11ec-8377-0242ac110003 UniProtKB:O15296 biolink:molecularly_interacts_with DrugCentral:611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroxine targets Enzyme (Arachidonate 15-lipoxygenase, type II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:14684ca8-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:14687598-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.818']} DrugCentral uuid:14689dde-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.167']} DrugCentral uuid:1468c76e-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1468efbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:146918ae-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.967']} DrugCentral uuid:14694234-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.06']} DrugCentral uuid:14696a8e-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:14699bee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:14699bee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:14699bee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1469da96-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y468 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Unclassified (Lethal(3)malignant brain tumor-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:146a02dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q96JM7 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Unclassified (Lethal(3)malignant brain tumor-like protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:146a2b90-d20a-11ec-8377-0242ac110003 UniProtKB:Q05BQ5 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Unclassified (MBT domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:146a53ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:146a7c3a-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.842']} DrugCentral uuid:146aa48a-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphenamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.975']} DrugCentral uuid:146ace9c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphentermine is substrate of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.471']} DrugCentral uuid:146af9c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorphentermine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.404']} DrugCentral uuid:146b2220-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:619 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorproethazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.979']} DrugCentral uuid:146b4a8e-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:619 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorproethazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.987']} DrugCentral uuid:146b7360-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:619 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorproethazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:146b9bc4-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.233']} DrugCentral uuid:146bc428-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:146beca0-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:146c15ae-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:146c3e26-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.724']} DrugCentral uuid:146c6694-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:146c8fde-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:146cb9d2-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:146ce22c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:146d0b76-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:146d33da-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:146d5cd4-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:146d8524-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:146dad7e-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:146dd68c-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:146dfedc-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.553']} DrugCentral uuid:146e272c-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:146e4f90-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:146e7948-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:146ea1de-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:146eca42-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.759']} DrugCentral uuid:146ef3d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:146f1cae-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:146f4512-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.746']} DrugCentral uuid:146f6d6c-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.251']} DrugCentral uuid:146f95e4-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:146fbede-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:146fe738-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:14700f7e-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.827']} DrugCentral uuid:147037d8-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.345']} DrugCentral uuid:14706320-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:14708d00-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:1470b550-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:1470ddc8-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:1471076c-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.708']} DrugCentral uuid:14712fda-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:14715820-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.092']} DrugCentral uuid:147180fc-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.353']} DrugCentral uuid:1471b130-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.91']} DrugCentral uuid:1471b130-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.91']} DrugCentral uuid:1471b130-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.91']} DrugCentral uuid:1471efa6-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.133']} DrugCentral uuid:147217f6-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.928']} DrugCentral uuid:14724104-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.463']} DrugCentral uuid:1472695e-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:147291ae-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1472bad0-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.061']} DrugCentral uuid:1472e320-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.713']} DrugCentral uuid:14730b52-d20a-11ec-8377-0242ac110003 UniProtKB:P21817 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Ryanodine receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.569']} DrugCentral uuid:147333a2-d20a-11ec-8377-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:14735c60-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1473849c-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.043']} DrugCentral uuid:1473ad14-d20a-11ec-8377-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1473d55a-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.797']} DrugCentral uuid:1473fe90-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.305']} DrugCentral uuid:147426fe-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:1474505c-d20a-11ec-8377-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.835']} DrugCentral uuid:147478ac-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.146']} DrugCentral uuid:1474a2d2-d20a-11ec-8377-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.673']} DrugCentral uuid:1474cb40-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.777']} DrugCentral uuid:1474f3ae-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:14751bf4-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:147544da-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:14756d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:14759584-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1475bdd4-d20a-11ec-8377-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1475e980-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:147611ee-d20a-11ec-8377-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:14763a3e-d20a-11ec-8377-0242ac110003 UniProtKB:O35433 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:14766360-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:14768c14-d20a-11ec-8377-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1476b45a-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.854']} DrugCentral uuid:1476dcb4-d20a-11ec-8377-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:14771cf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:14771cf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:14771cf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:14771cf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:14771cf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:14771cf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:14771cf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:14779f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:14779f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:14779f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:14779f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:14779f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:14779f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:14779f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:14781b2e-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:14781b2e-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:14781b2e-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:14781b2e-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:14781b2e-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:14787970-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:14787970-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1478bc50-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1478bc50-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1478bc50-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1478bc50-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1478bc50-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:14791a7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:14791a7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:14791a7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:147960ba-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:147960ba-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:147960ba-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:1479baf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:1479baf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:1479baf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:1479baf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:1479baf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:1479baf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:1479baf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:1479baf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:147a333c-d20a-11ec-8377-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:147a5b6e-d20a-11ec-8377-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:147a83b4-d20a-11ec-8377-0242ac110003 UniProtKB:P04925 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Unclassified (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:147aac72-d20a-11ec-8377-0242ac110003 UniProtKB:P17405 biolink:molecularly_interacts_with DrugCentral:621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpromazine targets Enzyme (Sphingomyelin phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:147ad4ae-d20a-11ec-8377-0242ac110003 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:622 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpropamide targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:147b010e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:622 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpropamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:147b010e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:622 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorpropamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:147b349e-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:147b5f14-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.53']} DrugCentral uuid:147b8764-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.367']} DrugCentral uuid:147bafb4-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:147bd840-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.34']} DrugCentral uuid:147c013a-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:147c2994-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:147c52b6-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:147c7b6a-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:147ca3ce-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:147ccc1e-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:147cf54a-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:147d204c-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.194']} DrugCentral uuid:147d49be-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:147d71fa-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:147d9a5e-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.97']} DrugCentral uuid:147dc3a8-d20a-11ec-8377-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorprothixene targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:147debe4-d20a-11ec-8377-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortetracycline targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:147e1416-d20a-11ec-8377-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortetracycline targets Surface antigen (Major prion protein) DrugCentral uuid:147e3842-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM07 biolink:molecularly_interacts_with DrugCentral:624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortetracycline targets Enzyme (Protein-arginine deiminase type-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:147e60d8-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.56']} DrugCentral uuid:147e8950-d20a-11ec-8377-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:147ead86-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:147ed5e0-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:147f00c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:147f2a72-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:147f5312-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:147f7b58-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:147fa416-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:147fcc84-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:147ff4f2-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:14801d60-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:14804646-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:625 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlortalidone targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:14806ebe-d20a-11ec-8377-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorzoxazone is activator of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1480970e-d20a-11ec-8377-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1480c06c-d20a-11ec-8377-0242ac110003 UniProtKB:P29475 biolink:molecularly_interacts_with DrugCentral:626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, brain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1480ec54-d20a-11ec-8377-0242ac110003 UniProtKB:P29474 biolink:molecularly_interacts_with DrugCentral:626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, endothelial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1481149a-d20a-11ec-8377-0242ac110003 UniProtKB:P29476 biolink:molecularly_interacts_with DrugCentral:626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorzoxazone targets Enzyme (Nitric oxide synthase, brain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.554']} DrugCentral uuid:14813cea-d20a-11ec-8377-0242ac110003 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorzoxazone is activator of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1481659e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorzoxazone is opener of Ion channel (Calcium-activated potassium channel subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.523']} DrugCentral uuid:14818dee-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:1481b620-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:1481de7a-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:14820738-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:14822f92-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:148257ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:14828050-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1482aa8a-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.31']} DrugCentral uuid:1482d2e4-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1482fc60-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:148324ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:14834d64-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:148375dc-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:14839eb8-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1483c726-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:1483efee-d20a-11ec-8377-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:14841816-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.39']} DrugCentral uuid:14844066-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:148469c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:1484921e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1484ba8c-d20a-11ec-8377-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1484e3e0-d20a-11ec-8377-0242ac110003 UniProtKB:O96394 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Arginase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:14850ca8-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:1485350c-d20a-11ec-8377-0242ac110003 UniProtKB:Q4QEW7 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Dihydroorotate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:14855d66-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:148585b6-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:1485ae6a-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:629 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cianidanol targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1485d69c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cibenzoline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1485feec-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cibenzoline targets Ion channel (ATP-sensitive inward rectifier potassium channel 11) DrugCentral uuid:1486230e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cibenzoline targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:14864cb2-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:148674e4-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:14869d3e-d20a-11ec-8377-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1486c57a-d20a-11ec-8377-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1486ee7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.873']} DrugCentral uuid:148716d8-d20a-11ec-8377-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.873']} DrugCentral uuid:14873f28-d20a-11ec-8377-0242ac110003 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:14876778-d20a-11ec-8377-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:14879036-d20a-11ec-8377-0242ac110003 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicaprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1487b886-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:1487f3be-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1487f3be-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1487f3be-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1487f3be-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1487f3be-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1487f3be-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1487f3be-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:148857f0-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclesonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:14888144-d20a-11ec-8377-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:636 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclopirox is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1488a9a8-d20a-11ec-8377-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:636 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclopirox is inhibitor of Unclassified (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1488d248-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:636 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclopirox targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1488fa84-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicloprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:148922ca-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cicloprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:14894bce-d20a-11ec-8377-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cidofovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:1489700e-d20a-11ec-8377-0242ac110003 UniProtKB:P16444 biolink:molecularly_interacts_with DrugCentral:640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilastatin is inhibitor of Enzyme (Dipeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.959']} DrugCentral uuid:1489985e-d20a-11ec-8377-0242ac110003 UniProtKB:P22412 biolink:molecularly_interacts_with DrugCentral:640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilastatin targets Enzyme (Dipeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1489c0f4-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilazapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1489ea48-d20a-11ec-8377-0242ac110003 UniProtKB:Q02294 biolink:molecularly_interacts_with DrugCentral:642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilnidipine is blocker of Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:148a1720-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:148a1720-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilnidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:148a4538-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilostazol is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:148a6d74-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilostazol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:148a966e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cilostazol is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:148abeaa-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:645 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cimetidine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:148ae6fa-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:645 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cimetidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:148b0f54-d20a-11ec-8377-0242ac110003 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:645 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cimetidine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.58']} DrugCentral uuid:148b3812-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:645 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cimetidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:148b6062-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:645 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cimetidine is inhibitor of Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:148b8934-d20a-11ec-8377-0242ac110003 UniProtKB:P25102 biolink:molecularly_interacts_with DrugCentral:645 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cimetidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:148bb21a-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:647 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinacalcet targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:148bdc22-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:647 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinacalcet targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:148c0486-d20a-11ec-8377-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:647 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinacalcet is positive allosteric modulator of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:148c2cc2-d20a-11ec-8377-0242ac110003 UniProtKB:P31424 biolink:molecularly_interacts_with DrugCentral:647 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinacalcet is allosteric modulator of GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:148c5530-d20a-11ec-8377-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinalukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:148c7f42-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinalukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) DrugCentral uuid:148ca382-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.035']} DrugCentral uuid:148ccbdc-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:148cf472-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.777']} DrugCentral uuid:148d1cfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:148d4562-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.237']} DrugCentral uuid:148d6dbc-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.552']} DrugCentral uuid:148d9756-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.208']} DrugCentral uuid:148dc000-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.987']} DrugCentral uuid:148de85a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.333']} DrugCentral uuid:148e11f4-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:148e3aee-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:148e6352-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.064']} DrugCentral uuid:148e8b98-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.849']} DrugCentral uuid:148eb3f2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:148edca6-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:148f0500-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.292']} DrugCentral uuid:148f2d46-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.264']} DrugCentral uuid:148f5618-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:148f7f30-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.885']} DrugCentral uuid:148fa762-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.242']} DrugCentral uuid:148fcf9e-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.299']} DrugCentral uuid:148ff802-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.793']} DrugCentral uuid:149020ca-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:14904906-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.97']} DrugCentral uuid:14907a52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:14907a52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:14907a52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinnarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1490b968-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinoxacin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:1490e582-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:1490e582-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:14911386-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:14913c8a-d20a-11ec-8377-0242ac110003 UniProtKB:P0AFI2 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.602']} DrugCentral uuid:149164c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q45066 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.658']} DrugCentral uuid:14918d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin is inhibitor of Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1491b566-d20a-11ec-8377-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1491de74-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin is inhibitor of Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:149206a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:149268c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:14934458-d20a-11ec-8377-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:14934458-d20a-11ec-8377-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Enzyme (DNA topoisomerase II) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:14937c0c-d20a-11ec-8377-0242ac110003 UniProtKB:P37340 biolink:molecularly_interacts_with DrugCentral:659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciprofloxacin targets Unclassified (Multidrug resistance protein mdtK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1493a650-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:1493cf54-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1493f790-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:14941fea-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:149448c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.379']} DrugCentral uuid:14947116-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.19']} DrugCentral uuid:14949966-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:1494c1ac-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:1494eb82-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:14951422-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:14953c86-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:149564e0-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.396']} DrugCentral uuid:14958da8-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1495b5e4-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.281']} DrugCentral uuid:1495de48-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:14960724-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.947']} DrugCentral uuid:14962fd8-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.155']} DrugCentral uuid:1496581e-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:14968172-d20a-11ec-8377-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.472']} DrugCentral uuid:1496a9d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1496d406-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.063']} DrugCentral uuid:1496fc60-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:149724b0-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:14974d00-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:14977618-d20a-11ec-8377-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:14979e72-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1497c6d6-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1497ef26-d20a-11ec-8377-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1498191a-d20a-11ec-8377-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:14984570-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:14984570-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:149888be-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:149888be-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:149888be-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:149888be-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:149888be-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1498ebec-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1498ebec-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1498ebec-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1498ebec-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:14993de0-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:14993de0-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:14993de0-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:14998516-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:14998516-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:14998516-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:1499c3b4-d20a-11ec-8377-0242ac110003 UniProtKB:P97288 biolink:molecularly_interacts_with DrugCentral:660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:1499f442-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:661 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisatracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1499f442-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:661 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisatracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1499f442-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:661 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisatracurium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:149a32b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.777']} DrugCentral uuid:149a5afe-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:149a8696-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.935']} DrugCentral uuid:149ab1ca-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:149adac4-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.191']} DrugCentral uuid:149b03c8-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.931']} DrugCentral uuid:149b2c18-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:149b545e-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.456']} DrugCentral uuid:149b7c90-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.875']} DrugCentral uuid:149ba544-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:149bcd8a-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.148']} DrugCentral uuid:149bf5ee-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:149c1e2a-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:149c486e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:149c70d2-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:149c99e0-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:149cc370-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:149cec88-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:149d15dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:149d3e36-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citalopram targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:149d669a-d20a-11ec-8377-0242ac110003 UniProtKB:Q48255 biolink:molecularly_interacts_with DrugCentral:666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citric acid targets Enzyme (3-dehydroquinate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:149d8f6c-d20a-11ec-8377-0242ac110003 UniProtKB:P15474 biolink:molecularly_interacts_with DrugCentral:666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citric acid targets Enzyme (3-dehydroquinate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:149db7e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9EPK8 biolink:molecularly_interacts_with DrugCentral:666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 citric acid is activator of Ion channel (Transient receptor potential cation channel subfamily V member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:149de00c-d20a-11ec-8377-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cladribine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:149e0456-d20a-11ec-8377-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cladribine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.441']} DrugCentral uuid:149e2fda-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cladribine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:149e583e-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cladribine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.69']} DrugCentral uuid:149e80a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:668 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clarithromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:149ea9b0-d20a-11ec-8377-0242ac110003 UniProtKB:P00807 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'MPC', 'has_quantitative_value': ['8.719']} DrugCentral uuid:149ed228-d20a-11ec-8377-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid is inhibitor of Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.187']} DrugCentral uuid:149efa78-d20a-11ec-8377-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:149f22c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q59401 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:149f4b72-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD63 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:149f73a4-d20a-11ec-8377-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:149f9c08-d20a-11ec-8377-0242ac110003 UniProtKB:P13661 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase OXA-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:149fc458-d20a-11ec-8377-0242ac110003 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:149fedb6-d20a-11ec-8377-0242ac110003 UniProtKB:A4KCT8 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:14a0161a-d20a-11ec-8377-0242ac110003 UniProtKB:A1E3K9 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:14a03e6a-d20a-11ec-8377-0242ac110003 UniProtKB:A8RR46 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:14a066a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q6JP75 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Carbapenem-hydrolizing beta-lactamase SFC-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:14a08f6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9F663 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Carbepenem-hydrolyzing beta-lactamase KPC) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:14a0b7d2-d20a-11ec-8377-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:14a0e00e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9EXV5 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:14a1085e-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD64 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:14a13216-d20a-11ec-8377-0242ac110003 UniProtKB:Q6GWS8 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:14a15a48-d20a-11ec-8377-0242ac110003 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:14a18270-d20a-11ec-8377-0242ac110003 UniProtKB:A0ZX81 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:14a1aaac-d20a-11ec-8377-0242ac110003 UniProtKB:Q4TVR4 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:14a1d5ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q50H31 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Unclassified (Class D beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:14a1fde0-d20a-11ec-8377-0242ac110003 UniProtKB:Q2XPY6 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:14a22612-d20a-11ec-8377-0242ac110003 UniProtKB:P0A3M1 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase SHV-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:14a24e62-d20a-11ec-8377-0242ac110003 UniProtKB:D2SSQ3 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:14a2773e-d20a-11ec-8377-0242ac110003 UniProtKB:Q3SAW3 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:14a2a13c-d20a-11ec-8377-0242ac110003 UniProtKB:Q670S6 biolink:molecularly_interacts_with DrugCentral:669 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clavulanic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:14a2c978-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:14a2f24a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:14a31aa4-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:14a342ea-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:14a36b76-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:14a3948e-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:14a3bce8-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.95']} DrugCentral uuid:14a3e524-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:14a40da6-d20a-11ec-8377-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:14a43e8e-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:14a43e8e-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:14a43e8e-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:14a48506-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:14a48506-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:14a48506-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clebopride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:14a4c43a-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.115']} DrugCentral uuid:14a4ed98-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:14a515fc-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.161']} DrugCentral uuid:14a53e6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:14a56804-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:14a5909a-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.514']} DrugCentral uuid:14a5b8fe-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.036']} DrugCentral uuid:14a5e158-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:14a60a52-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:14a632b6-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:14a65b06-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.848']} DrugCentral uuid:14a68360-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.604']} DrugCentral uuid:14a6ac32-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:14a6d4aa-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:14a6fd04-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:14a72554-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.703']} DrugCentral uuid:14a74fac-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.084']} DrugCentral uuid:14a77806-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.558']} DrugCentral uuid:14a7a060-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:14a7c8ce-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:14a7f1dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.269']} DrugCentral uuid:14a81a22-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:14a843a8-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:14a86c8e-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:14a89574-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:14a8bdba-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:14a8e704-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.658']} DrugCentral uuid:14a910b2-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:14a9390c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:14a96152-d20a-11ec-8377-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemastine targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:14a98998-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemizole targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.396']} DrugCentral uuid:14a9b288-d20a-11ec-8377-0242ac110003 UniProtKB:P23711 biolink:molecularly_interacts_with DrugCentral:672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemizole targets Enzyme (Heme oxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:14a9daba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBN4 biolink:molecularly_interacts_with DrugCentral:672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:14aa0314-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:14aa2c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q13507 biolink:molecularly_interacts_with DrugCentral:672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:14aa54f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y210 biolink:molecularly_interacts_with DrugCentral:672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clemizole is blocker of Ion channel (Short transient receptor potential channel 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:14aa7d4e-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clenbuterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.161']} DrugCentral uuid:14aaa5a8-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clenbuterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:14aace02-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clenbuterol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:14aaf922-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clenbuterol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:14ab23d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clenbuterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:14ab4c38-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:674 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clevidipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:14ab708c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:674 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clevidipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:14ab958a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:14abb9d4-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:14abe238-d20a-11ec-8377-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:678 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clindamycin targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:14ac0682-d20a-11ec-8377-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:681 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clioquinol targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:14ac2f5e-d20a-11ec-8377-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:681 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clioquinol targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:14ac57cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:681 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clioquinol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:14ac803a-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:681 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clioquinol targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:14acb0e6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobazam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:14acb0e6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobazam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:14acb0e6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobazam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:14aced72-d20a-11ec-8377-0242ac110003 UniProtKB:P05141 biolink:molecularly_interacts_with DrugCentral:690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clodronic acid targets Enzyme (ADP/ATP translocase 2) DrugCentral uuid:14ad11a8-d20a-11ec-8377-0242ac110003 UniProtKB:P12235 biolink:molecularly_interacts_with DrugCentral:690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clodronic acid targets Transporter (ADP/ATP translocase 1) DrugCentral uuid:14ad35de-d20a-11ec-8377-0242ac110003 UniProtKB:P12236 biolink:molecularly_interacts_with DrugCentral:690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clodronic acid targets Enzyme (ADP/ATP translocase 3) DrugCentral uuid:14ad5a8c-d20a-11ec-8377-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clodronic acid targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) DrugCentral uuid:14ad7ed6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BYT1 biolink:molecularly_interacts_with DrugCentral:690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clodronic acid is inhibitor of Transporter (Solute carrier family 17 member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:14ada71c-d20a-11ec-8377-0242ac110003 UniProtKB:B1LRJ1 biolink:molecularly_interacts_with DrugCentral:690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clodronic acid targets Unclassified (Type IV secretion-like conjugative transfer relaxase protein TraI) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:14adcf9e-d20a-11ec-8377-0242ac110003 UniProtKB:P09884 biolink:molecularly_interacts_with DrugCentral:691 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofarabine is inhibitor of Enzyme (DNA polymerase alpha catalytic subunit) DrugCentral uuid:14adf5aa-d20a-11ec-8377-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:691 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofarabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14ae1e22-d20a-11ec-8377-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:691 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofarabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14ae4640-d20a-11ec-8377-0242ac110003 UniProtKB:P60891 biolink:molecularly_interacts_with DrugCentral:691 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofarabine targets Kinase (Ribose-phosphate pyrophosphokinase 1) DrugCentral uuid:14ae6a76-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HA47 biolink:molecularly_interacts_with DrugCentral:691 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofarabine targets Kinase (Uridine-cytidine kinase 1) DrugCentral uuid:14ae9064-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BZX2 biolink:molecularly_interacts_with DrugCentral:691 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofarabine targets Kinase (Uridine-cytidine kinase 2) DrugCentral uuid:14aeb706-d20a-11ec-8377-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:691 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofarabine targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:14aedf4c-d20a-11ec-8377-0242ac110003 UniProtKB:Q5L2G3 biolink:molecularly_interacts_with DrugCentral:692 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofazimine targets Enzyme (Uncharacterized oxidoreductase CzcO-like) DrugCentral uuid:14af0396-d20a-11ec-8377-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:692 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofazimine targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:14af2c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:694 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:14af549a-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:694 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:14af7cd6-d20a-11ec-8377-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofibric acid targets Enzyme (Lipoprotein lipase) DrugCentral uuid:14afa134-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofibric acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:14afca24-d20a-11ec-8377-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofibric acid targets Transcription factor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:14aff274-d20a-11ec-8377-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:698 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clometacin targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:14b01ace-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.461']} DrugCentral uuid:14b04346-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.455']} DrugCentral uuid:14b06c9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:14b094fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.745']} DrugCentral uuid:14b0bd58-d20a-11ec-8377-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:14b0e6d4-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:14b10fa6-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:14b13800-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.025']} DrugCentral uuid:14b16064-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.062']} DrugCentral uuid:14b188c8-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:14b1b1ea-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:14b1da3a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.142']} DrugCentral uuid:14b2029e-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:14b22ae4-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.187']} DrugCentral uuid:14b25690-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.407']} DrugCentral uuid:14b281ba-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.889']} DrugCentral uuid:14b2aa32-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.358']} DrugCentral uuid:14b2d304-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.638']} DrugCentral uuid:14b2fb68-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.896']} DrugCentral uuid:14b323c2-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.371']} DrugCentral uuid:14b34c1c-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.668']} DrugCentral uuid:14b374d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.206']} DrugCentral uuid:14b39d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:14b3c674-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.519']} DrugCentral uuid:14b3ef00-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:14b41a3e-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.979']} DrugCentral uuid:14b445e0-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:14b46e6c-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.778']} DrugCentral uuid:14b496bc-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.822']} DrugCentral uuid:14b4bfca-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:14b4e914-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.597']} DrugCentral uuid:14b51182-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:14b539e6-d20a-11ec-8377-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomifene targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:14b5629a-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:14b58aea-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:14b5b330-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:14b5dc98-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.243']} DrugCentral uuid:14b6052e-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.703']} DrugCentral uuid:14b62d88-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:14b655c4-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:14b67ebe-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.818']} DrugCentral uuid:14b6a70e-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:14b6cf72-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:14b6f7b8-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.495']} DrugCentral uuid:14b72062-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.337']} DrugCentral uuid:14b748b2-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.412']} DrugCentral uuid:14b77102-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.007']} DrugCentral uuid:14b79966-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.696']} DrugCentral uuid:14b7c3fa-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:14b7ee98-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:14b816e8-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:14b83f42-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:14b86864-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:14b89096-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.319']} DrugCentral uuid:14b8b8d2-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:14b8e230-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:14b90ae4-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:14b93352-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:14b95c6a-d20a-11ec-8377-0242ac110003 UniProtKB:P09211 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Enzyme (Glutathione S-transferase P) DrugCentral uuid:14b980a0-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:14b9a9c2-d20a-11ec-8377-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:14b9d352-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.137']} DrugCentral uuid:14b9fbc0-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.937']} DrugCentral uuid:14ba2578-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.4']} DrugCentral uuid:14ba4daa-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:14ba7618-d20a-11ec-8377-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:14ba9e5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:14bac6fe-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:14bb2130-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14bb2130-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14bb2130-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14bb2130-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14bb2130-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14bb2130-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14bb2130-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14bb2130-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14bb2130-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14bb2130-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14bb2130-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14bb2130-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14bb2130-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14bb2130-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14bbe8c2-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:14bbe8c2-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:14bbe8c2-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:14bbe8c2-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:14bc3af2-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:14bc3af2-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:14bc3af2-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:14bc8142-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:14bc8142-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:14bc8142-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:14bcc0d0-d20a-11ec-8377-0242ac110003 UniProtKB:P39051 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:14bce920-d20a-11ec-8377-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clomipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:14bd194a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.071']} DrugCentral uuid:14bd194a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.071']} DrugCentral uuid:14bd194a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.071']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14bd96a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:14be7c22-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14be7c22-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14be7c22-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14be7c22-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14be7c22-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14be7c22-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bf166e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:14bfe71a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:14c010aa-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:14c03940-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:14c061cc-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:14c08a30-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:14c0b26c-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:14c0dc4c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:14c1076c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:14c132aa-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:14c15b04-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:14c183b8-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:14c1ac30-d20a-11ec-8377-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:14c1d480-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:14c1fcd0-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:14c22584-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.41']} DrugCentral uuid:14c24e88-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:14c276ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:14c29f0a-d20a-11ec-8377-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:14c2cae8-d20a-11ec-8377-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:14c2f338-d20a-11ec-8377-0242ac110003 UniProtKB:O88704 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:14c31b6a-d20a-11ec-8377-0242ac110003 UniProtKB:O88703 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:14c344d2-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.796']} DrugCentral uuid:14c36d68-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:14c39d88-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:14c39d88-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:14c39d88-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:14c3dc30-d20a-11ec-8377-0242ac110003 UniProtKB:O70507 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:14c404da-d20a-11ec-8377-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:14c42dde-d20a-11ec-8377-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clonixin targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:14c45688-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloperastine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:14c47faa-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clopidogrel targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.524']} DrugCentral uuid:14c4a822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clopidogrel is antagonist of GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:14c4d068-d20a-11ec-8377-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clopidogrel targets Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:14c500a6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:14c500a6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:14c500a6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:14c54782-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:14c54782-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:14c54782-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:14c587f6-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:14c587f6-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:14c587f6-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:14c5c8ba-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:14c5c8ba-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:14c5c8ba-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorazepate is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:14c60096-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.825']} DrugCentral uuid:14c628e6-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:14c6523a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:14c67e90-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:14c6a938-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:14c6e114-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:14c6e114-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:14c6e114-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:14c6e114-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:14c6e114-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:14c73e2a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:14c73e2a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:14c73e2a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotiapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:14c77cbe-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.186']} DrugCentral uuid:14c7a586-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.379']} DrugCentral uuid:14c7cdc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole is antagonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:14c7f612-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.136']} DrugCentral uuid:14c81e80-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.346']} DrugCentral uuid:14c84a68-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.391']} DrugCentral uuid:14c872e0-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.147']} DrugCentral uuid:14c89c5c-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.351']} DrugCentral uuid:14c8c506-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:14c8ed60-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:14c915b0-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.174']} DrugCentral uuid:14c93e0a-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.514']} DrugCentral uuid:14c966d2-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.104']} DrugCentral uuid:14c98f40-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.995']} DrugCentral uuid:14c9b8b2-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:14c9e134-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.132']} DrugCentral uuid:14ca0b8c-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:14ca35ee-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.235']} DrugCentral uuid:14ca5e52-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.429']} DrugCentral uuid:14ca87ec-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.046']} DrugCentral uuid:14cab0be-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.466']} DrugCentral uuid:14cad92c-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.294']} DrugCentral uuid:14cb0186-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.781']} DrugCentral uuid:14cb29ea-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.287']} DrugCentral uuid:14cb52d0-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.677']} DrugCentral uuid:14cb7b3e-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.785']} DrugCentral uuid:14cba3a2-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:14cbcc10-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.267']} DrugCentral uuid:14cbf816-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.353']} DrugCentral uuid:14cc2070-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.106']} DrugCentral uuid:14cc48ca-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.571']} DrugCentral uuid:14cc71b0-d20a-11ec-8377-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:14cc99f6-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:14ccbe36-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.156']} DrugCentral uuid:14cce6ae-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.521']} DrugCentral uuid:14cd0fc6-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.132']} DrugCentral uuid:14cd3848-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.598']} DrugCentral uuid:14cd60ca-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:14cd8500-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.756']} DrugCentral uuid:14cdaec2-d20a-11ec-8377-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:14cdd884-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.712']} DrugCentral uuid:14ce00f2-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:14ce2942-d20a-11ec-8377-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.645']} DrugCentral uuid:14ce528c-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:14ce7ac8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:14cea32c-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.159']} DrugCentral uuid:14cecb5e-d20a-11ec-8377-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:14cef46c-d20a-11ec-8377-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.058']} DrugCentral uuid:14cf1cb2-d20a-11ec-8377-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.089']} DrugCentral uuid:14cf44f8-d20a-11ec-8377-0242ac110003 UniProtKB:P22001 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Ion channel (Potassium voltage-gated channel subfamily A member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:14cf6d48-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:14cf9778-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.497']} DrugCentral uuid:14cfbfc8-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.178']} DrugCentral uuid:14cfe80e-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.854']} DrugCentral uuid:14d01040-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:14d03908-d20a-11ec-8377-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:14d06270-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:14d08ade-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.471']} DrugCentral uuid:14d0b3c4-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.112']} DrugCentral uuid:14d0dc46-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.906']} DrugCentral uuid:14d104be-d20a-11ec-8377-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:14d12d18-d20a-11ec-8377-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:14d156a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.942']} DrugCentral uuid:14d180e2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:14d1a914-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:14d1d268-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:14d1fb1c-d20a-11ec-8377-0242ac110003 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:14d22376-d20a-11ec-8377-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:14d24bc6-d20a-11ec-8377-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.99']} DrugCentral uuid:14d27420-d20a-11ec-8377-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:14d29cde-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:14d2c52e-d20a-11ec-8377-0242ac110003 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Transitional endoplasmic reticulum ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:14d2ed60-d20a-11ec-8377-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:14d315a6-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPN5 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Putative cytochrome P450 130) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.88']} DrugCentral uuid:14d33ebe-d20a-11ec-8377-0242ac110003 UniProtKB:P00766 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Alpha-chymotrypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:14d36722-d20a-11ec-8377-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:14d39058-d20a-11ec-8377-0242ac110003 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (Transitional endoplasmic reticulum ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:14d3b8bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clotrimazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:14d3e1a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:14d405ce-d20a-11ec-8377-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:14d42e1e-d20a-11ec-8377-0242ac110003 UniProtKB:A4ZYU9 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:14d45682-d20a-11ec-8377-0242ac110003 UniProtKB:Q3S5C3 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin targets Transporter (Efflux transporter; SugE) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:14d47f22-d20a-11ec-8377-0242ac110003 UniProtKB:Q48435 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:14d4a75e-d20a-11ec-8377-0242ac110003 UniProtKB:P62594 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:14d4df26-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:14d4df26-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:14d4df26-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:14d4df26-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:14d4df26-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:14d52d6e-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:721 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxazolam targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:14d555d2-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:14d57e4a-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.783']} DrugCentral uuid:14d5a870-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:14d5d0fc-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:14d5fa96-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.154']} DrugCentral uuid:14d622fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:14d64bb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:14d67408-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:14d69c6c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:14d6c4d0-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:14d6f090-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:14d71912-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:14d74162-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:14d76a48-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:14d7da6e-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.78']} DrugCentral uuid:14d80840-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:14d830a4-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:14d85912-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:14d8818a-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.594']} DrugCentral uuid:14d8aaca-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:14d8d310-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.815']} DrugCentral uuid:14d8fb56-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:14d923a6-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.181']} DrugCentral uuid:14d94ca0-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:14d974f0-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.591']} DrugCentral uuid:14d99d40-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:14d9c568-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.792']} DrugCentral uuid:14d9ef7a-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.356']} DrugCentral uuid:14da17ac-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:14da4006-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:14da686a-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:14da9376-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:14dabbb2-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:14dae3f8-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:14db0c52-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:14db35b0-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:14db5fae-d20a-11ec-8377-0242ac110003 UniProtKB:P22310 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (UDP-glucuronosyltransferase 1-4) {'has_attribute_type': 'IAO:0000004', 'name': 'app Km', 'has_quantitative_value': ['4.208']} DrugCentral uuid:14db87e0-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:14dbb0a8-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:14dbd92a-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:14dc0184-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.445']} DrugCentral uuid:14dc2b0a-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:14dc54d6-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:14dc7d6c-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:14dca5c6-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:14dcce48-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:14dcf756-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:14dd1fba-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:14dd4832-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:14dd7096-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:14dd9990-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:14ddc1e0-d20a-11ec-8377-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:14ddea3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:14de1384-d20a-11ec-8377-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:14de3ecc-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:14de6744-d20a-11ec-8377-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:14de8f94-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:14deb7da-d20a-11ec-8377-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:14dee106-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:14df096a-d20a-11ec-8377-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:14df31b0-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:14df5a3c-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:14df8282-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:14dfaad2-d20a-11ec-8377-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:14dfd322-d20a-11ec-8377-0242ac110003 UniProtKB:P52702 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:14dffcc6-d20a-11ec-8377-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:14e02548-d20a-11ec-8377-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:14e04d8e-d20a-11ec-8377-0242ac110003 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:14e075e8-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:14e09f96-d20a-11ec-8377-0242ac110003 UniProtKB:P50130 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:14e0c7fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:14e0f036-d20a-11ec-8377-0242ac110003 UniProtKB:P52703 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:14e1187c-d20a-11ec-8377-0242ac110003 UniProtKB:Q91ZY2 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:14e14144-d20a-11ec-8377-0242ac110003 UniProtKB:Q91ZY1 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:14e16d90-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:14e16d90-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:14e1b0a2-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:14e1b0a2-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:14e1b0a2-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:14e1b0a2-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:14e1b0a2-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:14e217d6-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:14e217d6-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:14e217d6-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:14e217d6-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:14e26a42-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:14e26a42-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:14e26a42-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:14e2acc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:14e2acc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:14e2efbc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:14e2efbc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:14e2efbc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:14e2efbc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:14e2efbc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:14e34caa-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:14e34caa-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:14e34caa-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:14e3a7cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:14e3a7cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:14e3a7cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:14e3a7cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:14e3a7cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:14e3a7cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:14e3a7cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:14e3a7cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:14e426ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:14e426ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:14e426ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:14e465fe-d20a-11ec-8377-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:14e48e3a-d20a-11ec-8377-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:14e4b676-d20a-11ec-8377-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.21']} DrugCentral uuid:14e4df34-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP23 biolink:molecularly_interacts_with DrugCentral:722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clozapine targets Cytosolic other (Calmodulin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:14e50766-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:14e52b92-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:14e553d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:14e57d72-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:14e5a87e-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:14e5d0ce-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:14e5f928-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.67']} DrugCentral uuid:14e62222-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:14e64aa4-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:14e672e0-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:14e69b30-d20a-11ec-8377-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:14e6c3c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UI33 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Ion channel (Sodium channel protein type 11 subunit alpha) DrugCentral uuid:14e6e7e8-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:14e71024-d20a-11ec-8377-0242ac110003 UniProtKB:Q16568 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transcription factor (Cocaine- and amphetamine-regulated transcript protein) DrugCentral uuid:14e73536-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:14e75f98-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:14e78ad6-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:14e7b600-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:14e7df5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:14e80830-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:14e8347c-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:14e8347c-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:14e87054-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:14e87054-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:14e87054-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:14e8af1a-d20a-11ec-8377-0242ac110003 UniProtKB:P27922 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:14e8d742-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GJT6 biolink:molecularly_interacts_with DrugCentral:723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cocaine targets Transporter (Dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:14e8ff88-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 codeine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:14e928a0-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 codeine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:14e950fa-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 codeine is agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:14e984da-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:14e984da-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:14e984da-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:14e984da-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 codeine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:14e9ceb8-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:14e9f6cc-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.801']} DrugCentral uuid:14ea1fd0-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:14ea43f2-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.49']} DrugCentral uuid:14ea6c9c-d20a-11ec-8377-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.194']} DrugCentral uuid:14ea94ce-d20a-11ec-8377-0242ac110003 UniProtKB:P07437 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine is inhibitor of Structural (Tubulin beta chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:14eabd32-d20a-11ec-8377-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:14eae550-d20a-11ec-8377-0242ac110003 UniProtKB:P02550 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:14eb102a-d20a-11ec-8377-0242ac110003 UniProtKB:Q6B856 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin beta-2B chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:14eb387a-d20a-11ec-8377-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine is inhibitor of Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:14eb61ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q27957 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Unclassified (Tubulin polymerization-promoting protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:14eb89d8-d20a-11ec-8377-0242ac110003 UniProtKB:P68371 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin beta-4B chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:14ebbaca-d20a-11ec-8377-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:14ebbaca-d20a-11ec-8377-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:14ebbaca-d20a-11ec-8377-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:14ebfd00-d20a-11ec-8377-0242ac110003 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:14ebfd00-d20a-11ec-8377-0242ac110003 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colchicine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:14ec30ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q08828 biolink:molecularly_interacts_with DrugCentral:729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colforsin daropate targets Enzyme (Adenylate cyclase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:14ec6100-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colforsin daropate targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:14ec6100-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colforsin daropate targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:14ec6100-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colforsin daropate targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:14ec9f80-d20a-11ec-8377-0242ac110003 UniProtKB:P11166 biolink:molecularly_interacts_with DrugCentral:729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colforsin daropate targets Transporter (Solute carrier family 2, facilitated glucose transporter member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:14ecc87a-d20a-11ec-8377-0242ac110003 UniProtKB:P19754 biolink:molecularly_interacts_with DrugCentral:729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colforsin daropate targets Enzyme (Adenylate cyclase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:14ecf0de-d20a-11ec-8377-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 conivaptan is antagonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:14ed1956-d20a-11ec-8377-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 conivaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:14ed41b0-d20a-11ec-8377-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 conivaptan targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:14ed6ab4-d20a-11ec-8377-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 conivaptan targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:14ed9304-d20a-11ec-8377-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 conivaptan targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:14edbb68-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:14ede3a4-d20a-11ec-8377-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate targets Cytosolic other (Annexin A1) DrugCentral uuid:14ee0820-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:14ee308e-d20a-11ec-8377-0242ac110003 UniProtKB:Q09470 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate targets Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:14ee58c0-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:14ee81b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:14eeae88-d20a-11ec-8377-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:14eeae88-d20a-11ec-8377-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortisone acetate targets Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:14eee308-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:736 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cortivazol is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:14ef0716-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:737 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cotinine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:14ef2b42-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:14ef543c-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:14ef7c8c-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:14efa4d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:14efcd22-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:14eff5d6-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:14f01e12-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.28']} DrugCentral uuid:14f0466c-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:14f070a6-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.25']} DrugCentral uuid:14f09b3a-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:14f0c380-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:14f0ebe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:14f114d4-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:14f13cfc-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:14f165b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 coumarin targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:14f18e0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q33BM1 biolink:molecularly_interacts_with DrugCentral:741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cromoglicic acid targets GPCR (G protein-coupled receptor GPR35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:14f1b6d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES90 biolink:molecularly_interacts_with DrugCentral:741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cromoglicic acid targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:14f1df0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cromoglicic acid targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:14f20772-d20a-11ec-8377-0242ac110003 UniProtKB:P25815 biolink:molecularly_interacts_with DrugCentral:741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cromoglicic acid targets Cytosolic other (Protein S100-P) DrugCentral uuid:14f22b8a-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:14f255ba-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.237']} DrugCentral uuid:14f28116-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:14f2a9b6-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:14f2d2e2-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:14f2fbdc-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:14f32422-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.602']} DrugCentral uuid:14f34c7c-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:14f374c2-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:14f39d80-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:14f3c59e-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:14f3edf8-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:14f41634-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyamemazine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.531']} DrugCentral uuid:14f44258-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.235']} DrugCentral uuid:14f46dc8-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:14f49668-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.623']} DrugCentral uuid:14f4bf44-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.272']} DrugCentral uuid:14f4e78a-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.993']} DrugCentral uuid:14f51052-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.353']} DrugCentral uuid:14f53898-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.788']} DrugCentral uuid:14f56138-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.385']} DrugCentral uuid:14f58974-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.799']} DrugCentral uuid:14f5b1b0-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.924']} DrugCentral uuid:14f5da1e-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.342']} DrugCentral uuid:14f603e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:14f62c26-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.206']} DrugCentral uuid:14f6558e-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:14f67ea6-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:14f6a34a-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclizine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:14f6cc6c-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.728']} DrugCentral uuid:14f6f4b2-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:14f71ce4-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:14f745c0-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.541']} DrugCentral uuid:14f76e06-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.812']} DrugCentral uuid:14f7966a-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:14f7bea6-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:14f7ea98-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:14f812de-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.829']} DrugCentral uuid:14f83b38-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:14f863c4-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:14f88c0a-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.222']} DrugCentral uuid:14f8b432-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.509']} DrugCentral uuid:14f8dc64-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclobenzaprine targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:14f90518-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclofenil targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:14f92d4a-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclofenil targets Nuclear other (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:14f95590-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:14f97dea-d20a-11ec-8377-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:14f9a87e-d20a-11ec-8377-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloguanil is inhibitor of Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:14f9d2f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:14f9fb1c-d20a-11ec-8377-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:14fa2362-d20a-11ec-8377-0242ac110003 UniProtKB:P00378 biolink:molecularly_interacts_with DrugCentral:754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:14fa4c20-d20a-11ec-8377-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloguanil targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:14fa7484-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclopentolate is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:14fa989c-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclophosphamide targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:14fac1c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:14faea5e-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:14fb12a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:14fb3ad6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:14fb62fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:14fb8efa-d20a-11ec-8377-0242ac110003 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:14fbb736-d20a-11ec-8377-0242ac110003 UniProtKB:P9WQA8 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Enzyme (Alanine racemase) DrugCentral uuid:14fbdb58-d20a-11ec-8377-0242ac110003 UniProtKB:Q05586 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:14fc038a-d20a-11ec-8377-0242ac110003 UniProtKB:O60391 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:14fc2d74-d20a-11ec-8377-0242ac110003 UniProtKB:P9WP31 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine is inhibitor of Enzyme (D-alanine--D-alanine ligase) DrugCentral uuid:14fc51a0-d20a-11ec-8377-0242ac110003 UniProtKB:P9WQA9 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine is inhibitor of Enzyme (Alanine racemase) DrugCentral uuid:14fc75cc-d20a-11ec-8377-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:14fc9df4-d20a-11ec-8377-0242ac110003 UniProtKB:Q00961 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:14fcddc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:14fcddc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:14fcddc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:14fcddc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:14fcddc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:14fcddc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:14fcddc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycloserine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:14fd4a6a-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:14fd7454-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:14fd9c7c-d20a-11ec-8377-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:14fdc4d6-d20a-11ec-8377-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:14fded62-d20a-11ec-8377-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:14fe159e-d20a-11ec-8377-0242ac110003 UniProtKB:P62937 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin is modulator of Enzyme (Peptidyl-prolyl cis-trans isomerase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.046']} DrugCentral uuid:14fe3ec0-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:14fe66f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:14fe8f88-d20a-11ec-8377-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin is antagonist of GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:14feb792-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:14fedfb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:14ff080a-d20a-11ec-8377-0242ac110003 UniProtKB:Q02790 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:14ff329e-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:14ff5aee-d20a-11ec-8377-0242ac110003 UniProtKB:P23284 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.01']} DrugCentral uuid:14ff8334-d20a-11ec-8377-0242ac110003 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:14ffab8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:14ffd442-d20a-11ec-8377-0242ac110003 UniProtKB:P68106 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:14fffc74-d20a-11ec-8377-0242ac110003 UniProtKB:Q08752 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Enzyme (Peptidyl-prolyl cis-trans isomerase D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1500249c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPD5 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:15004ce2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin is inhibitor of Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:15007564-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:15009da0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JHG7 biolink:molecularly_interacts_with DrugCentral:760 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciclosporin targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1500c5dc-d20a-11ec-8377-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:1500ea26-d20a-11ec-8377-0242ac110003 UniProtKB:P42261 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:15011596-d20a-11ec-8377-0242ac110003 UniProtKB:P42262 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:15013ddc-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide is allosteric modulator of Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:150165fa-d20a-11ec-8377-0242ac110003 UniProtKB:P42263 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide is allosteric modulator of Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:15019b74-d20a-11ec-8377-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:15019b74-d20a-11ec-8377-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:15019b74-d20a-11ec-8377-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:15019b74-d20a-11ec-8377-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclothiazide targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1501e6a6-d20a-11ec-8377-0242ac110003 UniProtKB:P19838 biolink:molecularly_interacts_with DrugCentral:762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclovalone targets Cytosolic other (Nuclear factor NF-kappa-B p105 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:15020ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclovalone targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:150237fa-d20a-11ec-8377-0242ac110003 UniProtKB:P05412 biolink:molecularly_interacts_with DrugCentral:762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclovalone targets Transcription factor (Transcription factor AP-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:15026054-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cycrimine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:15028462-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.932']} DrugCentral uuid:1502ac94-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:1502d714-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:1502ff64-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.855']} DrugCentral uuid:150327a0-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:15034bd6-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:15037476-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:15039cbc-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:1503c4ee-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.419']} DrugCentral uuid:1503ed2a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.812']} DrugCentral uuid:150415c0-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.652']} DrugCentral uuid:15043df2-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1504662e-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:15048e60-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1504b994-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1504e1da-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:15050a2a-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.222']} DrugCentral uuid:150532e8-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:15055b1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.185']} DrugCentral uuid:1505836a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1505ac6e-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1505d540-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1505fe94-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:150626da-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.559']} DrugCentral uuid:15064f0c-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.886']} DrugCentral uuid:15067856-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.733']} DrugCentral uuid:1506a092-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1506c8c4-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1506f8c6-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Cytosolic other (Calmodulin) DrugCentral uuid:1506f8c6-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Cytosolic other (Calmodulin) DrugCentral uuid:1506f8c6-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Cytosolic other (Calmodulin) DrugCentral uuid:150731ec-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:15075a28-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.899']} DrugCentral uuid:15078246-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1507ab5e-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:1507d39a-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1507fbc2-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:150823ea-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:15084df2-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:15087642-d20a-11ec-8377-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:15089e92-d20a-11ec-8377-0242ac110003 UniProtKB:P34968 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1508c6ec-d20a-11ec-8377-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:1508efaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:150917f0-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:15094f72-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:15094f72-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:15094f72-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:15094f72-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:15094f72-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1509b4f8-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1509b4f8-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1509b4f8-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1509b4f8-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1509b4f8-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:150a116e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:150a116e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:150a116e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:150a589a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:150a589a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:150a589a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:150a96b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WTS6 biolink:molecularly_interacts_with DrugCentral:765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproheptadine targets Enzyme (Histone-lysine N-methyltransferase SETD7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:150abf42-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproterone acetate targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.053']} DrugCentral uuid:150ae760-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproterone acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:150b0fb0-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproterone acetate is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.432']} DrugCentral uuid:150b37d8-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproterone acetate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.678']} DrugCentral uuid:150b6172-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproterone acetate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:150b899a-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproterone acetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.315']} DrugCentral uuid:150bb1ea-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyproterone acetate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:150bda1c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPY5 biolink:molecularly_interacts_with DrugCentral:769 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cysteine targets Transporter (Cystine/glutamate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:150c0582-d20a-11ec-8377-0242ac110003 UniProtKB:P15309 biolink:molecularly_interacts_with DrugCentral:770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytarabine targets Enzyme (Prostatic acid phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'GI50', 'has_quantitative_value': ['7']} DrugCentral uuid:150c2dbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytarabine targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:150c55d2-d20a-11ec-8377-0242ac110003 UniProtKB:P06746 biolink:molecularly_interacts_with DrugCentral:770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytarabine targets Enzyme (DNA polymerase beta) DrugCentral uuid:150c81d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytarabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:150c81d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytarabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:150c81d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytarabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:150cbb08-d20a-11ec-8377-0242ac110003 UniProtKB:Q00987 biolink:molecularly_interacts_with DrugCentral:770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytarabine targets Nuclear other (E3 ubiquitin-protein ligase Mdm2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:150ce326-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacarbazine targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.255']} DrugCentral uuid:150d0b4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14181 biolink:molecularly_interacts_with DrugCentral:773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacarbazine targets Enzyme (DNA polymerase alpha subunit B) DrugCentral uuid:150d2fde-d20a-11ec-8377-0242ac110003 UniProtKB:P62993 biolink:molecularly_interacts_with DrugCentral:774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dactinomycin targets Cytosolic other (Growth factor receptor-bound protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:150d5806-d20a-11ec-8377-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dactinomycin targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:150d8060-d20a-11ec-8377-0242ac110003 UniProtKB:Q60631 biolink:molecularly_interacts_with DrugCentral:774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dactinomycin targets Cytosolic other (Growth factor receptor-bound protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:150da8a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q96IV0 biolink:molecularly_interacts_with DrugCentral:774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dactinomycin targets Enzyme (Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.05']} DrugCentral uuid:150dd452-d20a-11ec-8377-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:150dff86-d20a-11ec-8377-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:150e2aec-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:150e538c-d20a-11ec-8377-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:150e7c36-d20a-11ec-8377-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.34']} DrugCentral uuid:150ea47c-d20a-11ec-8377-0242ac110003 UniProtKB:P04070 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Vitamin K-dependent protein C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:150ecccc-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:150ef54e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:150f1db2-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:150f4d96-d20a-11ec-8377-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:150f4d96-d20a-11ec-8377-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:150f4d96-d20a-11ec-8377-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:150f8bee-d20a-11ec-8377-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:150fb54c-d20a-11ec-8377-0242ac110003 UniProtKB:Q28731 biolink:molecularly_interacts_with DrugCentral:776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabigatran etexilate targets Unclassified (Thrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:150fdd7e-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.243']} DrugCentral uuid:151005ce-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:15102ea0-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.163']} DrugCentral uuid:151057ea-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.087']} DrugCentral uuid:1510801c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.248']} DrugCentral uuid:1510a86c-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.597']} DrugCentral uuid:1510d24c-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.976']} DrugCentral uuid:1510faa6-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.009']} DrugCentral uuid:151122ec-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.425']} DrugCentral uuid:15114b32-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.708']} DrugCentral uuid:15117544-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.894']} DrugCentral uuid:15119ff6-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.462']} DrugCentral uuid:1511c846-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.265']} DrugCentral uuid:1511f08c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:15121990-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.207']} DrugCentral uuid:151241e0-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.294']} DrugCentral uuid:15126a26-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:15128e48-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:1512b2c4-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:1512dace-d20a-11ec-8377-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Enzyme (Steryl-sulfatase) DrugCentral uuid:1512fee6-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:15132736-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.053']} DrugCentral uuid:151351ac-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:15137a88-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 danazol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:1513a2ce-d20a-11ec-8377-0242ac110003 UniProtKB:P21817 biolink:molecularly_interacts_with DrugCentral:780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dantrolene is antagonist of Ion channel (Ryanodine receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.757']} DrugCentral uuid:1513cb46-d20a-11ec-8377-0242ac110003 UniProtKB:Q15413 biolink:molecularly_interacts_with DrugCentral:780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dantrolene is antagonist of Ion channel (Ryanodine receptor 3) DrugCentral uuid:1513f026-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dantrolene targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1514188a-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.929']} DrugCentral uuid:151440ee-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.762']} DrugCentral uuid:15146a4c-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:151495c6-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.485']} DrugCentral uuid:1514be98-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole is antagonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:1514e2ce-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.279']} DrugCentral uuid:15150bfa-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.388']} DrugCentral uuid:1515379c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:15155e66-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:151588a0-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:1515b186-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:1515d9ae-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:151601f4-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:15162a3a-d20a-11ec-8377-0242ac110003 UniProtKB:P0C0X1 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone is inhibitor of Enzyme (Dihydropteroate synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:151652d0-d20a-11ec-8377-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:15167ada-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1516a2e4-d20a-11ec-8377-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:1516c832-d20a-11ec-8377-0242ac110003 UniProtKB:Q4Z710 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets Unclassified (Dihydropteroate synthetase, putative) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:1516f15e-d20a-11ec-8377-0242ac110003 UniProtKB:A0A113T0T6 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets Unclassified (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:151719b8-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapsone targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:151741e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q57P83 biolink:molecularly_interacts_with DrugCentral:783 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daptomycin targets Transporter (Outer membrane porin protein OmpD) DrugCentral uuid:151765f8-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:15178eb6-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:1517b724-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1517df56-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:151807a6-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1518305a-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:151858aa-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:151881ea-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:1518aa26-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1518d492-d20a-11ec-8377-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darifenacin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1518fcd8-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:15192528-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:15194d5a-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.6']} DrugCentral uuid:15197618-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:15199ec2-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1519c708-d20a-11ec-8377-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1519ef12-d20a-11ec-8377-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Breakpoint cluster region protein) DrugCentral uuid:151a13ac-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:151a3c06-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:151a6456-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:151a8c9c-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.1']} DrugCentral uuid:151ab7ee-d20a-11ec-8377-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.07']} DrugCentral uuid:151ae02a-d20a-11ec-8377-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:151b0870-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:151b312e-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:151b5974-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:151b819c-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:151ba9e2-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:151bd25a-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:151bfa96-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.33']} DrugCentral uuid:151c22be-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:151c4ae6-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:151c7552-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.46']} DrugCentral uuid:151c9d98-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:151cc6ec-d20a-11ec-8377-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:151cef28-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:151d17e6-d20a-11ec-8377-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:151d4022-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:151d687c-d20a-11ec-8377-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:151d90ae-d20a-11ec-8377-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.62']} DrugCentral uuid:151db96c-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:151de1a8-d20a-11ec-8377-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.85']} DrugCentral uuid:151e09f8-d20a-11ec-8377-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:151e323e-d20a-11ec-8377-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:151e5d2c-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:151e8572-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:151ead9a-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.77']} DrugCentral uuid:151ed64e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15759 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:151efe94-d20a-11ec-8377-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.62']} DrugCentral uuid:151f26d0-d20a-11ec-8377-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.92']} DrugCentral uuid:151f4ef8-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:151f77a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:151f9fe8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:151fc81a-d20a-11ec-8377-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:151ff04c-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:15201aea-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.03']} DrugCentral uuid:15204628-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:15206f4a-d20a-11ec-8377-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.03']} DrugCentral uuid:1520977c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:1520c030-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.51']} DrugCentral uuid:1520e86c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:15211094-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:152138bc-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.59']} DrugCentral uuid:1521615c-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1521898e-d20a-11ec-8377-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.35']} DrugCentral uuid:1521b1ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1521d9fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.25']} DrugCentral uuid:15220562-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:15222d94-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.16']} DrugCentral uuid:152255bc-d20a-11ec-8377-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.47']} DrugCentral uuid:15227e52-d20a-11ec-8377-0242ac110003 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1522a68e-d20a-11ec-8377-0242ac110003 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1522cfe2-d20a-11ec-8377-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1522f832-d20a-11ec-8377-0242ac110003 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:152320e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1523492c-d20a-11ec-8377-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:15237172-d20a-11ec-8377-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:152399ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:1523c3e8-d20a-11ec-8377-0242ac110003 UniProtKB:P06240 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Proto-oncogene tyrosine-protein kinase LCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.19']} DrugCentral uuid:1523eca6-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.85']} DrugCentral uuid:15241500-d20a-11ec-8377-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:15243df0-d20a-11ec-8377-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.41']} DrugCentral uuid:15246794-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:15248fda-d20a-11ec-8377-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:1524b802-d20a-11ec-8377-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1524e034-d20a-11ec-8377-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:152508de-d20a-11ec-8377-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:15253110-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:15255942-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.68']} DrugCentral uuid:15258174-d20a-11ec-8377-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1525acee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1525d520-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1525fd52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:15262598-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.19']} DrugCentral uuid:15264e24-d20a-11ec-8377-0242ac110003 UniProtKB:P27037 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Activin receptor type-2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:15267656-d20a-11ec-8377-0242ac110003 UniProtKB:Q13705 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Activin receptor type-2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:15269e88-d20a-11ec-8377-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1526c7c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1526f004-d20a-11ec-8377-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:15271836-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:15274068-d20a-11ec-8377-0242ac110003 UniProtKB:Q6DT37 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase MRCK gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:152769f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1527922a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99640 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1527ba5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1527e270-d20a-11ec-8377-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:15280af2-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:15283338-d20a-11ec-8377-0242ac110003 UniProtKB:P36894 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Bone morphogenetic protein receptor type-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:15285c50-d20a-11ec-8377-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:15288496-d20a-11ec-8377-0242ac110003 UniProtKB:Q5VT25 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase MRCK alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1528ad2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1528d694-d20a-11ec-8377-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:1528fed0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib is inhibitor of Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:15292720-d20a-11ec-8377-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1529525e-d20a-11ec-8377-0242ac110003 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:15297aa4-d20a-11ec-8377-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.39']} DrugCentral uuid:1529a2cc-d20a-11ec-8377-0242ac110003 UniProtKB:P54753 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.16']} DrugCentral uuid:1529cb12-d20a-11ec-8377-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1529f3b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:152a1bf8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:152a442a-d20a-11ec-8377-0242ac110003 UniProtKB:P16277 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:152a6c98-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.41']} DrugCentral uuid:152a94de-d20a-11ec-8377-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:152abd1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:152ae54c-d20a-11ec-8377-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:152b0e6e-d20a-11ec-8377-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:152b36a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:152b5ed2-d20a-11ec-8377-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:152b8704-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:152baff4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:152bd830-d20a-11ec-8377-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:152c0058-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:152c2876-d20a-11ec-8377-0242ac110003 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:152c5224-d20a-11ec-8377-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:152c7a74-d20a-11ec-8377-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:152ca27e-d20a-11ec-8377-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:152ccab0-d20a-11ec-8377-0242ac110003 UniProtKB:Q86Y07 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase VRK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:152cf53a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:152d1d6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.48']} DrugCentral uuid:152d459e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NG66 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Serine/threonine-protein kinase Nek11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:152d6e3e-d20a-11ec-8377-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:152da2d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:152da2d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:152da2d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:152da2d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (MAP kinase p38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:152df00c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase; MEK1/2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:152df00c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase; MEK1/2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:152e2784-d20a-11ec-8377-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:152e2784-d20a-11ec-8377-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:152e5c2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01538 biolink:molecularly_interacts_with DrugCentral:785 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasatinib targets Transcription factor (Myelin transcription factor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:152e844a-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:152ea880-d20a-11ec-8377-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:152ecef0-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicin targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:152ef308-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicin targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:152f1720-d20a-11ec-8377-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicin targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:152f3b38-d20a-11ec-8377-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:152f6414-d20a-11ec-8377-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicin targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:152f8c32-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deanol targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:152fb46e-d20a-11ec-8377-0242ac110003 UniProtKB:P28570 biolink:molecularly_interacts_with DrugCentral:787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deanol targets Transporter (Creatine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:152fdda4-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:788 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 debrisoquine targets Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:1530020c-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:788 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 debrisoquine targets Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:15302624-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:15304e7e-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:153076b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:15309f96-d20a-11ec-8377-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1530cbd8-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1530cbd8-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:15310ed6-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:15310ed6-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:15310ed6-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:15310ed6-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:15310ed6-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:789 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decamethonium is partial agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:15315ac6-d20a-11ec-8377-0242ac110003 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:790 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decitabine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:153182ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:790 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 decitabine is inhibitor of Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:1531a738-d20a-11ec-8377-0242ac110003 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:792 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deferoxamine targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1531cfba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:792 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deferoxamine targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1531f7f6-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prasterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1532203c-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prasterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.84']} DrugCentral uuid:15324896-d20a-11ec-8377-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prasterone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:15327320-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GRG7 biolink:molecularly_interacts_with DrugCentral:795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prasterone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:15329e36-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:798 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.921']} DrugCentral uuid:1532c6a4-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:798 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.97']} DrugCentral uuid:1532eeea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delavirdine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.276']} DrugCentral uuid:153317da-d20a-11ec-8377-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delavirdine targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1533400c-d20a-11ec-8377-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delavirdine targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:15336852-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delavirdine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:15339228-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delavirdine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1533bbcc-d20a-11ec-8377-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delavirdine targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1533ec46-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:1533ec46-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:1533ec46-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:153465ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delorazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:1535345c-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 demecarium is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:15355860-d20a-11ec-8377-0242ac110003 UniProtKB:P0A7V8 biolink:molecularly_interacts_with DrugCentral:802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 demeclocycline targets Ribosomal protein (30S ribosomal protein S4) DrugCentral uuid:15357cbe-d20a-11ec-8377-0242ac110003 UniProtKB:P0A7X3 biolink:molecularly_interacts_with DrugCentral:802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 demeclocycline targets Ribosomal protein (30S ribosomal protein S9) DrugCentral uuid:1535a0f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 demeclocycline targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:1535ca16-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 denopamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:1535f234-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 denopamine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:15361ca0-d20a-11ec-8377-0242ac110003 UniProtKB:P58154 biolink:molecularly_interacts_with DrugCentral:808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deptropine targets Unclassified (Acetylcholine-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:153644e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WSF8 biolink:molecularly_interacts_with DrugCentral:808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deptropine targets Unclassified (Soluble acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:153674de-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desalkylflurazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:153674de-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desalkylflurazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:153674de-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desalkylflurazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1536b408-d20a-11ec-8377-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deserpidine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:1536d82a-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:1536fc6a-d20a-11ec-8377-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:153720be-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:1537456c-d20a-11ec-8377-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:153769a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:153792d8-d20a-11ec-8377-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:153792d8-d20a-11ec-8377-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1537fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1538b44c-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:1538dc92-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.631']} DrugCentral uuid:153904ce-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:15392d64-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:153955a0-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.755']} DrugCentral uuid:15397dfa-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.081']} DrugCentral uuid:1539a636-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.194']} DrugCentral uuid:1539d1a6-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:1539fbd6-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:153a23f4-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:153a4cc6-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:153a7516-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:153a992e-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:153ac174-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:153aea28-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:153b12f0-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:153b3b40-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:153b6386-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.84']} DrugCentral uuid:153b8d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:153bb8b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:153be54a-d20a-11ec-8377-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:153c09da-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:153c32b6-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.6']} DrugCentral uuid:153c5afc-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:153c8428-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:153cac8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.19']} DrugCentral uuid:153cd54a-d20a-11ec-8377-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:153cfd90-d20a-11ec-8377-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:153d25ae-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:153d4dea-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:153dac86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:153dac86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:153dac86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:153dac86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:153dac86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:153dac86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:153dac86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:153dac86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:153dac86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:153dac86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:153dac86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:153dac86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:153dac86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:153dac86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:153e6dc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:153e6dc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:153e6dc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:153eacd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:153ed520-d20a-11ec-8377-0242ac110003 UniProtKB:P48545 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:153efe4c-d20a-11ec-8377-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:153f42b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:153f42b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:153f42b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:153f42b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:153f42b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:153f42b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:153f42b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:153f42b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deslanoside is inhibitor of Transporter (Sodium/potassium-transporting ATPase) DrugCentral uuid:153fabb2-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:153fd484-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.914']} DrugCentral uuid:153ffcde-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.956']} DrugCentral uuid:15402524-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.025']} DrugCentral uuid:15404d74-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:15407646-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:15409eb4-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.997']} DrugCentral uuid:1540c6fa-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.009']} DrugCentral uuid:1540ef36-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.189']} DrugCentral uuid:15411844-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:154140a8-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.967']} DrugCentral uuid:154169a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:154191d4-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1541bac4-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1541e31e-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:15420b50-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:154233a0-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:15425c5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.511']} DrugCentral uuid:15428594-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desloratadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.698']} DrugCentral uuid:1542adb2-d20a-11ec-8377-0242ac110003 UniProtKB:O75899 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets GPCR (Gamma-aminobutyric acid type B receptor subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.027']} DrugCentral uuid:1542d724-d20a-11ec-8377-0242ac110003 UniProtKB:P28476 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit rho-2) DrugCentral uuid:15430334-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.284']} DrugCentral uuid:15430334-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.284']} DrugCentral uuid:15430334-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.284']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15437828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15443cd6-d20a-11ec-8377-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:15446530-d20a-11ec-8377-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:15448d76-d20a-11ec-8377-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin is agonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1544b6fc-d20a-11ec-8377-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.01']} DrugCentral uuid:1544e00a-d20a-11ec-8377-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:15450832-d20a-11ec-8377-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.97']} DrugCentral uuid:15453078-d20a-11ec-8377-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:154559ae-d20a-11ec-8377-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desmopressin is agonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:154581fe-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desogestrel is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:1545a620-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desogestrel targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1545ce66-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:819 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoximetasone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.932']} DrugCentral uuid:1545f710-d20a-11ec-8377-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:819 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoximetasone targets Cytosolic other (Annexin A1) DrugCentral uuid:15461b28-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:819 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoximetasone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:1546435a-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycortone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.854']} DrugCentral uuid:15466b8c-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycortone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.498']} DrugCentral uuid:15469544-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycortone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1546bd80-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycortone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1546e5bc-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycortone is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11']} DrugCentral uuid:15470df8-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycortone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:154736e8-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycortone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:15475f2e-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycorticosterone acetate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) DrugCentral uuid:1547835a-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:822 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desoxycorticosterone pivalate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:1547ab82-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.886']} DrugCentral uuid:1547d45e-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.88']} DrugCentral uuid:1547fc90-d20a-11ec-8377-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Cytosolic other (Annexin A1) DrugCentral uuid:1548209e-d20a-11ec-8377-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:154848d0-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:154873be-d20a-11ec-8377-0242ac110003 UniProtKB:P05112 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Cytokine (Interleukin-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.33']} DrugCentral uuid:15489c86-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1548c4ea-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1548ee2a-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.786']} DrugCentral uuid:15491738-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:15493f92-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.517']} DrugCentral uuid:154967d8-d20a-11ec-8377-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:15499096-d20a-11ec-8377-0242ac110003 UniProtKB:O54915 biolink:molecularly_interacts_with DrugCentral:824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1549b9ea-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1549de0c-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:154a065c-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:154a2fb0-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:154a580a-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:154a8050-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:154aa882-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:154ad14a-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:154af972-d20a-11ec-8377-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone palmitate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:154b21ae-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:154b49ea-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:154b7294-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:154b9ada-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:154bc32a-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:154beb52-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:154c15fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:154c3e40-d20a-11ec-8377-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone valerate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:154c6672-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexbrompheniramine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:154c8abc-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexetimide is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:154cb49c-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexetimide is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:154cec5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:154cec5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:154cec5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:154cec5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:154cec5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexetimide targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:154d415a-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.002']} DrugCentral uuid:154d69aa-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:154d91f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.664']} DrugCentral uuid:154dba22-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.176']} DrugCentral uuid:154de452-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:154e0cd4-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.607']} DrugCentral uuid:154e351a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.384']} DrugCentral uuid:154e5d56-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:154e863c-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.042']} DrugCentral uuid:154eae82-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.257']} DrugCentral uuid:154ed6c8-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:154f003a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:154f28f8-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.733']} DrugCentral uuid:154f5148-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.577']} DrugCentral uuid:154f7984-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.326']} DrugCentral uuid:154fa1c0-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.156']} DrugCentral uuid:154fcace-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:154ff364-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.898']} DrugCentral uuid:15501c18-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.706']} DrugCentral uuid:1550460c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.848']} DrugCentral uuid:15506e48-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfenfluramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:15509684-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:833 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:1550bed4-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:833 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:1550e788-d20a-11ec-8377-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexloxiglumide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:15510fd8-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:155137f6-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15516050-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:15518a62-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1551b2b2-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:1551dada-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:155203de-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:15522cc4-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:15525cbc-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:15525cbc-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:15525cbc-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:1552a316-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1552a316-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1552a316-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1552e286-d20a-11ec-8377-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmedetomidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:15530a9a-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:15532ec6-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1553586a-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.13']} DrugCentral uuid:1553820e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1553b9d6-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:1553b9d6-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:1553b9d6-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:1553b9d6-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:1553b9d6-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexmethylphenidate targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:15541138-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1554399c-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:155461f6-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:15548b18-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1554b386-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1554dbd6-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:15550430-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:15552dde-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:15555642-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.824']} DrugCentral uuid:15557ea6-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1555a6f6-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1555cfa0-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:1555f7e6-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:155620b8-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:15564908-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.42']} DrugCentral uuid:15567978-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:15567978-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:15567978-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1556bbf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:1556bbf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexniguldipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:1556e9da-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:15570f50-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:15573890-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:155760cc-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:15578912-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:1557adf2-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine is releasing agent of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1557d642-d20a-11ec-8377-0242ac110003 UniProtKB:Q16568 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets Transcription factor (Cocaine- and amphetamine-regulated transcript protein) DrugCentral uuid:1557fa5a-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:155822b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:15584730-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.87']} DrugCentral uuid:15586f6c-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:15589794-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1558bfb2-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:1558eabe-d20a-11ec-8377-0242ac110003 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:15591372-d20a-11ec-8377-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:15593bb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:155996d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:155996d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:155996d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:155996d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:155996d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:155996d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:155996d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:155996d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:155996d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:155996d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:155996d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:155996d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:155996d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:155996d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:155a51ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan is agonist of Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'D2', 'has_quantitative_value': ['6.458']} DrugCentral uuid:155a7a3c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.842']} DrugCentral uuid:155aa28c-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ks', 'has_quantitative_value': ['4.48']} DrugCentral uuid:155ace7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan is antagonist of Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:155af85e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan is blocker of Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:155b20ae-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:155b4994-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:155b71ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:155bb154-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:155bb154-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:155bb154-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:155bb154-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:155bb154-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:155bb154-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:155bb154-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:155c24b8-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:155c24b8-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:155c24b8-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:155c6356-d20a-11ec-8377-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:155c8da4-d20a-11ec-8377-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextromethorphan targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:155cb5cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:844 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextropropoxyphene targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:155cda0c-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:844 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextropropoxyphene is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:155cfe42-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:844 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextropropoxyphene targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:155d27fa-d20a-11ec-8377-0242ac110003 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:155d555e-d20a-11ec-8377-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor) DrugCentral uuid:155d555e-d20a-11ec-8377-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor) DrugCentral uuid:155d9aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:155d9aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:155d9aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:155d9aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:155d9aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:155d9aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:155d9aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dextrothyroxine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:155e065c-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dezocine is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:155e2ea2-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dezocine is antagonist of GPCR (Kappa-type opioid receptor) DrugCentral uuid:155e5436-d20a-11ec-8377-0242ac110003 UniProtKB:P42574 biolink:molecularly_interacts_with DrugCentral:849 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diacerein targets Enzyme (Caspase-3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:155e7ee8-d20a-11ec-8377-0242ac110003 UniProtKB:P55210 biolink:molecularly_interacts_with DrugCentral:849 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diacerein targets Enzyme (Caspase-7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:155ea710-d20a-11ec-8377-0242ac110003 UniProtKB:Q17339 biolink:molecularly_interacts_with DrugCentral:849 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diacerein targets Unclassified (Female germline-specific tumor suppressor gld-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:155ecf56-d20a-11ec-8377-0242ac110003 UniProtKB:Q02083 biolink:molecularly_interacts_with DrugCentral:849 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diacerein targets Enzyme (N-acylethanolamine-hydrolyzing acid amidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:155effc6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:155effc6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:155effc6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:155f3e64-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:155f66aa-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:155f8f86-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is allosteric modulator of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:155fb7e0-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:155fe09e-d20a-11ec-8377-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:1560095c-d20a-11ec-8377-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:15603512-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:15606122-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:15608cb0-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1560b82a-d20a-11ec-8377-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.67']} DrugCentral uuid:1560e160-d20a-11ec-8377-0242ac110003 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:156109a6-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:15613200-d20a-11ec-8377-0242ac110003 UniProtKB:P62813 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:15615ba4-d20a-11ec-8377-0242ac110003 UniProtKB:P23576 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:15618408-d20a-11ec-8377-0242ac110003 UniProtKB:P19969 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:1561b446-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.143']} DrugCentral uuid:1561b446-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.143']} DrugCentral uuid:1561b446-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.143']} DrugCentral uuid:1561fba4-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:1561fba4-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:1561fba4-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:156243a2-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:156243a2-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:156243a2-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:15628a38-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:15628a38-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:15628a38-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:1562d128-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.705']} DrugCentral uuid:1562d128-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.705']} DrugCentral uuid:1562d128-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.705']} DrugCentral uuid:156318d6-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:156318d6-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:156318d6-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15639446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15647cb2-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:15647cb2-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:15647cb2-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:15647cb2-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:15647cb2-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:15647cb2-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1564e59e-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:1564e59e-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:1564e59e-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:15652dc4-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:15652dc4-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:15652dc4-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:15657428-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:15657428-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:15657428-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1565ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0Y8 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1566b734-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1566b734-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1566b734-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1566fe38-d20a-11ec-8377-0242ac110003 UniProtKB:P63079 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1566fe38-d20a-11ec-8377-0242ac110003 UniProtKB:P63079 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1566fe38-d20a-11ec-8377-0242ac110003 UniProtKB:P63079 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:156744b0-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:156744b0-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:156744b0-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.939']} DrugCentral uuid:15678d44-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.665']} DrugCentral uuid:15678d44-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.665']} DrugCentral uuid:15678d44-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.665']} DrugCentral uuid:1567d38a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:1567d38a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:1567d38a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:15681b10-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:15681b10-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:15681b10-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.004']} DrugCentral uuid:15685ada-d20a-11ec-8377-0242ac110003 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazoxide targets Enzyme (Nicotinamide phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.64']} DrugCentral uuid:15688726-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazoxide is opener of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:15688726-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazoxide is opener of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:1568bb74-d20a-11ec-8377-0242ac110003 UniProtKB:Q61743 biolink:molecularly_interacts_with DrugCentral:854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diazoxide is activator of Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:1568e3a6-d20a-11ec-8377-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dibekacin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.921']} DrugCentral uuid:15690d0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinchocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:15693144-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinchocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:15695e76-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinchocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:15695e76-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinchocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:15695e76-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinchocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:15699ca6-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1569c528-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazone is blocker of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.081']} DrugCentral uuid:1569eddc-d20a-11ec-8377-0242ac110003 UniProtKB:Q15118 biolink:molecularly_interacts_with DrugCentral:862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3']} DrugCentral uuid:156a1636-d20a-11ec-8377-0242ac110003 UniProtKB:Q15119 biolink:molecularly_interacts_with DrugCentral:862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.699']} DrugCentral uuid:156a3e86-d20a-11ec-8377-0242ac110003 UniProtKB:Q15120 biolink:molecularly_interacts_with DrugCentral:862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.097']} DrugCentral uuid:156a66d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q16654 biolink:molecularly_interacts_with DrugCentral:862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichloroacetic acid is inhibitor of Kinase ([Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.301']} DrugCentral uuid:156a8fee-d20a-11ec-8377-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorophen targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:156ab834-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorophen targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:156ae084-d20a-11ec-8377-0242ac110003 UniProtKB:P11021 biolink:molecularly_interacts_with DrugCentral:863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorophen targets Unclassified (78 kDa glucose-regulated protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:156b08b6-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:156b3322-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:156b5e56-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:156b8886-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.602']} DrugCentral uuid:156bb0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:156bd96c-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:156c01b2-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:156c29ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:156c5216-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide is inhibitor of Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.577']} DrugCentral uuid:156c7b10-d20a-11ec-8377-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.423']} DrugCentral uuid:156ca43c-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:156ccc96-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:156cf5e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:156d1e58-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:156d46bc-d20a-11ec-8377-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:156d6f0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:156d984c-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:156dc1d2-d20a-11ec-8377-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:156dea22-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:156e127c-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:156e3b44-d20a-11ec-8377-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:156e639e-d20a-11ec-8377-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:156e8bee-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:156eb42a-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:156ede96-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:156f083a-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:156f3094-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:156f58da-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:156f81d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:156faa10-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dichlorphenamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:156fd27e-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:156ffaba-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1570236e-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:15704baa-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:157073d2-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac is antagonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:15709ea2-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1570c742-d20a-11ec-8377-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1570ef88-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:157117b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:157140e6-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:15716918-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1571914a-d20a-11ec-8377-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1571b99a-d20a-11ec-8377-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1571e230-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac is blocker of Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:15720a80-d20a-11ec-8377-0242ac110003 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:157232c6-d20a-11ec-8377-0242ac110003 UniProtKB:P22309 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:15725b0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HAW7 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:157284a6-d20a-11ec-8377-0242ac110003 UniProtKB:P19224 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:1572acf6-d20a-11ec-8377-0242ac110003 UniProtKB:O60656 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1572d55a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HAW8 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Enzyme (UDP-glucuronosyltransferase 1-10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:1572fe2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HCF6 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:15732726-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diclofenac targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:15734f6c-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:157377a8-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:15739fd0-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1573c9c4-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1573f1ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:1574160e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:15743e4a-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:157469d8-d20a-11ec-8377-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:1574932c-d20a-11ec-8377-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1574caf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:1574caf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:1574caf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:1574caf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:1574caf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicloxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:15751662-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.971']} DrugCentral uuid:15753ea8-d20a-11ec-8377-0242ac110003 UniProtKB:P15559 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (NAD(P)H dehydrogenase [quinone] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:157566ee-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.388']} DrugCentral uuid:15758fa2-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.354']} DrugCentral uuid:1575b7f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q16549 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (Proprotein convertase subtilisin/kexin type 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1575e042-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:157608ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:15763268-d20a-11ec-8377-0242ac110003 UniProtKB:P07374 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (Urease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:15765a9a-d20a-11ec-8377-0242ac110003 UniProtKB:P9WMN1 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (ATP phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:157682e0-d20a-11ec-8377-0242ac110003 UniProtKB:P05982 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol targets Enzyme (NULLD(P)H dehydrogenase [quinone] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1576ab44-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicoumarol is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.509']} DrugCentral uuid:1576d448-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.686']} DrugCentral uuid:1576fca2-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.773']} DrugCentral uuid:15772510-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.161']} DrugCentral uuid:15774d56-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.082']} DrugCentral uuid:15777628-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.611']} DrugCentral uuid:15779e6e-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.847']} DrugCentral uuid:1577c6be-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.386']} DrugCentral uuid:1577eef0-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:15781b0a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.079']} DrugCentral uuid:15784468-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:15786cea-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.033']} DrugCentral uuid:157895f8-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.386']} DrugCentral uuid:1578be5c-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.767']} DrugCentral uuid:1578e72e-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.327']} DrugCentral uuid:15790f74-d20a-11ec-8377-0242ac110003 UniProtKB:P70676 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets Unclassified (SMR1-alpha2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:15793968-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:157961c2-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.61']} DrugCentral uuid:157991e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:157991e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:157991e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dicycloverine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:1579d13e-d20a-11ec-8377-0242ac110003 UniProtKB:Q72549 biolink:molecularly_interacts_with DrugCentral:869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 didanosine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1579f9ac-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dienestrol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:157a2206-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:871 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dienogest is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:157a4650-d20a-11ec-8377-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:157a6f0e-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylcarbamazine targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:157a9330-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylcarbamazine targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:157abb58-d20a-11ec-8377-0242ac110003 UniProtKB:E1G1C3 biolink:molecularly_interacts_with DrugCentral:873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylcarbamazine is positive modulator of Ion channel (Nematode GABA-A receptor) DrugCentral uuid:157abb58-d20a-11ec-8377-0242ac110003 UniProtKB:E1G1C3 biolink:molecularly_interacts_with DrugCentral:873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylcarbamazine is positive modulator of Ion channel (Nematode GABA-A receptor) DrugCentral uuid:157ae95c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:874 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylpropion is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:157b0e32-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:874 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylpropion is inhibitor of Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:157b3268-d20a-11ec-8377-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.316']} DrugCentral uuid:157b5ac2-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.894']} DrugCentral uuid:157b831c-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.252']} DrugCentral uuid:157bacac-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:157bd51a-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.411']} DrugCentral uuid:157bfe50-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.353']} DrugCentral uuid:157c26a0-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.296']} DrugCentral uuid:157c4f68-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.276']} DrugCentral uuid:157c77d6-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.178']} DrugCentral uuid:157ca026-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.439']} DrugCentral uuid:157cc876-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.864']} DrugCentral uuid:157cf17a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:157d19b6-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.575']} DrugCentral uuid:157d41fc-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.223']} DrugCentral uuid:157d6a4c-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.272']} DrugCentral uuid:157d9508-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.525']} DrugCentral uuid:157dbd4e-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.437']} DrugCentral uuid:157de59e-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.408']} DrugCentral uuid:157e0ef2-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.317']} DrugCentral uuid:157e3756-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.657']} DrugCentral uuid:157e5fb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:157e880a-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.778']} DrugCentral uuid:157eb21c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.904']} DrugCentral uuid:157eda76-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:157f02bc-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.274']} DrugCentral uuid:157f2b16-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.739']} DrugCentral uuid:157f5578-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:157f7fee-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.019']} DrugCentral uuid:157fa83e-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.593']} DrugCentral uuid:157fd174-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:157ffb22-d20a-11ec-8377-0242ac110003 UniProtKB:P62508 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol is antagonist of Nuclear hormone receptor (Estrogen-related receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:15802354-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:15804b90-d20a-11ec-8377-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.983']} DrugCentral uuid:158073ea-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.847']} DrugCentral uuid:15809ce4-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.361']} DrugCentral uuid:1580c520-d20a-11ec-8377-0242ac110003 UniProtKB:O95718 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol is antagonist of Nuclear hormone receptor (Steroid hormone receptor ERR2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1580ed52-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.483']} DrugCentral uuid:1581158e-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:15813ef6-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:15816732-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.528']} DrugCentral uuid:15818f64-d20a-11ec-8377-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.052']} DrugCentral uuid:1581b818-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.214']} DrugCentral uuid:1581e05e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:15820886-d20a-11ec-8377-0242ac110003 UniProtKB:Q14376 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol targets Enzyme (UDP-glucose 4-epimerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:158230cc-d20a-11ec-8377-0242ac110003 UniProtKB:O08580 biolink:molecularly_interacts_with DrugCentral:875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diethylstilbestrol is antagonist of Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1582599e-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 difenoxin is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:15827db6-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflunisal is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1582a5fc-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflunisal is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1582ce38-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflunisal targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:1582f7fa-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflunisal targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd1', 'has_quantitative_value': ['7.125']} DrugCentral uuid:15832086-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflunisal targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:158348d6-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflunisal is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:15837126-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflunisal is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:158399ee-d20a-11ec-8377-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.648']} DrugCentral uuid:1583c22a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.857']} DrugCentral uuid:1583ec0a-d20a-11ec-8377-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:15841036-d20a-11ec-8377-0242ac110003 UniProtKB:P50997 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:15843912-d20a-11ec-8377-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:15847c60-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:15847c60-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:15847c60-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:15847c60-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:15847c60-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:15847c60-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:15847c60-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:15847c60-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digitoxin targets Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1584f500-d20a-11ec-8377-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.783']} DrugCentral uuid:15851d1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.136']} DrugCentral uuid:15854546-d20a-11ec-8377-0242ac110003 UniProtKB:P51449 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:15856de6-d20a-11ec-8377-0242ac110003 UniProtKB:P50997 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1585960e-d20a-11ec-8377-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:1585d998-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1585d998-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1585d998-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1585d998-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1585d998-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1585d998-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1585d998-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1585d998-d20a-11ec-8377-0242ac110003 UniProtKB:Q13733 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin is inhibitor of Transporter (Sodium/potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1586513e-d20a-11ec-8377-0242ac110003 UniProtKB:P51450 biolink:molecularly_interacts_with DrugCentral:882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 digoxin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1586797a-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.007']} DrugCentral uuid:1586a27e-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:1586cae2-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.187']} DrugCentral uuid:1586f31e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.526']} DrugCentral uuid:15871b6e-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:1587442c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:15876c86-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:158794f4-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.085']} DrugCentral uuid:1587bd44-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.114']} DrugCentral uuid:1587e634-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.121']} DrugCentral uuid:15880e98-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:158836d4-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.699']} DrugCentral uuid:15885f24-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.728']} DrugCentral uuid:15888a4e-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.261']} DrugCentral uuid:1588b2bc-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.369']} DrugCentral uuid:1588db0c-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:1589035c-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:15892d3c-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.299']} DrugCentral uuid:15895618-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:15897e4a-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpha-Ergocryptine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:1589a74e-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:886 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydrocodeine is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:1589cb66-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.087']} DrugCentral uuid:1589f3b6-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.462']} DrugCentral uuid:158a1bf2-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.23']} DrugCentral uuid:158a4686-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.309']} DrugCentral uuid:158a6f30-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.127']} DrugCentral uuid:158a9780-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:158abfa8-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.385']} DrugCentral uuid:158ae852-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.373']} DrugCentral uuid:158b1098-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.377']} DrugCentral uuid:158b38fc-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.903']} DrugCentral uuid:158b614c-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:158b8a64-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:158bae90-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.442']} DrugCentral uuid:158bd6e0-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:158bff3a-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.605']} DrugCentral uuid:158c2992-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1D) DrugCentral uuid:158c5098-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:158c78fc-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.183']} DrugCentral uuid:158ca14c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:158cc5e6-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:158cee36-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:158d1672-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.896']} DrugCentral uuid:158d3ec2-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:158d6776-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.79']} DrugCentral uuid:158d8f9e-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.14']} DrugCentral uuid:158db7c6-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocristine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:158de02a-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.804']} DrugCentral uuid:158e0a78-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.922']} DrugCentral uuid:158e32d2-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.529']} DrugCentral uuid:158e5c1c-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.412']} DrugCentral uuid:158e8476-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:158eae06-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.424']} DrugCentral uuid:158ed782-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.644']} DrugCentral uuid:158effe6-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.364']} DrugCentral uuid:158f29d0-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:158f5234-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.83']} DrugCentral uuid:158f7a8e-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:158fa388-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:158fc91c-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.752']} DrugCentral uuid:158ff4c8-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.742']} DrugCentral uuid:15901f34-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:1590477a-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:15907088-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.821']} DrugCentral uuid:159098c4-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.69']} DrugCentral uuid:1590c10a-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:1590e522-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 5A) DrugCentral uuid:159109bc-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:15913216-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:15915a70-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.349']} DrugCentral uuid:159182c0-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.416']} DrugCentral uuid:1591ad5e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1591d57c-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.18']} DrugCentral uuid:1591fdb8-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:15922612-d20a-11ec-8377-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:15924eee-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:15927842-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1592a088-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1592c8d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1592f952-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:1592f952-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:1592f952-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergotamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:159337aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinidine targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:15935bb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:15938250-d20a-11ec-8377-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:1593a816-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:1593cc42-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinidine targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:1593f082-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:15941562-d20a-11ec-8377-0242ac110003 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilazep targets Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:159445a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilazep targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:159445a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilazep targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:159445a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilazep targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:15948574-d20a-11ec-8377-0242ac110003 UniProtKB:O54699 biolink:molecularly_interacts_with DrugCentral:893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilazep targets Transporter (Equilibrative nucleoside transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1594ae00-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:894 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilevalol targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:1594d222-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:894 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilevalol targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:1594f644-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:894 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilevalol targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:15951a5c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:894 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilevalol targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:15953f96-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:894 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dilevalol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:1595680e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:15959054-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.736']} DrugCentral uuid:1595b87c-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:1595e1bc-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:15960a16-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem is blocker of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:15963338-d20a-11ec-8377-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:15965b7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.319']} DrugCentral uuid:15968568-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.017']} DrugCentral uuid:1596adc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1596d612-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:1596fe4e-d20a-11ec-8377-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:159728d8-d20a-11ec-8377-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:15975178-d20a-11ec-8377-0242ac110003 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:159779a0-d20a-11ec-8377-0242ac110003 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem is blocker of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1597a9c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1597a9c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1597a9c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1597f09c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1597f09c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1597f09c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:15982f1c-d20a-11ec-8377-0242ac110003 UniProtKB:P15388 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1598579e-d20a-11ec-8377-0242ac110003 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:15987fda-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JIS7 biolink:molecularly_interacts_with DrugCentral:897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diltiazem is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1598a820-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:900 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimemorfan is inhibitor of Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1598d052-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.791']} DrugCentral uuid:1598f99c-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.312']} DrugCentral uuid:159921d8-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.695']} DrugCentral uuid:15994a14-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.703']} DrugCentral uuid:15997264-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:15999c26-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.479']} DrugCentral uuid:1599c5c0-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:1599ee24-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:159a1688-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:159a3fb4-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.785']} DrugCentral uuid:159a67fa-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:159a9036-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:159ab87c-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.644']} DrugCentral uuid:159ae45a-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.749']} DrugCentral uuid:159b0fc0-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.821']} DrugCentral uuid:159b3afe-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimenhydrinate targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.847']} DrugCentral uuid:159b65ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q7KQK5 biolink:molecularly_interacts_with DrugCentral:902 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimetacrine targets Unclassified (Apical membrane antigen 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:159b8de2-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimetindene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.16']} DrugCentral uuid:159bb6b4-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:159bdefa-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:159c0808-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:159c3044-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:159c5894-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimetindene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:159c88aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:908 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimethyltubocurarinium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:159c88aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:908 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimethyltubocurarinium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:159c88aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:908 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimethyltubocurarinium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:159ccff4-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:908 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimethyltubocurarinium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:159ccff4-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:908 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimethyltubocurarinium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:159cfdbc-d20a-11ec-8377-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:911 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dioxyline targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:159d25e4-d20a-11ec-8377-0242ac110003 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:911 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dioxyline targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:159d4f92-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:159d77ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:159da03c-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:159dc90e-d20a-11ec-8377-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:159df168-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:159e19b8-d20a-11ec-8377-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:159e4208-d20a-11ec-8377-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:159e6c9c-d20a-11ec-8377-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:159e97e4-d20a-11ec-8377-0242ac110003 UniProtKB:P37289 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:159ec052-d20a-11ec-8377-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:159ee8a2-d20a-11ec-8377-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:159f117e-d20a-11ec-8377-0242ac110003 UniProtKB:P43117 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:159f39ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:159f634a-d20a-11ec-8377-0242ac110003 UniProtKB:P43114 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:159f8b9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:159fb4a8-d20a-11ec-8377-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:159fdcee-d20a-11ec-8377-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:15a00570-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.04']} DrugCentral uuid:15a02db6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:15a05886-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.48']} DrugCentral uuid:15a080b8-d20a-11ec-8377-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:15a0a8e0-d20a-11ec-8377-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:15a0d14e-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:15a0fa16-d20a-11ec-8377-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:15a1225c-d20a-11ec-8377-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:15a14ba6-d20a-11ec-8377-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:15a174c8-d20a-11ec-8377-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:15a19d2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:15a1c590-d20a-11ec-8377-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:15a1ede0-d20a-11ec-8377-0242ac110003 UniProtKB:P32240 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:15a217ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:15a24042-d20a-11ec-8377-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:15a2691e-d20a-11ec-8377-0242ac110003 UniProtKB:P43117 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:15a2916e-d20a-11ec-8377-0242ac110003 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:15a2ba0e-d20a-11ec-8377-0242ac110003 UniProtKB:P43114 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:15a2e25e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:15a30a9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:15a332f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:15a35bd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is activator of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:15a3840c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:15a3ac52-d20a-11ec-8377-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.39']} DrugCentral uuid:15a3d47a-d20a-11ec-8377-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:913 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dinoprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:15a3ff7c-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:915 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphemanil is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:15a423a8-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:915 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphemanil is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:15a447d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:15a46ffc-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.018']} DrugCentral uuid:15a498b0-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.432']} DrugCentral uuid:15a4c100-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.148']} DrugCentral uuid:15a4e950-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:15a51196-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.81']} DrugCentral uuid:15a53b6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:15a564de-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:15a58d24-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:15a5b560-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:15a5de82-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:15a606e6-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.585']} DrugCentral uuid:15a62f22-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.932']} DrugCentral uuid:15a657ea-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:15a68026-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.678']} DrugCentral uuid:15a6b046-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:15a6b046-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:15a6b046-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:15a6eeb2-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:15a71798-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenhydramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.658']} DrugCentral uuid:15a74006-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:918 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenoxylate is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.167']} DrugCentral uuid:15a76856-d20a-11ec-8377-0242ac110003 UniProtKB:P22001 biolink:molecularly_interacts_with DrugCentral:918 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenoxylate targets Ion channel (Potassium voltage-gated channel subfamily A member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:15a791be-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenylpyraline is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.076']} DrugCentral uuid:15a7ba36-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenylpyraline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:15a7e27c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenylpyraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.377']} DrugCentral uuid:15a80ab8-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenylpyraline targets Enzyme (Cytochrome P450 2D6) DrugCentral uuid:15a82f48-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diphenylpyraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:15a85770-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipivefrine is agonist of GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:15a87b92-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipivefrine is agonist of GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:15a8a05e-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipivefrine is agonist of GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:15a8c502-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diprafenone targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:15a8e92e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diprafenone targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:15a90e18-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diprafenone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:15a93258-d20a-11ec-8377-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:15a95ac6-d20a-11ec-8377-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:15a98640-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:15a9aea4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:15a9d712-d20a-11ec-8377-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.802']} DrugCentral uuid:15a9ffd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:15aa2848-d20a-11ec-8377-0242ac110003 UniProtKB:O95263 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:15aa50ac-d20a-11ec-8377-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:15aa791a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 7B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:15aaa214-d20a-11ec-8377-0242ac110003 UniProtKB:O60658 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:15aaca50-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.158']} DrugCentral uuid:15aaf3c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XSW7 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole targets Enzyme (Cyclic nucleotide phosphodiesterase PDE3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:15ab1c08-d20a-11ec-8377-0242ac110003 UniProtKB:O77823 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole targets Enzyme (Cyclic AMP-specific phosphodiesterase SSPDE4A1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:15ab498a-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:15ab498a-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:15ab8116-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:15ab8116-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:15abc806-d20a-11ec-8377-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:15abc806-d20a-11ec-8377-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:15abc806-d20a-11ec-8377-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:15abc806-d20a-11ec-8377-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:15abc806-d20a-11ec-8377-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:15abc806-d20a-11ec-8377-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:15ac3188-d20a-11ec-8377-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:15ac3188-d20a-11ec-8377-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:15ac3188-d20a-11ec-8377-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:15ac7080-d20a-11ec-8377-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:15ac98e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q86TP1 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole targets Enzyme (Protein prune homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:15acc0f8-d20a-11ec-8377-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:15ace920-d20a-11ec-8377-0242ac110003 UniProtKB:P0DTD1 biolink:molecularly_interacts_with DrugCentral:924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dipyridamole is inhibitor of Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:15ad1238-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:15ad3678-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.036']} DrugCentral uuid:15ad5eaa-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.569']} DrugCentral uuid:15ad86fa-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:15adac8e-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:15add0c4-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:15adf4e6-d20a-11ec-8377-0242ac110003 UniProtKB:P48544 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets Ion channel (G protein-activated inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:15ae1d5e-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:15ae45fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:926 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disopyramide targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.604']} DrugCentral uuid:15ae6f2a-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 distigmine is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:15ae9360-d20a-11ec-8377-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.237']} DrugCentral uuid:15aebbc4-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.846']} DrugCentral uuid:15aee4f0-d20a-11ec-8377-0242ac110003 UniProtKB:P30536 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Transporter (Translocator protein) DrugCentral uuid:15af0926-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.967']} DrugCentral uuid:15af316c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.115']} DrugCentral uuid:15af59da-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.735']} DrugCentral uuid:15af8306-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.156']} DrugCentral uuid:15afab56-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.658']} DrugCentral uuid:15afd4e6-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.129']} DrugCentral uuid:15affe62-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.833']} DrugCentral uuid:15b02720-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.434']} DrugCentral uuid:15b04f98-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.434']} DrugCentral uuid:15b077f2-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:15b0a04c-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.957']} DrugCentral uuid:15b0cac2-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.612']} DrugCentral uuid:15b0f376-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:15b11bbc-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.862']} DrugCentral uuid:15b14402-d20a-11ec-8377-0242ac110003 UniProtKB:P05091 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram is inhibitor of Enzyme (Aldehyde dehydrogenase, mitochondrial) DrugCentral uuid:15b16888-d20a-11ec-8377-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.319']} DrugCentral uuid:15b190c4-d20a-11ec-8377-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.738']} DrugCentral uuid:15b1b914-d20a-11ec-8377-0242ac110003 UniProtKB:P25025 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (C-X-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.376']} DrugCentral uuid:15b1e15a-d20a-11ec-8377-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:15b20a18-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.821']} DrugCentral uuid:15b2325e-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.794']} DrugCentral uuid:15b25aae-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.669']} DrugCentral uuid:15b28308-d20a-11ec-8377-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.357']} DrugCentral uuid:15b2af22-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.333']} DrugCentral uuid:15b2da4c-d20a-11ec-8377-0242ac110003 UniProtKB:P11884 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Aldehyde dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:15b30558-d20a-11ec-8377-0242ac110003 UniProtKB:Q99685 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Monoglyceride lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:15b32ff6-d20a-11ec-8377-0242ac110003 UniProtKB:P9WMN3 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Bifunctional protein GlmU) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:15b35846-d20a-11ec-8377-0242ac110003 UniProtKB:P28300 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Protein-lysine 6-oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:15b38078-d20a-11ec-8377-0242ac110003 UniProtKB:P29375 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Lysine-specific demethylase 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:15b3a8be-d20a-11ec-8377-0242ac110003 UniProtKB:P58215 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Lysyl oxidase homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:15b3d17c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96JB6 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Lysyl oxidase homolog 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:15b3fa80-d20a-11ec-8377-0242ac110003 UniProtKB:Q96KQ7 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Histone-lysine N-methyltransferase EHMT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:15b423ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H9B1 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Histone-lysine N-methyltransferase EHMT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:15b44d46-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K0 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Enzyme (Lysyl oxidase homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:15b478de-d20a-11ec-8377-0242ac110003 UniProtKB:P57764 biolink:molecularly_interacts_with DrugCentral:928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disulfiram targets Unclassified (Gasdermin-D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:15b4a3b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9VTU8 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 2, isoform A; LD26647p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:15b4cc12-d20a-11ec-8377-0242ac110003 UniProtKB:Q9V396 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 1; GH09688p) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:15b4f476-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:15b51d8e-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:15b545f2-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:15b56e42-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:15b5971e-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:15b5c004-d20a-11ec-8377-0242ac110003 UniProtKB:P05181 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Cytochrome P450 2E1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:15b5e98a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:15b611f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q96KQ7 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Histone-lysine N-methyltransferase EHMT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:15b63b1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H9B1 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Enzyme (Histone-lysine N-methyltransferase EHMT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:15b6636a-d20a-11ec-8377-0242ac110003 UniProtKB:P57764 biolink:molecularly_interacts_with DrugCentral:931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ditiocarb targets Unclassified (Gasdermin-D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:15b68bb0-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:15b6b3ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q8R4D5 biolink:molecularly_interacts_with DrugCentral:934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:15b6dcc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8R455 biolink:molecularly_interacts_with DrugCentral:934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:15b704fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenthol is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:15b72d54-d20a-11ec-8377-0242ac110003 UniProtKB:Q7Z2W7 biolink:molecularly_interacts_with DrugCentral:934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenthol is activator of Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:15b75590-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:15b77e26-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:15b7a658-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.976']} DrugCentral uuid:15b7ce9e-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.997']} DrugCentral uuid:15b7f6f8-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:15b822fe-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.868']} DrugCentral uuid:15b84c02-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.771']} DrugCentral uuid:15b87448-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:15b89c8e-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:15b8c592-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:15b8edf6-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:15b91650-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:15b93ef0-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:15b96754-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:15b98fae-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.256']} DrugCentral uuid:15b9b7f4-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:15b9e17a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:15ba0bfa-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:15ba3454-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.258']} DrugCentral uuid:15ba5c90-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.401']} DrugCentral uuid:15ba8562-d20a-11ec-8377-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.301']} DrugCentral uuid:15baadbc-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:15bad616-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:15bafe7a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:15bb272e-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:15bb4f6a-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.223']} DrugCentral uuid:15bb77a6-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:15bb9fd8-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:15bbc940-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:15bbf29e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:15bc1bd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dobutamine targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:15bc4438-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:15bc6d14-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:15bc9140-d20a-11ec-8377-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:15bcb576-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.086']} DrugCentral uuid:15bcde52-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.283']} DrugCentral uuid:15bd074c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02643 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel targets GPCR (Growth hormone-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:15bd4e96-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:15bd4e96-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:15bd4e96-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:15bd4e96-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:15bd4e96-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:15bd4e96-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:15bd4e96-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:15bd4e96-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:15bd4e96-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'ID50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:15bdd17c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC29 biolink:molecularly_interacts_with DrugCentral:939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docetaxel targets Cytosolic other (Nucleotide-binding oligomerization domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:15be255a-d20a-11ec-8377-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:15be255a-d20a-11ec-8377-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:15be255a-d20a-11ec-8377-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:15be255a-d20a-11ec-8377-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:15be255a-d20a-11ec-8377-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:15be255a-d20a-11ec-8377-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:15be255a-d20a-11ec-8377-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:15be255a-d20a-11ec-8377-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:15be255a-d20a-11ec-8377-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:15be255a-d20a-11ec-8377-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:15be255a-d20a-11ec-8377-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:15be255a-d20a-11ec-8377-0242ac110003 UniProtKB:Q69091 biolink:molecularly_interacts_with DrugCentral:940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanol is inhibitor of Membrane other (Envelope glycoprotein) DrugCentral uuid:15beb574-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dofetilide is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:15bede46-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dofetilide targets Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:15bf0290-d20a-11ec-8377-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dofetilide is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:15bf2af4-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.766']} DrugCentral uuid:15bf534e-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:15bf7f18-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.988']} DrugCentral uuid:15bfa9d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:15bfd206-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:15bff826-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:15c02076-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.586']} DrugCentral uuid:15c048da-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:15c07148-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.781']} DrugCentral uuid:15c09a24-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.156']} DrugCentral uuid:15c0c26a-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:15c0eaba-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.013']} DrugCentral uuid:15c11300-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:15c13d26-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:15c16580-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:15c18db2-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.833']} DrugCentral uuid:15c1b602-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.097']} DrugCentral uuid:15c1dede-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.936']} DrugCentral uuid:15c2072e-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.276']} DrugCentral uuid:15c22f74-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.553']} DrugCentral uuid:15c25f8a-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Cytosolic other (Calmodulin) DrugCentral uuid:15c25f8a-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Cytosolic other (Calmodulin) DrugCentral uuid:15c25f8a-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Cytosolic other (Calmodulin) DrugCentral uuid:15c298ba-d20a-11ec-8377-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:15c2c0f6-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:15c2e946-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:15c312ae-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:15c33b1c-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.93']} DrugCentral uuid:15c36376-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:15c38ba8-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:15c3b48e-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domperidone targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:15c3dcca-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:15c404fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:15c42d38-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:15c455ce-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.046']} DrugCentral uuid:15c47eaa-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:15c4a704-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:15c4cf4a-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:15c4fac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:15c52300-d20a-11ec-8377-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:15c54b28-d20a-11ec-8377-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:15c573dc-d20a-11ec-8377-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:15c59c04-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:15c5c558-d20a-11ec-8377-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:15c5ed94-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:15c61652-d20a-11ec-8377-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:15c63ea2-d20a-11ec-8377-0242ac110003 UniProtKB:P32738 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Choline O-acetyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:15c666de-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:15c6901e-d20a-11ec-8377-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:15c6b9e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:15c6e564-d20a-11ec-8377-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:15c70fb2-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 donepezil targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:15c737da-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:15c760b6-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.19']} DrugCentral uuid:15c78910-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:15c7b160-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:15c7d9b0-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.18']} DrugCentral uuid:15c8023c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.084']} DrugCentral uuid:15c82a8c-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:15c852d2-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:15c87b2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:15c8a71e-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:15c8d27a-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.375']} DrugCentral uuid:15c8fab6-d20a-11ec-8377-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:15c923ce-d20a-11ec-8377-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:15c94c28-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:15c97482-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15c99caa-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:15c9c536-d20a-11ec-8377-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:15c9ed68-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:15ca15ae-d20a-11ec-8377-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:15ca3dfe-d20a-11ec-8377-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:15ca675c-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:15ca8fa2-d20a-11ec-8377-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:15cab8c4-d20a-11ec-8377-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:15cae178-d20a-11ec-8377-0242ac110003 UniProtKB:P09172 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Dopamine beta-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3']} DrugCentral uuid:15cb162a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:15cb162a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:15cb162a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:15cb162a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:15cb6756-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:15cb6756-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:15cb6756-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:15cbabf8-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:15cbabf8-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:15cbeece-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:15cbeece-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:15cbeece-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:15cbeece-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:15cbeece-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:15cc4c48-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:15cc4c48-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:15cc4c48-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:15cca5ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:15cca5ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:15cca5ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:15cca5ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:15cca5ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:15cca5ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:15cca5ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:15cca5ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:15cd1d3a-d20a-11ec-8377-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:15cd4594-d20a-11ec-8377-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:15cd6e5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8I2J3 biolink:molecularly_interacts_with DrugCentral:947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopamine targets Enzyme (M18 aspartyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:15cd968e-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:948 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopexamine targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:15cdbaa6-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:948 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dopexamine targets GPCR (D(1A) dopamine receptor) DrugCentral uuid:15cddef0-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:15ce089e-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:15ce312a-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:15ce597a-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:15ce81c0-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:15ceaa60-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:15ced29c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:15ceface-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:15cf2328-d20a-11ec-8377-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:15cf4be6-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:15cf7436-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:15cf9c86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:15cfc616-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:15cfef74-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:15d017ce-d20a-11ec-8377-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:15d0400a-d20a-11ec-8377-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:15d06882-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:15d09122-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:15d0b972-d20a-11ec-8377-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:15d0e1ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:15d10b0c-d20a-11ec-8377-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:15d13410-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:15d15cd8-d20a-11ec-8377-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:15d1851e-d20a-11ec-8377-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:15d1ae90-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:15d1d6f4-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:15d1ff58-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:15d227a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:15d2505c-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:15d2788e-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:15d2a0ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:15d2c910-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dorzolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:15d2f21e-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.066']} DrugCentral uuid:15d31a82-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.337']} DrugCentral uuid:15d342be-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.588']} DrugCentral uuid:15d36b18-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.378']} DrugCentral uuid:15d3952a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:15d3bd52-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:15d3e584-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.744']} DrugCentral uuid:15d40dca-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:15d4366a-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:15d45ea6-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:15d486d8-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.036']} DrugCentral uuid:15d4af14-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dosulepin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.275']} DrugCentral uuid:15d4d804-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:953 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxapram targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:15d50126-d20a-11ec-8377-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:953 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxapram is blocker of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:15d52570-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:953 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxapram is blocker of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:15d5497e-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:15d57458-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:15d59ca8-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:15d5c62e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:15d5eec4-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:15d6173c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.845']} DrugCentral uuid:15d63f8c-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.631']} DrugCentral uuid:15d667f0-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.545']} DrugCentral uuid:15d690c2-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:15d6b91c-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:15d6e162-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.827']} DrugCentral uuid:15d709d0-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:15d7339c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:15d75ed0-d20a-11ec-8377-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:15d78702-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.381']} DrugCentral uuid:15d7af3e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.81']} DrugCentral uuid:15d7d806-d20a-11ec-8377-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxazosin targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:15d80038-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:15d8282e-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:15d85042-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:15d878ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:15d8a132-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.17']} DrugCentral uuid:15d8c982-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.53']} DrugCentral uuid:15d8f290-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:15d91b80-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.45']} DrugCentral uuid:15d9439e-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:15d96bbc-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:15d993f8-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:15d9bcf2-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (5-hydroxytryptamine receptor 7) DrugCentral uuid:15d9e11e-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.629']} DrugCentral uuid:15da0964-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:15da31a0-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.325']} DrugCentral uuid:15da5a40-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:15da8272-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:15daaa72-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:15dad3bc-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:15dafe46-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:15db2678-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.086']} DrugCentral uuid:15db4ea0-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:15db7858-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:15dba08a-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:15dbca10-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:15dbf238-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:15dc1b0a-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11']} DrugCentral uuid:15dc433c-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.886']} DrugCentral uuid:15dc9d32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15dc9d32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15dc9d32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15dc9d32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15dc9d32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15dc9d32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15dc9d32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15dc9d32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15dc9d32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15dc9d32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15dc9d32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15dc9d32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15dc9d32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15dc9d32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15dd595c-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxepin is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:15dd81a2-d20a-11ec-8377-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:957 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxercalciferol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:15dda5c4-d20a-11ec-8377-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxifluridine targets Enzyme (Thymidylate synthase) DrugCentral uuid:15ddc9fa-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.682']} DrugCentral uuid:15ddf2e0-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:15de1b30-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.433']} DrugCentral uuid:15de438a-d20a-11ec-8377-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:15de67e8-d20a-11ec-8377-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:15de92ea-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:15deb996-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:15dee02e-d20a-11ec-8377-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:15df04aa-d20a-11ec-8377-0242ac110003 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.914']} DrugCentral uuid:15df2d7c-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.496']} DrugCentral uuid:15df55b8-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.288']} DrugCentral uuid:15df7df4-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.605']} DrugCentral uuid:15dfa63a-d20a-11ec-8377-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:15dfceee-d20a-11ec-8377-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:15dff81a-d20a-11ec-8377-0242ac110003 UniProtKB:O14746 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (Telomerase reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15e0204c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:15e0489c-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:15e072c2-d20a-11ec-8377-0242ac110003 UniProtKB:P61823 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (Ribonuclease pancreatic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:15e09b12-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.867']} DrugCentral uuid:15e0c358-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.805']} DrugCentral uuid:15e0ec48-d20a-11ec-8377-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:15e11498-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:15e13ce8-d20a-11ec-8377-0242ac110003 UniProtKB:P43870 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Unclassified (Type-2 restriction enzyme HindIII) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:15e1652e-d20a-11ec-8377-0242ac110003 UniProtKB:O52691 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Unclassified (Type-2 restriction enzyme ScaI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:15e18dce-d20a-11ec-8377-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.84']} DrugCentral uuid:15e1b5e2-d20a-11ec-8377-0242ac110003 UniProtKB:P9WIQ1 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Enzyme (UDP-galactopyranose mutase) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:15e1de0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxorubicin targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:15e20646-d20a-11ec-8377-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:15e22b3a-d20a-11ec-8377-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:15e25380-d20a-11ec-8377-0242ac110003 UniProtKB:P08254 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline targets Enzyme (Stromelysin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:15e27ba8-d20a-11ec-8377-0242ac110003 UniProtKB:P22894 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline is inhibitor of Enzyme (Neutrophil collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:15e2a3e4-d20a-11ec-8377-0242ac110003 UniProtKB:P45452 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline is inhibitor of Enzyme (Collagenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:15e2ccc0-d20a-11ec-8377-0242ac110003 UniProtKB:P02980 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline targets Transporter (Tetracycline resistance protein, class B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:15e2f4e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:15e31cfc-d20a-11ec-8377-0242ac110003 UniProtKB:P09237 biolink:molecularly_interacts_with DrugCentral:961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxycycline is inhibitor of Enzyme (Matrilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.14']} DrugCentral uuid:15e3454c-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxylamine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:15e369d2-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:965 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 drostanolone propionate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:15e38dfe-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.199']} DrugCentral uuid:15e3b658-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.263']} DrugCentral uuid:15e3debc-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.602']} DrugCentral uuid:15e409d2-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.954']} DrugCentral uuid:15e4325e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:15e45aa4-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:15e4839e-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.132']} DrugCentral uuid:15e4acac-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.069']} DrugCentral uuid:15e4d4fc-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.623']} DrugCentral uuid:15e4fd60-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.996']} DrugCentral uuid:15e525c4-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.027']} DrugCentral uuid:15e54e8c-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:15e576e6-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:15e59f4a-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.782']} DrugCentral uuid:15e5c7b8-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.592']} DrugCentral uuid:15e5f3a0-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.076']} DrugCentral uuid:15e61c22-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.175']} DrugCentral uuid:15e6447c-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:15e66eb6-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.695']} DrugCentral uuid:15e69724-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.78']} DrugCentral uuid:15e6bf6a-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:15e6efa8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:15e6efa8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:15e6efa8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:15e72eb4-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 drospirenone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.5']} DrugCentral uuid:15e756fa-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 drospirenone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:15e77f4a-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 drospirenone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.5']} DrugCentral uuid:15e7a8bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:969 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 drotaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:15e7d08a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:969 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 drotaverine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:15e7f754-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:15e840c4-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:15e840c4-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:15e840c4-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:15e840c4-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:15e840c4-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:15e840c4-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:15e840c4-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:15e840c4-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:15e840c4-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is agonist of GPCR (Adrenergic receptor) DrugCentral uuid:15e8b270-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 droxidopa is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:15e8db42-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:15e903ba-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:15e92bec-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:15e95450-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:15e97dd6-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:15e9a928-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:15e9d1f0-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:15e9fa22-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:15ea22fe-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.638']} DrugCentral uuid:15ea4b1c-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.402']} DrugCentral uuid:15ea7358-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:15ea9b9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:15eac4b6-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.352']} DrugCentral uuid:15eaecf2-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.428']} DrugCentral uuid:15eb15c4-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.09']} DrugCentral uuid:15eb3f40-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:15eb6b50-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:15eb968e-d20a-11ec-8377-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duloxetine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:15ebc0e6-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dutasteride targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:15ebe9d6-d20a-11ec-8377-0242ac110003 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dutasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:15ec1226-d20a-11ec-8377-0242ac110003 UniProtKB:P18405 biolink:molecularly_interacts_with DrugCentral:973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dutasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:15ec3a62-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dyclonine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:15ec6294-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dyclonine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:15ec8756-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:975 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dydrogesterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:15ecafa6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:975 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dydrogesterone targets Nuclear hormone receptor (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.561']} DrugCentral uuid:15ecd814-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:976 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diprophylline is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) DrugCentral uuid:15ecfc4a-d20a-11ec-8377-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:976 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diprophylline is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:15ed212a-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:15ed4984-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:15ed71c0-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.506']} DrugCentral uuid:15ed9a10-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:15edc30a-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:15edeb46-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.185']} DrugCentral uuid:15ee136e-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:15ee3baa-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:15ee644a-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.588']} DrugCentral uuid:15ee8c86-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.701']} DrugCentral uuid:15eeb4c2-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.905']} DrugCentral uuid:15eedd12-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:15ef0774-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.472']} DrugCentral uuid:15ef2fb0-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.384']} DrugCentral uuid:15ef57ce-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.543']} DrugCentral uuid:15ef8104-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:15efa99a-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.554']} DrugCentral uuid:15efd1fe-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.863']} DrugCentral uuid:15effa58-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.937']} DrugCentral uuid:15f022a8-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.615']} DrugCentral uuid:15f04b98-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.719']} DrugCentral uuid:15f073de-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.397']} DrugCentral uuid:15f09c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.106']} DrugCentral uuid:15f0c4d8-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.743']} DrugCentral uuid:15f0f0d4-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:15f11b72-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:15f14502-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.126']} DrugCentral uuid:15f16df2-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.253']} DrugCentral uuid:15f19642-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.091']} DrugCentral uuid:15f1be88-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.976']} DrugCentral uuid:15f1e6a6-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.191']} DrugCentral uuid:15f20f3c-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.633']} DrugCentral uuid:15f2378c-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.849']} DrugCentral uuid:15f25fe6-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.871']} DrugCentral uuid:15f28818-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:15f2b16c-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.35']} DrugCentral uuid:15f2d994-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:15f301d0-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:979 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ebrotidine is antagonist of GPCR (Histamine H2 receptor) DrugCentral uuid:15f32624-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 echothiophate is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:15f34ac8-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.131']} DrugCentral uuid:15f3730e-d20a-11ec-8377-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.543']} DrugCentral uuid:15f39c58-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.636']} DrugCentral uuid:15f3c4a8-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.336']} DrugCentral uuid:15f3edb6-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:15f415f2-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.086']} DrugCentral uuid:15f43e4c-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:15f466a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.052']} DrugCentral uuid:15f49202-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:15f4ba7a-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.648']} DrugCentral uuid:15f4e2b6-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.617']} DrugCentral uuid:15f50afc-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.034']} DrugCentral uuid:15f533ba-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.939']} DrugCentral uuid:15f55c0a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.362']} DrugCentral uuid:15f5845a-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.202']} DrugCentral uuid:15f5ad68-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.296']} DrugCentral uuid:15f5d5ae-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.572']} DrugCentral uuid:15f5fdfe-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.792']} DrugCentral uuid:15f6263a-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.805']} DrugCentral uuid:15f65074-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.197']} DrugCentral uuid:15f67bd0-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.936']} DrugCentral uuid:15f6a434-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.421']} DrugCentral uuid:15f6cc7a-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.529']} DrugCentral uuid:15f6f52e-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.336']} DrugCentral uuid:15f71d6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.178']} DrugCentral uuid:15f746c8-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:15f76edc-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.006']} DrugCentral uuid:15f798b2-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:15f7c10c-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.485']} DrugCentral uuid:15f7e970-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.359']} DrugCentral uuid:15f811a2-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.463']} DrugCentral uuid:15f83b46-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:15f85f4a-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.294']} DrugCentral uuid:15f8879a-d20a-11ec-8377-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:15f8afc2-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.864']} DrugCentral uuid:15f8d844-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:15f90062-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:15f9288a-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.489']} DrugCentral uuid:15f950c6-d20a-11ec-8377-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.189']} DrugCentral uuid:15f979ca-d20a-11ec-8377-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:15f9a21a-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:15f9ca4c-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.916']} DrugCentral uuid:15f9f42c-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.857']} DrugCentral uuid:15fa1c86-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:15fa44d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:15fa6d1c-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.155']} DrugCentral uuid:15fa95a8-d20a-11ec-8377-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:15fabde4-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.697']} DrugCentral uuid:15fae60c-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.171']} DrugCentral uuid:15fb0e5c-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.999']} DrugCentral uuid:15fb3724-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.431']} DrugCentral uuid:15fb5f60-d20a-11ec-8377-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.503']} DrugCentral uuid:15fb8792-d20a-11ec-8377-0242ac110003 UniProtKB:P49146 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Neuropeptide Y receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.959']} DrugCentral uuid:15fbb0c8-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.498']} DrugCentral uuid:15fbda44-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.875']} DrugCentral uuid:15fc0280-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:15fc2b20-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:15fc5370-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:15fc7c10-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:15fca44c-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15fcccb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:15fcf4d8-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:15fd1db4-d20a-11ec-8377-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:15fd473a-d20a-11ec-8377-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:15fd6f94-d20a-11ec-8377-0242ac110003 UniProtKB:Q96D31 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Ion channel (Calcium release-activated calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:15fd97f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 econazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.51']} DrugCentral uuid:15fdc3ea-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:986 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edatrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.36']} DrugCentral uuid:15fdec3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:986 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edatrexate targets Enzyme (Folylpolyglutamate synthase, mitochondrial) DrugCentral uuid:15fe1052-d20a-11ec-8377-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:986 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edatrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:15fe392e-d20a-11ec-8377-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:986 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edatrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:15fe6188-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:15fe89ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q16739 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Enzyme (Ceramide glucosyltransferase) DrugCentral uuid:15feaddc-d20a-11ec-8377-0242ac110003 UniProtKB:Q79MP6 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:15fed6e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XAY4 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Unclassified (Beta-lactamase VIM-1; Class B carbapenemase VIM-1; Metallo-beta-lactamase; Metallo-beta-lactamase VIM-1; Metallobeta-lactamase; VIM-1; VIM-1 metallo-beta lactamase; VIM-1 metallo-beta-lactamase; VIM-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:15feff3a-d20a-11ec-8377-0242ac110003 UniProtKB:J3SE37 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:15ff2758-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:15ff4f9e-d20a-11ec-8377-0242ac110003 UniProtKB:O00167 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Enzyme (Eyes absent homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:15ff7924-d20a-11ec-8377-0242ac110003 UniProtKB:O00167 biolink:molecularly_interacts_with DrugCentral:987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edetic acid targets Enzyme (Eyes absent homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:15ffa548-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edrophonium is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.79']} DrugCentral uuid:15ffd040-d20a-11ec-8377-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edrophonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:15fff8a4-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efavirenz is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:16002144-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efavirenz targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:1600457a-d20a-11ec-8377-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efavirenz is inhibitor of Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:16006dd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efavirenz is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:16009638-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efavirenz targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1600bf32-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efavirenz is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:1600e7fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efavirenz targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:1601104a-d20a-11ec-8377-0242ac110003 UniProtKB:P11926 biolink:molecularly_interacts_with DrugCentral:990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eflornithine is inhibitor of Enzyme (Ornithine decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1601389a-d20a-11ec-8377-0242ac110003 UniProtKB:P09057 biolink:molecularly_interacts_with DrugCentral:990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eflornithine targets Enzyme (Ornithine decarboxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:160163c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9TZZ6 biolink:molecularly_interacts_with DrugCentral:990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eflornithine is inhibitor of Enzyme (Ornithine decarboxylase) DrugCentral uuid:16018962-d20a-11ec-8377-0242ac110003 UniProtKB:O54898 biolink:molecularly_interacts_with DrugCentral:992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efonidipine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1601b1b2-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efonidipine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.621']} DrugCentral uuid:1601dde0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efonidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:1601dde0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efonidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:16020c34-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:16023498-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:16025d10-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.05']} DrugCentral uuid:160285ec-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1602ae32-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eletriptan is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1602d678-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elliptinium targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1602febe-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elliptinium targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:160329d4-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elliptinium targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:16035d14-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:16035d14-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:16035d14-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1603d7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltanolone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1604a796-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emedastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:1604d00e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emetine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:1604f9d0-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emetine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:16052482-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emetine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.578']} DrugCentral uuid:16054cd2-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emetine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:16057518-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emetine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:16059db8-d20a-11ec-8377-0242ac110003 UniProtKB:O75884 biolink:molecularly_interacts_with DrugCentral:1001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emetine targets Enzyme (Putative hydrolase RBBP9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1605c5ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1003 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emtricitabine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:1605eaf2-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1005 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:16061310-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1005 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:16063bce-d20a-11ec-8377-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:1005 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1606641e-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalaprilat is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:16068c5a-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1606b4b4-d20a-11ec-8377-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:1006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:1606df52-d20a-11ec-8377-0242ac110003 UniProtKB:Q5EGZ1 biolink:molecularly_interacts_with DrugCentral:1006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:160707a2-d20a-11ec-8377-0242ac110003 UniProtKB:P09470 biolink:molecularly_interacts_with DrugCentral:1006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enalaprilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.94']} DrugCentral uuid:16072fd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1007 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encainide targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:160753ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:1007 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:16077994-d20a-11ec-8377-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:1007 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:16079dac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:1007 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:1607c26e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:1007 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encainide targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:1607e690-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 endralazine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:16080b84-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enflurane is positive modulator of Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:16082fba-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:160853fa-d20a-11ec-8377-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:16087830-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:16089db0-d20a-11ec-8377-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:1009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:1608c236-d20a-11ec-8377-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:1009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:1608e64e-d20a-11ec-8377-0242ac110003 UniProtKB:Q53I07 biolink:molecularly_interacts_with DrugCentral:1010 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfuvirtide targets Viral envelope protein (Envelope glycoprotein) DrugCentral uuid:16090a8e-d20a-11ec-8377-0242ac110003 UniProtKB:O40239 biolink:molecularly_interacts_with DrugCentral:1010 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfuvirtide is inhibitor of Membrane other (Transmembrane glycoprotein gp41) DrugCentral uuid:16092ea6-d20a-11ec-8377-0242ac110003 UniProtKB:Q76270 biolink:molecularly_interacts_with DrugCentral:1010 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfuvirtide targets Unclassified (GP41) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:160957f0-d20a-11ec-8377-0242ac110003 UniProtKB:P43700 biolink:molecularly_interacts_with DrugCentral:1013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxacin targets Enzyme (DNA gyrase subunit A) DrugCentral uuid:16097c08-d20a-11ec-8377-0242ac110003 UniProtKB:P21281 biolink:molecularly_interacts_with DrugCentral:1013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxacin targets Enzyme (V-type proton ATPase subunit B, brain isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1609a836-d20a-11ec-8377-0242ac110003 UniProtKB:Q5EP76 biolink:molecularly_interacts_with DrugCentral:1013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:1609a836-d20a-11ec-8377-0242ac110003 UniProtKB:Q5EP76 biolink:molecularly_interacts_with DrugCentral:1013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:1609da9a-d20a-11ec-8377-0242ac110003 UniProtKB:P48371 biolink:molecularly_interacts_with DrugCentral:1013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:1609da9a-d20a-11ec-8377-0242ac110003 UniProtKB:P48371 biolink:molecularly_interacts_with DrugCentral:1013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:160a0858-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoximone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.345']} DrugCentral uuid:160a3d1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:160a3d1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:160a3d1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:160a3d1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoximone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:160a88a0-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:160ab104-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:160ad95e-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:160b01ae-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.03']} DrugCentral uuid:160b2aa8-d20a-11ec-8377-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:160b4ed4-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:160b772e-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:160b9f7e-d20a-11ec-8377-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:160bc83c-d20a-11ec-8377-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:160bf082-d20a-11ec-8377-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:1015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprofylline targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.04']} DrugCentral uuid:160c18d2-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprostil targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:160c41a4-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprostil targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:160c69fe-d20a-11ec-8377-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:1016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprostil targets GPCR (Prostacyclin receptor) DrugCentral uuid:160c8e16-d20a-11ec-8377-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprostil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:160cb792-d20a-11ec-8377-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprostil is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:160ce0c8-d20a-11ec-8377-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:1016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprostil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.13']} DrugCentral uuid:160d097c-d20a-11ec-8377-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:1016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enprostil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:160d31d6-d20a-11ec-8377-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:1018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entacapone targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:160d5a12-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entacapone targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:160d82a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9C0B1 biolink:molecularly_interacts_with DrugCentral:1018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entacapone targets Unclassified (Alpha-ketoglutarate-dependent dioxygenase FTO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:160daad0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9C0B1 biolink:molecularly_interacts_with DrugCentral:1018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entacapone targets Unclassified (Alpha-ketoglutarate-dependent dioxygenase FTO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:160dd3a2-d20a-11ec-8377-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:1018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entacapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.523']} DrugCentral uuid:160dfcc4-d20a-11ec-8377-0242ac110003 UniProtKB:P17394 biolink:molecularly_interacts_with DrugCentral:1019 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entecavir targets Polyprotein (Protein P) DrugCentral uuid:160e219a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:1019 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entecavir is inhibitor of Polyprotein (Protein P) DrugCentral uuid:160e45e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:1019 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entecavir targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:160e6e02-d20a-11ec-8377-0242ac110003 UniProtKB:P14550 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:160e962a-d20a-11ec-8377-0242ac110003 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:160ebefc-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:160ee742-d20a-11ec-8377-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:160f0f92-d20a-11ec-8377-0242ac110003 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:160f37ec-d20a-11ec-8377-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:160f6082-d20a-11ec-8377-0242ac110003 UniProtKB:Q00796 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat targets Enzyme (Sorbitol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:160f88c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q02928 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat is inhibitor of Enzyme (Cytochrome P450 4A11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:160fb118-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epalrestat is inhibitor of Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.678']} DrugCentral uuid:160fd95e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eperisone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:1610035c-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eperisone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.859']} DrugCentral uuid:16102bca-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eperisone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:16105438-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eperisone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:16107c74-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1024 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ephedrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1610a578-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:1610c9a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1610f1e0-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:16111602-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:16113a88-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:16115eb4-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:1611870e-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets GPCR (Histamine H2 receptor) DrugCentral uuid:1611ab30-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1611d498-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1611fcb6-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:161225d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinastine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:16124e00-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.401']} DrugCentral uuid:1612784e-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1612a0c6-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.26']} DrugCentral uuid:1612c920-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1612f198-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.559']} DrugCentral uuid:16131a74-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.434']} DrugCentral uuid:161342d8-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:16136b64-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.401']} DrugCentral uuid:16139512-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.449']} DrugCentral uuid:1613c096-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1613eb2a-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:16141398-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.484']} DrugCentral uuid:16143c60-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:161464a6-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:16148cec-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1614b546-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1614de18-d20a-11ec-8377-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1615067c-d20a-11ec-8377-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:16152ee0-d20a-11ec-8377-0242ac110003 UniProtKB:P10608 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:16155744-d20a-11ec-8377-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:16158a5c-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:16158a5c-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:16158a5c-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1615d0e8-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1615d0e8-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1615d0e8-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:16161120-d20a-11ec-8377-0242ac110003 UniProtKB:Q8I2J3 biolink:molecularly_interacts_with DrugCentral:1028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epinephrine targets Enzyme (M18 aspartyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1616395c-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1030 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epirubicin targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.878']} DrugCentral uuid:161661c0-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1030 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epirubicin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.286']} DrugCentral uuid:16168a10-d20a-11ec-8377-0242ac110003 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:1030 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epirubicin targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1616b2c4-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eplerenone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:1616db14-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eplerenone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:16170364-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eplerenone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:16172bc8-d20a-11ec-8377-0242ac110003 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:1032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eplerenone targets Transcription factor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:16175684-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eplerenone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:16178140-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eplerenone targets Nuclear other (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1617a9a4-d20a-11ec-8377-0242ac110003 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:1032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eplerenone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1617d1fe-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoprostenol is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1617faf8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:1034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoprostenol targets GPCR (P2Y purinoceptor 12) DrugCentral uuid:16182046-d20a-11ec-8377-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:1034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoprostenol is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:161848be-d20a-11ec-8377-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoprostenol is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1618712c-d20a-11ec-8377-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:16189a76-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1618c2bc-d20a-11ec-8377-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1618eecc-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1618eecc-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:16192c48-d20a-11ec-8377-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:16192c48-d20a-11ec-8377-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:16192c48-d20a-11ec-8377-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eprosartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:16197298-d20a-11ec-8377-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:1040 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eptifibatide is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:16197298-d20a-11ec-8377-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:1040 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eptifibatide is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:1619a5f6-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:1619cef0-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1619f72c-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:161a1f7c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.333']} DrugCentral uuid:161a47c2-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:161a7062-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.58']} DrugCentral uuid:161a98a8-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:161ac0f8-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:161aea60-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.879']} DrugCentral uuid:161b131e-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.714']} DrugCentral uuid:161b3b50-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:161b636e-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.367']} DrugCentral uuid:161b8c4a-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:161bb486-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.889']} DrugCentral uuid:161bdccc-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:161c04fe-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:161c2d9e-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.578']} DrugCentral uuid:161c55ee-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.621']} DrugCentral uuid:161c7e52-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.722']} DrugCentral uuid:161ca6a2-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:161cd082-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:161cf8c8-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.099']} DrugCentral uuid:161d2118-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:161d4a58-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.354']} DrugCentral uuid:161d7348-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:161d9cba-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:161dc4f6-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:161ded50-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:161e1618-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:161e3a3a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.754']} DrugCentral uuid:161e6280-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.836']} DrugCentral uuid:161e8ad0-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:161eb636-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.064']} DrugCentral uuid:161ede7c-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:161f06c2-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:161f2fee-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:161f5848-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.742']} DrugCentral uuid:161f8098-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.487']} DrugCentral uuid:161fa8e8-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:161fd19c-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:161ffa82-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:162022c8-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:16204afa-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:16207426-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.514']} DrugCentral uuid:16209c76-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.342']} DrugCentral uuid:1620c4c6-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.041']} DrugCentral uuid:1620ed02-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:162116ce-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.11']} DrugCentral uuid:16213f82-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:162168cc-d20a-11ec-8377-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1621911c-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1621b9ee-d20a-11ec-8377-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1621e22a-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:16220a7a-d20a-11ec-8377-0242ac110003 UniProtKB:O08786 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets GPCR (Cholecystokinin A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:16223298-d20a-11ec-8377-0242ac110003 UniProtKB:O32393 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine targets Unclassified (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:16225b88-d20a-11ec-8377-0242ac110003 UniProtKB:P35364 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:162283d8-d20a-11ec-8377-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1622acd2-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergotamine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1622d4fa-d20a-11ec-8377-0242ac110003 UniProtKB:O00206 biolink:molecularly_interacts_with DrugCentral:1044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eritoran targets Membrane receptor (Toll-like receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1622fdd6-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:16232608-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:16234e26-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:162376d0-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1623a04c-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1623c874-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1623f0c4-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:16241a68-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:162445ce-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:16246e3c-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:16249682-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1624bf5e-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1624e7a4-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:16250ffe-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:16253858-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:16256206-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:16258a56-d20a-11ec-8377-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1625b2a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1625daec-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:16260486-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:16262cd6-d20a-11ec-8377-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:162654f4-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:16267dc6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1626a68e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1626cede-d20a-11ec-8377-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1626f6f2-d20a-11ec-8377-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:16271fba-d20a-11ec-8377-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:16274800-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:16277050-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:16279878-d20a-11ec-8377-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.03']} DrugCentral uuid:1627c2c6-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1627eaf8-d20a-11ec-8377-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1628132a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:16283b66-d20a-11ec-8377-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:16286456-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:16288ca6-d20a-11ec-8377-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1628b4ec-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1628dd3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:16290604-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:16292e5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:16295794-d20a-11ec-8377-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:162980e8-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1629ac58-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1629d7be-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:162a0022-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:162a2854-d20a-11ec-8377-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:162a5126-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:162a796c-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:162aa19e-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.51']} DrugCentral uuid:162aca70-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:162af2b6-d20a-11ec-8377-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:162b1af2-d20a-11ec-8377-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:162b434c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:162b6ce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:162b977a-d20a-11ec-8377-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:162bbfb6-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:162be806-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:162c10e2-d20a-11ec-8377-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:162c391e-d20a-11ec-8377-0242ac110003 UniProtKB:Q3U3Q1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:162c615a-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:162c89a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:162cb254-d20a-11ec-8377-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:162cdaa4-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:162d02ea-d20a-11ec-8377-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:162d2b30-d20a-11ec-8377-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:162d5830-d20a-11ec-8377-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:162d8080-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:162da8a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:162dd0ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:162df9de-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:162e2210-d20a-11ec-8377-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:162e4a60-d20a-11ec-8377-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:162e730a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:162e9b5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q6DT37 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase MRCK gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:162ec3aa-d20a-11ec-8377-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:162eebe6-d20a-11ec-8377-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:162f159e-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:162f3dee-d20a-11ec-8377-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:162f662a-d20a-11ec-8377-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:162f8f92-d20a-11ec-8377-0242ac110003 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:162fb88c-d20a-11ec-8377-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:162fe0be-d20a-11ec-8377-0242ac110003 UniProtKB:P31152 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:16300904-d20a-11ec-8377-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:16303154-d20a-11ec-8377-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:163059ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:16308230-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1630aa80-d20a-11ec-8377-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1630d2c6-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1630fd5a-d20a-11ec-8377-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:163125aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:16314eea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:16317730-d20a-11ec-8377-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1631a020-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1631c866-d20a-11ec-8377-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1631f0ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:16321942-d20a-11ec-8377-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:16324192-d20a-11ec-8377-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:163269c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:16329200-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1632bb86-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:1632e6b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:16330f78-d20a-11ec-8377-0242ac110003 UniProtKB:O94956 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib is inhibitor of Transporter (Solute carrier organic anion transporter family member 2B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:163337c8-d20a-11ec-8377-0242ac110003 UniProtKB:P28028 biolink:molecularly_interacts_with DrugCentral:1045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erlotinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:16336086-d20a-11ec-8377-0242ac110003 UniProtKB:Q9X6V3 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem targets Enzyme (Penicillin-binding protein 2) DrugCentral uuid:16338494-d20a-11ec-8377-0242ac110003 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem targets Enzyme (Penicillin-binding protein 4) DrugCentral uuid:1633a8b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9X6V7 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem targets Enzyme (D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5) DrugCentral uuid:1633cd6e-d20a-11ec-8377-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:1633f1ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q7CHG0 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem targets Enzyme (D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6) DrugCentral uuid:1634160c-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem is inhibitor of Enzyme (D-alanyl-D-alanine carboxypeptidase DacB) DrugCentral uuid:16343a38-d20a-11ec-8377-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem is inhibitor of Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:16345e6e-d20a-11ec-8377-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:1046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertapenem is inhibitor of Enzyme (Penicillin-binding protein 1B) DrugCentral uuid:163482a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erythromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1634abb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erythromycin targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.824']} DrugCentral uuid:1634d3f8-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erythromycin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1634fc2a-d20a-11ec-8377-0242ac110003 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:1048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erythromycin targets GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:16352484-d20a-11ec-8377-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erythromycin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:16354e28-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erythromycin propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1635777c-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erythromycin propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:16359fcc-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:1635c88a-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.186']} DrugCentral uuid:1635f0d0-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.597']} DrugCentral uuid:16361916-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.412']} DrugCentral uuid:16364152-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.706']} DrugCentral uuid:16366a6a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.906']} DrugCentral uuid:163692ba-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:1636bb0a-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1636e346-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 escitalopram targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:16370d08-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esmolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:16373544-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esmolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:16375da8-d20a-11ec-8377-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esmolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:163789fe-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esomeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:163789fe-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esomeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:1637c054-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1637c054-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1637c054-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1637ff9c-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:1637ff9c-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:1637ff9c-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:163840a6-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:163840a6-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:163840a6-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:163880b6-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:163880b6-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:163880b6-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:1638b98c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.243']} DrugCentral uuid:1638e268-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.538']} DrugCentral uuid:16390aa4-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.725']} DrugCentral uuid:163932f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.926']} DrugCentral uuid:16395b4e-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:163983ee-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1639ac34-d20a-11ec-8377-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol is activator of Ion channel (Calcium-activated potassium channel subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1639d466-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1639fca2-d20a-11ec-8377-0242ac110003 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:163a27ea-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:163a5350-d20a-11ec-8377-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Enzyme (Steryl-sulfatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:163a7b78-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.83']} DrugCentral uuid:163aa454-d20a-11ec-8377-0242ac110003 UniProtKB:P11474 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.44']} DrugCentral uuid:163accb8-d20a-11ec-8377-0242ac110003 UniProtKB:O95718 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Nuclear hormone receptor (Steroid hormone receptor ERR2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:163af4fe-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:163b1d30-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.947']} DrugCentral uuid:163b45e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.372']} DrugCentral uuid:163b6e3e-d20a-11ec-8377-0242ac110003 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:163b968e-d20a-11ec-8377-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:163bbeac-d20a-11ec-8377-0242ac110003 UniProtKB:O08537 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:163be7a6-d20a-11ec-8377-0242ac110003 UniProtKB:P19785 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:163c0fec-d20a-11ec-8377-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:163c3c1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:163c3c1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:163c70ae-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:163c99b2-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.767']} DrugCentral uuid:163cc202-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.133']} DrugCentral uuid:163cea52-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.637']} DrugCentral uuid:163d12a2-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.446']} DrugCentral uuid:163d3b60-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:163d63c4-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:163d8c28-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.94']} DrugCentral uuid:163db5a4-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.638']} DrugCentral uuid:163de128-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.156']} DrugCentral uuid:163e09e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1058 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol benzoate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.902']} DrugCentral uuid:163e3254-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1059 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol cypionate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:163e573e-d20a-11ec-8377-0242ac110003 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:1062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol mustard targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:163e7f98-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol valerate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:163ea3d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estramustine phosphate is modulator of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:163ec80e-d20a-11ec-8377-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:1066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estramustine phosphate targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:163ef0cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q06124 biolink:molecularly_interacts_with DrugCentral:1066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estramustine phosphate targets Enzyme (Tyrosine-protein phosphatase non-receptor type 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:163f191c-d20a-11ec-8377-0242ac110003 UniProtKB:P29350 biolink:molecularly_interacts_with DrugCentral:1066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estramustine phosphate targets Enzyme (Protein-tyrosine phosphatase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:163f416c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:163f69bc-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:163f9388-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:163fbe58-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.9']} DrugCentral uuid:163fe66c-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:16400fc0-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.63']} DrugCentral uuid:164038b0-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:164061e6-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:16408a40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:1067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol succinate targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1640b272-d20a-11ec-8377-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1640db6c-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:164103d0-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:16412c2a-d20a-11ec-8377-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:16415d4e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:16415d4e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:16415d4e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:16419cfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) DrugCentral uuid:16419cfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) DrugCentral uuid:16419cfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) DrugCentral uuid:1641dc6a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) DrugCentral uuid:1641dc6a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) DrugCentral uuid:1641dc6a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) DrugCentral uuid:16421cc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) DrugCentral uuid:16421cc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) DrugCentral uuid:16421cc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) DrugCentral uuid:16425c12-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) DrugCentral uuid:16425c12-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) DrugCentral uuid:16425c12-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) DrugCentral uuid:16429c0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) DrugCentral uuid:16429c0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) DrugCentral uuid:16429c0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eszopiclone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) DrugCentral uuid:1642d3c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:1071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacrynic acid is inhibitor of Transporter (Solute carrier family 12 member 1) DrugCentral uuid:1642f7ee-d20a-11ec-8377-0242ac110003 UniProtKB:P09211 biolink:molecularly_interacts_with DrugCentral:1071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacrynic acid targets Enzyme (Glutathione S-transferase P) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:16432002-d20a-11ec-8377-0242ac110003 UniProtKB:P08263 biolink:molecularly_interacts_with DrugCentral:1071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacrynic acid targets Enzyme (Glutathione S-transferase A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:16434b90-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacrynic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.939']} DrugCentral uuid:164373cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q14376 biolink:molecularly_interacts_with DrugCentral:1071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacrynic acid targets Enzyme (UDP-glucose 4-epimerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:16439c12-d20a-11ec-8377-0242ac110003 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:1071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacrynic acid targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1643c43a-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1643ed16-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:16441548-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:16443d8e-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:164465ca-d20a-11ec-8377-0242ac110003 UniProtKB:P9WNL8 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets Enzyme (Probable arabinosyltransferase A) DrugCentral uuid:16448b5e-d20a-11ec-8377-0242ac110003 UniProtKB:P9WNL6 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets Enzyme (Probable arabinosyltransferase B) DrugCentral uuid:1644af8a-d20a-11ec-8377-0242ac110003 UniProtKB:P9WNL5 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets Enzyme (Probable arabinosyltransferase C) DrugCentral uuid:1644d3b6-d20a-11ec-8377-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:1644fc06-d20a-11ec-8377-0242ac110003 UniProtKB:P9WNL9 biolink:molecularly_interacts_with DrugCentral:1073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethambutol is inhibitor of Enzyme (Probable arabinosyltransferase A) DrugCentral uuid:164521a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1076 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethanol targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:164545bc-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1076 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethanol targets Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:164569e8-d20a-11ec-8377-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:1076 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethanol targets Ion channel (Glycine receptor subunit alpha-2) DrugCentral uuid:164595e4-d20a-11ec-8377-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1076 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethanol targets Ion channel (GABA A receptor alpha-4/beta-2/delta) DrugCentral uuid:164595e4-d20a-11ec-8377-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1076 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethanol targets Ion channel (GABA A receptor alpha-4/beta-2/delta) DrugCentral uuid:164595e4-d20a-11ec-8377-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1076 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethanol targets Ion channel (GABA A receptor alpha-4/beta-2/delta) DrugCentral uuid:1645d680-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethchlorvynol is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:1645d680-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethchlorvynol is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:1645d680-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethchlorvynol is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:16460e0c-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.877']} DrugCentral uuid:16463648-d20a-11ec-8377-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:16465fba-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.964']} DrugCentral uuid:16468814-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:1646b05a-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:1646d92c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.022']} DrugCentral uuid:164703ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.244']} DrugCentral uuid:16472ce2-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:16475546-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.353']} DrugCentral uuid:16477e0e-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:1647a64a-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.985']} DrugCentral uuid:1647cec2-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.83']} DrugCentral uuid:1647f708-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:16481fd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:16484802-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.81']} DrugCentral uuid:16487052-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:16489870-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.246']} DrugCentral uuid:1648c160-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.857']} DrugCentral uuid:1648e9ba-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:164911ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:16493a46-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethinylestradiol targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:164962dc-d20a-11ec-8377-0242ac110003 UniProtKB:P9WIE4 biolink:molecularly_interacts_with DrugCentral:1083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethionamide targets Enzyme (Catalase-peroxidase) DrugCentral uuid:1649871c-d20a-11ec-8377-0242ac110003 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:1083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethionamide is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) DrugCentral uuid:1649ab48-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethionamide targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1649d4b0-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1084 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethisterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.022']} DrugCentral uuid:1649fdaa-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1084 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethisterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.78']} DrugCentral uuid:164a2604-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1084 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethisterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:164a4e4a-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1084 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethisterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.111']} DrugCentral uuid:164a769a-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1084 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethisterone targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:164aa17e-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:164ac5a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:164ae9c2-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.61']} DrugCentral uuid:164b11fe-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:164b3c38-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:164b6500-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:164b8d3c-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:164bb58c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:164bde54-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1086 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 profenamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:164c06b8-d20a-11ec-8377-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1087 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethosuximide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:164c4da8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:164c4da8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:164c4da8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:164c4da8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:164c4da8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:164c4da8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:164c4da8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:164c4da8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:164c4da8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:164c4da8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethotoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:164ccd50-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:164cf690-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:164d1efe-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:164d4776-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:164d6fc6-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:164d988e-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:164dc0e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:164de956-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:164e119c-d20a-11ec-8377-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:164e3bcc-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:164e6444-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:164e8ca8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:164eb5ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:164edfd2-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:164f0840-d20a-11ec-8377-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:164f30ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:164f5930-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:164f8202-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:164faa52-d20a-11ec-8377-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:164fd2a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:164ffafc-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:16502608-d20a-11ec-8377-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:16504e4e-d20a-11ec-8377-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:165076a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1650a038-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1650c888-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:1650f0e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:16511950-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:1651460a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1651460a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide is inhibitor of Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:16517986-d20a-11ec-8377-0242ac110003 UniProtKB:Q3SZX4 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1651a1cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:1651ca26-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:1651f3d4-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethoxzolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.03']} DrugCentral uuid:16521c10-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:1091 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl biscoumacetate targets Enzyme (Vitamin K epoxide reductase complex subunit 1) DrugCentral uuid:1652403c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:16526896-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.682']} DrugCentral uuid:1652917c-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.983']} DrugCentral uuid:1652bad0-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:1652e320-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:16530742-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:16532fec-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.889']} DrugCentral uuid:1653583c-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:16538096-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethylestrenol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:1653a8f0-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etynodiol targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:1653cfce-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etynodiol is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:1653f404-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etynodiol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.368']} DrugCentral uuid:16541c4a-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etynodiol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:165444b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etynodiol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:16546da8-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:16549300-d20a-11ec-8377-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:1654b72c-d20a-11ec-8377-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:1654db62-d20a-11ec-8377-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etidocaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:1655042a-d20a-11ec-8377-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etidocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:16552c52-d20a-11ec-8377-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etidocaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:165554a2-d20a-11ec-8377-0242ac110003 UniProtKB:B1LRJ1 biolink:molecularly_interacts_with DrugCentral:1098 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etidronic acid targets Unclassified (Type IV secretion-like conjugative transfer relaxase protein TraI) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:16557d06-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1100 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etilamfetamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1655a736-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1101 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etilefrine is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:1655d3a0-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1655d3a0-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1655d3a0-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:165619d2-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:165619d2-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:165619d2-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:165659c4-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:165659c4-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:165659c4-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:16569a2e-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:16569a2e-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:16569a2e-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etizolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:1656d278-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etodolac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1656faaa-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1103 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etodolac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.577']} DrugCentral uuid:165722fa-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:1107 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etofylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:16574b72-d20a-11ec-8377-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:165776a6-d20a-11ec-8377-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:16579f1e-d20a-11ec-8377-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:1657c750-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1657f82e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:1657f82e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:1657f82e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:16583e7e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:16583e7e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:16583e7e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etomidate targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:16587c9a-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etonogestrel targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:1658a13e-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etonogestrel is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:1658c56a-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etonogestrel targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1658ed9c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.638']} DrugCentral uuid:1659174a-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.051']} DrugCentral uuid:165941ca-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.071']} DrugCentral uuid:16596a56-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:16599292-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.282']} DrugCentral uuid:1659bba0-d20a-11ec-8377-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.21']} DrugCentral uuid:1659e490-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:165a08b2-d20a-11ec-8377-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide is inhibitor of Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:165a30e4-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:165a5506-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:165a7996-d20a-11ec-8377-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:165a9db8-d20a-11ec-8377-0242ac110003 UniProtKB:O15438 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Transporter (Canalicular multispecific organic anion transporter 2) DrugCentral uuid:165ac1c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:165aea0c-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.497']} DrugCentral uuid:165b13f6-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoricoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:165b3c3c-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoricoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:165b645a-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoricoxib targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.102']} DrugCentral uuid:165b8cbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoricoxib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:165bb5ae-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoricoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:165bddea-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoricoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:165c06bc-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:165c2f02-d20a-11ec-8377-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:165c57ac-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:165c7fe8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:165ca842-d20a-11ec-8377-0242ac110003 UniProtKB:O15438 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Transporter (Canalicular multispecific organic anion transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:165cd074-d20a-11ec-8377-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:165cf978-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:165d1d90-d20a-11ec-8377-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:165d45b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:165d6e62-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:1115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etravirine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:165d96b2-d20a-11ec-8377-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:1116 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etretinate is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) DrugCentral uuid:165dbbc4-d20a-11ec-8377-0242ac110003 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:1116 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etretinate is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) DrugCentral uuid:165ddff0-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1117 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etryptamine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.63']} DrugCentral uuid:165e0818-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1117 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etryptamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:165e30a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1117 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etryptamine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:165e58e0-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 everolimus targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:165e7d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:1118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 everolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:165ea55c-d20a-11ec-8377-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:1118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 everolimus is inhibitor of Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:165ece56-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 exemestane targets Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:165ef3ae-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 exemestane is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.692']} DrugCentral uuid:165f1bfe-d20a-11ec-8377-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:1123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 exenatide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.18']} DrugCentral uuid:165f44f8-d20a-11ec-8377-0242ac110003 UniProtKB:P32301 biolink:molecularly_interacts_with DrugCentral:1123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 exenatide targets GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:165f6d48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHC9 biolink:molecularly_interacts_with DrugCentral:1125 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ezetimibe is antagonist of Membrane other (Niemann-Pick C1-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:165f95a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q6T3U3 biolink:molecularly_interacts_with DrugCentral:1125 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ezetimibe targets Unclassified (Niemann-Pick C1-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:165fbdf2-d20a-11ec-8377-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1126 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fadrozole is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:165fe6b0-d20a-11ec-8377-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1126 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fadrozole is inhibitor of Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16600ef6-d20a-11ec-8377-0242ac110003 UniProtKB:P15539 biolink:molecularly_interacts_with DrugCentral:1126 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fadrozole targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:16603746-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1126 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fadrozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:16605f8c-d20a-11ec-8377-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:1128 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:166084da-d20a-11ec-8377-0242ac110003 UniProtKB:P09252 biolink:molecularly_interacts_with DrugCentral:1128 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famciclovir targets Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:1660a942-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.93']} DrugCentral uuid:1660d192-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1660f9e2-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:166122f0-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:16614b40-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:16617412-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:16619c62-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.84']} DrugCentral uuid:1661c61a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1661ee74-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:166216c4-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:16623f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:16626818-d20a-11ec-8377-0242ac110003 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1662905e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1662b8ae-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:1662e0e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:166309e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:1663322a-d20a-11ec-8377-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.304']} DrugCentral uuid:16635a66-d20a-11ec-8377-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famotidine targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:16638298-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:1130 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 famprofazone targets Nuclear hormone receptor (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.18']} DrugCentral uuid:1663ab4c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1663d392-d20a-11ec-8377-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.44']} DrugCentral uuid:1663fbf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:16642428-d20a-11ec-8377-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:16644f66-d20a-11ec-8377-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:166477b6-d20a-11ec-8377-0242ac110003 UniProtKB:P13500 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Cytokine (C-C motif chemokine 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:16649fd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1664c9f0-d20a-11ec-8377-0242ac110003 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:1664f2b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q62868 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:16651afe-d20a-11ec-8377-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil is inhibitor of Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:16654376-d20a-11ec-8377-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:1132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fasudil is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.11']} DrugCentral uuid:16656c2a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 febuxostat targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:1665945c-d20a-11ec-8377-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:1137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 febuxostat is inhibitor of Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1665bd74-d20a-11ec-8377-0242ac110003 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:1137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 febuxostat targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1665e5ba-d20a-11ec-8377-0242ac110003 UniProtKB:P22985 biolink:molecularly_interacts_with DrugCentral:1137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 febuxostat targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:16660ebe-d20a-11ec-8377-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1140 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felbamate is antagonist of Ion channel (Glutamate receptor ionotropic, NMDA 2A) DrugCentral uuid:166632f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1140 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felbamate is antagonist of Ion channel (Glutamate receptor ionotropic, NMDA 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.284']} DrugCentral uuid:16665b26-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1141 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felbinac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:16667f48-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1141 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felbinac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.049']} DrugCentral uuid:1666a81a-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:1666d0ce-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:1666f914-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:16671d40-d20a-11ec-8377-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:166741c6-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.339']} DrugCentral uuid:166769f8-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.168']} DrugCentral uuid:1667925c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1667ba98-d20a-11ec-8377-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine is activator of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1667eb8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:1667eb8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:1667eb8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felodipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:166829f6-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenbufen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1668521e-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenbufen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:16687b18-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenbufen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:16689f44-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenbufen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:1668c35c-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1148 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fendiline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1668ebac-d20a-11ec-8377-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:1148 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fendiline targets GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1669142e-d20a-11ec-8377-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:1148 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fendiline targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:16693c60-d20a-11ec-8377-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:1148 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fendiline targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:166964b0-d20a-11ec-8377-0242ac110003 UniProtKB:P35384 biolink:molecularly_interacts_with DrugCentral:1148 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fendiline is positive allosteric modulator of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:16698dc8-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.004']} DrugCentral uuid:1669b726-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.111']} DrugCentral uuid:1669df6c-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.428']} DrugCentral uuid:166a07bc-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.176']} DrugCentral uuid:166a2ff8-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.172']} DrugCentral uuid:166a58f2-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.845']} DrugCentral uuid:166a825a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.398']} DrugCentral uuid:166aaac8-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:166ad322-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.042']} DrugCentral uuid:166afbe0-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.378']} DrugCentral uuid:166b243a-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:166b4c8a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.717']} DrugCentral uuid:166b7520-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.016']} DrugCentral uuid:166ba068-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.726']} DrugCentral uuid:166bc8a4-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.489']} DrugCentral uuid:166bf0cc-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.167']} DrugCentral uuid:166c19bc-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:166c41f8-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.195']} DrugCentral uuid:166c6a48-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.735']} DrugCentral uuid:166c9298-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.848']} DrugCentral uuid:166cbb60-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenfluramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:166ce392-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.673']} DrugCentral uuid:166d0bec-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:166d343c-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.906']} DrugCentral uuid:166d5eb2-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.331']} DrugCentral uuid:166d8aae-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.032']} DrugCentral uuid:166db308-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.164']} DrugCentral uuid:166ddb4e-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.492']} DrugCentral uuid:166e0416-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.808']} DrugCentral uuid:166e2c7a-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:166e54ca-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:166e7d10-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:166ea5b0-d20a-11ec-8377-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenofibrate targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:166ecdf6-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:166ef632-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:166f1e78-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:166f4ab0-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:166f7314-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:166f9b64-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:166fc42c-d20a-11ec-8377-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:166fec86-d20a-11ec-8377-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:16701cb0-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:16701cb0-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:16701cb0-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:16705ce8-d20a-11ec-8377-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:1670854c-d20a-11ec-8377-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:1153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoldopam targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:1670ad74-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1670d5ce-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1670ffd6-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:16712ede-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:16712ede-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:16716340-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N695 biolink:molecularly_interacts_with DrugCentral:1154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoprofen is inhibitor of Transporter (Sodium-coupled monocarboxylate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:16718b86-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1671b426-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1671dc6c-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.001']} DrugCentral uuid:16720494-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.45']} DrugCentral uuid:16722cd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:16725566-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:16727db6-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1672a61a-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:1672cfb4-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1672f7f0-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:16732036-d20a-11ec-8377-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:1673487c-d20a-11ec-8377-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:167371a8-d20a-11ec-8377-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:167399f8-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:1673c252-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1673ea8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:16741fc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:16741fc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:16741fc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:16741fc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:16746d60-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:16746d60-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1674a226-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:1674cc7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Unclassified (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1674f596-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentanyl targets Unclassified (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.45']} DrugCentral uuid:16751dc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:1165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fentiazac targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:16754672-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fexofenadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:16756e86-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fexofenadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.699']} DrugCentral uuid:167596cc-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fexofenadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1675c066-d20a-11ec-8377-0242ac110003 UniProtKB:P46721 biolink:molecularly_interacts_with DrugCentral:1170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fexofenadine targets Transporter (Solute carrier organic anion transporter family member 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.699']} DrugCentral uuid:1675e942-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:16761192-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:167639ce-d20a-11ec-8377-0242ac110003 UniProtKB:P14060 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride targets Enzyme (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:16766232-d20a-11ec-8377-0242ac110003 UniProtKB:P24008 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:16768ce4-d20a-11ec-8377-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.55']} DrugCentral uuid:1676b8fe-d20a-11ec-8377-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1676b8fe-d20a-11ec-8377-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1676eca2-d20a-11ec-8377-0242ac110003 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:1677156a-d20a-11ec-8377-0242ac110003 UniProtKB:P18405 biolink:molecularly_interacts_with DrugCentral:1171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 finasteride is inhibitor of Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:16773db0-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.704']} DrugCentral uuid:1677719a-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:1677719a-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:1677719a-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:1677719a-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 4) DrugCentral uuid:1677b754-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 7) DrugCentral uuid:1677b754-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 7) DrugCentral uuid:1677e94a-d20a-11ec-8377-0242ac110003 UniProtKB:O95263 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 8) DrugCentral uuid:1677e94a-d20a-11ec-8377-0242ac110003 UniProtKB:O95263 biolink:molecularly_interacts_with DrugCentral:1175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flavoxate is inhibitor of Enzyme (Phosphodiesterase 8) DrugCentral uuid:16781744-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:16783f80-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:16786a1e-d20a-11ec-8377-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide targets Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.745']} DrugCentral uuid:16789368-d20a-11ec-8377-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:1678bba4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.77']} DrugCentral uuid:1678e3fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:16790cbc-d20a-11ec-8377-0242ac110003 UniProtKB:Q63881 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide targets Ion channel (Potassium voltage-gated channel subfamily D member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:167934f8-d20a-11ec-8377-0242ac110003 UniProtKB:P15388 biolink:molecularly_interacts_with DrugCentral:1176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flecainide is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:16795dac-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:1177 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fleroxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:1679866a-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 floctafenine is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.959']} DrugCentral uuid:1679aeba-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 floctafenine is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.268']} DrugCentral uuid:1679d714-d20a-11ec-8377-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:1180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flopropione is inhibitor of Enzyme (Catechol O-methyltransferase) DrugCentral uuid:1679fb22-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 floxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:167a207a-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 floxacillin targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:167a48c0-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:1183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 floxacillin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:167a7106-d20a-11ec-8377-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1184 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 floxuridine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:167a9546-d20a-11ec-8377-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:1184 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 floxuridine targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:167abe04-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:167ae65e-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:167b0fe4-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:167b3834-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:167b60d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:167b8924-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:167bb17e-d20a-11ec-8377-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.92']} DrugCentral uuid:167bd9d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:167c0476-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:167c2d48-d20a-11ec-8377-0242ac110003 UniProtKB:Q7Z1V1 biolink:molecularly_interacts_with DrugCentral:1187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluconazole targets Enzyme (Sterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.06']} DrugCentral uuid:167c5566-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flucytosine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:167c7e9c-d20a-11ec-8377-0242ac110003 UniProtKB:P0CS13 biolink:molecularly_interacts_with DrugCentral:1188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flucytosine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:167ca336-d20a-11ec-8377-0242ac110003 UniProtKB:P12461 biolink:molecularly_interacts_with DrugCentral:1188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flucytosine is inhibitor of Enzyme (Thymidylate synthase) DrugCentral uuid:167cc762-d20a-11ec-8377-0242ac110003 UniProtKB:P02829 biolink:molecularly_interacts_with DrugCentral:1188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flucytosine targets Cytosolic other (ATP-dependent molecular chaperone HSP82) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:167cefa8-d20a-11ec-8377-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:167d17ee-d20a-11ec-8377-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:167d40a2-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:167d68f2-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:167d9156-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:167db9c4-d20a-11ec-8377-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:167de340-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:167e0b86-d20a-11ec-8377-0242ac110003 UniProtKB:P09884 biolink:molecularly_interacts_with DrugCentral:1189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludarabine phosphate is inhibitor of Enzyme (DNA polymerase alpha catalytic subunit) DrugCentral uuid:167e2fa8-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludrocortisone acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:167e57bc-d20a-11ec-8377-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:1191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludrocortisone acetate targets Cytosolic other (Annexin A1) DrugCentral uuid:167e7c74-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludrocortisone acetate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:167ea4ba-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.93']} DrugCentral uuid:167ecda0-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:167ef5e6-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:167f1e90-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:167f46cc-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:167f6efe-d20a-11ec-8377-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:167f971c-d20a-11ec-8377-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:167fc1e2-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:167fea14-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1680123c-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:16803ae6-d20a-11ec-8377-0242ac110003 UniProtKB:Q6UVM3 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid is activator of Ion channel (Potassium channel subfamily T member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:168063fe-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:16808c44-d20a-11ec-8377-0242ac110003 UniProtKB:O94759 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily M member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:1680b5ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TD43 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1680de60-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:168106a6-d20a-11ec-8377-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:16812ece-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZQ8 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily M member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:1681571e-d20a-11ec-8377-0242ac110003 UniProtKB:Q7TN37 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily M member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:16818112-d20a-11ec-8377-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:1681a958-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1681d19e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:1681f9e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:168222b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYV8 biolink:molecularly_interacts_with DrugCentral:1193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flufenamic acid is agonist of GPCR (Taste receptor type 2 member 14) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.863']} DrugCentral uuid:16824ad4-d20a-11ec-8377-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1194 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:16827306-d20a-11ec-8377-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:16829b60-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1682c41e-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:1682ec6e-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:168314fa-d20a-11ec-8377-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:16834600-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:16834600-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:16834600-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:16838ee4-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.979']} DrugCentral uuid:16838ee4-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.979']} DrugCentral uuid:16838ee4-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.979']} DrugCentral uuid:1683d642-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:1683d642-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:1683d642-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:16841d3c-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:16841d3c-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:16841d3c-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16849686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:16857bf0-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:16857bf0-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:16857bf0-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:16857bf0-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:16857bf0-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:16857bf0-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:1685e54a-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1685e54a-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1685e54a-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:16862bb8-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:16862bb8-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:16862bb8-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:16867276-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:16867276-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:16867276-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1686b902-d20a-11ec-8377-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:1686b902-d20a-11ec-8377-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:1686b902-d20a-11ec-8377-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil is allosteric antagonist of Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16873238-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1195 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumazenil targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:1688047e-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1198 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flumetasone pivalate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1688290e-d20a-11ec-8377-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.621']} DrugCentral uuid:1688515e-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:168879a4-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.713']} DrugCentral uuid:1688a1e0-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.932']} DrugCentral uuid:1688cb70-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.662']} DrugCentral uuid:1688f3e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:16891c2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.304']} DrugCentral uuid:1689446a-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:16896d14-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.877']} DrugCentral uuid:16899550-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.612']} DrugCentral uuid:1689bdb4-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.936']} DrugCentral uuid:1689e60e-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:168a0ee0-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.455']} DrugCentral uuid:168a3730-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:168a5f8a-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:168a88de-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:168ab318-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.151']} DrugCentral uuid:168adb68-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.504']} DrugCentral uuid:168b03c2-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.103']} DrugCentral uuid:168b2c08-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:168b54bc-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:168b7d0c-d20a-11ec-8377-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:168ba5c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.333']} DrugCentral uuid:168bce10-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.532']} DrugCentral uuid:168bf6ce-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.357']} DrugCentral uuid:168c1f28-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:168c475a-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:168c7144-d20a-11ec-8377-0242ac110003 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.78']} DrugCentral uuid:168c998a-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:168cc1e4-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:168cea34-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:168d12de-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:168d3b06-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:168d6342-d20a-11ec-8377-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:168d9448-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:168d9448-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:168d9448-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:168dd35e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y256 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:168dfb68-d20a-11ec-8377-0242ac110003 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:168e239a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8HY88 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:168e4e88-d20a-11ec-8377-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:168e7700-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:168e9f64-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunarizine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:168ec7c8-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunisolide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:168ef068-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunisolide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:168f18cc-d20a-11ec-8377-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:168f414e-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:168f69bc-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:168f92a2-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:168fc2b8-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:168fc2b8-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:168fc2b8-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:169008f4-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:169008f4-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:169008f4-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:169052b4-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:169052b4-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:169052b4-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:169098f0-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:169098f0-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:169098f0-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:1690dfae-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:1690dfae-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:1690dfae-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:169126da-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:169126da-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:169126da-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16919ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16927cec-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:16927cec-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:16927cec-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:1692c4ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:1692c4ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:1692c4ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:16930c0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:16930c0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:16930c0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:169352fc-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:169352fc-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:169352fc-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:16939960-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:16939960-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:16939960-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flunitrazepam targets Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1693dac4-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1204 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluocinolone acetonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.848']} DrugCentral uuid:16940346-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1204 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluocinolone acetonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.475']} DrugCentral uuid:16942ba0-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1205 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluocinonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.622']} DrugCentral uuid:16945404-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1205 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluocinonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.538']} DrugCentral uuid:16947cb8-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorescein targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.042']} DrugCentral uuid:1694a4fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:1207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorescein targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1694cd4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:1207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorescein targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:1694f594-d20a-11ec-8377-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:1207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorescein targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:16951ea2-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1208 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorometholone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.801']} DrugCentral uuid:169546f2-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1208 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorometholone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.067']} DrugCentral uuid:1695706e-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1208 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorometholone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:169599b8-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.356']} DrugCentral uuid:1695c4e2-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1695ed50-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:16961672-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:16963f94-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.091']} DrugCentral uuid:169667e4-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:16969016-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:1696b884-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1696e156-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:169709ba-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:169731f6-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:16975a5a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.156']} DrugCentral uuid:16978520-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:1697af50-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.959']} DrugCentral uuid:1697d782-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.047']} DrugCentral uuid:1697ffc8-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.569']} DrugCentral uuid:16982890-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:169850e0-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.538']} DrugCentral uuid:1698791c-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.569']} DrugCentral uuid:1698a158-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.444']} DrugCentral uuid:1698ca52-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:1698f298-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:16991b74-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:169944dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:16996f48-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:16999784-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1699bfd4-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1699e860-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.84']} DrugCentral uuid:169a11a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.97']} DrugCentral uuid:169a39fa-d20a-11ec-8377-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:169a6254-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:169a8b44-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:169ab3b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:169ae792-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:169ae792-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:169ae792-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:169ae792-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:169b3b66-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:169b3b66-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:169b3b66-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:169b81e8-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:169b81e8-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:169b81e8-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:169bc0d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:169be91c-d20a-11ec-8377-0242ac110003 UniProtKB:P25122 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine targets Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:169c1162-d20a-11ec-8377-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxetine is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:169c39bc-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoxymesterone is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:169c62d4-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:169c8b24-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:169cb356-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.65']} DrugCentral uuid:169cdb7e-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.095']} DrugCentral uuid:169d069e-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.058']} DrugCentral uuid:169d315a-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:169d5662-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:169d7e9e-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:169da748-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.066']} DrugCentral uuid:169dcf70-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:169df7b6-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:169e1fe8-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:169e48b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:169e710a-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:169ea8c8-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:169ea8c8-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:169ea8c8-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:169ea8c8-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:169ea8c8-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupentixol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:169f0200-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.075']} DrugCentral uuid:169f2a50-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.649']} DrugCentral uuid:169f52aa-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.269']} DrugCentral uuid:169f7bea-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.503']} DrugCentral uuid:169fa430-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.067']} DrugCentral uuid:169fcc6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:169ff4bc-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.101']} DrugCentral uuid:16a01dac-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.711']} DrugCentral uuid:16a04714-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.838']} DrugCentral uuid:16a06f5a-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.044']} DrugCentral uuid:16a098fe-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:16a0c1a8-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:16a0eade-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.464']} DrugCentral uuid:16a112fc-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:16a13b7e-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.191']} DrugCentral uuid:16a163b0-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.087']} DrugCentral uuid:16a18c0a-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:16a1b446-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.887']} DrugCentral uuid:16a1dd40-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.793']} DrugCentral uuid:16a20630-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:16a22e76-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:16a256c6-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.575']} DrugCentral uuid:16a27fe8-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.999']} DrugCentral uuid:16a2a838-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.315']} DrugCentral uuid:16a2d060-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.447']} DrugCentral uuid:16a2f8a6-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.655']} DrugCentral uuid:16a32146-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:16a34982-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:16a371b4-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.539']} DrugCentral uuid:16a39a0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.788']} DrugCentral uuid:16a3c308-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.171']} DrugCentral uuid:16a3eb62-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.535']} DrugCentral uuid:16a413b2-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.019']} DrugCentral uuid:16a43ce8-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:16a46862-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.005']} DrugCentral uuid:16a493fa-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.072']} DrugCentral uuid:16a4bca4-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:16a4e63e-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:16a50e70-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.397']} DrugCentral uuid:16a536a2-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:16a55ec0-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.097']} DrugCentral uuid:16a5879c-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.708']} DrugCentral uuid:16a5afce-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.125']} DrugCentral uuid:16a5d832-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:16a6006e-d20a-11ec-8377-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.67']} DrugCentral uuid:16a62b16-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:16a65370-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.061']} DrugCentral uuid:16a67bc0-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.049']} DrugCentral uuid:16a6a410-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.013']} DrugCentral uuid:16a6ccb0-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:16a6f4ba-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.78']} DrugCentral uuid:16a71cf6-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:16a7453c-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:16a76e54-d20a-11ec-8377-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:16a79e60-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:16a79e60-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:16a79e60-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:16a7f93c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:16a7f93c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:16a7f93c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:16a7f93c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:16a7f93c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:16a7f93c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:16a7f93c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:16a7f93c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1212 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:16a87056-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1213 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine decanoate is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:16a894e6-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:16a8bd40-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.268']} DrugCentral uuid:16a8e59a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.503']} DrugCentral uuid:16a90de0-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.225']} DrugCentral uuid:16a936d0-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.837']} DrugCentral uuid:16a95f20-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.979']} DrugCentral uuid:16a9877a-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.048']} DrugCentral uuid:16a9afb6-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:16a9db1c-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:16aa0614-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:16aa2e78-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.087']} DrugCentral uuid:16aa572c-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.611']} DrugCentral uuid:16aa7f68-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.887']} DrugCentral uuid:16aaa7ae-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:16aacff4-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:16aafa10-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.961']} DrugCentral uuid:16ab2256-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.145']} DrugCentral uuid:16ab4a92-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.841']} DrugCentral uuid:16ab72d8-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.274']} DrugCentral uuid:16ab9cae-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.447']} DrugCentral uuid:16abc51c-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:16abee3e-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.476']} DrugCentral uuid:16ac168e-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.539']} DrugCentral uuid:16ac3f42-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:16ac679c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:16ac8fe2-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:16acb81e-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluphenazine enanthate targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:16ace0d2-d20a-11ec-8377-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:1215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupirtine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:16ad08fa-d20a-11ec-8377-0242ac110003 UniProtKB:O43525 biolink:molecularly_interacts_with DrugCentral:1215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupirtine targets Ion channel (Potassium voltage-gated channel subfamily KQT member 3) DrugCentral uuid:16ad2d3a-d20a-11ec-8377-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:1215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flupirtine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:16ad55a8-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1216 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluprednisolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:16ad7be6-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludroxycortide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.695']} DrugCentral uuid:16ada440-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fludroxycortide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:16adcc86-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurazepam targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.222']} DrugCentral uuid:16adfca6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:16adfca6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:16adfca6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:16ae3bc6-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.39']} DrugCentral uuid:16ae640c-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:16ae8c66-d20a-11ec-8377-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:16aeb52e-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:16aedd60-d20a-11ec-8377-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:16af05ba-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:16af2dec-d20a-11ec-8377-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:16af5844-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:16af8076-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flurbiprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:16afa9a2-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.229']} DrugCentral uuid:16afd1e8-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.292']} DrugCentral uuid:16affad8-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.436']} DrugCentral uuid:16b0231e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.244']} DrugCentral uuid:16b04b82-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:16b0742c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:16b09dd0-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:16b0c634-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:16b0ee98-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:16b11828-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:16b14140-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.409']} DrugCentral uuid:16b169a4-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:16b191f4-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.951']} DrugCentral uuid:16b1baf8-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:16b1e33e-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.208']} DrugCentral uuid:16b20b8e-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.056']} DrugCentral uuid:16b233d4-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:16b25c60-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:16b284b0-d20a-11ec-8377-0242ac110003 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:1222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluspirilene targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:16b2ad00-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutamide targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:16b2d56e-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutamide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.082']} DrugCentral uuid:16b30002-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:16b3285c-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutamide targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.356']} DrugCentral uuid:16b350d4-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.049']} DrugCentral uuid:16b3791a-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutamide targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:16b3a32c-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone propionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.74']} DrugCentral uuid:16b3cb86-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone propionate is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:16b3f458-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone propionate is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.77']} DrugCentral uuid:16b41d16-d20a-11ec-8377-0242ac110003 UniProtKB:P47712 biolink:molecularly_interacts_with DrugCentral:1225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone propionate targets Enzyme (Cytosolic phospholipase A2) DrugCentral uuid:16b44142-d20a-11ec-8377-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:1225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone propionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.12']} DrugCentral uuid:16b46988-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutrimazole targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:16b491c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flutrimazole targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:16b4bac8-d20a-11ec-8377-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:1229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:16b4defe-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvastatin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:16b5073a-d20a-11ec-8377-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:1229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvastatin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.96']} DrugCentral uuid:16b52f76-d20a-11ec-8377-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:1229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:16b5587a-d20a-11ec-8377-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:1229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvastatin targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:16b580ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:1229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvastatin targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:16b5a906-d20a-11ec-8377-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:1229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:16b5d138-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvoxamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:16b5f9ec-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvoxamine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:16b62232-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvoxamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.951']} DrugCentral uuid:16b64a96-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvoxamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:16b673f4-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvoxamine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:16b69e92-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvoxamine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:16b6c93a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1230 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluvoxamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:16b6f18a-d20a-11ec-8377-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 folic acid targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:16b719e4-d20a-11ec-8377-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:1231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 folic acid targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:16b742e8-d20a-11ec-8377-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1232 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leucovorin targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.071']} DrugCentral uuid:16b76b38-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:1232 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leucovorin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:16b79c66-d20a-11ec-8377-0242ac110003 UniProtKB:P07327 biolink:molecularly_interacts_with DrugCentral:1233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fomepizole is inhibitor of Enzyme (Alcohol dehydrogenase) DrugCentral uuid:16b79c66-d20a-11ec-8377-0242ac110003 UniProtKB:P07327 biolink:molecularly_interacts_with DrugCentral:1233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fomepizole is inhibitor of Enzyme (Alcohol dehydrogenase) DrugCentral uuid:16b79c66-d20a-11ec-8377-0242ac110003 UniProtKB:P07327 biolink:molecularly_interacts_with DrugCentral:1233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fomepizole is inhibitor of Enzyme (Alcohol dehydrogenase) DrugCentral uuid:16b7d866-d20a-11ec-8377-0242ac110003 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:1233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fomepizole targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:16b7d866-d20a-11ec-8377-0242ac110003 UniProtKB:P00328 biolink:molecularly_interacts_with DrugCentral:1233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fomepizole targets Enzyme (Alcohol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:16b80bec-d20a-11ec-8377-0242ac110003 UniProtKB:P01008 biolink:molecularly_interacts_with DrugCentral:1236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fondaparinux is activator of Secreted (Antithrombin-III) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:16b83428-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1238 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formestane targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:16b85c82-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formoterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:16b885c2-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formoterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.6']} DrugCentral uuid:16b8ae3a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formoterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:16b8d694-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formoterol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:16b8ffac-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formoterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:16b927fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:16b95024-d20a-11ec-8377-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:1239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 formoterol targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:16b97900-d20a-11ec-8377-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosamprenavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:16b99da4-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosamprenavir is inhibitor of Enzyme (Pol polyprotein) DrugCentral uuid:16b9c1ee-d20a-11ec-8377-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:1241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 foscarnet is inhibitor of Enzyme (DNA polymerase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:16b9ea3e-d20a-11ec-8377-0242ac110003 UniProtKB:P08546 biolink:molecularly_interacts_with DrugCentral:1241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 foscarnet targets Enzyme (DNA polymerase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:16ba1266-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 foscarnet targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:16ba3c0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:1241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 foscarnet targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:16ba6770-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosfluconazole targets Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:16ba8e6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q836E5 biolink:molecularly_interacts_with DrugCentral:1243 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosfomycin targets Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1) DrugCentral uuid:16bab2ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q831A8 biolink:molecularly_interacts_with DrugCentral:1243 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosfomycin targets Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2) DrugCentral uuid:16bad7dc-d20a-11ec-8377-0242ac110003 UniProtKB:P0A749 biolink:molecularly_interacts_with DrugCentral:1243 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosfomycin is inhibitor of Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:16bb0018-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HVW7 biolink:molecularly_interacts_with DrugCentral:1243 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosfomycin targets Enzyme (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:16bb2854-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosinopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:16bb5090-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosinopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:16bb7a3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosphenytoin is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:16bb9e7e-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 frovatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:16bbc6ec-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 frovatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.99']} DrugCentral uuid:16bbef6e-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 frovatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:16bc19da-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fructose targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:16bc420c-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1253 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ftivazide targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:16bc6a5c-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:16bc9284-d20a-11ec-8377-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:16bcbb74-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant is antagonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:16bce3b0-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.68']} DrugCentral uuid:16bd0c0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant is antagonist of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:16bd345a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:16bd5d0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:16bd854a-d20a-11ec-8377-0242ac110003 UniProtKB:P11474 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:16bdad68-d20a-11ec-8377-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:16bdd5a4-d20a-11ec-8377-0242ac110003 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:16be013c-d20a-11ec-8377-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:1255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fulvestrant targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:16be2982-d20a-11ec-8377-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furaltadone targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:16be51d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:16be7a86-d20a-11ec-8377-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:16be9f3e-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:16bec784-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:16beefde-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:16bf1892-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:16bf40d8-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:16bf6a22-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:16bf927c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:16bfbc3e-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:16bfe72c-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:16c00f7c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:16c037cc-d20a-11ec-8377-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:16c060c6-d20a-11ec-8377-0242ac110003 UniProtKB:P55011 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide is inhibitor of Transporter (Solute carrier family 12 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:16c089ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:16c0b224-d20a-11ec-8377-0242ac110003 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:16c0da38-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:16c102ec-d20a-11ec-8377-0242ac110003 UniProtKB:P96618 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Enzyme (Holo-[acyl-carrieir-protein] synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:16c12b32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furosemide targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:16c1538c-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fusidic acid targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:16c17bc8-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fusidic acid targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:16c1a6e8-d20a-11ec-8377-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:16c1cf24-d20a-11ec-8377-0242ac110003 UniProtKB:P23978 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:16c1f896-d20a-11ec-8377-0242ac110003 UniProtKB:P31648 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:16c220e6-d20a-11ec-8377-0242ac110003 UniProtKB:P62813 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:16c24a6c-d20a-11ec-8377-0242ac110003 UniProtKB:P23576 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:16c272c6-d20a-11ec-8377-0242ac110003 UniProtKB:P24046 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit rho-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:16c29aee-d20a-11ec-8377-0242ac110003 UniProtKB:P48066 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:16c2c398-d20a-11ec-8377-0242ac110003 UniProtKB:P48065 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent betaine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:16c2ebde-d20a-11ec-8377-0242ac110003 UniProtKB:P31650 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:16c31410-d20a-11ec-8377-0242ac110003 UniProtKB:P31646 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:16c33dfa-d20a-11ec-8377-0242ac110003 UniProtKB:P31649 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:16c367a8-d20a-11ec-8377-0242ac110003 UniProtKB:P23574 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Ion channel (Gamma-aminobutyric acid receptor subunit gamma-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:16c39066-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z0U4 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid is agonist of GPCR (Gamma-aminobutyric acid type B receptor subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:16c3b8b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSD5 biolink:molecularly_interacts_with DrugCentral:1262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobutyric acid targets Transporter (Sodium- and chloride-dependent GABA transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:16c3e0f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:16c405a0-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:16c429d6-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets GPCR (Adenosine receptor A1) DrugCentral uuid:16c44e02-d20a-11ec-8377-0242ac110003 UniProtKB:O75899 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets GPCR (Gamma-aminobutyric acid type B receptor subunit 2) DrugCentral uuid:16c47238-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:16c496d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.523']} DrugCentral uuid:16c4bfcc-d20a-11ec-8377-0242ac110003 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:16c4e808-d20a-11ec-8377-0242ac110003 UniProtKB:O43525 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:16c51062-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:16c539a2-d20a-11ec-8377-0242ac110003 UniProtKB:O08532 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:16c561fc-d20a-11ec-8377-0242ac110003 UniProtKB:O77773 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin targets Ion channel (Uncharacterized protein; Voltage-dependent calcium channel alpha-2 delta subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:16c58a56-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY47 biolink:molecularly_interacts_with DrugCentral:1264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.928']} DrugCentral uuid:16c5b2b0-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:16c5dbaa-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:16c60422-d20a-11ec-8377-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:16c62c5e-d20a-11ec-8377-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:16c65490-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:16c67d12-d20a-11ec-8377-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:16c6a544-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:16c6cd80-d20a-11ec-8377-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:16c6f5b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:16c720dc-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galantamine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:16c74940-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:16c77190-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:16c799f4-d20a-11ec-8377-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallamine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:16c7c42e-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:16c7ec92-d20a-11ec-8377-0242ac110003 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:1273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:16c814d8-d20a-11ec-8377-0242ac110003 UniProtKB:P02708 biolink:molecularly_interacts_with DrugCentral:1273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallamine is blocker of Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:16c83d28-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallamine is negative allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.148']} DrugCentral uuid:16c86da2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallopamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:16c86da2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallopamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:16c86da2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallopamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:16c8abe6-d20a-11ec-8377-0242ac110003 UniProtKB:P31213 biolink:molecularly_interacts_with DrugCentral:1276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gamolenic acid targets Enzyme (3-oxo-5-alpha-steroid 4-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:16c8d418-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:1276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gamolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:16c8ffce-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gamolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:16c92b02-d20a-11ec-8377-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:1276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gamolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:16c9537a-d20a-11ec-8377-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:1276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gamolenic acid targets GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:16c97c4c-d20a-11ec-8377-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:1276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gamolenic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:16c9a492-d20a-11ec-8377-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:1277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ganciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:16c9c896-d20a-11ec-8377-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:1277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ganciclovir targets Kinase (Thymidine kinase) DrugCentral uuid:16c9ecc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13255 biolink:molecularly_interacts_with DrugCentral:1277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ganciclovir targets GPCR (Metabotropic glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:16ca15da-d20a-11ec-8377-0242ac110003 UniProtKB:P41594 biolink:molecularly_interacts_with DrugCentral:1277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ganciclovir targets GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:16ca3e20-d20a-11ec-8377-0242ac110003 UniProtKB:P10210 biolink:molecularly_interacts_with DrugCentral:1277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ganciclovir targets Enzyme (Capsid scaffolding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:16ca6652-d20a-11ec-8377-0242ac110003 UniProtKB:P9WP01 biolink:molecularly_interacts_with DrugCentral:1277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ganciclovir targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:16ca8f2e-d20a-11ec-8377-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ganirelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) DrugCentral uuid:16cab490-d20a-11ec-8377-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:16cae032-d20a-11ec-8377-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:16cb0c74-d20a-11ec-8377-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:16cb0c74-d20a-11ec-8377-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:16cb3e88-d20a-11ec-8377-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:16cb3e88-d20a-11ec-8377-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:16cb711e-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:16cb711e-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gatifloxacin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:16cba4a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:16cbccea-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:16cbf59e-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:16cc1e0c-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:16cc465c-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:16cc6ea2-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:16cc9904-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:16ccc460-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:16ccef6c-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:16cd179e-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:16cd41ba-d20a-11ec-8377-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:16cd6a0a-d20a-11ec-8377-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:16cd925a-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:16cdbaaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:16cde368-d20a-11ec-8377-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:16ce0bae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:16ce33fe-d20a-11ec-8377-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:16ce5d3e-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:16ce88cc-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:16ceb22a-d20a-11ec-8377-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:16ceda8e-d20a-11ec-8377-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:16cf0360-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:16cf2bba-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:16cf540a-d20a-11ec-8377-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:16cf7c64-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:16cfa4f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:16cfce12-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:16cff662-d20a-11ec-8377-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:16d01ebc-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:16d049a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:16d0747a-d20a-11ec-8377-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:16d09cc0-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:16d0c524-d20a-11ec-8377-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:16d0efe0-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:16d11858-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:16d140b2-d20a-11ec-8377-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:16d16a2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:16d1927e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:16d1bace-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:16d1e31e-d20a-11ec-8377-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:16d20c2c-d20a-11ec-8377-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:16d23472-d20a-11ec-8377-0242ac110003 UniProtKB:Q3U3Q1 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:16d25d62-d20a-11ec-8377-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:16d28594-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:16d2af88-d20a-11ec-8377-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:16d2d7d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:16d30028-d20a-11ec-8377-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:16d3299a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:16d35262-d20a-11ec-8377-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:16d37aa8-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:16d3a302-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:16d3cb5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:16d3f46a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:16d41cce-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:16d44500-d20a-11ec-8377-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:16d46d64-d20a-11ec-8377-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:16d4965e-d20a-11ec-8377-0242ac110003 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:16d4beae-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:16d4e6ea-d20a-11ec-8377-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:16d50f76-d20a-11ec-8377-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:16d537da-d20a-11ec-8377-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:16d56034-d20a-11ec-8377-0242ac110003 UniProtKB:Q16659 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:16d58870-d20a-11ec-8377-0242ac110003 UniProtKB:P31152 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:16d5b1f6-d20a-11ec-8377-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:16d5da64-d20a-11ec-8377-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:16d6028c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:16d62b5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:16d65430-d20a-11ec-8377-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:16d67c76-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:16d6a5a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:16d6ce06-d20a-11ec-8377-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.16']} DrugCentral uuid:16d6f6c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:16d71f1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:16d74764-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:16d76fbe-d20a-11ec-8377-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:16d79a70-d20a-11ec-8377-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:16d7c414-d20a-11ec-8377-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:16d7ec50-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:16d814aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:16d83dae-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gefitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:16d865fe-d20a-11ec-8377-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine targets Enzyme (Thymidylate synthase) DrugCentral uuid:16d88a20-d20a-11ec-8377-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:16d8ae56-d20a-11ec-8377-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) DrugCentral uuid:16d8d318-d20a-11ec-8377-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) DrugCentral uuid:16d8f730-d20a-11ec-8377-0242ac110003 UniProtKB:P30085 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine targets Kinase (UMP-CMP kinase) DrugCentral uuid:16d92476-d20a-11ec-8377-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:16d92476-d20a-11ec-8377-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:16d92476-d20a-11ec-8377-0242ac110003 UniProtKB:Q07864 biolink:molecularly_interacts_with DrugCentral:1283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemcitabine is inhibitor of Enzyme (DNA polymerase (alpha/delta/epsilon)) DrugCentral uuid:16d95d92-d20a-11ec-8377-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:1285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemfibrozil targets Enzyme (Lipoprotein lipase) DrugCentral uuid:16d981f0-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemfibrozil targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:16d9aa40-d20a-11ec-8377-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:1285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemfibrozil targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:16d9d29a-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemfibrozil targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.523']} DrugCentral uuid:16d9fb9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:1285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemfibrozil is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:16da23ee-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemfibrozil targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:16da4c52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemfibrozil targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:16da7484-d20a-11ec-8377-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemifloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:16da9fcc-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES7 biolink:molecularly_interacts_with DrugCentral:1286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemifloxacin targets Enzyme (DNA gyrase subunit B) DrugCentral uuid:16dac42a-d20a-11ec-8377-0242ac110003 UniProtKB:P72525 biolink:molecularly_interacts_with DrugCentral:1286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemifloxacin is inhibitor of Enzyme (DNA topoisomerase 4 subunit A) DrugCentral uuid:16dae860-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gestodene targets Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:16db0c6e-d20a-11ec-8377-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gestodene targets Enzyme (Cytochrome P450 3A5) DrugCentral uuid:16db3194-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1292 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gestrinone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:16db5a02-d20a-11ec-8377-0242ac110003 UniProtKB:Q12882 biolink:molecularly_interacts_with DrugCentral:1293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gimeracil is inhibitor of Enzyme (Dihydropyrimidine dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.638']} DrugCentral uuid:16db8248-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glafenine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:16dbaa52-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glafenine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:16dbd734-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:16dbd734-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:16dc0eb6-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.046']} DrugCentral uuid:16dc0eb6-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibornuride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.046']} DrugCentral uuid:16dc4610-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:16dc4610-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:16dc7e78-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.222']} DrugCentral uuid:16dc7e78-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gliclazide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.222']} DrugCentral uuid:16dcb5e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:16dcb5e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:16dced4a-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:16dced4a-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glimepiride is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:16dd26e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1301 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glipizide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.097']} DrugCentral uuid:16dd26e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1301 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glipizide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.097']} DrugCentral uuid:16dd5e74-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gliquidone is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:16dd5e74-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gliquidone is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:16dd960a-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glisoxepide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.959']} DrugCentral uuid:16dd960a-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glisoxepide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.959']} DrugCentral uuid:16ddcb48-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:16ddf4ce-d20a-11ec-8377-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:16de1d32-d20a-11ec-8377-0242ac110003 UniProtKB:P42261 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:16de45fa-d20a-11ec-8377-0242ac110003 UniProtKB:P39086 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:16de6e4a-d20a-11ec-8377-0242ac110003 UniProtKB:P42262 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:16de96ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q13255 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:16debee0-d20a-11ec-8377-0242ac110003 UniProtKB:P00367 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Enzyme (Glutamate dehydrogenase 1, mitochondrial) DrugCentral uuid:16dee4c4-d20a-11ec-8377-0242ac110003 UniProtKB:P49448 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Enzyme (Glutamate dehydrogenase 2, mitochondrial) DrugCentral uuid:16df0a58-d20a-11ec-8377-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:16df329e-d20a-11ec-8377-0242ac110003 UniProtKB:P41594 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:16df5ae4-d20a-11ec-8377-0242ac110003 UniProtKB:Q14833 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:16df8492-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:16dfad6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13002 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:16dfd5d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13003 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:16dffe22-d20a-11ec-8377-0242ac110003 UniProtKB:Q14831 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:16e026c2-d20a-11ec-8377-0242ac110003 UniProtKB:O15303 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:16e04efe-d20a-11ec-8377-0242ac110003 UniProtKB:Q14416 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:16e07744-d20a-11ec-8377-0242ac110003 UniProtKB:P43003 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:16e09fa8-d20a-11ec-8377-0242ac110003 UniProtKB:P43004 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:16e0cb86-d20a-11ec-8377-0242ac110003 UniProtKB:P43005 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:16e0f3b8-d20a-11ec-8377-0242ac110003 UniProtKB:P19491 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:16e11bfe-d20a-11ec-8377-0242ac110003 UniProtKB:P42263 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.595']} DrugCentral uuid:16e1446c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16099 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.738']} DrugCentral uuid:16e16ce4-d20a-11ec-8377-0242ac110003 UniProtKB:Q14832 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid is agonist of GPCR (Metabotropic glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:16e19516-d20a-11ec-8377-0242ac110003 UniProtKB:O00222 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid is agonist of GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:16e1be24-d20a-11ec-8377-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:16e1e6b0-d20a-11ec-8377-0242ac110003 UniProtKB:P42260 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:16e20ef6-d20a-11ec-8377-0242ac110003 UniProtKB:P22756 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:16e2375a-d20a-11ec-8377-0242ac110003 UniProtKB:P31423 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:16e25f82-d20a-11ec-8377-0242ac110003 UniProtKB:P35349 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:16e2884a-d20a-11ec-8377-0242ac110003 UniProtKB:P19490 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:16e2b072-d20a-11ec-8377-0242ac110003 UniProtKB:P19492 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:16e2d926-d20a-11ec-8377-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:16e3016c-d20a-11ec-8377-0242ac110003 UniProtKB:P42264 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.31']} DrugCentral uuid:16e32a66-d20a-11ec-8377-0242ac110003 UniProtKB:Q03469 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Enzyme (Glutamate racemase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:16e352ca-d20a-11ec-8377-0242ac110003 UniProtKB:P70579 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:16e37b1a-d20a-11ec-8377-0242ac110003 UniProtKB:P47743 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:16e3a356-d20a-11ec-8377-0242ac110003 UniProtKB:P31424 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:16e3ccfa-d20a-11ec-8377-0242ac110003 UniProtKB:P23385 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:16e3f52c-d20a-11ec-8377-0242ac110003 UniProtKB:P31421 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:16e41d54-d20a-11ec-8377-0242ac110003 UniProtKB:P31422 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets GPCR (Metabotropic glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:16e445a4-d20a-11ec-8377-0242ac110003 UniProtKB:P56068 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Enzyme (Glutamate racemase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:16e4710a-d20a-11ec-8377-0242ac110003 UniProtKB:O35921 biolink:molecularly_interacts_with DrugCentral:1310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamic acid targets Transporter (Excitatory amino acid transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:16e49946-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z1J7 biolink:molecularly_interacts_with DrugCentral:1311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutamine targets Transporter (Amino acid transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:16e4c16e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2Q3 biolink:molecularly_interacts_with DrugCentral:1312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutathione targets Enzyme (Glutathione S-transferase kappa 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:16e4f242-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutethimide is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:16e4f242-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutethimide is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:16e4f242-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glutethimide is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:16e529d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:16e55214-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:16e57b4a-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is inhibitor of Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.795']} DrugCentral uuid:16e5a408-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:16e5cc62-d20a-11ec-8377-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is blocker of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:16e5f8b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:16e5f8b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:16e62d38-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:16e6572c-d20a-11ec-8377-0242ac110003 UniProtKB:Q61743 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is blocker of Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:16e67f72-d20a-11ec-8377-0242ac110003 UniProtKB:Q96P20 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide targets Unclassified (NACHT, LRR and PYD domains-containing protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:16e6a7ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:16e6d094-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide targets Nuclear other (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:16e6fcf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ESQ5 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is inhibitor of Ion channel (Sur1-Trpm4; Sulfonylurea receptor 1 - Transient receptor potential melastatin 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:16e6fcf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ESQ5 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is inhibitor of Ion channel (Sur1-Trpm4; Sulfonylurea receptor 1 - Transient receptor potential melastatin 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:16e73430-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.523']} DrugCentral uuid:16e73430-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glibenclamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.523']} DrugCentral uuid:16e7681a-d20a-11ec-8377-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:16e7904c-d20a-11ec-8377-0242ac110003 UniProtKB:P48067 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Transporter (Sodium- and chloride-dependent glycine transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:16e7cfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:16e7cfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:16e7cfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:16e7cfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:16e7cfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:16e7cfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:16e7cfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:16e83fb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:1319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycine targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:16e868be-d20a-11ec-8377-0242ac110003 UniProtKB:P80365 biolink:molecularly_interacts_with DrugCentral:1325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycyrrhizic acid targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:16e89226-d20a-11ec-8377-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:1325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycyrrhizic acid targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:16e8bb16-d20a-11ec-8377-0242ac110003 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:1325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycyrrhizic acid targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:16e8e3fc-d20a-11ec-8377-0242ac110003 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:1325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycyrrhizic acid targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.06']} DrugCentral uuid:16e90c1a-d20a-11ec-8377-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:1327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 goserelin targets GPCR (Lutropin-choriogonadotropic hormone receptor) DrugCentral uuid:16e93046-d20a-11ec-8377-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 goserelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) DrugCentral uuid:16e954ea-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:16e97d26-d20a-11ec-8377-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:16e9a558-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:16e9cd8a-d20a-11ec-8377-0242ac110003 UniProtKB:P10415 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Cytosolic other (Apoptosis regulator Bcl-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:16e9f7f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q07820 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Cytosolic other (Induced myeloid leukemia cell differentiation protein Mcl-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:16ea2032-d20a-11ec-8377-0242ac110003 UniProtKB:Q07817 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Cytosolic other (Bcl-2-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:16ea4864-d20a-11ec-8377-0242ac110003 UniProtKB:P00346 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (Malate dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:16ea7140-d20a-11ec-8377-0242ac110003 UniProtKB:Q0PJ46 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (Lactate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:16ea9968-d20a-11ec-8377-0242ac110003 UniProtKB:Q6VVP7 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (Malate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:16eac19a-d20a-11ec-8377-0242ac110003 UniProtKB:P11708 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (Malate dehydrogenase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:16eae9b8-d20a-11ec-8377-0242ac110003 UniProtKB:P00338 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (L-lactate dehydrogenase A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:16eb1258-d20a-11ec-8377-0242ac110003 UniProtKB:Q92843 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Cytosolic other (Apoptosis regulator Bcl-W) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:16eb3a9e-d20a-11ec-8377-0242ac110003 UniProtKB:P52732 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (Kinesin-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:16eb62ee-d20a-11ec-8377-0242ac110003 UniProtKB:P11166 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Transporter (Solute carrier family 2, facilitated glucose transporter member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:16eb8b3e-d20a-11ec-8377-0242ac110003 UniProtKB:P29372 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (DNA-3-methyladenine glycosylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:16ebb528-d20a-11ec-8377-0242ac110003 UniProtKB:P07195 biolink:molecularly_interacts_with DrugCentral:1328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gossypol targets Enzyme (L-lactate dehydrogenase B chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:16ebe02a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.428']} DrugCentral uuid:16ec085c-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:16ec30c0-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:16ec5a8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:16ec86b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:16ec86b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:16ecbe0a-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:16ecbe0a-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:16ecf1cc-d20a-11ec-8377-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:16ed1a12-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 granisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:16ed424e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grepafloxacin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:16ed6e90-d20a-11ec-8377-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:16ed6e90-d20a-11ec-8377-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:16eda496-d20a-11ec-8377-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:16eda496-d20a-11ec-8377-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grepafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:16edd272-d20a-11ec-8377-0242ac110003 UniProtKB:P10875 biolink:molecularly_interacts_with DrugCentral:1331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 griseofulvin targets Structural (Tubulin beta chain) DrugCentral uuid:16edf68a-d20a-11ec-8377-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 griseofulvin targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:16ee20ba-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 griseofulvin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:16ee5148-d20a-11ec-8377-0242ac110003 UniProtKB:F2SZD3 biolink:molecularly_interacts_with DrugCentral:1331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 griseofulvin is inhibitor of Structural (Tubulin) DrugCentral uuid:16ee5148-d20a-11ec-8377-0242ac110003 UniProtKB:F2SZD3 biolink:molecularly_interacts_with DrugCentral:1331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 griseofulvin is inhibitor of Structural (Tubulin) DrugCentral uuid:16ee5148-d20a-11ec-8377-0242ac110003 UniProtKB:F2SZD3 biolink:molecularly_interacts_with DrugCentral:1331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 griseofulvin is inhibitor of Structural (Tubulin) DrugCentral uuid:16ee88d4-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1334 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guaiacol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:16eeb1d8-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1334 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guaiacol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:16eeda32-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanadrel is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:16eefe54-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanadrel targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:16ef228a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanethidine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:16ef46c0-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanethidine is substrate of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:16ef6d4e-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanethidine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:16ef9170-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanethidine targets GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:16efb592-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanethidine targets GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:16efd9b4-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanethidine targets GPCR (Alpha-1D adrenergic receptor) DrugCentral uuid:16effe6c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanethidine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:16f023ce-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.065']} DrugCentral uuid:16f04c28-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.875']} DrugCentral uuid:16f074aa-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.119']} DrugCentral uuid:16f09d86-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.926']} DrugCentral uuid:16f0c5d6-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:16f0ee1c-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.263']} DrugCentral uuid:16f1166c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:16f140ce-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:16f1693c-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanfacine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.164']} DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f22822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:1344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanidine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f412d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1348 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halazepam is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:16f4cafa-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ulobetasol propionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:16f4f020-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halofantrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:16f51866-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:16f540de-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.003']} DrugCentral uuid:16f56abe-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:16f59386-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is inverse agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:16f5bbcc-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.947']} DrugCentral uuid:16f5e426-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:16f60cc6-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:16f63502-d20a-11ec-8377-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:16f65d52-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:16f685c0-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:16f6afa0-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:16f6d804-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:16f70180-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:16f729da-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:16f752a2-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:16f77b06-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:16f7a34c-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.45']} DrugCentral uuid:16f7cba6-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:16f7f478-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.319']} DrugCentral uuid:16f81cc8-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is inverse agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:16f844fa-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:16f86e80-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:16f89a5e-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.999']} DrugCentral uuid:16f8c2cc-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:16f8eb30-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:16f913f8-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.182']} DrugCentral uuid:16f93c48-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.569']} DrugCentral uuid:16f964ac-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:16f98d06-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:16f9b63c-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:16f9de8c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:16fa0ff6-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:16fa0ff6-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:16fa0ff6-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:16fa4f98-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.648']} DrugCentral uuid:16fa77e8-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:16faa02e-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:16fac892-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:16faf132-d20a-11ec-8377-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:16fb1964-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.305']} DrugCentral uuid:16fb41aa-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:16fb69fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:16fb92d6-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.76']} DrugCentral uuid:16fbbb1c-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:16fbe376-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:16fc0bda-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:16fc375e-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:16fc5ff4-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:16fc8858-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:16fcb0bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:16fcd97a-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:16fd01de-d20a-11ec-8377-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:16fd2a38-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:16fd5288-d20a-11ec-8377-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:16fd7baa-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:16fda4c2-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:16fdcd1c-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:16fdf756-d20a-11ec-8377-0242ac110003 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:16fe1fe2-d20a-11ec-8377-0242ac110003 UniProtKB:P52702 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:16fe4832-d20a-11ec-8377-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:16fe7078-d20a-11ec-8377-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:16fe9936-d20a-11ec-8377-0242ac110003 UniProtKB:P50130 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:16fec19a-d20a-11ec-8377-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:16fee9e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:16ff1226-d20a-11ec-8377-0242ac110003 UniProtKB:P50129 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:16ff3b20-d20a-11ec-8377-0242ac110003 UniProtKB:P52703 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:16ff6384-d20a-11ec-8377-0242ac110003 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:16ff8bca-d20a-11ec-8377-0242ac110003 UniProtKB:P62744 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Unclassified (AP-2 complex subunit sigma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:16ffc4b4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:16ffc4b4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:16ffc4b4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:16ffc4b4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:16ffc4b4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:17002bfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:17002bfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:17002bfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:17002bfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:17008200-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:17008200-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:17008200-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:17008200-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1700d35e-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1700d35e-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1700d35e-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:170116e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:170116e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:170159be-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:170159be-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:170159be-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:170159be-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:170159be-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1701b986-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1701b986-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1701b986-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1701fff4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:1701fff4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:1701fff4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:17025b02-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:17025b02-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:17025b02-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:17025b02-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:17025b02-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:17025b02-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:17025b02-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:17025b02-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1702d94c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:1702d94c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:1702d94c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:17031948-d20a-11ec-8377-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:170341ac-d20a-11ec-8377-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:17036a1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:170395ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U3Y7 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Unclassified (Sigma intracellular receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1703c154-d20a-11ec-8377-0242ac110003 UniProtKB:Q60493 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol targets Unclassified (Zinc finger protein 664) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:1703ea62-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol is inverse agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.42']} DrugCentral uuid:1704133e-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halopredone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:17043788-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:17045fc4-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.339']} DrugCentral uuid:17048828-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.366']} DrugCentral uuid:1704b12c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.561']} DrugCentral uuid:1704da12-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:17050258-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.866']} DrugCentral uuid:17052ac6-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:170553de-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:17057d50-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:1705a5aa-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.231']} DrugCentral uuid:1705ce04-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.805']} DrugCentral uuid:1705f6ae-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:17061f08-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.338']} DrugCentral uuid:1706474e-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.309']} DrugCentral uuid:17066fbc-d20a-11ec-8377-0242ac110003 UniProtKB:Q14376 biolink:molecularly_interacts_with DrugCentral:1355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloprogin targets Enzyme (UDP-glucose 4-epimerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:170698ac-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:1706bd00-d20a-11ec-8377-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:1706e12c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:1707056c-d20a-11ec-8377-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:17072b50-d20a-11ec-8377-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:170755bc-d20a-11ec-8377-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:170755bc-d20a-11ec-8377-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1707bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halothane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:170875b4-d20a-11ec-8377-0242ac110003 UniProtKB:P01008 biolink:molecularly_interacts_with DrugCentral:1358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 heparin is activator of Secreted (Antithrombin-III) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:17089e0e-d20a-11ec-8377-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:1358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 heparin targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.14']} DrugCentral uuid:1708c668-d20a-11ec-8377-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:1358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 heparin targets Unclassified (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.14']} DrugCentral uuid:1708eea4-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:170917b2-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:17094002-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:17096866-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:17099106-d20a-11ec-8377-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1709b94c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1709e16a-d20a-11ec-8377-0242ac110003 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:170a09a6-d20a-11ec-8377-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:170a3264-d20a-11ec-8377-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:1362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hesperetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:170a6df6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:170a6df6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:170a6df6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:170a6df6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:170a6df6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:170a6df6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9RET4 biolink:molecularly_interacts_with DrugCentral:1363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hetacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:170ac242-d20a-11ec-8377-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.212']} DrugCentral uuid:170aebfa-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.191']} DrugCentral uuid:170b142c-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.043']} DrugCentral uuid:170b3c7c-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.686']} DrugCentral uuid:170c3c8a-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.636']} DrugCentral uuid:170c7da8-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.441']} DrugCentral uuid:170ca7ba-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.618']} DrugCentral uuid:170cd190-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.994']} DrugCentral uuid:170cfc42-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.442']} DrugCentral uuid:170d25a0-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:170d503e-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.521']} DrugCentral uuid:170d796a-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:170da1e2-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.882']} DrugCentral uuid:170dca64-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.126']} DrugCentral uuid:170df37c-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.911']} DrugCentral uuid:170e1c08-d20a-11ec-8377-0242ac110003 UniProtKB:P06149 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (D-lactate dehydrogenase) DrugCentral uuid:170e405c-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.614']} DrugCentral uuid:170e692e-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.459']} DrugCentral uuid:170e9264-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.479']} DrugCentral uuid:170ebadc-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:170ee34a-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.605']} DrugCentral uuid:170f0c58-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.057']} DrugCentral uuid:170f34c6-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:170f5d70-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.479']} DrugCentral uuid:170f8606-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.708']} DrugCentral uuid:170faf78-d20a-11ec-8377-0242ac110003 UniProtKB:P0AEK4 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) DrugCentral uuid:170fd3cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:170ffc8a-d20a-11ec-8377-0242ac110003 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (Transitional endoplasmic reticulum ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:17102502-d20a-11ec-8377-0242ac110003 UniProtKB:P11142 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Unclassified (Heat shock cognate 71 kDa protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:17104e56-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMV8 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Unclassified (Heat shock 70 kDa protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:171076a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:17109f28-d20a-11ec-8377-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:1710c7a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1710f1a8-d20a-11ec-8377-0242ac110003 UniProtKB:P14174 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Unclassified (Macrophage migration inhibitory factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:17111b4c-d20a-11ec-8377-0242ac110003 UniProtKB:Q6IQ20 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene is inhibitor of Unclassified (N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:171143d8-d20a-11ec-8377-0242ac110003 UniProtKB:P11021 biolink:molecularly_interacts_with DrugCentral:1364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexachlorophene targets Unclassified (78 kDa glucose-regulated protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:17116c46-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexafluronium is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:171191a8-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexafluronium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1711ba0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:1365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexafluronium targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1711e69e-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1711e69e-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:17121ff6-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:17121ff6-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:171257d2-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:171257d2-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:17129760-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:17129760-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:17129760-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:17129760-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1712e3f0-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:17130c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamethonium is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:17133486-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1368 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexestrol is antagonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:17136532-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:17136532-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:17136532-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:1713a452-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:1713a452-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:1713a452-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:1713e3f4-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:1713e3f4-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:1713e3f4-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:1714272e-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:1714272e-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:1714272e-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:171466a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobendine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:171466a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobendine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:171466a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexobendine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1714a5b4-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:1714c9e0-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1714f226-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:17151a80-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:17154384-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:17156bd4-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexocyclium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:17159bf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexylcaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17159bf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexylcaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17159bf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexylcaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1715dcae-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexylresorcinol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:171604b8-d20a-11ec-8377-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:1374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexylresorcinol targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:17162cea-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexylresorcinol targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:17165530-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine is agonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:17167dda-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1716a616-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1716ce52-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.508']} DrugCentral uuid:1716f7b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:1717208c-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:17174a4e-d20a-11ec-8377-0242ac110003 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:17177294-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:17179be8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1717c42e-d20a-11ec-8377-0242ac110003 UniProtKB:P58406 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:1717ec9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q91ZY2 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:171814d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q91ZY1 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:17183d82-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JI35 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.84']} DrugCentral uuid:171865d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q91ZY3 biolink:molecularly_interacts_with DrugCentral:1375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histamine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:17188e2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histidine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1718b65e-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:1718df4e-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:171907a8-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:17193020-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:17195866-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 homatropine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:17198250-d20a-11ec-8377-0242ac110003 UniProtKB:P27695 biolink:molecularly_interacts_with DrugCentral:1383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hycanthone targets Enzyme (DNA-(apurinic or apyrimidinic site) lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:1719aaa0-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1719d2be-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:1719f6cc-d20a-11ec-8377-0242ac110003 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (DNA (cytosine-5)-methyltransferase 1) DrugCentral uuid:171a1b34-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:171a3f60-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBC3 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (DNA (cytosine-5)-methyltransferase 3B) DrugCentral uuid:171a636e-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:171a8b8c-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.438']} DrugCentral uuid:171ab47c-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:171adcb8-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:171b04fe-d20a-11ec-8377-0242ac110003 UniProtKB:P80025 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:171b2d3a-d20a-11ec-8377-0242ac110003 UniProtKB:B0LPN4 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine targets Ion channel (Ryanodine receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.152']} DrugCentral uuid:171b583c-d20a-11ec-8377-0242ac110003 UniProtKB:Q92736 biolink:molecularly_interacts_with DrugCentral:1384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydralazine is blocker of Ion channel (Ryanodine receptor 2) DrugCentral uuid:171b7c5e-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:171ba4a4-d20a-11ec-8377-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7.01']} DrugCentral uuid:171bccb8-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:171bf558-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase 4) DrugCentral uuid:171c1a10-d20a-11ec-8377-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:171c3e46-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:171c6696-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:171c8fc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:171cb93e-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:171ce18e-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochlorothiazide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:171d0a92-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocodone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.02']} DrugCentral uuid:171d3602-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocodone is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:171d5e70-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1387 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortamate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:171d829c-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:171daaba-d20a-11ec-8377-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:1388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone targets Cytosolic other (Annexin A1) DrugCentral uuid:171dcf4a-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone is agonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.95']} DrugCentral uuid:171df768-d20a-11ec-8377-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:1388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:171e1f86-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.881']} DrugCentral uuid:171e47c2-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:171e70b2-d20a-11ec-8377-0242ac110003 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:1388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.37']} DrugCentral uuid:171e98f8-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone cypionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:171ebd1a-d20a-11ec-8377-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroflumethiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7.37']} DrugCentral uuid:171ee542-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydromorphone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:171f1120-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydromorphone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:171f3c54-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydromorphone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:171f74b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:171f74b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:171f74b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:171f74b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydromorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:171fbeb8-d20a-11ec-8377-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:1394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyamfetamine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.1']} DrugCentral uuid:171fe71c-d20a-11ec-8377-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:1394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:17200f80-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyamfetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.529']} DrugCentral uuid:1720385c-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:172060ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:172088e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:1720ad00-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.14']} DrugCentral uuid:1720d7c6-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.81']} DrugCentral uuid:17210336-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.979']} DrugCentral uuid:17212bcc-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1721541c-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:17217cd0-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1721a520-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1721cd70-d20a-11ec-8377-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:1721f1b0-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:17221a78-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYK1 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine is antagonist of Membrane receptor (Toll-like receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:172243e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NR96 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine is antagonist of Membrane receptor (Toll-like receptor 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:17226c94-d20a-11ec-8377-0242ac110003 UniProtKB:Q5BJF2 biolink:molecularly_interacts_with DrugCentral:1395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxychloroquine targets Enzyme (Transmembrane protein 97) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:172295ac-d20a-11ec-8377-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:1398 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxystilbamidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:1722c0a4-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxycarbamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:1722e8d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxycarbamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17231234-d20a-11ec-8377-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:1399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxycarbamide is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase large subunit) DrugCentral uuid:1723371e-d20a-11ec-8377-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:1399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxycarbamide is inhibitor of Enzyme (Ribonucleoside-diphosphate reductase subunit M2) DrugCentral uuid:17235b54-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxycarbamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:17238390-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyzine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1723abe0-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyzine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1723d494-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyzine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1723fcd0-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyzine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.409']} DrugCentral uuid:17242502-d20a-11ec-8377-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:1400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyzine targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:17244d34-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hymecromone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:172476ec-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hymecromone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:17249f28-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hymecromone targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1724c764-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hymecromone targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1724ef96-d20a-11ec-8377-0242ac110003 UniProtKB:P37058 biolink:molecularly_interacts_with DrugCentral:1401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hymecromone targets Enzyme (Testosterone 17-beta-dehydrogenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:17251840-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hymecromone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:1725405e-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hyoscyamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:172568c2-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hyoscyamine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:172590fe-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hyoscyamine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:1725b9f8-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hyoscyamine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:1725e234-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hyoscyamine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:17260a84-d20a-11ec-8377-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:1404 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibandronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:172632b6-d20a-11ec-8377-0242ac110003 UniProtKB:O95749 biolink:molecularly_interacts_with DrugCentral:1404 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibandronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:17265bb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q02769 biolink:molecularly_interacts_with DrugCentral:1404 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibandronic acid targets Enzyme (Squalene synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:172683c4-d20a-11ec-8377-0242ac110003 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:1404 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibandronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1726abe2-d20a-11ec-8377-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:1406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1726d428-d20a-11ec-8377-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:1406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:1726fda4-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:172725d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q08493 biolink:molecularly_interacts_with DrugCentral:1406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibudilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:17274e12-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:17277720-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:17279f66-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1727c7b6-d20a-11ec-8377-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:1727efde-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:17281a7c-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:17284088-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:172868d8-d20a-11ec-8377-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1728924a-d20a-11ec-8377-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1728bae0-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1728e326-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:17290b4e-d20a-11ec-8377-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:17293376-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:17295c5c-d20a-11ec-8377-0242ac110003 UniProtKB:P02769 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Secreted (Serum albumin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:172984b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1729ace8-d20a-11ec-8377-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1729d506-d20a-11ec-8377-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:172a024c-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:172a024c-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:172a35d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N695 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen is inhibitor of Transporter (Sodium-coupled monocarboxylate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:172a5e0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VD48 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen targets Enzyme (Dehydrogenase/reductase SDR family member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:172a86c2-d20a-11ec-8377-0242ac110003 UniProtKB:P78348 biolink:molecularly_interacts_with DrugCentral:1407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuprofen is blocker of Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.53']} DrugCentral uuid:172aaef4-d20a-11ec-8377-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuproxam targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:172adbea-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuproxam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:172adbea-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibuproxam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:172b0f5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibutilide is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:172b3806-d20a-11ec-8377-0242ac110003 UniProtKB:O75907 biolink:molecularly_interacts_with DrugCentral:1413 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icosapent ethyl is inhibitor of Enzyme (Diacylglycerol O-acyltransferase 1) DrugCentral uuid:172b5ca0-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idarubicin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:172b80d6-d20a-11ec-8377-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idarubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:172ba4f8-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idarubicin targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:172bca46-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idebenone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.155']} DrugCentral uuid:172bf26e-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idebenone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:172c1abe-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idebenone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:172c42e6-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idebenone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:172c6ba4-d20a-11ec-8377-0242ac110003 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:1417 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idoxuridine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:172c93ea-d20a-11ec-8377-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:1417 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idoxuridine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:172cbc3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:172ce46c-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.41']} DrugCentral uuid:172d0d02-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:172d353e-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:172d5d8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:172d8606-d20a-11ec-8377-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:172db130-d20a-11ec-8377-0242ac110003 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:172dd980-d20a-11ec-8377-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:172e01a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:172e2a70-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:172e5324-d20a-11ec-8377-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:172e7b60-d20a-11ec-8377-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:172ea39c-d20a-11ec-8377-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.99']} DrugCentral uuid:172ed11e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:172ed11e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:172f0c56-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:172f0c56-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:172f0c56-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:172f4ad6-d20a-11ec-8377-0242ac110003 UniProtKB:Q00960 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate [NMDA] receptor subunit epsilon 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:172f74ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q60490 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Unclassified (3-beta-hydroxysteroid-delta(8),delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.57']} DrugCentral uuid:172f9d10-d20a-11ec-8377-0242ac110003 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:172fc56a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:172fed9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:17301632-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U3Y7 biolink:molecularly_interacts_with DrugCentral:1419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ifenprodil targets Unclassified (Sigma intracellular receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:17303e6e-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:17306682-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:17308ebe-d20a-11ec-8377-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:1730b754-d20a-11ec-8377-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1730df86-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:173107cc-d20a-11ec-8377-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1731303a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:17315c04-d20a-11ec-8377-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:173186d4-d20a-11ec-8377-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1731aefc-d20a-11ec-8377-0242ac110003 UniProtKB:Q62053 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1731d7b0-d20a-11ec-8377-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:17320000-d20a-11ec-8377-0242ac110003 UniProtKB:P32240 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:17322864-d20a-11ec-8377-0242ac110003 UniProtKB:Q62928 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:17325096-d20a-11ec-8377-0242ac110003 UniProtKB:P43252 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:17327a3a-d20a-11ec-8377-0242ac110003 UniProtKB:P43253 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.16']} DrugCentral uuid:1732a28a-d20a-11ec-8377-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:1732cab2-d20a-11ec-8377-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:1422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1732f2ee-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:17331c74-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:173344c4-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:17336e72-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.714']} DrugCentral uuid:173396d6-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1733bf80-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:1733e3a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:17340bde-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:17343424-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:17345d64-d20a-11ec-8377-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:173485c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:1734adfa-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1734d65e-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:173501e2-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:17352cb2-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:173554f8-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:17357d20-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.69']} DrugCentral uuid:1735a5ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1735ce24-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1735f66a-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:17361f14-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1736475a-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:17367086-d20a-11ec-8377-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:173698cc-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1736c22a-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1736ea70-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:173712a2-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:17373af2-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:173763b0-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:17378be2-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:1737b41e-d20a-11ec-8377-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1737dc6e-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1738050e-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:17382d54-d20a-11ec-8377-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:17385586-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:17387dc2-d20a-11ec-8377-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1738a8f6-d20a-11ec-8377-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1738d330-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1738fb76-d20a-11ec-8377-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:173923a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:17394c52-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:173975b0-d20a-11ec-8377-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:17399e00-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:1739c6aa-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1739eefa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:173a175e-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:173a3fa4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:173a69e8-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:173a921a-d20a-11ec-8377-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:173abb0a-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:173ae3b4-d20a-11ec-8377-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:173b0c72-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:173b349a-d20a-11ec-8377-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:173b5cf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:173b8530-d20a-11ec-8377-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:173badd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15046 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Lysine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:173bd616-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:173bfe5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:173c26ac-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:173c5244-d20a-11ec-8377-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:173c7cb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:173ca4ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:173ccd14-d20a-11ec-8377-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:173cf5dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:173d1e18-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:173d4654-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:173d6ef4-d20a-11ec-8377-0242ac110003 UniProtKB:P00520 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.97']} DrugCentral uuid:173d971c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:173dbf30-d20a-11ec-8377-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:173de76c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:173e10d4-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:173e38fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:173e6214-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:173e8a3c-d20a-11ec-8377-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:173eb6e2-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:173eb6e2-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:173eee32-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:173eee32-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:173f25a0-d20a-11ec-8377-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:173f25a0-d20a-11ec-8377-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:173f5b06-d20a-11ec-8377-0242ac110003 UniProtKB:Q05030 biolink:molecularly_interacts_with DrugCentral:1423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imatinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:173f836a-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imidapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:173faba6-d20a-11ec-8377-0242ac110003 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem targets Enzyme (Penicillin-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:173fd3e2-d20a-11ec-8377-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem targets Enzyme (Penicillin-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:173fffc0-d20a-11ec-8377-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:17402aae-d20a-11ec-8377-0242ac110003 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:174069ec-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:174069ec-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:174069ec-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:174069ec-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:174069ec-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:174069ec-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:174069ec-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1740c84c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:1740f0a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.284']} DrugCentral uuid:17411978-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:17414272-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.854']} DrugCentral uuid:17416ab8-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.432']} DrugCentral uuid:17419308-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.237']} DrugCentral uuid:1741bd9c-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.825']} DrugCentral uuid:1741e5f6-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:17420e5a-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.495']} DrugCentral uuid:174236a0-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:17425f5e-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.412']} DrugCentral uuid:174287cc-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.614']} DrugCentral uuid:1742b008-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:1742d862-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:1743012a-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:17432984-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:174351ca-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.081']} DrugCentral uuid:17437a2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.071']} DrugCentral uuid:1743a5a8-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.36']} DrugCentral uuid:1743d12c-d20a-11ec-8377-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1743f97c-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:174421c2-d20a-11ec-8377-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:17444a94-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:174472e4-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:17449c7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1744c546-d20a-11ec-8377-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:1744edaa-d20a-11ec-8377-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:17451604-d20a-11ec-8377-0242ac110003 UniProtKB:P34968 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:17453e68-d20a-11ec-8377-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1745685c-d20a-11ec-8377-0242ac110003 UniProtKB:Q60857 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:174592a0-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:1745bbcc-d20a-11ec-8377-0242ac110003 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1745e426-d20a-11ec-8377-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:17460cd0-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:17464c22-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:17464c22-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:17464c22-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:17464c22-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:17464c22-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:17464c22-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:17464c22-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1746c6c0-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1746c6c0-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1746c6c0-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1746c6c0-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1746c6c0-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:17474f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:17474f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:17474f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:17474f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:17474f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:17474f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:17474f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:17474f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:17474f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:17474f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:17474f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:17474f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:17474f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:17474f14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:174810c0-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:174810c0-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:174810c0-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1748605c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1748605c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1748605c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1748605c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1748605c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1748bdb8-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1748bdb8-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1748bdb8-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:17490480-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:17490480-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:17490480-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:17494bd4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:17494bd4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:17494bd4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:17498a86-d20a-11ec-8377-0242ac110003 UniProtKB:P48545 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:1749b326-d20a-11ec-8377-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1749dc70-d20a-11ec-8377-0242ac110003 UniProtKB:P17405 biolink:molecularly_interacts_with DrugCentral:1427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imipramine targets Enzyme (Sphingomyelin phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:174a04ca-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imiquimod targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.525']} DrugCentral uuid:174a2e0a-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imiquimod targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:174a56be-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imiquimod targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:174a7f36-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYK1 biolink:molecularly_interacts_with DrugCentral:1429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imiquimod is agonist of Membrane receptor (Toll-like receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:174aa77c-d20a-11ec-8377-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:1431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 incadronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:174acfea-d20a-11ec-8377-0242ac110003 UniProtKB:Q8MTZ4 biolink:molecularly_interacts_with DrugCentral:1431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 incadronic acid targets Unclassified (Vacuolar-type proton translocating pyrophosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:174afbc8-d20a-11ec-8377-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:1431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 incadronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.523']} DrugCentral uuid:174b272e-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indalpine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:174b4fe2-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:174b78dc-d20a-11ec-8377-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7.54']} DrugCentral uuid:174ba118-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:174bc97c-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:174bf1d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:174c1abc-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:174c4320-d20a-11ec-8377-0242ac110003 UniProtKB:P51787 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Ion channel (Potassium voltage-gated channel subfamily KQT member 1) DrugCentral uuid:174c6760-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:174c8fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:174cb9e0-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:174ce582-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:174d126e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:174d3d84-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.535']} DrugCentral uuid:174d662e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:174d8e7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indapamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:174db6e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indecainide is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:174ddaf0-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indenolol targets GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:174dff6c-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indenolol targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:174e23a2-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:174e4cd8-d20a-11ec-8377-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.222']} DrugCentral uuid:174e751e-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.733']} DrugCentral uuid:174e9f94-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:174ec898-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:174ef0de-d20a-11ec-8377-0242ac110003 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:174f1924-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:174f41ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:174f6a00-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.27']} DrugCentral uuid:174f925a-d20a-11ec-8377-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:174fbabe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:1437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.42']} DrugCentral uuid:174fe39a-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1438 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indisetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:17500bea-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indobufen targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:17503016-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indobufen targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:17505492-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:17507e18-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:1750a672-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1750ceae-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1750f780-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:17511fa8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.53']} DrugCentral uuid:1751480c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BPW9 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Dehydrogenase/reductase SDR family member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:17517034-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:175198fc-d20a-11ec-8377-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:1751c12e-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1751e974-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:175211b0-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.691']} DrugCentral uuid:17523b22-d20a-11ec-8377-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:1752648a-d20a-11ec-8377-0242ac110003 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:17528cee-d20a-11ec-8377-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1752b520-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:1752dde8-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:17530746-d20a-11ec-8377-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.19']} DrugCentral uuid:17532fa0-d20a-11ec-8377-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:175357dc-d20a-11ec-8377-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:17538090-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1753a8e0-d20a-11ec-8377-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1753d130-d20a-11ec-8377-0242ac110003 UniProtKB:P35355 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1753f96c-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:17542554-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:17544fd4-d20a-11ec-8377-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.39']} DrugCentral uuid:17547c02-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:17547c02-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1754b42e-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1754b42e-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1754ebb0-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase (cyclooxygenase)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1754ebb0-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin G/H synthase (cyclooxygenase)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:17551f40-d20a-11ec-8377-0242ac110003 UniProtKB:P29477 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:175547e0-d20a-11ec-8377-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:17557026-d20a-11ec-8377-0242ac110003 UniProtKB:P17516 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Aldo-keto reductase family 1 member C4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:17559876-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin is agonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:1755c0ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:1440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indomethacin targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:1755ebbe-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoprofen targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:17561512-d20a-11ec-8377-0242ac110003 UniProtKB:P08659 biolink:molecularly_interacts_with DrugCentral:1442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoprofen targets Unclassified (Luciferin 4-monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:17563d58-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:175665bc-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:17568e8e-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1756b706-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:1756df6a-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:175707ba-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:17573082-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:175758e6-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1757815e-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1757b304-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1757b304-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1757b304-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1757fa3a-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:1757fa3a-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:1757fa3a-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indoramin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.61']} DrugCentral uuid:17583a36-d20a-11ec-8377-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 intoplicine targets Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:175862e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q969P6 biolink:molecularly_interacts_with DrugCentral:1446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 intoplicine targets Enzyme (DNA topoisomerase I, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:17588b12-d20a-11ec-8377-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:1446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 intoplicine targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1758b362-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.278']} DrugCentral uuid:1758dbb2-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.724']} DrugCentral uuid:17590452-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.609']} DrugCentral uuid:17592d24-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.804']} DrugCentral uuid:17595592-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.067']} DrugCentral uuid:17597db0-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.279']} DrugCentral uuid:1759aace-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.439']} DrugCentral uuid:1759d5bc-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.043']} DrugCentral uuid:1759fdf8-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.532']} DrugCentral uuid:175a26a2-d20a-11ec-8377-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:1457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diiodohydroxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:175a4eca-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:175a7710-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:175a9f7e-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.292']} DrugCentral uuid:175ac896-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.181']} DrugCentral uuid:175af0e6-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:175b1940-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:175b41a4-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:175b6c06-d20a-11ec-8377-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.74']} DrugCentral uuid:175b944c-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipratropium targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.824']} DrugCentral uuid:175bbc74-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipriflavone targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.531']} DrugCentral uuid:175be4c4-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipriflavone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:175c0d82-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iprindole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:175c35d2-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iprindole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.899']} DrugCentral uuid:175c5e22-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iprindole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:175c867c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iprindole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.185']} DrugCentral uuid:175caf1c-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:1480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iproniazid targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:175cd79e-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:1480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iproniazid targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:175cffe4-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iproniazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:175d2834-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iproniazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:175d535e-d20a-11ec-8377-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:175d7bae-d20a-11ec-8377-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:175da4e4-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:175dd1b2-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:175dd1b2-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:175e0e2a-d20a-11ec-8377-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:175e0e2a-d20a-11ec-8377-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:175e0e2a-d20a-11ec-8377-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:175e4d0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:1481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irbesartan is inhibitor of Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:175e75e0-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:175e9a20-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.664']} DrugCentral uuid:175ec270-d20a-11ec-8377-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:175ee6b0-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.336']} DrugCentral uuid:175f111c-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:175f37e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:175f5c1c-d20a-11ec-8377-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:175f803e-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:175fa8e8-d20a-11ec-8377-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan is inhibitor of Enzyme (DNA topoisomerase 1) DrugCentral uuid:175fcd28-d20a-11ec-8377-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.218']} DrugCentral uuid:175ff578-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:17601db4-d20a-11ec-8377-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:17604686-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:17606ed6-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:17609726-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1760bf58-d20a-11ec-8377-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irinotecan targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:1760e884-d20a-11ec-8377-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:1483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 irofulven targets Kinase (Serine/threonine-protein kinase Chk2) DrugCentral uuid:17610d32-d20a-11ec-8377-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:1486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isepamicin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.87']} DrugCentral uuid:1761358c-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1490 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isocarboxazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:176159d6-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1490 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isocarboxazid is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:17617f88-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoetarine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1761a7d8-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.109']} DrugCentral uuid:1761d046-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:1761f490-d20a-11ec-8377-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:1762192a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:17623d6a-d20a-11ec-8377-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:176261a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:176289dc-d20a-11ec-8377-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:176289dc-d20a-11ec-8377-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive modulator of Ion channel (Glycine receptor (alpha-1/beta)) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1762f322-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1763aa9c-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluostigmine targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1763d30a-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1763fbd2-d20a-11ec-8377-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.15']} DrugCentral uuid:176423fa-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:17644d58-d20a-11ec-8377-0242ac110003 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:1494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluostigmine targets Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1764758a-d20a-11ec-8377-0242ac110003 UniProtKB:Q29550 biolink:molecularly_interacts_with DrugCentral:1494 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluostigmine targets Enzyme (Liver carboxylesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:17649f2e-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoniazid targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1764c74c-d20a-11ec-8377-0242ac110003 UniProtKB:P9WIE4 biolink:molecularly_interacts_with DrugCentral:1497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoniazid targets Enzyme (Catalase-peroxidase) DrugCentral uuid:1764ebb4-d20a-11ec-8377-0242ac110003 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:1497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoniazid is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:176513dc-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoniazid targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:17653cfe-d20a-11ec-8377-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoniazid targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:17656512-d20a-11ec-8377-0242ac110003 UniProtKB:P9WNX1 biolink:molecularly_interacts_with DrugCentral:1497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoniazid targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:17658d6c-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1765b5a8-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.8']} DrugCentral uuid:1765de48-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:17660698-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:17662ef2-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:17665878-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:176680be-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.752']} DrugCentral uuid:1766a8e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1766d10e-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1766f99a-d20a-11ec-8377-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:176721cc-d20a-11ec-8377-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:17674a94-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYV8 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 14) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176772d0-d20a-11ec-8377-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:17679b66-d20a-11ec-8377-0242ac110003 UniProtKB:P04274 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:1767c514-d20a-11ec-8377-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1767ed5a-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:176815aa-d20a-11ec-8377-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:17683fa8-d20a-11ec-8377-0242ac110003 UniProtKB:P59533 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 38) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:1768699c-d20a-11ec-8377-0242ac110003 UniProtKB:P59534 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 39) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176891ce-d20a-11ec-8377-0242ac110003 UniProtKB:P59535 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 40) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:1768ba1e-d20a-11ec-8377-0242ac110003 UniProtKB:P59536 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 41) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:1768e2aa-d20a-11ec-8377-0242ac110003 UniProtKB:P59537 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 43) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:17690afa-d20a-11ec-8377-0242ac110003 UniProtKB:P59538 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 31) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:1769334a-d20a-11ec-8377-0242ac110003 UniProtKB:P59539 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 45) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:17695b9a-d20a-11ec-8377-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:17698430-d20a-11ec-8377-0242ac110003 UniProtKB:P59541 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 30) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:1769ac6c-d20a-11ec-8377-0242ac110003 UniProtKB:P59542 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 19) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:1769d494-d20a-11ec-8377-0242ac110003 UniProtKB:P59543 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:1769fdf2-d20a-11ec-8377-0242ac110003 UniProtKB:P59544 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 50) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176a262e-d20a-11ec-8377-0242ac110003 UniProtKB:P59551 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 60) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176a4e88-d20a-11ec-8377-0242ac110003 UniProtKB:Q7RTR8 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 42) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176a76ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYV7 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 16) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176a9f82-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYV8 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 14) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176ac7c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYV9 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 13) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176af00e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYW0 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176b1872-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYW1 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176b40ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYW2 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176b6930-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYW3 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176b91f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYW4 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176bba2a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYW5 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176be4f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYW6 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176c0e94-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYW7 biolink:molecularly_interacts_with DrugCentral:1499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoprenaline targets GPCR (Taste receptor type 2 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:176c36b2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isopropamide is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:176c5bce-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isopropamide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:176c86b2-d20a-11ec-8377-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide dinitrate targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:176cb6d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:176cb6d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:176cb6d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:176cb6d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide dinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:176cf818-d20a-11ec-8377-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1506 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide mononitrate targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:176d2838-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:176d2838-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:176d2838-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:176d2838-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1506 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isosorbide mononitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:176d6b22-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:176d9368-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:176dbe2e-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.628']} DrugCentral uuid:176de94e-d20a-11ec-8377-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['8.229']} DrugCentral uuid:176e1360-d20a-11ec-8377-0242ac110003 UniProtKB:P08319 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Enzyme (Alcohol dehydrogenase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:176e3ba6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BPW9 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Enzyme (Dehydrogenase/reductase SDR family member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.523']} DrugCentral uuid:176e64aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q92781 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Enzyme (11-cis retinol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:176e8cf0-d20a-11ec-8377-0242ac110003 UniProtKB:O14756 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Enzyme (17-beta-hydroxysteroid dehydrogenase type 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:176eb568-d20a-11ec-8377-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin is inhibitor of Nuclear hormone receptor (Retinoic acid receptor beta) DrugCentral uuid:176ed99e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.597']} DrugCentral uuid:176f025c-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.335']} DrugCentral uuid:176f2a98-d20a-11ec-8377-0242ac110003 UniProtKB:P40220 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:176f52d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:1508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isotretinoin targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:176f7bd8-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1509 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoxicam targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:176fa414-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1509 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:176fcc5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:176ff086-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:177015b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:17703e9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:177066d8-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:17708f3c-d20a-11ec-8377-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:1770b818-d20a-11ec-8377-0242ac110003 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1770e072-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JIS7 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:177108cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q01815 biolink:molecularly_interacts_with DrugCentral:1511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isradipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:177131a8-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:17715ab6-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.046']} DrugCentral uuid:177182fc-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['9.246']} DrugCentral uuid:1771ab60-d20a-11ec-8377-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1771d3b0-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1771fcbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:17722554-d20a-11ec-8377-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:17724d9a-d20a-11ec-8377-0242ac110003 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:177275ea-d20a-11ec-8377-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:17729e76-d20a-11ec-8377-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1772c7e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1772f056-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:1513 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 itraconazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:17733912-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:17733912-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:17733912-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:17733912-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:17733912-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:17733912-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:17733912-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:17733912-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:17733912-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:1517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixabepilone is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1773ab4a-d20a-11ec-8377-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:1519 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kanamycin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.678']} DrugCentral uuid:1773d430-d20a-11ec-8377-0242ac110003 UniProtKB:P0A6R0 biolink:molecularly_interacts_with DrugCentral:1519 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kanamycin targets Unclassified (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1773fc76-d20a-11ec-8377-0242ac110003 UniProtKB:P29033 biolink:molecularly_interacts_with DrugCentral:1519 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kanamycin targets Unclassified (Gap junction beta-2 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:177424b2-d20a-11ec-8377-0242ac110003 UniProtKB:C3TDZ2 biolink:molecularly_interacts_with DrugCentral:1520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bekanamycin targets Enzyme (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:17744d16-d20a-11ec-8377-0242ac110003 UniProtKB:P0A6R0 biolink:molecularly_interacts_with DrugCentral:1520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bekanamycin targets Unclassified (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:177475d4-d20a-11ec-8377-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1774b576-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1774b576-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1774b576-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1774b576-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1774b576-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1774b576-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1774b576-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is blocker of Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:17753870-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:17753870-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:17753870-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:17753870-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:17753870-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:17753870-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:17753870-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1775af8a-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:1775af8a-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:1775af8a-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:1775af8a-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:1523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketamine is opener of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:1775f1de-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:17761a42-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:17764300-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki'} DrugCentral uuid:17766d26-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:17769558-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:1776bdbc-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1776e760-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:17770fb0-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:177737ec-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:17776050-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:17778940-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1777b212-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1777da76-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.701']} DrugCentral uuid:177802d0-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:17782b70-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.747']} DrugCentral uuid:177853ca-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:17787bfc-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1778a53c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:1778d066-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:1778fb0e-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1779235e-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:17794c44-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1779746c-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.903']} DrugCentral uuid:17799cbc-d20a-11ec-8377-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:1779c4f8-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1779eea6-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:177a1714-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:177a3f64-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.33']} DrugCentral uuid:177a67c8-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:177a92b6-d20a-11ec-8377-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:177abc0a-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:177ae46e-d20a-11ec-8377-0242ac110003 UniProtKB:P54219 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is inhibitor of Transporter (Chromaffin granule amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:177b1542-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:177b1542-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:177b1542-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:177b5bc4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:177b5bc4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:177b5bc4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:177b9a94-d20a-11ec-8377-0242ac110003 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:177bc352-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BRU6 biolink:molecularly_interacts_with DrugCentral:1524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketanserin targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:177beb5c-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:177c14d8-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.223']} DrugCentral uuid:177c3d3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.585']} DrugCentral uuid:177c6866-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.845']} DrugCentral uuid:177c9c64-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:177c9c64-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:177c9c64-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:177c9c64-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:177cf236-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:177cf236-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:177cf236-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:177cf236-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1526 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketobemidone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:177d3cdc-d20a-11ec-8377-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.821']} DrugCentral uuid:177d6540-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:177d8eb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:177db702-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:177ddf48-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:177e07ac-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:177e325e-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:177e5ab8-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.084']} DrugCentral uuid:177e8312-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.667']} DrugCentral uuid:177eab6c-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.028']} DrugCentral uuid:177ed448-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:177efc84-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.729']} DrugCentral uuid:177f24d4-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:177f4914-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:177f71dc-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:177f9ae0-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.346']} DrugCentral uuid:177fc33a-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:177fec84-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:17801704-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:17803f40-d20a-11ec-8377-0242ac110003 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:17806772-d20a-11ec-8377-0242ac110003 UniProtKB:Q16322 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:17809044-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:1780b92a-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.665']} DrugCentral uuid:1780e256-d20a-11ec-8377-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'app Ki', 'has_quantitative_value': ['7.197']} DrugCentral uuid:17810a6a-d20a-11ec-8377-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1781331e-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:17815c86-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:17818620-d20a-11ec-8377-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1781ae66-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.266']} DrugCentral uuid:1781d788-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.897']} DrugCentral uuid:1781ffe2-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.211']} DrugCentral uuid:1782283c-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.009']} DrugCentral uuid:1782508c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:17827986-d20a-11ec-8377-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.66']} DrugCentral uuid:1782a1cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q07973 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.506']} DrugCentral uuid:1782ca26-d20a-11ec-8377-0242ac110003 UniProtKB:P08686 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 21) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1782f262-d20a-11ec-8377-0242ac110003 UniProtKB:P15150 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 11B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:17831af8-d20a-11ec-8377-0242ac110003 UniProtKB:P14137 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 11A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:1783432a-d20a-11ec-8377-0242ac110003 UniProtKB:Q09128 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 24A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:17836b5c-d20a-11ec-8377-0242ac110003 UniProtKB:P18125 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 7A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:17839398-d20a-11ec-8377-0242ac110003 UniProtKB:Q64654 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 51) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1783bcb0-d20a-11ec-8377-0242ac110003 UniProtKB:P11715 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (Cytochrome P450 17A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:1783e500-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.81']} DrugCentral uuid:17840d32-d20a-11ec-8377-0242ac110003 UniProtKB:O35084 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1784355a-d20a-11ec-8377-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole is inhibitor of Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.174']} DrugCentral uuid:17845e54-d20a-11ec-8377-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole is inhibitor of Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:178486ae-d20a-11ec-8377-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoconazole is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.896']} DrugCentral uuid:1784aee0-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1784d8ac-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:178500e8-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:17852942-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1785558e-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1785558e-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketoprofen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:17858b94-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketorolac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1785b718-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketorolac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.72']} DrugCentral uuid:1785dff4-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketorolac targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:17860858-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketorolac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.214']} DrugCentral uuid:17863148-d20a-11ec-8377-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketorolac targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:178659b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:1529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketorolac targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:178681de-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.361']} DrugCentral uuid:1786aa42-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.086']} DrugCentral uuid:1786d2f6-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:1786f7ae-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.839']} DrugCentral uuid:17872206-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.047']} DrugCentral uuid:17874baa-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:1787740e-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.076']} DrugCentral uuid:17879c86-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.276']} DrugCentral uuid:1787c4cc-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.489']} DrugCentral uuid:1787edd0-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.176']} DrugCentral uuid:17881634-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.509']} DrugCentral uuid:17883e84-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.391']} DrugCentral uuid:178866de-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:17888f6a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.016']} DrugCentral uuid:1788b7a6-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.359']} DrugCentral uuid:1788e0e6-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:17890936-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.075']} DrugCentral uuid:178933d4-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.73']} DrugCentral uuid:17895f58-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.737']} DrugCentral uuid:17898b0e-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:1789b674-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1530 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ketotifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1789dfc8-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.234']} DrugCentral uuid:178a0836-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:178a3090-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.117']} DrugCentral uuid:178a5a84-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.478']} DrugCentral uuid:178a831a-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.648']} DrugCentral uuid:178aab7e-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.714']} DrugCentral uuid:178ad3d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.894']} DrugCentral uuid:178afdae-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:178b26f8-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:178b4f5c-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.491']} DrugCentral uuid:178b77b6-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:178ba0b0-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:178bc900-d20a-11ec-8377-0242ac110003 UniProtKB:P47154 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets Enzyme (CAAX prenyl protease 1) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:178bf1e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:1531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 labetalol targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:178c1a04-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.046']} DrugCentral uuid:178c42a4-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.245']} DrugCentral uuid:178c6afe-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.679']} DrugCentral uuid:178c9358-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.642']} DrugCentral uuid:178cbb94-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:178ce678-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:178d0ebe-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.771']} DrugCentral uuid:178d38a8-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:178d65c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:178d65c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:178d93ca-d20a-11ec-8377-0242ac110003 UniProtKB:O00214 biolink:molecularly_interacts_with DrugCentral:1535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lactose targets Unclassified (Galectin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.21']} DrugCentral uuid:178dbc10-d20a-11ec-8377-0242ac110003 UniProtKB:O00182 biolink:molecularly_interacts_with DrugCentral:1535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lactose targets Unclassified (Galectin-9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.64']} DrugCentral uuid:178de442-d20a-11ec-8377-0242ac110003 UniProtKB:P17931 biolink:molecularly_interacts_with DrugCentral:1535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lactose targets Unclassified (Galectin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.03']} DrugCentral uuid:178e0cc4-d20a-11ec-8377-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:1539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamivudine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:178e30fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:1539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamivudine is inhibitor of Polyprotein (Protein P) DrugCentral uuid:178e553a-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1539 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamivudine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:178e7d9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:178ea6ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.839']} DrugCentral uuid:178ecede-d20a-11ec-8377-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:178ef2f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:178f1b78-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:178f445e-d20a-11ec-8377-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:178f6cc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:178f90ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:178fb934-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.744']} DrugCentral uuid:178fe206-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:17900a56-d20a-11ec-8377-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:17903288-d20a-11ec-8377-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1790628a-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:1790628a-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:1790628a-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:1790a4f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:1540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lamotrigine targets Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1790cd38-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1545 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 landiolol is antagonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:1790f178-d20a-11ec-8377-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:17911a68-d20a-11ec-8377-0242ac110003 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:179142e0-d20a-11ec-8377-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:17916b30-d20a-11ec-8377-0242ac110003 UniProtKB:P30875 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:17919394-d20a-11ec-8377-0242ac110003 UniProtKB:P30935 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1791bc2a-d20a-11ec-8377-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide targets GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:1791e47a-d20a-11ec-8377-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:17920cb6-d20a-11ec-8377-0242ac110003 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide targets GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.301']} DrugCentral uuid:17923510-d20a-11ec-8377-0242ac110003 UniProtKB:P30680 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:17925ee6-d20a-11ec-8377-0242ac110003 UniProtKB:P30936 biolink:molecularly_interacts_with DrugCentral:1546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1792874a-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.275']} DrugCentral uuid:1792afa4-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.473']} DrugCentral uuid:1792d90c-d20a-11ec-8377-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.28']} DrugCentral uuid:17930292-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCT1 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (Phosphoethanolamine/phosphocholine phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:17932ae2-d20a-11ec-8377-0242ac110003 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1793533c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:17937fe2-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:17937fe2-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:1793addc-d20a-11ec-8377-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:1793d62c-d20a-11ec-8377-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:1793fe68-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:1547 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lansoprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:1794283e-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:17944c6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:17947082-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:179499a4-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:1794c2a8-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.04']} DrugCentral uuid:1794eb0c-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1795137a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Transporter (Solute carrier organic anion transporter family member 1B1) DrugCentral uuid:1795379c-d20a-11ec-8377-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:17956046-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:17958882-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.27']} DrugCentral uuid:1795b0c8-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1795d90e-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:17960280-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:17962abc-d20a-11ec-8377-0242ac110003 UniProtKB:O14733 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:179653d4-d20a-11ec-8377-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.27']} DrugCentral uuid:17967c1a-d20a-11ec-8377-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1796a514-d20a-11ec-8377-0242ac110003 UniProtKB:O00750 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1796cd5a-d20a-11ec-8377-0242ac110003 UniProtKB:O75747 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1796f5aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:17971df0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lapatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:17974690-d20a-11ec-8377-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:1549 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arginine hydrochloride targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17976ed6-d20a-11ec-8377-0242ac110003 UniProtKB:Q5T6X5 biolink:molecularly_interacts_with DrugCentral:1549 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arginine hydrochloride is agonist of GPCR (G-protein coupled receptor family C group 6 member A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:179796f4-d20a-11ec-8377-0242ac110003 UniProtKB:O75746 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Transporter (Calcium-binding mitochondrial carrier protein Aralar1) DrugCentral uuid:1797baf8-d20a-11ec-8377-0242ac110003 UniProtKB:P17174 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Aspartate aminotransferase, cytoplasmic) DrugCentral uuid:1797e17c-d20a-11ec-8377-0242ac110003 UniProtKB:P45381 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Aspartoacylase) DrugCentral uuid:17980594-d20a-11ec-8377-0242ac110003 UniProtKB:P08243 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Asparagine synthetase [glutamine-hydrolyzing]) DrugCentral uuid:179829a2-d20a-11ec-8377-0242ac110003 UniProtKB:P00966 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Argininosuccinate synthase) DrugCentral uuid:17984da6-d20a-11ec-8377-0242ac110003 UniProtKB:Q03154 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Aminoacylase-1) DrugCentral uuid:1798736c-d20a-11ec-8377-0242ac110003 UniProtKB:P00505 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Aspartate aminotransferase, mitochondrial) DrugCentral uuid:1798987e-d20a-11ec-8377-0242ac110003 UniProtKB:P14868 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Aspartate--tRNA ligase, cytoplasmic) DrugCentral uuid:1798bca0-d20a-11ec-8377-0242ac110003 UniProtKB:Q12797 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Enzyme (Aspartyl/asparaginyl beta-hydroxylase) DrugCentral uuid:1798e0d6-d20a-11ec-8377-0242ac110003 UniProtKB:P43003 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:17990a20-d20a-11ec-8377-0242ac110003 UniProtKB:P43004 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:179932a2-d20a-11ec-8377-0242ac110003 UniProtKB:P43005 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:17995ae8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UJS0 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Transporter (Calcium-binding mitochondrial carrier protein Aralar2) DrugCentral uuid:1799960c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1799960c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1799960c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1799960c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1799960c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1799960c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1799960c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:179a0358-d20a-11ec-8377-0242ac110003 UniProtKB:O35921 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Transporter (Excitatory amino acid transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:179a2b94-d20a-11ec-8377-0242ac110003 UniProtKB:O59010 biolink:molecularly_interacts_with DrugCentral:1550 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aspartic acid targets Transporter (Glutamate transporter homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:179a5434-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latanoprost targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.757']} DrugCentral uuid:179a7c7a-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latanoprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.187']} DrugCentral uuid:179aa4ca-d20a-11ec-8377-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latanoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:179acd06-d20a-11ec-8377-0242ac110003 UniProtKB:P37289 biolink:molecularly_interacts_with DrugCentral:1551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latanoprost targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:179af5b0-d20a-11ec-8377-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.287']} DrugCentral uuid:179b1df6-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.338']} DrugCentral uuid:179b4646-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:179b7026-d20a-11ec-8377-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide is inhibitor of Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:179b9876-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:179bc0bc-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.684']} DrugCentral uuid:179be9de-d20a-11ec-8377-0242ac110003 UniProtKB:Q63707 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:179c1288-d20a-11ec-8377-0242ac110003 UniProtKB:O35435 biolink:molecularly_interacts_with DrugCentral:1552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:179c3ace-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 letrozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:179c6300-d20a-11ec-8377-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 letrozole targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:179c8b28-d20a-11ec-8377-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 letrozole targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:179cb3fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leucine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:179cdc36-d20a-11ec-8377-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1559 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leuprorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.523']} DrugCentral uuid:179d049a-d20a-11ec-8377-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:1559 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 leuprorelin targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:179d2d08-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levallorphan is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:179d5814-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levallorphan targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:179d8064-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levallorphan targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:179db5a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:179db5a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:179db5a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:179db5a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levallorphan targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.27']} DrugCentral uuid:179dffbc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N587 biolink:molecularly_interacts_with DrugCentral:1561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamisole targets Ion channel (Acetylcholine receptor subunit alpha-type unc-63) DrugCentral uuid:179e23d4-d20a-11ec-8377-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:1561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamisole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:179e4c38-d20a-11ec-8377-0242ac110003 UniProtKB:O96760 biolink:molecularly_interacts_with DrugCentral:1561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamisole is agonist of Ion channel (Nicotinic acetylcholine receptor alpha subunit) DrugCentral uuid:179e705a-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamisole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.568']} DrugCentral uuid:179e9986-d20a-11ec-8377-0242ac110003 UniProtKB:P09487 biolink:molecularly_interacts_with DrugCentral:1561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamisole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:179ec1c2-d20a-11ec-8377-0242ac110003 UniProtKB:P09923 biolink:molecularly_interacts_with DrugCentral:1561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamisole targets Enzyme (Intestinal-type alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:179ee9e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:179f1226-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:179f3b70-d20a-11ec-8377-0242ac110003 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:179f6398-d20a-11ec-8377-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.47']} DrugCentral uuid:179f8cba-d20a-11ec-8377-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:179fe7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:179fe7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:179fe7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:179fe7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:179fe7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:179fe7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:179fe7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:179fe7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:179fe7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:179fe7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:179fe7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:179fe7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:179fe7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:179fe7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamfetamine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:17a0a05a-d20a-11ec-8377-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levetiracetam targets Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:17a0c47c-d20a-11ec-8377-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levetiracetam targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:17a0e88a-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levetiracetam targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:17a11044-d20a-11ec-8377-0242ac110003 UniProtKB:Q02563 biolink:molecularly_interacts_with DrugCentral:1563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levetiracetam is inhibitor of Unclassified (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:17a13aa6-d20a-11ec-8377-0242ac110003 UniProtKB:Q7L0J3 biolink:molecularly_interacts_with DrugCentral:1563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levetiracetam is modulator of Transporter (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:17a162ec-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocabastine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:17a187d6-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocabastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.279']} DrugCentral uuid:17a1b044-d20a-11ec-8377-0242ac110003 UniProtKB:O95665 biolink:molecularly_interacts_with DrugCentral:1564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocabastine is agonist of GPCR (Neurotensin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:17a1d9c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q63384 biolink:molecularly_interacts_with DrugCentral:1564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocabastine targets GPCR (Neurotensin receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:17a20224-d20a-11ec-8377-0242ac110003 UniProtKB:P70310 biolink:molecularly_interacts_with DrugCentral:1564 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocabastine is agonist of GPCR (Neurotensin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:17a22ad8-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levocetirizine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:17a2542c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:1567 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levodopa targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:17a27c68-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1567 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levodopa targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.541']} DrugCentral uuid:17a2a4a4-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1567 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levodopa targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.428']} DrugCentral uuid:17a2cef2-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1567 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levodopa targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.668']} DrugCentral uuid:17a2fa58-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1567 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levodopa targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.646']} DrugCentral uuid:17a3229e-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1567 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levodopa is agonist of GPCR (D(1A) dopamine receptor) DrugCentral uuid:17a346ca-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1567 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levodopa is agonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:17a36b5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.04']} DrugCentral uuid:17a3938c-d20a-11ec-8377-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:17a3bbc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:17a3e800-d20a-11ec-8377-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:17a3e800-d20a-11ec-8377-0242ac110003 UniProtKB:Q59961 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin is inhibitor of Enzyme (DNA topoisomerase 4) DrugCentral uuid:17a41a6e-d20a-11ec-8377-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:17a41a6e-d20a-11ec-8377-0242ac110003 UniProtKB:P72524 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:17a44872-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y256 biolink:molecularly_interacts_with DrugCentral:1569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levofloxacin targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:17a470cc-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomethadyl acetate is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:17a4962e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomethadyl acetate targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:17a4bf78-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levonorgestrel targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.225']} DrugCentral uuid:17a4e7d2-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levonorgestrel targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.167']} DrugCentral uuid:17a5102c-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levonorgestrel targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:17a534d0-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levonorgestrel is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['12.796']} DrugCentral uuid:17a55d16-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levonorgestrel targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.91']} DrugCentral uuid:17a58606-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levonorgestrel targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.37']} DrugCentral uuid:17a5ae74-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levonorgestrel targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.339']} DrugCentral uuid:17a5d73c-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:17a5ff8c-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:17a6280e-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:17a6514e-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:17a67ac0-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:17a6a31a-d20a-11ec-8377-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:17a6cb7e-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:17a6f3e2-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:17a71cb4-d20a-11ec-8377-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:17a74504-d20a-11ec-8377-0242ac110003 UniProtKB:O55242 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:17a785d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:17a785d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:17a785d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:17a785d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:17a785d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:17a785d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:17a785d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:17a808ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:17a808ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:17a808ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:17a808ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:17a808ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:17a808ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:17a808ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:17a885ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:17a885ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:17a885ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:17a885ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:17a8d7fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:17a8d7fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:17a8d7fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:17a91730-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levorphanol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:17a93f80-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1575 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosalbutamol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:17a967d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosimendan targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) DrugCentral uuid:17a98c60-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosimendan targets Ion channel (ATP-sensitive inward rectifier potassium channel 11) DrugCentral uuid:17a9b082-d20a-11ec-8377-0242ac110003 UniProtKB:Q15842 biolink:molecularly_interacts_with DrugCentral:1576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosimendan targets Ion channel (ATP-sensitive inward rectifier potassium channel 8) DrugCentral uuid:17a9d4cc-d20a-11ec-8377-0242ac110003 UniProtKB:P63316 biolink:molecularly_interacts_with DrugCentral:1576 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosimendan is opener of Cytosolic other (Troponin C, slow skeletal and cardiac muscles) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.155']} DrugCentral uuid:17a9fd1c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:17aa26ac-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:17aa4efc-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:17aa77d8-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:17aaa000-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:17aac8be-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:17ab0086-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:17ab0086-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:17ab0086-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:17ab0086-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:17ab0086-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:17ab5e82-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:17ab5e82-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:17ab5e82-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:17aba522-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:17aba522-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:17aba522-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levosulpiride targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:17abe4ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:17ac10ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:17ac34ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:17ac5d32-d20a-11ec-8377-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:17ac8618-d20a-11ec-8377-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:17acae54-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.296']} DrugCentral uuid:17acd6cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:17acfb02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.559']} DrugCentral uuid:17ad2b7c-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.955']} DrugCentral uuid:17ad2b7c-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.955']} DrugCentral uuid:17ad2b7c-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.955']} DrugCentral uuid:17ad7208-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:17ad7208-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:17ad7208-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:17adb0ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:17addc70-d20a-11ec-8377-0242ac110003 UniProtKB:P15389 biolink:molecularly_interacts_with DrugCentral:1579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidocaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:17ae0510-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidoflazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:17ae2d6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:1580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidoflazine targets Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:17ae5e0c-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidoflazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:17ae5e0c-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidoflazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:17ae5e0c-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:1580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lidoflazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:17ae9d04-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1581 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 limaprost is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) DrugCentral uuid:17aec112-d20a-11ec-8377-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:1582 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lincomycin targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:17aee534-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (Gamma-aminobutyric acid receptor subunit beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:17af0dde-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:17af3700-d20a-11ec-8377-0242ac110003 UniProtKB:Q75NA5 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (Gamma-aminobutyric acid receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:17af5f46-d20a-11ec-8377-0242ac110003 UniProtKB:P24046 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (Gamma-aminobutyric acid receptor subunit rho-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:17af8f52-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:17af8f52-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:17af8f52-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:17afd9e4-d20a-11ec-8377-0242ac110003 UniProtKB:H9U2W1 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:17afd9e4-d20a-11ec-8377-0242ac110003 UniProtKB:H9U2W1 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:17afd9e4-d20a-11ec-8377-0242ac110003 UniProtKB:H9U2W1 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:17b01ab2-d20a-11ec-8377-0242ac110003 UniProtKB:E0W492 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:17b01ab2-d20a-11ec-8377-0242ac110003 UniProtKB:E0W492 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:17b01ab2-d20a-11ec-8377-0242ac110003 UniProtKB:E0W492 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane is negative allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:17b05aae-d20a-11ec-8377-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:17b05aae-d20a-11ec-8377-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:17b05aae-d20a-11ec-8377-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA-A receptor alpha-6/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:17b0a194-d20a-11ec-8377-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:17b0a194-d20a-11ec-8377-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:17b0a194-d20a-11ec-8377-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:1583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lindane targets Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:17b0e08c-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linezolid targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:17b10904-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linezolid targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:17b1317c-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:1584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linezolid targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:17b159e0-d20a-11ec-8377-0242ac110003 UniProtKB:P31040 biolink:molecularly_interacts_with DrugCentral:1584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linezolid targets Enzyme (Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:17b1838e-d20a-11ec-8377-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine is agonist of Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.24']} DrugCentral uuid:17b1abfc-d20a-11ec-8377-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine is agonist of Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:17b1d44c-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:17b1fc9c-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:17b2255a-d20a-11ec-8377-0242ac110003 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:17b24eae-d20a-11ec-8377-0242ac110003 UniProtKB:P12004 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Nuclear other (Proliferating cell nuclear antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:17b276f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Unclassified (THAP domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b2d9dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b3ee3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liothyronine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:17b4bfb8-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1587 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisinopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:17b4e808-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1587 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisinopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:17b511ac-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.491']} DrugCentral uuid:17b53a7e-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:17b562ce-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:17b58b1e-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:17b5b3dc-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.936']} DrugCentral uuid:17b5dc36-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:17b6049a-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.061']} DrugCentral uuid:17b62cea-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:17b655c6-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.259']} DrugCentral uuid:17b67e0c-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:17b6a666-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.625']} DrugCentral uuid:17b6ceb6-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:17b6f936-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:17b721a4-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:17b74ada-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:17b77334-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:17b79c10-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:17b7c47e-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.203']} DrugCentral uuid:17b7ece2-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:17b816e0-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:17b83fb2-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.037']} DrugCentral uuid:17b8680c-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.78']} DrugCentral uuid:17b89066-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.174']} DrugCentral uuid:17b8b96a-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.338']} DrugCentral uuid:17b8e21e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:17b90a5a-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:17b93296-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.33']} DrugCentral uuid:17b95b40-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:17b9839a-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:17b9ac30-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisuride is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.489']} DrugCentral uuid:17b9d476-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.699']} DrugCentral uuid:17ba2d54-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:17ba5de2-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.268']} DrugCentral uuid:17ba863c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:17bab148-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:17bad9b6-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:17bb0206-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.444']} DrugCentral uuid:17bb2ac4-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.174']} DrugCentral uuid:17bb5314-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.481']} DrugCentral uuid:17bb7c54-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.886']} DrugCentral uuid:17bba4b8-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.468']} DrugCentral uuid:17bbcdda-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofepramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.337']} DrugCentral uuid:17bbf634-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:17bc1eb6-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:17bc472e-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:17bc7154-d20a-11ec-8377-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:17bca37c-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:17bca37c-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:17bca37c-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:17bcea1c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:17bcea1c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:17bcea1c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:17bd29a0-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lofexidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:17bd51fa-d20a-11ec-8377-0242ac110003 UniProtKB:P43700 biolink:molecularly_interacts_with DrugCentral:1594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lomefloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:17bd7e6e-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lomefloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:17bd7e6e-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1594 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lomefloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:17bdae02-d20a-11ec-8377-0242ac110003 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:1595 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lomerizine targets Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:17bdd652-d20a-11ec-8377-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:1597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonazolac targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:17bdfeac-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:17be26fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:17be510e-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.824']} DrugCentral uuid:17be7954-d20a-11ec-8377-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) DrugCentral uuid:17be9d80-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.578']} DrugCentral uuid:17bec6ac-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.932']} DrugCentral uuid:17beef9c-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:17bf18dc-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.343']} DrugCentral uuid:17bf412c-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:17bf6972-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.519']} DrugCentral uuid:17bf923a-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:17bfba4e-d20a-11ec-8377-0242ac110003 UniProtKB:O00555 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) DrugCentral uuid:17bfde8e-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:17c006ca-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.599']} DrugCentral uuid:17c03294-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:17c062fa-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Cytosolic other (Calmodulin) DrugCentral uuid:17c062fa-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Cytosolic other (Calmodulin) DrugCentral uuid:17c062fa-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Cytosolic other (Calmodulin) DrugCentral uuid:17c09a9a-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:17c0c3a8-d20a-11ec-8377-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.345']} DrugCentral uuid:17c0ec0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2B) DrugCentral uuid:17c11056-d20a-11ec-8377-0242ac110003 UniProtKB:Q14957 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) DrugCentral uuid:17c13496-d20a-11ec-8377-0242ac110003 UniProtKB:O15399 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Glutamate receptor ionotropic, NMDA 2D) DrugCentral uuid:17c1593a-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:17c181a8-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:17c1a9e4-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.272']} DrugCentral uuid:17c1d23e-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.072']} DrugCentral uuid:17c1fd0e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:17c2254a-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:17c24d9a-d20a-11ec-8377-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:17c275e0-d20a-11ec-8377-0242ac110003 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:17c2a63c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:17c2a63c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:17c2a63c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:17c2e5c0-d20a-11ec-8377-0242ac110003 UniProtKB:O00255 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Unclassified (Menin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:17c30dde-d20a-11ec-8377-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:1599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loperamide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:17c337f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:17c3604a-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:17c388a4-d20a-11ec-8377-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:17c3acee-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:17c3d8c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q80W54 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir targets Enzyme (CAAX prenyl protease 1 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:17c404aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:17c42cfa-d20a-11ec-8377-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.59']} DrugCentral uuid:17c455fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:1601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lopinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.54']} DrugCentral uuid:17c48628-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:17c48628-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:17c48628-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:17c4c566-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:17c4c566-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:17c4c566-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:17c505da-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:17c505da-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:17c505da-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:17c54518-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:17c54518-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:17c54518-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1602 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loprazolam targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:17c57ccc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:17c5bb88-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:17c5bb88-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:17c5bb88-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:17c5bb88-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:17c5bb88-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:17c5bb88-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:17c5bb88-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loracarbef is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:17c61ae2-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:17c643a0-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:17c66c22-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:17c69490-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:17c6bd26-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:17c6e5da-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:17c70e2a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:17c73666-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:17c75f6a-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:17c78940-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:17c7b19a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2J7 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Transporter (Sodium-dependent neutral amino acid transporter B(0)AT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:17c7d9ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loratadine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:17c802b2-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1606 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorazepam targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:17c832f0-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1606 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:17c832f0-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1606 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:17c832f0-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1606 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.456']} DrugCentral uuid:17c8718e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcainide targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:17c895ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:1607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:17c8ba7c-d20a-11ec-8377-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:1607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:17c8de94-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:1607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:17c902c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:1607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcainide targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:17c926ec-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.498']} DrugCentral uuid:17c9507c-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:17c978d6-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:17c9a13a-d20a-11ec-8377-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:17c9c98a-d20a-11ec-8377-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:17c9f338-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:17ca1b92-d20a-11ec-8377-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:17ca43d8-d20a-11ec-8377-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:17ca6cc8-d20a-11ec-8377-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:17ca9522-d20a-11ec-8377-0242ac110003 UniProtKB:P34976 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:17cabd86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WV26 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:17cae9aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:17cae9aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:17cb2a0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:17cb2a0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:17cb2a0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:17cb2a0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:17cb785c-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:17cb785c-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:17cbb498-d20a-11ec-8377-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:17cbb498-d20a-11ec-8377-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:17cbb498-d20a-11ec-8377-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:17cbf714-d20a-11ec-8377-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.43']} DrugCentral uuid:17cbf714-d20a-11ec-8377-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets GPCR (Angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.43']} DrugCentral uuid:17cc2aae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HCN6 biolink:molecularly_interacts_with DrugCentral:1610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 losartan targets Unclassified (Platelet glycoprotein VI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:17cc5394-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loteprednol etabonate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:17cc7914-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.061']} DrugCentral uuid:17cca164-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.095']} DrugCentral uuid:17ccc9c8-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.807']} DrugCentral uuid:17ccf358-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:17cd1b9e-d20a-11ec-8377-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.67']} DrugCentral uuid:17cd44c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:17cd6d10-d20a-11ec-8377-0242ac110003 UniProtKB:P49019 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets GPCR (Hydroxycarboxylic acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:17cd95ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:17cdbe1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:17cde664-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:17ce0eb4-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.027']} DrugCentral uuid:17ce3754-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.697']} DrugCentral uuid:17ce5fae-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:17ce8812-d20a-11ec-8377-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:17ceb058-d20a-11ec-8377-0242ac110003 UniProtKB:Q01237 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:17cedc90-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:17cf06fc-d20a-11ec-8377-0242ac110003 UniProtKB:P20701 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Adhesion (Leukocyte adhesion glycoprotein LFA-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.89']} DrugCentral uuid:17cf2f2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q95214 biolink:molecularly_interacts_with DrugCentral:1612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lovastatin targets Enzyme (Acyl-CoA:cholesterol acyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:17cf5792-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.268']} DrugCentral uuid:17cf8000-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:17cfa846-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:17cfd0aa-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.244']} DrugCentral uuid:17cff986-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:17d021fe-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:17d04a6c-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:17d0729e-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:17d09c6a-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.509']} DrugCentral uuid:17d0c4a6-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:17d0ece2-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:17d11514-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:17d13ea4-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:17d16708-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.682']} DrugCentral uuid:17d18f58-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.297']} DrugCentral uuid:17d1b7bc-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:17d1e0c0-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.376']} DrugCentral uuid:17d209a6-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.914']} DrugCentral uuid:17d2320a-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.087']} DrugCentral uuid:17d25ad2-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.829']} DrugCentral uuid:17d2849e-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.411']} DrugCentral uuid:17d2ad02-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:17d2d566-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:17d2fe60-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.31']} DrugCentral uuid:17d326e2-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:17d34fa0-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.276']} DrugCentral uuid:17d377f0-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:17d3a0d6-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.854']} DrugCentral uuid:17d3c930-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:17d3f158-d20a-11ec-8377-0242ac110003 UniProtKB:Q5JUK3 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is activator of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:17d4196c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:17d44324-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:17d46b7e-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:17d493e2-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:17d4bc0a-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:17d4e4be-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:17d514f2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:17d514f2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:17d514f2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:17d554c6-d20a-11ec-8377-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:1614 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxiglumide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:17d57dca-d20a-11ec-8377-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:1614 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxiglumide is antagonist of GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:17d5a62e-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1615 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:17d5ce88-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1615 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loxoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:17d5f6ce-d20a-11ec-8377-0242ac110003 UniProtKB:P27695 biolink:molecularly_interacts_with DrugCentral:1616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lucanthone targets Enzyme (DNA-(apurinic or apyrimidinic site) lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:17d620fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1617 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumefantrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:17d64944-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumiracoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:17d671bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumiracoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:17d69a34-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumiracoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:17d6c31a-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:17d6eb74-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:17d713d8-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.979']} DrugCentral uuid:17d73c00-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.856']} DrugCentral uuid:17d76504-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.12']} DrugCentral uuid:17d78d68-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:17d7b5c2-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:17d7df02-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:17d80770-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:17d82fac-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:17d85932-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:17d881dc-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.81']} DrugCentral uuid:17d8aa40-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:17d8d31c-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:17d8fc8e-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:17d92574-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:17d94dd8-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:17d97628-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:17d99e8c-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:17d9c97a-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:17d9f21a-d20a-11ec-8377-0242ac110003 UniProtKB:Q61616 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:17da1a88-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:17da4af8-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:17da4af8-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:17da4af8-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:17da89dc-d20a-11ec-8377-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1622 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lysine targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:17dab236-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:17dada86-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:17db038a-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:17db2bda-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:17db5420-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:17db7c7a-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:17dba312-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.56']} DrugCentral uuid:17dbcb62-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:17dbf3b2-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:17dc1c02-d20a-11ec-8377-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:17dc44ca-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:17dc6d1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:17dc957e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:17dcbe46-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:17dce790-d20a-11ec-8377-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:17dd0ff4-d20a-11ec-8377-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:17dd3844-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:17dd6210-d20a-11ec-8377-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:17dd8b0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:17ddb382-d20a-11ec-8377-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:17dddbf0-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:17de0508-d20a-11ec-8377-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:17de2e8e-d20a-11ec-8377-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:17de5706-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:17de7ff6-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:17dea8dc-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:17ded15e-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:17def9b8-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:17df21f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.87']} DrugCentral uuid:17df4d6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:17df78b6-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mafenide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:17dfa2e6-d20a-11ec-8377-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:1626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 malathion targets GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.538']} DrugCentral uuid:17dfcc08-d20a-11ec-8377-0242ac110003 UniProtKB:A2PZ98 biolink:molecularly_interacts_with DrugCentral:1626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 malathion is inhibitor of Enzyme (Acetylcholinesterase) DrugCentral uuid:17dff020-d20a-11ec-8377-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 manidipine targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:17e01c3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 manidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:17e01c3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 manidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:17e04a34-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.308']} DrugCentral uuid:17e072d4-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:17e09b38-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.165']} DrugCentral uuid:17e0c388-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.364']} DrugCentral uuid:17e0ecdc-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.237']} DrugCentral uuid:17e116a8-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.27']} DrugCentral uuid:17e13ee4-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:17e16720-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:17e18f84-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:17e1b87e-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:17e1e0c4-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.854']} DrugCentral uuid:17e2090a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.876']} DrugCentral uuid:17e2316e-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.298']} DrugCentral uuid:17e25a04-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.367']} DrugCentral uuid:17e2825e-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.777']} DrugCentral uuid:17e2ab6c-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.406']} DrugCentral uuid:17e2d3c6-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.845']} DrugCentral uuid:17e2ffc2-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:17e32b28-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:17e354d6-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:17e37dbc-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.939']} DrugCentral uuid:17e3a5f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:17e3ce34-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.355']} DrugCentral uuid:17e3f67a-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:17e4206e-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:17e448b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:17e46cfe-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.046']} DrugCentral uuid:17e49530-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:17e4c032-d20a-11ec-8377-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline is blocker of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:17e4e97c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HCF6 biolink:molecularly_interacts_with DrugCentral:1634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maprotiline is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:17e511d6-d20a-11ec-8377-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:1635 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maraviroc is antagonist of GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:17e53a3a-d20a-11ec-8377-0242ac110003 UniProtKB:P51682 biolink:molecularly_interacts_with DrugCentral:1635 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maraviroc targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:17e5633e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1635 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maraviroc targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:17e58b7a-d20a-11ec-8377-0242ac110003 UniProtKB:P61813 biolink:molecularly_interacts_with DrugCentral:1635 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maraviroc targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:17e5b3ac-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:17e5dbde-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:17e604a6-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:17e62d00-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:17e6553c-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:17e67d78-d20a-11ec-8377-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:17e6a91a-d20a-11ec-8377-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:17e6d430-d20a-11ec-8377-0242ac110003 UniProtKB:P14061 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Estradiol 17-beta-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:17e6fcbc-d20a-11ec-8377-0242ac110003 UniProtKB:P37059 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Estradiol 17-beta-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:17e7258e-d20a-11ec-8377-0242ac110003 UniProtKB:P18054 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Arachidonate 12-lipoxygenase, 12S-type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:17e74dc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15722 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets GPCR (Leukotriene B4 receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:17e7761a-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:17e79e56-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:17e7c71e-d20a-11ec-8377-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:17e7ef6e-d20a-11ec-8377-0242ac110003 UniProtKB:P08170 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Seed linoleate 13S-lipoxygenase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:17e817be-d20a-11ec-8377-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:17e83fe6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:17e869a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BEG3 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:17e891e4-d20a-11ec-8377-0242ac110003 UniProtKB:P48999 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:17e8bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:17e8bdfe-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:17e8f31e-d20a-11ec-8377-0242ac110003 UniProtKB:O15296 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Arachidonate 15-lipoxygenase, type II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:17e91b50-d20a-11ec-8377-0242ac110003 UniProtKB:Q39829 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Unclassified (Lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:17e94378-d20a-11ec-8377-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:17e96bb4-d20a-11ec-8377-0242ac110003 UniProtKB:K4CF70 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Enzyme (Fatty acid hydroperoxide lyase, chloroplastic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:17e9945e-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 masoprocol targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:17e9bc9a-d20a-11ec-8377-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:1638 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maxacalcitol targets Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:17e9e602-d20a-11ec-8377-0242ac110003 UniProtKB:P13053 biolink:molecularly_interacts_with DrugCentral:1638 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maxacalcitol is agonist of Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:17ea0e3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:17ea3922-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:17ea64d8-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:17ea8da0-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.222']} DrugCentral uuid:17eab604-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:17eaded6-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:17eb0726-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.06']} DrugCentral uuid:17eb2f62-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:17eb57b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:1640 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mazindol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:17eb8048-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:17eba88e-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:17ebd0ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BJF5 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole targets Kinase (Calmodulin-domain protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:17ec0248-d20a-11ec-8377-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:17ec0248-d20a-11ec-8377-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:17ec0248-d20a-11ec-8377-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:17ec514e-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:17ec514e-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:17ec514e-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:17ec514e-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:17ec514e-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:17ec514e-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:17ec514e-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:1641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:17ecb0c6-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebhydrolin is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.119']} DrugCentral uuid:17ecd916-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebhydrolin targets GPCR (Histamine H4 receptor) DrugCentral uuid:17ecfd38-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebhydrolin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.745']} DrugCentral uuid:17ed2574-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebhydrolin targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:17ed4e00-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.161']} DrugCentral uuid:17ed7646-d20a-11ec-8377-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:17eda24c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:17eda24c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:17eddb40-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.602']} DrugCentral uuid:17eddb40-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.602']} DrugCentral uuid:17ee12d6-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is negative allosteric modulator of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.222']} DrugCentral uuid:17ee12d6-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is negative allosteric modulator of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.222']} DrugCentral uuid:17ee4a44-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:17ee4a44-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:17ee8202-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:17ee8202-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:17eec26c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:17eec26c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:17eec26c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:17eec26c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:17ef0cea-d20a-11ec-8377-0242ac110003 UniProtKB:P02708 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is blocker of Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:17ef3616-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:17ef5e5c-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:17ef86b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecamylamine is blocker of Ion channel (Neuronal acetylcholine receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:17efb0be-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:1648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecillinam is inhibitor of Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.035']} DrugCentral uuid:17efdc4c-d20a-11ec-8377-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:1649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclozine is antagonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:17f007b2-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclozine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:17f02bf2-d20a-11ec-8377-0242ac110003 UniProtKB:O35627 biolink:molecularly_interacts_with DrugCentral:1649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclozine is agonist of Nuclear hormone receptor (Constitutive androstane receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:17f05500-d20a-11ec-8377-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:1649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclozine targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:17f07de6-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:17f0a636-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:17f0ce72-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:17f0f726-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:17f11f8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:17f147d0-d20a-11ec-8377-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:17f1702a-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:17f19b7c-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:17f1c5fc-d20a-11ec-8377-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:17f1ef0a-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:17f217c8-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.503']} DrugCentral uuid:17f24004-d20a-11ec-8377-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:17f26854-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:17f29086-d20a-11ec-8377-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:17f2bd36-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:17f2bd36-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meclofenamic acid targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f32aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:17f4137a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:17f4137a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:17f4137a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:17f459de-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:17f459de-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:17f459de-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:17f4a0d8-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:17f4a0d8-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:17f4a0d8-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:17f4e728-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:17f4e728-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:17f4e728-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medetomidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:17f52828-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxalol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'pA2', 'has_quantitative_value': ['7.82']} DrugCentral uuid:17f55118-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxalol targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'pA2', 'has_quantitative_value': ['6.08']} DrugCentral uuid:17f5797c-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.561']} DrugCentral uuid:17f5a1f4-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.88']} DrugCentral uuid:17f5cb66-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:17f5f3ac-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:17f61be8-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.59']} DrugCentral uuid:17f64424-d20a-11ec-8377-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:17f66cb0-d20a-11ec-8377-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:17f694f6-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:17f6bdaa-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:17f6e690-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:17f71098-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.45']} DrugCentral uuid:17f738d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.032']} DrugCentral uuid:17f76124-d20a-11ec-8377-0242ac110003 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:17f78e60-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:17f78e60-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medroxyprogesterone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:17f7c268-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1662 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 medrysone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:17f7e6b2-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:17f80f02-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:17f837ac-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:17f85fca-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:17f88810-d20a-11ec-8377-0242ac110003 UniProtKB:Q04828 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member C1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:17f8b146-d20a-11ec-8377-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:17f8db62-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:17f90646-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:17f92e96-d20a-11ec-8377-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:17f956e6-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:17f97f5e-d20a-11ec-8377-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:17f9a79a-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:17f9cfc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:1663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefenamic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:17f9f812-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1665 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefloquine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:17fa20bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1665 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefloquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:17fa48e4-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1665 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefloquine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:17fa6d06-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1665 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefloquine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.91']} DrugCentral uuid:17fa9556-d20a-11ec-8377-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1665 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefloquine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:17fabbe4-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1665 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefloquine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:17fae420-d20a-11ec-8377-0242ac110003 UniProtKB:P90584 biolink:molecularly_interacts_with DrugCentral:1665 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefloquine targets Unclassified (Protein kinase Pfmrk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:17fb0c48-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 megestrol acetate targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:17fb309c-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 megestrol acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.057']} DrugCentral uuid:17fb596e-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 megestrol acetate is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:17fb7d86-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 megestrol acetate targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:17fba5ae-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 megestrol acetate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:17fbce08-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 megestrol acetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.842']} DrugCentral uuid:17fbf6bc-d20a-11ec-8377-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:1670 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meglutol targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:17fc1ef8-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:17fc473e-d20a-11ec-8377-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.56']} DrugCentral uuid:17fc6f98-d20a-11ec-8377-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:17fc9b30-d20a-11ec-8377-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:17fcc484-d20a-11ec-8377-0242ac110003 UniProtKB:P35398 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets Nuclear hormone receptor (Nuclear receptor ROR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:17fcecca-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:17fd156a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:17fd3ee6-d20a-11ec-8377-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:17fd6754-d20a-11ec-8377-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:17fd977e-d20a-11ec-8377-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:17fd977e-d20a-11ec-8377-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:17fd977e-d20a-11ec-8377-0242ac110003 UniProtKB:P51050 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets GPCR (Melatonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:17fdd6bc-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:17fdfef8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melatonin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:17fe2770-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meloxicam is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:17fe510a-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:17fe7b58-d20a-11ec-8377-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:1676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:17fea3bc-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:17fecbda-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meloxicam targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:17fef452-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:17ff1c98-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:17ff44ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:17ff68f6-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:17ff91aa-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.717']} DrugCentral uuid:17ffb9f0-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:17ffe240-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:18000ae0-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.063']} DrugCentral uuid:180034de-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.237']} DrugCentral uuid:18005d06-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:18008538-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.357']} DrugCentral uuid:1800ae6e-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.469']} DrugCentral uuid:1800d72c-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets Enzyme (Cytochrome P450 2D6) DrugCentral uuid:1800fb4e-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.387']} DrugCentral uuid:1801248e-d20a-11ec-8377-0242ac110003 UniProtKB:Q63016 biolink:molecularly_interacts_with DrugCentral:1678 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 melphalan targets Transporter (L-type amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:18014ce8-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine targets Ion channel (5-hydroxytryptamine receptor 3A) DrugCentral uuid:180171b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:18019608-d20a-11ec-8377-0242ac110003 UniProtKB:Q05586 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1801be3a-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1801e658-d20a-11ec-8377-0242ac110003 UniProtKB:Q00961 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:180214ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:180214ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:18024c56-d20a-11ec-8377-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:18024c56-d20a-11ec-8377-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 memantine is negative allosteric modulator of Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:18028068-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1802a8f4-d20a-11ec-8377-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1802d284-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1802fae8-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:18032338-d20a-11ec-8377-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:18034c3c-d20a-11ec-8377-0242ac110003 UniProtKB:P30305 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (M-phase inducer phosphatase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:180374aa-d20a-11ec-8377-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:18039ce6-d20a-11ec-8377-0242ac110003 UniProtKB:P30307 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Dual specificity phosphatase Cdc25C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:1803c50e-d20a-11ec-8377-0242ac110003 UniProtKB:P15374 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Ubiquitin carboxyl-terminal hydrolase isozyme L3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:1803f0ec-d20a-11ec-8377-0242ac110003 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Dual specificity phosphatase Cdc25A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:18041b76-d20a-11ec-8377-0242ac110003 UniProtKB:Q64346 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Dual specificity protein phosphatase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:180443b2-d20a-11ec-8377-0242ac110003 UniProtKB:P28563 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Dual specificity protein phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:18046d38-d20a-11ec-8377-0242ac110003 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (M-phase inducer phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:18049614-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1804be64-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:1684 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menadione sodium bisulfite targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:1804e6b4-d20a-11ec-8377-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1685 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 menatetrenone targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:18050f54-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.263']} DrugCentral uuid:1805379a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.119']} DrugCentral uuid:18055ff4-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:1805886c-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.959']} DrugCentral uuid:1805b288-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.485']} DrugCentral uuid:1805dac4-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:18060314-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.069']} DrugCentral uuid:18062b6e-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.742']} DrugCentral uuid:1806544a-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.167']} DrugCentral uuid:18067c86-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.504']} DrugCentral uuid:1806a4cc-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:1806cd08-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:1806f5bc-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:18071e02-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:18074666-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:18076eb6-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:18079a6c-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:1807c370-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.411']} DrugCentral uuid:1807ebac-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:180814d8-d20a-11ec-8377-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:18083cec-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UDY8 biolink:molecularly_interacts_with DrugCentral:1688 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pecazine targets Enzyme (Mucosa-associated lymphoid tissue lymphoma translocation protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:18086604-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1689 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepenzolate is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:18088a26-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1689 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepenzolate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:1808b2e4-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1689 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepenzolate is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:1808dcba-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1689 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepenzolate targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:1809051e-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:18092d78-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1809565e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:18097a8a-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.625']} DrugCentral uuid:1809a2bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:1809c706-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:1809efd8-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:180a1832-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:180a408c-d20a-11ec-8377-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:180a7462-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:180a7462-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:180a7462-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:180a7462-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:180aca02-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:180aca02-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:180aca02-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:180aca02-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:180b13b8-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pethidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:180b4022-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1694 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephentermine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:180b871c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:180b871c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:180b871c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:180b871c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:180b871c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:180b871c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:180b871c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:180b871c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:180b871c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:180b871c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mephenytoin is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:180c0b6a-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:180c0b6a-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:180c0b6a-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:180c4332-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:180c67ea-d20a-11ec-8377-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:180c8c34-d20a-11ec-8377-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:180cb06a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:180cd4aa-d20a-11ec-8377-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:180cfb56-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:1700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:180d1fe6-d20a-11ec-8377-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1700 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepivacaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:180d443a-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprednisone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:180d6884-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.821']} DrugCentral uuid:180d99da-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:180d99da-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:180d99da-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) DrugCentral uuid:180dd94a-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:180dd94a-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:180dd94a-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) DrugCentral uuid:180e189c-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:180e189c-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:180e189c-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) DrugCentral uuid:180e5cc6-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:180e5cc6-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:180e5cc6-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprobamate is agonist of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:180e9466-d20a-11ec-8377-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:1705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meproscillarin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:180eb9a0-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meptazinol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:180ee4b6-d20a-11ec-8377-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:1706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meptazinol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:180f0d7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:1706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meptazinol targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:180f35ce-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meptazinol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:180f5e14-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meptazinol is partial agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.06']} DrugCentral uuid:180f86f0-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.237']} DrugCentral uuid:180faf36-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.252']} DrugCentral uuid:180fd7a4-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:1810003a-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.276']} DrugCentral uuid:1810288a-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.955']} DrugCentral uuid:181050e4-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:181079f2-d20a-11ec-8377-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1810a378-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1810cdda-d20a-11ec-8377-0242ac110003 UniProtKB:Q389T8 biolink:molecularly_interacts_with DrugCentral:1707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequitazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:1810f616-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mercaptopurine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.789']} DrugCentral uuid:18111e52-d20a-11ec-8377-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:1708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mercaptopurine targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:1811430a-d20a-11ec-8377-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:1708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mercaptopurine targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:1811674a-d20a-11ec-8377-0242ac110003 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:1708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mercaptopurine targets Enzyme (Purine nucleoside phosphorylase) DrugCentral uuid:18118b8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q06203 biolink:molecularly_interacts_with DrugCentral:1708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mercaptopurine is inhibitor of Enzyme (Amidophosphoribosyltransferase) DrugCentral uuid:1811afb6-d20a-11ec-8377-0242ac110003 UniProtKB:P51580 biolink:molecularly_interacts_with DrugCentral:1708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mercaptopurine targets Enzyme (Thiopurine S-methyltransferase) DrugCentral uuid:1811d54a-d20a-11ec-8377-0242ac110003 UniProtKB:P9WP01 biolink:molecularly_interacts_with DrugCentral:1708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mercaptopurine targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1811fda4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9X6V3 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (Penicillin-binding protein 2) DrugCentral uuid:181221bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q5D1E9 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (Penicillin-binding protein 4) DrugCentral uuid:181245f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9X6V7 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5) DrugCentral uuid:18126a14-d20a-11ec-8377-0242ac110003 UniProtKB:A1KS91 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (Penicillin-binding protein 1) DrugCentral uuid:1812903e-d20a-11ec-8377-0242ac110003 UniProtKB:Q7CHG0 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6) DrugCentral uuid:1812b46a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem is inhibitor of Enzyme (D-alanyl-D-alanine carboxypeptidase DacB) DrugCentral uuid:1812d968-d20a-11ec-8377-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:18130190-d20a-11ec-8377-0242ac110003 UniProtKB:Q9K2N0 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Unclassified (Beta-lactamase class B VIM-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.92']} DrugCentral uuid:18132bde-d20a-11ec-8377-0242ac110003 UniProtKB:C7C422 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (Beta-lactamase NDM-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.96']} DrugCentral uuid:18135438-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XEC0 biolink:molecularly_interacts_with DrugCentral:1709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meropenem targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:18137c9c-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1813a4d8-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:1813c990-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:1813ee84-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) DrugCentral uuid:181412d8-d20a-11ec-8377-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:18143b14-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:181464ae-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:18148cf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WU19 biolink:molecularly_interacts_with DrugCentral:1710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesalazine targets Enzyme (Hydroxyacid oxidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1814b53a-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:1814ddb2-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.724']} DrugCentral uuid:1815067a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:18152eca-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:18155724-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.125']} DrugCentral uuid:1815800a-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.804']} DrugCentral uuid:1815a850-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1815d0aa-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:1815f8f0-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.744']} DrugCentral uuid:1816221c-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:18164a58-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1816729e-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.046']} DrugCentral uuid:18169aee-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:1816c3ca-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:1816ed1e-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesoridazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.041']} DrugCentral uuid:1817158c-d20a-11ec-8377-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestranol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.647']} DrugCentral uuid:18173df0-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestranol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:181766c2-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestranol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:18178f26-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestranol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.282']} DrugCentral uuid:1817b88e-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestranol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.147']} DrugCentral uuid:1817e0e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestranol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.958']} DrugCentral uuid:18180b2c-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orciprenaline is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:18183386-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:1720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orciprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:18185bfe-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1721 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metaraminol is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:1818803e-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.562']} DrugCentral uuid:1818a960-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:1818d1ba-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:1818fa0a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.658']} DrugCentral uuid:1819226e-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.504']} DrugCentral uuid:18194b2c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:18197386-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:18199be0-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1819c4c6-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1819ede8-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:181a1610-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:181a3e60-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:181a67fa-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.124']} DrugCentral uuid:181a9054-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.583']} DrugCentral uuid:181ab8b8-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.319']} DrugCentral uuid:181ae1e4-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.018']} DrugCentral uuid:181b0a84-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:181b32f2-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:181b5b4c-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:181b83c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:181bad90-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:181bd5e0-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:181bfe4e-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.872']} DrugCentral uuid:181c268a-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:181c4f98-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:181c77fc-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:181ca04c-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.867']} DrugCentral uuid:181cc8ba-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.839']} DrugCentral uuid:181cf150-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:181d19a0-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:181d41e6-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:181d6a5e-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:181d97d6-d20a-11ec-8377-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:181dc076-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:181df47e-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:181df47e-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:181df47e-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:181df47e-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:181e46e0-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:181e46e0-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:181e46e0-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metergoline targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:181e8696-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y478 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin targets Kinase (5'-AMP-activated protein kinase subunit beta-1) DrugCentral uuid:181eab26-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:181ed330-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.697']} DrugCentral uuid:181efb76-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.401']} DrugCentral uuid:181f239e-d20a-11ec-8377-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['2.499']} DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18201038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M9 biolink:molecularly_interacts_with DrugCentral:1725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metformin is inhibitor of Enzyme (Mitochondrial complex I (NADH dehydrogenase)) DrugCentral uuid:18221f86-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:1822486c-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:18227148-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine is agonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:18229574-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1822bdc4-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:1822e70e-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:18231012-d20a-11ec-8377-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:18233858-d20a-11ec-8377-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:1726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methacholine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:182360b2-d20a-11ec-8377-0242ac110003 UniProtKB:P43351 biolink:molecularly_interacts_with DrugCentral:1727 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metacycline targets Nuclear other (DNA repair protein RAD52 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1823898e-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.78']} DrugCentral uuid:1823b1f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1823db64-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:182403a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:1824283a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GZZ6 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets Ion channel (Neuronal acetylcholine receptor subunit alpha-10) DrugCentral uuid:18244c70-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:18248078-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:18248078-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:18248078-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:18248078-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:1824cb6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylmethadol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1824f404-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetylmethadol is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:18251812-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.383']} DrugCentral uuid:1825406c-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1825695c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.133']} DrugCentral uuid:182591ca-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:1825ba06-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1825e260-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:18260b28-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:18263396-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.611']} DrugCentral uuid:18265c04-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1826853a-d20a-11ec-8377-0242ac110003 UniProtKB:Q01827 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:1826af7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1826d7ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.88']} DrugCentral uuid:1826ffe2-d20a-11ec-8377-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:1732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methamphetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:18273890-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:18273890-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:18273890-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:18273890-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:18273890-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1736 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methanthelinium is antagonist of GPCR (Muscarinic acetylcholine receptor) DrugCentral uuid:18278340-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1827aba4-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:1827d46c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:1827fcda-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.745']} DrugCentral uuid:182825ca-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:18284e38-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.409']} DrugCentral uuid:18287822-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.843']} DrugCentral uuid:1828a090-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1828c8e0-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:1828f27a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.939']} DrugCentral uuid:18291b38-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.228']} DrugCentral uuid:1829439c-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:18296bce-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1829941e-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methapyrilene targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:1829c4ca-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:1829c4ca-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:1829c4ca-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:182a0bf6-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:182a0bf6-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:182a0bf6-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:182a5458-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:182a5458-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:182a5458-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:182a9fb2-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:182a9fb2-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:182a9fb2-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:182ae698-d20a-11ec-8377-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:182ae698-d20a-11ec-8377-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:182ae698-d20a-11ec-8377-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:182b2d24-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:182b2d24-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:182b2d24-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:182b73ba-d20a-11ec-8377-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is agonist of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3.91']} DrugCentral uuid:182b73ba-d20a-11ec-8377-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is agonist of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3.91']} DrugCentral uuid:182b73ba-d20a-11ec-8377-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is agonist of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3.91']} DrugCentral uuid:182bb6f4-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:182bb6f4-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:182bf20e-d20a-11ec-8377-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:182bf20e-d20a-11ec-8377-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:182bf20e-d20a-11ec-8377-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-2/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:182c3b2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:182c3b2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:182c3b2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1739 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methaqualone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182cb3ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metharbital is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:182d6bb6-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:182d941a-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:182dbc88-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:182de4f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:182e0f62-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:182e37b2-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:182e6016-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:182e896a-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide is inhibitor of Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:182eb2aa-d20a-11ec-8377-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:182edae6-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:182f03fe-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:182f2cee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:182f5552-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:182f7dac-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:182fa61a-d20a-11ec-8377-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:182fcf5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:182ff7b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:18301ffa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1830484a-d20a-11ec-8377-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:18307108-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:18309980-d20a-11ec-8377-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1830c1da-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:1830ea5c-d20a-11ec-8377-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:1831136a-d20a-11ec-8377-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:18313cdc-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:18316536-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:18318d90-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1831b90a-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1831e16e-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1832345c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1832345c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1832345c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1832345c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1832345c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1832345c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1832345c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1832345c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1832345c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1832345c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1832345c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1832345c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1832dc5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1832dc5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:18330fe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1833382a-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.58']} DrugCentral uuid:18336070-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:1741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methazolamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:18338c80-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1742 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methdilazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:1833b2b4-d20a-11ec-8377-0242ac110003 UniProtKB:P07944 biolink:molecularly_interacts_with DrugCentral:1744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meticillin targets Enzyme (Beta-lactam-inducible penicillin-binding protein) DrugCentral uuid:1833d6e0-d20a-11ec-8377-0242ac110003 UniProtKB:P18843 biolink:molecularly_interacts_with DrugCentral:1744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meticillin targets Enzyme (NH(3)-dependent NAD(+) synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:18340f48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:18340f48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:18340f48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:18340f48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:18340f48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meticillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:18345ac0-d20a-11ec-8377-0242ac110003 UniProtKB:P07202 biolink:molecularly_interacts_with DrugCentral:1745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamazole is inhibitor of Enzyme (Thyroid peroxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:18348310-d20a-11ec-8377-0242ac110003 UniProtKB:P80025 biolink:molecularly_interacts_with DrugCentral:1745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamazole targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1834abce-d20a-11ec-8377-0242ac110003 UniProtKB:P22079 biolink:molecularly_interacts_with DrugCentral:1745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamazole targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:1834d400-d20a-11ec-8377-0242ac110003 UniProtKB:P15101 biolink:molecularly_interacts_with DrugCentral:1745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamazole targets Enzyme (Dopamine beta-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1834fc50-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1747 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methocarbamol is inhibitor of Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:183524b4-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1748 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methohexital targets Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:183552cc-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1748 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methohexital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:183552cc-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1748 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methohexital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:183552cc-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1748 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methohexital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:183590a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1748 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methohexital targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:183590a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1748 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methohexital targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) DrugCentral uuid:1835be7e-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:1835e2f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:18360712-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:18362b2a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:18364f4c-d20a-11ec-8377-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:183677f6-d20a-11ec-8377-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:18369c0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Folylpolyglutamate synthase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1836c42c-d20a-11ec-8377-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:1836e862-d20a-11ec-8377-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1837117a-d20a-11ec-8377-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:183739ca-d20a-11ec-8377-0242ac110003 UniProtKB:P14207 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Membrane receptor (Folate receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:183761fc-d20a-11ec-8377-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:18378a38-d20a-11ec-8377-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1837b2ec-d20a-11ec-8377-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1837db3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.14']} DrugCentral uuid:18380378-d20a-11ec-8377-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:18382ba0-d20a-11ec-8377-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1838545e-d20a-11ec-8377-0242ac110003 UniProtKB:P07382 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.89']} DrugCentral uuid:18387ccc-d20a-11ec-8377-0242ac110003 UniProtKB:P00378 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1838a4fe-d20a-11ec-8377-0242ac110003 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1838cd3a-d20a-11ec-8377-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.68']} DrugCentral uuid:1838f7ba-d20a-11ec-8377-0242ac110003 UniProtKB:C3SWJ7 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:18392014-d20a-11ec-8377-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1839494a-d20a-11ec-8377-0242ac110003 UniProtKB:P0A017 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:183971ae-d20a-11ec-8377-0242ac110003 UniProtKB:P9WNX1 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.08']} DrugCentral uuid:18399a4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q81R22 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.91']} DrugCentral uuid:1839c294-d20a-11ec-8377-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:1839ead0-d20a-11ec-8377-0242ac110003 UniProtKB:P00380 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:183a130c-d20a-11ec-8377-0242ac110003 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:183a3bd4-d20a-11ec-8377-0242ac110003 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:183a641a-d20a-11ec-8377-0242ac110003 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:183a8cd8-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:1751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methotrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:183ab532-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomepromazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.237']} DrugCentral uuid:183adf80-d20a-11ec-8377-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:1752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomepromazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:183b07da-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxamine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:183b3016-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxamine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:183b591a-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxamine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:183b8174-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:1753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxamine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:183bb18a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:183bb18a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:183bb18a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1753 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:183bf03c-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is agonist of Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183c4ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:1754 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxyflurane is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:183d0f8a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methscopolamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:183d388e-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:183d6106-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methscopolamine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:183d8942-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.01']} DrugCentral uuid:183db19c-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:183dda3c-d20a-11ec-8377-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:1757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methscopolamine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:183e0a48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methsuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:183e0a48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methsuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:183e0a48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methsuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:183e42d8-d20a-11ec-8377-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylclothiazide is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:183e681c-d20a-11ec-8377-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:1761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metildigoxin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:183e8edc-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopa is agonist of GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:183eb56a-d20a-11ec-8377-0242ac110003 UniProtKB:P20711 biolink:molecularly_interacts_with DrugCentral:1762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopa targets Enzyme (Aromatic-L-amino-acid decarboxylase) DrugCentral uuid:183ed9aa-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopa targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.282']} DrugCentral uuid:183f029a-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopa targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.286']} DrugCentral uuid:183f2ac2-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopa targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.672']} DrugCentral uuid:183f52ea-d20a-11ec-8377-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:1762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopa targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:183f7b26-d20a-11ec-8377-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:183fa3da-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:183fcc34-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:183ff556-d20a-11ec-8377-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Enzyme (Thioredoxin reductase 1, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:18401d74-d20a-11ec-8377-0242ac110003 UniProtKB:O15770 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Enzyme (Glutathione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:18404696-d20a-11ec-8377-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:18406edc-d20a-11ec-8377-0242ac110003 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:18409704-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:1763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylthioninium chloride targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1840bfea-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.268']} DrugCentral uuid:1840e8c6-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.559']} DrugCentral uuid:1841112a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.225']} DrugCentral uuid:18413998-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.633']} DrugCentral uuid:184161fc-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:18418b1e-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is partial agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1841b382-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1841dbdc-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.928']} DrugCentral uuid:18420436-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.678']} DrugCentral uuid:18422f9c-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.244']} DrugCentral uuid:1842586e-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:184280b4-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:1842a94a-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1842d1ae-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.033']} DrugCentral uuid:1842f9ea-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.39']} DrugCentral uuid:18432208-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:18434b0c-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1764 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylergometrine is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:18437370-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:18439bde-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1843c424-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.93']} DrugCentral uuid:1843ee68-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.99']} DrugCentral uuid:184416d6-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:18443f26-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.34']} DrugCentral uuid:18446780-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.58']} DrugCentral uuid:1844914c-d20a-11ec-8377-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:1844b9a6-d20a-11ec-8377-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:1844e1f6-d20a-11ec-8377-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:18450a32-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:1845334a-d20a-11ec-8377-0242ac110003 UniProtKB:P09483 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:18455b68-d20a-11ec-8377-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.97']} DrugCentral uuid:184583b8-d20a-11ec-8377-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:1845b888-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:1845b888-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:1845b888-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:1845b888-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:18460c7a-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:18460c7a-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1765 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naltrexone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:18464384-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:18466c42-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1846949c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1846bcf6-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1846e5be-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:18470ea4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1766 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylparaben targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:184736d6-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenidate targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.252']} DrugCentral uuid:18475f30-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenidate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:18478794-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenidate is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1847b192-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenidate targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.615']} DrugCentral uuid:1847d9e2-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenidate targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:18480246-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenidate is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:18482b0e-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylphenidate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.08']} DrugCentral uuid:1848535e-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1768 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylprednisolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:18487b90-d20a-11ec-8377-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:1768 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylprednisolone targets Cytosolic other (Annexin A1) DrugCentral uuid:18489fc6-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1768 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylprednisolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1848c8ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:1768 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylprednisolone is activator of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1848f0fc-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylprednisolone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1849151e-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1771 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylprednisolone succinate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:18494110-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyprylon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:18494110-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyprylon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:18494110-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:1774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyprylon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) DrugCentral uuid:18497b62-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.326']} DrugCentral uuid:1849a66e-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1849cff4-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.214']} DrugCentral uuid:1849f844-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:184a20ee-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.509']} DrugCentral uuid:184a4966-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:184a71c0-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:184a9ab0-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.663']} DrugCentral uuid:184ac332-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:184aeb6e-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:184b13be-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:184b3d58-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.213']} DrugCentral uuid:184b65a8-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.334']} DrugCentral uuid:184b8ed4-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:184bb72e-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:184bdfe2-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.054']} DrugCentral uuid:184c083c-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:184c308c-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:184c58be-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:184c81d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q07820 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets Cytosolic other (Induced myeloid leukemia cell differentiation protein Mcl-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:184caae4-d20a-11ec-8377-0242ac110003 UniProtKB:Q07817 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets Cytosolic other (Bcl-2-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:184cd33e-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.967']} DrugCentral uuid:184cfb8e-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:184d25dc-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:184d4e22-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:184d7708-d20a-11ec-8377-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:184d9f80-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:184dc85c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:184df84a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:184df84a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:184df84a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:184e36e8-d20a-11ec-8377-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:184e5fa6-d20a-11ec-8377-0242ac110003 UniProtKB:P35364 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:184e87e2-d20a-11ec-8377-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:184eb01e-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:184ed864-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.45']} DrugCentral uuid:184f0410-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.34']} DrugCentral uuid:184f2ca6-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methysergide is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.34']} DrugCentral uuid:184f55d2-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metiazinic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:184f7fe4-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metipranolol is antagonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:184fa424-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1779 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metipranolol is antagonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:184fc864-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metixene is antagonist of GPCR (5-hydroxytryptamine receptor 2C) DrugCentral uuid:184feca4-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metixene is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:185010da-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metixene targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:18503984-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metochalcone targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:185061a2-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:185089fc-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:1850b300-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:1850db8c-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.979']} DrugCentral uuid:185103dc-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.397']} DrugCentral uuid:18512c22-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.904']} DrugCentral uuid:185154e0-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:18517d1c-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:1851a152-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.509']} DrugCentral uuid:1851c998-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:1851f2b0-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.699']} DrugCentral uuid:18521b00-d20a-11ec-8377-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:18524350-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:18526c04-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:18529526-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:1852bd62-d20a-11ec-8377-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1852e594-d20a-11ec-8377-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:18530dee-d20a-11ec-8377-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:185336ac-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:185363de-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:185363de-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1853a704-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1853a704-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1853a704-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1853a704-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1853a704-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1854792c-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1854792c-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1854792c-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1854792c-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1854d0de-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1854d0de-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1854d0de-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:18551a08-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:18551a08-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:18551a08-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:18556184-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:18556184-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:18556184-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:1855a5c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1855a5c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1855da6a-d20a-11ec-8377-0242ac110003 UniProtKB:P97288 biolink:molecularly_interacts_with DrugCentral:1782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoclopramide is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:18560328-d20a-11ec-8377-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:1783 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metolazone targets Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.45']} DrugCentral uuid:18562be6-d20a-11ec-8377-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:1783 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metolazone is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:185652f6-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1783 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metolazone targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:18567c40-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metopimazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:1856a530-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metopimazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:1856ce7a-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metopimazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:1856f724-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:18571fd8-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:18574850-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1857719a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.79']} DrugCentral uuid:18579a6c-d20a-11ec-8377-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.83']} DrugCentral uuid:1857caa0-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1857caa0-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1857caa0-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:18580ac4-d20a-11ec-8377-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:185833be-d20a-11ec-8377-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:1786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metoprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:18585c5e-d20a-11ec-8377-0242ac110003 UniProtKB:C4LW95 biolink:molecularly_interacts_with DrugCentral:1790 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metronidazole targets Enzyme (Thioredoxin reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1858860c-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1791 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metyrapone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:1858aea2-d20a-11ec-8377-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:1791 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metyrapone targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:1858d74c-d20a-11ec-8377-0242ac110003 UniProtKB:P15150 biolink:molecularly_interacts_with DrugCentral:1791 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metyrapone targets Enzyme (Cytochrome P450 11B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1858ffba-d20a-11ec-8377-0242ac110003 UniProtKB:P15393 biolink:molecularly_interacts_with DrugCentral:1791 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metyrapone targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1859286e-d20a-11ec-8377-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1791 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metyrapone is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.84']} DrugCentral uuid:18595136-d20a-11ec-8377-0242ac110003 UniProtKB:P07101 biolink:molecularly_interacts_with DrugCentral:1792 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metirosine is inhibitor of Enzyme (Tyrosine 3-monooxygenase) DrugCentral uuid:185975c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:18599e48-d20a-11ec-8377-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:1859c2ce-d20a-11ec-8377-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:1859e9f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:185a0f5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:185a3394-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:185a5d10-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:185a8632-d20a-11ec-8377-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:185aae78-d20a-11ec-8377-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:185ad6dc-d20a-11ec-8377-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:185aff22-d20a-11ec-8377-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:185b2808-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:185b5030-d20a-11ec-8377-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:185b7858-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.51']} DrugCentral uuid:185ba076-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:185bca92-d20a-11ec-8377-0242ac110003 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:185bf2ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q62205 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:185c1ae2-d20a-11ec-8377-0242ac110003 UniProtKB:A2APX8 biolink:molecularly_interacts_with DrugCentral:1794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mexiletine targets Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:185c4314-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:185c6c18-d20a-11ec-8377-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:185c9440-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:185cbd1c-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:185ce54e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:185d09ca-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:185d324c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:185d5a92-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:185d82ce-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:185dad58-d20a-11ec-8377-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:185dd580-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:185dfdda-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:185e26c0-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:185e4fe2-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:185e7800-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:185ea0aa-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:185ec940-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:185ef208-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:185f1a44-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:185f428a-d20a-11ec-8377-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.33']} DrugCentral uuid:185f6d00-d20a-11ec-8377-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:185f976c-d20a-11ec-8377-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:185fc0ca-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:185fe910-d20a-11ec-8377-0242ac110003 UniProtKB:P02768 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Secreted (Serum albumin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.18']} DrugCentral uuid:1860120a-d20a-11ec-8377-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:18603a3c-d20a-11ec-8377-0242ac110003 UniProtKB:P14778 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Membrane receptor (Interleukin-1 receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:18606278-d20a-11ec-8377-0242ac110003 UniProtKB:P41222 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1860a274-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1860a274-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1860a274-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1860a274-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1860a274-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1860a274-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1860a274-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:1795 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mezlocillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:186100ac-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:18612906-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1861550c-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.319']} DrugCentral uuid:18617f5a-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:1861a796-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.149']} DrugCentral uuid:1861d0a4-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:1861fa20-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:1862227a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:18624ac0-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1862734c-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.175']} DrugCentral uuid:18629b88-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1862c3d8-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1862ec14-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.569']} DrugCentral uuid:18631680-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:18633f2a-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.245']} DrugCentral uuid:1863678e-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.003']} DrugCentral uuid:18638fb6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.125']} DrugCentral uuid:1863b888-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.465']} DrugCentral uuid:1863e0c4-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:1864091e-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.526']} DrugCentral uuid:18643178-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.541']} DrugCentral uuid:18645a40-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.638']} DrugCentral uuid:18648272-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:1864aac2-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:1864d308-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1864ff0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.027']} DrugCentral uuid:18652894-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:186550da-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:186579de-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1865a224-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1865ca60-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.06']} DrugCentral uuid:1865f396-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:18661c2c-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:18664486-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:18666cae-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:1866958a-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:1866c01e-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1866eac6-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:186712ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:18673b16-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:18676410-d20a-11ec-8377-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:18678c7e-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1867b4ec-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1867dd3c-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:1868060e-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:18682e54-d20a-11ec-8377-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1868569a-d20a-11ec-8377-0242ac110003 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:18687ecc-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1868ad02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1868ad02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1868ec04-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1868ec04-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1868ec04-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1868ec04-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:18693df8-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:18693df8-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:18693df8-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:1869854c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1869854c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1869854c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1869c7e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:1869c7e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:186a02f6-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:186a02f6-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:186a02f6-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:186a46c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:186a46c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:186a7e0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NG02 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin targets GPCR (G-protein coupled receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:186aa65c-d20a-11ec-8377-0242ac110003 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:1796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mianserin is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:186aced4-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:186af7d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:186b2028-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:186b485a-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:186b70a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:186b9936-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:186bc1ae-d20a-11ec-8377-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:186be9e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:186c1316-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:186c3cd8-d20a-11ec-8377-0242ac110003 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:186c651e-d20a-11ec-8377-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:186c8d64-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:186cb712-d20a-11ec-8377-0242ac110003 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:186ce00c-d20a-11ec-8377-0242ac110003 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:186d085c-d20a-11ec-8377-0242ac110003 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is blocker of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:186d308e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07652 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is gating inhibitor of Ion channel (Voltage-dependent R-type calcium channel subunit alpha-1E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:186d58de-d20a-11ec-8377-0242ac110003 UniProtKB:P54282 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is gating inhibitor of Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:186d81c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q96D31 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Calcium release-activated calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:186daa28-d20a-11ec-8377-0242ac110003 UniProtKB:P15390 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:186dd26e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:186dfac8-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mibefradil is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.602']} DrugCentral uuid:186e2598-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AIC4 biolink:molecularly_interacts_with DrugCentral:1798 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 micafungin targets Unclassified (Beta-1,3-glucan synthase) DrugCentral uuid:186e49d8-d20a-11ec-8377-0242ac110003 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:1798 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 micafungin is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) DrugCentral uuid:186e6e04-d20a-11ec-8377-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.715']} DrugCentral uuid:186e964a-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.137']} DrugCentral uuid:186ebf58-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.588']} DrugCentral uuid:186ee7a8-d20a-11ec-8377-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:186f1020-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.609']} DrugCentral uuid:186f3906-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.505']} DrugCentral uuid:186f6160-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:186f89c4-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.097']} DrugCentral uuid:186fb214-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.828']} DrugCentral uuid:186fdc3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:1870007a-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:187028b6-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:1870511a-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.535']} DrugCentral uuid:18707a0a-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.183']} DrugCentral uuid:1870a368-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.952']} DrugCentral uuid:1870cbcc-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.452']} DrugCentral uuid:1870f426-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.555']} DrugCentral uuid:18711d16-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.296']} DrugCentral uuid:18714566-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.785']} DrugCentral uuid:18716dc0-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.964']} DrugCentral uuid:18719610-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.178']} DrugCentral uuid:1871c068-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1871e8ae-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.812']} DrugCentral uuid:18721112-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.175']} DrugCentral uuid:187239da-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.351']} DrugCentral uuid:187262f2-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.386']} DrugCentral uuid:18728b7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.869']} DrugCentral uuid:1872b3ce-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1872dc0a-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.136']} DrugCentral uuid:187304d2-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.799']} DrugCentral uuid:18732d18-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.271']} DrugCentral uuid:18735568-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.825']} DrugCentral uuid:18737e80-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:1873a73e-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:1873cb60-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.923']} DrugCentral uuid:1873f3c4-d20a-11ec-8377-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:18741caa-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.729']} DrugCentral uuid:187444fa-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:18746d18-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1874954a-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.534']} DrugCentral uuid:1874beda-d20a-11ec-8377-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1874e716-d20a-11ec-8377-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:18750f7a-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:187537d4-d20a-11ec-8377-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:187561d2-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.381']} DrugCentral uuid:18758cca-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.562']} DrugCentral uuid:1875b61e-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.58']} DrugCentral uuid:1875de78-d20a-11ec-8377-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:18760772-d20a-11ec-8377-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:18762fc2-d20a-11ec-8377-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.109']} DrugCentral uuid:18765812-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.792']} DrugCentral uuid:18768058-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.326']} DrugCentral uuid:1876a920-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.029']} DrugCentral uuid:1876d18e-d20a-11ec-8377-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.922']} DrugCentral uuid:1876f9e8-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.674']} DrugCentral uuid:18772242-d20a-11ec-8377-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.792']} DrugCentral uuid:18774dee-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.692']} DrugCentral uuid:18777698-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.711']} DrugCentral uuid:18779ee8-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:1877c7ce-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:1877f096-d20a-11ec-8377-0242ac110003 UniProtKB:P22443 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:187818d2-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:18784104-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:187869cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:187891fe-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPP7 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Mycocyclosin synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1878bb34-d20a-11ec-8377-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1878e38e-d20a-11ec-8377-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:18790dfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q96D31 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Ion channel (Calcium release-activated calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:187938ca-d20a-11ec-8377-0242ac110003 UniProtKB:K4CF70 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (Fatty acid hydroperoxide lyase, chloroplastic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:18796106-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:1800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miconazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1879894c-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['6']} DrugCentral uuid:1879b246-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.353']} DrugCentral uuid:1879daaa-d20a-11ec-8377-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187a02fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is antagonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:187a3360-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:187a3360-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:187a3360-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:187a79c4-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:187a79c4-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:187a79c4-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:187ac028-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:187ac028-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:187ac028-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187b3d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:187c1842-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.444']} DrugCentral uuid:187c1842-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.444']} DrugCentral uuid:187c1842-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.444']} DrugCentral uuid:187c5ece-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.613']} DrugCentral uuid:187c5ece-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.613']} DrugCentral uuid:187c5ece-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.613']} DrugCentral uuid:187ca618-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:187ca618-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:187ca618-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:187cec9a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:187cec9a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:187cec9a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.125']} DrugCentral uuid:187d3344-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:187d3344-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:187d3344-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:1802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:187d7354-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midodrine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:187d978a-d20a-11ec-8377-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:1803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midodrine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:187dbfbc-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.001']} DrugCentral uuid:187de884-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.957']} DrugCentral uuid:187e10ac-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:187e3906-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.918']} DrugCentral uuid:187e61ec-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone is antagonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:187e8d66-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:187eb598-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.095']} DrugCentral uuid:187eddfc-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:187f064c-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:187f2eec-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:187f5746-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone is antagonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:187f7faa-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:187fa7fa-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:187fd0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.081']} DrugCentral uuid:187ff8f4-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.255']} DrugCentral uuid:1880213a-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.256']} DrugCentral uuid:1880496c-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.374']} DrugCentral uuid:188074a0-d20a-11ec-8377-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:18809cc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q63449 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.46']} DrugCentral uuid:1880c50e-d20a-11ec-8377-0242ac110003 UniProtKB:P21447 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Transporter (P-glycoprotein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1880edd6-d20a-11ec-8377-0242ac110003 UniProtKB:F1Q298 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:18811644-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N1U3 biolink:molecularly_interacts_with DrugCentral:1805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifepristone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:18813f7a-d20a-11ec-8377-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol is inhibitor of Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:188167c0-d20a-11ec-8377-0242ac110003 UniProtKB:P04746 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Pancreatic alpha-amylase) DrugCentral uuid:18818c5a-d20a-11ec-8377-0242ac110003 UniProtKB:P04062 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:1881b4aa-d20a-11ec-8377-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol is inhibitor of Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1881dd0e-d20a-11ec-8377-0242ac110003 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:18820554-d20a-11ec-8377-0242ac110003 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:18822e94-d20a-11ec-8377-0242ac110003 UniProtKB:P35574 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:188256c6-d20a-11ec-8377-0242ac110003 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:18827eee-d20a-11ec-8377-0242ac110003 UniProtKB:P09848 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Lactase-phlorizin hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1882a72a-d20a-11ec-8377-0242ac110003 UniProtKB:Q58D55 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:1882cfe8-d20a-11ec-8377-0242ac110003 UniProtKB:C0HJB3 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Alpha-mannosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1882f84c-d20a-11ec-8377-0242ac110003 UniProtKB:P56526 biolink:molecularly_interacts_with DrugCentral:1806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglitol targets Enzyme (Alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:188320a6-d20a-11ec-8377-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:18834914-d20a-11ec-8377-0242ac110003 UniProtKB:Q16739 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat is inhibitor of Enzyme (Ceramide glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:18837204-d20a-11ec-8377-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:18839a4a-d20a-11ec-8377-0242ac110003 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1883c286-d20a-11ec-8377-0242ac110003 UniProtKB:Q69ZF3 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Non-lysosomal glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1883ead6-d20a-11ec-8377-0242ac110003 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:18841632-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HCG7 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Non-lysosomal glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:18843f22-d20a-11ec-8377-0242ac110003 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1884675e-d20a-11ec-8377-0242ac110003 UniProtKB:P35573 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:188490bc-d20a-11ec-8377-0242ac110003 UniProtKB:P70699 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1884b98e-d20a-11ec-8377-0242ac110003 UniProtKB:B5THE3 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Sucrase-isomaltase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1884e1c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9LGC6 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Putative alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:188509fc-d20a-11ec-8377-0242ac110003 UniProtKB:O70282 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Trehalase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:188532ba-d20a-11ec-8377-0242ac110003 UniProtKB:I3LIR5 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:18855be6-d20a-11ec-8377-0242ac110003 UniProtKB:O88693 biolink:molecularly_interacts_with DrugCentral:1807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miglustat targets Enzyme (Ceramide glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:1885842c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:1808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milnacipran targets Ion channel (Glutamate receptor ionotropic, NMDA 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1885ac68-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milnacipran is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:1885d68e-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milnacipran is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:18860208-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milnacipran targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:18862d8c-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milnacipran targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:188656f4-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milnacipran targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:18867f9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milnacipran targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1886a7ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1886d034-d20a-11ec-8377-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:1886f866-d20a-11ec-8377-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:18872110-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XSW7 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Cyclic nucleotide phosphodiesterase PDE3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:18874942-d20a-11ec-8377-0242ac110003 UniProtKB:O77823 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Cyclic AMP-specific phosphodiesterase SSPDE4A1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:18877188-d20a-11ec-8377-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:188799b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q28156 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1887c2fa-d20a-11ec-8377-0242ac110003 UniProtKB:O89085 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1887ef1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1887ef1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:18882e20-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:18882e20-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:18882e20-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:18882e20-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:1809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 milrinone targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1888789e-d20a-11ec-8377-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:1810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miltefosine targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1888a0c6-d20a-11ec-8377-0242ac110003 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:1810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 miltefosine targets Enzyme (Dual specificity phosphatase Cdc25A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1888c8d0-d20a-11ec-8377-0242ac110003 UniProtKB:P34896 biolink:molecularly_interacts_with DrugCentral:1811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mimosine targets Enzyme (Serine hydroxymethyltransferase, cytosolic) DrugCentral uuid:1888ee8c-d20a-11ec-8377-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:1811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mimosine targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:188916b4-d20a-11ec-8377-0242ac110003 UniProtKB:P08543 biolink:molecularly_interacts_with DrugCentral:1811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mimosine targets Enzyme (Ribonucleoside-diphosphate reductase large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:18893f0e-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:1811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mimosine targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:18896736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:1811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mimosine targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:18899224-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minaprine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1889bd62-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minaprine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1889e5d0-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minaprine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:188a0f38-d20a-11ec-8377-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:1812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minaprine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:188a37c4-d20a-11ec-8377-0242ac110003 UniProtKB:P02980 biolink:molecularly_interacts_with DrugCentral:1813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minocycline targets Transporter (Tetracycline resistance protein, class B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.638']} DrugCentral uuid:188a6014-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z7H2 biolink:molecularly_interacts_with DrugCentral:1813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minocycline targets Unclassified (30S ribosomal protein S4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ka', 'has_quantitative_value': ['6']} DrugCentral uuid:188a895e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z8T8 biolink:molecularly_interacts_with DrugCentral:1813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minocycline targets Unclassified (30S ribosomal protein S9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ka', 'has_quantitative_value': ['5.756']} DrugCentral uuid:188ab26c-d20a-11ec-8377-0242ac110003 UniProtKB:P48048 biolink:molecularly_interacts_with DrugCentral:1814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minoxidil targets Ion channel (ATP-sensitive inward rectifier potassium channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:188adeae-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minoxidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) DrugCentral uuid:188adeae-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minoxidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) DrugCentral uuid:188b0c9e-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:188b34da-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:188b5f6e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:188b8ade-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:188bb644-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:188be07e-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:188c0964-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:188c31b4-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:188c5a40-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:188c8326-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:188cab62-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:188cd394-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:188cfcde-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:188d21fa-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:188d463a-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:188d6e76-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:188d96c6-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.84']} DrugCentral uuid:188dbf7a-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:188de7f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:188e1038-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:188e3874-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:188e693e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:188e693e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:188e693e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirtazapine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:188ea7e6-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:1817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 misoprostol is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:188ed02c-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:1817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 misoprostol is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:188ef9a8-d20a-11ec-8377-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:1817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 misoprostol is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:188f243c-d20a-11ec-8377-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:1817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 misoprostol targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.028']} DrugCentral uuid:188f5092-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitiglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:188f5092-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitiglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:188f83f0-d20a-11ec-8377-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:1819 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitomycin targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:188fadf8-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:188fd666-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:188ffec0-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:18902710-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.512']} DrugCentral uuid:1890501e-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.186']} DrugCentral uuid:1890786e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1890a0a0-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.376']} DrugCentral uuid:1890cb2a-d20a-11ec-8377-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) DrugCentral uuid:1890ef42-d20a-11ec-8377-0242ac110003 UniProtKB:P10109 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane targets Unclassified (Adrenodoxin, mitochondrial) DrugCentral uuid:18911382-d20a-11ec-8377-0242ac110003 UniProtKB:P05108 biolink:molecularly_interacts_with DrugCentral:1820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitotane is inhibitor of Enzyme (Cholesterol side-chain cleavage enzyme, mitochondrial) DrugCentral uuid:1891379a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.532']} DrugCentral uuid:18915fe0-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.841']} DrugCentral uuid:1891888a-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.306']} DrugCentral uuid:1891b0c6-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.729']} DrugCentral uuid:1891d90c-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.744']} DrugCentral uuid:189201ca-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.108']} DrugCentral uuid:18922a2e-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.047']} DrugCentral uuid:1892526a-d20a-11ec-8377-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:189276aa-d20a-11ec-8377-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone is inhibitor of Enzyme (DNA topoisomerase 2-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC90', 'has_quantitative_value': ['5.959']} DrugCentral uuid:18929fc2-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.287']} DrugCentral uuid:1892c812-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kact', 'has_quantitative_value': ['5.155']} DrugCentral uuid:1892f058-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.269']} DrugCentral uuid:18931880-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1893415c-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.691']} DrugCentral uuid:189369a2-d20a-11ec-8377-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:189391e8-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:1893ba10-d20a-11ec-8377-0242ac110003 UniProtKB:P27695 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Enzyme (DNA-(apurinic or apyrimidinic site) lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1893e2a6-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.748']} DrugCentral uuid:18940ace-d20a-11ec-8377-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:189432ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:18945b14-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:189485a8-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:1894b122-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1894d968-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1895019a-d20a-11ec-8377-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:18952a44-d20a-11ec-8377-0242ac110003 UniProtKB:P29372 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Enzyme (DNA-3-methyladenine glycosylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:18955276-d20a-11ec-8377-0242ac110003 UniProtKB:Q63470 biolink:molecularly_interacts_with DrugCentral:1821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoxantrone targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:18957bc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1822 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mivacurium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:1895a7c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1822 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mivacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:1895a7c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1822 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mivacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:1895a7c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1822 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mivacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:1895e010-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mizolastine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.456']} DrugCentral uuid:18960838-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mizolastine targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:18962c82-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mizolastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.84']} DrugCentral uuid:18965680-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moclobemide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:18967f02-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moclobemide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1896a7e8-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:1825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:1896d060-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moclobemide is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1896f90a-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:1825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.97']} DrugCentral uuid:1897215a-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:1825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:18974982-d20a-11ec-8377-0242ac110003 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:1825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moclobemide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:189771c8-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 modafinil targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:18979a72-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 modafinil is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.837']} DrugCentral uuid:1897c2cc-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 modafinil targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:1897e6e4-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 modafinil targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.396']} DrugCentral uuid:18980f20-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 modafinil targets Enzyme (Cytochrome P450 2C19) DrugCentral uuid:1898359a-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 modafinil targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:189860a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 modafinil targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:189889c8-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moexipril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.59']} DrugCentral uuid:1898b1fa-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1898dae0-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1899031c-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:18992b58-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mofezolac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:18995394-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.157']} DrugCentral uuid:18997c20-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1899a470-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.907']} DrugCentral uuid:1899cd24-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.421']} DrugCentral uuid:1899f6f0-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:189a1f36-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:189a477c-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.997']} DrugCentral uuid:189a6fcc-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:189a98c6-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:189ac10c-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.254']} DrugCentral uuid:189ae952-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:189b1198-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:189b3b96-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:189b63d2-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.763']} DrugCentral uuid:189b8c2c-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:189bb454-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:189bde3e-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:189c0670-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molindone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:189c2ede-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 molsidomine targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:189c5706-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mometasone furoate targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.13']} DrugCentral uuid:189c80f0-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mometasone furoate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:189ca92c-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mometasone furoate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.9']} DrugCentral uuid:189cd154-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 monobenzone targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.429']} DrugCentral uuid:189cf97c-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 monobenzone targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.992']} DrugCentral uuid:189d221c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 monobenzone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.414']} DrugCentral uuid:189d4a62-d20a-11ec-8377-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:1834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 monobenzone is inhibitor of Enzyme (Tyrosinase) DrugCentral uuid:189d6f42-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 monobenzone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.311']} DrugCentral uuid:189d977e-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:189dc3b6-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.833']} DrugCentral uuid:189dec88-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.574']} DrugCentral uuid:189e14d8-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:189e3dfa-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:189e6654-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.713']} DrugCentral uuid:189e8e9a-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.853']} DrugCentral uuid:189eb6fe-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.495']} DrugCentral uuid:189edf94-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.115']} DrugCentral uuid:189f07ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:189f3034-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.611']} DrugCentral uuid:189f588e-d20a-11ec-8377-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.958']} DrugCentral uuid:189f81ba-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.772']} DrugCentral uuid:189faa14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:189fd23c-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.328']} DrugCentral uuid:189ffa8c-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.495']} DrugCentral uuid:18a0235e-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.328']} DrugCentral uuid:18a04b90-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.817']} DrugCentral uuid:18a074a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:18a09d0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.068']} DrugCentral uuid:18a0c5d4-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.895']} DrugCentral uuid:18a0ee1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:18a11796-d20a-11ec-8377-0242ac110003 UniProtKB:Q13304 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast targets GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:18a13ffa-d20a-11ec-8377-0242ac110003 UniProtKB:Q6NS65 biolink:molecularly_interacts_with DrugCentral:1836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 montelukast is antagonist of GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:18a16aca-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:18a192f2-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:18a1bb38-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1837 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.134']} DrugCentral uuid:18a1e446-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1842 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moracizine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:18a20886-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.86']} DrugCentral uuid:18a230ae-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:18a25908-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:18a281c6-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:18a2a9e4-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:18a2d220-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:18a2fa70-d20a-11ec-8377-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:18a32414-d20a-11ec-8377-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:18a34f84-d20a-11ec-8377-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:18a37888-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:18a3a0ce-d20a-11ec-8377-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:18a3c9be-d20a-11ec-8377-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:18a3f204-d20a-11ec-8377-0242ac110003 UniProtKB:P79350 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:18a41a68-d20a-11ec-8377-0242ac110003 UniProtKB:P47748 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:18a44e48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:18a44e48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:18a44e48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:18a44e48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:18a4a92e-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:18a4a92e-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:18a4a92e-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:18a4a92e-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:18a4a92e-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:18a50aa4-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:18a50aa4-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:18a50aa4-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:18a50aa4-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:18a5543c-d20a-11ec-8377-0242ac110003 UniProtKB:Q98UH1 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Mu opioid receptor-like OR2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:18a57c96-d20a-11ec-8377-0242ac110003 UniProtKB:B3DH72 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor, delta 1b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:18a5a798-d20a-11ec-8377-0242ac110003 UniProtKB:O57585 biolink:molecularly_interacts_with DrugCentral:1845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 morphine targets GPCR (Opioid receptor homologue) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:18a5cfd4-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapramine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:18a5f806-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapramine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:18a621a0-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:18a64a72-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:18a672d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.891']} DrugCentral uuid:18a69b30-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:18a6c4c0-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:18a6f030-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.694']} DrugCentral uuid:18a718f8-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.725']} DrugCentral uuid:18a74148-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.683']} DrugCentral uuid:18a769fc-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:18a79238-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:18a7bb78-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:18a7e3a0-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:18a80c54-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:18a8388c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:18a8388c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:18a86c12-d20a-11ec-8377-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:1848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mosapride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:18a89476-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:1851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latamoxef is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.938']} DrugCentral uuid:18a8bfa0-d20a-11ec-8377-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:1851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latamoxef is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.716']} DrugCentral uuid:18a8e7f0-d20a-11ec-8377-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:1851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latamoxef is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.637']} DrugCentral uuid:18a910cc-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:18a9355c-d20a-11ec-8377-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxifloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:18a95da2-d20a-11ec-8377-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxifloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:18a989bc-d20a-11ec-8377-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:1854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:18a989bc-d20a-11ec-8377-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:1854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:18a9bc3e-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxifloxacin is inhibitor of Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:18a9bc3e-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1854 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxifloxacin is inhibitor of Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:18a9f01e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxonidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:18aa1878-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.397']} DrugCentral uuid:18aa40c8-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxonidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:18aa6922-d20a-11ec-8377-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:1856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxonidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:18aa9262-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxonidine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:18aaba94-d20a-11ec-8377-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:1856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxonidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:18aae2f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:1856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxonidine is agonist of Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:18ab0bca-d20a-11ec-8377-0242ac110003 UniProtKB:P00956 biolink:molecularly_interacts_with DrugCentral:1857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mupirocin targets Enzyme (Isoleucine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:18ab3424-d20a-11ec-8377-0242ac110003 UniProtKB:P41252 biolink:molecularly_interacts_with DrugCentral:1857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mupirocin targets Enzyme (Isoleucine--tRNA ligase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:18ab5c56-d20a-11ec-8377-0242ac110003 UniProtKB:P41972 biolink:molecularly_interacts_with DrugCentral:1857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mupirocin is inhibitor of Enzyme (Isoleucine--tRNA ligase) DrugCentral uuid:18ab8096-d20a-11ec-8377-0242ac110003 UniProtKB:Q99YW3 biolink:molecularly_interacts_with DrugCentral:1857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mupirocin is inhibitor of Enzyme (Isoleucine--tRNA ligase) DrugCentral uuid:18aba65c-d20a-11ec-8377-0242ac110003 UniProtKB:P56690 biolink:molecularly_interacts_with DrugCentral:1857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mupirocin targets Enzyme (Isoleucine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:18abcfe2-d20a-11ec-8377-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mycophenolate mofetil is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:18abf864-d20a-11ec-8377-0242ac110003 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:1859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mycophenolate mofetil is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:18ac20be-d20a-11ec-8377-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1860 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mycophenolic acid targets Enzyme (Inosine-5'-monophosphate dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:18ac4a08-d20a-11ec-8377-0242ac110003 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:1860 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mycophenolic acid targets Enzyme (Inosine-5'-monophosphate dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:18ac764a-d20a-11ec-8377-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1860 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mycophenolic acid is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase (IMPDH)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:18ac764a-d20a-11ec-8377-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:1860 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mycophenolic acid is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase (IMPDH)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:18aca9bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q5KP44 biolink:molecularly_interacts_with DrugCentral:1860 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mycophenolic acid targets Unclassified (Inosine-5'-monophosphate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:18acd20c-d20a-11ec-8377-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabilone is agonist of GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:18acfaca-d20a-11ec-8377-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:1862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabilone targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:18ad2306-d20a-11ec-8377-0242ac110003 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:1862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabilone targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:18ad4b4c-d20a-11ec-8377-0242ac110003 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:1862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabilone targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:18ad73c4-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabumetone is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:18ad9886-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabumetone targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.34']} DrugCentral uuid:18adc0ae-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabumetone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.732']} DrugCentral uuid:18ade908-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabumetone targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:18ae1130-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nabumetone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.001']} DrugCentral uuid:18ae3d36-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nadolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:18ae659a-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nadolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:18ae8de0-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nadolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:18aeb676-d20a-11ec-8377-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:18aede94-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:18af06e4-d20a-11ec-8377-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat is inhibitor of Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:18af2f0c-d20a-11ec-8377-0242ac110003 UniProtKB:P06870 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Kallikrein-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:18af57f2-d20a-11ec-8377-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:18af8100-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:18afa9d2-d20a-11ec-8377-0242ac110003 UniProtKB:P00736 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat is inhibitor of Enzyme (Complement C1r subcomponent) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:18afd218-d20a-11ec-8377-0242ac110003 UniProtKB:P09871 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Complement C1s subcomponent) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:18affb6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16515 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat is blocker of Ion channel (Acid-sensing ion channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:18b02394-d20a-11ec-8377-0242ac110003 UniProtKB:P78348 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat is blocker of Ion channel (Acid-sensing ion channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:18b04bd0-d20a-11ec-8377-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:18b073e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHC3 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat is blocker of Ion channel (Acid-sensing ion channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:18b09c98-d20a-11ec-8377-0242ac110003 UniProtKB:Q15661 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat is inhibitor of Enzyme (Tryptase alpha/beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:18b0c4d4-d20a-11ec-8377-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:18b0ed06-d20a-11ec-8377-0242ac110003 UniProtKB:Q04756 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat targets Enzyme (Hepatocyte growth factor activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:18b11556-d20a-11ec-8377-0242ac110003 UniProtKB:O15393 biolink:molecularly_interacts_with DrugCentral:1867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafamostat is inhibitor of Enzyme (Transmembrane protease serine 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:18b13e64-d20a-11ec-8377-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:1868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafarelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.699']} DrugCentral uuid:18b1668c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:1869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafcillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:18b19b8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:18b19b8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:18b19b8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:18b19b8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:18b19b8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:1869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nafcillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:18b1ea1c-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftidrofuryl targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:18b21276-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftifine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:18b23ac6-d20a-11ec-8377-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:1872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftifine targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:18b26370-d20a-11ec-8377-0242ac110003 UniProtKB:Q14534 biolink:molecularly_interacts_with DrugCentral:1872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftifine targets Enzyme (Squalene monooxygenase) DrugCentral uuid:18b2879c-d20a-11ec-8377-0242ac110003 UniProtKB:Q4JEY0 biolink:molecularly_interacts_with DrugCentral:1872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftifine is inhibitor of Enzyme (Squalene epoxidase) DrugCentral uuid:18b2abf0-d20a-11ec-8377-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:1872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftifine targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.51']} DrugCentral uuid:18b2d436-d20a-11ec-8377-0242ac110003 UniProtKB:O07855 biolink:molecularly_interacts_with DrugCentral:1872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftifine targets Enzyme (Dehydrosqualene desaturase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:18b2fd30-d20a-11ec-8377-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:18b32d50-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:18b32d50-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:18b32d50-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:18b374f4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:18b374f4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:18b374f4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:18b3b496-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.432']} DrugCentral uuid:18b3dcdc-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.921']} DrugCentral uuid:18b40536-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naftopidil is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:18b42d90-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1874 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalbuphine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:18b4563a-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1874 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalbuphine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:18b47e94-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1874 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalbuphine is agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:18b4a6f8-d20a-11ec-8377-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1874 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalbuphine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:18b4cfe8-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalidixic acid targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:18b4fc34-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalidixic acid is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:18b4fc34-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalidixic acid is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:18b52a42-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalmefene is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.53']} DrugCentral uuid:18b552c4-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalmefene is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:18b57d26-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalmefene is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.04']} DrugCentral uuid:18b5a580-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalmefene targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:18b5cdd0-d20a-11ec-8377-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalmefene targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:18b5f620-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalmefene targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:18b61eca-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:18b64724-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:18b66f38-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.42']} DrugCentral uuid:18b69896-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:18b6c14a-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:18b6ea80-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:18b71e6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:18b71e6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:18b71e6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:18b71e6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:18b776b2-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:18b776b2-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:18b776b2-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:18b776b2-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:18b7c054-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:18b7e94e-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:18b81194-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:18b839c6-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:18b862d4-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.27']} DrugCentral uuid:18b88b9c-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:18b8b3c4-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:18b8dc00-d20a-11ec-8377-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:18b9043c-d20a-11ec-8377-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:18b92f70-d20a-11ec-8377-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:18b957c0-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:18b97ff2-d20a-11ec-8377-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:18b9a82e-d20a-11ec-8377-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone is antagonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:18b9d11e-d20a-11ec-8377-0242ac110003 UniProtKB:P79350 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:18b9f96e-d20a-11ec-8377-0242ac110003 UniProtKB:P51682 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.98']} DrugCentral uuid:18ba2d3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:18ba2d3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:18ba2d3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:18ba2d3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:18ba7876-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1879 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:18ba9c84-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1879 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:18bac4e8-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1879 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:18baeec8-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1879 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:18bb193e-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1879 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.678']} DrugCentral uuid:18bb41a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1879 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:18bb6a10-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone decanoate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:18bb901c-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:1881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone decanoate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.14']} DrugCentral uuid:18bbb880-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone decanoate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:18bbe242-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone decanoate targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:18bc0a88-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone decanoate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:18bc3346-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone decanoate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.65']} DrugCentral uuid:18bc5b82-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone phenpropionate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:18bc83b4-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nandrolone phenpropionate is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.5']} DrugCentral uuid:18bcac0e-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:18bcd706-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:18bcff88-d20a-11ec-8377-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:18bd2814-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:18bd503c-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:18bd7904-d20a-11ec-8377-0242ac110003 UniProtKB:O09114 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Prostaglandin-H2 D-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:18bda154-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:18bdc9a4-d20a-11ec-8377-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:18bdf1f4-d20a-11ec-8377-0242ac110003 UniProtKB:P15304 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Hormone-sensitive lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:18be1f3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:18be1f3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naproxen targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:18be52a2-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1884 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naratriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:18be7afc-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1884 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:18bea5a4-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1884 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.796']} DrugCentral uuid:18becde0-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1884 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:18bef630-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1884 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naratriptan is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:18bf1e94-d20a-11ec-8377-0242ac110003 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:1886 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nateglinide targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:18bf4b44-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:18bf4b44-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:18bf82b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:18bf82b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1886 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nateglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:18bfb638-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nebivolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:18bfdef6-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nebivolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:18c0073c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nebivolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:18c02f6e-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nebivolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:18c057aa-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1887 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nebivolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:18c08252-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:1889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nedocromil targets GPCR (Cysteinyl leukotriene receptor 1) DrugCentral uuid:18c0a6ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nedocromil is agonist of GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.013']} DrugCentral uuid:18c0cece-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.745']} DrugCentral uuid:18c0f732-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:18c12130-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.699']} DrugCentral uuid:18c14994-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.444']} DrugCentral uuid:18c171ee-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:18c19a66-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:18c1c45a-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.143']} DrugCentral uuid:18c1ec96-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.789']} DrugCentral uuid:18c214f0-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.635']} DrugCentral uuid:18c23eee-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.432']} DrugCentral uuid:18c26a72-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.444']} DrugCentral uuid:18c295f6-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:18c2be5a-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:18c2e704-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:18c30f36-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:18c33772-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:18c35fb8-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:18c388b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:18c3b0f8-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:18c3d92a-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:18c4017a-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:18c42cc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefopam targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:18c453aa-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefopam targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:18c47d94-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefopam targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:18c4a5d0-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefopam targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.773']} DrugCentral uuid:18c4ce70-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefopam targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.481']} DrugCentral uuid:18c4f6ac-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefopam targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.252']} DrugCentral uuid:18c51ef2-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nefopam targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:18c547d8-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.232']} DrugCentral uuid:18c57014-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.189']} DrugCentral uuid:18c59850-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:18c5c168-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:18c5eaee-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.057']} DrugCentral uuid:18c61352-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.209']} DrugCentral uuid:18c63b84-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.592']} DrugCentral uuid:18c663d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.909']} DrugCentral uuid:18c68c7e-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.078']} DrugCentral uuid:18c6b4b0-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.842']} DrugCentral uuid:18c6dcf6-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.632']} DrugCentral uuid:18c70532-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.255']} DrugCentral uuid:18c72f12-d20a-11ec-8377-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:18c7533e-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.101']} DrugCentral uuid:18c77b70-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.098']} DrugCentral uuid:18c7a456-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.676']} DrugCentral uuid:18c7cd5a-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.648']} DrugCentral uuid:18c7f5c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.739']} DrugCentral uuid:18c81e04-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.009']} DrugCentral uuid:18c84636-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.615']} DrugCentral uuid:18c86ed6-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:18c89712-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.236']} DrugCentral uuid:18c8bfee-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:18c8e83e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:18c91124-d20a-11ec-8377-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:18c9396a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:1893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nelfinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.68']} DrugCentral uuid:18c961a6-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nemonapride is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:18c989e2-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nemonapride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:18c9b304-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nemonapride targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:18c9dc30-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nemonapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:18ca0480-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nemonapride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.31']} DrugCentral uuid:18ca2d0c-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nemonapride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:18ca5570-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:18ca7da2-d20a-11ec-8377-0242ac110003 UniProtKB:P0A7S3 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin targets Cytosolic other (30S ribosomal protein S12) DrugCentral uuid:18caa1b0-d20a-11ec-8377-0242ac110003 UniProtKB:P08312 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin targets Enzyme (Phenylalanine--tRNA ligase alpha subunit) DrugCentral uuid:18cac67c-d20a-11ec-8377-0242ac110003 UniProtKB:P07395 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin targets Enzyme (Phenylalanine--tRNA ligase beta subunit) DrugCentral uuid:18caeabc-d20a-11ec-8377-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:18cb1302-d20a-11ec-8377-0242ac110003 UniProtKB:O95237 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin targets Enzyme (Lecithin retinol acyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:18cb3b5c-d20a-11ec-8377-0242ac110003 UniProtKB:O00255 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin targets Unclassified (Menin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.81']} DrugCentral uuid:18cb64a6-d20a-11ec-8377-0242ac110003 UniProtKB:P48442 biolink:molecularly_interacts_with DrugCentral:1896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 framycetin is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:18cb8d0a-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:18cbb528-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:1897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:18cbdd64-d20a-11ec-8377-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:1897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.34']} DrugCentral uuid:18cc060e-d20a-11ec-8377-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:1897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:18cc2e4a-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:18cc56ae-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:18cc7f80-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nepafenac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:18cca85c-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nepafenac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:18ccd480-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:18ccd480-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:1899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:18cd0cf2-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:18cd0cf2-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:1899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nepafenac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:18cd41b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1900 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nepinalone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:18cd6d32-d20a-11ec-8377-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nesiritide is agonist of Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:18cd941a-d20a-11ec-8377-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:1904 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nevirapine targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:18cdbd5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:1904 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nevirapine targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:18cde5e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:1904 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nevirapine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:18ce0e40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:1904 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nevirapine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:18ce367c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:1904 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nevirapine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:18ce5eb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets GPCR (Hydroxycarboxylic acid receptor 2) DrugCentral uuid:18ce83e8-d20a-11ec-8377-0242ac110003 UniProtKB:P49019 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets GPCR (Hydroxycarboxylic acid receptor 3) DrugCentral uuid:18cea81e-d20a-11ec-8377-0242ac110003 UniProtKB:P40261 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (Nicotinamide N-methyltransferase) DrugCentral uuid:18cecc22-d20a-11ec-8377-0242ac110003 UniProtKB:Q15274 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (Nicotinate-nucleotide pyrophosphorylase [carboxylating]) DrugCentral uuid:18cef04e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96EB6 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (NAD-dependent protein deacetylase sirtuin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:18cf1a74-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IXJ6 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (NAD-dependent protein deacetylase sirtuin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:18cf45e4-d20a-11ec-8377-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:18cf6e8e-d20a-11ec-8377-0242ac110003 UniProtKB:P53686 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (NAD-dependent deacetylase HST2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:18cf96d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NTG7 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (NAD-dependent deacetylase sirtuin 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:18cfbf60-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NXA8 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Enzyme (NAD-dependent protein deacylase sirtuin-5, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:18cfe79c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8I6E4 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Unclassified (Putative silent information regulator 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:18d00fec-d20a-11ec-8377-0242ac110003 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:1906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinamide targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:18d03814-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.377']} DrugCentral uuid:18d06118-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:18d08954-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:18d0b1ae-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:18d0d5e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:18d10154-d20a-11ec-8377-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:18d12b8e-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.553']} DrugCentral uuid:18d153d4-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.553']} DrugCentral uuid:18d17c7e-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:18d1a4d8-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:18d1ce0e-d20a-11ec-8377-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:18d1f668-d20a-11ec-8377-0242ac110003 UniProtKB:O54698 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:18d21f94-d20a-11ec-8377-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:18d24f82-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:18d24f82-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:18d24f82-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:18d2971c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:18d2971c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:18d2971c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:18d2de70-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:18d2de70-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:18d2de70-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:18d320d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:18d320d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:18d34ec8-d20a-11ec-8377-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:18d37768-d20a-11ec-8377-0242ac110003 UniProtKB:P15385 biolink:molecularly_interacts_with DrugCentral:1909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicardipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:18d39fa4-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.046']} DrugCentral uuid:18d3c7cc-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:18d3f0a8-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:18d418da-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:18d4410c-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:18d4693e-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:18d49224-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:18d4ba60-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:18d4e332-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:18d50c72-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:18d53512-d20a-11ec-8377-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:18d55d44-d20a-11ec-8377-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:18d58576-d20a-11ec-8377-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:18d5ad9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q5JUK3 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide is activator of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:18d5d670-d20a-11ec-8377-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:18d5feac-d20a-11ec-8377-0242ac110003 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:1912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niclosamide targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:18d626de-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:1919 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicorandil targets Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.886']} DrugCentral uuid:18d64f06-d20a-11ec-8377-0242ac110003 UniProtKB:P48048 biolink:molecularly_interacts_with DrugCentral:1919 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicorandil targets Ion channel (ATP-sensitive inward rectifier potassium channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:18d67846-d20a-11ec-8377-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1919 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicorandil targets Enzyme (Atrial natriuretic peptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:18d6a05a-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:18d6c8b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:18d6f1b8-d20a-11ec-8377-0242ac110003 UniProtKB:P11509 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Enzyme (Cytochrome P450 2A6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.356']} DrugCentral uuid:18d71aa8-d20a-11ec-8377-0242ac110003 UniProtKB:P58154 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Unclassified (Acetylcholine-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:18d74302-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:18d76b3e-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:18d7937a-d20a-11ec-8377-0242ac110003 UniProtKB:P09483 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.03']} DrugCentral uuid:18d7bc2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:18d7e5a0-d20a-11ec-8377-0242ac110003 UniProtKB:P49582 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:18d80e0e-d20a-11ec-8377-0242ac110003 UniProtKB:P43144 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:18d83776-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit beta-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:18d8630e-d20a-11ec-8377-0242ac110003 UniProtKB:P04757 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:18d88b54-d20a-11ec-8377-0242ac110003 UniProtKB:P12389 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:18d8b3a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WSF8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Unclassified (Soluble acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:18d8dd8e-d20a-11ec-8377-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:18d905a2-d20a-11ec-8377-0242ac110003 UniProtKB:P21687 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Enzyme (Lycopene cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:18d92df2-d20a-11ec-8377-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:18d9564c-d20a-11ec-8377-0242ac110003 UniProtKB:P25162 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit beta-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:18d97ee2-d20a-11ec-8377-0242ac110003 UniProtKB:P09482 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:18d9a732-d20a-11ec-8377-0242ac110003 UniProtKB:O70174 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:18d9d338-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:18d9d338-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:18da0baa-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:18da0baa-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:18da4354-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:18da4354-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:18da7b4e-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:18da7b4e-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:18dab33e-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:18dab33e-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:18daeae8-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:18daeae8-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:18db4e16-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:18db4e16-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:18db4e16-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:18db4e16-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:18db4e16-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:18db4e16-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:18db4e16-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:18db4e16-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:18db4e16-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:18db4e16-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:18db4e16-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:18db4e16-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:18db4e16-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JLB5 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:18dc0432-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:18dc0432-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:18dc3d12-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:18dc3d12-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:18dc74da-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:18dc74da-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:18dcad2e-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:18dcad2e-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:18dce4ba-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:18dce4ba-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:18dd2844-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:18dd2844-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:18dd2844-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:18dd2844-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:18dd2844-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.15']} DrugCentral uuid:18dd888e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:18dd888e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:18dd888e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:18dd888e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:18dde25c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:18dde25c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:18dde25c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:18dde25c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15825 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:18de2f96-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:18de2f96-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:18de6f42-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:18de6f42-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:18de6f42-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:18de6f42-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:18dec852-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:18dec852-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:18dec852-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:18dec852-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:18dec852-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:18df1d84-d20a-11ec-8377-0242ac110003 UniProtKB:P02708 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:18df45c0-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.35']} DrugCentral uuid:18df6e24-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:18df9782-d20a-11ec-8377-0242ac110003 UniProtKB:Q62897 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine is blocker of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:18dfbfb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:1920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotine targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:18dfe91c-d20a-11ec-8377-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.089']} DrugCentral uuid:18e01176-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.65']} DrugCentral uuid:18e03b4c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:18e06388-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:18e08bb0-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.495']} DrugCentral uuid:18e0b400-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.019']} DrugCentral uuid:18e0dcaa-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.348']} DrugCentral uuid:18e104dc-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:18e12da4-d20a-11ec-8377-0242ac110003 UniProtKB:P00390 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Glutathione reductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:18e155e0-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.658']} DrugCentral uuid:18e17ec6-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:18e1a734-d20a-11ec-8377-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:18e1cf52-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:18e1f84c-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.672']} DrugCentral uuid:18e2209c-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:18e248ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q09470 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:18e2713c-d20a-11ec-8377-0242ac110003 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:18e299fa-d20a-11ec-8377-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:18e2c22c-d20a-11ec-8377-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.355']} DrugCentral uuid:18e2ea54-d20a-11ec-8377-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is antagonist of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:18e31272-d20a-11ec-8377-0242ac110003 UniProtKB:P16389 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Potassium voltage-gated channel subfamily A member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:18e33c3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:18e366fa-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.731']} DrugCentral uuid:18e38f36-d20a-11ec-8377-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.072']} DrugCentral uuid:18e3b786-d20a-11ec-8377-0242ac110003 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:18e3e06c-d20a-11ec-8377-0242ac110003 UniProtKB:O75311 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is antagonist of Ion channel (Glycine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:18e40984-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.821']} DrugCentral uuid:18e431ac-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:18e459f2-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:18e482a6-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:18e4ab00-d20a-11ec-8377-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:18e4d346-d20a-11ec-8377-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:18e4fba0-d20a-11ec-8377-0242ac110003 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:18e52634-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:18e54e70-d20a-11ec-8377-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:18e576ca-d20a-11ec-8377-0242ac110003 UniProtKB:O35505 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.59']} DrugCentral uuid:18e5a79e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:18e5a79e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:18e5a79e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:18e5ef42-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:18e5ef42-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:18e5ef42-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:18e62e62-d20a-11ec-8377-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:18e656f8-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:18e67f34-d20a-11ec-8377-0242ac110003 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:18e6a784-d20a-11ec-8377-0242ac110003 UniProtKB:P16388 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:18e6cfd4-d20a-11ec-8377-0242ac110003 UniProtKB:P63142 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:18e6faa4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8HY88 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:18e722f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1922 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifedipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:18e74b4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifekalant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:18e7752e-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifekalant targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:18e79d88-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifekalant targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:18e7c5ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifekalant targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:18e7edf6-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.037']} DrugCentral uuid:18e816a0-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.973']} DrugCentral uuid:18e83efa-d20a-11ec-8377-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:18e86722-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:18e88f5e-d20a-11ec-8377-0242ac110003 UniProtKB:P51800 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid is activator of Ion channel (Chloride channel protein ClC-Ka) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:18e8b862-d20a-11ec-8377-0242ac110003 UniProtKB:Q6UVM3 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid is activator of Ion channel (Potassium channel subfamily T member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:18e8e09e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:18e908ee-d20a-11ec-8377-0242ac110003 UniProtKB:P51801 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid is activator of Ion channel (Chloride channel protein ClC-Kb) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:18e93134-d20a-11ec-8377-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:1925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niflumic acid targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.55']} DrugCentral uuid:18e95a2e-d20a-11ec-8377-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:1928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifuroxazide targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:18e98292-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:18e9aace-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:18e9d31e-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:18e9fbe6-d20a-11ec-8377-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:18ea2418-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:18ea4c54-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:18ea749a-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:18ea9fc4-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:18eac832-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:18eaf082-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:18eb18e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.83']} DrugCentral uuid:18eb41a4-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:18eb6bca-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:18eb941a-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.33']} DrugCentral uuid:18ebbd1e-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:18ebe56e-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:18ec0dc8-d20a-11ec-8377-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:18ec360e-d20a-11ec-8377-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:18ec5fbc-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:18ec87f8-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:18ecb048-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:18ecd938-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:18ed0228-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.13']} DrugCentral uuid:18ed2a64-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.387']} DrugCentral uuid:18ed52aa-d20a-11ec-8377-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:18ed7af0-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:18eda3a4-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:18edcbea-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:18edf430-d20a-11ec-8377-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:18ee1c6c-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.069']} DrugCentral uuid:18ee4732-d20a-11ec-8377-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:18ee6f64-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:18ee97b4-d20a-11ec-8377-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:18eebfe6-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:18eee8ea-d20a-11ec-8377-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.318']} DrugCentral uuid:18ef113a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:18ef3976-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.096']} DrugCentral uuid:18ef62a2-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:18ef8b38-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:18efb374-d20a-11ec-8377-0242ac110003 UniProtKB:Q15759 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:18efdbb0-d20a-11ec-8377-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:18f004f0-d20a-11ec-8377-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:18f02fa2-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.141']} DrugCentral uuid:18f057de-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:18f0801a-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:18f0a8e2-d20a-11ec-8377-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:18f0d11e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:18f0f950-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:18f121a0-d20a-11ec-8377-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:18f14a5e-d20a-11ec-8377-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:18f173d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:18f19c16-d20a-11ec-8377-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:18f1c466-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:18f1eebe-d20a-11ec-8377-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:18f21718-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:18f23f5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:18f267b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:18f29094-d20a-11ec-8377-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:18f2b8ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:18f2e116-d20a-11ec-8377-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:18f30966-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:18f3321a-d20a-11ec-8377-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:18f35b5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:18f38396-d20a-11ec-8377-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:18f3ad12-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:18f3d56c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:18f3fe3e-d20a-11ec-8377-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:18f42666-d20a-11ec-8377-0242ac110003 UniProtKB:P54753 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:18f44f56-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:18f4777e-d20a-11ec-8377-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:18f49fce-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:18f4c80a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:18f4f0be-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:18f518e6-d20a-11ec-8377-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:18f54514-d20a-11ec-8377-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:18f54514-d20a-11ec-8377-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:1932 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilotinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:18f5798a-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1933 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:18f5a450-d20a-11ec-8377-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:1934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilvadipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:18f5c872-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilvadipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:18f5ec9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilvadipine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:18f614a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilvadipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:18f614a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nilvadipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:18f642de-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:18f66b24-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:18f69374-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.927']} DrugCentral uuid:18f6bc46-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:18f6e482-d20a-11ec-8377-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:18f70cc8-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:18f7370c-d20a-11ec-8377-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.632']} DrugCentral uuid:18f76024-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:18f78856-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:18f7b088-d20a-11ec-8377-0242ac110003 UniProtKB:Q2A865 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide is inhibitor of Transporter (Sodium-dependent neutral amino acid transporter B(0)AT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:18f7d8e2-d20a-11ec-8377-0242ac110003 UniProtKB:L8I2E6 biolink:molecularly_interacts_with DrugCentral:1935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimesulide targets Enzyme (Dipeptidyl peptidase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.16']} DrugCentral uuid:18f801d2-d20a-11ec-8377-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.364']} DrugCentral uuid:18f82a0e-d20a-11ec-8377-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:18f85240-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:18f87a72-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.072']} DrugCentral uuid:18f8a33a-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:18f8cb6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:18f8ef8e-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:18f917f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) DrugCentral uuid:18f93dcc-d20a-11ec-8377-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:18f9620c-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:18f98a52-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.252']} DrugCentral uuid:18f9b2c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:18f9dbc4-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:18fa0428-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:18fa2ce6-d20a-11ec-8377-0242ac110003 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:18fa552c-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:18fa7dcc-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:18faa612-d20a-11ec-8377-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:18face6c-d20a-11ec-8377-0242ac110003 UniProtKB:P27732 biolink:molecularly_interacts_with DrugCentral:1937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nimodipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:18faf6b2-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.642']} DrugCentral uuid:18fb20d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.638']} DrugCentral uuid:18fb491e-d20a-11ec-8377-0242ac110003 UniProtKB:O00555 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) DrugCentral uuid:18fb6d54-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.395']} DrugCentral uuid:18fb95cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:18fbbf84-d20a-11ec-8377-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) DrugCentral uuid:18fbe39c-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:18fc0c00-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:18fc3ca2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:18fc3ca2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:18fc3ca2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:18fc7b0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01815 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:18fca34a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99246 biolink:molecularly_interacts_with DrugCentral:1942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nisoldipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:18fcccd0-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:1943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitazoxanide targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:18fcf7dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q968X7 biolink:molecularly_interacts_with DrugCentral:1943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitazoxanide is inhibitor of Enzyme (Pyruvate dehydrogenase [NADP(+)]) DrugCentral uuid:18fd1c1c-d20a-11ec-8377-0242ac110003 UniProtKB:Q24982 biolink:molecularly_interacts_with DrugCentral:1943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitazoxanide is inhibitor of Enzyme (Pyruvate:ferredoxin oxidoreductase) DrugCentral uuid:18fd405c-d20a-11ec-8377-0242ac110003 UniProtKB:Q0P8E1 biolink:molecularly_interacts_with DrugCentral:1943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitazoxanide targets Enzyme (Pyruvate-flavodoxin oxidoreductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:18fd68c0-d20a-11ec-8377-0242ac110003 UniProtKB:P32754 biolink:molecularly_interacts_with DrugCentral:1944 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitisinone is inhibitor of Enzyme (4-hydroxyphenylpyruvate dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:18fd91c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q02110 biolink:molecularly_interacts_with DrugCentral:1944 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitisinone targets Enzyme (4-hydroxyphenylpyruvate dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:18fdba14-d20a-11ec-8377-0242ac110003 UniProtKB:P32755 biolink:molecularly_interacts_with DrugCentral:1944 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitisinone targets Unclassified (4-hydroxyphenylpyruvate dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:18fdea3e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:18fdea3e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:18fdea3e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:18fe3c28-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:18fe3c28-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:18fe3c28-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:18fe3c28-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:18fe3c28-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:18fe3c28-d20a-11ec-8377-0242ac110003 UniProtKB:P22300 biolink:molecularly_interacts_with DrugCentral:1945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:18fe9d30-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:18fec65c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.081']} DrugCentral uuid:18feeea2-d20a-11ec-8377-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine is blocker of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:18ff16ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) DrugCentral uuid:18ff3b0a-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.921']} DrugCentral uuid:18ff63d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q01668 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:18ff8c22-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:18ffb45e-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.056']} DrugCentral uuid:18ffdcae-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:19000558-d20a-11ec-8377-0242ac110003 UniProtKB:O60840 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:19002dc6-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:19005698-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:19008050-d20a-11ec-8377-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1900ab66-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine is gating inhibitor of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1900d5fa-d20a-11ec-8377-0242ac110003 UniProtKB:P21556 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:1901062e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:1901062e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:1901062e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:19014558-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:1947 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrendipine is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:19017956-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:19017956-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:19017956-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:19017956-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1948 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitric oxide is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:1901bd30-d20a-11ec-8377-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:1949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrofurantoin targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:1901e198-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:1949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrofurantoin targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:190209f2-d20a-11ec-8377-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:1950 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrofurazone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:19022e3c-d20a-11ec-8377-0242ac110003 UniProtKB:P83512 biolink:molecularly_interacts_with DrugCentral:1950 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitrofurazone targets Enzyme (Snake venom metalloproteinase Bap1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:1902584e-d20a-11ec-8377-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:1952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glyceryl trinitrate targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:19028846-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:19028846-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:19028846-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:19028846-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:1952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glyceryl trinitrate is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:1902c9c8-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroxoline targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:1902f290-d20a-11ec-8377-0242ac110003 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:1954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroxoline targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19031ad6-d20a-11ec-8377-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:1954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroxoline targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:19034312-d20a-11ec-8377-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:1954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroxoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:19036b62-d20a-11ec-8377-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:1954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroxoline targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1903940c-d20a-11ec-8377-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:1954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroxoline targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1903bc5c-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1955 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nizatidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1903e4b6-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:1955 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nizatidine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.251']} DrugCentral uuid:19040cfc-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:190437c2-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:19046012-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:1904884e-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1904b120-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:1904d9d4-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['2.947']} DrugCentral uuid:19050210-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.963']} DrugCentral uuid:19052a74-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:190552d8-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:19057c7c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1905a4c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1905d10e-d20a-11ec-8377-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Enzyme (Hemoglobin HbA) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.678']} DrugCentral uuid:1905d10e-d20a-11ec-8377-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:1958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nomifensine targets Enzyme (Hemoglobin HbA) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.678']} DrugCentral uuid:19060660-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1959 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norelgestromin is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:19062cf8-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:19065552-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:19067dd4-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1906a692-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1906cef6-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:1906f89a-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:190720fe-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:190749a8-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.367']} DrugCentral uuid:19077220-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:19079a7a-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.071']} DrugCentral uuid:1907c2ca-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1907ec50-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.69']} DrugCentral uuid:190814a0-d20a-11ec-8377-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:19083cfa-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19086554-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:19088e12-d20a-11ec-8377-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1908b662-d20a-11ec-8377-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1908dea8-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1909077a-d20a-11ec-8377-0242ac110003 UniProtKB:P10608 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:19092fb6-d20a-11ec-8377-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:19095824-d20a-11ec-8377-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:19098948-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:19098948-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:19098948-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1909d4d4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1909d4d4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1909d4d4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:190a2682-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:190a2682-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:190a2682-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:190a2682-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:190a2682-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:190a2682-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:190a8e7e-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:190a8e7e-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:190a8e7e-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:190acd12-d20a-11ec-8377-0242ac110003 UniProtKB:Q01337 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:190af5bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:1960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norepinephrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:190b1e02-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.618']} DrugCentral uuid:190b465c-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.706']} DrugCentral uuid:190b6eb6-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.636']} DrugCentral uuid:190b9bac-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:190bc6cc-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['11.26']} DrugCentral uuid:190bf138-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.97']} DrugCentral uuid:190c1a0a-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:190c42c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.914']} DrugCentral uuid:190c6ff0-d20a-11ec-8377-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:190c6ff0-d20a-11ec-8377-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:1962 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethisterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:190ca34e-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:190ccc0c-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.533']} DrugCentral uuid:190cf48e-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:190d1ce8-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:190d4524-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['11.26']} DrugCentral uuid:190d708a-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:190d98b2-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.97']} DrugCentral uuid:190dc102-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.149']} DrugCentral uuid:190de9ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:1963 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethindrone acetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.441']} DrugCentral uuid:190e122e-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1965 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethynodrel is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:190e363c-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:1965 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norethynodrel targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:190e5e6e-d20a-11ec-8377-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:190e872c-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:190eaf72-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:190ed7a4-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:190effd6-d20a-11ec-8377-0242ac110003 UniProtKB:P0AFI2 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin is inhibitor of Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:190f29ca-d20a-11ec-8377-0242ac110003 UniProtKB:P0C1U9 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Enzyme (DNA topoisomerase 4 subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:190f5512-d20a-11ec-8377-0242ac110003 UniProtKB:P9WG47 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:190f7da8-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin is inhibitor of Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:190fa5e4-d20a-11ec-8377-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:190fce8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:190ff6c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q02880 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Enzyme (DNA topoisomerase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:19101fd8-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1910828e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:19115d62-d20a-11ec-8377-0242ac110003 UniProtKB:P37340 biolink:molecularly_interacts_with DrugCentral:1967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norfloxacin targets Unclassified (Multidrug resistance protein mdtK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.01']} DrugCentral uuid:1911859e-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:1968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norgestimate is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:1911aa42-d20a-11ec-8377-0242ac110003 UniProtKB:Q13507 biolink:molecularly_interacts_with DrugCentral:1968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norgestimate is blocker of Ion channel (Short transient receptor potential channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1911d292-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y210 biolink:molecularly_interacts_with DrugCentral:1968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 norgestimate is blocker of Ion channel (Short transient receptor potential channel 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1911fac4-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:191222f6-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:19124baa-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.561']} DrugCentral uuid:191273fa-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:19129dbc-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.36']} DrugCentral uuid:1912c5ee-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.509']} DrugCentral uuid:1912f0dc-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.356']} DrugCentral uuid:1913192c-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:19134168-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:19136a26-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:1913926c-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1913babc-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1913e30c-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:19140c74-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.033']} DrugCentral uuid:191434ba-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.639']} DrugCentral uuid:19145cf6-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:1914851e-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.959']} DrugCentral uuid:1914aeb8-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:1914d6ea-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.076']} DrugCentral uuid:1914ff26-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.013']} DrugCentral uuid:19152758-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.071']} DrugCentral uuid:19155002-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:19157848-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.921']} DrugCentral uuid:1915a084-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['6.225']} DrugCentral uuid:1915ca14-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:1915f2d2-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:19161afa-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:19164340-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.943']} DrugCentral uuid:19166b72-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.837']} DrugCentral uuid:19169746-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.4']} DrugCentral uuid:1916bf64-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:1916e7a0-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:19171036-d20a-11ec-8377-0242ac110003 UniProtKB:P78508 biolink:molecularly_interacts_with DrugCentral:1971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nortriptyline is blocker of Ion channel (ATP-sensitive inward rectifier potassium channel 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.796']} DrugCentral uuid:1917387c-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 noscapine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.087']} DrugCentral uuid:191760ae-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 noscapine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:191788e0-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 noscapine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1917b1b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 noscapine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1917da02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:1918023e-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:19182a84-d20a-11ec-8377-0242ac110003 UniProtKB:P0A4L9 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:19185388-d20a-11ec-8377-0242ac110003 UniProtKB:Q7X1P7 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (ParE) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:19187bb0-d20a-11ec-8377-0242ac110003 UniProtKB:C3SLN2 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:1918a7f2-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1918a7f2-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNA gyrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1918df74-d20a-11ec-8377-0242ac110003 UniProtKB:Q5HK04 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:1918df74-d20a-11ec-8377-0242ac110003 UniProtKB:Q5HK04 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:19190e54-d20a-11ec-8377-0242ac110003 UniProtKB:P0C559 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1919367c-d20a-11ec-8377-0242ac110003 UniProtKB:P0A0K8 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:19195ecc-d20a-11ec-8377-0242ac110003 UniProtKB:A0QNE0 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNULL gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1919878a-d20a-11ec-8377-0242ac110003 UniProtKB:C3SLN3 biolink:molecularly_interacts_with DrugCentral:1974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 novobiocin targets Enzyme (DNULL gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1919b796-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1976 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buphenine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1919b796-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1976 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buphenine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1919b796-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1976 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 buphenine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1919f60c-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:191a1f38-d20a-11ec-8377-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.699']} DrugCentral uuid:191a4896-d20a-11ec-8377-0242ac110003 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:191a70fa-d20a-11ec-8377-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:191a9936-d20a-11ec-8377-0242ac110003 UniProtKB:P30875 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide targets GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.55']} DrugCentral uuid:191ac23a-d20a-11ec-8377-0242ac110003 UniProtKB:P30935 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide targets GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:191aeab2-d20a-11ec-8377-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:191b130c-d20a-11ec-8377-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.98']} DrugCentral uuid:191b3b66-d20a-11ec-8377-0242ac110003 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:191b6532-d20a-11ec-8377-0242ac110003 UniProtKB:P30680 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:191b8e0e-d20a-11ec-8377-0242ac110003 UniProtKB:P30936 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:191bb668-d20a-11ec-8377-0242ac110003 UniProtKB:O08858 biolink:molecularly_interacts_with DrugCentral:1980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octreotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:191bdec2-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.23']} DrugCentral uuid:191c0960-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:191c3494-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:191c5f46-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin is inhibitor of Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:191c878c-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES7 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Enzyme (DNA gyrase subunit B) DrugCentral uuid:191cac4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:191cd494-d20a-11ec-8377-0242ac110003 UniProtKB:P03362 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Polyprotein (Gag-Pro-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191d3736-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:191e0cf6-d20a-11ec-8377-0242ac110003 UniProtKB:P47154 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Enzyme (CAAX prenyl protease 1) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:191e3514-d20a-11ec-8377-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:1981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofloxacin targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:191e5d46-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:191e8640-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:191eae9a-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:191ed6f4-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.523']} DrugCentral uuid:191eff9e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.492']} DrugCentral uuid:191f27ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:191f5052-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:191f788e-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.9']} DrugCentral uuid:191fa1ec-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.319']} DrugCentral uuid:191fcb54-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:191ff3b8-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:19201c12-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:192044da-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:19206dde-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:1920962e-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.086']} DrugCentral uuid:1920bf64-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.097']} DrugCentral uuid:1920e818-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.046']} DrugCentral uuid:19211072-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:192138b8-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.356']} DrugCentral uuid:192160e0-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.506']} DrugCentral uuid:192189ee-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.102']} DrugCentral uuid:1921b22a-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.136']} DrugCentral uuid:1921da66-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.682']} DrugCentral uuid:192202ac-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.046']} DrugCentral uuid:19222bb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:192253ce-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.233']} DrugCentral uuid:19227c32-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.121']} DrugCentral uuid:1922a478-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:1922cd68-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:1922f5c2-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:19231e12-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:19234838-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:1923707e-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.916']} DrugCentral uuid:192398ce-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.509']} DrugCentral uuid:1923c146-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1923ea36-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.558']} DrugCentral uuid:1924127c-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:19243ae0-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.364']} DrugCentral uuid:19246330-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:19248bda-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1924b51a-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1924dd7e-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:192505ec-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:19253094-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:19255934-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1925817a-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1925a9ca-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1925d40e-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1925fc68-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:192624ae-d20a-11ec-8377-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:19264d12-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:192675c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1926a5f0-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1926a5f0-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1926a5f0-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1926ec5e-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1926ec5e-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1926ec5e-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:19272bf6-d20a-11ec-8377-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1927540a-d20a-11ec-8377-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:1982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olanzapine targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:19277cf0-d20a-11ec-8377-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:1985 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olmesartan medoxomil is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1927a5cc-d20a-11ec-8377-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:1985 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olmesartan medoxomil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.09']} DrugCentral uuid:1927ce12-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1986 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olopatadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.284']} DrugCentral uuid:1927f676-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:1986 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olopatadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:192822a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olprinone is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:192822a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:1987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olprinone is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:19285210-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:1988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olsalazine is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:1928765a-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:1988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olsalazine is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) DrugCentral uuid:19289e64-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olsalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:19289e64-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:1988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olsalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:1928cdb2-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:1989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omapatrilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:1928f8dc-d20a-11ec-8377-0242ac110003 UniProtKB:P08473 biolink:molecularly_interacts_with DrugCentral:1989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omapatrilat targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:19292190-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:1989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omapatrilat targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:192949cc-d20a-11ec-8377-0242ac110003 UniProtKB:P07861 biolink:molecularly_interacts_with DrugCentral:1989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omapatrilat targets Enzyme (Neprilysin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:19297384-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:1989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omapatrilat targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:19299bc0-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:1989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omapatrilat targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1929c3f2-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.31']} DrugCentral uuid:1929ec24-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.051']} DrugCentral uuid:192a14d8-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.347']} DrugCentral uuid:192a3d1e-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:192a658c-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:192a8ddc-d20a-11ec-8377-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:192abb9a-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:192abb9a-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:192af416-d20a-11ec-8377-0242ac110003 UniProtKB:P19156 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:192af416-d20a-11ec-8377-0242ac110003 UniProtKB:P19156 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:192b27ba-d20a-11ec-8377-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:192b50be-d20a-11ec-8377-0242ac110003 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:192b7918-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:192ba53c-d20a-11ec-8377-0242ac110003 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:192ba53c-d20a-11ec-8377-0242ac110003 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:1990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omeprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:192bd912-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.091']} DrugCentral uuid:192c0252-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:192c2a98-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.678']} DrugCentral uuid:192c52de-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:192c7bec-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:192ca400-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:192ccc50-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:192cf4a0-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:192d1d9a-d20a-11ec-8377-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:192d45fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:192d6ebc-d20a-11ec-8377-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:192d9702-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:192dbfd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:192de84c-d20a-11ec-8377-0242ac110003 UniProtKB:P35563 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:192e10ce-d20a-11ec-8377-0242ac110003 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:192e393c-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:192e64ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:192e8d60-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:192eb5a6-d20a-11ec-8377-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:192ee256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:192ee256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:192f19ec-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.34']} DrugCentral uuid:192f19ec-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.34']} DrugCentral uuid:192f552e-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:192f552e-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:192f552e-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:192f9926-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:192f9926-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:192fcc98-d20a-11ec-8377-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:1992 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ondansetron targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:192ff4fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:1993 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 opipramol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:19301f18-d20a-11ec-8377-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:1993 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 opipramol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:19304916-d20a-11ec-8377-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:1993 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 opipramol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1930717a-d20a-11ec-8377-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:193099e8-d20a-11ec-8377-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Lipoprotein lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.18']} DrugCentral uuid:1930c29c-d20a-11ec-8377-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1930ead8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4D2 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Sn1-specific diacylglycerol lipase alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1931130a-d20a-11ec-8377-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:19313b5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NCG7 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Sn1-specific diacylglycerol lipase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:193163f0-d20a-11ec-8377-0242ac110003 UniProtKB:O95870 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Abhydrolase domain-containing protein 16A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:19318c2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N2K0 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Monoacylglycerol lipase ABHD12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1931b47c-d20a-11ec-8377-0242ac110003 UniProtKB:Q13093 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Platelet-activating factor acetylhydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1931dcb8-d20a-11ec-8377-0242ac110003 UniProtKB:P00591 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Pancreatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1932072e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BV23 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Monoacylglycerol lipase ABHD6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:19322f6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q6WQJ1 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Sn1-specific diacylglycerol lipase alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:193257a6-d20a-11ec-8377-0242ac110003 UniProtKB:P06858 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Lipoprotein lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.18']} DrugCentral uuid:19328118-d20a-11ec-8377-0242ac110003 UniProtKB:P11150 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Hepatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1932a9d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5X9 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat targets Enzyme (Endothelial lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:1932d21c-d20a-11ec-8377-0242ac110003 UniProtKB:P16233 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat is inhibitor of Enzyme (Pancreatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.9']} DrugCentral uuid:1932fa62-d20a-11ec-8377-0242ac110003 UniProtKB:P07098 biolink:molecularly_interacts_with DrugCentral:1996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orlistat is inhibitor of Enzyme (Gastric triacylglycerol lipase) DrugCentral uuid:19331e84-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.886']} DrugCentral uuid:19334800-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.092']} DrugCentral uuid:19337140-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.174']} DrugCentral uuid:19339986-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.614']} DrugCentral uuid:1933c30c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.578']} DrugCentral uuid:1933ecf6-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.903']} DrugCentral uuid:1934155a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.666']} DrugCentral uuid:19343dd2-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.553']} DrugCentral uuid:19346690-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.283']} DrugCentral uuid:19348ef4-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:1934b758-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:1934dfc6-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.165']} DrugCentral uuid:193508f2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:19353138-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.873']} DrugCentral uuid:193559b0-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:19358214-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1935ac62-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:1935d4c6-d20a-11ec-8377-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.889']} DrugCentral uuid:1935fd20-d20a-11ec-8377-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:193626a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.764']} DrugCentral uuid:19364f3c-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:19367796-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.201']} DrugCentral uuid:19369fd2-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1936c80e-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:19370882-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:19370882-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:19370882-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:19370882-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:19370882-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:19370882-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:19370882-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:1999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 orphenadrine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:193774fc-d20a-11ec-8377-0242ac110003 UniProtKB:P06818 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.83']} DrugCentral uuid:19379d2e-d20a-11ec-8377-0242ac110003 UniProtKB:P16207 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1937c60a-d20a-11ec-8377-0242ac110003 UniProtKB:P03468 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1937ee64-d20a-11ec-8377-0242ac110003 UniProtKB:P03474 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:19381740-d20a-11ec-8377-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:19383f72-d20a-11ec-8377-0242ac110003 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:193867b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q75VQ4 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.81']} DrugCentral uuid:19388ff4-d20a-11ec-8377-0242ac110003 UniProtKB:Q6Q793 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:1938b90c-d20a-11ec-8377-0242ac110003 UniProtKB:A5Z252 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1938e15c-d20a-11ec-8377-0242ac110003 UniProtKB:Q2LFS1 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.31']} DrugCentral uuid:193909ac-d20a-11ec-8377-0242ac110003 UniProtKB:C4LRQ6 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:193931fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q20MD3 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:19395d44-d20a-11ec-8377-0242ac110003 UniProtKB:P03470 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:193988be-d20a-11ec-8377-0242ac110003 UniProtKB:Q194T1 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1939b3fc-d20a-11ec-8377-0242ac110003 UniProtKB:P03469 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.86']} DrugCentral uuid:1939dcba-d20a-11ec-8377-0242ac110003 UniProtKB:Q07599 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:193a0500-d20a-11ec-8377-0242ac110003 UniProtKB:P03471 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.96']} DrugCentral uuid:193a2d50-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XV28 biolink:molecularly_interacts_with DrugCentral:2001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oseltamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:193a558c-d20a-11ec-8377-0242ac110003 UniProtKB:P11172 biolink:molecularly_interacts_with DrugCentral:2002 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oteracil is inhibitor of Enzyme (Uridine 5'-monophosphate synthase) DrugCentral uuid:193a7a62-d20a-11ec-8377-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:2004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ouabain targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.169']} DrugCentral uuid:193aa28a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ouabain targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.009']} DrugCentral uuid:193acad0-d20a-11ec-8377-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ouabain targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:193af000-d20a-11ec-8377-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:2004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ouabain targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:193b1972-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:193b44c4-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:193b6dbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:193b930c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:193bcb24-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:193bcb24-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:193bcb24-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:193bcb24-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:193bcb24-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XDB3 biolink:molecularly_interacts_with DrugCentral:2006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxacillin is inhibitor of Enzyme (Penicillin-binding protein) DrugCentral uuid:193c162e-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxametacin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:193c3e9c-d20a-11ec-8377-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:2008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxametacin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:193c6b9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxametacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:193c6b9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxametacin targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:193c9f04-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2011 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxandrolone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:193cc33a-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxaprozin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:193cecca-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxaprozin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.068']} DrugCentral uuid:193d1682-d20a-11ec-8377-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxaprozin targets GPCR (fMet-Leu-Phe receptor) DrugCentral uuid:193d3ac2-d20a-11ec-8377-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxaprozin is inhibitor of Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:193d6380-d20a-11ec-8377-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxaprozin targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:193d8c02-d20a-11ec-8377-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxaprozin targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:193db452-d20a-11ec-8377-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxaprozin targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:193ddc5c-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxatomide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.056']} DrugCentral uuid:193e048e-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxatomide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.148']} DrugCentral uuid:193e2d60-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxatomide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.203']} DrugCentral uuid:193e55a6-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxatomide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:193e7e00-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxatomide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:193ea736-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxatomide is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:193eda08-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:193eda08-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:193eda08-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:193f1cca-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2017 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxcarbazepine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:193f410a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2026 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphencyclimine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:193f6590-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2026 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphencyclimine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:193f89da-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxprenolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:193fb234-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxprenolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:193fdaca-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxprenolol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:19400392-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxprenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:19402c0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.991']} DrugCentral uuid:19405464-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.589']} DrugCentral uuid:19407cc8-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.298']} DrugCentral uuid:1940a888-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.837']} DrugCentral uuid:1940d3d0-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.09']} DrugCentral uuid:1940fc7a-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:194124ca-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:19414d6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.168']} DrugCentral uuid:194175ba-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:19419df6-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.086']} DrugCentral uuid:1941c6fa-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:1941f120-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1942195c-d20a-11ec-8377-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:194241a2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:19429c2e-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2028 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybutynin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:1942cd70-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:1942fb2e-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:194328a6-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1943556a-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:19438a9e-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1943babe-d20a-11ec-8377-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1943e796-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:19441464-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:19444484-d20a-11ec-8377-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:19447efe-d20a-11ec-8377-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1944b946-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:2029 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycodone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1944f488-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:19452ef8-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.493']} DrugCentral uuid:1945695e-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1945a43c-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:1945deac-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:194618cc-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.111']} DrugCentral uuid:194645a4-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.342']} DrugCentral uuid:19467254-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.019']} DrugCentral uuid:19469ef0-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1946cc0e-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1946f8d2-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:194725aa-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:194752a0-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:19478072-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1947ad40-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.379']} DrugCentral uuid:1947db62-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.21']} DrugCentral uuid:19480b6e-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.162']} DrugCentral uuid:19483846-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.041']} DrugCentral uuid:19486514-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:1948923c-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1948bf0a-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:1948eb7e-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.88']} DrugCentral uuid:19491860-d20a-11ec-8377-0242ac110003 UniProtKB:P18871 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:19494592-d20a-11ec-8377-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:19497242-d20a-11ec-8377-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:1949a79e-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:1949a79e-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:1949a79e-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:1949fb22-d20a-11ec-8377-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1949fb22-d20a-11ec-8377-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1949fb22-d20a-11ec-8377-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:194a4104-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:194a6ed6-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetazoline is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:194a9b72-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2033 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetholone targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:194ac3a4-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2033 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetholone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:194aebd6-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2033 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymetholone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.863']} DrugCentral uuid:194b1926-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.444']} DrugCentral uuid:194b461c-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:194b72fe-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone is agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:194ba2b0-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.01']} DrugCentral uuid:194bcfa6-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:194bfc60-d20a-11ec-8377-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.27']} DrugCentral uuid:194c2988-d20a-11ec-8377-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:194c5656-d20a-11ec-8377-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.09']} DrugCentral uuid:194c831a-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:194cafde-d20a-11ec-8377-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:194ce9ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:194ce9ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:194ce9ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:194ce9ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.89']} DrugCentral uuid:194d4052-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:194d4052-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2034 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxymorphone targets GPCR (Opioid receptors; mu and delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:194d7de2-d20a-11ec-8377-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2036 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenbutazone targets GPCR (fMet-Leu-Phe receptor) DrugCentral uuid:194da5e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q16647 biolink:molecularly_interacts_with DrugCentral:2036 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenbutazone targets Enzyme (Prostacyclin synthase) DrugCentral uuid:194dd27e-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2036 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenbutazone is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:194dd27e-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2036 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenbutazone is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:194e062c-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2036 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenbutazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:194e32d2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenonium is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:194e5afa-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenonium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:194e8318-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyphenonium is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.84']} DrugCentral uuid:194eb004-d20a-11ec-8377-0242ac110003 UniProtKB:P0A7V8 biolink:molecularly_interacts_with DrugCentral:2041 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytetracycline targets Ribosomal protein (30S ribosomal protein S4) DrugCentral uuid:194ed818-d20a-11ec-8377-0242ac110003 UniProtKB:P0A7X3 biolink:molecularly_interacts_with DrugCentral:2041 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytetracycline targets Ribosomal protein (30S ribosomal protein S9) DrugCentral uuid:194f0022-d20a-11ec-8377-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:194f2cb4-d20a-11ec-8377-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:194f5d24-d20a-11ec-8377-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:194f89d4-d20a-11ec-8377-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin is agonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:194fb6a2-d20a-11ec-8377-0242ac110003 UniProtKB:P01178 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin targets Secreted (Oxytocin-neurophysin 1) DrugCentral uuid:194fe01e-d20a-11ec-8377-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:19500cce-d20a-11ec-8377-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:1950397e-d20a-11ec-8377-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:2042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxytocin is agonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:19506624-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ozagrel targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:19509338-d20a-11ec-8377-0242ac110003 UniProtKB:P49430 biolink:molecularly_interacts_with DrugCentral:2043 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ozagrel targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1950bfde-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1950ec84-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:19511aec-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:195147a6-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Transporter (Bile salt export pump) DrugCentral uuid:19516fce-d20a-11ec-8377-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:19519800-d20a-11ec-8377-0242ac110003 UniProtKB:P07437 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Structural (Tubulin beta chain) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1951c5aa-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.621']} DrugCentral uuid:1951f250-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.954']} DrugCentral uuid:19521ee2-d20a-11ec-8377-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.643']} DrugCentral uuid:19524c46-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:195278e2-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.794']} DrugCentral uuid:1952a59c-d20a-11ec-8377-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1952d238-d20a-11ec-8377-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1953028a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13509 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Structural (Tubulin beta-3 chain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:1953328c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC29 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel targets Cytosolic other (Nucleotide-binding oligomerization domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:19538228-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:19538228-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:19538228-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:19538228-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:19538228-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:19538228-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:19538228-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:19538228-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:19538228-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paclitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:19541512-d20a-11ec-8377-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:2045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palmidrol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1954423a-d20a-11ec-8377-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:2045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palmidrol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:19546f08-d20a-11ec-8377-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:2045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palmidrol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:19549ba4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:2045 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palmidrol is agonist of GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1954c994-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palonosetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.5']} DrugCentral uuid:1954faa4-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palonosetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.74']} DrugCentral uuid:1954faa4-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palonosetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.74']} DrugCentral uuid:195533de-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:2047 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pamabrom targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:195560fc-d20a-11ec-8377-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:2048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pamidronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:19558dac-d20a-11ec-8377-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:2048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pamidronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1955ba52-d20a-11ec-8377-0242ac110003 UniProtKB:Q07010 biolink:molecularly_interacts_with DrugCentral:2048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pamidronic acid targets Enzyme (Hypoxanthine-guanine phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1955e716-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2049 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobenzoic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1956145c-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2049 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobenzoic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1956410c-d20a-11ec-8377-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2049 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobenzoic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.45']} DrugCentral uuid:19566dc6-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2049 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobenzoic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:19569be8-d20a-11ec-8377-0242ac110003 UniProtKB:Q81VW8 biolink:molecularly_interacts_with DrugCentral:2049 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobenzoic acid targets Enzyme (Dihydropteroate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.25']} DrugCentral uuid:1956c8ca-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2049 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminobenzoic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1956f548-d20a-11ec-8377-0242ac110003 UniProtKB:P9WNC6 biolink:molecularly_interacts_with DrugCentral:2050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminosalicylic acid targets Kinase (2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase) DrugCentral uuid:19571d52-d20a-11ec-8377-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:2050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminosalicylic acid targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['2.92']} DrugCentral uuid:19574eda-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminosalicylic acid is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:19574eda-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aminosalicylic acid is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:19578a94-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:19578a94-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:19578a94-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:1957d698-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:1957d698-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:19581cfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:19581cfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:19581cfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:19581cfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:195871c0-d20a-11ec-8377-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:195899e8-d20a-11ec-8377-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1958c6c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1958f366-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:19592098-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:19594d52-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:19597e4e-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:19597e4e-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:1959b1f2-d20a-11ec-8377-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:1959e302-d20a-11ec-8377-0242ac110003 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1959e302-d20a-11ec-8377-0242ac110003 UniProtKB:P27112 biolink:molecularly_interacts_with DrugCentral:2054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pantoprazole targets Enzyme (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:195a1c32-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:195a4b6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:195a7b1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:195aa346-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:195ad05a-d20a-11ec-8377-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:195afd0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:195b29a6-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.118']} DrugCentral uuid:195b575a-d20a-11ec-8377-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.088']} DrugCentral uuid:195b8464-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:195bb114-d20a-11ec-8377-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:195bddce-d20a-11ec-8377-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:195c0c0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM07 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Protein-arginine deiminase type-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:195c38aa-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:195c6546-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XSW7 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Cyclic nucleotide phosphodiesterase PDE3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:195c91ec-d20a-11ec-8377-0242ac110003 UniProtKB:O77823 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Cyclic AMP-specific phosphodiesterase SSPDE4A1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:195cbeec-d20a-11ec-8377-0242ac110003 UniProtKB:Q9QYJ6 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:195cf43e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:195cf43e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:195cf43e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:195d3e1c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:195d3e1c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:195d803e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:195d803e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:195d803e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:195dc616-d20a-11ec-8377-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:195df604-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2056 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 papaverine targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:195e2d9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2059 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paramethadione is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:195e2d9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2059 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paramethadione is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:195e2d9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2059 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paramethadione is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:195e6d0a-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 parecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.854']} DrugCentral uuid:195e9a3c-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 parecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:195ec700-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2065 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pargyline is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:195ef4e6-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2065 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pargyline is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:195f21dc-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2065 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pargyline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:195f4ea0-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2065 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pargyline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:195f7b3c-d20a-11ec-8377-0242ac110003 UniProtKB:P11884 biolink:molecularly_interacts_with DrugCentral:2065 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pargyline targets Enzyme (Aldehyde dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:195fa7ec-d20a-11ec-8377-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paricalcitol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:195fd7f8-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:196007f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.647']} DrugCentral uuid:1960368a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.068']} DrugCentral uuid:1960645c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:1960910c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.398']} DrugCentral uuid:1960bdb2-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1960eabc-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1961178a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:1961441c-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.724']} DrugCentral uuid:196170e0-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:19619fc0-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:1961cc84-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.051']} DrugCentral uuid:1961f92a-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:196226a2-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:19625334-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:19627fc6-d20a-11ec-8377-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1962ac58-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1962d958-d20a-11ec-8377-0242ac110003 UniProtKB:P25098 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Kinase (Beta-adrenergic receptor kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:196305ea-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:19633286-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:19636184-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:19638e3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.36']} DrugCentral uuid:1963bb20-d20a-11ec-8377-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1963e7d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:1964155c-d20a-11ec-8377-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:196442c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99571 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Ion channel (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1964781c-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1964781c-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1964781c-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1964c8a8-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1964c8a8-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1964c8a8-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:19650e9e-d20a-11ec-8377-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:19653ce8-d20a-11ec-8377-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:1965698e-d20a-11ec-8377-0242ac110003 UniProtKB:P21146 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Kinase (Beta-adrenergic receptor kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1965963e-d20a-11ec-8377-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:2068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paroxetine targets Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:1965c2d0-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES4 biolink:molecularly_interacts_with DrugCentral:2071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pefloxacin targets Enzyme (DNA gyrase subunit A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.785']} DrugCentral uuid:1965efbc-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pefloxacin targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.097']} DrugCentral uuid:19661c3a-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pefloxacin targets Enzyme (DNA gyrase subunit B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.785']} DrugCentral uuid:196648ea-d20a-11ec-8377-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed is inhibitor of Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.468']} DrugCentral uuid:196675ea-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.181']} DrugCentral uuid:1966a268-d20a-11ec-8377-0242ac110003 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Folylpolyglutamate synthase, mitochondrial) DrugCentral uuid:1966ca72-d20a-11ec-8377-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1966f718-d20a-11ec-8377-0242ac110003 UniProtKB:P34896 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Serine hydroxymethyltransferase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.77']} DrugCentral uuid:19672512-d20a-11ec-8377-0242ac110003 UniProtKB:P14207 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Membrane receptor (Folate receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1967519a-d20a-11ec-8377-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:19677f58-d20a-11ec-8377-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1967ac6c-d20a-11ec-8377-0242ac110003 UniProtKB:P0A884 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1967d8fe-d20a-11ec-8377-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:196805ae-d20a-11ec-8377-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:19683272-d20a-11ec-8377-0242ac110003 UniProtKB:P45352 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:19685f68-d20a-11ec-8377-0242ac110003 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:19688c0e-d20a-11ec-8377-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1968b8b4-d20a-11ec-8377-0242ac110003 UniProtKB:C3SWJ7 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1968e690-d20a-11ec-8377-0242ac110003 UniProtKB:E2QDN0 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Enzyme (Thymidylate synthase (EC 2.1.1.45) (TS) (TSase)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1969132c-d20a-11ec-8377-0242ac110003 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.86']} DrugCentral uuid:19693fb4-d20a-11ec-8377-0242ac110003 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:19696c46-d20a-11ec-8377-0242ac110003 UniProtKB:Q64737 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed is inhibitor of Enzyme (Trifunctional purine biosynthetic protein adenosine-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:19699982-d20a-11ec-8377-0242ac110003 UniProtKB:P22102 biolink:molecularly_interacts_with DrugCentral:2073 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemetrexed is inhibitor of Enzyme (Trifunctional purine biosynthetic protein adenosine-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1969c646-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2075 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemoline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:1969f300-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penbutolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:196a203c-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penbutolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:196a4ce2-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penbutolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:196a7974-d20a-11ec-8377-0242ac110003 UniProtKB:P02763 biolink:molecularly_interacts_with DrugCentral:2078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penbutolol targets Secreted (Alpha-1-acid glycoprotein 1) DrugCentral uuid:196aa17e-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penbutolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:196ad1ee-d20a-11ec-8377-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2079 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:196afaa2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:2079 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penciclovir targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:196b2748-d20a-11ec-8377-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:2079 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penciclovir targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:196b54a2-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:196b8170-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.83']} DrugCentral uuid:196bae52-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:196bdb16-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.45']} DrugCentral uuid:196c0942-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:196c3606-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:196c62b6-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.682']} DrugCentral uuid:196c90f6-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:196cbebe-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:196ceb78-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:196d181e-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:196d45aa-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:196d725a-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:196d9f3c-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:196dcc64-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:196df93c-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:196e25f6-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:196e52ce-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:196e8302-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:196eafc6-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:196edc8a-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:196f1b32-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:196f1b32-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:196f1b32-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:196f1b32-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:196f1b32-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penfluridol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:196f79b0-d20a-11ec-8377-0242ac110003 UniProtKB:P44514 biolink:molecularly_interacts_with DrugCentral:2081 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 penicillamine targets Enzyme (Succinyl-diaminopimelate desuccinylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:196fa782-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:196fcf96-d20a-11ec-8377-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:196ffc5a-d20a-11ec-8377-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:19704520-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19704520-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19704520-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19704520-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19704520-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19704520-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19704520-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1970b046-d20a-11ec-8377-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylpenicillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1970ddb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:19711f9a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19711f9a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19711f9a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19711f9a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19711f9a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19711f9a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19711f9a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxymethylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19718a7a-d20a-11ec-8377-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:2088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentagastrin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:1971b73e-d20a-11ec-8377-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:2088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentagastrin targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1971e3e4-d20a-11ec-8377-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:2088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentagastrin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:19721292-d20a-11ec-8377-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:2088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentagastrin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:19723fce-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.287']} DrugCentral uuid:19726c7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:19729942-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.658']} DrugCentral uuid:1972c6ba-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1972f360-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.765']} DrugCentral uuid:1973201a-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.867']} DrugCentral uuid:19734d42-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.295']} DrugCentral uuid:197379f2-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.658']} DrugCentral uuid:1973a7b0-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.683']} DrugCentral uuid:1973d460-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:197403c2-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.309']} DrugCentral uuid:19743090-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.101']} DrugCentral uuid:19745d4a-d20a-11ec-8377-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:19748a9a-d20a-11ec-8377-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1974b754-d20a-11ec-8377-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:1974e3f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:1975112c-d20a-11ec-8377-0242ac110003 UniProtKB:P04271 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Cytosolic other (Protein S100-B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:19753e04-d20a-11ec-8377-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:19756abe-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:19759750-d20a-11ec-8377-0242ac110003 UniProtKB:P19801 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Amiloride-sensitive amine oxidase [copper-containing]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1975c630-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.272']} DrugCentral uuid:1975f2e0-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:19761f90-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:19764ccc-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:19767972-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1976a5fa-d20a-11ec-8377-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1976ecb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:1976ecb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:1976ecb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:1976ecb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:1976ecb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:1976ecb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:1976ecb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19776986-d20a-11ec-8377-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:19776986-d20a-11ec-8377-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1977a77a-d20a-11ec-8377-0242ac110003 UniProtKB:P21673 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Spermidine/spermine N(1)-acetyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1977d736-d20a-11ec-8377-0242ac110003 UniProtKB:O75365 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Protein-tyrosine phosphatase 4A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:19780422-d20a-11ec-8377-0242ac110003 UniProtKB:P08001 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Acrosin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:19783122-d20a-11ec-8377-0242ac110003 UniProtKB:P04631 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Unclassified (Protein S100-B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.36']} DrugCentral uuid:19785dfa-d20a-11ec-8377-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:19788aa0-d20a-11ec-8377-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1978b728-d20a-11ec-8377-0242ac110003 UniProtKB:Q12974 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Protein tyrosine phosphatase type IVA 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1978e428-d20a-11ec-8377-0242ac110003 UniProtKB:Q93096 biolink:molecularly_interacts_with DrugCentral:2090 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentamidine targets Enzyme (Protein tyrosine phosphatase type IVA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:197910ec-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:19793d9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.553']} DrugCentral uuid:19797460-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:19797460-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:19797460-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1979faac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:197aee12-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:197aee12-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:197aee12-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentobarbital targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:197b355c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GZZ6 biolink:molecularly_interacts_with DrugCentral:2096 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentolonium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-10) DrugCentral uuid:197b61e4-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2096 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentolonium is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:197b61e4-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2096 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentolonium is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:197b9524-d20a-11ec-8377-0242ac110003 UniProtKB:P00813 biolink:molecularly_interacts_with DrugCentral:2098 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentostatin is inhibitor of Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.8']} DrugCentral uuid:197bc1de-d20a-11ec-8377-0242ac110003 UniProtKB:P56658 biolink:molecularly_interacts_with DrugCentral:2098 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentostatin targets Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:197bef2e-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:2099 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxifylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:197c1c06-d20a-11ec-8377-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:2099 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxifylline is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) DrugCentral uuid:197c442e-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2099 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxifylline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:197c711a-d20a-11ec-8377-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2099 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentoxifylline is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) DrugCentral uuid:197c992e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:197cc5ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:197cf266-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:197d21b4-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:197d4e28-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:197d7ab0-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:197da7b0-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:197dd546-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:197e01ec-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:197e2e92-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:197e5b9c-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:197e8842-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:197eb4de-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:197ee332-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:197f0fec-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:197f3c88-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:197f69ce-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:197f9714-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:197fc3ba-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.838']} DrugCentral uuid:197ff1dc-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.398']} DrugCentral uuid:19801f0e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:19804bb4-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1980785a-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1980a4d8-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1980d264-d20a-11ec-8377-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:1980ff0a-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:19812bb0-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:19816184-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:19816184-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:19816184-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:1981ab62-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1981ab62-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1981f61c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:1981f61c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:1981f61c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:1981f61c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:1981f61c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.51']} DrugCentral uuid:19825a62-d20a-11ec-8377-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:19825a62-d20a-11ec-8377-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide targets GPCR (Cerebral cortex alpha adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.39']} DrugCentral uuid:19829662-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1982c68c-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pergolide is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1982f4f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.962']} DrugCentral uuid:19832262-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:19834efe-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.486']} DrugCentral uuid:19837bb8-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.185']} DrugCentral uuid:1983a854-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1983d57c-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1984022c-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.105']} DrugCentral uuid:19842edc-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.027']} DrugCentral uuid:19845cfe-d20a-11ec-8377-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:19848756-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.356']} DrugCentral uuid:1984b410-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) DrugCentral uuid:1984dc1a-d20a-11ec-8377-0242ac110003 UniProtKB:P50416 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Enzyme (Carnitine O-palmitoyltransferase 1, liver isoform) DrugCentral uuid:198504e2-d20a-11ec-8377-0242ac110003 UniProtKB:P23786 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Enzyme (Carnitine O-palmitoyltransferase 2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:19853174-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.828']} DrugCentral uuid:19855e24-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.391']} DrugCentral uuid:19858caa-d20a-11ec-8377-0242ac110003 UniProtKB:Q63704 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Enzyme (Carnitine O-palmitoyltransferase 1, muscle isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1985c1b6-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1985c1b6-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1985c1b6-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:19860888-d20a-11ec-8377-0242ac110003 UniProtKB:P18886 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Enzyme (Carnitine palmitoyltransferase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:198637a4-d20a-11ec-8377-0242ac110003 UniProtKB:P32198 biolink:molecularly_interacts_with DrugCentral:2106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perhexiline targets Enzyme (Carnitine palmitoyltransferase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:19866788-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2107 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 periciazine is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:19869708-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2107 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 periciazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1986c46c-d20a-11ec-8377-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2107 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 periciazine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1986f108-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2107 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 periciazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:19871da4-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2108 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perindopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:19874a2c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perlapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.222']} DrugCentral uuid:19877736-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perlapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.704']} DrugCentral uuid:1987a3c8-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perlapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.824']} DrugCentral uuid:1987d06e-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perlapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:19881772-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perlapine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:19885192-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perlapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:19887e42-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perlapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1988ab74-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perospirone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1988d810-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perospirone is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:198904d4-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perospirone is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:1989317a-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perospirone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:19895e7a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.32']} DrugCentral uuid:19898b3e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1989b7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.462']} DrugCentral uuid:1989e674-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:198a1306-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.252']} DrugCentral uuid:198a40e2-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.879']} DrugCentral uuid:198a6e00-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:198a9a9c-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:198ac742-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:198af3de-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:198b20fc-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.521']} DrugCentral uuid:198b4dac-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.088']} DrugCentral uuid:198b7a52-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.733']} DrugCentral uuid:198ba82e-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.481']} DrugCentral uuid:198bd4a2-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:198c015c-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.588']} DrugCentral uuid:198c2f4c-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:198c5c7e-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:198c8942-d20a-11ec-8377-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perphenazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:198cb5e8-d20a-11ec-8377-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenacemide is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:198cdec4-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenacetin targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:198d06d8-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:198d33b0-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazocine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:198d6060-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazocine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:198d8e64-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:2119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:198dbaf6-d20a-11ec-8377-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:2119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:198e0e02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:198e0e02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:198e0e02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:198e0e02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:198e0e02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:198e0e02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:198e0e02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:198e0e02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:198e0e02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:198e0e02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:198e9a84-d20a-11ec-8377-0242ac110003 UniProtKB:P83512 biolink:molecularly_interacts_with DrugCentral:2120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenazopyridine targets Enzyme (Snake venom metalloproteinase Bap1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:198ec8ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:198ef5ba-d20a-11ec-8377-0242ac110003 UniProtKB:P42785 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Enzyme (Lysosomal Pro-X carboxypeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:198f226a-d20a-11ec-8377-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:198f5046-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:198f7cec-d20a-11ec-8377-0242ac110003 UniProtKB:Q00961 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate receptor ionotropic, NMDA 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:198fa99c-d20a-11ec-8377-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:198fd66a-d20a-11ec-8377-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:19901dfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:19901dfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:19901dfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:19901dfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:19901dfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:19901dfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:19901dfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1990afc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:1990afc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:1990afc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:1990afc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:1990afc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:1990afc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:1990afc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:19912fb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:19912fb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:19916d22-d20a-11ec-8377-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:19916d22-d20a-11ec-8377-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1991b750-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1991b750-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1991b750-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1991b750-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1991b750-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2121 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phencyclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:19921682-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phendimetrazine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:19923ea0-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phendimetrazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.9']} DrugCentral uuid:19926bc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phendimetrazine is inhibitor of Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:1992940e-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:1992c0aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.076']} DrugCentral uuid:1992ed82-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:19931d98-d20a-11ec-8377-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine is inhibitor of Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:19934a7a-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:19937716-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1993a484-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.836']} DrugCentral uuid:1993d12a-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:1993fdc6-d20a-11ec-8377-0242ac110003 UniProtKB:Q16853 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Membrane primary amine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:19942a44-d20a-11ec-8377-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19945762-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:199483d6-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1994b05e-d20a-11ec-8377-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1994e006-d20a-11ec-8377-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenelzine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:19950c7a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y478 biolink:molecularly_interacts_with DrugCentral:2126 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenformin targets Kinase (5'-AMP-activated protein kinase subunit beta-1) DrugCentral uuid:19953506-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2129 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenindamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:199561ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:2130 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenindione is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) DrugCentral uuid:19958a88-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2130 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenindione targets Enzyme (Prothrombin) DrugCentral uuid:1995b2b0-d20a-11ec-8377-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:2130 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1995df56-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2131 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pheniprazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:19960922-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2131 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pheniprazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:1996314a-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pheniramine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:19965972-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pheniramine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.378']} DrugCentral uuid:19968ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:19968ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:19968ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2132 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pheniramine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:1996d6d6-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenmetrazine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.298']} DrugCentral uuid:19970372-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenmetrazine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.883']} DrugCentral uuid:19972ff0-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenmetrazine targets Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:199758ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:199780c2-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:1997b146-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1997b146-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1997b146-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1997f84a-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1997f84a-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1997f84a-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenobarbital targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:19983e0e-d20a-11ec-8377-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:2135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:19986ac8-d20a-11ec-8377-0242ac110003 UniProtKB:P0A884 biolink:molecularly_interacts_with DrugCentral:2135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:19989b1a-d20a-11ec-8377-0242ac110003 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:2135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1998cc5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q834R3 biolink:molecularly_interacts_with DrugCentral:2135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenolphthalein targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1998fc72-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:19992b52-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:199957f8-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.456']} DrugCentral uuid:199984a8-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1999c300-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1999c300-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1999c300-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1999c300-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1999c300-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:199a2a0c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:199a2a0c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:199a2a0c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:199a7cbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:199a7cbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:199a7cbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2136 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenoxybenzamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:199ac390-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenprocoumon targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:199af0f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q6TEK4 biolink:molecularly_interacts_with DrugCentral:2138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenprocoumon targets Unclassified (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:199b1dae-d20a-11ec-8377-0242ac110003 UniProtKB:Q6TEK4 biolink:molecularly_interacts_with DrugCentral:2138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenprocoumon targets Unclassified (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:199b4a72-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:2138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenprocoumon is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.745']} DrugCentral uuid:199b7fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2139 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phensuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:199b7fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2139 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phensuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:199b7fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2139 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phensuximide is blocker of Ion channel (Voltage-gated T-type calcium channel) DrugCentral uuid:199bbe8a-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2140 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentermine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:199be6b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2140 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentermine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.801']} DrugCentral uuid:199c1470-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:199c4490-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:199c7410-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.784']} DrugCentral uuid:199ca0a2-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.667']} DrugCentral uuid:199ccde8-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.609']} DrugCentral uuid:199cfaa2-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.616']} DrugCentral uuid:199d2752-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.684']} DrugCentral uuid:199d54b6-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:199d8224-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:199daee8-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:199ddbb6-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:199e0af0-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:199e3b4c-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.71']} DrugCentral uuid:199e6a9a-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:199e983a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.94']} DrugCentral uuid:199ec51c-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:199ef1d6-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:199f1e9a-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:199f4bb8-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:199f7886-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:199fa536-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:199fd31c-d20a-11ec-8377-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.03']} DrugCentral uuid:199fffd6-d20a-11ec-8377-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:19a0350a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:19a0350a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:19a0350a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:19a08596-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:19a08596-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:19a08596-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phentolamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:19a0ccc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:2144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylalanine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:19a0f95e-d20a-11ec-8377-0242ac110003 UniProtKB:O08532 biolink:molecularly_interacts_with DrugCentral:2144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylalanine targets Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:19a1269a-d20a-11ec-8377-0242ac110003 UniProtKB:Q63016 biolink:molecularly_interacts_with DrugCentral:2144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylalanine targets Transporter (L-type amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:19a15354-d20a-11ec-8377-0242ac110003 UniProtKB:P19111 biolink:molecularly_interacts_with DrugCentral:2144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylalanine targets Enzyme (Intestinal alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:19a18004-d20a-11ec-8377-0242ac110003 UniProtKB:Q6DWJ6 biolink:molecularly_interacts_with DrugCentral:2144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylalanine is agonist of GPCR (Probable G-protein coupled receptor 139) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:19a1aec6-d20a-11ec-8377-0242ac110003 UniProtKB:P09923 biolink:molecularly_interacts_with DrugCentral:2144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylalanine targets Enzyme (Intestinal-type alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:19a1dfd6-d20a-11ec-8377-0242ac110003 UniProtKB:P98170 biolink:molecularly_interacts_with DrugCentral:2144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylalanine targets Unclassified (E3 ubiquitin-protein ligase XIAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:19a20d44-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:19a23a8a-d20a-11ec-8377-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone targets GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:19a26726-d20a-11ec-8377-0242ac110003 UniProtKB:Q16647 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone targets Enzyme (Prostacyclin synthase) DrugCentral uuid:19a28f26-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:19a2bbcc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8SPQ9 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone targets Enzyme (Cyclooxygenase 2; Prostaglandin G/H synthase-2; Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:19a2ed5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:19a2ed5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:19a32670-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2145 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylbutazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:19a35320-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:19a380de-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:19a3ad7a-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:19a3da34-d20a-11ec-8377-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:19a406e4-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:19a43416-d20a-11ec-8377-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:19a46a6c-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:19a46a6c-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:19a46a6c-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:19a4b9f4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:19a4b9f4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:19a4b9f4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:19a5085a-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:19a5085a-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:19a5085a-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:19a54f86-d20a-11ec-8377-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:2146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylephrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:19a57c4a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:19a5a8fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:19a5d12c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:19a5fe40-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.155']} DrugCentral uuid:19a62af0-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine is agonist of GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:19a65430-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.398']} DrugCentral uuid:19a681a8-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.171']} DrugCentral uuid:19a6ae62-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.577']} DrugCentral uuid:19a6db12-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.166']} DrugCentral uuid:19a707fe-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:19a7363e-d20a-11ec-8377-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:19a76302-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:19a78fd0-d20a-11ec-8377-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylpropanolamine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:19a7bcee-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenyltoloxamine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:19a7e9a8-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenyltoloxamine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:19a81752-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenyltoloxamine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:19a84416-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenyltoloxamine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:19a871b6-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenyltoloxamine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:19a899d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:19a8c1f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:19a8eaba-d20a-11ec-8377-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:19a91684-d20a-11ec-8377-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:19a9437a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:19a96bb6-d20a-11ec-8377-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:19a998d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:19a9c0fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:19a9e92e-d20a-11ec-8377-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:19aa1e76-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19aa1e76-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19aa1e76-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenytoin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19aa64f8-d20a-11ec-8377-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:2153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phloroglucinol targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:19aa95d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:19aa95d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:19aad9e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:19aad9e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:19aad9e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxagrelate targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:19ab230c-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:19ab4fa8-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.37']} DrugCentral uuid:19ab7cb2-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:19aba96c-d20a-11ec-8377-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:19abd5fe-d20a-11ec-8377-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.17']} DrugCentral uuid:19ac04c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:19ac3288-d20a-11ec-8377-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.17']} DrugCentral uuid:19ac5f42-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.47']} DrugCentral uuid:19ac8c10-d20a-11ec-8377-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:19acba32-d20a-11ec-8377-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:19ace6c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:19ad1360-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:19ad4074-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:19ad6d2e-d20a-11ec-8377-0242ac110003 UniProtKB:P36196 biolink:molecularly_interacts_with DrugCentral:2159 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 physostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:19ad99d4-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin is blocker of Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:19adc68e-d20a-11ec-8377-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin is blocker of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:19adf3d4-d20a-11ec-8377-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin is blocker of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:19ae207a-d20a-11ec-8377-0242ac110003 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin is blocker of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19ae90aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotoxin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:19af7b0a-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotin targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:19afa814-d20a-11ec-8377-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:2163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotin is blocker of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:19afd4e2-d20a-11ec-8377-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:2163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotin is blocker of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:19b0021e-d20a-11ec-8377-0242ac110003 UniProtKB:O75311 biolink:molecularly_interacts_with DrugCentral:2163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picrotin targets Ion channel (Glycine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:19b02eb0-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:19b0593a-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piketoprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:19b081bc-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:19b0ae62-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:19b0db26-d20a-11ec-8377-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:19b1086c-d20a-11ec-8377-0242ac110003 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:19b14782-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:19b14782-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:19b14782-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:19b14782-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:19b14782-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:19b1a6c8-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:19b1d36e-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:19b20000-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:19b22efe-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:19b25bb8-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilocarpine is agonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:19b2884a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilsicainide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:19b2b6d0-d20a-11ec-8377-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:2167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pilsicainide is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.377']} DrugCentral uuid:19b2e358-d20a-11ec-8377-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:2168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimecrolimus targets Cytokine (Interleukin-5) DrugCentral uuid:19b30b3a-d20a-11ec-8377-0242ac110003 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:2168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimecrolimus targets Cytokine (Interferon gamma) DrugCentral uuid:19b3339e-d20a-11ec-8377-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimecrolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:19b360a8-d20a-11ec-8377-0242ac110003 UniProtKB:P60568 biolink:molecularly_interacts_with DrugCentral:2168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimecrolimus targets Cytokine (Interleukin-2) DrugCentral uuid:19b388bc-d20a-11ec-8377-0242ac110003 UniProtKB:P48454 biolink:molecularly_interacts_with DrugCentral:2168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimecrolimus targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform) DrugCentral uuid:19b3b10c-d20a-11ec-8377-0242ac110003 UniProtKB:Q62658 biolink:molecularly_interacts_with DrugCentral:2168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimecrolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:19b3ddd0-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimethixene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:19b40c24-d20a-11ec-8377-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimethixene targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:19b438c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WTS6 biolink:molecularly_interacts_with DrugCentral:2169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimethixene targets Enzyme (Histone-lysine N-methyltransferase SETD7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:19b46566-d20a-11ec-8377-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:2171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimobendan targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:19b49720-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimobendan is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:19b49720-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimobendan is inhibitor of Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:19b4d06e-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:19b4fd1e-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.862']} DrugCentral uuid:19b52a3c-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.798']} DrugCentral uuid:19b55700-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.842']} DrugCentral uuid:19b5839c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:19b5b038-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.538']} DrugCentral uuid:19b5de50-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.63']} DrugCentral uuid:19b60af6-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.559']} DrugCentral uuid:19b63792-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.058']} DrugCentral uuid:19b66500-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.149']} DrugCentral uuid:19b69192-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.301']} DrugCentral uuid:19b6be2e-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.704']} DrugCentral uuid:19b6eb6a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.086']} DrugCentral uuid:19b71aae-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:19b7474a-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:19b7742c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:19b7a212-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.709']} DrugCentral uuid:19b7ceb8-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:19b7fb7c-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.424']} DrugCentral uuid:19b8282c-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:19b8557c-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:19b88204-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:19b8ae78-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:19b8db46-d20a-11ec-8377-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:19b9105c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:19b9105c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:19b9105c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:19b955f8-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:19b984e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0X4 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1I) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:19b9b188-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:19b9de10-d20a-11ec-8377-0242ac110003 UniProtKB:Q16322 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:19ba0b74-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:19ba3838-d20a-11ec-8377-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:19ba64ca-d20a-11ec-8377-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:19ba9152-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:19babe5c-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:19bafbf6-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:19bafbf6-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:19bafbf6-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:19bafbf6-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:19bafbf6-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:19bb5ea2-d20a-11ec-8377-0242ac110003 UniProtKB:O94782 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide targets Enzyme (Ubiquitin carboxyl-terminal hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:19bb8b8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9EQ60 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:19bbb85c-d20a-11ec-8377-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:19bbe660-d20a-11ec-8377-0242ac110003 UniProtKB:O54898 biolink:molecularly_interacts_with DrugCentral:2172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimozide is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:19bc132e-d20a-11ec-8377-0242ac110003 UniProtKB:O60706 biolink:molecularly_interacts_with DrugCentral:2173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pinacidil targets Ion channel (ATP-binding cassette sub-family C member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:19bc3fc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q12791 biolink:molecularly_interacts_with DrugCentral:2173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pinacidil targets Ion channel (Calcium-activated potassium channel subunit alpha-1) DrugCentral uuid:19bc6c70-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pinacidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:19bc6c70-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pinacidil is opener of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:19bca636-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol is partial agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:19bcd2fa-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol is partial agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:19bd00ea-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:19bd306a-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:19bd609e-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:19bd90d2-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.27']} DrugCentral uuid:19bdbe90-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.78']} DrugCentral uuid:19bdeb2c-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:19be17d2-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.209']} DrugCentral uuid:19be4478-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:19be7196-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:19beab98-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:19beab98-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:19beab98-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:19beab98-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:19bf0930-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:19bf0930-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:19bf0930-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pindolol targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:19bf4f08-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.943']} DrugCentral uuid:19bf7b90-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:19bfa8d6-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:19bfd5ae-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.455']} DrugCentral uuid:19c0025e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:19c02f5e-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:19c05bfa-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.879']} DrugCentral uuid:19c08882-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:19c0b546-d20a-11ec-8377-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Transcription factor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:19c0e2c8-d20a-11ec-8377-0242ac110003 UniProtKB:P37238 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Transcription factor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:19c10f82-d20a-11ec-8377-0242ac110003 UniProtKB:O88275 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Transcription factor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:19c13c3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:19c1695a-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:19c1960a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:19c1c2b0-d20a-11ec-8377-0242ac110003 UniProtKB:B0K020 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:19c1ef42-d20a-11ec-8377-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:19c21c74-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N5K1 biolink:molecularly_interacts_with DrugCentral:2179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pioglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:19c24910-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:19c275c0-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.87']} DrugCentral uuid:19c2a32e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:19c2d0ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:19c2fdb0-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.461']} DrugCentral uuid:19c32bdc-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.351']} DrugCentral uuid:19c35968-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.992']} DrugCentral uuid:19c38672-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.256']} DrugCentral uuid:19c3b340-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.509']} DrugCentral uuid:19c3e068-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:19c40d18-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:19c439dc-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.105']} DrugCentral uuid:19c46722-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.799']} DrugCentral uuid:19c495d0-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.939']} DrugCentral uuid:19c4c302-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:19c4efc6-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.189']} DrugCentral uuid:19c51d02-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:19c54994-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:19c57658-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.848']} DrugCentral uuid:19c5a3ee-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.864']} DrugCentral uuid:19c5d0a8-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.429']} DrugCentral uuid:19c5fd58-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:19c629d6-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:19c6573a-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:19c683d6-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:19c6b072-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:19c6dd86-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.066']} DrugCentral uuid:19c70a36-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:19c737ea-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:19c764c2-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.324']} DrugCentral uuid:19c79230-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.644']} DrugCentral uuid:19c7bef4-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:19c7ebae-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.602']} DrugCentral uuid:19c81980-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:19c8463a-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:19c87312-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:19c89fd6-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.538']} DrugCentral uuid:19c8ccfe-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:19c8f9ae-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipamperone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:19c92adc-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:19c92adc-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:19c9674a-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:19c9674a-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:19c9674a-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:19c9ab10-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:19c9ab10-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:19c9e292-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:19c9e292-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:19ca1938-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:19ca412e-d20a-11ec-8377-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:19ca6dca-d20a-11ec-8377-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:19cab474-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19cab474-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19cab474-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19cab474-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19cab474-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19cab474-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19cab474-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperacillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:19cb1ffe-d20a-11ec-8377-0242ac110003 UniProtKB:O18276 biolink:molecularly_interacts_with DrugCentral:2188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperazine targets Ion channel (Gamma-aminobutyric acid receptor subunit beta) DrugCentral uuid:19cb48e4-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipotiazine palmitate is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.699']} DrugCentral uuid:19cb75a8-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2193 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pipotiazine palmitate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.553']} DrugCentral uuid:19cba280-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2199 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirbuterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:19cbcbde-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:19cbf88e-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:19cc2552-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:19cc51e4-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:19cc7f16-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:19ccabda-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:19ccd88a-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:19cd068e-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:19cd3352-d20a-11ec-8377-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:19cd5ff8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WMX0 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:19cd8cbc-d20a-11ec-8377-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:19cdba20-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VH26 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:19cde6f8-d20a-11ec-8377-0242ac110003 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:19ce24e2-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:19ce24e2-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:19ce24e2-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:19ce24e2-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:19ce24e2-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:19ce9684-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:19ce9684-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:19ce9684-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:19ce9684-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:19ce9684-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2200 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirenzepine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:19cef700-d20a-11ec-8377-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:2201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piretanide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:19cf23c4-d20a-11ec-8377-0242ac110003 UniProtKB:P55011 biolink:molecularly_interacts_with DrugCentral:2201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piretanide is inhibitor of Transporter (Solute carrier family 12 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:19cf5056-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:19cf7dd8-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:19cfaa7e-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:19cfd76a-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:19d004ce-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:19d0317e-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:19d05e24-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:19d08ae8-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:19d0b7f2-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:19d0e4ac-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:19d1115c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piribedil is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:19d13f60-d20a-11ec-8377-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:2206 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:19d16f44-d20a-11ec-8377-0242ac110003 UniProtKB:P28347 biolink:molecularly_interacts_with DrugCentral:2206 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.92']} DrugCentral uuid:19d19f46-d20a-11ec-8377-0242ac110003 UniProtKB:Q15561 biolink:molecularly_interacts_with DrugCentral:2206 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:19d1cbf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q15562 biolink:molecularly_interacts_with DrugCentral:2206 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:19d1f964-d20a-11ec-8377-0242ac110003 UniProtKB:Q99594 biolink:molecularly_interacts_with DrugCentral:2206 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirlindole targets Transcription factor (Transcriptional enhancer factor TEF-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:19d22614-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2206 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirlindole is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:19d252ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirmenol targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:19d27b3c-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piroxicam is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:19d2a800-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piroxicam is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:19d2d49c-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piroxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:19d30688-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:19d30688-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:19d349cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:19d349cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piroxicam targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:19d38310-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2213 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirprofen targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:19d3abd8-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2213 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pirprofen targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:19d3d446-d20a-11ec-8377-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitavastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.168']} DrugCentral uuid:19d4018c-d20a-11ec-8377-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitavastatin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.88']} DrugCentral uuid:19d42e46-d20a-11ec-8377-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitavastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:19d45c86-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pizotifen targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:19d48954-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pizotifen is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:19d4b618-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:19d4e3f4-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:19d510ae-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:19d53d72-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pizotifen targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:19d56a2c-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pizotifen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:19d597ae-d20a-11ec-8377-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:2228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polythiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['9.09']} DrugCentral uuid:19d5c45e-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralidoxime is activator of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.59']} DrugCentral uuid:19d5f0fa-d20a-11ec-8377-0242ac110003 UniProtKB:O08725 biolink:molecularly_interacts_with DrugCentral:2232 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralmorelin is agonist of GPCR (Growth hormone secretagogue receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:19d61e40-d20a-11ec-8377-0242ac110003 UniProtKB:Q92847 biolink:molecularly_interacts_with DrugCentral:2232 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralmorelin is agonist of GPCR (Growth hormone secretagogue receptor type 1) DrugCentral uuid:19d6465e-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:19d67318-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:19d69fa0-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.121']} DrugCentral uuid:19d6ce58-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:19d6fb1c-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:19d727ae-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.925']} DrugCentral uuid:19d7562a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:19d7830c-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.668']} DrugCentral uuid:19d7af80-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.571']} DrugCentral uuid:19d7dc62-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.455']} DrugCentral uuid:19d8096c-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:19d83612-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.282']} DrugCentral uuid:19d862cc-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:19d890bc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:19d8bda8-d20a-11ec-8377-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:19d8ea6c-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramipexole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:19d91b72-d20a-11ec-8377-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:19d91b72-d20a-11ec-8377-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:19d98472-d20a-11ec-8377-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:19d98472-d20a-11ec-8377-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.45']} DrugCentral uuid:19d9f560-d20a-11ec-8377-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:19d9f560-d20a-11ec-8377-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramlintide is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:19da5d52-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranlukast targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:19daaee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:2237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:19db0090-d20a-11ec-8377-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:2237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranlukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:19db2d5e-d20a-11ec-8377-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:2237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranlukast targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:19db5b44-d20a-11ec-8377-0242ac110003 UniProtKB:Q13304 biolink:molecularly_interacts_with DrugCentral:2237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranlukast targets GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:19db888a-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranlukast targets Nuclear other (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:19dbb59e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:2237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:19dbe230-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2238 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranoprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:19dc0eae-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2238 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pranoprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:19dc3cee-d20a-11ec-8377-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pravastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:19dc698a-d20a-11ec-8377-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pravastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:19dc961c-d20a-11ec-8377-0242ac110003 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:2239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pravastatin targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:19dccb64-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:19dccb64-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:19dccb64-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:19dd0eda-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 praziquantel targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:19dd3b3a-d20a-11ec-8377-0242ac110003 UniProtKB:P08515 biolink:molecularly_interacts_with DrugCentral:2241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 praziquantel targets Enzyme (Glutathione S-transferase class-mu 26 kDa isozyme) DrugCentral uuid:19dd636c-d20a-11ec-8377-0242ac110003 UniProtKB:Q95US7 biolink:molecularly_interacts_with DrugCentral:2241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 praziquantel is blocker of Ion channel (High voltage-activated calcium channel beta subunit CavB1) DrugCentral uuid:19dd8c20-d20a-11ec-8377-0242ac110003 UniProtKB:Q962H3 biolink:molecularly_interacts_with DrugCentral:2241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 praziquantel is blocker of Ion channel (High voltage-activated calcium channel beta subunit CavB2) DrugCentral uuid:19ddb452-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2243 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednicarbate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:19dddc84-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:19de0970-d20a-11ec-8377-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Cytosolic other (Annexin A1) DrugCentral uuid:19de31ac-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:19de5e5c-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:19de8af8-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:19deb97e-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:19dee624-d20a-11ec-8377-0242ac110003 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Cytokine (Interleukin-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:19df12b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:19df3f70-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:19df6c52-d20a-11ec-8377-0242ac110003 UniProtKB:P15104 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Enzyme (Glutamine synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:19df98ee-d20a-11ec-8377-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:19dfc56c-d20a-11ec-8377-0242ac110003 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:19dff2b2-d20a-11ec-8377-0242ac110003 UniProtKB:P78536 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Unclassified (Disintegrin and metalloproteinase domain-containing protein 17) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:19e01f4e-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:19e04c12-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:19e075d4-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.28']} DrugCentral uuid:19e0a64e-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:19e0d63c-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:19e10314-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:19e130be-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:19e15dd2-d20a-11ec-8377-0242ac110003 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Cytokine (Interleukin-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.38']} DrugCentral uuid:19e18ba4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:19e1b912-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:19e1e5ae-d20a-11ec-8377-0242ac110003 UniProtKB:P15104 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Enzyme (Glutamine synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:19e21236-d20a-11ec-8377-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:19e23ebe-d20a-11ec-8377-0242ac110003 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:19e26ed4-d20a-11ec-8377-0242ac110003 UniProtKB:P78536 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Unclassified (Disintegrin and metalloproteinase domain-containing protein 17) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:19e29bfc-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone tebutate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:19e2c88e-d20a-11ec-8377-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2253 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisone targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.772']} DrugCentral uuid:19e2f5ac-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2253 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:19e32216-d20a-11ec-8377-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2253 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisone targets Cytosolic other (Annexin A1) DrugCentral uuid:19e34a20-d20a-11ec-8377-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:2255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pregabalin targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.801']} DrugCentral uuid:19e376a8-d20a-11ec-8377-0242ac110003 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:2255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pregabalin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:19e3a40c-d20a-11ec-8377-0242ac110003 UniProtKB:O77773 biolink:molecularly_interacts_with DrugCentral:2255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pregabalin targets Ion channel (Uncharacterized protein; Voltage-dependent calcium channel alpha-2 delta subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:19e3d0d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY47 biolink:molecularly_interacts_with DrugCentral:2255 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pregabalin is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:19e3fd4e-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pregnenolone succinate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:19e42b48-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:2256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pregnenolone succinate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.15']} DrugCentral uuid:19e45ba4-d20a-11ec-8377-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:2256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pregnenolone succinate targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:19e48836-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenalterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:19e4b5e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenalterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.97']} DrugCentral uuid:19e4eba0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenylamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:19e4eba0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenylamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:19e4eba0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenylamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:19e539c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenylamine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:19e539c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenylamine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:19e539c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenylamine targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:19e58056-d20a-11ec-8377-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:2261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prenylamine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:19e5acfc-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2263 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:19e5d998-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2263 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:19e60814-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2263 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.194']} DrugCentral uuid:19e6371c-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2263 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:19e663c2-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2263 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pridinol targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.799']} DrugCentral uuid:19e69996-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prilocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:19e69996-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prilocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:19e69996-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prilocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:19e6dfbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.668']} DrugCentral uuid:19e70c5a-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.075']} DrugCentral uuid:19e739a0-d20a-11ec-8377-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:19e76312-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:19e78f90-d20a-11ec-8377-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:19e7bc0e-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.739']} DrugCentral uuid:19e7eac6-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:19e81726-d20a-11ec-8377-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:19e83f26-d20a-11ec-8377-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:19e86d34-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:19e899bc-d20a-11ec-8377-0242ac110003 UniProtKB:P35869 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Transcription factor (Aryl hydrocarbon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.328']} DrugCentral uuid:19e8c658-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:19e8f2fe-d20a-11ec-8377-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:19e9204e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primaquine targets Unclassified (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:19e95578-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primidone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:19e95578-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primidone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:19e95578-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primidone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:19e99362-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HCF6 biolink:molecularly_interacts_with DrugCentral:2267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 primidone is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:19e9c0ee-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:19e9ed94-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:19ea1a3a-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:19ea4762-d20a-11ec-8377-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid is inhibitor of Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:19ea7412-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid is inhibitor of Transporter (Solute carrier family 22 member 8) DrugCentral uuid:19ea9c44-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSA0 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid is inhibitor of Transporter (Solute carrier family 22 member 11) DrugCentral uuid:19eac462-d20a-11ec-8377-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid targets Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:19eaf1a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:19eb1e76-d20a-11ec-8377-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:19eb4b12-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HAW7 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid targets Enzyme (UDP-glucuronosyltransferase 1-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.02']} DrugCentral uuid:19eb78bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WUD2 biolink:molecularly_interacts_with DrugCentral:2268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probenecid is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:19eba54e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probucol targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.686']} DrugCentral uuid:19ebd1ea-d20a-11ec-8377-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:2269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probucol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19ebfe86-d20a-11ec-8377-0242ac110003 UniProtKB:O95477 biolink:molecularly_interacts_with DrugCentral:2269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probucol is inhibitor of Transporter (ATP-binding cassette sub-family A member 1) DrugCentral uuid:19ec2776-d20a-11ec-8377-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:2269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probucol targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:19ec552a-d20a-11ec-8377-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:2269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 probucol targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:19ec819e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.86']} DrugCentral uuid:19ecafa2-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.812']} DrugCentral uuid:19ecdc66-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:19ed08f8-d20a-11ec-8377-0242ac110003 UniProtKB:P26358 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide targets Enzyme (DNA (cytosine-5)-methyltransferase 1) DrugCentral uuid:19ed3102-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6K1 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide targets Enzyme (DNA (cytosine-5)-methyltransferase 3A) DrugCentral uuid:19ed5b28-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBC3 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide targets Enzyme (DNA (cytosine-5)-methyltransferase 3B) DrugCentral uuid:19ed8670-d20a-11ec-8377-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:19eddc06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:19eddc06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:19eddc06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:19eddc06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:19eddc06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:19eddc06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:19eddc06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:19eddc06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:19eddc06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:19eddc06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procainamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:19ee6680-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.569']} DrugCentral uuid:19ee9358-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaine targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.529']} DrugCentral uuid:19eec008-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:19eee812-d20a-11ec-8377-0242ac110003 UniProtKB:P21817 biolink:molecularly_interacts_with DrugCentral:2271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaine targets Ion channel (Ryanodine receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.222']} DrugCentral uuid:19ef1d46-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.342']} DrugCentral uuid:19ef1d46-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.342']} DrugCentral uuid:19ef1d46-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaine targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.342']} DrugCentral uuid:19ef63dc-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:19ef9064-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2273 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procaterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:19efbdb4-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.712']} DrugCentral uuid:19efea5a-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.108']} DrugCentral uuid:19f0173c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.764']} DrugCentral uuid:19f04540-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.201']} DrugCentral uuid:19f072b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:19f09f72-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:19f0cc22-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.207']} DrugCentral uuid:19f0f9f4-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.402']} DrugCentral uuid:19f126b8-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.229']} DrugCentral uuid:19f15354-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:19f18004-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.187']} DrugCentral uuid:19f1ad5e-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.914']} DrugCentral uuid:19f1da0e-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.907']} DrugCentral uuid:19f20696-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.622']} DrugCentral uuid:19f233b4-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.324']} DrugCentral uuid:19f26078-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.611']} DrugCentral uuid:19f28d1e-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.723']} DrugCentral uuid:19f2b9c4-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.613']} DrugCentral uuid:19f2eab6-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.956']} DrugCentral uuid:19f31ae0-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.493']} DrugCentral uuid:19f347a4-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:19f37508-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.801']} DrugCentral uuid:19f3a23a-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:19f3cef4-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:19f3fba4-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:19f42890-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:19f45540-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:19f481f0-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:19f4b094-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.245']} DrugCentral uuid:19f4dd3a-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:19f509cc-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:19f53686-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.919']} DrugCentral uuid:19f563ea-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.381']} DrugCentral uuid:19f59090-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:19f5bd0e-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:19f5ea72-d20a-11ec-8377-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prochlorperazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:19f6172c-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.337']} DrugCentral uuid:19f643dc-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:19f6708c-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.907']} DrugCentral uuid:19f6a1a6-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:19f6d0fe-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:19f6fdae-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:19f74476-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:19f74476-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:19f74476-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:19f74476-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:19f74476-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:19f74476-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:19f74476-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 procyclidine targets Ion channel (Glutamate [NMDA] receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:19f7c568-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.398']} DrugCentral uuid:19f7c568-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.398']} DrugCentral uuid:19f7c568-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.398']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f84c40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19f9766a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progabide targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:19fa616a-d20a-11ec-8377-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.174']} DrugCentral uuid:19fa8e56-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:19fabb7e-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.32']} DrugCentral uuid:19fae824-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:19fb14d4-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:19fb417a-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:19fb6a1a-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:19fb9774-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['9.876']} DrugCentral uuid:19fbc50a-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:19fbf250-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.94']} DrugCentral uuid:19fc1f28-d20a-11ec-8377-0242ac110003 UniProtKB:P35610 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Enzyme (Sterol O-acyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:19fc4ba6-d20a-11ec-8377-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:19fc782e-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:19fca524-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:19fcd1d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.441']} DrugCentral uuid:19fcfea2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:19fd2be8-d20a-11ec-8377-0242ac110003 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:19fd588e-d20a-11ec-8377-0242ac110003 UniProtKB:P06186 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.98']} DrugCentral uuid:19fd8552-d20a-11ec-8377-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:19fdb324-d20a-11ec-8377-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:19fde556-d20a-11ec-8377-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:19fde556-d20a-11ec-8377-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:19fe2304-d20a-11ec-8377-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:19fe2304-d20a-11ec-8377-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.41']} DrugCentral uuid:19fe5c52-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NEC5 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:19fe895c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96P56 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:19feb5ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q86XQ3 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:19fee2a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q7RTX7 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone is activator of Ion channel (Cation channel sperm-associated protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:19ff0fda-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone is blocker of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:19ff3c76-d20a-11ec-8377-0242ac110003 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:2279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 progesterone targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:19ff6908-d20a-11ec-8377-0242ac110003 UniProtKB:P25102 biolink:molecularly_interacts_with DrugCentral:2281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proglumide targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['2.6']} DrugCentral uuid:19ff95d6-d20a-11ec-8377-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:2281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proglumide is antagonist of GPCR (Gastrin/cholecystokinin type B receptor) DrugCentral uuid:19ffc164-d20a-11ec-8377-0242ac110003 UniProtKB:Q0IJY2 biolink:molecularly_interacts_with DrugCentral:2282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proguanil targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) DrugCentral uuid:19ffebb2-d20a-11ec-8377-0242ac110003 UniProtKB:O02604 biolink:molecularly_interacts_with DrugCentral:2282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proguanil targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) DrugCentral uuid:1a0013da-d20a-11ec-8377-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:2282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proguanil is inhibitor of Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) DrugCentral uuid:1a003c70-d20a-11ec-8377-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:2282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proguanil targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1a0068f8-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.909']} DrugCentral uuid:1a0095bc-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.704']} DrugCentral uuid:1a00c262-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1a00efc6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.943']} DrugCentral uuid:1a011c76-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.337']} DrugCentral uuid:1a014930-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:1a01772a-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.529']} DrugCentral uuid:1a01a524-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.796']} DrugCentral uuid:1a01d2c4-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.656']} DrugCentral uuid:1a0200b4-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:1a022dc8-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:1a025a64-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.226']} DrugCentral uuid:1a028700-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1a02b41e-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.799']} DrugCentral uuid:1a02e0ba-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1a030d7e-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.551']} DrugCentral uuid:1a033a1a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.825']} DrugCentral uuid:1a036990-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.412']} DrugCentral uuid:1a039636-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.056']} DrugCentral uuid:1a03c2e6-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:1a03efdc-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.337']} DrugCentral uuid:1a041c5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.796']} DrugCentral uuid:1a0448d8-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:1a047592-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:1a04a2e2-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.427']} DrugCentral uuid:1a04cf92-d20a-11ec-8377-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1a04fc2e-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:1a052974-d20a-11ec-8377-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:1a05561a-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.344']} DrugCentral uuid:1a0582d4-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.806']} DrugCentral uuid:1a05af66-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:1a05dc52-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1a0608e4-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1a06367a-d20a-11ec-8377-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:1a06682a-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1a06682a-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1a06b26c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:1a06b26c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:1a06b26c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:1a06b26c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:1a06b26c-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:1a071b94-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1a071b94-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1a071b94-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1a07616c-d20a-11ec-8377-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1a078e58-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promegestone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1a07bb12-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promegestone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:1a07e90c-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:1a0815c6-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.609']} DrugCentral uuid:1a084334-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.592']} DrugCentral uuid:1a08707a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:1a089d02-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1a08cb06-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.376']} DrugCentral uuid:1a08f7b6-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:1a092470-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1a09512a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.367']} DrugCentral uuid:1a097e48-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.188']} DrugCentral uuid:1a09ab16-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.948']} DrugCentral uuid:1a09d8b6-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:1a0a01b0-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:1a0a2e60-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.721']} DrugCentral uuid:1a0a5b1a-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.62']} DrugCentral uuid:1a0a87de-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.941']} DrugCentral uuid:1a0ab538-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.823']} DrugCentral uuid:1a0ae1f2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.479']} DrugCentral uuid:1a0b0ea2-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:1a0b3bc0-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.382']} DrugCentral uuid:1a0b685c-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.975']} DrugCentral uuid:1a0b9516-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:1a0bc1b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.292']} DrugCentral uuid:1a0bef0c-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.452']} DrugCentral uuid:1a0c1b94-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1a0c484e-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:1a0c765c-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1a0ca6c2-d20a-11ec-8377-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1a0cd6d8-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:1a0d0374-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.678']} DrugCentral uuid:1a0d3088-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1a0d5d38-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1a0d89e8-d20a-11ec-8377-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1a0dbfe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1a0dbfe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1a0dbfe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1a0e06ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1a0e3492-d20a-11ec-8377-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1a0e6232-d20a-11ec-8377-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1a0e8ee2-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP23 biolink:molecularly_interacts_with DrugCentral:2286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 promethazine targets Cytosolic other (Calmodulin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:1a0ebc00-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pronetalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1a0ee91e-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:1a0f15d8-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:1a0f42b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1a0f6f24-d20a-11ec-8377-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:1a0f97f6-d20a-11ec-8377-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:1a0fbff6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:1a0fe800-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:1a101028-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1a1040d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:1a106d7a-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'ED50', 'has_quantitative_value': ['7.056']} DrugCentral uuid:1a109a2a-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.524']} DrugCentral uuid:1a10c72a-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.029']} DrugCentral uuid:1a10f3f8-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.728']} DrugCentral uuid:1a1120bc-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:1a114d9e-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:1a117ac6-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.063']} DrugCentral uuid:1a11a762-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.602']} DrugCentral uuid:1a11d3fe-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.498']} DrugCentral uuid:1a12022a-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.829']} DrugCentral uuid:1a122ec6-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.337']} DrugCentral uuid:1a125b62-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:1a12897a-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.483']} DrugCentral uuid:1a12b634-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1a12e2e4-d20a-11ec-8377-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1a130f9e-d20a-11ec-8377-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1a133cf8-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:1a136976-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.845']} DrugCentral uuid:1a13961c-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.849']} DrugCentral uuid:1a13c3e4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1a13f08a-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1a141d1c-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.602']} DrugCentral uuid:1a144e22-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1a144e22-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propafenone targets Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1a1487de-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1a14b5ce-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:1a14e29c-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:1a15101e-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propantheline is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.2']} DrugCentral uuid:1a153d6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proparacaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1a156a1e-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proparacaine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1a1597fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proparacaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:1a15c8e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proparacaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1a15c8e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proparacaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1a15c8e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proparacaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1a160e92-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2296 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propentofylline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1a163b60-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (D(1A) dopamine receptor) DrugCentral uuid:1a166356-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (D(2) dopamine receptor) DrugCentral uuid:1a168c64-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:1a16b46e-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (5-hydroxytryptamine receptor 2C) DrugCentral uuid:1a16dd4a-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:1a170554-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:1a172d68-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:1a175572-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:1a177f0c-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M4) DrugCentral uuid:1a17a70c-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (Muscarinic acetylcholine receptor M5) DrugCentral uuid:1a17cf02-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (D(4) dopamine receptor) DrugCentral uuid:1a17f702-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiomazine targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:1a181fac-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propiram is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:1a1847b6-d20a-11ec-8377-0242ac110003 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.284']} DrugCentral uuid:1a187448-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.417']} DrugCentral uuid:1a18a166-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.031']} DrugCentral uuid:1a18ce16-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:1a18fad0-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.218']} DrugCentral uuid:1a19279e-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.005']} DrugCentral uuid:1a195692-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:1a198338-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:1a19afa2-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.119']} DrugCentral uuid:1a19dcb6-d20a-11ec-8377-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1a1a0952-d20a-11ec-8377-0242ac110003 UniProtKB:O88704 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1a1a3e9a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1a1a3e9a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1a1a3e9a-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1a1a8e5e-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1a1a8e5e-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1a1a8e5e-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1b1612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a1c0784-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:1a1c0784-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:1a1c0784-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propofol is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:1a1c4db6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.919']} DrugCentral uuid:1a1c7a5c-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:1a1ca7ac-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:1a1cd434-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.913']} DrugCentral uuid:1a1d04b8-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.378']} DrugCentral uuid:1a1d33b6-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.662']} DrugCentral uuid:1a1d6066-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1a1d8d8e-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.847']} DrugCentral uuid:1a1dba34-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.699']} DrugCentral uuid:1a1de6f8-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1a1e139e-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.197']} DrugCentral uuid:1a1e410c-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.346']} DrugCentral uuid:1a1e6dbc-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:1a1e9a6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.319']} DrugCentral uuid:1a1ec7e4-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:1a1ef48a-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:1a1f2252-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.297']} DrugCentral uuid:1a1f4ef8-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1a1f7c20-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.671']} DrugCentral uuid:1a1fa8f8-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1a1fd5bc-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1a2002e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.01']} DrugCentral uuid:1a202f94-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.05']} DrugCentral uuid:1a205c3a-d20a-11ec-8377-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1a2088f4-d20a-11ec-8377-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1a20b8a6-d20a-11ec-8377-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.76']} DrugCentral uuid:1a20ede4-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:1a20ede4-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:1a20ede4-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:1a213588-d20a-11ec-8377-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1a21624c-d20a-11ec-8377-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:1a218efc-d20a-11ec-8377-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:1a21bbe8-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.71']} DrugCentral uuid:1a225fc6-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propranolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:1a22934c-d20a-11ec-8377-0242ac110003 UniProtKB:P07202 biolink:molecularly_interacts_with DrugCentral:2308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propylthiouracil is inhibitor of Enzyme (Thyroid peroxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1a22c0ce-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propylthiouracil targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1a22ee3c-d20a-11ec-8377-0242ac110003 UniProtKB:P49895 biolink:molecularly_interacts_with DrugCentral:2308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propylthiouracil is inhibitor of Enzyme (Type I iodothyronine deiodinase) DrugCentral uuid:1a2317a4-d20a-11ec-8377-0242ac110003 UniProtKB:P59533 biolink:molecularly_interacts_with DrugCentral:2308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propylthiouracil targets GPCR (Taste receptor type 2 member 38) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1a234544-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:2309 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propyphenazone is blocker of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.481']} DrugCentral uuid:1a2372d0-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proquazone targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:1a239b20-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proquazone targets Enzyme (Prostaglandin G/H synthase 1) DrugCentral uuid:1a23c9d8-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proquazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1a23c9d8-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proquazone targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1a240312-d20a-11ec-8377-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:2313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proscillaridin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.056']} DrugCentral uuid:1a243012-d20a-11ec-8377-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proscillaridin targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:1a245ac4-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protionamide targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1a2487ce-d20a-11ec-8377-0242ac110003 UniProtKB:P34981 biolink:molecularly_interacts_with DrugCentral:2316 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protirelin is agonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1a24b4ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q01717 biolink:molecularly_interacts_with DrugCentral:2316 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protirelin targets GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1a24e2aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R297 biolink:molecularly_interacts_with DrugCentral:2316 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protirelin targets GPCR (Protein Trhr2; Thyrotropin releasing hormone receptor 2; Thyrotropin-releasing hormone receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1a250faa-d20a-11ec-8377-0242ac110003 UniProtKB:P21761 biolink:molecularly_interacts_with DrugCentral:2316 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protirelin targets GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1a253cbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERT1 biolink:molecularly_interacts_with DrugCentral:2316 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protirelin targets GPCR (Thyrotropin-releasing hormone receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1a256978-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protokylol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:1a2592cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.928']} DrugCentral uuid:1a25c10c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1a25ee7a-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.39']} DrugCentral uuid:1a261cf6-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1a264a14-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1a2676ec-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1a26a428-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1a26d18c-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1a26fe6e-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1a272b32-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1a2758e6-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:1a2785d2-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:1a27b2dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:1a27dfc8-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protriptyline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:1a280e3a-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pseudoephedrine targets GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:1a28368a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pseudoephedrine targets GPCR (Alpha-2A adrenergic receptor) DrugCentral uuid:1a285f3e-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pseudoephedrine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:1a2887fc-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pseudoephedrine targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:1a28b06a-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrazinamide targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1a28dd1a-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrazinamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1a290a1a-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPB6 biolink:molecularly_interacts_with DrugCentral:2328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrazinamide targets Enzyme (Cyclopropane mycolic acid synthase 1) DrugCentral uuid:1a2932f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q50575 biolink:molecularly_interacts_with DrugCentral:2328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrazinamide targets Enzyme (Amidase; Nicotinamidase; Nicotinamidase/pyrazinamidase; Pyrazinamidase; Pyrazinamidase/nicotinamidase; Pyrazinamidase/nicotinamidase PncA) DrugCentral uuid:1a295b50-d20a-11ec-8377-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:2328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrazinamide targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1a298832-d20a-11ec-8377-0242ac110003 UniProtKB:P95029 biolink:molecularly_interacts_with DrugCentral:2328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrazinamide is inhibitor of Enzyme (3-oxoacyl-ACP synthase; Fatty acid synthase Fas; Probable fatty acid synthase Fas (Fatty acid synthetase)) DrugCentral uuid:1a29b0dc-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridostigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1a29dec2-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridostigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1a2a0bae-d20a-11ec-8377-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:2330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1a2a3868-d20a-11ec-8377-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridostigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:1a2a65c2-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.952']} DrugCentral uuid:1a2a93bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.184']} DrugCentral uuid:1a2ac10c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1a2aedb2-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:1a2b1b16-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1a2b47d0-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.751']} DrugCentral uuid:1a2b7494-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.228']} DrugCentral uuid:1a2ba2a2-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1a2bcf70-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.156']} DrugCentral uuid:1a2bfc20-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:1a2c2a4c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1a2c56fc-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.5']} DrugCentral uuid:1a2c83a2-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepyramine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1a2cb03e-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.721']} DrugCentral uuid:1a2cdd66-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1a2d0a0c-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.288']} DrugCentral uuid:1a2d36d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.409']} DrugCentral uuid:1a2d66c8-d20a-11ec-8377-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:1a2d974c-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:1a2dc780-d20a-11ec-8377-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine is inhibitor of Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:1a2df7be-d20a-11ec-8377-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1a2e2568-d20a-11ec-8377-0242ac110003 UniProtKB:P07382 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.602']} DrugCentral uuid:1a2e5222-d20a-11ec-8377-0242ac110003 UniProtKB:P22906 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1a2e7ec8-d20a-11ec-8377-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:1a2eabf0-d20a-11ec-8377-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:1a2ed878-d20a-11ec-8377-0242ac110003 UniProtKB:Q27793 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.009']} DrugCentral uuid:1a2f065e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine is inhibitor of Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1a2f3304-d20a-11ec-8377-0242ac110003 UniProtKB:Q27783 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:1a2f631a-d20a-11ec-8377-0242ac110003 UniProtKB:O08966 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1a2f8fb6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K0H1 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Unclassified (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.84']} DrugCentral uuid:1a2fbc3e-d20a-11ec-8377-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1a2fe984-d20a-11ec-8377-0242ac110003 UniProtKB:P06865 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Beta-hexosaminidase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1a30162a-d20a-11ec-8377-0242ac110003 UniProtKB:P07686 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Beta-hexosaminidase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1a3042d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q3V050 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine is inhibitor of Unclassified (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1a306fd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:1a309c8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8I1R6 biolink:molecularly_interacts_with DrugCentral:2332 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrimethamine targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:1a30c958-d20a-11ec-8377-0242ac110003 UniProtKB:F1KRD8 biolink:molecularly_interacts_with DrugCentral:2335 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrvinium targets Unclassified (Fumarate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1a30f694-d20a-11ec-8377-0242ac110003 UniProtKB:O15056 biolink:molecularly_interacts_with DrugCentral:2335 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrvinium targets Enzyme (Synaptojanin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1a312542-d20a-11ec-8377-0242ac110003 UniProtKB:O43426 biolink:molecularly_interacts_with DrugCentral:2335 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrvinium targets Enzyme (Synaptojanin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1a3151de-d20a-11ec-8377-0242ac110003 UniProtKB:P34897 biolink:molecularly_interacts_with DrugCentral:2335 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrvinium targets Enzyme (Serine hydroxymethyltransferase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1a318726-d20a-11ec-8377-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.708']} DrugCentral uuid:1a318726-d20a-11ec-8377-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.708']} DrugCentral uuid:1a318726-d20a-11ec-8377-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.708']} DrugCentral uuid:1a31d64a-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.627']} DrugCentral uuid:1a31d64a-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.627']} DrugCentral uuid:1a31d64a-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.627']} DrugCentral uuid:1a3224ce-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:1a3224ce-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:1a3224ce-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quazepam is positive allosteric modulator of Ion channel (GABA A receptor alpha-2/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.688']} DrugCentral uuid:1a326c22-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1a3299b8-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1a32c668-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1a32f46c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.483']} DrugCentral uuid:1a332126-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1a334dea-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.016']} DrugCentral uuid:1a337a9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1a33a7d6-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1a33d472-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:1a340118-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.131']} DrugCentral uuid:1a342e54-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:1a345af0-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1a348796-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1a34b432-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.512']} DrugCentral uuid:1a34e1d2-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.027']} DrugCentral uuid:1a350e82-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.127']} DrugCentral uuid:1a353b32-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1a356878-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1a359546-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.35']} DrugCentral uuid:1a35c1e2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:1a35ef6e-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.037']} DrugCentral uuid:1a361c1e-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.795']} DrugCentral uuid:1a3648ce-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.266']} DrugCentral uuid:1a36757e-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.524']} DrugCentral uuid:1a36a576-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:1a36d4b0-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.822']} DrugCentral uuid:1a370250-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1a372f78-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.241']} DrugCentral uuid:1a375c32-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1a3788ec-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.457']} DrugCentral uuid:1a37b5a6-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:1a37e30a-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.506']} DrugCentral uuid:1a380fba-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1a383c92-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1a386af0-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.866']} DrugCentral uuid:1a38985e-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.936']} DrugCentral uuid:1a38c644-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1a38f448-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1a3921ac-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1a394e84-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1a397b7a-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1a39a8e8-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1a39d566-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a3a022a-d20a-11ec-8377-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:2337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quetiapine targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1a3a2ed0-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.068']} DrugCentral uuid:1a3a5efa-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.542']} DrugCentral uuid:1a3a8ba0-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.119']} DrugCentral uuid:1a3ab85a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.079']} DrugCentral uuid:1a3ae578-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:1a3b1214-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.459']} DrugCentral uuid:1a3b3eb0-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.445']} DrugCentral uuid:1a3b6d18-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.465']} DrugCentral uuid:1a3b99d2-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.575']} DrugCentral uuid:1a3bc696-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.558']} DrugCentral uuid:1a3bf346-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.571']} DrugCentral uuid:1a3c228a-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.481']} DrugCentral uuid:1a3c4f4e-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:1a3c7c8a-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.994']} DrugCentral uuid:1a3ca9b2-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.574']} DrugCentral uuid:1a3cd676-d20a-11ec-8377-0242ac110003 UniProtKB:P04156 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Surface antigen (Major prion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1a3d0308-d20a-11ec-8377-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.72']} DrugCentral uuid:1a3d2fcc-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:1a3d5d3a-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1a3d89e0-d20a-11ec-8377-0242ac110003 UniProtKB:P02752 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Unclassified (Riboflavin-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.58']} DrugCentral uuid:1a3dbadc-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1a3dbadc-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1a3e001e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1a3e001e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1a3e001e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1a3e52b2-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1a3e52b2-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1a3e52b2-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1a3e52b2-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Bacterial DNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1a3ea528-d20a-11ec-8377-0242ac110003 UniProtKB:P00592 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Phospholipase A2 group 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1a3ed336-d20a-11ec-8377-0242ac110003 UniProtKB:P04055 biolink:molecularly_interacts_with DrugCentral:2338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepacrine targets Enzyme (Phospholipase A2 group 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1a3f3862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a3f3862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a3f3862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a3f3862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a3f3862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a3f3862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a3f3862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a3f3862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a3f3862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a3f3862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a3f3862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a3f3862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a3f3862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a3f3862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a401552-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:1a401552-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:1a401552-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:1a405fc6-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1a405fc6-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1a40a18e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1a40a18e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1a40a18e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinagolide targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1a40e748-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2340 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.08']} DrugCentral uuid:1a41147a-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2340 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.397']} DrugCentral uuid:1a414116-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinestrol is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:1a41693e-d20a-11ec-8377-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:2343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinethazone is inhibitor of Transporter (Solute carrier family 12 member 3) DrugCentral uuid:1a4192ec-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quingestanol acetate is agonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:1a41bc2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1a41e8b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q07699 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-1) DrugCentral uuid:1a4210d2-d20a-11ec-8377-0242ac110003 UniProtKB:O60939 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-2) DrugCentral uuid:1a423972-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY72 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-3) DrugCentral uuid:1a426172-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IWT1 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Ion channel (Sodium channel subunit beta-4) DrugCentral uuid:1a4289ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1a42b654-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1a42e3b8-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.125']} DrugCentral uuid:1a43109a-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:1a433d36-d20a-11ec-8377-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1a436d24-d20a-11ec-8377-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1a439d26-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.106']} DrugCentral uuid:1a43cd3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1a43fd48-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1a4429bc-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.061']} DrugCentral uuid:1a445644-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:1a448b96-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1a448b96-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1a448b96-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1a44d268-d20a-11ec-8377-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1a44ff2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q63881 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine targets Ion channel (Potassium voltage-gated channel subfamily D member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1a452bc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z258 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1a4559ae-d20a-11ec-8377-0242ac110003 UniProtKB:P15389 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1a45867c-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinidine is inhibitor of Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.921']} DrugCentral uuid:1a45b336-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.101']} DrugCentral uuid:1a45e158-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.102']} DrugCentral uuid:1a460e12-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.119']} DrugCentral uuid:1a463ac2-d20a-11ec-8377-0242ac110003 UniProtKB:P05023 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Transporter (Sodium/potassium-transporting ATPase subunit alpha-1) DrugCentral uuid:1a4662e0-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1a46903a-d20a-11ec-8377-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1a46c154-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:1a46c154-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:1a46f52a-d20a-11ec-8377-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1a4724c8-d20a-11ec-8377-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1a475344-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1a477fe0-d20a-11ec-8377-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1a47acea-d20a-11ec-8377-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1a47d9a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:2350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rabeprazole targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:1a480622-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.321']} DrugCentral uuid:1a4832be-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.714']} DrugCentral uuid:1a486018-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.408']} DrugCentral uuid:1a488cd2-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.926']} DrugCentral uuid:1a48b98c-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.205']} DrugCentral uuid:1a48e740-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:1a4913f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1a494096-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.721']} DrugCentral uuid:1a496d46-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.553']} DrugCentral uuid:1a499be0-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.383']} DrugCentral uuid:1a49c8b8-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:1a49f55e-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1a4a22a4-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1a4a5076-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.773']} DrugCentral uuid:1a4a7d1c-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:1a4aa9cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.538']} DrugCentral uuid:1a4ada96-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.523']} DrugCentral uuid:1a4b0b06-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.971']} DrugCentral uuid:1a4b39aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.828']} DrugCentral uuid:1a4b66d2-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:1a4b9350-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.321']} DrugCentral uuid:1a4bbfec-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.193']} DrugCentral uuid:1a4bed50-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene is antagonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1a4c19f6-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:1a4c4692-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.398']} DrugCentral uuid:1a4c7338-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:1a4ca2e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene is modulator of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1a4ccfa4-d20a-11ec-8377-0242ac110003 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1a4cfc0e-d20a-11ec-8377-0242ac110003 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Cytokine (Interleukin-6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1a4d2990-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.436']} DrugCentral uuid:1a4d562c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:1a4d82dc-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.876']} DrugCentral uuid:1a4dafa0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13393 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (Phospholipase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a4ddd04-d20a-11ec-8377-0242ac110003 UniProtKB:O14939 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (Phospholipase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1a4e0982-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.827']} DrugCentral uuid:1a4e3632-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.073']} DrugCentral uuid:1a4e63dc-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.625']} DrugCentral uuid:1a4e9064-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1a4ebde6-d20a-11ec-8377-0242ac110003 UniProtKB:P06211 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:1a4eea78-d20a-11ec-8377-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Transcription factor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:1a4f1796-d20a-11ec-8377-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:1a4f443c-d20a-11ec-8377-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:1a4f7506-d20a-11ec-8377-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.73']} DrugCentral uuid:1a4f7506-d20a-11ec-8377-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.73']} DrugCentral uuid:1a4faf30-d20a-11ec-8377-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1a4fdbd6-d20a-11ec-8377-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1a50087c-d20a-11ec-8377-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raloxifene targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1a503752-d20a-11ec-8377-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:2352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltegravir is inhibitor of Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.523']} DrugCentral uuid:1a506416-d20a-11ec-8377-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:2352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1a50909e-d20a-11ec-8377-0242ac110003 UniProtKB:P32246 biolink:molecularly_interacts_with DrugCentral:2352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltegravir targets GPCR (C-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1a50bd44-d20a-11ec-8377-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:2352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1a50ea62-d20a-11ec-8377-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1a5116ea-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.678']} DrugCentral uuid:1a514386-d20a-11ec-8377-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.32']} DrugCentral uuid:1a5170f4-d20a-11ec-8377-0242ac110003 UniProtKB:P14207 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Membrane receptor (Folate receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1a519d5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1a51c9e6-d20a-11ec-8377-0242ac110003 UniProtKB:P0A884 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.244']} DrugCentral uuid:1a51f664-d20a-11ec-8377-0242ac110003 UniProtKB:P07607 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1a5225da-d20a-11ec-8377-0242ac110003 UniProtKB:P45352 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1a525262-d20a-11ec-8377-0242ac110003 UniProtKB:P00469 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1a527eea-d20a-11ec-8377-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:1a52abcc-d20a-11ec-8377-0242ac110003 UniProtKB:C3SWJ7 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Enzyme (Thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1a52d868-d20a-11ec-8377-0242ac110003 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1a530608-d20a-11ec-8377-0242ac110003 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:2353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raltitrexed targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1a5332a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:2354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramatroban targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.37']} DrugCentral uuid:1a535fd6-d20a-11ec-8377-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:2354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramatroban is inverse agonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:1a538c7c-d20a-11ec-8377-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:2354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramatroban targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1a53b90e-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XKD3 biolink:molecularly_interacts_with DrugCentral:2354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramatroban is antagonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1a53e816-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z2J6 biolink:molecularly_interacts_with DrugCentral:2354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramatroban is antagonist of GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1a541804-d20a-11ec-8377-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:2355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramelteon is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.9']} DrugCentral uuid:1a5444d2-d20a-11ec-8377-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:2355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramelteon is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.39']} DrugCentral uuid:1a547218-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramipril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.342']} DrugCentral uuid:1a549ef0-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramipril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1a54cba0-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2357 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramosetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:1a54f864-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranitidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.86']} DrugCentral uuid:1a5525a0-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranitidine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1a555228-d20a-11ec-8377-0242ac110003 UniProtKB:P47747 biolink:molecularly_interacts_with DrugCentral:2358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranitidine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1a557eec-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranitidine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1a55ac64-d20a-11ec-8377-0242ac110003 UniProtKB:P25102 biolink:molecularly_interacts_with DrugCentral:2358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranitidine is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1a55dc7a-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranolazine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1a56090c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranolazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:1a56359e-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranolazine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:1a565e7a-d20a-11ec-8377-0242ac110003 UniProtKB:Q5YLN7 biolink:molecularly_interacts_with DrugCentral:2359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranolazine targets Unclassified (Voltage-gated sodium channel Nav1.5 cardiac isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1a568b16-d20a-11ec-8377-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:2360 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rebamipide is agonist of GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1a56b8fc-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1a56e624-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:1a5712e8-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1a573f7a-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1a576d1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1a579b46-d20a-11ec-8377-0242ac110003 UniProtKB:P48051 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.194']} DrugCentral uuid:1a57c7ec-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1a57f492-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.86']} DrugCentral uuid:1a582214-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.16']} DrugCentral uuid:1a58531a-d20a-11ec-8377-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.317']} DrugCentral uuid:1a58531a-d20a-11ec-8377-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.317']} DrugCentral uuid:1a5890a0-d20a-11ec-8377-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.387']} DrugCentral uuid:1a5890a0-d20a-11ec-8377-0242ac110003 UniProtKB:P48549 biolink:molecularly_interacts_with DrugCentral:2361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reboxetine targets Ion channel (Kir3.1/Kir3.4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.387']} DrugCentral uuid:1a58ca34-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regadenoson is agonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.886']} DrugCentral uuid:1a58f6bc-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regadenoson targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.398']} DrugCentral uuid:1a592358-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:2362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regadenoson targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1a594fe0-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regadenoson targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1a597f38-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regadenoson targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1a59abe8-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remifentanil is agonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:1a59d3fc-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remifentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1a5a014c-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remifentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1a5a2df2-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.06']} DrugCentral uuid:1a5a5b2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1a5a87ca-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a5ab4ca-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.509']} DrugCentral uuid:1a5ae152-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:1a5b0dee-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1a5b3cc4-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1a5b694c-d20a-11ec-8377-0242ac110003 UniProtKB:P52702 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:1a5b95f2-d20a-11ec-8377-0242ac110003 UniProtKB:P52703 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1a5bd59e-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1a5bd59e-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1a5bd59e-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1a5bd59e-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1a5bd59e-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remoxipride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1a5c344e-d20a-11ec-8377-0242ac110003 UniProtKB:Q09428 biolink:molecularly_interacts_with DrugCentral:2366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 repaglinide targets Ion channel (ATP-binding cassette sub-family C member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1a5c613a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:2366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 repaglinide targets Transporter (Solute carrier organic anion transporter family member 1B1) DrugCentral uuid:1a5c8958-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 repaglinide targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1a5cbb76-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:1a5cbb76-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:1a5cf924-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:1a5cf924-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 repaglinide is blocker of Ion channel (Sulfonylurea receptor 2, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:1a5d33c6-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2368 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reproterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:1a5d5c02-d20a-11ec-8377-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:2369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rescinnamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:1a5d842a-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.773']} DrugCentral uuid:1a5db152-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.415']} DrugCentral uuid:1a5dddee-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.232']} DrugCentral uuid:1a5e0ab2-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1a5e379e-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.737']} DrugCentral uuid:1a5e643a-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.223']} DrugCentral uuid:1a5e90ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:1a5ebe6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1a5eee46-d20a-11ec-8377-0242ac110003 UniProtKB:Q27963 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1a5f1b64-d20a-11ec-8377-0242ac110003 UniProtKB:P0A0J7 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Transporter (Quinolone resistance protein NorA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1a5f47e2-d20a-11ec-8377-0242ac110003 UniProtKB:P54219 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine is inhibitor of Transporter (Chromaffin granule amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:1a5f7dd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1a5f7dd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1a5f7dd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1a5fc4c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BRU6 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:1a5ff160-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2370 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reserpine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.836']} DrugCentral uuid:1a601e9c-d20a-11ec-8377-0242ac110003 UniProtKB:P02753 biolink:molecularly_interacts_with DrugCentral:2372 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol acetate targets Secreted (Retinol-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1a604b2e-d20a-11ec-8377-0242ac110003 UniProtKB:P02754 biolink:molecularly_interacts_with DrugCentral:2372 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol acetate targets Unclassified (Beta-lactoglobulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:1a6077f2-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1a60a48e-d20a-11ec-8377-0242ac110003 UniProtKB:P55263 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin targets Kinase (Adenosine kinase) DrugCentral uuid:1a60ce82-d20a-11ec-8377-0242ac110003 UniProtKB:P22413 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin targets Enzyme (Ectonucleotide pyrophosphatase/phosphodiesterase family member 1) DrugCentral uuid:1a60f6aa-d20a-11ec-8377-0242ac110003 UniProtKB:P49902 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin targets Enzyme (Cytosolic purine 5'-nucleotidase) DrugCentral uuid:1a611ed2-d20a-11ec-8377-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1a614c90-d20a-11ec-8377-0242ac110003 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1a617936-d20a-11ec-8377-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:1a61a5dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin is inhibitor of Enzyme (NS5B protein) DrugCentral uuid:1a61ce04-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribavirin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1a61fb18-d20a-11ec-8377-0242ac110003 UniProtKB:P9WGY9 biolink:molecularly_interacts_with DrugCentral:2376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifabutin targets Enzyme (DNA-directed RNA polymerase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1a6234ca-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:1a6234ca-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:1a6234ca-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:1a6234ca-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifabutin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:1a62804c-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a62acca-d20a-11ec-8377-0242ac110003 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1a62d952-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.95']} DrugCentral uuid:1a6305da-d20a-11ec-8377-0242ac110003 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1a6332ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1a635fb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1a638c44-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin is inhibitor of Enzyme (DNA-directed RNA polymerase subunit beta) DrugCentral uuid:1a63b5ca-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:1a63e270-d20a-11ec-8377-0242ac110003 UniProtKB:P46721 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.29']} DrugCentral uuid:1a640f34-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPD5 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1a643bbc-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1a646ad8-d20a-11ec-8377-0242ac110003 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:2377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifampicin targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1a64a44e-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:1a64a44e-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:1a64a44e-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:1a64a44e-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2378 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifapentine is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:1a64ed96-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifaximin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1a65273e-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:1a65273e-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:1a65273e-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:1a65273e-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:2379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifaximin is inhibitor of Enzyme (Bacterial DNA-directed RNA polymerase) DrugCentral uuid:1a65704a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilmenidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:1a659d54-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilmenidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1a65ca18-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilmenidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:1a65f6b4-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilmenidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1a662382-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilmenidine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:1a665424-d20a-11ec-8377-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:2381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilmenidine targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.95']} DrugCentral uuid:1a6680b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:1a66a8b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1a66d5b6-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.765']} DrugCentral uuid:1a670266-d20a-11ec-8377-0242ac110003 UniProtKB:O15554 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole is activator of Ion channel (Intermediate conductance calcium-activated potassium channel protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1a672eee-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCU5 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole targets Ion channel (Glutamate receptor ionotropic, NMDA 3A) DrugCentral uuid:1a67570c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UGI6 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole is activator of Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1a6783f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a67b1c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q92952 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole is activator of Ion channel (Small conductance calcium-activated potassium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:1a67df38-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole is activator of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1a680dc8-d20a-11ec-8377-0242ac110003 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:2382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riluzole is activator of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1a683b68-d20a-11ec-8377-0242ac110003 UniProtKB:P21430 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine targets Ion channel (Matrix protein 2) DrugCentral uuid:1a686386-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1a689022-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1a68bd4a-d20a-11ec-8377-0242ac110003 UniProtKB:P63231 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine is inhibitor of Ion channel (Matrix protein 2) DrugCentral uuid:1a68e5b8-d20a-11ec-8377-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1a691286-d20a-11ec-8377-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine targets Unclassified (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1a693f9a-d20a-11ec-8377-0242ac110003 UniProtKB:P05778 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1a696c4a-d20a-11ec-8377-0242ac110003 UniProtKB:P0DOF8 biolink:molecularly_interacts_with DrugCentral:2383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimantadine targets Unclassified (Matrix protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1a69990e-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimexolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6a029a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripazepam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1a6aece6-d20a-11ec-8377-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:2387 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risedronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:1a6b1a36-d20a-11ec-8377-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:2387 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risedronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1a6b46f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q197X6 biolink:molecularly_interacts_with DrugCentral:2387 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risedronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.13']} DrugCentral uuid:1a6b738c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WS26 biolink:molecularly_interacts_with DrugCentral:2387 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risedronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:1a6ba03c-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levisoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1a6bce9a-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levisoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:1a6bfb4a-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levisoprenaline targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1a6c27e6-d20a-11ec-8377-0242ac110003 UniProtKB:P04274 biolink:molecularly_interacts_with DrugCentral:2388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levisoprenaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:1a6c550e-d20a-11ec-8377-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levisoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1a6c81dc-d20a-11ec-8377-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levisoprenaline targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1a6caea0-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1a6cdb8c-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1a6d097c-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1a6d3654-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:1a6d6304-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1a6d91bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1a6dbe80-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.788']} DrugCentral uuid:1a6deafe-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1a6e18d0-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.443']} DrugCentral uuid:1a6e458a-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.364']} DrugCentral uuid:1a6e7230-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:1a6e9ef4-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1a6ecd02-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:1a6ef9b2-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:1a6f2676-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:1a6f5420-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1a6f8102-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:1a6fad9e-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.023']} DrugCentral uuid:1a6fda44-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:1a7007bc-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:1a703480-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1a706126-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.432']} DrugCentral uuid:1a708e58-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1a70bafe-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.538']} DrugCentral uuid:1a70e7cc-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:1a711490-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1a71423a-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.495']} DrugCentral uuid:1a716f1c-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.278']} DrugCentral uuid:1a719bd6-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1a71c91c-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1a71f5e0-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:1a7222a4-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1a724f2c-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.687']} DrugCentral uuid:1a727c5e-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1a72a904-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1a72d5be-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.967']} DrugCentral uuid:1a73041c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1a733202-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1a735ebc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:1a738b76-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1a73ba2e-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:1a73e71a-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1a7413d4-d20a-11ec-8377-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1a7440e8-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1a746da2-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1a749a3e-d20a-11ec-8377-0242ac110003 UniProtKB:P61168 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1a74c6e4-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.84']} DrugCentral uuid:1a74f484-d20a-11ec-8377-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1a75213e-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1a754dda-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.01']} DrugCentral uuid:1a757b7a-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1a75a852-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:1a75d5f2-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1a76028e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1a763c72-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1a763c72-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1a763c72-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1a763c72-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1a769762-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:1a769762-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:1a769762-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:1a76eb68-d20a-11ec-8377-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1a76eb68-d20a-11ec-8377-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1a76eb68-d20a-11ec-8377-0242ac110003 UniProtKB:Q02152 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1a7732c6-d20a-11ec-8377-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:2389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risperidone targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1a776034-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritodrine is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:1a778cd0-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritodrine targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1a77b980-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.575']} DrugCentral uuid:1a77e69e-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:1a781326-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:1a783fd6-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.301']} DrugCentral uuid:1a786c68-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:1a78974c-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:1a78c410-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:1a78f0c0-d20a-11ec-8377-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.303']} DrugCentral uuid:1a791e06-d20a-11ec-8377-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:1a794b06-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.119']} DrugCentral uuid:1a7978f6-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:1a79a5ba-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.058']} DrugCentral uuid:1a79d2ec-d20a-11ec-8377-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir is inhibitor of Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1a79ffce-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:1a7a2c9c-d20a-11ec-8377-0242ac110003 UniProtKB:P22309 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir is inhibitor of Enzyme (UDP-glucuronosyltransferase 1-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1a7a5b22-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:1a7a87d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1a7ab450-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1a7ae0e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:2391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ritonavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.47']} DrugCentral uuid:1a7b0e64-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:1a7b3b32-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine is inhibitor of Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1a7b68e6-d20a-11ec-8377-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:1a7b9604-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1a7bc2a0-d20a-11ec-8377-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1a7bef50-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1a7c1c00-d20a-11ec-8377-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1a7c49dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1a7c766e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1a7ca314-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivastigmine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:1a7cd0dc-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1a7cfdaa-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1a7d2a78-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1a7d5796-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1a7d8478-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1a7db13c-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.854']} DrugCentral uuid:1a7dddf6-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1a7e0b8c-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1a7e3832-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1a7e64ce-d20a-11ec-8377-0242ac110003 UniProtKB:P79400 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1a7e96b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a7e96b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rizatriptan targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1a7ed8aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rocuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1a7ed8aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rocuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1a7ed8aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rocuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1a7f2ba2-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1a7f2ba2-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1a7f2ba2-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1a7f2ba2-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rocuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1a7f8070-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1a7fad16-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1a7fdb1a-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.466']} DrugCentral uuid:1a8007c0-d20a-11ec-8377-0242ac110003 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1a803466-d20a-11ec-8377-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1a8060ee-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:1a808e48-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1a80bada-d20a-11ec-8377-0242ac110003 UniProtKB:P35355 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1a80e76c-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:1a811458-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:2397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rofecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1a814108-d20a-11ec-8377-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rolitetracycline targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1a816d86-d20a-11ec-8377-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:2399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rolitetracycline targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:1a819a2c-d20a-11ec-8377-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:2399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rolitetracycline targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1a81cace-d20a-11ec-8377-0242ac110003 UniProtKB:P43351 biolink:molecularly_interacts_with DrugCentral:2399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rolitetracycline targets Nuclear other (DNA repair protein RAD52 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1a81f76a-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1a82241a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:1a825192-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:1a827e1a-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1a82aaca-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1a82d7ac-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1a830452-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1a8330d0-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1a835d76-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:1a838de6-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:1a83bb04-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.86']} DrugCentral uuid:1a83e80e-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1a841590-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1a844236-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1a846ef0-d20a-11ec-8377-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1a849b8c-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropinirole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:1a84c8be-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:1a84f578-d20a-11ec-8377-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:1a851da0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) DrugCentral uuid:1a854654-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 3 subunit alpha) DrugCentral uuid:1a856ecc-d20a-11ec-8377-0242ac110003 UniProtKB:P35499 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 4 subunit alpha) DrugCentral uuid:1a8596ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 8 subunit alpha) DrugCentral uuid:1a85bf12-d20a-11ec-8377-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) DrugCentral uuid:1a85e906-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:1a86114c-d20a-11ec-8377-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1a863df2-d20a-11ec-8377-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropivacaine targets Ion channel (Potassium channel subfamily K member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1a866aa2-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1a8697de-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.391']} DrugCentral uuid:1a86c484-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1a86f102-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1a871efc-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.56']} DrugCentral uuid:1a874e86-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1a877b18-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:1a87a7a0-d20a-11ec-8377-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1a87d4b4-d20a-11ec-8377-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1a88024a-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.449']} DrugCentral uuid:1a882f04-d20a-11ec-8377-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1a885c7c-d20a-11ec-8377-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1a888918-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1a88b5e6-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1a88e296-d20a-11ec-8377-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Transcription factor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1a891216-d20a-11ec-8377-0242ac110003 UniProtKB:P37238 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Transcription factor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1a893ec6-d20a-11ec-8377-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:1a896b76-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone is activator of Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:1a89988a-d20a-11ec-8377-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1a89c526-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1a89f276-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1a8a1f1c-d20a-11ec-8377-0242ac110003 UniProtKB:B0K020 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1a8a4c76-d20a-11ec-8377-0242ac110003 UniProtKB:P23204 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1a8a7908-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1a8aa5d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1a8ad3da-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N5K1 biolink:molecularly_interacts_with DrugCentral:2405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosiglitazone targets Unclassified (CDGSH iron-sulfur domain-containing protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1a8b0076-d20a-11ec-8377-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosuvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:1a8b2d3a-d20a-11ec-8377-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosuvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:1a8b59cc-d20a-11ec-8377-0242ac110003 UniProtKB:O43924 biolink:molecularly_interacts_with DrugCentral:2406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rosuvastatin targets Enzyme (Phosphodiesterase 6D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1a8b86f4-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rotigotine is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1a8bb39a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rotigotine is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:1a8be054-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rotigotine is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1a8c0d9a-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rotigotine is agonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:1a8c3b76-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rotigotine is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1a8c6998-d20a-11ec-8377-0242ac110003 UniProtKB:Q95136 biolink:molecularly_interacts_with DrugCentral:2407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rotigotine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1a8c9652-d20a-11ec-8377-0242ac110003 UniProtKB:P20288 biolink:molecularly_interacts_with DrugCentral:2407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rotigotine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1a8cc3e8-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxatidine acetate is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1a8cf098-d20a-11ec-8377-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:2410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxithromycin targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:1a8d18ac-d20a-11ec-8377-0242ac110003 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:2410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxithromycin is agonist of GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1a8d45ca-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxithromycin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.261']} DrugCentral uuid:1a8d7298-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2413 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rupatadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.41']} DrugCentral uuid:1a8d9f48-d20a-11ec-8377-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:2413 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rupatadine targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1a8dcbda-d20a-11ec-8377-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:2414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ademetionine targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1a8df952-d20a-11ec-8377-0242ac110003 UniProtKB:P17708 biolink:molecularly_interacts_with DrugCentral:2414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ademetionine targets Enzyme (S-adenosylmethionine decarboxylase proenzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:1a8e25f8-d20a-11ec-8377-0242ac110003 UniProtKB:C3SIU2 biolink:molecularly_interacts_with DrugCentral:2414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ademetionine targets Unclassified (Met repressor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1a8e5294-d20a-11ec-8377-0242ac110003 UniProtKB:P11086 biolink:molecularly_interacts_with DrugCentral:2414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ademetionine targets Enzyme (Phenylethanolamine N-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1a8e812e-d20a-11ec-8377-0242ac110003 UniProtKB:P22061 biolink:molecularly_interacts_with DrugCentral:2414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ademetionine targets Enzyme (Protein-beta-aspartate methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:1a8eae06-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1a8edab6-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1a8f0770-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.95']} DrugCentral uuid:1a8f3466-d20a-11ec-8377-0242ac110003 UniProtKB:Q6RYA0 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Salicylic acid-binding protein 2) DrugCentral uuid:1a8f5c8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1a8f893e-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1a8fb6ac-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:1a8fe348-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1a901002-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1a903c9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:1a906dfe-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1a909a7c-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1a90c830-d20a-11ec-8377-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.36']} DrugCentral uuid:1a90f530-d20a-11ec-8377-0242ac110003 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1a9121cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salicylic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:1a914e5e-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1a917bcc-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.41']} DrugCentral uuid:1a91a890-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:1a91d54a-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:1a9201e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.004']} DrugCentral uuid:1a922fea-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1a925c90-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:1a92894a-d20a-11ec-8377-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1a92b6a4-d20a-11ec-8377-0242ac110003 UniProtKB:P34971 biolink:molecularly_interacts_with DrugCentral:2419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 salmeterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1a92e4a8-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.408']} DrugCentral uuid:1a931158-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:1a933df4-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.921']} DrugCentral uuid:1a936b62-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.612']} DrugCentral uuid:1a939812-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.282']} DrugCentral uuid:1a93c4cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Transporter (Canalicular multispecific organic anion transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.699']} DrugCentral uuid:1a93f2d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.555']} DrugCentral uuid:1a941fd0-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.556']} DrugCentral uuid:1a944c4e-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:1a947458-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.003']} DrugCentral uuid:1a94a176-d20a-11ec-8377-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.153']} DrugCentral uuid:1a94ce26-d20a-11ec-8377-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.187']} DrugCentral uuid:1a94facc-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.661']} DrugCentral uuid:1a95283a-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.684']} DrugCentral uuid:1a9555f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:1a9582bc-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1a95af4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1a95de88-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:1a960b56-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1a9637de-d20a-11ec-8377-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:1a96651a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:2422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saquinavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:1a9691de-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarpogrelate is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:1a96beac-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarpogrelate is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1a96eb66-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarpogrelate is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1a972220-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarpogrelate targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:1a972220-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarpogrelate targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:1a972220-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarpogrelate targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:1a9767e4-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1a979476-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.86']} DrugCentral uuid:1a97c48c-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1a97f128-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:1a981dd8-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.75']} DrugCentral uuid:1a984b00-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1a9877b0-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.28']} DrugCentral uuid:1a98a456-d20a-11ec-8377-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:1a98d1ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WMX0 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:1a98fe88-d20a-11ec-8377-0242ac110003 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:1a993c40-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:1a993c40-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:1a993c40-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:1a993c40-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:1a993c40-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 scopolamine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:1a99a2ca-d20a-11ec-8377-0242ac110003 UniProtKB:C3TDZ2 biolink:molecularly_interacts_with DrugCentral:2427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secnidazole targets Enzyme (3-oxoacyl-[acyl-carrier-protein] synthase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:1a99cfa2-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:2428 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secobarbital targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.578']} DrugCentral uuid:1a9a0508-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2428 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1a9a0508-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2428 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1a9a0508-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2428 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secobarbital is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1a9a4342-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.171']} DrugCentral uuid:1a9a6fde-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.764']} DrugCentral uuid:1a9a9cac-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1a9aca1a-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1a9af6ac-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:1a9b235c-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:1a9b5106-d20a-11ec-8377-0242ac110003 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1a9b7db6-d20a-11ec-8377-0242ac110003 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1a9baea8-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1a9baea8-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selegiline targets Enzyme (Monoamine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1a9be850-d20a-11ec-8377-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:2432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 seratrodast targets GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:1a9c14ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q02643 biolink:molecularly_interacts_with DrugCentral:2433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sermorelin is agonist of GPCR (Growth hormone-releasing hormone receptor) DrugCentral uuid:1a9c3d0a-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertaconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:1a9c6514-d20a-11ec-8377-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:2434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertaconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1a9c9250-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1a9cbee2-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1a9ceb88-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1a9d1964-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.194']} DrugCentral uuid:1a9d4768-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:1a9d7418-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1a9da140-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1a9dce5e-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1a9dfaf0-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.553']} DrugCentral uuid:1a9e27a0-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.745']} DrugCentral uuid:1a9e54fa-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.347']} DrugCentral uuid:1a9e81c8-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:1a9eae78-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.29']} DrugCentral uuid:1a9edb32-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1a9f0c60-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:1a9f3938-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1a9f65e8-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.347']} DrugCentral uuid:1a9f92e8-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1a9fbfca-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1a9fec84-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1aa01948-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:1aa046ac-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:1aa07352-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:1aa0a00c-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1aa0cea6-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1aa0fea8-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.29']} DrugCentral uuid:1aa12b6c-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:1aa1581c-d20a-11ec-8377-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.48']} DrugCentral uuid:1aa18dd2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1aa18dd2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1aa18dd2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1aa1dd5a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.41']} DrugCentral uuid:1aa1dd5a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.41']} DrugCentral uuid:1aa1dd5a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.41']} DrugCentral uuid:1aa2240e-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:1aa250be-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1aa27d96-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2435 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertindole is inverse agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1aa2abfe-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.965']} DrugCentral uuid:1aa2d89a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1aa3055e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.167']} DrugCentral uuid:1aa332a4-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.54']} DrugCentral uuid:1aa35f36-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1aa38bf0-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.106']} DrugCentral uuid:1aa3b8be-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.666']} DrugCentral uuid:1aa3e640-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.246']} DrugCentral uuid:1aa412dc-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.863']} DrugCentral uuid:1aa43fa0-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.082']} DrugCentral uuid:1aa46dc2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.128']} DrugCentral uuid:1aa49a72-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:1aa4c722-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.886']} DrugCentral uuid:1aa4f3b4-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.854']} DrugCentral uuid:1aa520aa-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.721']} DrugCentral uuid:1aa54e9a-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.187']} DrugCentral uuid:1aa57b36-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1aa5a994-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1aa5d630-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.475']} DrugCentral uuid:1aa602ea-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.365']} DrugCentral uuid:1aa62fa4-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.885']} DrugCentral uuid:1aa66014-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:1aa68d00-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:1aa6b9b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1aa6e6b0-d20a-11ec-8377-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sertraline targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1aa71342-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:1aa73b42-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive modulator of Ion channel (Glycine receptor subunit alpha-1) DrugCentral uuid:1aa763e2-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 2) DrugCentral uuid:1aa78cc8-d20a-11ec-8377-0242ac110003 UniProtKB:O14649 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 3) DrugCentral uuid:1aa7b4fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 9) DrugCentral uuid:1aa7dd18-d20a-11ec-8377-0242ac110003 UniProtKB:P57789 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 10) DrugCentral uuid:1aa80540-d20a-11ec-8377-0242ac110003 UniProtKB:Q7Z418 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is opener of Ion channel (Potassium channel subfamily K member 18) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa8702a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sevoflurane is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1aa93d3e-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.526']} DrugCentral uuid:1aa96aca-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.263']} DrugCentral uuid:1aa99784-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.962']} DrugCentral uuid:1aa9c6be-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine targets GPCR (Alpha-2C adrenergic receptor) DrugCentral uuid:1aa9f1a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.026']} DrugCentral uuid:1aaa20fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK17 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine targets Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1aaa4da0-d20a-11ec-8377-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine is inhibitor of Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1aaa7a50-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.538']} DrugCentral uuid:1aaaa764-d20a-11ec-8377-0242ac110003 UniProtKB:Q62897 biolink:molecularly_interacts_with DrugCentral:2440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sibutramine is blocker of Ion channel (Potassium voltage-gated channel subfamily D member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1aaad40a-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1aab00ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1aab2e00-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:1aab5b32-d20a-11ec-8377-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Transporter (Multidrug resistance-associated protein 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1aab87d8-d20a-11ec-8377-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1aabb460-d20a-11ec-8377-0242ac110003 UniProtKB:P16499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) DrugCentral uuid:1aabdfe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1aac0ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1aac3b88-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1aac686a-d20a-11ec-8377-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:1aac9506-d20a-11ec-8377-0242ac110003 UniProtKB:Q13946 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1aacc198-d20a-11ec-8377-0242ac110003 UniProtKB:P51160 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1aacee34-d20a-11ec-8377-0242ac110003 UniProtKB:O76083 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1aad1b7a-d20a-11ec-8377-0242ac110003 UniProtKB:O60658 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1aad4910-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.094']} DrugCentral uuid:1aad75c0-d20a-11ec-8377-0242ac110003 UniProtKB:O54735 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.74']} DrugCentral uuid:1aada34c-d20a-11ec-8377-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1aadcfd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q28156 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:1aadfc5c-d20a-11ec-8377-0242ac110003 UniProtKB:P16586 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1aae28e4-d20a-11ec-8377-0242ac110003 UniProtKB:P11541 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1aae55e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1aae8262-d20a-11ec-8377-0242ac110003 UniProtKB:O77746 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1aaeb340-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1aaeb340-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1aaef9ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1aaef9ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1aaef9ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1aaef9ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1aaf58cc-d20a-11ec-8377-0242ac110003 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1aaf58cc-d20a-11ec-8377-0242ac110003 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1aaf58cc-d20a-11ec-8377-0242ac110003 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1aaf58cc-d20a-11ec-8377-0242ac110003 UniProtKB:P54748 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1aafb466-d20a-11ec-8377-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1aafb466-d20a-11ec-8377-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1aafb466-d20a-11ec-8377-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1ab0004c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1ab0004c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1ab04eb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1ab04eb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1ab04eb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1ab04eb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1ab04eb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1ab04eb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1ab0c414-d20a-11ec-8377-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1ab0c414-d20a-11ec-8377-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1ab0c414-d20a-11ec-8377-0242ac110003 UniProtKB:Q9EPR9 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1ab109c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPD5 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1ab13674-d20a-11ec-8377-0242ac110003 UniProtKB:P14099 biolink:molecularly_interacts_with DrugCentral:2441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sildenafil targets Enzyme (Phosphodiesterase 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:1ab166e4-d20a-11ec-8377-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:1ab193a8-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1ab1c06c-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:1ab1edee-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1ab21aa8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.99']} DrugCentral uuid:1ab24762-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1ab2749e-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.73']} DrugCentral uuid:1ab2a158-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1ab2cec6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1ab2fb94-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1ab32b50-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1ab35ada-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1ab38776-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.93']} DrugCentral uuid:1ab3b4ee-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1ab3e194-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1ab40e58-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1ab43b12-d20a-11ec-8377-0242ac110003 UniProtKB:P22985 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1ab4692a-d20a-11ec-8377-0242ac110003 UniProtKB:P21447 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Transporter (P-glycoprotein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1ab4962a-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1ab4c316-d20a-11ec-8377-0242ac110003 UniProtKB:P14142 biolink:molecularly_interacts_with DrugCentral:2443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silymarin targets Transporter (Solute carrier family 2, facilitated glucose transporter member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:1ab4f1a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2445 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simvastatin targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:1ab519d8-d20a-11ec-8377-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:2445 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simvastatin is inhibitor of Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1ab547c8-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2445 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simvastatin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1ab57496-d20a-11ec-8377-0242ac110003 UniProtKB:P51639 biolink:molecularly_interacts_with DrugCentral:2445 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:1ab5a1c8-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2445 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simvastatin targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1ab5ce78-d20a-11ec-8377-0242ac110003 UniProtKB:Q10283 biolink:molecularly_interacts_with DrugCentral:2445 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simvastatin targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:1ab5fb14-d20a-11ec-8377-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.431']} DrugCentral uuid:1ab62864-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:1ab65500-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1ab6819c-d20a-11ec-8377-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:1ab6ae56-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:1ab6dec6-d20a-11ec-8377-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:1ab70ed2-d20a-11ec-8377-0242ac110003 UniProtKB:Q00688 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1ab73ef2-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:1ab76c2e-d20a-11ec-8377-0242ac110003 UniProtKB:P68106 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1ab798ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q13451 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1ab7c58e-d20a-11ec-8377-0242ac110003 UniProtKB:Q53EL6 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Nuclear other (Programmed cell death protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1ab7f2d4-d20a-11ec-8377-0242ac110003 UniProtKB:P06730 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Nuclear other (Eukaryotic translation initiation factor 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1ab81f8e-d20a-11ec-8377-0242ac110003 UniProtKB:P26883 biolink:molecularly_interacts_with DrugCentral:2446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1ab84bee-d20a-11ec-8377-0242ac110003 UniProtKB:P0A7S3 biolink:molecularly_interacts_with DrugCentral:2447 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sisomicin targets Cytosolic other (30S ribosomal protein S12) DrugCentral uuid:1ab87420-d20a-11ec-8377-0242ac110003 UniProtKB:P14740 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1ab8a256-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1ab8d096-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.774']} DrugCentral uuid:1ab8fd46-d20a-11ec-8377-0242ac110003 UniProtKB:P28843 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:1ab92a50-d20a-11ec-8377-0242ac110003 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1ab9570a-d20a-11ec-8377-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1ab983c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1ab9b060-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHL4 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Enzyme (Dipeptidyl peptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:1ab9dde2-d20a-11ec-8377-0242ac110003 UniProtKB:O31048 biolink:molecularly_interacts_with DrugCentral:2448 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitagliptin targets Unclassified (Dipeptidyl peptidase IV) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1aba0a74-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES7 biolink:molecularly_interacts_with DrugCentral:2449 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitafloxacin targets Enzyme (DNA gyrase subunit B) DrugCentral uuid:1aba3288-d20a-11ec-8377-0242ac110003 UniProtKB:P72525 biolink:molecularly_interacts_with DrugCentral:2449 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitafloxacin targets Enzyme (DNA topoisomerase 4 subunit A) DrugCentral uuid:1aba5aba-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:1aba8990-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1abab640-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1abae2f0-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1abb1004-d20a-11ec-8377-0242ac110003 UniProtKB:P19838 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Cytosolic other (Nuclear factor NF-kappa-B p105 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1abb3ca0-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:1abb6950-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1abb95f6-d20a-11ec-8377-0242ac110003 UniProtKB:P06746 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (DNA polymerase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:1abbc404-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:1abbf1f4-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1abc1ed6-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1abc4cf8-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitosterol targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:1abc7980-d20a-11ec-8377-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:2452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sivelestat targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1abca61c-d20a-11ec-8377-0242ac110003 UniProtKB:P24158 biolink:molecularly_interacts_with DrugCentral:2452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sivelestat targets Enzyme (Myeloblastin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1abcd2fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q3UP87 biolink:molecularly_interacts_with DrugCentral:2452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sivelestat targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:1abcff9a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1abd2c54-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1abd5a12-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.88']} DrugCentral uuid:1abd874e-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1abdb3e0-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1abde086-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1abe0e76-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1abe3edc-d20a-11ec-8377-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solifenacin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1abe6f1a-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1abe9eae-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:1abecbe0-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.71']} DrugCentral uuid:1abef89a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.25']} DrugCentral uuid:1abf257c-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1abf5286-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1abf7f54-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1abfac0e-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1abfd904-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:1ac00690-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1ac03368-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1ac0600e-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:1ac08d86-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1ac0ba2c-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1ac0e6c8-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1ac1135a-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1ac14078-d20a-11ec-8377-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1ac16d28-d20a-11ec-8377-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:1ac199f6-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1ac1ca0c-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.35']} DrugCentral uuid:1ac1f70c-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:1ac223c6-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1ac2517a-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.68']} DrugCentral uuid:1ac27fc4-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1ac2ac88-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:1ac2d92e-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:1ac30656-d20a-11ec-8377-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1ac332fc-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1ac35f98-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1ac38d38-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1ac3ba06-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1ac3e698-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1ac41348-d20a-11ec-8377-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1ac44098-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1ac46d48-d20a-11ec-8377-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1ac499e4-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1ac4c6da-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1ac4f36c-d20a-11ec-8377-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1ac520b2-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1ac54dbc-d20a-11ec-8377-0242ac110003 UniProtKB:Q00535 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent-like kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1ac57bca-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1ac5a852-d20a-11ec-8377-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1ac5d4e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1ac60220-d20a-11ec-8377-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1ac62ff2-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1ac65c98-d20a-11ec-8377-0242ac110003 UniProtKB:Q15759 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1ac6893e-d20a-11ec-8377-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1ac6b666-d20a-11ec-8377-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1ac6e316-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1ac70fb2-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1ac73d20-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1ac769da-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1ac79676-d20a-11ec-8377-0242ac110003 UniProtKB:P53778 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1ac7c326-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1ac7f04e-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1ac81ccc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1ac8497c-d20a-11ec-8377-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ac87686-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1ac8a34a-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1ac8cffa-d20a-11ec-8377-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1ac8fcb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1ac92bbc-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1ac95876-d20a-11ec-8377-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1ac984fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1ac9b212-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1ac9de9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1aca0b4a-d20a-11ec-8377-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1aca37d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1aca64dc-d20a-11ec-8377-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1aca927c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96Q40 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1acabf4a-d20a-11ec-8377-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1acaeda8-d20a-11ec-8377-0242ac110003 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1acb1a76-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1acb46f4-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1acb73a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1acba0c2-d20a-11ec-8377-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1acbcd7c-d20a-11ec-8377-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1acbfa0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1acc2718-d20a-11ec-8377-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1acc545e-d20a-11ec-8377-0242ac110003 UniProtKB:O15264 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.18']} DrugCentral uuid:1acc810e-d20a-11ec-8377-0242ac110003 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1accadaa-d20a-11ec-8377-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1accddb6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1acd0a52-d20a-11ec-8377-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.17']} DrugCentral uuid:1acd3702-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1acd642a-d20a-11ec-8377-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1acd90f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1acdbdb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1acdeada-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1ace1780-d20a-11ec-8377-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1ace441c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.18']} DrugCentral uuid:1ace70c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1ace9fc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1acecc52-d20a-11ec-8377-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1acefa38-d20a-11ec-8377-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1acf276a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1acf542e-d20a-11ec-8377-0242ac110003 UniProtKB:P49336 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1acf80de-d20a-11ec-8377-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1acfad8e-d20a-11ec-8377-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1acfdc14-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1ad008c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q00526 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1ad0357e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1ad063a0-d20a-11ec-8377-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1ad09046-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1ad0bd00-d20a-11ec-8377-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1ad0e988-d20a-11ec-8377-0242ac110003 UniProtKB:P00520 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:1ad1169c-d20a-11ec-8377-0242ac110003 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1ad14338-d20a-11ec-8377-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1ad16fe8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IVW4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Cyclin-dependent kinase-like 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:1ad19cde-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1ad1c984-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1ad1f616-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1ad222bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.57']} DrugCentral uuid:1ad2528c-d20a-11ec-8377-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1ad27f3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:1ad2abec-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1ad2d8ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1ad30592-d20a-11ec-8377-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1ad3321a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:1ad35fce-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1ad38ce2-d20a-11ec-8377-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1ad3b97e-d20a-11ec-8377-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1ad3e624-d20a-11ec-8377-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1ad415ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q5GIT4 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1ad44286-d20a-11ec-8377-0242ac110003 UniProtKB:P10398 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase A-Raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1ad46f18-d20a-11ec-8377-0242ac110003 UniProtKB:Q8T9Z7 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1ad49bbe-d20a-11ec-8377-0242ac110003 UniProtKB:P35917 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1ad4c8c8-d20a-11ec-8377-0242ac110003 UniProtKB:P05622 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1ad4f596-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:1ad5223c-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1ad54f6e-d20a-11ec-8377-0242ac110003 UniProtKB:P28028 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1ad57c0a-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1ad5a8ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1ad5d588-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:2459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:1ad603a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9QNF7 biolink:molecularly_interacts_with DrugCentral:2463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1ad63032-d20a-11ec-8377-0242ac110003 UniProtKB:P09250 biolink:molecularly_interacts_with DrugCentral:2463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorivudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1ad65d00-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XZT6 biolink:molecularly_interacts_with DrugCentral:2463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorivudine targets Kinase (Deoxynucleoside kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:1ad68b4a-d20a-11ec-8377-0242ac110003 UniProtKB:O00142 biolink:molecularly_interacts_with DrugCentral:2463 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sorivudine targets Kinase (Thymidine kinase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:1ad6b82c-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2464 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotalol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1ad6e4f0-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2464 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotalol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1ad7122c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2464 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotalol is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:1ad73efa-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2464 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1ad76bb4-d20a-11ec-8377-0242ac110003 UniProtKB:P54833 biolink:molecularly_interacts_with DrugCentral:2464 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1ad7983c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sparfloxacin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.413']} DrugCentral uuid:1ad7cd70-d20a-11ec-8377-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sparfloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:1ad7cd70-d20a-11ec-8377-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sparfloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:1ad804e8-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sparfloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:1ad804e8-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sparfloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:1ad837ec-d20a-11ec-8377-0242ac110003 UniProtKB:P0A7S3 biolink:molecularly_interacts_with DrugCentral:2468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spectinomycin targets Cytosolic other (30S ribosomal protein S12) DrugCentral uuid:1ad86082-d20a-11ec-8377-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:2469 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiclomazine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:1ad88d00-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1ad8b9ec-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:1ad8e728-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1ad913ce-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1ad940b0-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.65']} DrugCentral uuid:1ad96d7e-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1ad99bc8-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:1ad9c896-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1ad9f5e6-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1ada2318-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1ada4ffa-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.92']} DrugCentral uuid:1ada7cb4-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1adaa964-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.322']} DrugCentral uuid:1adad68c-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:1adb033c-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1adb2fe2-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1adb5e72-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:1adb8b22-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:1adbb7c8-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1adbe45a-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.297']} DrugCentral uuid:1adc118c-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1adc3f4a-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1adc6c22-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:1adc992c-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1adcc5e6-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:1adcf3fe-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1add20cc-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1add5132-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1add8166-d20a-11ec-8377-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1addae70-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:1adddb7a-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.87']} DrugCentral uuid:1ade0884-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1ade353e-d20a-11ec-8377-0242ac110003 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:1ade73be-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1ade73be-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1ade73be-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1ade73be-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1ade73be-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1adedf8e-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1adedf8e-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1adedf8e-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1adedf8e-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1adf46a4-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1adf46a4-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1adf46a4-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1adf46a4-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1adf46a4-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1adfaf40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1adfaf40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1adfaf40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1adffd6a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:1adffd6a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:1adffd6a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:1ae05508-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1ae05508-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1ae05508-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1ae05508-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1ae05508-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BLD9 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1ae0b3ae-d20a-11ec-8377-0242ac110003 UniProtKB:P02665 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets Unclassified (Beta-casein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:1ae0e216-d20a-11ec-8377-0242ac110003 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1ae10f16-d20a-11ec-8377-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:2470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spiperone targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1ae13be4-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2474 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spirapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1ae16894-d20a-11ec-8377-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:2474 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spirapril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.17']} DrugCentral uuid:1ae196fc-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.227']} DrugCentral uuid:1ae1c438-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:1ae1ec74-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone is antagonist of Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.884']} DrugCentral uuid:1ae219b0-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1ae2464c-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.029']} DrugCentral uuid:1ae272d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1ae29f7a-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:1ae2ce3c-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1ae2faf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.663']} DrugCentral uuid:1ae328aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2475 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spironolactone targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:1ae355a0-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.033']} DrugCentral uuid:1ae3823c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.327']} DrugCentral uuid:1ae3aee2-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:1ae3db9c-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:1ae40446-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.948']} DrugCentral uuid:1ae430f6-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.319']} DrugCentral uuid:1ae45d9c-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1ae48c04-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stanozolol targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.316']} DrugCentral uuid:1ae4bc06-d20a-11ec-8377-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:2478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stavudine targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:1ae4e74e-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stavudine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1ae51732-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2478 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stavudine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1ae54446-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stiripentol targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:1ae56c5a-d20a-11ec-8377-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:2480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stiripentol targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1ae59900-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stiripentol targets Enzyme (Cytochrome P450 1A2) DrugCentral uuid:1ae5c1a0-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stiripentol targets Enzyme (Cytochrome P450 2C19) DrugCentral uuid:1ae5e9be-d20a-11ec-8377-0242ac110003 UniProtKB:P9WH62 biolink:molecularly_interacts_with DrugCentral:2481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 streptomycin targets Ribosomal protein (30S ribosomal protein S12) DrugCentral uuid:1ae611dc-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:1ae63e82-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:1ae66cb8-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1ae6994a-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:1ae6c5fa-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1ae6fb9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:1ae6fb9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:1ae6fb9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:1ae74106-d20a-11ec-8377-0242ac110003 UniProtKB:P07727 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1ae76e9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYW0 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine targets GPCR (Taste receptor type 2 member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1ae79be2-d20a-11ec-8377-0242ac110003 UniProtKB:P59540 biolink:molecularly_interacts_with DrugCentral:2484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 strychnine is agonist of GPCR (Taste receptor type 2 member 46) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.367']} DrugCentral uuid:1ae7c86a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:2487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 succinic acid targets Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1ae7f65a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BXA5 biolink:molecularly_interacts_with DrugCentral:2487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 succinic acid is agonist of GPCR (Succinate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1ae822e2-d20a-11ec-8377-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suxamethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:1ae8623e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:1ae8623e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:1ae8623e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:1ae8623e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:1ae8623e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2489 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suxamethonium is agonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:1ae8b61c-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:1ae8e31c-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1ae90f90-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.301']} DrugCentral uuid:1ae93c2c-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:1ae9695e-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:1ae99618-d20a-11ec-8377-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1ae9cf66-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:1ae9cf66-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:1ae9cf66-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:1ae9cf66-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.7']} DrugCentral uuid:1aea22c2-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:1aea4f54-d20a-11ec-8377-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:2491 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sufentanil targets Unclassified (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1aea7bdc-d20a-11ec-8377-0242ac110003 UniProtKB:P00807 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1aeaa8f0-d20a-11ec-8377-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam is inhibitor of Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1aead5a0-d20a-11ec-8377-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:1aeb035e-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD63 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1aeb3112-d20a-11ec-8377-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1aeb5e6c-d20a-11ec-8377-0242ac110003 UniProtKB:P13661 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase OXA-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1aeb8b1c-d20a-11ec-8377-0242ac110003 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1aebb7c2-d20a-11ec-8377-0242ac110003 UniProtKB:A1E3K9 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1aebe6d4-d20a-11ec-8377-0242ac110003 UniProtKB:A8RR46 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:1aec1514-d20a-11ec-8377-0242ac110003 UniProtKB:Q6JP75 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Carbapenem-hydrolizing beta-lactamase SFC-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:1aec41ba-d20a-11ec-8377-0242ac110003 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1aec6f00-d20a-11ec-8377-0242ac110003 UniProtKB:Q50H31 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Unclassified (Class D beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1aec9bb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q7X575 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1aecc842-d20a-11ec-8377-0242ac110003 UniProtKB:Q0VTR6 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:1aecf4fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q0VTR8 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1aed224c-d20a-11ec-8377-0242ac110003 UniProtKB:D5HSX5 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1aed4ee8-d20a-11ec-8377-0242ac110003 UniProtKB:P83111 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Serine beta-lactamase-like protein LACTB, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1aed7b7a-d20a-11ec-8377-0242ac110003 UniProtKB:P62594 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1aedaaa0-d20a-11ec-8377-0242ac110003 UniProtKB:Q0VTS0 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (ADC-18 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.93']} DrugCentral uuid:1aeddad4-d20a-11ec-8377-0242ac110003 UniProtKB:P00809 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1aee077a-d20a-11ec-8377-0242ac110003 UniProtKB:D2SSQ3 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1aee342a-d20a-11ec-8377-0242ac110003 UniProtKB:Q3SAW3 biolink:molecularly_interacts_with DrugCentral:2492 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1aee61d4-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.819']} DrugCentral uuid:1aee8e8e-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.155']} DrugCentral uuid:1aeebb52-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.125']} DrugCentral uuid:1aeee884-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.697']} DrugCentral uuid:1aef1534-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:1aef41e4-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.716']} DrugCentral uuid:1aef6e9e-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.836']} DrugCentral uuid:1aef9edc-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.786']} DrugCentral uuid:1aefd050-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.977']} DrugCentral uuid:1af00098-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.053']} DrugCentral uuid:1af02dde-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.142']} DrugCentral uuid:1af05a8e-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.258']} DrugCentral uuid:1af0873e-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.727']} DrugCentral uuid:1af0b4c0-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.144']} DrugCentral uuid:1af0e18e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:1af10e3e-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:1af13ada-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.828']} DrugCentral uuid:1af16a6e-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:1af19296-d20a-11ec-8377-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1af1bf32-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:1af1ec64-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:1af2190a-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:1af245e2-d20a-11ec-8377-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.22']} DrugCentral uuid:1af27260-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.431']} DrugCentral uuid:1af29fe2-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.738']} DrugCentral uuid:1af2cc9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1af2f938-d20a-11ec-8377-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1af326ba-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.782']} DrugCentral uuid:1af35374-d20a-11ec-8377-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1af37ff2-d20a-11ec-8377-0242ac110003 UniProtKB:P40925 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Malate dehydrogenase cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1af3ac98-d20a-11ec-8377-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:2495 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1af3d98e-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfacetamide targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:1af40634-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfacetamide is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:1af42e34-d20a-11ec-8377-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:2497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfacetamide targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1af45f30-d20a-11ec-8377-0242ac110003 UniProtKB:Q25704 biolink:molecularly_interacts_with DrugCentral:2499 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfacytine is inhibitor of Kinase (7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; Dihydropteroate synthetase) DrugCentral uuid:1af4876c-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1af4b408-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1af4e090-d20a-11ec-8377-0242ac110003 UniProtKB:Q08210 biolink:molecularly_interacts_with DrugCentral:2500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) DrugCentral uuid:1af50a2a-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:1af5323e-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:2500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:1af55ee4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GZV3 biolink:molecularly_interacts_with DrugCentral:2500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1af58b8a-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadimethoxine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.206']} DrugCentral uuid:1af5b8d0-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2502 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadimidine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:1af5e0d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:2502 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadimidine targets Enzyme (Lactoylglutathione lyase) DrugCentral uuid:1af6090c-d20a-11ec-8377-0242ac110003 UniProtKB:Q25704 biolink:molecularly_interacts_with DrugCentral:2503 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadoxine is inhibitor of Kinase (7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; Dihydropteroate synthetase) DrugCentral uuid:1af631e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IAU3 biolink:molecularly_interacts_with DrugCentral:2503 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadoxine targets Unclassified (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1af65efc-d20a-11ec-8377-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:2504 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfaethidole targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1af68ba2-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfaguanidine targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.02']} DrugCentral uuid:1af6c0fe-d20a-11ec-8377-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:2505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfaguanidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:1af6c0fe-d20a-11ec-8377-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:2505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfaguanidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:1af6c0fe-d20a-11ec-8377-0242ac110003 UniProtKB:P35030 biolink:molecularly_interacts_with DrugCentral:2505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfaguanidine targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:1af70c76-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2510 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfamerazine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:1af734c6-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfameter is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:1af75cf8-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2512 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfamethizole is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:1af7857a-d20a-11ec-8377-0242ac110003 UniProtKB:P08192 biolink:molecularly_interacts_with DrugCentral:2514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfamethoxazole targets Enzyme (Bifunctional protein FolC) DrugCentral uuid:1af7ad98-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfamethoxazole is inhibitor of Enzyme (Dihydropteroate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1af7da3e-d20a-11ec-8377-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfamethoxazole targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1af8078e-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfamethoxazole targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1af83452-d20a-11ec-8377-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:2514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfamethoxazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1af86102-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2517 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfalene is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:1af88920-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1af8b814-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1af8e5fa-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1af912b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1af93ff0-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:1af96cbe-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:1af994fa-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1af9c1b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1af9ef40-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1afa1be6-d20a-11ec-8377-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1afa48be-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1afa7834-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1afaa778-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1afad43c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:1afb010a-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1afb2e3c-d20a-11ec-8377-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1afb5b0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1afb87ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:1afbb550-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1afbe200-d20a-11ec-8377-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:1afc0eba-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1afc3b6a-d20a-11ec-8377-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1afc6a90-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1afc9740-d20a-11ec-8377-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1afcc40e-d20a-11ec-8377-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1afcf136-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1afd1dfa-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1afd4abe-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:1afd785e-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1afda5d6-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1afdd2b8-d20a-11ec-8377-0242ac110003 UniProtKB:P00921 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1afdff5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:1afe2ce0-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1afe5972-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfanilamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1afe862c-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfaphenazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:1afeb2dc-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfaphenazole is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:1afedb90-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfapyridine is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:1aff03c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q49184 biolink:molecularly_interacts_with DrugCentral:2524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfapyridine targets Enzyme (Dihydropteroate synthase type-1) DrugCentral uuid:1aff2bea-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1aff596c-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1aff861c-d20a-11ec-8377-0242ac110003 UniProtKB:P24752 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Enzyme (Acetyl-CoA acetyltransferase, mitochondrial) DrugCentral uuid:1affae4e-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:1affd680-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPY5 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Transporter (Cystine/glutamate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1b0003f8-d20a-11ec-8377-0242ac110003 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1b003134-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.707']} DrugCentral uuid:1b005dee-d20a-11ec-8377-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.628']} DrugCentral uuid:1b008a9e-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.533']} DrugCentral uuid:1b00b7da-d20a-11ec-8377-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine is inhibitor of Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:1b00e5a2-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.768']} DrugCentral uuid:1b011252-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.198']} DrugCentral uuid:1b014402-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:1b014402-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:1b017760-d20a-11ec-8377-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1b01a42e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfasalazine targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1b01d282-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfathiazole is inhibitor of Enzyme (Dihydropteroate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1b020018-d20a-11ec-8377-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:2527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfathiazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.161']} DrugCentral uuid:1b022cc8-d20a-11ec-8377-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:2527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfathiazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:1b025978-d20a-11ec-8377-0242ac110003 UniProtKB:P25084 biolink:molecularly_interacts_with DrugCentral:2527 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfathiazole targets Unclassified (Transcriptional activator protein LasR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1b028664-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfinpyrazone targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:1b02ae78-d20a-11ec-8377-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:2528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfinpyrazone targets GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1b02db3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:2528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfinpyrazone is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1b030850-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:2528 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfinpyrazone targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1b0334ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfafurazole targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1b03617e-d20a-11ec-8377-0242ac110003 UniProtKB:Q08210 biolink:molecularly_interacts_with DrugCentral:2529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfafurazole targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) DrugCentral uuid:1b03899c-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:2529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfafurazole is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:1b03b340-d20a-11ec-8377-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:2529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfafurazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1b03dffa-d20a-11ec-8377-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:2529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfafurazole targets GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:1b040ca0-d20a-11ec-8377-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:2529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfafurazole targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1b0439e6-d20a-11ec-8377-0242ac110003 UniProtKB:O60760 biolink:molecularly_interacts_with DrugCentral:2531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfobromophthalein targets Enzyme (Hematopoietic prostaglandin D synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1b04668c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulforidazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.611']} DrugCentral uuid:1b04933c-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2532 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulforidazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:1b04c00a-d20a-11ec-8377-0242ac110003 UniProtKB:P0C0X1 biolink:molecularly_interacts_with DrugCentral:2533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldesulfone is inhibitor of Enzyme (Dihydropteroate synthase 1) DrugCentral uuid:1b04e8a0-d20a-11ec-8377-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:2533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldesulfone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) DrugCentral uuid:1b0510fa-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1b053db4-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1b056a46-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1b059868-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1b05c504-d20a-11ec-8377-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.08']} DrugCentral uuid:1b05f1a0-d20a-11ec-8377-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Enzyme (72 kDa type IV collagenase) DrugCentral uuid:1b061a72-d20a-11ec-8377-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1b06472c-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.362']} DrugCentral uuid:1b0673be-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1b06a168-d20a-11ec-8377-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1b06cefe-d20a-11ec-8377-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1b06fb90-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.06']} DrugCentral uuid:1b07298a-d20a-11ec-8377-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:2534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulindac targets Unclassified (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1b07582e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1b0784f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.307']} DrugCentral uuid:1b07b1c0-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.177']} DrugCentral uuid:1b07de7a-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.857']} DrugCentral uuid:1b080bde-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.508']} DrugCentral uuid:1b0838b6-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.224']} DrugCentral uuid:1b08657a-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.146']} DrugCentral uuid:1b0892f2-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.606']} DrugCentral uuid:1b08bfb6-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.053']} DrugCentral uuid:1b08ec84-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.965']} DrugCentral uuid:1b091920-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.009']} DrugCentral uuid:1b094846-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.196']} DrugCentral uuid:1b09750a-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.492']} DrugCentral uuid:1b09a1d8-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.426']} DrugCentral uuid:1b09cf14-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1b09fbce-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:1b0a2874-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.679']} DrugCentral uuid:1b0a55d8-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1b0a827e-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.141']} DrugCentral uuid:1b0aaf24-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.645']} DrugCentral uuid:1b0adbca-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suloctidil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1b0b0c3a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:1b0b3958-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.121']} DrugCentral uuid:1b0b6626-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1b0b9362-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1b0bc026-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:1b0becd6-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1b0c199a-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1b0c46ea-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:1b0c73b8-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:1b0ca09a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1b0cce76-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:1b0cfaa4-d20a-11ec-8377-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1b0d22f4-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:1b0d4bbc-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1b0d7498-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1b0d9e1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GJU1 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1b0dc66e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1b0deedc-d20a-11ec-8377-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:1b0e17ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1b0e404e-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:1b0e688a-d20a-11ec-8377-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1b0e90da-d20a-11ec-8377-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1b0ebc68-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1b0ee4cc-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1b0f0cfe-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1b0f3544-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1b0f5efc-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:1b0f96c4-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1b0f96c4-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1b0f96c4-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1b0f96c4-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1b0f96c4-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1b0fec0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:1b101464-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:1b103cc8-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2537 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulpiride targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:1b10652c-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1b108e3a-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.46']} DrugCentral uuid:1b10b68a-d20a-11ec-8377-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone targets GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.111']} DrugCentral uuid:1b10dee4-d20a-11ec-8377-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1b11073e-d20a-11ec-8377-0242ac110003 UniProtKB:P35375 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1b112fe8-d20a-11ec-8377-0242ac110003 UniProtKB:P30557 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:1b115838-d20a-11ec-8377-0242ac110003 UniProtKB:P34980 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.38']} DrugCentral uuid:1b11804c-d20a-11ec-8377-0242ac110003 UniProtKB:P70597 biolink:molecularly_interacts_with DrugCentral:2538 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulprostone is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1b11a950-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1b11d178-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1b11f9c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:1b122204-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:1b124b94-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1b127614-d20a-11ec-8377-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:1b129e50-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1b12c6aa-d20a-11ec-8377-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1b12ef68-d20a-11ec-8377-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.91']} DrugCentral uuid:1b131916-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:1b134292-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1b136ad8-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1b1393d2-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1b13bc36-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:1b13e49a-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1b140cea-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2540 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultiame targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:1b1435e4-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2541 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultopride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.571']} DrugCentral uuid:1b145e20-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2541 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sultopride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1b148670-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1b14aeca-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1b14d7d8-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:1b14fff6-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1b15283c-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:1b1550dc-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.26']} DrugCentral uuid:1b157954-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:1b15a1cc-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:1b15ca12-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1b15f384-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1b161cec-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1b16451e-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1b166d64-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1b16962c-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1b16be68-d20a-11ec-8377-0242ac110003 UniProtKB:P79400 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1b16e6a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1b171002-d20a-11ec-8377-0242ac110003 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:1b1738b6-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1b176110-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1b178942-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N2B7 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:1b17b188-d20a-11ec-8377-0242ac110003 UniProtKB:Q8MI13 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan targets Unclassified (5-hydroxytryptamine 1D receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:1b17dc30-d20a-11ec-8377-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:2543 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sumatriptan is agonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1b180480-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1b182cd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1b18550c-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1b187dfc-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.12']} DrugCentral uuid:1b18a660-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1b18ceba-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.68']} DrugCentral uuid:1b18f782-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1b192040-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1b1949b2-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1b19720c-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1b199b74-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1b19c658-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.66']} DrugCentral uuid:1b19eebc-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1b1a1716-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1b1a4006-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1b1a6874-d20a-11ec-8377-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1b1a90a6-d20a-11ec-8377-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1b1ab8ce-d20a-11ec-8377-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1b1ae182-d20a-11ec-8377-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1b1b0ab8-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1b1b3312-d20a-11ec-8377-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1b1b5b4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1b1b856a-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1b1bad92-d20a-11ec-8377-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1b1bd5ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1b1bfe0a-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:1b1c26fa-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1b1c4f40-d20a-11ec-8377-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1b1c777c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1b1c9fd6-d20a-11ec-8377-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1b1cc894-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1b1cf0c6-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1b1d1920-d20a-11ec-8377-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1b1d426a-d20a-11ec-8377-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1b1d6ace-d20a-11ec-8377-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1b1d931e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:1b1dbb64-d20a-11ec-8377-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1b1de47c-d20a-11ec-8377-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1b1e0cb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1b1e34f4-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1b1e5d30-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1b1e85c6-d20a-11ec-8377-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1b1eae0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1b1ed648-d20a-11ec-8377-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1b1eff92-d20a-11ec-8377-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1b1f2b02-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1b1f5424-d20a-11ec-8377-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.26']} DrugCentral uuid:1b1f7c6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q00535 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent-like kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1b1fa4c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1b1fcdaa-d20a-11ec-8377-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1b1ff5fa-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1b201e36-d20a-11ec-8377-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1b20467c-d20a-11ec-8377-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1b206f26-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1b209776-d20a-11ec-8377-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1b20bfa8-d20a-11ec-8377-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1b20e7e4-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1b2113cc-d20a-11ec-8377-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1b213cc6-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1b21650c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1b218e1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1b21b656-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:1b21de88-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1b2206c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1b222f46-d20a-11ec-8377-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1b22578c-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1b227fbe-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1b22a7e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1b22d130-d20a-11ec-8377-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1b22fa5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.26']} DrugCentral uuid:1b2322d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P1W9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase pim-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1b234afc-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1b2373d8-d20a-11ec-8377-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1b239c1e-d20a-11ec-8377-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1b23c450-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2H1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 38-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1b23ec8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:1b24157c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1b243db8-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1b2465f4-d20a-11ec-8377-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:1b248e76-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1b24b7fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1b24e042-d20a-11ec-8377-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1b250888-d20a-11ec-8377-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1b253286-d20a-11ec-8377-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1b255ad6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:1b258326-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1b25ab76-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1b25d484-d20a-11ec-8377-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1b25fcca-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1b262574-d20a-11ec-8377-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1b264da6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1b2676e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1b269f18-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1b26c75e-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1b26f08a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1b27195c-d20a-11ec-8377-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1b2741ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1b276a06-d20a-11ec-8377-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1b279256-d20a-11ec-8377-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1b27bb50-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JI10 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1b27e396-d20a-11ec-8377-0242ac110003 UniProtKB:Q3U3Q1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1b280bf0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1b283436-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1b285dbc-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1b28860c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1b28ae52-d20a-11ec-8377-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:1b28d698-d20a-11ec-8377-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1b28ff42-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1b29279c-d20a-11ec-8377-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:1b294fe2-d20a-11ec-8377-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1b2978fa-d20a-11ec-8377-0242ac110003 UniProtKB:P31751 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (RAC-beta serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1b29a140-d20a-11ec-8377-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1b29c990-d20a-11ec-8377-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:1b29f1ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1b2a1ada-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1b2a4320-d20a-11ec-8377-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1b2a6b66-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1b2a9398-d20a-11ec-8377-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1b2abc56-d20a-11ec-8377-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1b2ae596-d20a-11ec-8377-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1b2b0dd2-d20a-11ec-8377-0242ac110003 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1b2b373a-d20a-11ec-8377-0242ac110003 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1b2b605c-d20a-11ec-8377-0242ac110003 UniProtKB:Q07002 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 18) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1b2b88a2-d20a-11ec-8377-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1b2bb0e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1b2bd94c-d20a-11ec-8377-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1b2c043a-d20a-11ec-8377-0242ac110003 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1b2c2c62-d20a-11ec-8377-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1b2c54a8-d20a-11ec-8377-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1b2c7cee-d20a-11ec-8377-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1b2ca642-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:1b2cce88-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N752 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase I isoform alpha-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1b2cf6ba-d20a-11ec-8377-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1b2d1f82-d20a-11ec-8377-0242ac110003 UniProtKB:P78368 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase I isoform gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1b2d47dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase I isoform gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1b2d7022-d20a-11ec-8377-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1b2d985e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:1b2dc1a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q86UE8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase tousled-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1b2de9e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1b2e120c-d20a-11ec-8377-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1b2e3a52-d20a-11ec-8377-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1b2e62e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1b2e8b24-d20a-11ec-8377-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1b2eb37e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:1b2edcbe-d20a-11ec-8377-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1b2f05e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1b2f2e30-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1b2f568a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1b2f7ed0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1b2fa9aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1b2fd218-d20a-11ec-8377-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1b2ffa40-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1b30227c-d20a-11ec-8377-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1b304b1c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1b30736c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1b309bbc-d20a-11ec-8377-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1b30c416-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1b30ed1a-d20a-11ec-8377-0242ac110003 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1b31156a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1b313ed2-d20a-11ec-8377-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1b316844-d20a-11ec-8377-0242ac110003 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1b31908a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1b31b8da-d20a-11ec-8377-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1b31e120-d20a-11ec-8377-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1b3209c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1b323224-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1b325a42-d20a-11ec-8377-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:1b328260-d20a-11ec-8377-0242ac110003 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1b32ab46-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1b32d486-d20a-11ec-8377-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1b32fcd6-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1b332526-d20a-11ec-8377-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1b335046-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDC3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase BRSK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1b3378f0-d20a-11ec-8377-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1b33a122-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1b33c968-d20a-11ec-8377-0242ac110003 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1b33f208-d20a-11ec-8377-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1b341a58-d20a-11ec-8377-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1b344294-d20a-11ec-8377-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1b346ae4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16566 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type IV) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1b3493e8-d20a-11ec-8377-0242ac110003 UniProtKB:P11799 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1b34bc10-d20a-11ec-8377-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1b34e460-d20a-11ec-8377-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1b350c9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1b353604-d20a-11ec-8377-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:1b355e5e-d20a-11ec-8377-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1b3586c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HCP0 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase I isoform gamma-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1b35af6c-d20a-11ec-8377-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1b35d7b2-d20a-11ec-8377-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1b35ffee-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1b36282a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NEV4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Myosin-IIIa) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1b3650d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1b3678f2-d20a-11ec-8377-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1b36a11a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IWQ3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase BRSK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1b36ca6e-d20a-11ec-8377-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1b36f4b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:1b371fd2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1b37498a-d20a-11ec-8377-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1b3771e4-d20a-11ec-8377-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1b379a84-d20a-11ec-8377-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1b37c2f2-d20a-11ec-8377-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1b37eb38-d20a-11ec-8377-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1b381388-d20a-11ec-8377-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:1b383c78-d20a-11ec-8377-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:1b3864c8-d20a-11ec-8377-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1b388cf0-d20a-11ec-8377-0242ac110003 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1b38b52c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1b38de44-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1b390676-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1b392ea8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:1b39575c-d20a-11ec-8377-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1b397f8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1b39a7d4-d20a-11ec-8377-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1b39d01a-d20a-11ec-8377-0242ac110003 UniProtKB:P80370 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Unclassified (Protein delta homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1b39f98c-d20a-11ec-8377-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1b3a21d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1b3a4a18-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1b3a7240-d20a-11ec-8377-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1b3a9c34-d20a-11ec-8377-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1b3ac858-d20a-11ec-8377-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1b3af09e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1b3b18d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1b3b4184-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:1b3b69c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1b3b9210-d20a-11ec-8377-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1b3bba56-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1b3be33c-d20a-11ec-8377-0242ac110003 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1b3c0b96-d20a-11ec-8377-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1b3c33d2-d20a-11ec-8377-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:1b3c5c2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1b3c881e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1b3cb366-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1b3cdbd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q15208 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1b3d0492-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1b3d2cf6-d20a-11ec-8377-0242ac110003 UniProtKB:O95747 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase OSR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1b3d5668-d20a-11ec-8377-0242ac110003 UniProtKB:O43172 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Nuclear other (U4/U6 small nuclear ribonucleoprotein Prp4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1b3d7ea4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:1b3da78a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.23']} DrugCentral uuid:1b3dcfe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1b3df82a-d20a-11ec-8377-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:1b3e205c-d20a-11ec-8377-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1b3e4aa0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1b3e75fc-d20a-11ec-8377-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1b3ea1a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1b3eca02-d20a-11ec-8377-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:1b3ef2a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1b3f1ad4-d20a-11ec-8377-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1b3f4310-d20a-11ec-8377-0242ac110003 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1b3f6b56-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1b3f9450-d20a-11ec-8377-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1b3fbcd2-d20a-11ec-8377-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1b3fe4fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1b400e4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1b403680-d20a-11ec-8377-0242ac110003 UniProtKB:P42679 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Megakaryocyte-associated tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1b405eda-d20a-11ec-8377-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1b40870c-d20a-11ec-8377-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1b40afb6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1b40d7de-d20a-11ec-8377-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1b410042-d20a-11ec-8377-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1b412914-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRH2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (SNF-related serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1b41520e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1b417a4a-d20a-11ec-8377-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1b41a290-d20a-11ec-8377-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:1b41cacc-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1b41f498-d20a-11ec-8377-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1b421cca-d20a-11ec-8377-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1b424510-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H8M2 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Unclassified (Bromodomain-containing protein 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1b426d42-d20a-11ec-8377-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1b4296dc-d20a-11ec-8377-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.509']} DrugCentral uuid:1b42bf40-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1b42e7c2-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.229']} DrugCentral uuid:1b43103a-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:2544 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sunitinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.959']} DrugCentral uuid:1b43393e-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1b43629c-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suprofen is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1b438ad8-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2546 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suprofen targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.347']} DrugCentral uuid:1b43b3c8-d20a-11ec-8377-0242ac110003 UniProtKB:P47872 biolink:molecularly_interacts_with DrugCentral:2548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secretin human is agonist of GPCR (Secretin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1b43dc4a-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1b44049a-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1b442cc2-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.523']} DrugCentral uuid:1b445576-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.954']} DrugCentral uuid:1b447dda-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1b44a620-d20a-11ec-8377-0242ac110003 UniProtKB:Q04844 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Ion channel (Acetylcholine receptor subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1b44ce48-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1b44f710-d20a-11ec-8377-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1b451f42-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:1b45477e-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1b456f9c-d20a-11ec-8377-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1b45999a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1b45c49c-d20a-11ec-8377-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1b45ecec-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1b46151e-d20a-11ec-8377-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1b463db4-d20a-11ec-8377-0242ac110003 UniProtKB:P32738 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Choline O-acetyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:1b466604-d20a-11ec-8377-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1b468f3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ERZ4 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1b46b794-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1b46e07a-d20a-11ec-8377-0242ac110003 UniProtKB:Q03311 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1b470924-d20a-11ec-8377-0242ac110003 UniProtKB:Q01984 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Histamine N-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1b473156-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1b47599c-d20a-11ec-8377-0242ac110003 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1b4784bc-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.61']} DrugCentral uuid:1b47b0f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:1b47b0f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13224 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:1b47e83a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1b47e83a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12879 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Ion channel (Glutamate NMDA receptor; GRIN1/GRIN2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1b482b56-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1b482b56-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1b482b56-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1b482b56-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1b482b56-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1b487fe8-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.91']} DrugCentral uuid:1b48a8ec-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:2551 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrine is inhibitor of Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.301']} DrugCentral uuid:1b48d25e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1b48faa4-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1b4922c2-d20a-11ec-8377-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:1b494c52-d20a-11ec-8377-0242ac110003 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Cytokine (Interferon gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.22']} DrugCentral uuid:1b49747a-d20a-11ec-8377-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.398']} DrugCentral uuid:1b499cb6-d20a-11ec-8377-0242ac110003 UniProtKB:P60568 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Cytokine (Interleukin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.72']} DrugCentral uuid:1b49c4e8-d20a-11ec-8377-0242ac110003 UniProtKB:P48454 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:1b49ee64-d20a-11ec-8377-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:1b4a16a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1b4a3ee6-d20a-11ec-8377-0242ac110003 UniProtKB:P68106 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1b4a6718-d20a-11ec-8377-0242ac110003 UniProtKB:Q13451 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1b4a8fea-d20a-11ec-8377-0242ac110003 UniProtKB:Q15393 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Nuclear other (Splicing factor 3B subunit 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1b4ab812-d20a-11ec-8377-0242ac110003 UniProtKB:Q96AY3 biolink:molecularly_interacts_with DrugCentral:2552 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacrolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.02']} DrugCentral uuid:1b4ae01c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1b4b0970-d20a-11ec-8377-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1b4b31ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1b4b59fc-d20a-11ec-8377-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:1b4b822e-d20a-11ec-8377-0242ac110003 UniProtKB:O54735 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1b4baace-d20a-11ec-8377-0242ac110003 UniProtKB:Q28156 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:1b4bd300-d20a-11ec-8377-0242ac110003 UniProtKB:P11541 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1b4c0eba-d20a-11ec-8377-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1b4c0eba-d20a-11ec-8377-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1b4c0eba-d20a-11ec-8377-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1b4c0eba-d20a-11ec-8377-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1b4c0eba-d20a-11ec-8377-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1b4c0eba-d20a-11ec-8377-0242ac110003 UniProtKB:Q13956 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1b4c823c-d20a-11ec-8377-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1b4c823c-d20a-11ec-8377-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1b4c823c-d20a-11ec-8377-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1b4c823c-d20a-11ec-8377-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1b4c823c-d20a-11ec-8377-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1b4c823c-d20a-11ec-8377-0242ac110003 UniProtKB:Q95142 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Phosphodiesterase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1b4ce43e-d20a-11ec-8377-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:2553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tadalafil targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4d479e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2556 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talbutal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b4dff72-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talinolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1b4e284e-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talinolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1b4e5076-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talinolol targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:1b4e74c0-d20a-11ec-8377-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talinolol targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1b4e9cfc-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talinolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1b4ec63c-d20a-11ec-8377-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talinolol targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1b4eee82-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.309']} DrugCentral uuid:1b4f16b4-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.915']} DrugCentral uuid:1b4f3efa-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1b4f67c2-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:1b4f8fea-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:1b4fb916-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1b4fe148-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.695']} DrugCentral uuid:1b500a38-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1b503292-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1b505aec-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1b508350-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1b50b456-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1b50b456-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1b50b456-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2558 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talipexole targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1b50f2e0-d20a-11ec-8377-0242ac110003 UniProtKB:P34981 biolink:molecularly_interacts_with DrugCentral:2560 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 taltirelin is agonist of GPCR (Thyrotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1b511b44-d20a-11ec-8377-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.807']} DrugCentral uuid:1b5143e4-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.001']} DrugCentral uuid:1b516c52-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1b51948e-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.357']} DrugCentral uuid:1b51bcf2-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.146']} DrugCentral uuid:1b51e592-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.372']} DrugCentral uuid:1b520f22-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.335']} DrugCentral uuid:1b523772-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1b526116-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.139']} DrugCentral uuid:1b528bbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:1b52b40e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1b52dc36-d20a-11ec-8377-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.301']} DrugCentral uuid:1b53051c-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1b532d6c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.907']} DrugCentral uuid:1b5355c6-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.836']} DrugCentral uuid:1b537efc-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.158']} DrugCentral uuid:1b53a7ba-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.863']} DrugCentral uuid:1b53d00a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.877']} DrugCentral uuid:1b53f864-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.618']} DrugCentral uuid:1b5420b4-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:1b544c06-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.794']} DrugCentral uuid:1b54744c-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:1b549ca6-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.034']} DrugCentral uuid:1b54c500-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.167']} DrugCentral uuid:1b54ee18-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.557']} DrugCentral uuid:1b551668-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.201']} DrugCentral uuid:1b553ecc-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.173']} DrugCentral uuid:1b557a68-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.731']} DrugCentral uuid:1b55b226-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.658']} DrugCentral uuid:1b55da62-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.238']} DrugCentral uuid:1b5603ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.835']} DrugCentral uuid:1b562e54-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.858']} DrugCentral uuid:1b5656b8-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.679']} DrugCentral uuid:1b567f08-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:1b56a7e4-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.407']} DrugCentral uuid:1b56d020-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.611']} DrugCentral uuid:1b56f866-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.204']} DrugCentral uuid:1b5720f2-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1b5749e2-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1b577228-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.328']} DrugCentral uuid:1b579bae-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:1b57c3f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q99527 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (G-protein coupled estrogen receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.5']} DrugCentral uuid:1b57ee38-d20a-11ec-8377-0242ac110003 UniProtKB:P62508 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Nuclear hormone receptor (Estrogen-related receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1b5819a8-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.449']} DrugCentral uuid:1b58432e-d20a-11ec-8377-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.069']} DrugCentral uuid:1b586b9c-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.095']} DrugCentral uuid:1b589450-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.923']} DrugCentral uuid:1b58bcaa-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:1b58e4f0-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.038']} DrugCentral uuid:1b590d36-d20a-11ec-8377-0242ac110003 UniProtKB:P11474 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Nuclear hormone receptor (Steroid hormone receptor ERR1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1b593644-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.913']} DrugCentral uuid:1b595ebc-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.821']} DrugCentral uuid:1b59870c-d20a-11ec-8377-0242ac110003 UniProtKB:P30411 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.919']} DrugCentral uuid:1b59b02e-d20a-11ec-8377-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.533']} DrugCentral uuid:1b59d87e-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.604']} DrugCentral uuid:1b5a00d8-d20a-11ec-8377-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.761']} DrugCentral uuid:1b5a2928-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.419']} DrugCentral uuid:1b5a52c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.515']} DrugCentral uuid:1b5a7afe-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.587']} DrugCentral uuid:1b5aa33a-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1b5acb6c-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1b5af45c-d20a-11ec-8377-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1b5b1c98-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.061']} DrugCentral uuid:1b5b44c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BY08 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Emopamil-binding protein-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.55']} DrugCentral uuid:1b5b710c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBM7 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Anti-estrogen binding site (AEBS)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:1b5b710c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBM7 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Enzyme (Anti-estrogen binding site (AEBS)) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:1b5ba938-d20a-11ec-8377-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2561 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamoxifen targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1b5bd19c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1b5bfa14-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.87']} DrugCentral uuid:1b5c22f0-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1b5c4b54-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:1b5c73ae-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.54']} DrugCentral uuid:1b5c9c1c-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:1b5cc52a-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1b5ceda2-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.24']} DrugCentral uuid:1b5d15f2-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:1b5d3e60-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.52']} DrugCentral uuid:1b5d6854-d20a-11ec-8377-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:1b5d90a4-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:1b5db8fe-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:1b5de158-d20a-11ec-8377-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1b5e15b0-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1b5e15b0-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1b5e15b0-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1b5e15b0-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamsulosin targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1b5e60ce-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tandospirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:1b5e890a-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tandospirone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:1b5eb204-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2563 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tandospirone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:1b5eda72-d20a-11ec-8377-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:2571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1b5f02fe-d20a-11ec-8377-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:2571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1b5f2d1a-d20a-11ec-8377-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:2571 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1b5f5556-d20a-11ec-8377-0242ac110003 UniProtKB:P00808 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1b5f7d74-d20a-11ec-8377-0242ac110003 UniProtKB:P00807 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.527']} DrugCentral uuid:1b5fa632-d20a-11ec-8377-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam is inhibitor of Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.602']} DrugCentral uuid:1b5fced2-d20a-11ec-8377-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1b5ff704-d20a-11ec-8377-0242ac110003 UniProtKB:Q59401 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1b601f2c-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD63 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:1b604768-d20a-11ec-8377-0242ac110003 UniProtKB:P10424 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.524']} DrugCentral uuid:1b607044-d20a-11ec-8377-0242ac110003 UniProtKB:Q46991 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (IMI-1; IMI-1 carbapenemase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1b6098a8-d20a-11ec-8377-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1b60c0c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q6W9J1 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1b60e90c-d20a-11ec-8377-0242ac110003 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1b611364-d20a-11ec-8377-0242ac110003 UniProtKB:P94958 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1b613eca-d20a-11ec-8377-0242ac110003 UniProtKB:P05193 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1b616a3a-d20a-11ec-8377-0242ac110003 UniProtKB:A4KCT8 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1b619596-d20a-11ec-8377-0242ac110003 UniProtKB:A1E3K9 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1b61be68-d20a-11ec-8377-0242ac110003 UniProtKB:A8RR46 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1b61e69a-d20a-11ec-8377-0242ac110003 UniProtKB:Q6JP75 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Carbapenem-hydrolizing beta-lactamase SFC-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1b620eb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9F663 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Carbepenem-hydrolyzing beta-lactamase KPC) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:1b62371c-d20a-11ec-8377-0242ac110003 UniProtKB:A2RP81 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:1b625fbc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9EXV5 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1b6287f8-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD64 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase SHV-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1b62b020-d20a-11ec-8377-0242ac110003 UniProtKB:Q6GWS8 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1b62d956-d20a-11ec-8377-0242ac110003 UniProtKB:D1MIX9 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase GES-13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1b63019c-d20a-11ec-8377-0242ac110003 UniProtKB:A0ZX81 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1b6329ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q50H31 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Unclassified (Class D beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1b6352fa-d20a-11ec-8377-0242ac110003 UniProtKB:B8R6A5 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1b637b9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q2XPY6 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:1b63a3c2-d20a-11ec-8377-0242ac110003 UniProtKB:D2SSQ3 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1b63cc26-d20a-11ec-8377-0242ac110003 UniProtKB:Q3SAW3 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1b63f5a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q670S6 biolink:molecularly_interacts_with DrugCentral:2572 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazobactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1b641ea6-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tegaserod targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1b6446c4-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tegaserod targets GPCR (5-hydroxytryptamine receptor 1A) DrugCentral uuid:1b646afa-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tegaserod is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1b649340-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tegaserod targets GPCR (5-hydroxytryptamine receptor 1D) DrugCentral uuid:1b64b834-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tegaserod targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1b64e098-d20a-11ec-8377-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:2579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tegaserod is partial agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1b650910-d20a-11ec-8377-0242ac110003 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:2580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teicoplanin aglycone is inhibitor of Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.78']} DrugCentral uuid:1b65314c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2581 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telithromycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1b6559f6-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1b658232-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1b65aafa-d20a-11ec-8377-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.31']} DrugCentral uuid:1b65d34a-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1b65fc08-d20a-11ec-8377-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:1b662458-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1b664c94-d20a-11ec-8377-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:1b6674e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2583 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telmisartan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1b66a054-d20a-11ec-8377-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temazepam targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:1b66cc78-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1b66cc78-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1b66cc78-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2585 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temazepam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1b6703fa-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2586 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temocapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.444']} DrugCentral uuid:1b672d6c-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2586 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temocapril is inhibitor of Enzyme (Angiotensin-converting enzyme) DrugCentral uuid:1b6751a2-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2590 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teniposide targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:1b6775d8-d20a-11ec-8377-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:2590 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teniposide is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:1b679a18-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2590 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teniposide targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:1b67bed0-d20a-11ec-8377-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:2590 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teniposide targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:1b67e2f2-d20a-11ec-8377-0242ac110003 UniProtKB:O15438 biolink:molecularly_interacts_with DrugCentral:2590 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teniposide targets Transporter (Canalicular multispecific organic anion transporter 2) DrugCentral uuid:1b68071e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenofovir targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1b682f50-d20a-11ec-8377-0242ac110003 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:2592 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenofovir targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1b6858a4-d20a-11ec-8377-0242ac110003 UniProtKB:P03369 biolink:molecularly_interacts_with DrugCentral:2593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenofovir disoproxil targets Polyprotein (Gag-Pol polyprotein) DrugCentral uuid:1b687fa0-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2593 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenofovir disoproxil is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:1b68a660-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2595 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenoxicam targets Enzyme (Prostaglandin G/H synthase 2) DrugCentral uuid:1b68ccbc-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2595 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenoxicam targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.943']} DrugCentral uuid:1b68f570-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.67']} DrugCentral uuid:1b691dca-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.628']} DrugCentral uuid:1b694610-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.388']} DrugCentral uuid:1b696f8c-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:1b699886-d20a-11ec-8377-0242ac110003 UniProtKB:Q14534 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1b69c0f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q4JEY0 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine is inhibitor of Enzyme (Squalene epoxidase) DrugCentral uuid:1b69e534-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.662']} DrugCentral uuid:1b6a0dac-d20a-11ec-8377-0242ac110003 UniProtKB:P52020 biolink:molecularly_interacts_with DrugCentral:2597 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbinafine targets Enzyme (Squalene monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:1b6a3782-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2598 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbutaline is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1b6a6130-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2598 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terbutaline targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1b6a8980-d20a-11ec-8377-0242ac110003 UniProtKB:O00337 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Transporter (Sodium/nucleoside cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.373']} DrugCentral uuid:1b6ab1c6-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.609']} DrugCentral uuid:1b6ada66-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.895']} DrugCentral uuid:1b6b02b6-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.433']} DrugCentral uuid:1b6b2b06-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:1b6b54be-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.216']} DrugCentral uuid:1b6b7db8-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.599']} DrugCentral uuid:1b6ba61c-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.632']} DrugCentral uuid:1b6bce6c-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.438']} DrugCentral uuid:1b6bf6bc-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.904']} DrugCentral uuid:1b6c21a0-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:1b6c4a04-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.862']} DrugCentral uuid:1b6c7254-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.338']} DrugCentral uuid:1b6c9b12-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.511']} DrugCentral uuid:1b6cc34e-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.718']} DrugCentral uuid:1b6ceb9e-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.504']} DrugCentral uuid:1b6d13d0-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:1b6d3cac-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.362']} DrugCentral uuid:1b6d64fc-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1b6d8d74-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:1b6db196-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.666']} DrugCentral uuid:1b6ddb44-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.963']} DrugCentral uuid:1b6e0614-d20a-11ec-8377-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1b6e2e5a-d20a-11ec-8377-0242ac110003 UniProtKB:P23711 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Enzyme (Heme oxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1b6e5682-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.612']} DrugCentral uuid:1b6e7f72-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.102']} DrugCentral uuid:1b6ea7b8-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.389']} DrugCentral uuid:1b6ed012-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:1b6ef84e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:1b6f20f8-d20a-11ec-8377-0242ac110003 UniProtKB:P23711 biolink:molecularly_interacts_with DrugCentral:2599 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terconazole targets Enzyme (Heme oxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1b6f4a06-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.874']} DrugCentral uuid:1b6f7382-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.687']} DrugCentral uuid:1b6f9bd2-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.252']} DrugCentral uuid:1b6fc698-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:1b6feede-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.719']} DrugCentral uuid:1b701724-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.137']} DrugCentral uuid:1b703f74-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:1b706896-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1b7090dc-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:1b70b92c-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.292']} DrugCentral uuid:1b70e1f4-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1b710ac6-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1b7132ee-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.264']} DrugCentral uuid:1b715b66-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.693']} DrugCentral uuid:1b7184f6-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.448']} DrugCentral uuid:1b71b03e-d20a-11ec-8377-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1b71db18-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.213']} DrugCentral uuid:1b720354-d20a-11ec-8377-0242ac110003 UniProtKB:P51589 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Enzyme (Cytochrome P450 2J2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1b722c3a-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1b725476-d20a-11ec-8377-0242ac110003 UniProtKB:O95259 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine is blocker of Ion channel (Potassium voltage-gated channel subfamily H member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1b727ca8-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.734']} DrugCentral uuid:1b72a4f8-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.45']} DrugCentral uuid:1b72cd98-d20a-11ec-8377-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1b72fd86-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:1b72fd86-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:1b72fd86-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:1b733d0a-d20a-11ec-8377-0242ac110003 UniProtKB:P12746 biolink:molecularly_interacts_with DrugCentral:2600 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terfenadine targets Unclassified (Transcriptional activator protein luxR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1b73676c-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1b7392aa-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1b73bd84-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:1b73e5d4-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1b740ee2-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:1b74373c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:1b745f82-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1b74884a-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.5']} DrugCentral uuid:1b74b090-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1b74d91c-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1b750176-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:1b752c28-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1b755478-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1b757cdc-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1b75a52c-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1b75ce08-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:1b75f64e-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:1b761eb2-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1b7646d0-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1b766f66-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:1b7697ac-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1b76bff2-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terguride is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1b76e856-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2603 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terodiline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1b7713c6-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tertatolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.087']} DrugCentral uuid:1b773f2c-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tertatolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1b7767e0-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tertatolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:1b779044-d20a-11ec-8377-0242ac110003 UniProtKB:P25962 biolink:molecularly_interacts_with DrugCentral:2605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tertatolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1b77b95c-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tertatolol is antagonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1b77e242-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:2606 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testolactone is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1b780a9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1b783378-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.837']} DrugCentral uuid:1b785bc8-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:1b788418-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1b78ac4a-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1b78d5ee-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:1b790118-d20a-11ec-8377-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1b792b7a-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1b7953ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.599']} DrugCentral uuid:1b797d00-d20a-11ec-8377-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1b79a92e-d20a-11ec-8377-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1b79a92e-d20a-11ec-8377-0242ac110003 UniProtKB:P31214 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Enzyme (Steroid 5-alpha-reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1b79dcb4-d20a-11ec-8377-0242ac110003 UniProtKB:O35627 biolink:molecularly_interacts_with DrugCentral:2607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone targets Nuclear hormone receptor (Constitutive androstane receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1b7a04f0-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2608 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone undecanoate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:1b7a2980-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:1b7a51c6-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.018']} DrugCentral uuid:1b7a7a2a-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.886']} DrugCentral uuid:1b7aa342-d20a-11ec-8377-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1b7ace26-d20a-11ec-8377-0242ac110003 UniProtKB:Q27963 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1b7af78e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01827 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.12']} DrugCentral uuid:1b7b210a-d20a-11ec-8377-0242ac110003 UniProtKB:P54219 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine is inhibitor of Transporter (Chromaffin granule amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1b7b51c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1b7b51c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1b7b51c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetrabenazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1b7b9040-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1b7bb85e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.153']} DrugCentral uuid:1b7be130-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.011']} DrugCentral uuid:1b7c098a-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.766']} DrugCentral uuid:1b7c31f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q99250 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1b7c5a34-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQD0 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets Ion channel (Sodium channel protein type 8 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1b7c8400-d20a-11ec-8377-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1b7cac32-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.499']} DrugCentral uuid:1b7cd478-d20a-11ec-8377-0242ac110003 UniProtKB:Q00194 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets Ion channel (cGMP-gated cation channel alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1b7d048e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1b7d048e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1b7d048e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1b7d4c46-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1b7d4c46-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1b7d4c46-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:2610 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1b7d8aa8-d20a-11ec-8377-0242ac110003 UniProtKB:P0A7V8 biolink:molecularly_interacts_with DrugCentral:2611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracycline targets Ribosomal protein (30S ribosomal protein S4) DrugCentral uuid:1b7daec0-d20a-11ec-8377-0242ac110003 UniProtKB:P0A7X3 biolink:molecularly_interacts_with DrugCentral:2611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracycline targets Ribosomal protein (30S ribosomal protein S9) DrugCentral uuid:1b7dd31e-d20a-11ec-8377-0242ac110003 UniProtKB:P29475 biolink:molecularly_interacts_with DrugCentral:2612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sapropterin targets Enzyme (Nitric oxide synthase, brain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.95']} DrugCentral uuid:1b7dfb8c-d20a-11ec-8377-0242ac110003 UniProtKB:P00439 biolink:molecularly_interacts_with DrugCentral:2612 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sapropterin is activator of Enzyme (Phenylalanine-4-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1b7e24d6-d20a-11ec-8377-0242ac110003 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:2615 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:1b7e4e16-d20a-11ec-8377-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2615 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1b7e794a-d20a-11ec-8377-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2615 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1b7ea460-d20a-11ec-8377-0242ac110003 UniProtKB:Q8Z9J9 biolink:molecularly_interacts_with DrugCentral:2615 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetroxoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.35']} DrugCentral uuid:1b7ecefe-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.301']} DrugCentral uuid:1b7ef7c6-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.432']} DrugCentral uuid:1b7f1fee-d20a-11ec-8377-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:2616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thalidomide targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1b7f4834-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:2616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1b7f708e-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:2616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thalidomide targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1b7f994c-d20a-11ec-8377-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:2616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1b7fc1ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:2616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thalidomide is modulator of Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.393']} DrugCentral uuid:1b7fea1e-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1b801278-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline is inhibitor of Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.85']} DrugCentral uuid:1b803ce4-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1b806660-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1b808ec4-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1b80b732-d20a-11ec-8377-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1b80e036-d20a-11ec-8377-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:1b81087c-d20a-11ec-8377-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1b8130d6-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1b81596c-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1b8181b2-d20a-11ec-8377-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1b81a9da-d20a-11ec-8377-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1b81d22a-d20a-11ec-8377-0242ac110003 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1b81fba6-d20a-11ec-8377-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1b822bd0-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:1b822bd0-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:1b825f60-d20a-11ec-8377-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1b8293c2-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1b8293c2-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1b8293c2-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1b8293c2-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1b82e4b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1b82e4b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1b82e4b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1b83236e-d20a-11ec-8377-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1b834c0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q60614 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.25']} DrugCentral uuid:1b837454-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS9 biolink:molecularly_interacts_with DrugCentral:2620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 theophylline targets Unclassified (Transmembrane domain-containing protein TMIGD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.06']} DrugCentral uuid:1b839d44-d20a-11ec-8377-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.22']} DrugCentral uuid:1b83c59e-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.097']} DrugCentral uuid:1b83f118-d20a-11ec-8377-0242ac110003 UniProtKB:Q09508 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole targets Enzyme (Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial) DrugCentral uuid:1b841544-d20a-11ec-8377-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1b843d80-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:1b84660c-d20a-11ec-8377-0242ac110003 UniProtKB:P0AE18 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole targets Enzyme (Methionine aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1b848e5c-d20a-11ec-8377-0242ac110003 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1b84be5e-d20a-11ec-8377-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:1b84be5e-d20a-11ec-8377-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:1b84be5e-d20a-11ec-8377-0242ac110003 UniProtKB:C4PKZ6 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:1b850d96-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:1b850d96-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:1b850d96-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:1b850d96-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:1b850d96-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:1b850d96-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:1b850d96-d20a-11ec-8377-0242ac110003 UniProtKB:F1LCS0 biolink:molecularly_interacts_with DrugCentral:2621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiabendazole is inhibitor of Structural (Tubulin) DrugCentral uuid:1b856e58-d20a-11ec-8377-0242ac110003 UniProtKB:P15825 biolink:molecularly_interacts_with DrugCentral:2624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamphenicol targets Ribosomal protein (50S ribosomal protein L10) DrugCentral uuid:1b85927a-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamphenicol targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1b85bc78-d20a-11ec-8377-0242ac110003 UniProtKB:P10520 biolink:molecularly_interacts_with DrugCentral:2624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamphenicol targets Enzyme (Streptokinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b861e52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2626 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamylal is positive allosteric modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1b86d3ec-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.301']} DrugCentral uuid:1b86fca0-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1b8724fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:1b874d22-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.155']} DrugCentral uuid:1b87769e-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1b879ee4-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1b87c748-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1b87ef84-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1b88191e-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1b884164-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.602']} DrugCentral uuid:1b8869a0-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:1b888dae-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:1b88b220-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:1b88d61a-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M4) DrugCentral uuid:1b88fb7c-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets GPCR (Muscarinic acetylcholine receptor M5) DrugCentral uuid:1b891fb2-d20a-11ec-8377-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1b8948d4-d20a-11ec-8377-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiethylperazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1b897250-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.221']} DrugCentral uuid:1b899a78-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.912']} DrugCentral uuid:1b89c2b4-d20a-11ec-8377-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:1b89e730-d20a-11ec-8377-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:1b8a0b70-d20a-11ec-8377-0242ac110003 UniProtKB:P20839 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 1) DrugCentral uuid:1b8a2f60-d20a-11ec-8377-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:1b8a579c-d20a-11ec-8377-0242ac110003 UniProtKB:P12268 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine is inhibitor of Enzyme (Inosine-5'-monophosphate dehydrogenase 2) DrugCentral uuid:1b8a7baa-d20a-11ec-8377-0242ac110003 UniProtKB:P00492 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Enzyme (Hypoxanthine-guanine phosphoribosyltransferase) DrugCentral uuid:1b8aa12a-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.258']} DrugCentral uuid:1b8ac970-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.792']} DrugCentral uuid:1b8af1fc-d20a-11ec-8377-0242ac110003 UniProtKB:P26281 biolink:molecularly_interacts_with DrugCentral:2632 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioguanine targets Kinase (2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1b8b23b6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1b8b23b6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1b8b23b6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8b954e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1b8c6ae6-d20a-11ec-8377-0242ac110003 UniProtKB:Q63734 biolink:molecularly_interacts_with DrugCentral:2633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiopental is gating inhibitor of Ion channel (Potassium voltage-gated channel subfamily C member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1b8c9340-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2635 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioproperazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.347']} DrugCentral uuid:1b8cbb86-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2635 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioproperazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.921']} DrugCentral uuid:1b8ce3cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) DrugCentral uuid:1b8d0a96-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1b8d3458-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1b8d5c9e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.872']} DrugCentral uuid:1b8d8502-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.815']} DrugCentral uuid:1b8dada2-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1b8dd5c0-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1b8dfe06-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.813']} DrugCentral uuid:1b8e2660-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1b8e4f14-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1b8e773c-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.086']} DrugCentral uuid:1b8ea07c-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1b8eca2a-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1b8ef298-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1b8f1ade-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1b8f4324-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.466']} DrugCentral uuid:1b8f6bce-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1b8f941e-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1b8fbc6e-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1b8fe4b4-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.866']} DrugCentral uuid:1b900d54-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1b9035a4-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.569']} DrugCentral uuid:1b905dea-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:1b908630-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.595']} DrugCentral uuid:1b90b10a-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.046']} DrugCentral uuid:1b90db76-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:1b9103bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.796']} DrugCentral uuid:1b912bee-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.963']} DrugCentral uuid:1b9154a2-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.237']} DrugCentral uuid:1b917ce8-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.126']} DrugCentral uuid:1b91a524-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.774']} DrugCentral uuid:1b91cd60-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.751']} DrugCentral uuid:1b91f5f6-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.979']} DrugCentral uuid:1b921e50-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.686']} DrugCentral uuid:1b924696-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:1b926edc-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.002']} DrugCentral uuid:1b929d4e-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:1b92c5e4-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:1b92ee16-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.712']} DrugCentral uuid:1b9317e2-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.531']} DrugCentral uuid:1b934014-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.195']} DrugCentral uuid:1b936846-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.297']} DrugCentral uuid:1b939078-d20a-11ec-8377-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1b93b936-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:1b93e190-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.284']} DrugCentral uuid:1b9409cc-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:1b943208-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:1b945bca-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1b94842e-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.76']} DrugCentral uuid:1b94ac56-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1b94d49c-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1b94fd50-d20a-11ec-8377-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1b95355e-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1b95355e-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1b95355e-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1b95355e-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1b95355e-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1b959698-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1b959698-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1b959698-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1b959698-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1b95e8d2-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1b95e8d2-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1b95e8d2-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1b963800-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1b963800-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1b963800-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1b963800-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1b963800-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1b969458-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1b969458-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1b969458-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1b96db2a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1b96db2a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1b96db2a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1b9719c8-d20a-11ec-8377-0242ac110003 UniProtKB:P48542 biolink:molecularly_interacts_with DrugCentral:2637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioridazine is gating inhibitor of Ion channel (G protein-activated inward rectifier potassium channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:1b974344-d20a-11ec-8377-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2638 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiotepa is inhibitor of Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1b976c34-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.292']} DrugCentral uuid:1b9794a2-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.347']} DrugCentral uuid:1b97bce8-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.097']} DrugCentral uuid:1b97e54c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.411']} DrugCentral uuid:1b98101c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.387']} DrugCentral uuid:1b983862-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1b98609e-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.868']} DrugCentral uuid:1b9888da-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.681']} DrugCentral uuid:1b98b166-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.817']} DrugCentral uuid:1b98da92-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.94']} DrugCentral uuid:1b9902a6-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1b992ba0-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.412']} DrugCentral uuid:1b9953fa-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.583']} DrugCentral uuid:1b997c40-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1b99a486-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.386']} DrugCentral uuid:1b99ce48-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.585']} DrugCentral uuid:1b99f9b8-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:1b9a253c-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.398']} DrugCentral uuid:1b9a4e04-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.812']} DrugCentral uuid:1b9a76ea-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.318']} DrugCentral uuid:1b9a9f26-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:1b9ac76c-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.181']} DrugCentral uuid:1b9aefc6-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:1b9b18d4-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.693']} DrugCentral uuid:1b9b412e-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:1b9b6988-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.456']} DrugCentral uuid:1b9b91d8-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiothixene targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.442']} DrugCentral uuid:1b9bbcbc-d20a-11ec-8377-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor alpha) DrugCentral uuid:1b9be0e8-d20a-11ec-8377-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine is agonist of Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1b9c091a-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:1b9c3142-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1b9c59f6-d20a-11ec-8377-0242ac110003 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:1b9c821e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine targets Unclassified (THAP domain-containing protein 1) DrugCentral uuid:1b9ca65e-d20a-11ec-8377-0242ac110003 UniProtKB:P14174 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine targets Unclassified (Macrophage migration inhibitory factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1b9ccf8a-d20a-11ec-8377-0242ac110003 UniProtKB:P40926 biolink:molecularly_interacts_with DrugCentral:2646 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levothyroxine targets Enzyme (Malate dehydrogenase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.36']} DrugCentral uuid:1b9cf87a-d20a-11ec-8377-0242ac110003 UniProtKB:P30531 biolink:molecularly_interacts_with DrugCentral:2648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiagabine is inhibitor of Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1b9d220a-d20a-11ec-8377-0242ac110003 UniProtKB:P23978 biolink:molecularly_interacts_with DrugCentral:2648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiagabine targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:1b9d4a6e-d20a-11ec-8377-0242ac110003 UniProtKB:P31648 biolink:molecularly_interacts_with DrugCentral:2648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiagabine targets Transporter (Sodium- and chloride-dependent GABA transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1b9d7412-d20a-11ec-8377-0242ac110003 UniProtKB:P31651 biolink:molecularly_interacts_with DrugCentral:2648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiagabine targets Transporter (Sodium- and chloride-dependent betaine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1b9da45a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.04']} DrugCentral uuid:1b9da45a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.04']} DrugCentral uuid:1b9da45a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.04']} DrugCentral uuid:1b9dead2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1b9dead2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1b9dead2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2649 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiamenidine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1b9e29e8-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2650 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tianeptine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:1b9e522e-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2651 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiapride targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.077']} DrugCentral uuid:1b9e7a60-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2651 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiapride targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.108']} DrugCentral uuid:1b9ea2b0-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2651 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiapride targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.756']} DrugCentral uuid:1b9ecb8c-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2651 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiapride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:1b9ef3e6-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiaprofenic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1b9f1c36-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiaprofenic acid is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1b9f458a-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.317']} DrugCentral uuid:1b9f6de4-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.907']} DrugCentral uuid:1b9f9616-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:1b9fba42-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:1b9fded2-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:1ba006f0-d20a-11ec-8377-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Enzyme (Steryl-sulfatase) DrugCentral uuid:1ba02b1c-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.123']} DrugCentral uuid:1ba05358-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tibolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.542']} DrugCentral uuid:1ba07d4c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8XJ01 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin targets Enzyme (Penicillin-binding protein 1A) DrugCentral uuid:1ba0b924-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1ba0b924-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1ba0b924-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1ba0b924-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1ba0b924-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1ba0b924-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1ba0b924-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:2656 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticarcillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1ba1184c-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:1ba14088-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1ba168c4-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.845']} DrugCentral uuid:1ba19114-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.747']} DrugCentral uuid:1ba1ba04-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.857']} DrugCentral uuid:1ba1e24a-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.767']} DrugCentral uuid:1ba20bd0-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.201']} DrugCentral uuid:1ba23416-d20a-11ec-8377-0242ac110003 UniProtKB:P11509 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Enzyme (Cytochrome P450 2A6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1ba25cfc-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:1ba2854c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine is antagonist of GPCR (P2Y purinoceptor 12) DrugCentral uuid:1ba2a982-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.175']} DrugCentral uuid:1ba2d1dc-d20a-11ec-8377-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine is inhibitor of Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1ba2fc5c-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.697']} DrugCentral uuid:1ba326fa-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2657 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticlopidine targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:1ba34f22-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tienilic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.494']} DrugCentral uuid:1ba37740-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tilidine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1ba39fea-d20a-11ec-8377-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:2664 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiliquinol targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1ba3c808-d20a-11ec-8377-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:2666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiludronic acid targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) DrugCentral uuid:1ba3ec0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q13488 biolink:molecularly_interacts_with DrugCentral:2666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiludronic acid targets Enzyme (V-type proton ATPase 116 kDa subunit a isoform 3) DrugCentral uuid:1ba4104c-d20a-11ec-8377-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiludronic acid targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1ba43b30-d20a-11ec-8377-0242ac110003 UniProtKB:P50281 biolink:molecularly_interacts_with DrugCentral:2666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiludronic acid targets Enzyme (Matrix metalloproteinase-14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1ba4640c-d20a-11ec-8377-0242ac110003 UniProtKB:P22894 biolink:molecularly_interacts_with DrugCentral:2666 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiludronic acid targets Enzyme (Neutrophil collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1ba48c52-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:2672 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tinoridine is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.987']} DrugCentral uuid:1ba4b48e-d20a-11ec-8377-0242ac110003 UniProtKB:O69638 biolink:molecularly_interacts_with DrugCentral:2673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiocarlide targets Enzyme (Epoxide hydrolase EphE; Hydrolase, alpha/beta hydrolase fold family) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1ba4dfea-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2675 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tioconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:1ba5045c-d20a-11ec-8377-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:2675 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tioconazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1ba52cc0-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiopronin targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ba554e8-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:1ba57d9c-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:1ba5a5ec-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11.1']} DrugCentral uuid:1ba5ce32-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:1ba5f68c-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:1ba61f72-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:1ba647d6-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:1ba67026-d20a-11ec-8377-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2677 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiotropium bromide targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1ba6997a-d20a-11ec-8377-0242ac110003 UniProtKB:F1PT23 biolink:molecularly_interacts_with DrugCentral:2678 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiquizium targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1ba6c24c-d20a-11ec-8377-0242ac110003 UniProtKB:F1PWR7 biolink:molecularly_interacts_with DrugCentral:2678 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiquizium targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.94']} DrugCentral uuid:1ba6eaa6-d20a-11ec-8377-0242ac110003 UniProtKB:F1PGZ2 biolink:molecularly_interacts_with DrugCentral:2678 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiquizium targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:1ba712e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14994 biolink:molecularly_interacts_with DrugCentral:2679 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiracizine targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1ba73f74-d20a-11ec-8377-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:2680 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirofiban is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.959']} DrugCentral uuid:1ba73f74-d20a-11ec-8377-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:2680 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirofiban is inhibitor of Adhesion (Integrin alpha-IIb/beta-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.959']} DrugCentral uuid:1ba772dc-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tizanidine is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1ba79b0e-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tizanidine is agonist of GPCR (Alpha-2B adrenergic receptor) DrugCentral uuid:1ba7c070-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tizanidine is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:1ba7e96a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:2683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tizanidine targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:1ba812be-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:2683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tizanidine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.58']} DrugCentral uuid:1ba83b04-d20a-11ec-8377-0242ac110003 UniProtKB:G3HDX1 biolink:molecularly_interacts_with DrugCentral:2683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tizanidine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1ba86340-d20a-11ec-8377-0242ac110003 UniProtKB:O32553 biolink:molecularly_interacts_with DrugCentral:2684 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tobramycin targets Enzyme (Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['5.824']} DrugCentral uuid:1ba8b11a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1ba8b11a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1ba8b11a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1ba8b11a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1ba8b11a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1ba8b11a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1ba8b11a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1ba8b11a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1ba8b11a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1ba8b11a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:2686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocainide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1ba92cda-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2693 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofisopam targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1ba95516-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2693 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofisopam targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1ba97d48-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2694 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazamide targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.292']} DrugCentral uuid:1ba9aa3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2694 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) DrugCentral uuid:1ba9aa3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2694 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) DrugCentral uuid:1ba9d838-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1baa0092-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:1baa28d8-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:1baa5268-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1baa7a9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1baaaa88-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1baaaa88-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1baaaa88-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1baaf132-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1baaf132-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1baaf132-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2695 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1bab30d4-d20a-11ec-8377-0242ac110003 UniProtKB:O35956 biolink:molecularly_interacts_with DrugCentral:2696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolbutamide targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:1bab591a-d20a-11ec-8377-0242ac110003 UniProtKB:Q61743 biolink:molecularly_interacts_with DrugCentral:2696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolbutamide is blocker of Ion channel (ATP-sensitive inward rectifier potassium channel 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:1bab85e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:1bab85e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q14654 biolink:molecularly_interacts_with DrugCentral:2696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolbutamide is blocker of Ion channel (Sulfonylurea receptor 1, Kir6.2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.046']} DrugCentral uuid:1babb95a-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:2697 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolcapone targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.69']} DrugCentral uuid:1babe182-d20a-11ec-8377-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:2697 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolcapone targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:1bac0ae0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:2697 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolcapone targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1bac365a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13118 biolink:molecularly_interacts_with DrugCentral:2697 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolcapone targets Nuclear other (Krueppel-like factor 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1bac5f5e-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2697 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolcapone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:1bac87c2-d20a-11ec-8377-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:2697 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolcapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.569']} DrugCentral uuid:1bacb0a8-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2698 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolfenamic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1bacd8ee-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2698 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolfenamic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1bad012a-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:2698 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolfenamic acid targets Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1bad295c-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:2698 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolfenamic acid targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.33']} DrugCentral uuid:1bad526a-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:2698 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolfenamic acid targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1bad7a9c-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2699 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolmetin is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:1bada2d8-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2699 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolmetin is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:1badcb14-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2699 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolmetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1badf44a-d20a-11ec-8377-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:2699 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolmetin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.06']} DrugCentral uuid:1bae1c9a-d20a-11ec-8377-0242ac110003 UniProtKB:P10145 biolink:molecularly_interacts_with DrugCentral:2699 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolmetin targets Cytokine (Interleukin-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1bae44cc-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2699 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolmetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.667']} DrugCentral uuid:1bae6cea-d20a-11ec-8377-0242ac110003 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:2701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolonium targets Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.16']} DrugCentral uuid:1bae95b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:2701 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolonium targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:1baebde4-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1baee72e-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1baf0f7e-d20a-11ec-8377-0242ac110003 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:2702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1baf386e-d20a-11ec-8377-0242ac110003 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:2702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toloxatone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1baf60e6-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toloxatone is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1baf8940-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolperisone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.253']} DrugCentral uuid:1bafb19a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolperisone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.341']} DrugCentral uuid:1bafdd3c-d20a-11ec-8377-0242ac110003 UniProtKB:P70634 biolink:molecularly_interacts_with DrugCentral:2703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolperisone targets Unclassified (SMR1-alpha3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.685']} DrugCentral uuid:1bb007e4-d20a-11ec-8377-0242ac110003 UniProtKB:P70635 biolink:molecularly_interacts_with DrugCentral:2703 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolperisone targets Unclassified (BetaB2-crystallin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.474']} DrugCentral uuid:1bb03034-d20a-11ec-8377-0242ac110003 UniProtKB:P14550 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1bb058b6-d20a-11ec-8377-0242ac110003 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:1bb08106-d20a-11ec-8377-0242ac110003 UniProtKB:P80276 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1bb0a92e-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1bb0d16a-d20a-11ec-8377-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1bb0fa46-d20a-11ec-8377-0242ac110003 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1bb12278-d20a-11ec-8377-0242ac110003 UniProtKB:Q91WR5 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Aldo-keto reductase family 1 member C21) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1bb14ac8-d20a-11ec-8377-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1bb1732c-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolrestat is inhibitor of Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.509']} DrugCentral uuid:1bb19cd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1bb1c552-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1bb1edb6-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.57']} DrugCentral uuid:1bb21746-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.49']} DrugCentral uuid:1bb23ff0-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:1bb268d6-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:1bb2911c-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:1bb2b962-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1bb2e36a-d20a-11ec-8377-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1bb30bc4-d20a-11ec-8377-0242ac110003 UniProtKB:P08911 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:1bb33414-d20a-11ec-8377-0242ac110003 UniProtKB:P08485 biolink:molecularly_interacts_with DrugCentral:2705 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolterodine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.51']} DrugCentral uuid:1bb35c64-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is blocker of Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:1bb382ca-d20a-11ec-8377-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:1bb3a70a-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:1bb3cb40-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is inhibitor of Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1bb3f372-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1bb41c3a-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is inhibitor of Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1bb44494-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1bb46ce4-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1bb4952a-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1bb4be10-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1bb4e64c-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:1bb50e88-d20a-11ec-8377-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:1bb536e2-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:1bb562ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.84']} DrugCentral uuid:1bb58b42-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:1bb5b39c-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.27']} DrugCentral uuid:1bb5dc5a-d20a-11ec-8377-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:1bb604aa-d20a-11ec-8377-0242ac110003 UniProtKB:P27139 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1bb62cdc-d20a-11ec-8377-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1bb65518-d20a-11ec-8377-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.63']} DrugCentral uuid:1bb67df4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:1bb6a630-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.11']} DrugCentral uuid:1bb6ce94-d20a-11ec-8377-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1bb6f7b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1bb721c8-d20a-11ec-8377-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1bb74a22-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1bb7727c-d20a-11ec-8377-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1bb79b58-d20a-11ec-8377-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1bb7c42a-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1bb7edb0-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.42']} DrugCentral uuid:1bb81600-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1bb83e6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1bb8677c-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:1bb897a6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1bb897a6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1bb897a6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) DrugCentral uuid:1bb8d342-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1bb8d342-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1bb91a6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:1bb91a6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:1bb91a6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:1bb91a6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:1bb91a6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic kainate) DrugCentral uuid:1bb9711c-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:1bb9711c-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:1bb9711c-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:1bb9711c-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) DrugCentral uuid:1bb9b2da-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1bb9db0c-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiramate targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:1bba0366-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.818']} DrugCentral uuid:1bba2c24-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:1bba5122-d20a-11ec-8377-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:1bba7544-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) DrugCentral uuid:1bba9966-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:1bbabe96-d20a-11ec-8377-0242ac110003 UniProtKB:O15439 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transporter (Multidrug resistance-associated protein 4) DrugCentral uuid:1bbae2b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q969P6 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan is inhibitor of Enzyme (DNA topoisomerase I, mitochondrial) DrugCentral uuid:1bbb06d0-d20a-11ec-8377-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.58']} DrugCentral uuid:1bbb2f20-d20a-11ec-8377-0242ac110003 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1bbb57ca-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:1bbb7ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1bbba82e-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bbbd04c-d20a-11ec-8377-0242ac110003 UniProtKB:Q04750 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Enzyme (DNA topoisomerase I) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1bbbf91e-d20a-11ec-8377-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:1bbc213c-d20a-11ec-8377-0242ac110003 UniProtKB:P9WIQ1 biolink:molecularly_interacts_with DrugCentral:2707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topotecan targets Enzyme (UDP-galactopyranose mutase) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1bbc495a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:2708 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 torsemide is inhibitor of Transporter (Solute carrier family 12 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1bbc718c-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toremifene targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1bbc9b6c-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:2709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toremifene is modulator of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:1bbcc39e-d20a-11ec-8377-0242ac110003 UniProtKB:P62508 biolink:molecularly_interacts_with DrugCentral:2709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toremifene targets Nuclear hormone receptor (Estrogen-related receptor gamma) DrugCentral uuid:1bbce7e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q05320 biolink:molecularly_interacts_with DrugCentral:2709 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toremifene targets Unclassified (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1bbd1042-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:2711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramadol is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1bbd39be-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramadol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:1bbd61f0-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramadol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1bbd8a36-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:2711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramadol targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1bbdb272-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:2711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramadol targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.03']} DrugCentral uuid:1bbddb58-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramadol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1bbe0394-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2711 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramadol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1bbe2be4-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2712 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trandolapril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:1bbe5452-d20a-11ec-8377-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranexamic acid is inhibitor of Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1bbe8094-d20a-11ec-8377-0242ac110003 UniProtKB:O60760 biolink:molecularly_interacts_with DrugCentral:2714 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranilast targets Enzyme (Hematopoietic prostaglandin D synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.94']} DrugCentral uuid:1bbeabd2-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.229']} DrugCentral uuid:1bbed65c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.225']} DrugCentral uuid:1bbefede-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:1bbf272e-d20a-11ec-8377-0242ac110003 UniProtKB:P11509 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Cytochrome P450 2A6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.187']} DrugCentral uuid:1bbf4f92-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1bbf77e2-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1bbfa1ae-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1bbfca94-d20a-11ec-8377-0242ac110003 UniProtKB:P20813 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Cytochrome P450 2B6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1bbff302-d20a-11ec-8377-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.88']} DrugCentral uuid:1bc01b3e-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:1bc044ec-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:1bc06d1e-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1bc09532-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1bc0bdb4-d20a-11ec-8377-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1bc0e67c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NB78 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (Lysine-specific histone demethylase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1bc10eae-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:2715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tranylcypromine targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1bc136fe-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:2716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 travoprost targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:1bc15f6c-d20a-11ec-8377-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:2716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 travoprost is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.284']} DrugCentral uuid:1bc18870-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.428']} DrugCentral uuid:1bc1b138-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:1bc1d96a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:1bc201a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.033']} DrugCentral uuid:1bc22cbc-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1bc2550c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1bc27e24-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bc2a7c8-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:1bc2d02c-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:1bc2f87c-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.08']} DrugCentral uuid:1bc320e0-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:1bc349c6-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.749']} DrugCentral uuid:1bc3720c-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.551']} DrugCentral uuid:1bc39a34-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1bc3c28e-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.896']} DrugCentral uuid:1bc3ec28-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1bc4177a-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.483']} DrugCentral uuid:1bc43fc0-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.975']} DrugCentral uuid:1bc467f2-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:1bc49092-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1bc4b8f6-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.153']} DrugCentral uuid:1bc4e13c-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.328']} DrugCentral uuid:1bc50982-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:1bc53268-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.081']} DrugCentral uuid:1bc55ac2-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.083']} DrugCentral uuid:1bc58312-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.93']} DrugCentral uuid:1bc5ab26-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:1bc5d682-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1bc5feaa-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1bc626f0-d20a-11ec-8377-0242ac110003 UniProtKB:P04439 biolink:molecularly_interacts_with DrugCentral:2717 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trazodone targets Unclassified (HLA class I histocompatibility antigen, A-3 alpha chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1bc64f40-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:2720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1bc678d0-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:2720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1bc6a12a-d20a-11ec-8377-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:2720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 treprostinil is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:1bc6c948-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:2720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1bc6f238-d20a-11ec-8377-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:2720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 treprostinil is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1bc71a60-d20a-11ec-8377-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:2720 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 treprostinil is agonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1bc742a6-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.642']} DrugCentral uuid:1bc76ae2-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.525']} DrugCentral uuid:1bc79468-d20a-11ec-8377-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1bc7bc90-d20a-11ec-8377-0242ac110003 UniProtKB:Q92781 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Enzyme (11-cis retinol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1bc7e4cc-d20a-11ec-8377-0242ac110003 UniProtKB:P35398 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Nuclear hormone receptor (Nuclear receptor ROR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1bc80cfe-d20a-11ec-8377-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1bc835bc-d20a-11ec-8377-0242ac110003 UniProtKB:P28702 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1bc85df8-d20a-11ec-8377-0242ac110003 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1bc8876a-d20a-11ec-8377-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1bc8b032-d20a-11ec-8377-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1bc8d90e-d20a-11ec-8377-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1bc90154-d20a-11ec-8377-0242ac110003 UniProtKB:Q92753 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is antagonist of Nuclear hormone receptor (Nuclear receptor ROR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.82']} DrugCentral uuid:1bc9299a-d20a-11ec-8377-0242ac110003 UniProtKB:P51449 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1bc951c2-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1bc97bf2-d20a-11ec-8377-0242ac110003 UniProtKB:P40220 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1bc9a41a-d20a-11ec-8377-0242ac110003 UniProtKB:P28704 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1bc9cc60-d20a-11ec-8377-0242ac110003 UniProtKB:P28705 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1bc9f492-d20a-11ec-8377-0242ac110003 UniProtKB:P62965 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1bca1d50-d20a-11ec-8377-0242ac110003 UniProtKB:P22935 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Cytosolic other (Cellular retinoic acid-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1bca4672-d20a-11ec-8377-0242ac110003 UniProtKB:P11416 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1bca6eb8-d20a-11ec-8377-0242ac110003 UniProtKB:P28700 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1bca976c-d20a-11ec-8377-0242ac110003 UniProtKB:P22605 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1bcabfda-d20a-11ec-8377-0242ac110003 UniProtKB:P18911 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Transcription factor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1bcae820-d20a-11ec-8377-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1bcb1084-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is agonist of Nuclear hormone receptor (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1bcb3992-d20a-11ec-8377-0242ac110003 UniProtKB:P49116 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is agonist of Nuclear other (Nuclear receptor subfamily 2 group C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:1bcb620a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13526 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin targets Unclassified (Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1bcb8a6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y466 biolink:molecularly_interacts_with DrugCentral:2722 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretinoin is agonist of Nuclear other (Nuclear receptor subfamily 2 group E member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1bcbb28c-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.27']} DrugCentral uuid:1bcbdb18-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:1bcc0372-d20a-11ec-8377-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1bcc2b90-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:1bcc53b8-d20a-11ec-8377-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.76']} DrugCentral uuid:1bcc845a-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1bcc845a-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1bcc845a-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1bccd248-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1bccd248-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1bccd248-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1bccd248-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1bccd248-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1bcd3bf2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1bcd3bf2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1bcd3bf2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1bcd3bf2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1bcd3bf2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1bcd3bf2-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1bcda65a-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1bcda65a-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1bcda65a-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:2723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tretoquinol targets GPCR (Adrenergic receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1bcde4f8-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.585']} DrugCentral uuid:1bce0d3e-d20a-11ec-8377-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone targets Cytosolic other (Annexin A1) DrugCentral uuid:1bce314c-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:2725 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone targets Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:1bce5636-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone acetonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1bce7e5e-d20a-11ec-8377-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:2726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone acetonide targets Cytosolic other (Annexin A1) DrugCentral uuid:1bcea28a-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:2726 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone acetonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:1bcecaee-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:2727 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone diacetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1bcef0a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13621 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene targets Transporter (Solute carrier family 12 member 1) DrugCentral uuid:1bcf153a-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1bcf3d80-d20a-11ec-8377-0242ac110003 UniProtKB:P29466 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene targets Enzyme (Caspase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.436']} DrugCentral uuid:1bcf65a8-d20a-11ec-8377-0242ac110003 UniProtKB:P08311 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene targets Enzyme (Cathepsin G) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1bcf8e66-d20a-11ec-8377-0242ac110003 UniProtKB:Q01782 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene targets Enzyme (Pteridine reductase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1bcfbec2-d20a-11ec-8377-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1bcfbec2-d20a-11ec-8377-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1bcfbec2-d20a-11ec-8377-0242ac110003 UniProtKB:P51170 biolink:molecularly_interacts_with DrugCentral:2728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamterene is blocker of Ion channel (Amiloride-sensitive sodium channel, ENaC) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1bcffd2e-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.27']} DrugCentral uuid:1bd025f6-d20a-11ec-8377-0242ac110003 UniProtKB:P25105 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets GPCR (Platelet-activating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.879']} DrugCentral uuid:1bd04e28-d20a-11ec-8377-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:1bd07e34-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:1bd07e34-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:1bd07e34-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:1bd0c826-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:1bd0c826-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:1bd0c826-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:1bd110d8-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:1bd110d8-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:1bd110d8-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.845']} DrugCentral uuid:1bd157e6-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:1bd157e6-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:1bd157e6-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.02']} DrugCentral uuid:1bd19e90-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.638']} DrugCentral uuid:1bd19e90-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.638']} DrugCentral uuid:1bd19e90-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.638']} DrugCentral uuid:1bd1e648-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:1bd1e648-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:1bd1e648-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd25fc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd361da-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd361da-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd361da-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd361da-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd361da-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd361da-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd361da-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd361da-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd361da-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd361da-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd361da-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd361da-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd361da-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA-A receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1bd41828-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.876']} DrugCentral uuid:1bd41828-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.876']} DrugCentral uuid:1bd41828-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.876']} DrugCentral uuid:1bd46120-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.108']} DrugCentral uuid:1bd46120-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.108']} DrugCentral uuid:1bd46120-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.108']} DrugCentral uuid:1bd4a8f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1bd4a8f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1bd4a8f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1bd4ef78-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:1bd4ef78-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:1bd4ef78-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:1bd53654-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1bd53654-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1bd53654-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2729 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triazolam is positive allosteric modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1bd574f2-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.04']} DrugCentral uuid:1bd59dc4-d20a-11ec-8377-0242ac110003 UniProtKB:P55017 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide is inhibitor of Transporter (Solute carrier family 12 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'A2', 'has_quantitative_value': ['7']} DrugCentral uuid:1bd5c5d8-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1bd5ee32-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1bd616b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1bd64026-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1bd6690c-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1bd69148-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:1bd6b9a2-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1bd6e24c-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:1bd70ab0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1bd733fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trichlormethiazide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1bd75c54-d20a-11ec-8377-0242ac110003 UniProtKB:P25779 biolink:molecularly_interacts_with DrugCentral:2734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclabendazole targets Enzyme (Cruzipain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd7be92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2735 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclofos is positive modulator of Ion channel (GABA-A receptor; anion channel) DrugCentral uuid:1bd876f2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2737 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tridihexethyl is antagonist of GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:1bd89b1e-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2737 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tridihexethyl is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:1bd8bf9a-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:1bd8e7d6-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:1bd91030-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1bd93876-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:1bd961a2-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bd989ca-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:1bd9b21a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.31']} DrugCentral uuid:1bd9db3c-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1bda03a0-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:1bda2d12-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.37']} DrugCentral uuid:1bda5580-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1bda7e48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1bdaa6b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2738 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trientine targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.23']} DrugCentral uuid:1bdacf1a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.841']} DrugCentral uuid:1bdaf76a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.185']} DrugCentral uuid:1bdb2046-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1bdb4896-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.292']} DrugCentral uuid:1bdb70fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1bdb9968-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1bdbc3de-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.022']} DrugCentral uuid:1bdbeecc-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1bdc1726-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1bdc3f62-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.849']} DrugCentral uuid:1bdc6820-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.536']} DrugCentral uuid:1bdc9070-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:1bdcb8a2-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.786']} DrugCentral uuid:1bdce188-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.251']} DrugCentral uuid:1bdd0a8c-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1bdd32d2-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:1bdd5af0-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.407']} DrugCentral uuid:1bdd8408-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.377']} DrugCentral uuid:1bddb40a-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1bddb40a-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1bddb40a-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1bddf4ba-d20a-11ec-8377-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.64']} DrugCentral uuid:1bde1d14-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.27']} DrugCentral uuid:1bde45d2-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1bde6e2c-d20a-11ec-8377-0242ac110003 UniProtKB:P78527 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Kinase (DNA-dependent protein kinase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1bde965e-d20a-11ec-8377-0242ac110003 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1bdebf62-d20a-11ec-8377-0242ac110003 UniProtKB:P06760 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Enzyme (Beta-glucuronidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1bdee7a8-d20a-11ec-8377-0242ac110003 UniProtKB:P00697 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Enzyme (Lysozyme C-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1bdf0fc6-d20a-11ec-8377-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1bdf3820-d20a-11ec-8377-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1bdf6188-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BY08 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Enzyme (Emopamil-binding protein-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:1bdf91a8-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:1bdf91a8-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:1bdf91a8-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:1bdfd80c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1bdfd80c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1bdfd80c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1be01ed4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.98']} DrugCentral uuid:1be01ed4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.98']} DrugCentral uuid:1be01ed4-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.98']} DrugCentral uuid:1be05d5e-d20a-11ec-8377-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:2740 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluoperazine targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1be08590-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluperidol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.699']} DrugCentral uuid:1be0ae8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:1be0d6e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluperidol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:1be0ff0c-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluperidol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.456']} DrugCentral uuid:1be12748-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluperidol targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.456']} DrugCentral uuid:1be152e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:2741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluperidol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1be17b62-d20a-11ec-8377-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluperidol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:1be1a3b2-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2742 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triflupromazine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:1be1cc8e-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2742 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triflupromazine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1be1f4d4-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2742 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triflupromazine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.398']} DrugCentral uuid:1be21d38-d20a-11ec-8377-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:2742 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triflupromazine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1be2457e-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:2742 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triflupromazine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1be26e5a-d20a-11ec-8377-0242ac110003 UniProtKB:P33302 biolink:molecularly_interacts_with DrugCentral:2742 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triflupromazine targets Transporter (Pleiotropic ABC efflux transporter of multiple drugs) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1be2968c-d20a-11ec-8377-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:2743 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluridine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1be2bed2-d20a-11ec-8377-0242ac110003 UniProtKB:P9WKE1 biolink:molecularly_interacts_with DrugCentral:2743 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifluridine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.01']} DrugCentral uuid:1be2e7ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trihexyphenidyl targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.347']} DrugCentral uuid:1be31224-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trihexyphenidyl is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1be33a74-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.73']} DrugCentral uuid:1be362ba-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:1be38af6-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:1be3b3aa-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trihexyphenidyl targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.99']} DrugCentral uuid:1be3dbc8-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2745 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trihexyphenidyl targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.611']} DrugCentral uuid:1be40422-d20a-11ec-8377-0242ac110003 UniProtKB:P26439 biolink:molecularly_interacts_with DrugCentral:2746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilostane is inhibitor of Enzyme (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2) DrugCentral uuid:1be42862-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alimemazine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:1be44d38-d20a-11ec-8377-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:2749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alimemazine targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1be4754c-d20a-11ec-8377-0242ac110003 UniProtKB:Q63704 biolink:molecularly_interacts_with DrugCentral:2750 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetazidine targets Enzyme (Carnitine O-palmitoyltransferase 1, muscle isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1be49d9c-d20a-11ec-8377-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2751 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethadione is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:1be4c1be-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GZZ6 biolink:molecularly_interacts_with DrugCentral:2752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetaphan targets Ion channel (Neuronal acetylcholine receptor subunit alpha-10) DrugCentral uuid:1be4e6c6-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetaphan targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) DrugCentral uuid:1be50ae8-d20a-11ec-8377-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:2752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetaphan targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1be5332e-d20a-11ec-8377-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:2752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetaphan targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:1be5607e-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetaphan is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:1be5607e-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetaphan is antagonist of Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) DrugCentral uuid:1be58ef0-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1be5b736-d20a-11ec-8377-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:1be5df9a-d20a-11ec-8377-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1be607f4-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1be630da-d20a-11ec-8377-0242ac110003 UniProtKB:Q27713 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1be65916-d20a-11ec-8377-0242ac110003 UniProtKB:P13922 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.99']} DrugCentral uuid:1be68166-d20a-11ec-8377-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1be6a9ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:1be6d2d8-d20a-11ec-8377-0242ac110003 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1be6fb28-d20a-11ec-8377-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:1be7238c-d20a-11ec-8377-0242ac110003 UniProtKB:P07807 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1be74c2c-d20a-11ec-8377-0242ac110003 UniProtKB:P07382 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.921']} DrugCentral uuid:1be77468-d20a-11ec-8377-0242ac110003 UniProtKB:P22906 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:1be79ca4-d20a-11ec-8377-0242ac110003 UniProtKB:O30463 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1be7c4d6-d20a-11ec-8377-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1be7ee34-d20a-11ec-8377-0242ac110003 UniProtKB:Q27793 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:1be816b6-d20a-11ec-8377-0242ac110003 UniProtKB:P0A017 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:1be83ef2-d20a-11ec-8377-0242ac110003 UniProtKB:Q27783 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1be86742-d20a-11ec-8377-0242ac110003 UniProtKB:P04174 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1be89046-d20a-11ec-8377-0242ac110003 UniProtKB:Q59487 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1be8b99a-d20a-11ec-8377-0242ac110003 UniProtKB:Q81R22 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.62']} DrugCentral uuid:1be8e1fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q27552 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1be90a8a-d20a-11ec-8377-0242ac110003 UniProtKB:P00382 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1be93410-d20a-11ec-8377-0242ac110003 UniProtKB:Q8Z9J9 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.08']} DrugCentral uuid:1be95c74-d20a-11ec-8377-0242ac110003 UniProtKB:Q54801 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:1be984ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UUP5 biolink:molecularly_interacts_with DrugCentral:2755 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimethoprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:1be9acec-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1be9d5dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q05932 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Folylpolyglutamate synthase, mitochondrial) DrugCentral uuid:1be9f9fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q07422 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.29']} DrugCentral uuid:1bea2258-d20a-11ec-8377-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:1bea4aa8-d20a-11ec-8377-0242ac110003 UniProtKB:P00375 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:1bea7532-d20a-11ec-8377-0242ac110003 UniProtKB:Q920D2 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1bea9d5a-d20a-11ec-8377-0242ac110003 UniProtKB:P0ABQ4 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1beac596-d20a-11ec-8377-0242ac110003 UniProtKB:P00381 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:1beaedc8-d20a-11ec-8377-0242ac110003 UniProtKB:P07807 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:1beb1690-d20a-11ec-8377-0242ac110003 UniProtKB:P22906 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:1beb3eea-d20a-11ec-8377-0242ac110003 UniProtKB:O30463 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1beb6726-d20a-11ec-8377-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1beb9020-d20a-11ec-8377-0242ac110003 UniProtKB:Q27793 biolink:molecularly_interacts_with DrugCentral:2757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimetrexate targets Enzyme (Bifunctional dihydrofolate reductase-thymidylate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.18']} DrugCentral uuid:1bebb88e-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimipramine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.827']} DrugCentral uuid:1bebe0e8-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimipramine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:1bec0938-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimipramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.854']} DrugCentral uuid:1bec32dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimipramine is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.423']} DrugCentral uuid:1bec5e56-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trimipramine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.56']} DrugCentral uuid:1bec89c6-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:2759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trioxsalen targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.133']} DrugCentral uuid:1becb22a-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trioxsalen targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.909']} DrugCentral uuid:1becdaca-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2759 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trioxsalen targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:1bed02f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triparanol targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1bed2c32-d20a-11ec-8377-0242ac110003 UniProtKB:Q15125 biolink:molecularly_interacts_with DrugCentral:2761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triparanol targets Enzyme (3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1bed548c-d20a-11ec-8377-0242ac110003 UniProtKB:P32352 biolink:molecularly_interacts_with DrugCentral:2761 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triparanol targets Enzyme (C-8 sterol isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1bed7e3a-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2762 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tripelennamine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1beda66c-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triprolidine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:1bedcea8-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2763 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triprolidine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.9']} DrugCentral uuid:1bedf6ee-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.208']} DrugCentral uuid:1bee2272-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.078']} DrugCentral uuid:1bee4ae0-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.531']} DrugCentral uuid:1bee7326-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.013']} DrugCentral uuid:1bee9cf2-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1beec542-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:1beeeda6-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1bef15ec-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:1bef3ec8-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Aldose reductase) DrugCentral uuid:1bef62ea-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:1bef8b1c-d20a-11ec-8377-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:1befb33a-d20a-11ec-8377-0242ac110003 UniProtKB:P54840 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Glycogen [starch] synthase, liver) DrugCentral uuid:1befd87e-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.528']} DrugCentral uuid:1bf000c4-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.691']} DrugCentral uuid:1bf028f6-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.907']} DrugCentral uuid:1bf05128-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1bf079c8-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1bf0a236-d20a-11ec-8377-0242ac110003 UniProtKB:Q8R0V5 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Indoleamine 2,3-dioxygenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1bf0ca7c-d20a-11ec-8377-0242ac110003 UniProtKB:P19224 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (UDP-glucuronosyltransferase 1-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1bf0f2d6-d20a-11ec-8377-0242ac110003 UniProtKB:P28776 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:1bf11bd0-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:1bf14506-d20a-11ec-8377-0242ac110003 UniProtKB:P39654 biolink:molecularly_interacts_with DrugCentral:2767 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troglitazone targets Enzyme (Polyunsaturated fatty acid lipoxygenase ALOX15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1bf16d4c-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2769 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 troleandomycin is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1bf1959c-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.167']} DrugCentral uuid:1bf1c026-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:1bf1e88a-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropicamide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.523']} DrugCentral uuid:1bf210bc-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:1bf2393e-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropicamide targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:1bf26210-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropicamide targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1bf28a38-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2774 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropicamide targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1bf2b274-d20a-11ec-8377-0242ac110003 UniProtKB:O70528 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1bf2dac4-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.587']} DrugCentral uuid:1bf30396-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:1bf32bf0-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.606']} DrugCentral uuid:1bf354cc-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1bf37de4-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron is antagonist of Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1bf3a698-d20a-11ec-8377-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron is antagonist of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1bf3cede-d20a-11ec-8377-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1bf3f724-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:1bf4203c-d20a-11ec-8377-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron is antagonist of Ion channel (Glycine receptor subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1bf448aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1bf471ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1bf49a44-d20a-11ec-8377-0242ac110003 UniProtKB:P49582 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:1bf4c2ee-d20a-11ec-8377-0242ac110003 UniProtKB:O70212 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1bf4ef12-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1bf4ef12-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1bf52784-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:1bf52784-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.26']} DrugCentral uuid:1bf5674e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1bf5674e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1bf5674e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1bf5674e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1bf5b4f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1bf5b4f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JHJ5 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1bf5e868-d20a-11ec-8377-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1bf6119e-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron targets Ion channel (Neuronal acetylcholine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1bf63a0c-d20a-11ec-8377-0242ac110003 UniProtKB:P97288 biolink:molecularly_interacts_with DrugCentral:2775 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tropisetron is antagonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1bf66248-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trospium targets GPCR (Muscarinic acetylcholine receptor M1) DrugCentral uuid:1bf68688-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trospium is antagonist of GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:1bf6ab36-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trospium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:1bf6cf4e-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2776 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trospium targets GPCR (Muscarinic acetylcholine receptor M5) DrugCentral uuid:1bf6f370-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2777 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trovafloxacin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.306']} DrugCentral uuid:1bf71bde-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2777 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trovafloxacin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.395']} DrugCentral uuid:1bf748f2-d20a-11ec-8377-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2777 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trovafloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:1bf748f2-d20a-11ec-8377-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:2777 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trovafloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:1bf77ade-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2777 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trovafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:1bf77ade-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:2777 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trovafloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:1bf7a8b0-d20a-11ec-8377-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:2780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tryptophan is allosteric modulator of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1bf7d18c-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tryptophan targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:1bf7f9b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q6DWJ6 biolink:molecularly_interacts_with DrugCentral:2780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tryptophan is agonist of GPCR (Probable G-protein coupled receptor 139) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:1bf821dc-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:2780 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tryptophan targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:1bf849e6-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.013']} DrugCentral uuid:1bf8727c-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1bf89bb2-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1bf8c3da-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UGI6 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:1bf8ec2a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2S1 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1bf91736-d20a-11ec-8377-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1bf942b0-d20a-11ec-8377-0242ac110003 UniProtKB:P70605 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1bf96dda-d20a-11ec-8377-0242ac110003 UniProtKB:Q401N2 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Zinc-activated ligand-gated ion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1bf997e2-d20a-11ec-8377-0242ac110003 UniProtKB:P23979 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1bf9c03c-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1bf9e878-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:1bfa10b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:1bfa3972-d20a-11ec-8377-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1bfa61b8-d20a-11ec-8377-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:1bfa8e04-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1bfa8e04-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1bfac950-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:1bfac950-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:1bfac950-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:1bfb0c94-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:1bfb0c94-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.38']} DrugCentral uuid:1bfb43da-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:1bfb43da-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.579']} DrugCentral uuid:1bfb7bd4-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1bfb7bd4-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1bfbb338-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.066']} DrugCentral uuid:1bfbb338-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.066']} DrugCentral uuid:1bfbf38e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1bfbf38e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1bfbf38e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1bfbf38e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1bfc419a-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:1bfc419a-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is antagonist of Ion channel (Serotonin 3 receptor (5HT3)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:1bfc7520-d20a-11ec-8377-0242ac110003 UniProtKB:Q92952 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfcdac4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1bfdacba-d20a-11ec-8377-0242ac110003 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:2781 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tubocurarine is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1bfdd500-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:2782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tulobuterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1bfdfdaa-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2782 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tulobuterol is agonist of GPCR (Beta-2 adrenergic receptor) DrugCentral uuid:1bfe21e0-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.59']} DrugCentral uuid:1bfe4a1c-d20a-11ec-8377-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['2.7']} DrugCentral uuid:1bfe7258-d20a-11ec-8377-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1bfe9cb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1bfec4b0-d20a-11ec-8377-0242ac110003 UniProtKB:H9TVJ1 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (TyR1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1bff1f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bff1f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bff1f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bff1f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bff1f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bff1f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bff1f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bff1f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bff1f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bff1f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bff1f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bff1f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bff1f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bff1f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine targets GPCR (Serotonin (5-HT) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1bffd7ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:2784 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyramine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:1c000032-d20a-11ec-8377-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:2786 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tyrosine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:1c002850-d20a-11ec-8377-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1c0051b8-d20a-11ec-8377-0242ac110003 UniProtKB:P15144 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1c007ae4-d20a-11ec-8377-0242ac110003 UniProtKB:P28838 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1c00a3ac-d20a-11ec-8377-0242ac110003 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1c00cbde-d20a-11ec-8377-0242ac110003 UniProtKB:P15145 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1c00f47e-d20a-11ec-8377-0242ac110003 UniProtKB:O96935 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (M1 family aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1c011cba-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VCT3 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Aminopeptidase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1c0144ce-d20a-11ec-8377-0242ac110003 UniProtKB:P97629 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Leucyl-cystinyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1c016e4a-d20a-11ec-8377-0242ac110003 UniProtKB:O09175 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Aminopeptidase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1c019708-d20a-11ec-8377-0242ac110003 UniProtKB:P00727 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1c01bf58-d20a-11ec-8377-0242ac110003 UniProtKB:P97449 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1c01e7a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q01693 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Bacterial leucyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1c020fe4-d20a-11ec-8377-0242ac110003 UniProtKB:P28839 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1c023afa-d20a-11ec-8377-0242ac110003 UniProtKB:P15684 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Aminopeptidase N) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:1c026584-d20a-11ec-8377-0242ac110003 UniProtKB:P55786 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Puromycin-sensitive aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1c028dd4-d20a-11ec-8377-0242ac110003 UniProtKB:P28839 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1c02b5fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZ08 biolink:molecularly_interacts_with DrugCentral:2787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubenimex targets Enzyme (Endoplasmic reticulum aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1c02de7e-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 urapidil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.456']} DrugCentral uuid:1c0306d8-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 urapidil is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1c032f32-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 urapidil is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1c03576e-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 urapidil is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1c038022-d20a-11ec-8377-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:2797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ursodiol targets Enzyme (Aldo-keto reductase family 1 member C2) DrugCentral uuid:1c03a44e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:2797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ursodiol is agonist of Nuclear hormone receptor (Bile acid receptor) DrugCentral uuid:1c03c85c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:2797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ursodiol targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1c03f066-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:2797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ursodiol targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1c041c76-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZ45 biolink:molecularly_interacts_with DrugCentral:2797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ursodiol targets Unclassified (CDGSH iron-sulfur domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:1c0447a0-d20a-11ec-8377-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2798 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valaciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:1c046bd6-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1c04958e-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1c04bde8-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.537']} DrugCentral uuid:1c04e642-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:1c050e88-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.37']} DrugCentral uuid:1c053746-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.27']} DrugCentral uuid:1c055faa-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.87']} DrugCentral uuid:1c058804-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:1c05b054-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1c05da02-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1c06025c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1c062ac0-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1c065392-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1c067c50-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1c06a4aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:1c06cd04-d20a-11ec-8377-0242ac110003 UniProtKB:P00403 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Cytochrome c oxidase subunit 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1c06f568-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1c071e3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q95323 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1c07469e-d20a-11ec-8377-0242ac110003 UniProtKB:P40881 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1c07701a-d20a-11ec-8377-0242ac110003 UniProtKB:Q50565 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:1c07986a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1c07c3d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.18']} DrugCentral uuid:1c07ec2a-d20a-11ec-8377-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1c081466-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:1c083d24-d20a-11ec-8377-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1c08657e-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:1c088eb4-d20a-11ec-8377-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c08b718-d20a-11ec-8377-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1c08dfcc-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1c09081c-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1c09309e-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1c0958d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1c098332-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1c09ab96-d20a-11ec-8377-0242ac110003 UniProtKB:O78749 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Cytochrome c oxidase subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:1c09d3b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:1c09fbf0-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1c0a2490-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valdecoxib targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.28']} DrugCentral uuid:1c0a4ce0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valethamate targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1c0a7530-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.56']} DrugCentral uuid:1c0a9d80-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1c0ac648-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.25']} DrugCentral uuid:1c0aee98-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:1c0b1706-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valethamate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:1c0b3f60-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:2800 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valethamate targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1c0b69ae-d20a-11ec-8377-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valganciclovir is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:1c0b8e70-d20a-11ec-8377-0242ac110003 UniProtKB:P51649 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid is inhibitor of Enzyme (Succinate-semialdehyde dehydrogenase, mitochondrial) DrugCentral uuid:1c0bb29c-d20a-11ec-8377-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:1c0bdab0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1c0c0346-d20a-11ec-8377-0242ac110003 UniProtKB:P14550 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1c0c2b50-d20a-11ec-8377-0242ac110003 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1c0c5396-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1c0c7ba0-d20a-11ec-8377-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1c0ca558-d20a-11ec-8377-0242ac110003 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1c0ccd6c-d20a-11ec-8377-0242ac110003 UniProtKB:P35504 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (UDP-glucuronosyltransferase 1-5) DrugCentral uuid:1c0cf18e-d20a-11ec-8377-0242ac110003 UniProtKB:Q5RJP0 biolink:molecularly_interacts_with DrugCentral:2803 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valproic acid targets Enzyme (Aldose reductase-related protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1c0d19c0-d20a-11ec-8377-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:2805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valrubicin is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:1c0d41ac-d20a-11ec-8377-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:2806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valsartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1c0d6e20-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valsartan targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:1c0d9666-d20a-11ec-8377-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:2806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valsartan targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:1c0dc30c-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valsartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:1c0dc30c-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:2806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valsartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:1c0df67e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vancomycin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1c0e1eba-d20a-11ec-8377-0242ac110003 UniProtKB:Q06241 biolink:molecularly_interacts_with DrugCentral:2807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vancomycin targets Enzyme (D-alanyl-D-alanine dipeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:1c0e470a-d20a-11ec-8377-0242ac110003 UniProtKB:P17443 biolink:molecularly_interacts_with DrugCentral:2807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vancomycin targets Enzyme (UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1c0e6fb4-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1c0e980e-d20a-11ec-8377-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:1c0ec450-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:1c0ec450-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.66']} DrugCentral uuid:1c0efd80-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:1c0efd80-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:1c0f34f8-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1c0f34f8-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1c0f6c3e-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:1c0f6c3e-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:1c0fa424-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1c0fa424-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1c0fdb7e-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:1c0fdb7e-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline is agonist of Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:1c101404-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:1c101404-d20a-11ec-8377-0242ac110003 UniProtKB:P32297 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.066']} DrugCentral uuid:1c104bfe-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1c104bfe-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1c108b5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1c108b5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1c108b5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1c108b5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1c10db46-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1c10db46-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1c111fa2-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:1c111fa2-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:1c111fa2-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:1c111fa2-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:2808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 varenicline targets Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:1c116f7a-d20a-11ec-8377-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:1c1197ac-d20a-11ec-8377-0242ac110003 UniProtKB:P16499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.465']} DrugCentral uuid:1c11c11e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HCR9 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1c11e950-d20a-11ec-8377-0242ac110003 UniProtKB:P54750 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.041']} DrugCentral uuid:1c1212a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1c123ad6-d20a-11ec-8377-0242ac110003 UniProtKB:O00408 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (cGMP-dependent 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1c1262fe-d20a-11ec-8377-0242ac110003 UniProtKB:O76083 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1c128f18-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1c128f18-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1c12d248-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1c12d248-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1c12d248-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1c12d248-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1c131f6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1c131f6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vardenafil targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1c13536c-d20a-11ec-8377-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin is agonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.59']} DrugCentral uuid:1c137bc6-d20a-11ec-8377-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin is agonist of GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:1c13a434-d20a-11ec-8377-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin is agonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:1c13cc8e-d20a-11ec-8377-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.78']} DrugCentral uuid:1c13f51a-d20a-11ec-8377-0242ac110003 UniProtKB:P32307 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:1c141d56-d20a-11ec-8377-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.93']} DrugCentral uuid:1c1445a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.35']} DrugCentral uuid:1c146e00-d20a-11ec-8377-0242ac110003 UniProtKB:P48044 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1c149998-d20a-11ec-8377-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:1c14c1e8-d20a-11ec-8377-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:1c14ee2a-d20a-11ec-8377-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:1c14ee2a-d20a-11ec-8377-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:2810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vasopressin targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:1c15220a-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1c154a64-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1c15728c-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1c159eb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:1c159eb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta4) DrugCentral uuid:1c15d4d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1c15d4d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1c15d4d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium is antagonist of Ion channel (Acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1c16184a-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:1c16184a-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) DrugCentral uuid:1c164b80-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:1c164b80-d20a-11ec-8377-0242ac110003 UniProtKB:P43681 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) DrugCentral uuid:1c16855a-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1c16855a-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1c16855a-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1c16855a-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vecuronium targets Ion channel (Acetylcholine receptor; alpha1/beta1/delta/gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1c16d050-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.051']} DrugCentral uuid:1c16f918-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.975']} DrugCentral uuid:1c172168-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.652']} DrugCentral uuid:1c1749ae-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.698']} DrugCentral uuid:1c1771ea-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.554']} DrugCentral uuid:1c179ac6-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1c17c320-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1c17eb70-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c1813a2-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1c183fe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:1c18682a-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venlafaxine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1c18907a-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Sodium channel protein type 5 subunit alpha) DrugCentral uuid:1c18b4a6-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.664']} DrugCentral uuid:1c18dd82-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1c1905aa-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1c192e04-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1c1956d6-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.896']} DrugCentral uuid:1c197f26-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.763']} DrugCentral uuid:1c19a83e-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:1c19d0a2-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.979']} DrugCentral uuid:1c19fa8c-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:1c1a25de-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.201']} DrugCentral uuid:1c1a4ea6-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.594']} DrugCentral uuid:1c1a76f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:1c1a9f82-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.072']} DrugCentral uuid:1c1ac7e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1c1af018-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.88']} DrugCentral uuid:1c1b1854-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.43']} DrugCentral uuid:1c1b40cc-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Enzyme (Carbonic anhydrase 1) DrugCentral uuid:1c1b64da-d20a-11ec-8377-0242ac110003 UniProtKB:P48051 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (G protein-activated inward rectifier potassium channel 2) DrugCentral uuid:1c1b8910-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.485']} DrugCentral uuid:1c1bb188-d20a-11ec-8377-0242ac110003 UniProtKB:Q13698 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is blocker of Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) DrugCentral uuid:1c1bd76c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16322 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1c1bffda-d20a-11ec-8377-0242ac110003 UniProtKB:P22001 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily A member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1c1c2938-d20a-11ec-8377-0242ac110003 UniProtKB:Q96PR1 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1c1c5192-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1c1c7a14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.348']} DrugCentral uuid:1c1ca250-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RP8 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1c1cca8c-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:1c1cf2e6-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:1c1d1b86-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1c1d43ae-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1c1d6bd6-d20a-11ec-8377-0242ac110003 UniProtKB:P15381 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1c1d9502-d20a-11ec-8377-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1c1dbef6-d20a-11ec-8377-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1c1de746-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1S) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1c1e0f82-d20a-11ec-8377-0242ac110003 UniProtKB:P06199 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:1c1e380e-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.071']} DrugCentral uuid:1c1e68a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1c1e68a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1c1e68a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1c1eaee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:1c1eaee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:1c1eaee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q02485 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.43']} DrugCentral uuid:1c1eedb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.73']} DrugCentral uuid:1c1f1602-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N623 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil targets Transporter (Chloroquine resistance transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1c1f3e34-d20a-11ec-8377-0242ac110003 UniProtKB:P22462 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1c1f667a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULQ1 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is blocker of Ion channel (Two pore calcium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:1c1f9258-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NHX9 biolink:molecularly_interacts_with DrugCentral:2815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 verapamil is blocker of Ion channel (Two pore calcium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1c1fbd82-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vesnarinone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1c1fe5fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vesnarinone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:1c200ea4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13370 biolink:molecularly_interacts_with DrugCentral:2817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vesnarinone targets Enzyme (cGMP-inhibited 3',5'-cyclic phosphodiesterase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:1c203abe-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vesnarinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1c203abe-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:2817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vesnarinone targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1c206e12-d20a-11ec-8377-0242ac110003 UniProtKB:P55072 biolink:molecularly_interacts_with DrugCentral:2817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vesnarinone targets Enzyme (Transitional endoplasmic reticulum ATPase) DrugCentral uuid:1c20922a-d20a-11ec-8377-0242ac110003 UniProtKB:P04293 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine is inhibitor of Enzyme (DNA polymerase catalytic subunit) DrugCentral uuid:1c20b688-d20a-11ec-8377-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:1c20da96-d20a-11ec-8377-0242ac110003 UniProtKB:P09884 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Enzyme (DNA polymerase alpha catalytic subunit) DrugCentral uuid:1c20ffbc-d20a-11ec-8377-0242ac110003 UniProtKB:P23921 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Enzyme (Ribonucleoside-diphosphate reductase large subunit) DrugCentral uuid:1c2123c0-d20a-11ec-8377-0242ac110003 UniProtKB:P31350 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Enzyme (Ribonucleoside-diphosphate reductase subunit M2) DrugCentral uuid:1c214968-d20a-11ec-8377-0242ac110003 UniProtKB:Q16854 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Kinase (Deoxyguanosine kinase, mitochondrial) DrugCentral uuid:1c216f6a-d20a-11ec-8377-0242ac110003 UniProtKB:P60891 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Kinase (Ribose-phosphate pyrophosphokinase 1) DrugCentral uuid:1c2194b8-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:1c21bcf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q04400 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Enzyme (Adenylate cyclase type V) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:1c21e5bc-d20a-11ec-8377-0242ac110003 UniProtKB:P50247 biolink:molecularly_interacts_with DrugCentral:2818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vidarabine targets Enzyme (Adenosylhomocysteinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1c220e0c-d20a-11ec-8377-0242ac110003 UniProtKB:P80404 biolink:molecularly_interacts_with DrugCentral:2819 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vigabatrin is inhibitor of Enzyme (4-aminobutyrate aminotransferase, mitochondrial) DrugCentral uuid:1c223256-d20a-11ec-8377-0242ac110003 UniProtKB:P50554 biolink:molecularly_interacts_with DrugCentral:2819 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vigabatrin targets Enzyme (Gamma-amino-N-butyrate transaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:1c225a88-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 viloxazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.76']} DrugCentral uuid:1c228350-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 viloxazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.81']} DrugCentral uuid:1c22abaa-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:2820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 viloxazine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.78']} DrugCentral uuid:1c22d40e-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:2820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 viloxazine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:1c22fc68-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTR4 biolink:molecularly_interacts_with DrugCentral:2820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 viloxazine targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1c2326f2-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 viloxazine is antagonist of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1c234f56-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1c237788-d20a-11ec-8377-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:1c239ba0-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:1c23c012-d20a-11ec-8377-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:1c23e42a-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.728']} DrugCentral uuid:1c240c52-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.298']} DrugCentral uuid:1c24347a-d20a-11ec-8377-0242ac110003 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1c247cc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1c247cc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1c247cc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1c247cc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1c247cc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1c247cc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1c247cc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1c247cc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1c247cc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinblastine is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1c250120-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1c25297a-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.2']} DrugCentral uuid:1c2551ca-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1c257a10-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinburnine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1c25a2c4-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:1c25c6be-d20a-11ec-8377-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:1c25eaea-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:1c260f16-d20a-11ec-8377-0242ac110003 UniProtKB:Q5T3U5 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine targets Transporter (Multidrug resistance-associated protein 7) DrugCentral uuid:1c263b4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1c263b4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1c263b4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1c269a4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c269a4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c269a4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c269a4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c269a4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c269a4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c269a4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c269a4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c269a4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2825 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincristine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c270f92-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vindesine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['4.607']} DrugCentral uuid:1c2737e2-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1c276082-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.271']} DrugCentral uuid:1c27a7e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c27a7e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c27a7e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c27a7e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c27a7e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c27a7e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c27a7e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c27a7e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c27a7e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:2827 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinorelbine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1c281bd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinpocetine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1c284420-d20a-11ec-8377-0242ac110003 UniProtKB:P54750 biolink:molecularly_interacts_with DrugCentral:2828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinpocetine targets Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1c286c5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q14123 biolink:molecularly_interacts_with DrugCentral:2828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinpocetine is inhibitor of Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1c2899fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinpocetine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:1c2899fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:2828 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinpocetine targets Enzyme (Phosphodiesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:1c28d174-d20a-11ec-8377-0242ac110003 UniProtKB:Q92781 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Enzyme (11-cis retinol dehydrogenase) DrugCentral uuid:1c28f7d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q96NR8 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Enzyme (Retinol dehydrogenase 12) DrugCentral uuid:1c291bd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NBN7 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Enzyme (Retinol dehydrogenase 13) DrugCentral uuid:1c294078-d20a-11ec-8377-0242ac110003 UniProtKB:P10745 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Surface antigen (Retinol-binding protein 3) DrugCentral uuid:1c296472-d20a-11ec-8377-0242ac110003 UniProtKB:P82980 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Cytosolic other (Retinol-binding protein 5) DrugCentral uuid:1c29888a-d20a-11ec-8377-0242ac110003 UniProtKB:Q96R05 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Cytosolic other (Retinoid-binding protein 7) DrugCentral uuid:1c29aca2-d20a-11ec-8377-0242ac110003 UniProtKB:P02753 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Secreted (Retinol-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1c29d54c-d20a-11ec-8377-0242ac110003 UniProtKB:P50120 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Cytosolic other (Retinol-binding protein 2) DrugCentral uuid:1c29f96e-d20a-11ec-8377-0242ac110003 UniProtKB:O94788 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Enzyme (Retinal dehydrogenase 2) DrugCentral uuid:1c2a1d68-d20a-11ec-8377-0242ac110003 UniProtKB:P00352 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Enzyme (Retinal dehydrogenase 1) DrugCentral uuid:1c2a4158-d20a-11ec-8377-0242ac110003 UniProtKB:P12271 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Transporter (Retinaldehyde-binding protein 1) DrugCentral uuid:1c2a6692-d20a-11ec-8377-0242ac110003 UniProtKB:P02754 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Unclassified (Beta-lactoglobulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:1c2a8ff0-d20a-11ec-8377-0242ac110003 UniProtKB:P09455 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol targets Cytosolic other (Retinol-binding protein 1) DrugCentral uuid:1c2ab458-d20a-11ec-8377-0242ac110003 UniProtKB:P49116 biolink:molecularly_interacts_with DrugCentral:2831 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retinol is agonist of Nuclear other (Nuclear receptor subfamily 2 group C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.71']} DrugCentral uuid:1c2adc6c-d20a-11ec-8377-0242ac110003 UniProtKB:O60779 biolink:molecularly_interacts_with DrugCentral:2832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamine targets Transporter (Thiamine transporter 1) DrugCentral uuid:1c2b0106-d20a-11ec-8377-0242ac110003 UniProtKB:P29401 biolink:molecularly_interacts_with DrugCentral:2832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamine targets Enzyme (Transketolase) DrugCentral uuid:1c2b2564-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3S4 biolink:molecularly_interacts_with DrugCentral:2832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamine targets Kinase (Thiamin pyrophosphokinase 1) DrugCentral uuid:1c2b4968-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BU02 biolink:molecularly_interacts_with DrugCentral:2832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamine targets Enzyme (Thiamine-triphosphatase) DrugCentral uuid:1c2b6e7a-d20a-11ec-8377-0242ac110003 UniProtKB:P51854 biolink:molecularly_interacts_with DrugCentral:2832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamine targets Enzyme (Transketolase-like protein 1) DrugCentral uuid:1c2b92a6-d20a-11ec-8377-0242ac110003 UniProtKB:P07900 biolink:molecularly_interacts_with DrugCentral:2832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamine targets Cytosolic other (Heat shock protein HSP 90-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1c2bbba0-d20a-11ec-8377-0242ac110003 UniProtKB:A2RI47 biolink:molecularly_interacts_with DrugCentral:2832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiamine targets Transporter (Thiamine transporter ThiT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.91']} DrugCentral uuid:1c2be3c8-d20a-11ec-8377-0242ac110003 UniProtKB:P30043 biolink:molecularly_interacts_with DrugCentral:2834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riboflavin targets Enzyme (Flavin reductase (NADPH)) DrugCentral uuid:1c2c07e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q969G6 biolink:molecularly_interacts_with DrugCentral:2834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riboflavin targets Kinase (Riboflavin kinase) DrugCentral uuid:1c2c2c02-d20a-11ec-8377-0242ac110003 UniProtKB:P02752 biolink:molecularly_interacts_with DrugCentral:2834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riboflavin targets Unclassified (Riboflavin-binding protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1c2c5650-d20a-11ec-8377-0242ac110003 UniProtKB:P49019 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid is agonist of GPCR (Hydroxycarboxylic acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1c2c7e64-d20a-11ec-8377-0242ac110003 UniProtKB:P40261 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid targets Enzyme (Nicotinamide N-methyltransferase) DrugCentral uuid:1c2ca27c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15274 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid targets Enzyme (Nicotinate-nucleotide pyrophosphorylase [carboxylating]) DrugCentral uuid:1c2cc69e-d20a-11ec-8377-0242ac110003 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid targets Enzyme (Nicotinamide phosphoribosyltransferase) DrugCentral uuid:1c2ceb4c-d20a-11ec-8377-0242ac110003 UniProtKB:Q80Z39 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1c2d1388-d20a-11ec-8377-0242ac110003 UniProtKB:Q9EP66 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1c2d3bd8-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.88']} DrugCentral uuid:1c2d641e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:2835 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nicotinic acid is agonist of GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1c2d8ce6-d20a-11ec-8377-0242ac110003 UniProtKB:P34896 biolink:molecularly_interacts_with DrugCentral:2836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxine targets Enzyme (Serine hydroxymethyltransferase, cytosolic) DrugCentral uuid:1c2db108-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NVS9 biolink:molecularly_interacts_with DrugCentral:2836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxine targets Enzyme (Pyridoxine-5'-phosphate oxidase) DrugCentral uuid:1c2dd516-d20a-11ec-8377-0242ac110003 UniProtKB:Q96GD0 biolink:molecularly_interacts_with DrugCentral:2836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxine targets Enzyme (Pyridoxal phosphate phosphatase) DrugCentral uuid:1c2df938-d20a-11ec-8377-0242ac110003 UniProtKB:O00764 biolink:molecularly_interacts_with DrugCentral:2836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxine targets Kinase (Pyridoxal kinase) DrugCentral uuid:1c2e1e22-d20a-11ec-8377-0242ac110003 UniProtKB:P35520 biolink:molecularly_interacts_with DrugCentral:2836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxine targets Enzyme (Cystathionine beta-synthase) DrugCentral uuid:1c2e4230-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y617 biolink:molecularly_interacts_with DrugCentral:2836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxine targets Enzyme (Phosphoserine aminotransferase) DrugCentral uuid:1c2e6648-d20a-11ec-8377-0242ac110003 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:2838 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergocalciferol targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) DrugCentral uuid:1c2e8a6a-d20a-11ec-8377-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2838 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergocalciferol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:1c2eae6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q6VVX0 biolink:molecularly_interacts_with DrugCentral:2838 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ergocalciferol targets Enzyme (Vitamin D 25-hydroxylase) DrugCentral uuid:1c2ed312-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:2840 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colecalciferol targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1c2efb1c-d20a-11ec-8377-0242ac110003 UniProtKB:O15528 biolink:molecularly_interacts_with DrugCentral:2840 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colecalciferol targets Enzyme (25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial) DrugCentral uuid:1c2f1f5c-d20a-11ec-8377-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2840 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colecalciferol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.68']} DrugCentral uuid:1c2f4770-d20a-11ec-8377-0242ac110003 UniProtKB:Q6VVX0 biolink:molecularly_interacts_with DrugCentral:2840 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colecalciferol targets Enzyme (Vitamin D 25-hydroxylase) DrugCentral uuid:1c2f6bec-d20a-11ec-8377-0242ac110003 UniProtKB:Q02318 biolink:molecularly_interacts_with DrugCentral:2840 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colecalciferol targets Enzyme (Sterol 26-hydroxylase, mitochondrial) DrugCentral uuid:1c2f8ff0-d20a-11ec-8377-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:2841 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydrotachysterol targets Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:1c2fb426-d20a-11ec-8377-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:2845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voglibose targets Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1c2fde42-d20a-11ec-8377-0242ac110003 UniProtKB:P23739 biolink:molecularly_interacts_with DrugCentral:2845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voglibose targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1c300994-d20a-11ec-8377-0242ac110003 UniProtKB:Q6P7A9 biolink:molecularly_interacts_with DrugCentral:2845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voglibose targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1c30320c-d20a-11ec-8377-0242ac110003 UniProtKB:P35574 biolink:molecularly_interacts_with DrugCentral:2845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voglibose targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.15']} DrugCentral uuid:1c305a5c-d20a-11ec-8377-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:2845 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voglibose is inhibitor of Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1c30828e-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1c30ab7e-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['8.73']} DrugCentral uuid:1c30d3d8-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1c30fc0a-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1c3124d2-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['5.844']} DrugCentral uuid:1c314d2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1c3175fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1c319e30-d20a-11ec-8377-0242ac110003 UniProtKB:P00189 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (Cytochrome P450 11A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1c31c7c0-d20a-11ec-8377-0242ac110003 UniProtKB:P00189 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (Cholesterol side-chain cleavage enzyme, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1c31f02e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6A2 biolink:molecularly_interacts_with DrugCentral:2846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voriconazole targets Enzyme (Cholesterol 24-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1c321874-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 warfarin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['3.98']} DrugCentral uuid:1c3240b0-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 warfarin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.867']} DrugCentral uuid:1c3269be-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BQB6 biolink:molecularly_interacts_with DrugCentral:2847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 warfarin is inhibitor of Enzyme (Vitamin K epoxide reductase complex subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1c329218-d20a-11ec-8377-0242ac110003 UniProtKB:Q16549 biolink:molecularly_interacts_with DrugCentral:2847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 warfarin targets Enzyme (Proprotein convertase subtilisin/kexin type 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:1c32ba54-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N0U8 biolink:molecularly_interacts_with DrugCentral:2847 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 warfarin targets Enzyme (Vitamin K epoxide reductase complex subunit 1-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.284']} DrugCentral uuid:1c32e2a4-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xamoterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.75']} DrugCentral uuid:1c330b58-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xamoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1c33339e-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:2848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xamoterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1c335bda-d20a-11ec-8377-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1c33840c-d20a-11ec-8377-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1c33ae78-d20a-11ec-8377-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1c33d7b8-d20a-11ec-8377-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1c340012-d20a-11ec-8377-0242ac110003 UniProtKB:P08709 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Coagulation factor VII) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1c34284e-d20a-11ec-8377-0242ac110003 UniProtKB:P04070 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Vitamin K-dependent protein C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1c345148-d20a-11ec-8377-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:1c34798e-d20a-11ec-8377-0242ac110003 UniProtKB:P03951 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Coagulation factor XI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1c34a1ca-d20a-11ec-8377-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1c34ca6a-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2852 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ximelagatran is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.432']} DrugCentral uuid:1c34f2a6-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.873']} DrugCentral uuid:1c351aec-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.114']} DrugCentral uuid:1c354346-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.646']} DrugCentral uuid:1c356c9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y271 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.5']} DrugCentral uuid:1c3594d6-d20a-11ec-8377-0242ac110003 UniProtKB:P47712 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Enzyme (Cytosolic phospholipase A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1c35bd12-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1c35e684-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.61']} DrugCentral uuid:1c360f60-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.419']} DrugCentral uuid:1c3637b0-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.359']} DrugCentral uuid:1c365ff6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast is antagonist of GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1c368846-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.452']} DrugCentral uuid:1c36b0e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q15722 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets GPCR (Leukotriene B4 receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.147']} DrugCentral uuid:1c36d954-d20a-11ec-8377-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1c370226-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.269']} DrugCentral uuid:1c372a4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q2NNR5 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets GPCR (Cysteinyl leukotriene receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1c3754d8-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1c377d28-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1c37a550-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1c37ce90-d20a-11ec-8377-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1c37f7a8-d20a-11ec-8377-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:1c382002-d20a-11ec-8377-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:2855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zafirlukast targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1c38483e-d20a-11ec-8377-0242ac110003 UniProtKB:P27707 biolink:molecularly_interacts_with DrugCentral:2856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zalcitabine targets Kinase (Deoxycytidine kinase) DrugCentral uuid:1c386c92-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2856 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zalcitabine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:1c389d48-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.789']} DrugCentral uuid:1c389d48-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.789']} DrugCentral uuid:1c389d48-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.789']} DrugCentral uuid:1c38e38e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:1c38e38e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:1c38e38e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zaleplon is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:1c3922e0-d20a-11ec-8377-0242ac110003 UniProtKB:P16207 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1c394b30-d20a-11ec-8377-0242ac110003 UniProtKB:P03468 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1c39738a-d20a-11ec-8377-0242ac110003 UniProtKB:P03474 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:1c399be4-d20a-11ec-8377-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:1c39c4ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q75VQ4 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:1c39ecd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q6Q793 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1c3a1506-d20a-11ec-8377-0242ac110003 UniProtKB:A5Z252 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1c3a3d42-d20a-11ec-8377-0242ac110003 UniProtKB:Q2LFS1 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1c3a65f6-d20a-11ec-8377-0242ac110003 UniProtKB:C4LRQ6 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1c3a8e1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q20MD3 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1c3ab650-d20a-11ec-8377-0242ac110003 UniProtKB:P03470 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:1c3ade78-d20a-11ec-8377-0242ac110003 UniProtKB:Q194T1 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1c3b081c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ49 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Sialidase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1c3b303a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3R4 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Sialidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1c3b5a60-d20a-11ec-8377-0242ac110003 UniProtKB:Q07599 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:1c3b836e-d20a-11ec-8377-0242ac110003 UniProtKB:Q3S340 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1c3bac40-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WWR8 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Sialidase-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.58']} DrugCentral uuid:1c3bd4b8-d20a-11ec-8377-0242ac110003 UniProtKB:D5F1R0 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:1c3bfd12-d20a-11ec-8377-0242ac110003 UniProtKB:P03471 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.76']} DrugCentral uuid:1c3c25bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XV28 biolink:molecularly_interacts_with DrugCentral:2859 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanamivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1c3c4e02-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:1c3c762a-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1c3c9e84-d20a-11ec-8377-0242ac110003 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1c3cc878-d20a-11ec-8377-0242ac110003 UniProtKB:P23919 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:1c3cf0d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:1c3d1918-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1c3d414a-d20a-11ec-8377-0242ac110003 UniProtKB:P03362 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Polyprotein (Gag-Pro-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:1c3d69d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q72549 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1c3d921c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:1c3dba58-d20a-11ec-8377-0242ac110003 UniProtKB:P9WKE1 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.55']} DrugCentral uuid:1c3de2a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9PPP5 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1c3e0ba2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:2861 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zidovudine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1c3e3406-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton is inhibitor of Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1c3e5c2e-d20a-11ec-8377-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1c3e8456-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NS75 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets GPCR (Cysteinyl leukotriene receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:1c3eaf08-d20a-11ec-8377-0242ac110003 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.071']} DrugCentral uuid:1c3ed74e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15722 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets GPCR (Leukotriene B4 receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1c3eff94-d20a-11ec-8377-0242ac110003 UniProtKB:P20292 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets Cytosolic other (Arachidonate 5-lipoxygenase-activating protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1c3f27d0-d20a-11ec-8377-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1c3f5066-d20a-11ec-8377-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1c3f7988-d20a-11ec-8377-0242ac110003 UniProtKB:P48999 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1c3fa1c4-d20a-11ec-8377-0242ac110003 UniProtKB:O14684 biolink:molecularly_interacts_with DrugCentral:2862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zileuton targets Enzyme (Prostaglandin E synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1c3fcab4-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zimeldine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.727']} DrugCentral uuid:1c3ff2dc-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zimeldine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.818']} DrugCentral uuid:1c401b18-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zimeldine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.027']} DrugCentral uuid:1c404336-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1c406ce4-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1c409854-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.02']} DrugCentral uuid:1c40c3a6-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1c40ebe2-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1c41148c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1c413cbe-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1c41661c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:1c418f3e-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:1c41b856-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1c41e0b0-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.565']} DrugCentral uuid:1c420900-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1c423150-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1c425acc-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1c428308-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1c42ab3a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:1c42d376-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone is antagonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.14']} DrugCentral uuid:1c42fc02-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.818']} DrugCentral uuid:1c432448-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:1c434c8e-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.456']} DrugCentral uuid:1c43765a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1c439eb4-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.523']} DrugCentral uuid:1c43c6fa-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1c43ef4a-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:1c4418ee-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.796']} DrugCentral uuid:1c4443dc-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1c446c0e-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1c44945e-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.114']} DrugCentral uuid:1c44bd12-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:1c44e134-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1c450970-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1c4531c0-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.046']} DrugCentral uuid:1c455aba-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.536']} DrugCentral uuid:1c45830a-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1c45ab64-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1c45d3a0-d20a-11ec-8377-0242ac110003 UniProtKB:P31389 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1c45fe84-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1c462972-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:1c4651c2-d20a-11ec-8377-0242ac110003 UniProtKB:P31390 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1c4679f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q63380 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets Transporter (Transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.32']} DrugCentral uuid:1c46aa46-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1c46aa46-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1c46aa46-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1c46e8e4-d20a-11ec-8377-0242ac110003 UniProtKB:P07305 biolink:molecularly_interacts_with DrugCentral:2865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziprasidone targets Nuclear other (Histone H1.0) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1c47110c-d20a-11ec-8377-0242ac110003 UniProtKB:P12822 biolink:molecularly_interacts_with DrugCentral:2866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zofenopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1c473b14-d20a-11ec-8377-0242ac110003 UniProtKB:P47820 biolink:molecularly_interacts_with DrugCentral:2866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zofenopril targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1c476454-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:2866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zofenopril is inhibitor of Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1c478cc2-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:1c47b526-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1c47e154-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1c480c7e-d20a-11ec-8377-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:1c4834f6-d20a-11ec-8377-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1c485d96-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:1c4885fa-d20a-11ec-8377-0242ac110003 UniProtKB:P50281 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Matrix metalloproteinase-14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1c48aee0-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1c48d726-d20a-11ec-8377-0242ac110003 UniProtKB:P22894 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Neutrophil collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1c490002-d20a-11ec-8377-0242ac110003 UniProtKB:O95749 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1c49285c-d20a-11ec-8377-0242ac110003 UniProtKB:P22939 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1c4950ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q0GKD7 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1c497924-d20a-11ec-8377-0242ac110003 UniProtKB:Q12051 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1c49a3b8-d20a-11ec-8377-0242ac110003 UniProtKB:P05369 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid is inhibitor of Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1c49cc76-d20a-11ec-8377-0242ac110003 UniProtKB:O00481 biolink:molecularly_interacts_with DrugCentral:2868 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zoledronic acid targets Unclassified (Butyrophilin subfamily 3 member A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:1c49f46c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1c4a1cd0-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1c4a4598-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:1c4a6dde-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.45']} DrugCentral uuid:1c4a962e-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1c4abe74-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.4']} DrugCentral uuid:1c4ae76e-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1c4b1766-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1c4b1766-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1c4b1766-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:2869 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolmitriptan targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1c4b5726-d20a-11ec-8377-0242ac110003 UniProtKB:P14867 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1c4b82be-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1c4bab40-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1c4bd37c-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Km', 'has_quantitative_value': ['3.703']} DrugCentral uuid:1c4bfc08-d20a-11ec-8377-0242ac110003 UniProtKB:P16257 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Membrane receptor (Translocator protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1c4c2444-d20a-11ec-8377-0242ac110003 UniProtKB:P62813 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1c4c4c9e-d20a-11ec-8377-0242ac110003 UniProtKB:P23576 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1c4c74ee-d20a-11ec-8377-0242ac110003 UniProtKB:P19969 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (Gamma-aminobutyric acid receptor subunit alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:1c4ca5fe-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:1c4ca5fe-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:1c4ca5fe-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.703']} DrugCentral uuid:1c4cedb6-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:1c4cedb6-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:1c4cedb6-d20a-11ec-8377-0242ac110003 UniProtKB:P47869 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-2/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.807']} DrugCentral uuid:1c4d3492-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:1c4d3492-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:1c4d3492-d20a-11ec-8377-0242ac110003 UniProtKB:P34903 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-3/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.417']} DrugCentral uuid:1c4d7fa6-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.574']} DrugCentral uuid:1c4d7fa6-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.574']} DrugCentral uuid:1c4d7fa6-d20a-11ec-8377-0242ac110003 UniProtKB:P28472 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.574']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4df86e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1c4ed130-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1c4ed130-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1c4ed130-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1c4f187a-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1c4f187a-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1c4f187a-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-6/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1c4f5f2e-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1c4f5f2e-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1c4f5f2e-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1c4fa574-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:1c4fa574-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:1c4fa574-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.81']} DrugCentral uuid:1c4fedfe-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:1c4fedfe-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:1c4fedfe-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem is positive allosteric modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.164']} DrugCentral uuid:1c502c7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q03530 biolink:molecularly_interacts_with DrugCentral:2870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zolpidem targets Enzyme (CAAX prenyl protease 2) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1c50553c-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:2871 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zomepirac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:1c507d78-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:2871 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zomepirac targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.367']} DrugCentral uuid:1c50a9c4-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2871 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zomepirac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1c50a9c4-d20a-11ec-8377-0242ac110003 UniProtKB:O62698 biolink:molecularly_interacts_with DrugCentral:2871 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zomepirac targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1c50dd18-d20a-11ec-8377-0242ac110003 UniProtKB:P35498 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide is blocker of Ion channel (Sodium channel protein type 1 subunit alpha) DrugCentral uuid:1c5102e8-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.99']} DrugCentral uuid:1c512b38-d20a-11ec-8377-0242ac110003 UniProtKB:O43497 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1G) DrugCentral uuid:1c514f50-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.252']} DrugCentral uuid:1c517796-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1c51a040-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1c51c890-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.301']} DrugCentral uuid:1c51f0ea-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide is inhibitor of Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1c521a02-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1c524248-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1c526a8e-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:1c5292de-d20a-11ec-8377-0242ac110003 UniProtKB:O24855 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1c52bc8c-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1c52e72a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1c530f70-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1c5337ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1c53606a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1c5389d2-d20a-11ec-8377-0242ac110003 UniProtKB:P53615 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:1c53b218-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:1c53da9a-d20a-11ec-8377-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1c5403c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.94']} DrugCentral uuid:1c542bf8-d20a-11ec-8377-0242ac110003 UniProtKB:B5SU02 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Alpha carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1c545452-d20a-11ec-8377-0242ac110003 UniProtKB:C0IX24 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1c547ca2-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1c54a7fe-d20a-11ec-8377-0242ac110003 UniProtKB:A6YCJ1 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Astrosclerin-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.78']} DrugCentral uuid:1c54d04e-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1c54f89e-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U9J1 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Unclassified (Delta carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1c5520f8-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ9 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:1c554e48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:1c554e48-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase V) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.69']} DrugCentral uuid:1c55834a-d20a-11ec-8377-0242ac110003 UniProtKB:Q3SZX4 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1c55ab9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q6NSN2 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Amine oxidase [flavin-containing]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.51']} DrugCentral uuid:1c55d494-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TU56 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.58']} DrugCentral uuid:1c55fcf8-d20a-11ec-8377-0242ac110003 UniProtKB:Q31FD6 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Unclassified (Carbonic anhydrase, alpha family) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1c562566-d20a-11ec-8377-0242ac110003 UniProtKB:B2V8E3 biolink:molecularly_interacts_with DrugCentral:2872 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zonisamide targets Enzyme (Carbonate dehydratase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c56897a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c5761f6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.176']} DrugCentral uuid:1c5761f6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.176']} DrugCentral uuid:1c5761f6-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.176']} DrugCentral uuid:1c57a8b4-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:1c57a8b4-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:1c57a8b4-d20a-11ec-8377-0242ac110003 UniProtKB:P31644 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-5/beta-3/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:1c57ef40-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:1c57ef40-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:1c57ef40-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:1c58369e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:1c58369e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:1c58369e-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.582']} DrugCentral uuid:1c587d20-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:1c587d20-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:1c587d20-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.488']} DrugCentral uuid:1c58c564-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1c58c564-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1c58c564-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-3/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1c590cc2-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:1c590cc2-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:1c590cc2-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.278']} DrugCentral uuid:1c59533a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1c59533a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1c59533a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:2873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zopiclone is positive modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1c599264-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.394']} DrugCentral uuid:1c59ba96-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.638']} DrugCentral uuid:1c59e2f0-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c5a0c58-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1c5a3688-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.686']} DrugCentral uuid:1c5a5eb0-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.821']} DrugCentral uuid:1c5a86f6-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1c5aafb4-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1c5ad822-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.04']} DrugCentral uuid:1c5b0072-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:1c5b28c2-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1c5b5162-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1c5b7994-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.155']} DrugCentral uuid:1c5ba1da-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.273']} DrugCentral uuid:1c5bc9f8-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.19']} DrugCentral uuid:1c5bf2ca-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.606']} DrugCentral uuid:1c5c1bf6-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.21']} DrugCentral uuid:1c5c4428-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.301']} DrugCentral uuid:1c5c6c6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.704']} DrugCentral uuid:1c5c954a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.745']} DrugCentral uuid:1c5cbe08-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:1c5ce63a-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.137']} DrugCentral uuid:1c5d0e6c-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1c5d370c-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.585']} DrugCentral uuid:1c5d5f5c-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1c5d8798-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1c5db07e-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.016']} DrugCentral uuid:1c5ddba8-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.441']} DrugCentral uuid:1c5e066e-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1c5e2ffe-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.326']} DrugCentral uuid:1c5e58f8-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.301']} DrugCentral uuid:1c5e813e-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:1c5ea98e-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1c5ed1de-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1c5efaa6-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:2875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotepine is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:1c5f22ec-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:2877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zuclopenthixol targets GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:1c5f4722-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:2877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zuclopenthixol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1c5f6f5e-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:2877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zuclopenthixol targets GPCR (Alpha-1A adrenergic receptor) DrugCentral uuid:1c5f9448-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:2877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zuclopenthixol is antagonist of GPCR (D(1A) dopamine receptor) DrugCentral uuid:1c5fb860-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:2877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zuclopenthixol is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:1c5fdca0-d20a-11ec-8377-0242ac110003 UniProtKB:Q00975 biolink:molecularly_interacts_with DrugCentral:2878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziconotide is blocker of Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) DrugCentral uuid:1c6000cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q02294 biolink:molecularly_interacts_with DrugCentral:2878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziconotide is blocker of Ion channel (Voltage-dependent N-type calcium channel subunit alpha-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.3']} DrugCentral uuid:1c602a98-d20a-11ec-8377-0242ac110003 UniProtKB:P54282 biolink:molecularly_interacts_with DrugCentral:2878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ziconotide is blocker of Ion channel (Voltage-dependent P/Q-type calcium channel subunit alpha-1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1c6052f2-d20a-11ec-8377-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:2949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotarolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:1c607b42-d20a-11ec-8377-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:2949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zotarolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:1c60a37e-d20a-11ec-8377-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:2955 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eledoisin is agonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1c60cc28-d20a-11ec-8377-0242ac110003 UniProtKB:P29371 biolink:molecularly_interacts_with DrugCentral:2955 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eledoisin targets GPCR (Neuromedin-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.66']} DrugCentral uuid:1c60f45a-d20a-11ec-8377-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:2958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gonadorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1c611caa-d20a-11ec-8377-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:2958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gonadorelin targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1c6144dc-d20a-11ec-8377-0242ac110003 UniProtKB:P16235 biolink:molecularly_interacts_with DrugCentral:2958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gonadorelin targets GPCR (Lutropin-choriogonadotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:1c617678-d20a-11ec-8377-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2959 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lypressin is agonist of GPCR (Vasopressin receptor) DrugCentral uuid:1c617678-d20a-11ec-8377-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2959 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lypressin is agonist of GPCR (Vasopressin receptor) DrugCentral uuid:1c617678-d20a-11ec-8377-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:2959 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lypressin is agonist of GPCR (Vasopressin receptor) DrugCentral uuid:1c61ae2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC29 biolink:molecularly_interacts_with DrugCentral:2960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mifamurtide is activator of Cytosolic other (Nucleotide-binding oligomerization domain-containing protein 2) DrugCentral uuid:1c61d230-d20a-11ec-8377-0242ac110003 UniProtKB:Q96EB6 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (NAD-dependent protein deacetylase sirtuin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1c61fb16-d20a-11ec-8377-0242ac110003 UniProtKB:Q15077 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kb', 'has_quantitative_value': ['4']} DrugCentral uuid:1c622384-d20a-11ec-8377-0242ac110003 UniProtKB:P47900 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1c624bde-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IXJ6 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (NAD-dependent protein deacetylase sirtuin-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1c6273fc-d20a-11ec-8377-0242ac110003 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1c629c92-d20a-11ec-8377-0242ac110003 UniProtKB:Q96G91 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1c62c4e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1c62ed0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BPV8 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of GPCR (P2Y purinoceptor 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1c63153c-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:1c633e68-d20a-11ec-8377-0242ac110003 UniProtKB:P78527 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (DNA-dependent protein kinase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1c63671c-d20a-11ec-8377-0242ac110003 UniProtKB:Q5VLE3 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (RmtA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1c638f58-d20a-11ec-8377-0242ac110003 UniProtKB:Q99571 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Ion channel (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.749']} DrugCentral uuid:1c63b7d0-d20a-11ec-8377-0242ac110003 UniProtKB:O15648 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (ATP-dependent 6-phosphofructokinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1c640816-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1c640816-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1c640816-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1c640816-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1c640816-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1c640816-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1c640816-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1c640816-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1c640816-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1c640816-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1c640816-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1c64a122-d20a-11ec-8377-0242ac110003 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.963']} DrugCentral uuid:1c64c97c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NXA8 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (NAD-dependent protein deacylase sirtuin-5, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1c64f1b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q80Z26 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (Nucleoside triphosphate diphosphohydrolase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1c651c88-d20a-11ec-8377-0242ac110003 UniProtKB:O35795 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Enzyme (Ectonucleoside triphosphate diphosphohydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.18']} DrugCentral uuid:1c654532-d20a-11ec-8377-0242ac110003 UniProtKB:P49654 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1c656d6e-d20a-11ec-8377-0242ac110003 UniProtKB:P49653 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:1c6595c8-d20a-11ec-8377-0242ac110003 UniProtKB:P47824 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1c65be72-d20a-11ec-8377-0242ac110003 UniProtKB:P51578 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin is antagonist of Unclassified (P2X purinoceptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1c65e6b8-d20a-11ec-8377-0242ac110003 UniProtKB:P42224 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Unclassified (Signal transducer and activator of transcription 1-alpha/beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1c660f12-d20a-11ec-8377-0242ac110003 UniProtKB:P42229 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Unclassified (Signal transducer and activator of transcription 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:1c66374e-d20a-11ec-8377-0242ac110003 UniProtKB:P51692 biolink:molecularly_interacts_with DrugCentral:2966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suramin targets Unclassified (Signal transducer and activator of transcription 5B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.98']} DrugCentral uuid:1c66603e-d20a-11ec-8377-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:2968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triptorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.025']} DrugCentral uuid:1c668852-d20a-11ec-8377-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:2968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triptorelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1c66b070-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:2974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxacurium targets GPCR (Muscarinic acetylcholine receptor M2) DrugCentral uuid:1c66d488-d20a-11ec-8377-0242ac110003 UniProtKB:Q15822 biolink:molecularly_interacts_with DrugCentral:2974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxacurium targets Ion channel (Neuronal acetylcholine receptor subunit alpha-2) DrugCentral uuid:1c670264-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:1c670264-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:1c670264-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:2974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doxacurium is antagonist of Ion channel (Acetylcholine receptor) DrugCentral uuid:1c6739dc-d20a-11ec-8377-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:2975 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 histrelin is agonist of GPCR (Gonadotropin-releasing hormone receptor) DrugCentral uuid:1c675dfe-d20a-11ec-8377-0242ac110003 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:2977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caspofungin is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1c6786b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q4WLT4 biolink:molecularly_interacts_with DrugCentral:2977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caspofungin is inhibitor of Enzyme (1,3-beta-glucan synthase catalytic subunit FksP) DrugCentral uuid:1c67aad4-d20a-11ec-8377-0242ac110003 UniProtKB:O13383 biolink:molecularly_interacts_with DrugCentral:2977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caspofungin targets Unclassified (1,3-beta-D-glucan synthase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:1c67d702-d20a-11ec-8377-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.65']} DrugCentral uuid:1c67d702-d20a-11ec-8377-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:2989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.65']} DrugCentral uuid:1c680e70-d20a-11ec-8377-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.873']} DrugCentral uuid:1c680e70-d20a-11ec-8377-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:2989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.873']} DrugCentral uuid:1c684660-d20a-11ec-8377-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.499']} DrugCentral uuid:1c684660-d20a-11ec-8377-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:2989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.499']} DrugCentral uuid:1c687af4-d20a-11ec-8377-0242ac110003 UniProtKB:P30988 biolink:molecularly_interacts_with DrugCentral:2989 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin (salmon synthetic) is agonist of GPCR (Calcitonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.086']} DrugCentral uuid:1c68a326-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desirudin is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['12.7']} DrugCentral uuid:1c68ccd4-d20a-11ec-8377-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1c68f524-d20a-11ec-8377-0242ac110003 UniProtKB:P47871 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon is agonist of GPCR (Glucagon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1c691d6a-d20a-11ec-8377-0242ac110003 UniProtKB:P30082 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets GPCR (Glucagon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1c696180-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1c696180-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1c696180-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1c696180-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1c696180-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1c696180-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1c696180-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1c696180-d20a-11ec-8377-0242ac110003 UniProtKB:Q8CFM9 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets Enzyme (Adenylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1c69d818-d20a-11ec-8377-0242ac110003 UniProtKB:F8V479 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.51']} DrugCentral uuid:1c6a00ea-d20a-11ec-8377-0242ac110003 UniProtKB:O35659 biolink:molecularly_interacts_with DrugCentral:2994 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glucagon targets GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.36']} DrugCentral uuid:1c6a291c-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:2995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lepirudin is inhibitor of Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['13']} DrugCentral uuid:1c6a5158-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:1c6a7980-d20a-11ec-8377-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1c6aa504-d20a-11ec-8377-0242ac110003 UniProtKB:P30875 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.55']} DrugCentral uuid:1c6ad038-d20a-11ec-8377-0242ac110003 UniProtKB:P30935 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.1']} DrugCentral uuid:1c6af8a6-d20a-11ec-8377-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:1c6b30be-d20a-11ec-8377-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1c6b30be-d20a-11ec-8377-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1c6b30be-d20a-11ec-8377-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1c6b30be-d20a-11ec-8377-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1c6b30be-d20a-11ec-8377-0242ac110003 UniProtKB:P49660 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1c6b94b4-d20a-11ec-8377-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1c6b94b4-d20a-11ec-8377-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1c6b94b4-d20a-11ec-8377-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1c6b94b4-d20a-11ec-8377-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1c6b94b4-d20a-11ec-8377-0242ac110003 UniProtKB:P30938 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin targets GPCR (Somatostatin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1c6bea40-d20a-11ec-8377-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.46']} DrugCentral uuid:1c6c129a-d20a-11ec-8377-0242ac110003 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:1c6c3af4-d20a-11ec-8377-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:1c6c64e8-d20a-11ec-8377-0242ac110003 UniProtKB:P31391 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.23']} DrugCentral uuid:1c6c8d7e-d20a-11ec-8377-0242ac110003 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:2997 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatostatin is agonist of GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.54']} DrugCentral uuid:1c6cb6e6-d20a-11ec-8377-0242ac110003 UniProtKB:O96529 biolink:molecularly_interacts_with DrugCentral:2999 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrantel targets Enzyme (Acetylcholinesterase) DrugCentral uuid:1c6cdb08-d20a-11ec-8377-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:3008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atosiban targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:1c6d03c6-d20a-11ec-8377-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:3008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atosiban targets GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1c6d2d24-d20a-11ec-8377-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:3008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atosiban targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1c6d556a-d20a-11ec-8377-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:3008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atosiban targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1c6d7dd8-d20a-11ec-8377-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:3008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atosiban is antagonist of GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1c6da6c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel protein type 10 subunit alpha) DrugCentral uuid:1c6dd2d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1c6dd2d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1c6dd2d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybuprocaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1c6e113a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.934']} DrugCentral uuid:1c6e3b74-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.051']} DrugCentral uuid:1c6e6400-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.888']} DrugCentral uuid:1c6e8c3c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.046']} DrugCentral uuid:1c6eb48c-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.432']} DrugCentral uuid:1c6edd4a-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.269']} DrugCentral uuid:1c6f0590-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.532']} DrugCentral uuid:1c6f2e80-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.004']} DrugCentral uuid:1c6f56d0-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:1c6f7fc0-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.092']} DrugCentral uuid:1c6fa7f2-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.444']} DrugCentral uuid:1c6fd042-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:1c6ff874-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.545']} DrugCentral uuid:1c7021c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.965']} DrugCentral uuid:1c704a04-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.649']} DrugCentral uuid:1c70722c-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.115']} DrugCentral uuid:1c709a72-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.681']} DrugCentral uuid:1c70c2d6-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.192']} DrugCentral uuid:1c70ec3e-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.155']} DrugCentral uuid:1c71147a-d20a-11ec-8377-0242ac110003 UniProtKB:Q969F8 biolink:molecularly_interacts_with DrugCentral:3018 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzethonium targets GPCR (KiSS-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1c713d4c-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bergapten targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:1c716560-d20a-11ec-8377-0242ac110003 UniProtKB:Q63470 biolink:molecularly_interacts_with DrugCentral:3021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bergapten targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:1c718d92-d20a-11ec-8377-0242ac110003 UniProtKB:P04798 biolink:molecularly_interacts_with DrugCentral:3021 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bergapten targets Enzyme (Cytochrome P450 1A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1c71b5d8-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3025 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bietamiverine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1c71df36-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3025 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bietamiverine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.99']} DrugCentral uuid:1c72077c-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3025 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bietamiverine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:1c722fae-d20a-11ec-8377-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.299']} DrugCentral uuid:1c725920-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.651']} DrugCentral uuid:1c7281e8-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.184']} DrugCentral uuid:1c72aa2e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.843']} DrugCentral uuid:1c72d27e-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.912']} DrugCentral uuid:1c72face-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.501']} DrugCentral uuid:1c7323be-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.365']} DrugCentral uuid:1c734c22-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.337']} DrugCentral uuid:1c737468-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:1c739cb8-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.844']} DrugCentral uuid:1c73c800-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.195']} DrugCentral uuid:1c73f050-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.761']} DrugCentral uuid:1c741882-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1c7440e6-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1c746a26-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1c749276-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.212']} DrugCentral uuid:1c74bab2-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.647']} DrugCentral uuid:1c74e4e2-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.668']} DrugCentral uuid:1c750d28-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.735']} DrugCentral uuid:1c75355a-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.498']} DrugCentral uuid:1c755d96-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1c75871c-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.809']} DrugCentral uuid:1c75b098-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.415']} DrugCentral uuid:1c75d8d4-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1c760106-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1c7629b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1c765200-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:1c767a3c-d20a-11ec-8377-0242ac110003 UniProtKB:O75751 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Transporter (Solute carrier family 22 member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1c76a25a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:1c76cb36-d20a-11ec-8377-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol targets Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1c76f368-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z258 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol is activator of Ion channel (Potassium channel subfamily T member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1c771b9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q6IQ20 biolink:molecularly_interacts_with DrugCentral:3032 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bithionol is inhibitor of Unclassified (N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:1c7743cc-d20a-11ec-8377-0242ac110003 UniProtKB:P04183 biolink:molecularly_interacts_with DrugCentral:3042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 broxuridine targets Kinase (Thymidine kinase, cytosolic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1c776ef6-d20a-11ec-8377-0242ac110003 UniProtKB:P9WKE1 biolink:molecularly_interacts_with DrugCentral:3042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 broxuridine targets Kinase (Thymidylate kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1c779750-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:3047 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufexamac is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.97']} DrugCentral uuid:1c77bf96-d20a-11ec-8377-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:3047 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufexamac is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.91']} DrugCentral uuid:1c77e7f0-d20a-11ec-8377-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:3047 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufexamac targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1c78109a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IEK1 biolink:molecularly_interacts_with DrugCentral:3047 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufexamac targets Enzyme (M1-family alanyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:1c78409c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1c78409c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1c78409c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1c788822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butethamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:1c788822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butethamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:1c788822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3053 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butethamine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.26']} DrugCentral uuid:1c78c88c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin is opener of Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:1c78f0e6-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1c79190e-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:1c79421c-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1c796a3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q09470 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1c79926c-d20a-11ec-8377-0242ac110003 UniProtKB:P54577 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Enzyme (Tyrosine--tRNA ligase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:1c79bab2-d20a-11ec-8377-0242ac110003 UniProtKB:O35433 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1c79e35c-d20a-11ec-8377-0242ac110003 UniProtKB:P03887 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Unclassified (NADH-ubiquinone oxidoreductase chain 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1c7a0c24-d20a-11ec-8377-0242ac110003 UniProtKB:Q8R4D5 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:1c7a3474-d20a-11ec-8377-0242ac110003 UniProtKB:Q704Y3 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin is activator of Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1c7a5ca6-d20a-11ec-8377-0242ac110003 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1c7a8578-d20a-11ec-8377-0242ac110003 UniProtKB:P16388 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:1c7aadbe-d20a-11ec-8377-0242ac110003 UniProtKB:P63142 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1c7ad5fa-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capsaicin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1c7aff58-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1c7b28d4-d20a-11ec-8377-0242ac110003 UniProtKB:P23795 biolink:molecularly_interacts_with DrugCentral:3066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1c7b5138-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NJH6 biolink:molecularly_interacts_with DrugCentral:3066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbaryl targets Unclassified (Ace-orthologous acetylcholinesterase; Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1c7b7974-d20a-11ec-8377-0242ac110003 UniProtKB:Q7YWJ9 biolink:molecularly_interacts_with DrugCentral:3066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1c7ba20a-d20a-11ec-8377-0242ac110003 UniProtKB:K4JQ36 biolink:molecularly_interacts_with DrugCentral:3066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbaryl targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:1c7bca3c-d20a-11ec-8377-0242ac110003 UniProtKB:P05181 biolink:molecularly_interacts_with DrugCentral:3067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbon tetrachloride targets Enzyme (Cytochrome P450 2E1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.959']} DrugCentral uuid:1c7bf278-d20a-11ec-8377-0242ac110003 UniProtKB:P31327 biolink:molecularly_interacts_with DrugCentral:3068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carglumic acid is positive allosteric modulator of Enzyme (Carbamoyl-phosphate synthase [ammonia], mitochondrial) DrugCentral uuid:1c7c1e88-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3070 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 articaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:1c7c1e88-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3070 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 articaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:1c7c1e88-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3070 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 articaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:1c7c5e84-d20a-11ec-8377-0242ac110003 UniProtKB:Q05193 biolink:molecularly_interacts_with DrugCentral:3082 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetrimonium targets Structural (Dynamin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1c7c86b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:3083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetylpyridinium targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1c7caee8-d20a-11ec-8377-0242ac110003 UniProtKB:P42575 biolink:molecularly_interacts_with DrugCentral:3083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetylpyridinium targets Enzyme (Caspase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:1c7cd850-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroxylenol targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.928']} DrugCentral uuid:1c7d03a2-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chloroxylenol targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.738']} DrugCentral uuid:1c7d2c56-d20a-11ec-8377-0242ac110003 UniProtKB:P10845 biolink:molecularly_interacts_with DrugCentral:3095 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorquinaldol targets Enzyme (Botulinum neurotoxin type A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1c7d549c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:3096 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cholic acid targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1c7d7d82-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:3096 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cholic acid is agonist of GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1c7da5a0-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:1c7dcefe-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1c7dfb22-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:1c7dfb22-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha2/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.74']} DrugCentral uuid:1c7e3308-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:1c7e3308-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:1c7e6a58-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:1c7e6a58-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha3/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.32']} DrugCentral uuid:1c7ea1bc-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:1c7ea1bc-d20a-11ec-8377-0242ac110003 UniProtKB:P12390 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.43']} DrugCentral uuid:1c7edd1c-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:1c7edd1c-d20a-11ec-8377-0242ac110003 UniProtKB:P12392 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Ion channel (Neuronal acetylcholine receptor; alpha4/beta4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:1c7f108e-d20a-11ec-8377-0242ac110003 UniProtKB:P28570 biolink:molecularly_interacts_with DrugCentral:3097 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline targets Transporter (Creatine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:1c7f38de-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:3101 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinchophen targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['3.9']} DrugCentral uuid:1c7f62b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q695T7 biolink:molecularly_interacts_with DrugCentral:3102 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cinromide is inhibitor of Transporter (Sodium-dependent neutral amino acid transporter B(0)AT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1c7f8b86-d20a-11ec-8377-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:3111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorindione targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1c7fb3ae-d20a-11ec-8377-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:3114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxiquine targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1c7fdbe0-d20a-11ec-8377-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:3114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxiquine targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:1c800476-d20a-11ec-8377-0242ac110003 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:3114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cloxiquine targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1c803482-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclomethycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1c803482-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclomethycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1c803482-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyclomethycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1c8072ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:3124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cynarine targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1c809ea4-d20a-11ec-8377-0242ac110003 UniProtKB:P70536 biolink:molecularly_interacts_with DrugCentral:3126 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 demoxytocin targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:1c80d2ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1c80d2ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1c80d2ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1c80d2ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desomorphine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1c811d16-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1c81412e-d20a-11ec-8377-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dibrompropamidine targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1c81697e-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dibrompropamidine targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1c8191ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:3137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dibrompropamidine targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.27']} DrugCentral uuid:1c81ba78-d20a-11ec-8377-0242ac110003 UniProtKB:P08001 biolink:molecularly_interacts_with DrugCentral:3137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dibrompropamidine targets Enzyme (Acrosin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1c81e2c8-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 difluprednate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1c820ec4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinisocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1c820ec4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinisocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1c820ec4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinisocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1c824d26-d20a-11ec-8377-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3157 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:1c827a58-d20a-11ec-8377-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3157 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:1c82a3a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:3158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dioxadrol targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:1c82cc24-d20a-11ec-8377-0242ac110003 UniProtKB:Q39829 biolink:molecularly_interacts_with DrugCentral:3162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disufenton targets Unclassified (Lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1c82f4f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q39829 biolink:molecularly_interacts_with DrugCentral:3162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 disufenton targets Unclassified (Lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1c831d32-d20a-11ec-8377-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:3165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domitroban is antagonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:1c834582-d20a-11ec-8377-0242ac110003 UniProtKB:P30987 biolink:molecularly_interacts_with DrugCentral:3165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 domitroban is antagonist of GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:1c836dc8-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1c83965e-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.2']} DrugCentral uuid:1c83be9a-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1c83e6c2-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eburnamonine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1c840f08-d20a-11ec-8377-0242ac110003 UniProtKB:A3RLP8 biolink:molecularly_interacts_with DrugCentral:3173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edoxudine targets Kinase (Thymidine kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1c84387a-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:1c8460b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1c8488e8-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1c84b138-d20a-11ec-8377-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1c84da3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1c850296-d20a-11ec-8377-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1c852ad2-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1c85532c-d20a-11ec-8377-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1c857c6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDS5 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets GPCR (Oxoeicosanoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1c85a4b2-d20a-11ec-8377-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:3174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eicosapentaenoic acid targets Nuclear other (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1c85cce4-d20a-11ec-8377-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:3177 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enilconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:1c85f534-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:1c861f0a-d20a-11ec-8377-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:1c864778-d20a-11ec-8377-0242ac110003 UniProtKB:P23141 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Liver carboxylesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:1c8670ae-d20a-11ec-8377-0242ac110003 UniProtKB:P24723 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Kinase (Protein kinase C eta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1c8699b2-d20a-11ec-8377-0242ac110003 UniProtKB:P80365 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.91']} DrugCentral uuid:1c86c1e4-d20a-11ec-8377-0242ac110003 UniProtKB:P28845 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:1c86ea20-d20a-11ec-8377-0242ac110003 UniProtKB:P00489 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Glycogen phosphorylase, muscle form) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:1c871252-d20a-11ec-8377-0242ac110003 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:1c873af2-d20a-11ec-8377-0242ac110003 UniProtKB:P50172 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1c876324-d20a-11ec-8377-0242ac110003 UniProtKB:O60218 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Aldo-keto reductase family 1 member B10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1c878b4c-d20a-11ec-8377-0242ac110003 UniProtKB:P16232 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1c87b374-d20a-11ec-8377-0242ac110003 UniProtKB:P50233 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Corticosteroid 11-beta-dehydrogenase isozyme 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1c8847da-d20a-11ec-8377-0242ac110003 UniProtKB:Q06124 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Tyrosine-protein phosphatase non-receptor type 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1c887a34-d20a-11ec-8377-0242ac110003 UniProtKB:P29350 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Protein-tyrosine phosphatase 1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:1c88a360-d20a-11ec-8377-0242ac110003 UniProtKB:P09429 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Nuclear other (High mobility group protein B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.06']} DrugCentral uuid:1c88cdf4-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:1c88f6f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9CPU0 biolink:molecularly_interacts_with DrugCentral:3178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxolone targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1c89204c-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eseridine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1c894946-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:3186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eseridine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1c8971d2-d20a-11ec-8377-0242ac110003 UniProtKB:P04058 biolink:molecularly_interacts_with DrugCentral:3186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eseridine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:1c899a72-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1c89c48e-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.748']} DrugCentral uuid:1c89ed60-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:1c8a1600-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol is agonist of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1c8a3fae-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1c8a6858-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.63']} DrugCentral uuid:1c8a910c-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.064']} DrugCentral uuid:1c8ab9a2-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPP9 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:1c8ae3aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:3187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estriol targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1c8b0bf0-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1c8b358a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.062']} DrugCentral uuid:1c8b5e0c-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:1c8b883c-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:1c8bb064-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1c8bd8f0-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1c8c015e-d20a-11ec-8377-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Enzyme (Steryl-sulfatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:1c8c2a44-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.18']} DrugCentral uuid:1c8c52bc-d20a-11ec-8377-0242ac110003 UniProtKB:P14061 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Enzyme (Estradiol 17-beta-dehydrogenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1c8c7b66-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.111']} DrugCentral uuid:1c8ca3c0-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.181']} DrugCentral uuid:1c8cccc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.678']} DrugCentral uuid:1c8cf53c-d20a-11ec-8377-0242ac110003 UniProtKB:O14746 biolink:molecularly_interacts_with DrugCentral:3194 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacridine targets Enzyme (Telomerase reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1c8d1daa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:3194 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethacridine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1c8d462c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:1c8d70ca-d20a-11ec-8377-0242ac110003 UniProtKB:P42261 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1c8d9924-d20a-11ec-8377-0242ac110003 UniProtKB:P39086 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1c8dc1c4-d20a-11ec-8377-0242ac110003 UniProtKB:P42262 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.91']} DrugCentral uuid:1c8deab4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16478 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1c8e1354-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1c8e3bb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q13002 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:1c8e6462-d20a-11ec-8377-0242ac110003 UniProtKB:Q13003 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1c8e8d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P19491 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1c8eb5e8-d20a-11ec-8377-0242ac110003 UniProtKB:P42263 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:1c8ee068-d20a-11ec-8377-0242ac110003 UniProtKB:Q16099 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:1c8f0912-d20a-11ec-8377-0242ac110003 UniProtKB:P42260 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.43']} DrugCentral uuid:1c8f3270-d20a-11ec-8377-0242ac110003 UniProtKB:P22756 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1c8f5ad4-d20a-11ec-8377-0242ac110003 UniProtKB:P19490 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.32']} DrugCentral uuid:1c8f8324-d20a-11ec-8377-0242ac110003 UniProtKB:P19492 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1c8fab88-d20a-11ec-8377-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:1c8fd75c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01812 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.33']} DrugCentral uuid:1c8fff98-d20a-11ec-8377-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1c9027e8-d20a-11ec-8377-0242ac110003 UniProtKB:P42264 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1c905cea-d20a-11ec-8377-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:1c905cea-d20a-11ec-8377-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:1c905cea-d20a-11ec-8377-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:1c905cea-d20a-11ec-8377-0242ac110003 UniProtKB:P19493 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:1c90b6cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:1c90b6cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:1c90b6cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:1c90b6cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:1c90b6cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q63273 biolink:molecularly_interacts_with DrugCentral:3201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kainic acid targets Ion channel (Glutamate receptor ionotropic, kainate) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.37']} DrugCentral uuid:1c9115ea-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordefrin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:1c9115ea-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordefrin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:1c9115ea-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nordefrin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:1c9171d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:1c9171d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:1c9171d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:1c9171d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:1c9171d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:1c9171d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:1c9171d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:3215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoxadrol targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:1c91deb2-d20a-11ec-8377-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:3217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evans blue targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1c9206f8-d20a-11ec-8377-0242ac110003 UniProtKB:P25044 biolink:molecularly_interacts_with DrugCentral:3217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evans blue targets Enzyme (Tyrosine-protein phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1c922ffc-d20a-11ec-8377-0242ac110003 UniProtKB:Q7TSF2 biolink:molecularly_interacts_with DrugCentral:3217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evans blue targets Transporter (Vesicular glutamate transporter 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1c925874-d20a-11ec-8377-0242ac110003 UniProtKB:Q13822 biolink:molecularly_interacts_with DrugCentral:3217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evans blue targets Enzyme (Ectonucleotide pyrophosphatase/phosphodiesterase family member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:1c9280b0-d20a-11ec-8377-0242ac110003 UniProtKB:P08659 biolink:molecularly_interacts_with DrugCentral:3217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evans blue targets Unclassified (Luciferin 4-monooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1c92a900-d20a-11ec-8377-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:3219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 exisulind targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.217']} DrugCentral uuid:1c92d29a-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:3219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 exisulind targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1c92fd4c-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:3219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 exisulind targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.859']} DrugCentral uuid:1c93256a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.229']} DrugCentral uuid:1c934dc4-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.959']} DrugCentral uuid:1c93779a-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.119']} DrugCentral uuid:1c939fea-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.641']} DrugCentral uuid:1c93c830-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.377']} DrugCentral uuid:1c93f080-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.036']} DrugCentral uuid:1c941970-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.824']} DrugCentral uuid:1c9441ca-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.658']} DrugCentral uuid:1c946a1a-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.328']} DrugCentral uuid:1c949256-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.398']} DrugCentral uuid:1c94bd76-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.688']} DrugCentral uuid:1c94e882-d20a-11ec-8377-0242ac110003 UniProtKB:Q61327 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.04']} DrugCentral uuid:1c951104-d20a-11ec-8377-0242ac110003 UniProtKB:O55192 biolink:molecularly_interacts_with DrugCentral:3220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 femoxetine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1c9539c2-d20a-11ec-8377-0242ac110003 UniProtKB:P05121 biolink:molecularly_interacts_with DrugCentral:3224 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fendosal is inhibitor of Secreted (Plasminogen activator inhibitor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.824']} DrugCentral uuid:1c956302-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:3225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenoxazoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1c958b7a-d20a-11ec-8377-0242ac110003 UniProtKB:P04303 biolink:molecularly_interacts_with DrugCentral:3227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenticlor targets Enzyme (Uracil-DNA glycosylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:1c95b3d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:3229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fumaric acid targets Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.72']} DrugCentral uuid:1c95dcce-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:3236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flusalan targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1c960528-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:3236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flusalan targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.07']} DrugCentral uuid:1c962d64-d20a-11ec-8377-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:3236 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flusalan targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1c9659ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosfestrol is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:1c9659ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosfestrol is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:1c96b7c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:1c96b7c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:1c96b7c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:1c96b7c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:1c96b7c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:1c96b7c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:1c96b7c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:1c96b7c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:1c96b7c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:1c96b7c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:1c96b7c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:1c96b7c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:1c96b7c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:3249 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fospropofol is positive allosteric modulator of Ion channel (GABA-A receptor) DrugCentral uuid:1c975086-d20a-11ec-8377-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:3253 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fumagillin targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.2']} DrugCentral uuid:1c9778c2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1c97a11c-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.5']} DrugCentral uuid:1c97c9f8-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1c97f356-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 furtrethonium is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1c981c1e-d20a-11ec-8377-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1c984464-d20a-11ec-8377-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:1c986ee4-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1c98973e-d20a-11ec-8377-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1c98bf84-d20a-11ec-8377-0242ac110003 UniProtKB:P00750 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Tissue-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.81']} DrugCentral uuid:1c98e856-d20a-11ec-8377-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:1c99109c-d20a-11ec-8377-0242ac110003 UniProtKB:O08590 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Membrane primary amine oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1c99390a-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1c99613c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1c998a04-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.97']} DrugCentral uuid:1c99b218-d20a-11ec-8377-0242ac110003 UniProtKB:Q15661 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate is inhibitor of Enzyme (Tryptase alpha/beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:1c99da5e-d20a-11ec-8377-0242ac110003 UniProtKB:P05981 biolink:molecularly_interacts_with DrugCentral:3257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabexate targets Enzyme (Serine protease hepsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1c9a0290-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1c9a2c5c-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1c9a54b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:1c9a7d1a-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1c9aa56a-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentisic acid targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1c9ace14-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:3260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:1c9af664-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentisic acid targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:1c9b1ebe-d20a-11ec-8377-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamidine targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.84']} DrugCentral uuid:1c9b470e-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamidine targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:1c9b6ffe-d20a-11ec-8377-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:3275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamidine targets Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1c9b983a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:3275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamidine targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1c9bc09e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:3275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hexamidine targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1c9be8da-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1c9c1238-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:1c9c3a7e-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:1c9c62c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1c9c8bfa-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1c9cb4cc-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1c9cdd08-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1c9d056c-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1c9d2e70-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.38']} DrugCentral uuid:1c9d56c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:1c9d7f9c-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.91']} DrugCentral uuid:1c9da7f6-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1c9dd1a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:1c9dfdfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:3282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroquinone targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1c9e2866-d20a-11ec-8377-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:3290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyquinoline targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['3.89']} DrugCentral uuid:1c9e50b6-d20a-11ec-8377-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:3290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1c9e797e-d20a-11ec-8377-0242ac110003 UniProtKB:P50579 biolink:molecularly_interacts_with DrugCentral:3290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyquinoline targets Enzyme (Methionine aminopeptidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:1c9ea1ce-d20a-11ec-8377-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:3290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyquinoline targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:1c9ec9f6-d20a-11ec-8377-0242ac110003 UniProtKB:P53582 biolink:molecularly_interacts_with DrugCentral:3290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyquinoline targets Enzyme (Methionine aminopeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:1c9ef232-d20a-11ec-8377-0242ac110003 UniProtKB:Q01693 biolink:molecularly_interacts_with DrugCentral:3290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxyquinoline targets Enzyme (Bacterial leucyl aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1c9f1b4a-d20a-11ec-8377-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:3293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibufenac targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1c9f437c-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.67']} DrugCentral uuid:1c9f6be0-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.969']} DrugCentral uuid:1c9f9412-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:1c9fbed8-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1c9fe6e2-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:1ca00f28-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.181']} DrugCentral uuid:1ca037f0-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.859']} DrugCentral uuid:1ca06036-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.227']} DrugCentral uuid:1ca08958-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.37']} DrugCentral uuid:1ca0b194-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1ca0daa2-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:1ca102de-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.79']} DrugCentral uuid:1ca12b1a-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1ca15356-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.496']} DrugCentral uuid:1ca17d18-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.91']} DrugCentral uuid:1ca1a856-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1ca1d1dc-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1ca1fa2c-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1ca222ea-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1ca24b26-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1ca2736c-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.79']} DrugCentral uuid:1ca29bbc-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:1ca2c484-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1ca2ecb6-d20a-11ec-8377-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:1ca314fc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1ca33d2e-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1ca36862-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1ca3909e-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1ca3b8da-d20a-11ec-8377-0242ac110003 UniProtKB:Q64264 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1ca3e2ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q61616 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1ca40b3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q75Z89 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1ca43382-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone is antagonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1ca463a2-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1ca463a2-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1ca463a2-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3294 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iloperidone targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1ca4a510-d20a-11ec-8377-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:3309 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoconazole targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1ca4cd38-d20a-11ec-8377-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:3309 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isoconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:1ca4f59c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:3312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivabradine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1ca51f22-d20a-11ec-8377-0242ac110003 UniProtKB:O88704 biolink:molecularly_interacts_with DrugCentral:3312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivabradine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1ca547ae-d20a-11ec-8377-0242ac110003 UniProtKB:O88703 biolink:molecularly_interacts_with DrugCentral:3312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivabradine targets Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1ca56ff4-d20a-11ec-8377-0242ac110003 UniProtKB:O60741 biolink:molecularly_interacts_with DrugCentral:3312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivabradine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1ca59862-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL51 biolink:molecularly_interacts_with DrugCentral:3312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivabradine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) DrugCentral uuid:1ca5bcfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P1Z3 biolink:molecularly_interacts_with DrugCentral:3312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivabradine is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1ca5e588-d20a-11ec-8377-0242ac110003 UniProtKB:P04798 biolink:molecularly_interacts_with DrugCentral:3313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 khellin targets Enzyme (Cytochrome P450 1A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1ca60dd8-d20a-11ec-8377-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:3317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenalidomide targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.886']} DrugCentral uuid:1ca63696-d20a-11ec-8377-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:3317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1ca65f90-d20a-11ec-8377-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:3317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1ca687f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:3317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenalidomide is modulator of Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.527']} DrugCentral uuid:1ca6b03a-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1ca6d880-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.32']} DrugCentral uuid:1ca70224-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1ca72ab0-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1ca75332-d20a-11ec-8377-0242ac110003 UniProtKB:P15090 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Cytosolic other (Fatty acid-binding protein, adipocyte) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1ca77b6e-d20a-11ec-8377-0242ac110003 UniProtKB:P05413 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Cytosolic other (Fatty acid-binding protein, heart) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1ca7a436-d20a-11ec-8377-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1ca7cc7c-d20a-11ec-8377-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1ca7f4ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q14721 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid is activator of Ion channel (Potassium voltage-gated channel subfamily B member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1ca81dda-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.19']} DrugCentral uuid:1ca846d4-d20a-11ec-8377-0242ac110003 UniProtKB:P08170 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Enzyme (Seed linoleate 13S-lipoxygenase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1ca86f24-d20a-11ec-8377-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.39']} DrugCentral uuid:1ca89760-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:1ca8bfa6-d20a-11ec-8377-0242ac110003 UniProtKB:Q5NUL3 biolink:molecularly_interacts_with DrugCentral:3323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linoleic acid is agonist of GPCR (Free fatty acid receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1ca8eb2a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:3325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lodoxamide is agonist of GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.793']} DrugCentral uuid:1ca91366-d20a-11ec-8377-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:3328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lubeluzole targets Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1ca93ba2-d20a-11ec-8377-0242ac110003 UniProtKB:P62157 biolink:molecularly_interacts_with DrugCentral:3328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lubeluzole targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1ca96474-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestanolone is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:1ca989cc-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mestanolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.81']} DrugCentral uuid:1ca9b226-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesterolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.6']} DrugCentral uuid:1ca9db20-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mesterolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:1caa0406-d20a-11ec-8377-0242ac110003 UniProtKB:O34667 biolink:molecularly_interacts_with DrugCentral:3347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methionine targets Unclassified (S-ribosylhomocysteine lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.21']} DrugCentral uuid:1caa2c6a-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyltestosterone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.077']} DrugCentral uuid:1caa54ec-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyltestosterone is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.66']} DrugCentral uuid:1caa7d1e-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyltestosterone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.43']} DrugCentral uuid:1caaa60e-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyltestosterone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1caace4a-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyltestosterone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:1caaf69a-d20a-11ec-8377-0242ac110003 UniProtKB:P17708 biolink:molecularly_interacts_with DrugCentral:3362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoguazone targets Enzyme (S-adenosylmethionine decarboxylase proenzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cab1ecc-d20a-11ec-8377-0242ac110003 UniProtKB:P36633 biolink:molecularly_interacts_with DrugCentral:3362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mitoguazone targets Enzyme (Amiloride-sensitive amine oxidase [copper-containing]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1cab4b54-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxestrol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1cab4b54-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxestrol targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1cab7eda-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1caba72a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1cabd010-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1cabf95a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1cac21be-d20a-11ec-8377-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:1cac51de-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1cac51de-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1cac51de-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1cac9a68-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1cac9a68-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1cac9a68-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1cacec20-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1cacec20-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1cacec20-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1cacec20-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1cacec20-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1cacec20-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3369 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naphazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1cad4c56-d20a-11ec-8377-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:3377 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neridronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1cad74b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:3380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nifenalol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.88']} DrugCentral uuid:1cad9d14-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:3396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octopamine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:1cadc5fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:3396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octopamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1cadee22-d20a-11ec-8377-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:3396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octopamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1cae162c-d20a-11ec-8377-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:3396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octopamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1cae3e7c-d20a-11ec-8377-0242ac110003 UniProtKB:H9TVJ1 biolink:molecularly_interacts_with DrugCentral:3396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octopamine targets GPCR (TyR1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1cae6bb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q01705 biolink:molecularly_interacts_with DrugCentral:3399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleandrin targets Unclassified (Neurogenic locus notch homolog protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1cae962e-d20a-11ec-8377-0242ac110003 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1caebe74-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1caee70a-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1caf1040-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1caf389a-d20a-11ec-8377-0242ac110003 UniProtKB:P15090 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Cytosolic other (Fatty acid-binding protein, adipocyte) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:1caf60ea-d20a-11ec-8377-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:1caf89bc-d20a-11ec-8377-0242ac110003 UniProtKB:O14746 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Enzyme (Telomerase reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1cafb1f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q01469 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Cytosolic other (Fatty acid-binding protein, epidermal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.61']} DrugCentral uuid:1cafdad4-d20a-11ec-8377-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1cb00306-d20a-11ec-8377-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1cb02bf6-d20a-11ec-8377-0242ac110003 UniProtKB:P07148 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1cb05450-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1cb07c96-d20a-11ec-8377-0242ac110003 UniProtKB:P08170 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Enzyme (Seed linoleate 13S-lipoxygenase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1cb0a4f0-d20a-11ec-8377-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1cb0cd90-d20a-11ec-8377-0242ac110003 UniProtKB:Q5NUL3 biolink:molecularly_interacts_with DrugCentral:3400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oleic acid is agonist of GPCR (Free fatty acid receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1cb0f5c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q5T6X5 biolink:molecularly_interacts_with DrugCentral:3401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ornithine is agonist of GPCR (G-protein coupled receptor family C group 6 member A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1cb125d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxetacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1cb125d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxetacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1cb125d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3407 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxetacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1cb16502-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.684']} DrugCentral uuid:1cb18d70-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.815']} DrugCentral uuid:1cb1b5b6-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.046']} DrugCentral uuid:1cb1de24-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.372']} DrugCentral uuid:1cb20958-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.723']} DrugCentral uuid:1cb234a0-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:1cb25ebc-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.925']} DrugCentral uuid:1cb28770-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.533']} DrugCentral uuid:1cb2b0ba-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.778']} DrugCentral uuid:1cb2d90a-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.169']} DrugCentral uuid:1cb30150-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.943']} DrugCentral uuid:1cb32a68-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.018']} DrugCentral uuid:1cb352ae-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.449']} DrugCentral uuid:1cb37b08-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:1cb3a358-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.676']} DrugCentral uuid:1cb3ccd4-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb3f524-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.445']} DrugCentral uuid:1cb41d92-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:1cb442cc-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.728']} DrugCentral uuid:1cb46b8a-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.333']} DrugCentral uuid:1cb493c6-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:1cb4bc0c-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.398']} DrugCentral uuid:1cb4e434-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.209']} DrugCentral uuid:1cb50d1a-d20a-11ec-8377-0242ac110003 UniProtKB:P14902 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets Enzyme (Indoleamine 2,3-dioxygenase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:1cb53574-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.969']} DrugCentral uuid:1cb55dba-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxiconazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:1cb5865a-d20a-11ec-8377-0242ac110003 UniProtKB:P15304 biolink:molecularly_interacts_with DrugCentral:3412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxybenzone targets Enzyme (Hormone-sensitive lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1cb5afea-d20a-11ec-8377-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:3413 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycinchophen targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1cb5d826-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y233 biolink:molecularly_interacts_with DrugCentral:3413 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxycinchophen targets Enzyme (cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1cb60058-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.409']} DrugCentral uuid:1cb628a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine is modulator of Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.76']} DrugCentral uuid:1cb6513e-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.658']} DrugCentral uuid:1cb67966-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.307']} DrugCentral uuid:1cb6a2a6-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.16']} DrugCentral uuid:1cb6cb00-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.12']} DrugCentral uuid:1cb6f3f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1cb71c54-d20a-11ec-8377-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.27']} DrugCentral uuid:1cb7502a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1cb7502a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1cb7502a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1cb7502a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:3424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pentazocine targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1cb7a66a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1cb7a66a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1cb7a66a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenacaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1cb7e530-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3467 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picloxydine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1cb80de4-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:3467 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 picloxydine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1cb8363e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VC69 biolink:molecularly_interacts_with DrugCentral:3474 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adipic acid targets Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1cb85e98-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.222']} DrugCentral uuid:1cb886c0-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1cb8af92-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.398']} DrugCentral uuid:1cb8d7ec-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1cb90032-d20a-11ec-8377-0242ac110003 UniProtKB:P04015 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Unclassified (Regulatory protein E2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1cb92882-d20a-11ec-8377-0242ac110003 UniProtKB:P02550 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1cb9524e-d20a-11ec-8377-0242ac110003 UniProtKB:P03118 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Unclassified (Regulatory protein E2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.98']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cb9b0b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B7 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1cba8024-d20a-11ec-8377-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1cba8024-d20a-11ec-8377-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1cba8024-d20a-11ec-8377-0242ac110003 UniProtKB:Q862L2 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1cbac624-d20a-11ec-8377-0242ac110003 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1cbac624-d20a-11ec-8377-0242ac110003 UniProtKB:P02554 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Structural (Tubulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1cbaf978-d20a-11ec-8377-0242ac110003 UniProtKB:P03120 biolink:molecularly_interacts_with DrugCentral:3481 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 podophyllotoxin targets Unclassified (Human papillomavirus regulatory protein E2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.15']} DrugCentral uuid:1cbb22ae-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:3482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polyestradiol phosphate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:1cbb469e-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:3483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 posaconazole targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:1cbb6ac0-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:3483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 posaconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'MIC', 'has_quantitative_value': ['9.398']} DrugCentral uuid:1cbb9324-d20a-11ec-8377-0242ac110003 UniProtKB:Q4WNT5 biolink:molecularly_interacts_with DrugCentral:3483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 posaconazole targets Enzyme (14-alpha sterol demethylase Cyp51A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1cbbbbc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q96W81 biolink:molecularly_interacts_with DrugCentral:3483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 posaconazole targets Enzyme (14-alpha sterol demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1cbbe48c-d20a-11ec-8377-0242ac110003 UniProtKB:Q7Z1V1 biolink:molecularly_interacts_with DrugCentral:3483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 posaconazole targets Enzyme (Sterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:1cbc0cd2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNU6 biolink:molecularly_interacts_with DrugCentral:3483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 posaconazole targets Enzyme (7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1cbc3504-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:3486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 practolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1cbc5df4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:3486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 practolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1cbc8720-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:3486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 practolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.69']} DrugCentral uuid:1cbcaf52-d20a-11ec-8377-0242ac110003 UniProtKB:P18090 biolink:molecularly_interacts_with DrugCentral:3486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 practolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1cbcd784-d20a-11ec-8377-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:3486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 practolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.98']} DrugCentral uuid:1cbd0286-d20a-11ec-8377-0242ac110003 UniProtKB:P18762 biolink:molecularly_interacts_with DrugCentral:3486 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 practolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.87']} DrugCentral uuid:1cbd2dce-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:3487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramocaine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.292']} DrugCentral uuid:1cbd5862-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:3487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramocaine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.199']} DrugCentral uuid:1cbd88f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:1cbd88f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:1cbd88f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3487 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pramocaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:1cbdc8b0-d20a-11ec-8377-0242ac110003 UniProtKB:P07477 biolink:molecularly_interacts_with DrugCentral:3493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propamidine targets Enzyme (Trypsin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1cbdf0e2-d20a-11ec-8377-0242ac110003 UniProtKB:P08001 biolink:molecularly_interacts_with DrugCentral:3493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propamidine targets Enzyme (Acrosin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1cbe21d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propoxycaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:1cbe21d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propoxycaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:1cbe21d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 propoxycaine is blocker of Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:1cbe604a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XUB2 biolink:molecularly_interacts_with DrugCentral:3500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protoporphyrin targets Cytosolic other (Zinc finger protein mex-5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1cbe8868-d20a-11ec-8377-0242ac110003 UniProtKB:G5EF15 biolink:molecularly_interacts_with DrugCentral:3500 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 protoporphyrin targets Unclassified (Cytoplasmic zinc-finger protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1cbeb07c-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3502 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prucalopride targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.629']} DrugCentral uuid:1cbedafc-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:3502 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prucalopride targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1cbf0338-d20a-11ec-8377-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:3502 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prucalopride targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.58']} DrugCentral uuid:1cbf2b7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:3502 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prucalopride is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1cbf53b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:3505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 homonicotinic acid is agonist of GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1cbf7c32-d20a-11ec-8377-0242ac110003 UniProtKB:P51575 biolink:molecularly_interacts_with DrugCentral:3506 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxal phosphate targets Ion channel (P2X purinoceptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1cbfa45a-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1cbfcca0-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:1cbff59a-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1cc01ef8-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1cc0473e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:1cc06f8e-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1cc0991e-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1cc0c286-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1cc0eae0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1cc1140c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1cc13cd4-d20a-11ec-8377-0242ac110003 UniProtKB:P55789 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (FAD-linked sulfhydryl oxidase ALR) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1cc16506-d20a-11ec-8377-0242ac110003 UniProtKB:P28300 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Protein-lysine 6-oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:1cc18d56-d20a-11ec-8377-0242ac110003 UniProtKB:P58215 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Lysyl oxidase homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1cc1b5b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q96JB6 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Lysyl oxidase homolog 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1cc1de8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K0 biolink:molecularly_interacts_with DrugCentral:3508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione targets Enzyme (Lysyl oxidase homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1cc206dc-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:3511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrovalerone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1cc22f2c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrovalerone targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:1cc25786-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3511 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrovalerone targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1cc28184-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1cc2a9ca-d20a-11ec-8377-0242ac110003 UniProtKB:P00749 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Urokinase-type plasminogen activator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1cc2d1f2-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1cc2fa56-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1cc32314-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1cc34c7c-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1cc374b8-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1cc39d80-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1cc3c5bc-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1cc3eef2-d20a-11ec-8377-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1cc41fda-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1cc41fda-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1cc41fda-d20a-11ec-8377-0242ac110003 UniProtKB:P0DP25 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Cytosolic other (Calmodulin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1cc46166-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1cc4898e-d20a-11ec-8377-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1cc4b1ca-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.42']} DrugCentral uuid:1cc4da74-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1cc50292-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.17']} DrugCentral uuid:1cc52ad8-d20a-11ec-8377-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.58']} DrugCentral uuid:1cc553c8-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1cc57c86-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:1cc5a4cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1cc5cd08-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1cc5f530-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:1cc61fe2-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1cc64814-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1cc67046-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1cc69878-d20a-11ec-8377-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1cc6c10e-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1cc6e95e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1cc7119a-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1cc739f4-d20a-11ec-8377-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:1cc762b2-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1cc78aee-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1cc7b316-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1cc7db66-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1cc80802-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1cc83296-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1cc85ac8-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1cc88354-d20a-11ec-8377-0242ac110003 UniProtKB:P05164 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Myeloperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1cc8aba4-d20a-11ec-8377-0242ac110003 UniProtKB:P08253 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (72 kDa type IV collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:1cc8d3cc-d20a-11ec-8377-0242ac110003 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1cc8fbfe-d20a-11ec-8377-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1cc92610-d20a-11ec-8377-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1cc94ed8-d20a-11ec-8377-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1cc97728-d20a-11ec-8377-0242ac110003 UniProtKB:Q04760 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Lactoylglutathione lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1cc99f5a-d20a-11ec-8377-0242ac110003 UniProtKB:P04745 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Alpha-amylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:1cc9c958-d20a-11ec-8377-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1cc9f1a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1cca19c6-d20a-11ec-8377-0242ac110003 UniProtKB:P16050 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1cca4202-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1cca6b06-d20a-11ec-8377-0242ac110003 UniProtKB:P08254 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Stromelysin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.25']} DrugCentral uuid:1cca9356-d20a-11ec-8377-0242ac110003 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1ccabb92-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1ccae3e2-d20a-11ec-8377-0242ac110003 UniProtKB:P37059 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Estradiol 17-beta-dehydrogenase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.81']} DrugCentral uuid:1ccb0c6e-d20a-11ec-8377-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1ccb34aa-d20a-11ec-8377-0242ac110003 UniProtKB:P48147 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Prolyl endopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1ccb5ce6-d20a-11ec-8377-0242ac110003 UniProtKB:P18054 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Arachidonate 12-lipoxygenase, 12S-type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1ccb8522-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1ccbb088-d20a-11ec-8377-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1ccbd93c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1ccc02b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1ccc2c52-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1ccc5470-d20a-11ec-8377-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1ccc7c84-d20a-11ec-8377-0242ac110003 UniProtKB:P04054 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Phospholipase A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1ccca4b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1ccccd4c-d20a-11ec-8377-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1cccf592-d20a-11ec-8377-0242ac110003 UniProtKB:P39900 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Macrophage metalloelastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:1ccd1dba-d20a-11ec-8377-0242ac110003 UniProtKB:P45452 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Collagenase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1ccd45e2-d20a-11ec-8377-0242ac110003 UniProtKB:P17538 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Chymotrypsinogen B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1ccd6fae-d20a-11ec-8377-0242ac110003 UniProtKB:P56817 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Beta-secretase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1ccd9812-d20a-11ec-8377-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1ccdc03a-d20a-11ec-8377-0242ac110003 UniProtKB:P50578 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:1ccde876-d20a-11ec-8377-0242ac110003 UniProtKB:P80276 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1cce110c-d20a-11ec-8377-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:1cce392a-d20a-11ec-8377-0242ac110003 UniProtKB:P06737 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Glycogen phosphorylase, liver form) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1cce615c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15046 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Lysine--tRNA ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1cce89ac-d20a-11ec-8377-0242ac110003 UniProtKB:P00760 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Cationic trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1cceb292-d20a-11ec-8377-0242ac110003 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1ccedace-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1ccf02f6-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1ccf2c5e-d20a-11ec-8377-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1ccf57a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1ccf7fce-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1ccfa81e-d20a-11ec-8377-0242ac110003 UniProtKB:P16116 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1ccfd050-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:1ccff904-d20a-11ec-8377-0242ac110003 UniProtKB:P51635 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Alcohol dehydrogenase [NADP(+)]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:1cd02244-d20a-11ec-8377-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1cd04a80-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1cd0738e-d20a-11ec-8377-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1cd09bb6-d20a-11ec-8377-0242ac110003 UniProtKB:P21398 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1cd0c3de-d20a-11ec-8377-0242ac110003 UniProtKB:P56560 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1cd0ec1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1cd115b4-d20a-11ec-8377-0242ac110003 UniProtKB:P0AEK4 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1cd13de6-d20a-11ec-8377-0242ac110003 UniProtKB:Q965D5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Enoyl-acyl-carrier protein reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1cd16618-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:1cd18e68-d20a-11ec-8377-0242ac110003 UniProtKB:Q91WR5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Aldo-keto reductase family 1 member C21) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1cd1b726-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1cd1df4e-d20a-11ec-8377-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1cd2079e-d20a-11ec-8377-0242ac110003 UniProtKB:P25024 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (C-X-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1cd22fda-d20a-11ec-8377-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.93']} DrugCentral uuid:1cd25942-d20a-11ec-8377-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1cd28174-d20a-11ec-8377-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1cd2a99c-d20a-11ec-8377-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1cd2d1ce-d20a-11ec-8377-0242ac110003 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1cd2fbb8-d20a-11ec-8377-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.86']} DrugCentral uuid:1cd32426-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC97 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets GPCR (G-protein coupled receptor 35) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.81']} DrugCentral uuid:1cd34c6c-d20a-11ec-8377-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1cd374b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:1cd39d3e-d20a-11ec-8377-0242ac110003 UniProtKB:P10584 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Malate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1cd3c566-d20a-11ec-8377-0242ac110003 UniProtKB:P21588 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (5'-nucleotidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1cd3edca-d20a-11ec-8377-0242ac110003 UniProtKB:Q965D6 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (3-oxoacyl-acyl-carrier protein reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1cd416d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q965D7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Beta-hydroxyacyl-ACP dehydratase; Fatty acid synthesis protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1cd43f96-d20a-11ec-8377-0242ac110003 UniProtKB:P27986 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Phosphatidylinositol 3-kinase regulatory subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1cd467c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPH5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (NADPH oxidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1cd49004-d20a-11ec-8377-0242ac110003 UniProtKB:P0C6X7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1cd4b94e-d20a-11ec-8377-0242ac110003 UniProtKB:P80025 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Lactoperoxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1cd4e180-d20a-11ec-8377-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1cd509a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q1CTD3 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (D-alanine--D-alanine ligase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1cd53306-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC98 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Serine/threonine-protein kinase Nek6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1cd55bc4-d20a-11ec-8377-0242ac110003 UniProtKB:O96394 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Arginase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1cd587de-d20a-11ec-8377-0242ac110003 UniProtKB:P14635 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1cd587de-d20a-11ec-8377-0242ac110003 UniProtKB:P14635 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1cd5bf56-d20a-11ec-8377-0242ac110003 UniProtKB:Q15078 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 5/CDK5 activator 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:1cd5bf56-d20a-11ec-8377-0242ac110003 UniProtKB:Q15078 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 5/CDK5 activator 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.64']} DrugCentral uuid:1cd5ff2a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1cd5ff2a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1cd5ff2a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1cd5ff2a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WWL7 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 1/cyclin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1cd64c82-d20a-11ec-8377-0242ac110003 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:1cd64c82-d20a-11ec-8377-0242ac110003 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:1cd683b4-d20a-11ec-8377-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Glycogen synthase kinase-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1cd683b4-d20a-11ec-8377-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Glycogen synthase kinase-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1cd6b834-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1cd6e052-d20a-11ec-8377-0242ac110003 UniProtKB:P29477 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:1cd7087a-d20a-11ec-8377-0242ac110003 UniProtKB:Q00796 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Sorbitol dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.45']} DrugCentral uuid:1cd73110-d20a-11ec-8377-0242ac110003 UniProtKB:Q99895 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Chymotrypsin C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1cd75a5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q03114 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Cell division protein kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.2']} DrugCentral uuid:1cd78278-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NWT6 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Hypoxia-inducible factor 1-alpha inhibitor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.99']} DrugCentral uuid:1cd7aa96-d20a-11ec-8377-0242ac110003 UniProtKB:P07862 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (D-alanylalanine synthetase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1cd7d430-d20a-11ec-8377-0242ac110003 UniProtKB:P28907 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Tumour-associated antigen (Lymphocyte differentiation antigen CD38) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:1cd7fce4-d20a-11ec-8377-0242ac110003 UniProtKB:Q01062 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Phosphodiesterase 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.09']} DrugCentral uuid:1cd824f8-d20a-11ec-8377-0242ac110003 UniProtKB:P28839 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Cytosol aminopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1cd84d3e-d20a-11ec-8377-0242ac110003 UniProtKB:P41921 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Glutathione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.31']} DrugCentral uuid:1cd87886-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1cd8a112-d20a-11ec-8377-0242ac110003 UniProtKB:P04798 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Cytochrome P450 1A1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1cd8c958-d20a-11ec-8377-0242ac110003 UniProtKB:P11168 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Transporter (Solute carrier family 2, facilitated glucose transporter member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1cd8f18a-d20a-11ec-8377-0242ac110003 UniProtKB:Q14576 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Unclassified (ELAV-like protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1cd91a5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15717 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Unclassified (ELAV-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1cd9428e-d20a-11ec-8377-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1cd96ade-d20a-11ec-8377-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1cd99310-d20a-11ec-8377-0242ac110003 UniProtKB:P19357 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Transporter (Solute carrier family 2, facilitated glucose transporter member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1cd9bc1e-d20a-11ec-8377-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1cd9e45a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NFU5 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Inositol polyphosphate multikinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1cda0caa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHH9 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Kinase (Inositol hexakisphosphate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1cda35fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL62 biolink:molecularly_interacts_with DrugCentral:3514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quercetin targets Ion channel (Short transient receptor potential channel 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1cda71c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:1cda71c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:1cda71c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:1cda71c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:1cda71c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q07001 biolink:molecularly_interacts_with DrugCentral:3520 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rapacuronium is antagonist of Ion channel (Muscle-type nicotinic acetylcholine receptor) DrugCentral uuid:1cdabdee-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rasagiline targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1cdae6ac-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:3521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rasagiline is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1cdb0fce-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:3521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rasagiline targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1cdb3800-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rasagiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1cdb6046-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:3521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rasagiline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.36']} DrugCentral uuid:1cdb8922-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:3521 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rasagiline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1cdbb154-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1cdbd986-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.16']} DrugCentral uuid:1cdc01b8-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1cdc2d8c-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1cdc58e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1cdc81ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:1cdcaa8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:1cdcd2dc-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.06']} DrugCentral uuid:1cdcfb22-d20a-11ec-8377-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:3524 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 resorcinol targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1cdd276e-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 revaprazan is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:1cdd276e-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3525 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 revaprazan is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:1cdd55d6-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:3529 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rioprostil is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) DrugCentral uuid:1cdd7a84-d20a-11ec-8377-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1cdda2a2-d20a-11ec-8377-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.46']} DrugCentral uuid:1cddcad4-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.57']} DrugCentral uuid:1cde022e-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1cde022e-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1cde022e-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1cde022e-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1cde4c34-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WQX9 biolink:molecularly_interacts_with DrugCentral:3531 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roflumilast targets Enzyme (Phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.5']} DrugCentral uuid:1cde7466-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1cde9d1a-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1cdec650-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1cdeeeaa-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1cdf17ae-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1cdf3ffe-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1cdf6830-d20a-11ec-8377-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1cdf9062-d20a-11ec-8377-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1cdfbb14-d20a-11ec-8377-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1cdfe5b2-d20a-11ec-8377-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1ce00df8-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1ce03648-d20a-11ec-8377-0242ac110003 UniProtKB:P05771 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C beta type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.33']} DrugCentral uuid:1ce05efc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1ce08738-d20a-11ec-8377-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:1ce0af88-d20a-11ec-8377-0242ac110003 UniProtKB:P22694 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1ce0d7ce-d20a-11ec-8377-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1ce1008c-d20a-11ec-8377-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1ce128c8-d20a-11ec-8377-0242ac110003 UniProtKB:P05129 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C gamma type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1ce150f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1ce17940-d20a-11ec-8377-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1ce1a2f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1ce1cb3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1ce1f370-d20a-11ec-8377-0242ac110003 UniProtKB:P24723 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C eta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1ce21bb6-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1ce24456-d20a-11ec-8377-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1ce26c74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1ce29596-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1ce2be5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1ce2e69a-d20a-11ec-8377-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1ce30ee0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1ce33712-d20a-11ec-8377-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1ce3608e-d20a-11ec-8377-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1ce38bc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1ce3b4c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1ce3dcee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P1W9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase pim-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1ce405a2-d20a-11ec-8377-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1ce42dd4-d20a-11ec-8377-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1ce4562e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1ce47e6a-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1ce4a750-d20a-11ec-8377-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1ce4cfa0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1ce4f7f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1ce52022-d20a-11ec-8377-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1ce54a66-d20a-11ec-8377-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1ce572a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1ce59c0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ce5c43c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1ce5ecfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1ce61540-d20a-11ec-8377-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1ce63d90-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JI10 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1ce665cc-d20a-11ec-8377-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1ce68fa2-d20a-11ec-8377-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1ce6b7d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1ce6e024-d20a-11ec-8377-0242ac110003 UniProtKB:P31751 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (RAC-beta serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1ce70982-d20a-11ec-8377-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1ce733c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1ce75bf8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1ce78434-d20a-11ec-8377-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:1ce7acc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1ce7d524-d20a-11ec-8377-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:1ce7fd74-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1ce825c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1ce84eaa-d20a-11ec-8377-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1ce876f0-d20a-11ec-8377-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1ce89f36-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1ce8c77c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1ce8f1fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1ce91a60-d20a-11ec-8377-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1ce942a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1ce96b00-d20a-11ec-8377-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1ce993a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1ce9bbc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1ce9e3f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y243 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (RAC-gamma serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1cea0c22-d20a-11ec-8377-0242ac110003 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1cea359e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1cea5de4-d20a-11ec-8377-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1cea872e-d20a-11ec-8377-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1ceab08c-d20a-11ec-8377-0242ac110003 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1ceadbfc-d20a-11ec-8377-0242ac110003 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1ceb05f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1ceb2e40-d20a-11ec-8377-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1ceb56d6-d20a-11ec-8377-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1ceb803e-d20a-11ec-8377-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1ceba906-d20a-11ec-8377-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1cebd160-d20a-11ec-8377-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1cebfa50-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1cec228c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1cec4adc-d20a-11ec-8377-0242ac110003 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1cec7318-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1cec9d0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1cecc534-d20a-11ec-8377-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1ceced84-d20a-11ec-8377-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1ced15ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1ced3e6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1ced66ba-d20a-11ec-8377-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1ced8eec-d20a-11ec-8377-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1cedb728-d20a-11ec-8377-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1cede02c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1cee087c-d20a-11ec-8377-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1cee30d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1cee5b06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1cee834c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.11']} DrugCentral uuid:1ceeab6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1ceed3a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1ceefc46-d20a-11ec-8377-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1cef248c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1cef4cc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1cef74fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:1cef9de0-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:1cefc630-d20a-11ec-8377-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1cefee6c-d20a-11ec-8377-0242ac110003 UniProtKB:O76039 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Cyclin-dependent kinase-like 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1cf016b2-d20a-11ec-8377-0242ac110003 UniProtKB:P41743 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C iota type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1cf03ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1cf06842-d20a-11ec-8377-0242ac110003 UniProtKB:O60331 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1cf0907e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1cf0b950-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1cf0e1fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1cf10a4a-d20a-11ec-8377-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1cf14d8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1cf14d8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1cf14d8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1cf14d8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1cf14d8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1cf14d8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1cf14d8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1cf14d8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WTQ0 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (Protein kinase C (PKC)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1cf1d286-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1cf1d286-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1cf1d286-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1cf1d286-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:3533 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruboxistaurin targets Kinase (CaM kinase II) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1cf21ea8-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1cf269c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1cf269c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1cf269c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1cf269c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1cf269c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1cf269c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1cf269c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1cf269c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1cf269c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1cf269c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1cf2e5ae-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:3534 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rufinamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1cf30dfe-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:1cf3363a-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.454']} DrugCentral uuid:1cf35f2a-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1cf3877a-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1cf3afac-d20a-11ec-8377-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1cf3d8f6-d20a-11ec-8377-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:1cf40434-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1cf42cc0-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.16']} DrugCentral uuid:1cf454fc-d20a-11ec-8377-0242ac110003 UniProtKB:P02769 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Secreted (Serum albumin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:1cf47d7e-d20a-11ec-8377-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.47']} DrugCentral uuid:1cf4a5ce-d20a-11ec-8377-0242ac110003 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.51']} DrugCentral uuid:1cf4cef0-d20a-11ec-8377-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:1cf4f72c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GZQ4 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets GPCR (Neuromedin-U receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1cf51ff4-d20a-11ec-8377-0242ac110003 UniProtKB:P03469 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:1cf54970-d20a-11ec-8377-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:3535 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rutoside targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.67']} DrugCentral uuid:1cf571ca-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1cf59a06-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1cf5c328-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1cf5eb78-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1cf613b4-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline is agonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1cf64be0-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1cf64be0-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1cf64be0-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1cf64be0-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1cf64be0-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sabcomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1cf6a090-d20a-11ec-8377-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:3542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saralasin is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:1cf6c8fe-d20a-11ec-8377-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:3542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saralasin targets GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:1cf6f1f8-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saralasin targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:1cf71a34-d20a-11ec-8377-0242ac110003 UniProtKB:P35351 biolink:molecularly_interacts_with DrugCentral:3542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saralasin is antagonist of GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1cf74658-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saralasin targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:1cf74658-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3542 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saralasin targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:1cf77a6a-d20a-11ec-8377-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:3548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitaxentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:1cf7a60c-d20a-11ec-8377-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:3548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitaxentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1cf7ce52-d20a-11ec-8377-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:3548 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sitaxentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:1cf7f698-d20a-11ec-8377-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:3553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stallimycin targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1cf81f4c-d20a-11ec-8377-0242ac110003 UniProtKB:P01112 biolink:molecularly_interacts_with DrugCentral:3553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stallimycin targets Cytosolic other (GTPase HRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1cf84c6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stallimycin targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1cf84c6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:3553 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stallimycin targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1cf87ffa-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:3557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbentine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:1cf8a82c-d20a-11ec-8377-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:3557 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulbentine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1cf8d130-d20a-11ec-8377-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:3574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulmazole targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:1cf8fd54-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:3574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulmazole targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1cf8fd54-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:3574 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulmazole targets Enzyme (Phosphodiesterase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1cf930c6-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxedrine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.2']} DrugCentral uuid:1cf95a24-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GZQ4 biolink:molecularly_interacts_with DrugCentral:3577 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxedrine targets GPCR (Neuromedin-U receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:1cf9827e-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3579 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talastine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:1cf9a6aa-d20a-11ec-8377-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:3580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamibarotene targets Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:1cf9cefa-d20a-11ec-8377-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:3580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamibarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:1cf9f7c2-d20a-11ec-8377-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:3580 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tamibarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1cfa1ffe-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1cfa4844-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1cfa7076-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:1cfa9aa6-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.95']} DrugCentral uuid:1cfac2f6-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:1cfaeb50-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:1cfb13be-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:1cfb3e34-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:1cfb6972-d20a-11ec-8377-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) DrugCentral uuid:1cfb9046-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.63']} DrugCentral uuid:1cfbbb84-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:1cfbe438-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.09']} DrugCentral uuid:1cfc0c92-d20a-11ec-8377-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.11']} DrugCentral uuid:1cfc35dc-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1cfc5e36-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1cfc8726-d20a-11ec-8377-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:3584 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 terazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.16']} DrugCentral uuid:1cfcb75a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1cfcb75a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1cfcb75a-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1cfcfea4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1cfcfea4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1cfcfea4-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1cfd546c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1cfd546c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1cfd546c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1cfd546c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1cfd546c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1cfd546c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1cfdc8f2-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:1cfdc8f2-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:1cfdc8f2-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:1cfdc8f2-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:1cfdc8f2-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:1cfdc8f2-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3591 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetryzoline is agonist of GPCR (Adrenergic receptor alpha) DrugCentral uuid:1cfe1d8e-d20a-11ec-8377-0242ac110003 UniProtKB:O00519 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1cfe467e-d20a-11ec-8377-0242ac110003 UniProtKB:O75936 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Gamma-butyrobetaine dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1cfe6ec4-d20a-11ec-8377-0242ac110003 UniProtKB:Q99685 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Monoglyceride lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1cfe9700-d20a-11ec-8377-0242ac110003 UniProtKB:P9WMN3 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Bifunctional protein GlmU) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1cfebf50-d20a-11ec-8377-0242ac110003 UniProtKB:P28300 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Protein-lysine 6-oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:1cfeea0c-d20a-11ec-8377-0242ac110003 UniProtKB:P58215 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Lysyl oxidase homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1cff14b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q96JB6 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Lysyl oxidase homolog 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1cff3d0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96KQ7 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Histone-lysine N-methyltransferase EHMT2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1cff6572-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H9B1 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Histone-lysine N-methyltransferase EHMT1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1cff8e12-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K0 biolink:molecularly_interacts_with DrugCentral:3601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiram targets Enzyme (Lysyl oxidase homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1cffb64e-d20a-11ec-8377-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:3604 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thyropropic acid targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.39']} DrugCentral uuid:1cffde94-d20a-11ec-8377-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:3604 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thyropropic acid targets Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.72']} DrugCentral uuid:1d0006e4-d20a-11ec-8377-0242ac110003 UniProtKB:P12004 biolink:molecularly_interacts_with DrugCentral:3604 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thyropropic acid targets Nuclear other (Proliferating cell nuclear antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1d002fca-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tioxolone targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1d005810-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:3607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tioxolone targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1d008042-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3607 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tioxolone targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1d00a96e-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:3609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipranavir targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:1d00cf66-d20a-11ec-8377-0242ac110003 UniProtKB:P07339 biolink:molecularly_interacts_with DrugCentral:3609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipranavir targets Enzyme (Cathepsin D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1d00f7ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:3609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipranavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1d012010-d20a-11ec-8377-0242ac110003 UniProtKB:Q80W54 biolink:molecularly_interacts_with DrugCentral:3609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipranavir targets Enzyme (CAAX prenyl protease 1 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1d0148c4-d20a-11ec-8377-0242ac110003 UniProtKB:P14091 biolink:molecularly_interacts_with DrugCentral:3609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipranavir targets Enzyme (Cathepsin E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1d017100-d20a-11ec-8377-0242ac110003 UniProtKB:P0DJD9 biolink:molecularly_interacts_with DrugCentral:3609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipranavir targets Enzyme (Pepsin A-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1d019950-d20a-11ec-8377-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:3611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiratricol targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.85']} DrugCentral uuid:1d01c18c-d20a-11ec-8377-0242ac110003 UniProtKB:P10828 biolink:molecularly_interacts_with DrugCentral:3611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiratricol targets Nuclear hormone receptor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.39']} DrugCentral uuid:1d01ea54-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiratricol targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1d02127c-d20a-11ec-8377-0242ac110003 UniProtKB:P18113 biolink:molecularly_interacts_with DrugCentral:3611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiratricol targets Transcription factor (Thyroid hormone receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.82']} DrugCentral uuid:1d023ad6-d20a-11ec-8377-0242ac110003 UniProtKB:P12004 biolink:molecularly_interacts_with DrugCentral:3611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiratricol targets Nuclear other (Proliferating cell nuclear antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1d026308-d20a-11ec-8377-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:3611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiratricol targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1d028cc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:3611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tiratricol targets Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1d02b4fc-d20a-11ec-8377-0242ac110003 UniProtKB:P09211 biolink:molecularly_interacts_with DrugCentral:3613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 Vitamin E targets Enzyme (Glutathione S-transferase P) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1d02dd2e-d20a-11ec-8377-0242ac110003 UniProtKB:P49638 biolink:molecularly_interacts_with DrugCentral:3613 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 Vitamin E targets Transporter (Alpha-tocopherol transfer protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1d03065a-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:3616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toliprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.42']} DrugCentral uuid:1d032ef0-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:3616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toliprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.92']} DrugCentral uuid:1d035736-d20a-11ec-8377-0242ac110003 UniProtKB:Q28044 biolink:molecularly_interacts_with DrugCentral:3616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toliprolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1d037f72-d20a-11ec-8377-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:3616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 toliprolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.75']} DrugCentral uuid:1d03a7ae-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3617 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolnaftate targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.894']} DrugCentral uuid:1d03d0bc-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:3617 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolnaftate targets Enzyme (Cytochrome P450 2C19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:1d03f8f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16850 biolink:molecularly_interacts_with DrugCentral:3617 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolnaftate targets Enzyme (Lanosterol 14-alpha demethylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1d042102-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:1d04493e-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.86']} DrugCentral uuid:1d047436-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.56']} DrugCentral uuid:1d04a4ba-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:1d04a4ba-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:1d04a4ba-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:1d04ec90-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d04ec90-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d04ec90-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3620 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tramazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d052b1a-d20a-11ec-8377-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:3630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclocarban targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1d05536a-d20a-11ec-8377-0242ac110003 UniProtKB:P95276 biolink:molecularly_interacts_with DrugCentral:3630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclocarban targets Enzyme (Epoxide hydrolase; Epoxide hydrolase EphB) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1d057b9c-d20a-11ec-8377-0242ac110003 UniProtKB:P07099 biolink:molecularly_interacts_with DrugCentral:3630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclocarban targets Enzyme (Epoxide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1d05a482-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D379 biolink:molecularly_interacts_with DrugCentral:3630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclocarban targets Enzyme (Epoxide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1d05ccbe-d20a-11ec-8377-0242ac110003 UniProtKB:P9WGR1 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1d05f4fa-d20a-11ec-8377-0242ac110003 UniProtKB:P16152 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Carbonyl reductase [NADPH] 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1d061d40-d20a-11ec-8377-0242ac110003 UniProtKB:Q6GI75 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1d06466c-d20a-11ec-8377-0242ac110003 UniProtKB:P0AEK4 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan is inhibitor of Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1d066eb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q965D5 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-acyl-carrier protein reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.28']} DrugCentral uuid:1d0697d4-d20a-11ec-8377-0242ac110003 UniProtKB:P54616 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH] FabI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1d06c042-d20a-11ec-8377-0242ac110003 UniProtKB:Q6UCJ9 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-acyl carrier reductase; Enoyl-acyl carrier reductase ENR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1d06e8a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BJJ9 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-ACP reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1d0710ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q9RMI3 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADPH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:1d073928-d20a-11ec-8377-0242ac110003 UniProtKB:Q5NGQ3 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NADH]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1d076218-d20a-11ec-8377-0242ac110003 UniProtKB:M9TGV3 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Enzyme (Enoyl-[acyl-carrier-protein] reductase [NULLDH]) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1d078a86-d20a-11ec-8377-0242ac110003 UniProtKB:P11021 biolink:molecularly_interacts_with DrugCentral:3631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triclosan targets Unclassified (78 kDa glucose-regulated protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1d07b2b8-d20a-11ec-8377-0242ac110003 UniProtKB:P51582 biolink:molecularly_interacts_with DrugCentral:3639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1d07dad6-d20a-11ec-8377-0242ac110003 UniProtKB:Q15077 biolink:molecularly_interacts_with DrugCentral:3639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1d08042a-d20a-11ec-8377-0242ac110003 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:3639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1d082cfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q96G91 biolink:molecularly_interacts_with DrugCentral:3639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1d085524-d20a-11ec-8377-0242ac110003 UniProtKB:P56373 biolink:molecularly_interacts_with DrugCentral:3639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 uridine triphosphate targets Ion channel (P2X purinoceptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.583']} DrugCentral uuid:1d087d7e-d20a-11ec-8377-0242ac110003 UniProtKB:O35811 biolink:molecularly_interacts_with DrugCentral:3639 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 uridine triphosphate is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1d08a650-d20a-11ec-8377-0242ac110003 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:3642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vildagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1d08ce78-d20a-11ec-8377-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:3642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vildagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1d08f6be-d20a-11ec-8377-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:3642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vildagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.17']} DrugCentral uuid:1d091f0e-d20a-11ec-8377-0242ac110003 UniProtKB:P97321 biolink:molecularly_interacts_with DrugCentral:3642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vildagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1d0947fe-d20a-11ec-8377-0242ac110003 UniProtKB:E1BI31 biolink:molecularly_interacts_with DrugCentral:3642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vildagliptin targets Unclassified (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1d09703a-d20a-11ec-8377-0242ac110003 UniProtKB:O31048 biolink:molecularly_interacts_with DrugCentral:3642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vildagliptin targets Unclassified (Dipeptidyl peptidase IV) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1d0998a8-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:3642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vildagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1d09c0e4-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1d09eae2-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1d0a1346-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1d0a3b96-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3643 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vincamine is allosteric modulator of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.2']} DrugCentral uuid:1d0a83b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d0a83b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d0a83b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d0a83b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d0a83b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d0a83b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d0a83b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d0a83b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d0a83b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:3644 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vinflunine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d0af784-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3651 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorozole is inhibitor of Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.86']} DrugCentral uuid:1d0b204c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:1d0b489c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1d0b70f6-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1d0b9932-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1d0bc484-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1d0becfc-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1d0c1538-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1d0c3d74-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1d0c6614-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:1d0c8e64-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1d0cb6a0-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1d0cdf7c-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1d0d07b8-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1d0d2fe0-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1d0d581c-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1d0d81b6-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1d0dabdc-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1d0dd436-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1d0dfd58-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1d0e25e4-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1d0e4e16-d20a-11ec-8377-0242ac110003 UniProtKB:P12657 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1d0e8642-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:1d0e8642-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:1d0e8642-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:1d0e8642-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:1d0e8642-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:3652 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xanomeline targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.01']} DrugCentral uuid:1d0edb88-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1d0f03ec-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.04']} DrugCentral uuid:1d0f2d5e-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1d0f5720-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:1d0f7fb6-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1d0fafea-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1d0fafea-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1d0fafea-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1d0ff6bc-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1d0ff6bc-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1d0ff6bc-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1d104888-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1d104888-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1d104888-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1d104888-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1d104888-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1d104888-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline targets GPCR (Adrenergic receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1d10a9c2-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3658 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 xylometazoline is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:1d10d23a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.163']} DrugCentral uuid:1d10fa9e-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:1d112442-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1d114cd8-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1d117546-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.106']} DrugCentral uuid:1d119d96-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1d11c64a-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1d11eeb8-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1d121712-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:1d123f58-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1d126820-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1d129084-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1d12b8e8-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.692']} DrugCentral uuid:1d12e124-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.02']} DrugCentral uuid:1d130bcc-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1d133746-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:1d1362d4-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1d138d9a-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1d13b66c-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1d13debc-d20a-11ec-8377-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1d1406f8-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.182']} DrugCentral uuid:1d142f8e-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.91']} DrugCentral uuid:1d1458f6-d20a-11ec-8377-0242ac110003 UniProtKB:P19328 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1d14815a-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.28']} DrugCentral uuid:1d14aaa4-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.95']} DrugCentral uuid:1d14d3da-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:1d14fc20-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1d152484-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1d154d4c-d20a-11ec-8377-0242ac110003 UniProtKB:P22002 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:1d1575ec-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.44']} DrugCentral uuid:1d159e50-d20a-11ec-8377-0242ac110003 UniProtKB:P18871 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:1d15c6a0-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.61']} DrugCentral uuid:1d15eee6-d20a-11ec-8377-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:1d161fa6-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1d161fa6-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1d161fa6-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1d166dbc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1d166dbc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1d166dbc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1d166dbc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1d166dbc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1d16cd34-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:1d16cd34-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:1d16cd34-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:1d171384-d20a-11ec-8377-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1d171384-d20a-11ec-8377-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1d171384-d20a-11ec-8377-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1d17529a-d20a-11ec-8377-0242ac110003 UniProtKB:P30304 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine targets Enzyme (Dual specificity phosphatase Cdc25A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.65']} DrugCentral uuid:1d177af4-d20a-11ec-8377-0242ac110003 UniProtKB:P28334 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1d17a42a-d20a-11ec-8377-0242ac110003 UniProtKB:P30966 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:1d17cc7a-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:3659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 yohimbine is antagonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1d17f592-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3680 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azacyclonol targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1d1825a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3680 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azacyclonol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1d1825a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3680 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azacyclonol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1d1825a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3680 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azacyclonol targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1d186446-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:3686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.67']} DrugCentral uuid:1d188f34-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:3686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.93']} DrugCentral uuid:1d18bab8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:3686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:1d18e4c0-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:3686 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzylsulfamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1d190e6e-d20a-11ec-8377-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:3689 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bropirimine targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1d193704-d20a-11ec-8377-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:3707 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chlorthenoxazine targets Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1d195f68-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:3713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ciramadol is modulator of GPCR (Mu-type opioid receptor) DrugCentral uuid:1d19838a-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:3715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobenztropine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1d19b472-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diperodon targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1d19b472-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diperodon targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1d19b472-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3734 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diperodon targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1d19facc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprylcaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1d19facc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprylcaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1d19facc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3770 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meprylcaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1d1a3956-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3787 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 myrtecaine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.316']} DrugCentral uuid:1d1a6c1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 parethoxycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:1d1a6c1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 parethoxycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:1d1a6c1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:3805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 parethoxycaine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:1d1aafa8-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3839 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tasosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:1d1aafa8-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:3839 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tasosartan targets GPCR (Angiotensin II receptor (AT-1) type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:1d1ae32e-d20a-11ec-8377-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:3839 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tasosartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:1d1b0c50-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:3848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:1d1b3478-d20a-11ec-8377-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:3848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1d1b5cdc-d20a-11ec-8377-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:3848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1d1b85c2-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:3848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velnacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1d1bae12-d20a-11ec-8377-0242ac110003 UniProtKB:Q9N1N9 biolink:molecularly_interacts_with DrugCentral:3848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velnacrine targets Enzyme (Butyrylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.27']} DrugCentral uuid:1d1bd644-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:3851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1d1bfe94-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:3851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.01']} DrugCentral uuid:1d1c282e-d20a-11ec-8377-0242ac110003 UniProtKB:P52895 biolink:molecularly_interacts_with DrugCentral:3851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexibuprofen targets Enzyme (Aldo-keto reductase family 1 member C2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.37']} DrugCentral uuid:1d1c538a-d20a-11ec-8377-0242ac110003 UniProtKB:P42330 biolink:molecularly_interacts_with DrugCentral:3851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexibuprofen targets Enzyme (Aldo-keto reductase family 1 member C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1d1c7bb2-d20a-11ec-8377-0242ac110003 UniProtKB:P05979 biolink:molecularly_interacts_with DrugCentral:3851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:1d1ca3ee-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:3851 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexibuprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1d1ccc8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:3855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1d1cf4e8-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:3855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1d1d1d24-d20a-11ec-8377-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:3855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 docosanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1d1d4588-d20a-11ec-8377-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1d1d6e50-d20a-11ec-8377-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1d1d9696-d20a-11ec-8377-0242ac110003 UniProtKB:P28702 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1d1dbee6-d20a-11ec-8377-0242ac110003 UniProtKB:P48443 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1d1de736-d20a-11ec-8377-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1d1e12a6-d20a-11ec-8377-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.13']} DrugCentral uuid:1d1e3f42-d20a-11ec-8377-0242ac110003 UniProtKB:P51449 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Nuclear hormone receptor (Nuclear receptor ROR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1d1e68a0-d20a-11ec-8377-0242ac110003 UniProtKB:P28704 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor RXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1d1e9172-d20a-11ec-8377-0242ac110003 UniProtKB:P28705 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor RXR-gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1d1eb9b8-d20a-11ec-8377-0242ac110003 UniProtKB:P11416 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1d1ee230-d20a-11ec-8377-0242ac110003 UniProtKB:P28700 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:1d1f0a6c-d20a-11ec-8377-0242ac110003 UniProtKB:P22605 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1d1f335c-d20a-11ec-8377-0242ac110003 UniProtKB:P18911 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Transcription factor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1d1f5b98-d20a-11ec-8377-0242ac110003 UniProtKB:Q05343 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1d1f8398-d20a-11ec-8377-0242ac110003 UniProtKB:P22736 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Nuclear other (Nuclear receptor subfamily 4 group A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1d1fabf2-d20a-11ec-8377-0242ac110003 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:1d1fd5be-d20a-11ec-8377-0242ac110003 UniProtKB:Q13133 biolink:molecularly_interacts_with DrugCentral:3862 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alitretinoin targets Nuclear other (Oxysterols receptor LXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d1ffdfa-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:3871 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 artemisinin targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:1d2026c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzamycin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1d204f08-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:3875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzamycin targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:1d20779e-d20a-11ec-8377-0242ac110003 UniProtKB:O43193 biolink:molecularly_interacts_with DrugCentral:3875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzamycin targets GPCR (Motilin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1d209ff8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:3875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzamycin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1d20c82a-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:3875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzamycin targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.01']} DrugCentral uuid:1d20f066-d20a-11ec-8377-0242ac110003 UniProtKB:O95180 biolink:molecularly_interacts_with DrugCentral:3880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benidipine is blocker of Ion channel (Voltage-dependent T-type calcium channel subunit alpha-1H) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.843']} DrugCentral uuid:1d211d98-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:3880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1d211d98-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:3880 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1d215cae-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:1d215cae-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:1d215cae-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:1d215cae-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:3881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzydamine targets Enzyme (Soluble guanylate cyclase) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:1d21a7b8-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biriperone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1d21cff4-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biriperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.88']} DrugCentral uuid:1d21f920-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:3883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biriperone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:1d222166-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:3883 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 biriperone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1d224a38-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3911 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasone butyrate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1d226e8c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:1d2296dc-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:1d22bf2c-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.665']} DrugCentral uuid:1d22e808-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.372']} DrugCentral uuid:1d231062-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:1d2338bc-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:1d236116-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.307']} DrugCentral uuid:1d238a24-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:1d23b260-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.11']} DrugCentral uuid:1d23dbdc-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1d240436-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:1d242d08-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:1d245558-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:1d247dc6-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:1d24a60c-d20a-11ec-8377-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.25']} DrugCentral uuid:1d24de88-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1d24de88-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1d24de88-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1d24de88-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1d24de88-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1d253a7c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:1d253a7c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:1d253a7c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:1d25859a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:1d25859a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:1d25859a-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:1d25c42e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPC2 biolink:molecularly_interacts_with DrugCentral:3912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clorotepine targets Ion channel (Potassium channel subfamily K member 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.13']} DrugCentral uuid:1d25ecce-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1d261514-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:1d263e22-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1d266672-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1d268f76-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.79']} DrugCentral uuid:1d26b7bc-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1d26e020-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1d270ae6-d20a-11ec-8377-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:3920 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexamethasone phosphate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1d2734d0-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:1d275d02-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1d278548-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1d27ad8e-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1d27d5fc-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1d27fe38-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1d282674-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.74']} DrugCentral uuid:1d284ece-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.57']} DrugCentral uuid:1d287854-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.788']} DrugCentral uuid:1d28a09a-d20a-11ec-8377-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1d28caca-d20a-11ec-8377-0242ac110003 UniProtKB:P19091 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1d28f41e-d20a-11ec-8377-0242ac110003 UniProtKB:P06186 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1d291dea-d20a-11ec-8377-0242ac110003 UniProtKB:P22199 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Transcription factor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1d294630-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:3927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 androstanolone targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1d296e76-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:3931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolasetron targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.226']} DrugCentral uuid:1d299720-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:3931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolasetron is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.698']} DrugCentral uuid:1d29bf84-d20a-11ec-8377-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:3944 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etoposide phosphate is inhibitor of Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:1d29e3b0-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz is agonist of GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1d2a0bec-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.928']} DrugCentral uuid:1d2a34b4-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.951']} DrugCentral uuid:1d2a5d04-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.208']} DrugCentral uuid:1d2a8554-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.971']} DrugCentral uuid:1d2aadc2-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz is agonist of GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.167']} DrugCentral uuid:1d2ad770-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz is agonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.793']} DrugCentral uuid:1d2affc0-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.801']} DrugCentral uuid:1d2b281a-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.748']} DrugCentral uuid:1d2b504c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1d2b78ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.46']} DrugCentral uuid:1d2ba1c8-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1d2bc9fa-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.122']} DrugCentral uuid:1d2bf254-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1d2c1b08-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1d2c4b00-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:1d2c4b00-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:1d2c4b00-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:3952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guanabenz targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:1d2c8994-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:3959 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone butyrate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1d2cb46e-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ilaprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:1d2cb46e-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:3961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ilaprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:1d2ce740-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.646']} DrugCentral uuid:1d2d11b6-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1d2d3a9c-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1d2d62ce-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.407']} DrugCentral uuid:1d2d8af6-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.125']} DrugCentral uuid:1d2db35a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.924']} DrugCentral uuid:1d2ddc4a-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.891']} DrugCentral uuid:1d2e04a4-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.586']} DrugCentral uuid:1d2e2cd6-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.244']} DrugCentral uuid:1d2e5526-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.451']} DrugCentral uuid:1d2e80a0-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.539']} DrugCentral uuid:1d2ea90e-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is allosteric modulator of Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1d2ed14a-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1d2f0534-d20a-11ec-8377-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1d2f0534-d20a-11ec-8377-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1d2f0534-d20a-11ec-8377-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1d2f0534-d20a-11ec-8377-0242ac110003 UniProtKB:P48167 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is agonist of Ion channel (Glycine Receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1d2f4f26-d20a-11ec-8377-0242ac110003 UniProtKB:P91730 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is modulator of Ion channel (Glutamate-gated chloride channel) DrugCentral uuid:1d2f735c-d20a-11ec-8377-0242ac110003 UniProtKB:Q25634 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is modulator of Ion channel (Glutamate-gated chloride channel) DrugCentral uuid:1d2f9760-d20a-11ec-8377-0242ac110003 UniProtKB:P11507 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets Enzyme (Sarcoplasmic/endoplasmic reticulum calcium ATPase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1d2fc03c-d20a-11ec-8377-0242ac110003 UniProtKB:P06685 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets Enzyme (Sodium/potassium-transporting ATPase subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1d2fe846-d20a-11ec-8377-0242ac110003 UniProtKB:Q64578 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin targets Enzyme (Sarcoplasmic/endoplasmic reticulum calcium ATPase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1d301078-d20a-11ec-8377-0242ac110003 UniProtKB:P51577 biolink:molecularly_interacts_with DrugCentral:3972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivermectin is allosteric modulator of Unclassified (P2X purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1d303896-d20a-11ec-8377-0242ac110003 UniProtKB:P29029 biolink:molecularly_interacts_with DrugCentral:3976 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kinetin targets Enzyme (Endochitinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1d3063ca-d20a-11ec-8377-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1d4f71ca-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.65']} DrugCentral uuid:1d4fd12e-d20a-11ec-8377-0242ac110003 UniProtKB:P14920 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Enzyme (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1d50271e-d20a-11ec-8377-0242ac110003 UniProtKB:P00371 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Unclassified (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.68']} DrugCentral uuid:1d507796-d20a-11ec-8377-0242ac110003 UniProtKB:P11344 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.21']} DrugCentral uuid:1d50c8c2-d20a-11ec-8377-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:1d5118f4-d20a-11ec-8377-0242ac110003 UniProtKB:B2ZB02 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Unclassified (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1d516be2-d20a-11ec-8377-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Unclassified (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.91']} DrugCentral uuid:1d51bd5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q00024 biolink:molecularly_interacts_with DrugCentral:3977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 kojic acid targets Enzyme (Polyphenol oxidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1d51f63e-d20a-11ec-8377-0242ac110003 UniProtKB:O75936 biolink:molecularly_interacts_with DrugCentral:3995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 meldonium targets Enzyme (Gamma-butyrobetaine dioxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1d522316-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NQS5 biolink:molecularly_interacts_with DrugCentral:3998 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octanoic acid targets GPCR (G-protein coupled receptor 84) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:1d524fe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NQS5 biolink:molecularly_interacts_with DrugCentral:3998 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 octanoic acid targets GPCR (G-protein coupled receptor 84) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.71']} DrugCentral uuid:1d527cf8-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4002 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niperotidine is antagonist of GPCR (Histamine H2 receptor) DrugCentral uuid:1d52a516-d20a-11ec-8377-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.71']} DrugCentral uuid:1d52d1c6-d20a-11ec-8377-0242ac110003 UniProtKB:P47901 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan is antagonist of GPCR (Vasopressin V1b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1d52fe8a-d20a-11ec-8377-0242ac110003 UniProtKB:P30559 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan targets GPCR (Oxytocin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1d532c0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan targets GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1d5358a8-d20a-11ec-8377-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan targets GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1d5389ae-d20a-11ec-8377-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1d5389ae-d20a-11ec-8377-0242ac110003 UniProtKB:P48974 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan targets GPCR (Vasopressin V1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1d53c5fe-d20a-11ec-8377-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:4004 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mozavaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.03']} DrugCentral uuid:1d53f60a-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.04']} DrugCentral uuid:1d5422c4-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1d54514a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1d547dfa-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.74']} DrugCentral uuid:1d54aaa0-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oxitriptan targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.67']} DrugCentral uuid:1d54d75a-d20a-11ec-8377-0242ac110003 UniProtKB:Q14832 biolink:molecularly_interacts_with DrugCentral:4050 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spaglumic acid is agonist of GPCR (Metabotropic glutamate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1d5505b8-d20a-11ec-8377-0242ac110003 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.84']} DrugCentral uuid:1d553268-d20a-11ec-8377-0242ac110003 UniProtKB:P48147 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Enzyme (Prolyl endopeptidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1d555f18-d20a-11ec-8377-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d55cce6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UN88 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1d56b598-d20a-11ec-8377-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4055 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baicalin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:1d56e25c-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 timolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1d570f20-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 timolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1d573bda-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 timolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.81']} DrugCentral uuid:1d576966-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 timolol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1d57960c-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 timolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1d57c3fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 timolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.78']} DrugCentral uuid:1d57f142-d20a-11ec-8377-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:4061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 timolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.44']} DrugCentral uuid:1d581e06-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.807']} DrugCentral uuid:1d584aac-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.243']} DrugCentral uuid:1d58781a-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.929']} DrugCentral uuid:1d58a574-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.425']} DrugCentral uuid:1d58d224-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.857']} DrugCentral uuid:1d58fec0-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:1d592cba-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.69']} DrugCentral uuid:1d595d2a-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.802']} DrugCentral uuid:1d5989f8-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.952']} DrugCentral uuid:1d59b6a8-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.789']} DrugCentral uuid:1d59e3d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:4063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirilazad targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1d5a1076-d20a-11ec-8377-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4072 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ascorbic acid targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1d5a3cfe-d20a-11ec-8377-0242ac110003 UniProtKB:P13674 biolink:molecularly_interacts_with DrugCentral:4072 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ascorbic acid targets Enzyme (Prolyl 4-hydroxylase subunit alpha-1) DrugCentral uuid:1d5a65e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q02809 biolink:molecularly_interacts_with DrugCentral:4072 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ascorbic acid targets Enzyme (Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1) DrugCentral uuid:1d5a8de4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UGH3 biolink:molecularly_interacts_with DrugCentral:4072 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ascorbic acid targets Transporter (Solute carrier family 23 member 2) DrugCentral uuid:1d5ab5da-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHI7 biolink:molecularly_interacts_with DrugCentral:4072 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ascorbic acid targets Transporter (Solute carrier family 23 member 1) DrugCentral uuid:1d5addc6-d20a-11ec-8377-0242ac110003 UniProtKB:P00689 biolink:molecularly_interacts_with DrugCentral:4072 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ascorbic acid targets Enzyme (Pancreatic alpha-amylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:1d5b0b66-d20a-11ec-8377-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:4074 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minodronic acid targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1d5b380c-d20a-11ec-8377-0242ac110003 UniProtKB:O95749 biolink:molecularly_interacts_with DrugCentral:4074 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minodronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1d5b64a8-d20a-11ec-8377-0242ac110003 UniProtKB:P22939 biolink:molecularly_interacts_with DrugCentral:4074 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minodronic acid targets Enzyme (Farnesyl diphosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d5b9130-d20a-11ec-8377-0242ac110003 UniProtKB:Q12051 biolink:molecularly_interacts_with DrugCentral:4074 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 minodronic acid targets Enzyme (Geranylgeranyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1d5bc2c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4099 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamlodipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:1d5bc2c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4099 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levamlodipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:1d5bf5e4-d20a-11ec-8377-0242ac110003 UniProtKB:P0DJD9 biolink:molecularly_interacts_with DrugCentral:4106 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sucralfate is inhibitor of Enzyme (Pepsin A-5) DrugCentral uuid:1d5c1e02-d20a-11ec-8377-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol is agonist of GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:1d5c4c7e-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.99']} DrugCentral uuid:1d5c7910-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1d5ca58e-d20a-11ec-8377-0242ac110003 UniProtKB:P23416 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol is allosteric modulator of Ion channel (Glycine receptor subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1d5cd32e-d20a-11ec-8377-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:1d5cfffc-d20a-11ec-8377-0242ac110003 UniProtKB:O75311 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol is allosteric modulator of Ion channel (Glycine receptor subunit alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1d5d2ca2-d20a-11ec-8377-0242ac110003 UniProtKB:Q14330 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (N-arachidonyl glycine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1d5d595c-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1d5d8652-d20a-11ec-8377-0242ac110003 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.43']} DrugCentral uuid:1d5db302-d20a-11ec-8377-0242ac110003 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.04']} DrugCentral uuid:1d5ddfd0-d20a-11ec-8377-0242ac110003 UniProtKB:P47746 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1d5e0d52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1d5e3e6c-d20a-11ec-8377-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:1d5e3e6c-d20a-11ec-8377-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:1d5e7c1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9QZN9 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1d5e7c1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9QZN9 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol targets GPCR (Cannabinoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1d5eb66c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WUD2 biolink:molecularly_interacts_with DrugCentral:4109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronabinol is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1d5ee308-d20a-11ec-8377-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:4110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1d5f0fd6-d20a-11ec-8377-0242ac110003 UniProtKB:Q00788 biolink:molecularly_interacts_with DrugCentral:4110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:1d5f3c90-d20a-11ec-8377-0242ac110003 UniProtKB:P30560 biolink:molecularly_interacts_with DrugCentral:4110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V1a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1d5f6a76-d20a-11ec-8377-0242ac110003 UniProtKB:P30518 biolink:molecularly_interacts_with DrugCentral:4110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tolvaptan is antagonist of GPCR (Vasopressin V2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1d5f9cf8-d20a-11ec-8377-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:4111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 besifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:1d5f9cf8-d20a-11ec-8377-0242ac110003 UniProtKB:P20083 biolink:molecularly_interacts_with DrugCentral:4111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 besifloxacin is inhibitor of Enzyme (Topoisomerase IV) DrugCentral uuid:1d5fd4a2-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:4111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 besifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:1d5fd4a2-d20a-11ec-8377-0242ac110003 UniProtKB:P0AES6 biolink:molecularly_interacts_with DrugCentral:4111 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 besifloxacin is inhibitor of Enzyme (DNA gyrase) DrugCentral uuid:1d600878-d20a-11ec-8377-0242ac110003 UniProtKB:P10827 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone targets Nuclear hormone receptor (Thyroid hormone receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.229']} DrugCentral uuid:1d603514-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1d6062c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q06432 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone targets Ion channel (Voltage-dependent calcium channel gamma-1 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:1d6091b2-d20a-11ec-8377-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d60c196-d20a-11ec-8377-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone targets Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:1d60ef7c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NVV9 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone targets Unclassified (THAP domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.229']} DrugCentral uuid:1d611cd6-d20a-11ec-8377-0242ac110003 UniProtKB:O60741 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) DrugCentral uuid:1d614526-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL51 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2) DrugCentral uuid:1d616d62-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P1Z3 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3) DrugCentral uuid:1d6195bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3Q4 biolink:molecularly_interacts_with DrugCentral:4112 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dronedarone is blocker of Ion channel (Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4) DrugCentral uuid:1d61be8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:4113 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prasugrel is antagonist of GPCR (P2Y purinoceptor 12) DrugCentral uuid:1d61e6a2-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saxagliptin targets Enzyme (Cytochrome P450 3A4) DrugCentral uuid:1d620eac-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saxagliptin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:1d6236d4-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saxagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1d6265c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:4114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saxagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1d62932c-d20a-11ec-8377-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4114 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saxagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1d62bfe6-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1d62ed0e-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1d6319d2-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1d6346a0-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.75']} DrugCentral uuid:1d637346-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.187']} DrugCentral uuid:1d63a0c8-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.97']} DrugCentral uuid:1d63cd96-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.61']} DrugCentral uuid:1d63fa46-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:1d642822-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.93']} DrugCentral uuid:1d645504-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1d6481aa-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.47']} DrugCentral uuid:1d64ae6e-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:1d64dc86-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.73']} DrugCentral uuid:1d650936-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:1d6535dc-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.644']} DrugCentral uuid:1d6563d6-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1d659086-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:1d65be76-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.107']} DrugCentral uuid:1d65eb1c-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.039']} DrugCentral uuid:1d661b32-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.491']} DrugCentral uuid:1d664b2a-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.565']} DrugCentral uuid:1d66785c-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1d66a598-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1d66d234-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:1d66fee4-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.504']} DrugCentral uuid:1d672b80-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.71']} DrugCentral uuid:1d6758da-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.349']} DrugCentral uuid:1d678602-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.409']} DrugCentral uuid:1d67b2a8-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1d67e19c-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:4115 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asenapine is agonist of GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1d6811d0-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4117 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralatrexate is inhibitor of Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.35']} DrugCentral uuid:1d683f02-d20a-11ec-8377-0242ac110003 UniProtKB:Q96NT5 biolink:molecularly_interacts_with DrugCentral:4117 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralatrexate targets Transporter (Proton-coupled folate transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1d686c52-d20a-11ec-8377-0242ac110003 UniProtKB:P41440 biolink:molecularly_interacts_with DrugCentral:4117 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralatrexate targets Transporter (Folate transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.16']} DrugCentral uuid:1d689916-d20a-11ec-8377-0242ac110003 UniProtKB:P15328 biolink:molecularly_interacts_with DrugCentral:4117 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralatrexate targets Membrane receptor (Folate receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:1d68c5a8-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1d68f258-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1d691fbc-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1d694d70-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1d697a2a-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.74']} DrugCentral uuid:1d69a810-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1d69d7fe-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1d6a04ae-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1d6a315e-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1d6a5e7c-d20a-11ec-8377-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1d6a8b36-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1d6ab7e6-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:1d6ae52c-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1d6b1204-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1d6b3eb4-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1d6b6b8c-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:1d6b9b0c-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1d6bc7e4-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.31']} DrugCentral uuid:1d6bf49e-d20a-11ec-8377-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1d6c219e-d20a-11ec-8377-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1d6c4e80-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1d6c7c7a-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1d6ca934-d20a-11ec-8377-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1d6cd6c0-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1d6d0370-d20a-11ec-8377-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1d6d3020-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1d6d5e9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1d6d8b42-d20a-11ec-8377-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1d6db914-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1d6de5c4-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1d6e1350-d20a-11ec-8377-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1d6e3fec-d20a-11ec-8377-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1d6e6ca6-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1d6e99ec-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:1d6ec688-d20a-11ec-8377-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1d6ef342-d20a-11ec-8377-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1d6f20b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1d6f4fae-d20a-11ec-8377-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1d6f7c68-d20a-11ec-8377-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1d6fa8f0-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1d6fd5fa-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1d7002be-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1d702f6e-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1d705cc8-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1d70895a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1d70b614-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1d70e2b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1d7111ae-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1d713e54-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1d716adc-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1d7197fa-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1d71c4a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1d71f13c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1d721ef0-d20a-11ec-8377-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1d724c54-d20a-11ec-8377-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1d7278fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1d72a58c-d20a-11ec-8377-0242ac110003 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1d72d3c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib is inhibitor of Kinase (Tyrosine-protein kinase ITK/TSK) DrugCentral uuid:1d72fece-d20a-11ec-8377-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1d732e94-d20a-11ec-8377-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1d735b58-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1d738876-d20a-11ec-8377-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1d73b558-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1d73e212-d20a-11ec-8377-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1d7410b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1d744040-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1d746cd2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1d749978-d20a-11ec-8377-0242ac110003 UniProtKB:Q13705 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Activin receptor type-2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1d74c72c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:1d74f3dc-d20a-11ec-8377-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1d752078-d20a-11ec-8377-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1d754db4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1d757a5a-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1d75a7b4-d20a-11ec-8377-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1d75d450-d20a-11ec-8377-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1d7601a0-d20a-11ec-8377-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1d762e3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1d765af6-d20a-11ec-8377-0242ac110003 UniProtKB:P21127 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Cyclin-dependent kinase 11B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1d768af8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ88 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Cyclin-dependent kinase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1d76b80c-d20a-11ec-8377-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1d76e4b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1d7711ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:1d773ea8-d20a-11ec-8377-0242ac110003 UniProtKB:Q6P3R8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase Nek5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1d776b62-d20a-11ec-8377-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1d77983a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1d77c59e-d20a-11ec-8377-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1d77f23a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1d781ee0-d20a-11ec-8377-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1d784cbc-d20a-11ec-8377-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1d78798a-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1d78a64e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1d78d2f4-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1d79001c-d20a-11ec-8377-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1d792cea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1d795990-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1d798712-d20a-11ec-8377-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1d79b3cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:1d79e1d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1d7a0e80-d20a-11ec-8377-0242ac110003 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1d7a3e82-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1d7a6b46-d20a-11ec-8377-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1d7a97f6-d20a-11ec-8377-0242ac110003 UniProtKB:O60331 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1d7ac5f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1d7af2aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1d7b1f64-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:1d7b4c3c-d20a-11ec-8377-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:4118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pazopanib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1d7b79aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1d7ba66e-d20a-11ec-8377-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.328']} DrugCentral uuid:1d7bd314-d20a-11ec-8377-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1d7c0190-d20a-11ec-8377-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.604']} DrugCentral uuid:1d7c2efe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.523']} DrugCentral uuid:1d7c5bcc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1d7c887c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:1d7cb5b8-d20a-11ec-8377-0242ac110003 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.292']} DrugCentral uuid:1d7ce254-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d7d0efa-d20a-11ec-8377-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.44']} DrugCentral uuid:1d7d4118-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1d7d4118-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1d7d7e94-d20a-11ec-8377-0242ac110003 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:1d7d7e94-d20a-11ec-8377-0242ac110003 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.82']} DrugCentral uuid:1d7db7e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z2V5 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1d7e11c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d7e11c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d7e11c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d7e11c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d7e11c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d7e11c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d7e11c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d7e11c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d7e11c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d7e11c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d7e11c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4119 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romidepsin is inhibitor of Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1d7ebe26-d20a-11ec-8377-0242ac110003 UniProtKB:Q14833 biolink:molecularly_interacts_with DrugCentral:4120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfosfoserine targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1d7eeab8-d20a-11ec-8377-0242ac110003 UniProtKB:Q14831 biolink:molecularly_interacts_with DrugCentral:4120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfosfoserine is agonist of GPCR (Metabotropic glutamate receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:1d7f17c2-d20a-11ec-8377-0242ac110003 UniProtKB:O15303 biolink:molecularly_interacts_with DrugCentral:4120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfosfoserine is agonist of GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1d7f4576-d20a-11ec-8377-0242ac110003 UniProtKB:O00222 biolink:molecularly_interacts_with DrugCentral:4120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfosfoserine is agonist of GPCR (Metabotropic glutamate receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1d7f7230-d20a-11ec-8377-0242ac110003 UniProtKB:P31423 biolink:molecularly_interacts_with DrugCentral:4120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfosfoserine targets GPCR (Metabotropic glutamate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1d7f9fe4-d20a-11ec-8377-0242ac110003 UniProtKB:P35349 biolink:molecularly_interacts_with DrugCentral:4120 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexfosfoserine targets GPCR (Metabotropic glutamate receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1d7fcf28-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1d7ffbe2-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1d80289c-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:1d8055ce-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.223']} DrugCentral uuid:1d80827e-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1d80af2e-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.405']} DrugCentral uuid:1d80dc42-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets Enzyme (Arachidonate 5-lipoxygenase) DrugCentral uuid:1d810438-d20a-11ec-8377-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets Enzyme (Thioredoxin reductase 1, cytoplasmic) DrugCentral uuid:1d812c4c-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.922']} DrugCentral uuid:1d8158f2-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4122 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 auranofin is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1d8187c8-d20a-11ec-8377-0242ac110003 UniProtKB:P51788 biolink:molecularly_interacts_with DrugCentral:4123 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lubiprostone is opener of Ion channel (Chloride channel protein 2) DrugCentral uuid:1d81afdc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1d81dca0-d20a-11ec-8377-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1d820964-d20a-11ec-8377-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1d8236aa-d20a-11ec-8377-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1d8264ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1d8291c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1d82beea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:1d82eb9a-d20a-11ec-8377-0242ac110003 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1d83184a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:1d83463a-d20a-11ec-8377-0242ac110003 UniProtKB:P09960 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1d8374f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1d83a1de-d20a-11ec-8377-0242ac110003 UniProtKB:Q94F81 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (HD2 type histone deacetylase HDA106; Histone deacetylase 2b; Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1d83ce8e-d20a-11ec-8377-0242ac110003 UniProtKB:O09106 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:1d83fb84-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ZTP8 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:1d842816-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XYC7 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:1d845552-d20a-11ec-8377-0242ac110003 UniProtKB:Q70I53 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase-like amidohydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1d8482c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1d84af8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q7K6A1 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1d84dc0c-d20a-11ec-8377-0242ac110003 UniProtKB:B2RXH2 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Lysine-specific demethylase 4E) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1d8508b2-d20a-11ec-8377-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d853c06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1d853c06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y618 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2)) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1d8579d2-d20a-11ec-8377-0242ac110003 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1d8579d2-d20a-11ec-8377-0242ac110003 UniProtKB:O75376 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Transcription factor (Histone deacetylase 3/NCoR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1d85dfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d85dfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d85dfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d85dfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d85dfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d85dfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d85dfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d85dfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d85dfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d85dfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d85dfb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d8698c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1d8698c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1d8698c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1d8698c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase 1/3/5/8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1d86f0aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase (HDAC1 and HDAC2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d86f0aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase (HDAC1 and HDAC2)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1d8745aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:1d8745aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:1d8745aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:1d8745aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:1d8745aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:1d8745aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:1d8745aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99P99 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.78']} DrugCentral uuid:1d87bdbe-d20a-11ec-8377-0242ac110003 UniProtKB:A5H660 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Unclassified (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1d87ea8c-d20a-11ec-8377-0242ac110003 UniProtKB:P24527 biolink:molecularly_interacts_with DrugCentral:4124 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorinostat targets Enzyme (Leukotriene A-4 hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1d881750-d20a-11ec-8377-0242ac110003 UniProtKB:P12821 biolink:molecularly_interacts_with DrugCentral:4125 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proline targets Enzyme (Angiotensin-converting enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1d8844d2-d20a-11ec-8377-0242ac110003 UniProtKB:P35439 biolink:molecularly_interacts_with DrugCentral:4125 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 proline targets Ion channel (Glutamate receptor ionotropic, NMDA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.76']} DrugCentral uuid:1d887178-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z1J7 biolink:molecularly_interacts_with DrugCentral:4126 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asparagine targets Transporter (Amino acid transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1d889e1e-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:4127 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 serine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1d88cc68-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:4127 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 serine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1d88fab2-d20a-11ec-8377-0242ac110003 UniProtKB:P07314 biolink:molecularly_interacts_with DrugCentral:4127 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 serine targets Enzyme (Gamma-glutamyltranspeptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1d892780-d20a-11ec-8377-0242ac110003 UniProtKB:P63116 biolink:molecularly_interacts_with DrugCentral:4127 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 serine targets Unclassified (Asc-type amino acid transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1d895426-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z1J7 biolink:molecularly_interacts_with DrugCentral:4127 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 serine targets Transporter (Amino acid transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1d89814e-d20a-11ec-8377-0242ac110003 UniProtKB:Q01650 biolink:molecularly_interacts_with DrugCentral:4128 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valine targets Transporter (Large neutral amino acids transporter small subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.17']} DrugCentral uuid:1d89adf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q06278 biolink:molecularly_interacts_with DrugCentral:4134 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyridoxal targets Enzyme (Aldehyde oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1d89dab8-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisdexamfetamine is releasing agent of Transporter (Sodium-dependent noradrenaline transporter) DrugCentral uuid:1d8a04ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisdexamfetamine is releasing agent of Transporter (Sodium-dependent dopamine transporter) DrugCentral uuid:1d8a2cfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:4135 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lisdexamfetamine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:1d8a54fc-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1d8a81ac-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.301']} DrugCentral uuid:1d8ab136-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.387']} DrugCentral uuid:1d8ade86-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.925']} DrugCentral uuid:1d8b0b40-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1d8b3840-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1d8b650e-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.218']} DrugCentral uuid:1d8b91b4-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.209']} DrugCentral uuid:1d8bbe82-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:1d8bebdc-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.617']} DrugCentral uuid:1d8c188c-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.569']} DrugCentral uuid:1d8c453c-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.553']} DrugCentral uuid:1d8c7386-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.635']} DrugCentral uuid:1d8ca07c-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:1d8ccd36-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:1d8cf9d2-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.251']} DrugCentral uuid:1d8d2704-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.916']} DrugCentral uuid:1d8d5396-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3N8 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Histamine H4 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.061']} DrugCentral uuid:1d8d814a-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:1d8dae90-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:1d8ddb4a-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.195']} DrugCentral uuid:1d8e07f0-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.265']} DrugCentral uuid:1d8e34a0-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.155']} DrugCentral uuid:1d8e6344-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.556']} DrugCentral uuid:1d8e9008-d20a-11ec-8377-0242ac110003 UniProtKB:P28566 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (5-hydroxytryptamine receptor 1E) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.991']} DrugCentral uuid:1d8ebcc2-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1d8ee9f4-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.47']} DrugCentral uuid:1d8f16c2-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:1d8f4390-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.06']} DrugCentral uuid:1d8f7040-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.809']} DrugCentral uuid:1d8f9dd6-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.975']} DrugCentral uuid:1d8fcaa4-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:1d8ff74a-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.697']} DrugCentral uuid:1d9025ee-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1d9052f8-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.124']} DrugCentral uuid:1d9080f2-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.241']} DrugCentral uuid:1d90adca-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1d90db06-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.945']} DrugCentral uuid:1d9107b6-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.578']} DrugCentral uuid:1d913448-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.294']} DrugCentral uuid:1d9161c0-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.037']} DrugCentral uuid:1d918e5c-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:1d91bb20-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.416']} DrugCentral uuid:1d91e8de-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.562']} DrugCentral uuid:1d9216f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1d9243b0-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.084']} DrugCentral uuid:1d927060-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.628']} DrugCentral uuid:1d929e1e-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.012']} DrugCentral uuid:1d92caec-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1d92f7a6-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.233']} DrugCentral uuid:1d93251e-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.325']} DrugCentral uuid:1d9351ba-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.668']} DrugCentral uuid:1d937e60-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.252']} DrugCentral uuid:1d93ab24-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1d93d8a6-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:4138 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentian violet targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.701']} DrugCentral uuid:1d94057e-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4141 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 udenafil targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:1d942dd8-d20a-11ec-8377-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:4141 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 udenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.084']} DrugCentral uuid:1d945ad8-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:4142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine silver is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:1d94830a-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfadiazine silver targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:1d94afce-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darunavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:1d94dc9c-d20a-11ec-8377-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:4143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darunavir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.658']} DrugCentral uuid:1d950a50-d20a-11ec-8377-0242ac110003 UniProtKB:Q72874 biolink:molecularly_interacts_with DrugCentral:4143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darunavir is inhibitor of Enzyme (Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.85']} DrugCentral uuid:1d953714-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:4143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darunavir targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.21']} DrugCentral uuid:1d9563ba-d20a-11ec-8377-0242ac110003 UniProtKB:O90781 biolink:molecularly_interacts_with DrugCentral:4143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darunavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.96']} DrugCentral uuid:1d95907e-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darunavir targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:1d95be1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ30 biolink:molecularly_interacts_with DrugCentral:4143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darunavir targets Unclassified (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.82']} DrugCentral uuid:1d95eb00-d20a-11ec-8377-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:4144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium lauryl sulfate targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1d9617a6-d20a-11ec-8377-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:4144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium lauryl sulfate targets Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1d9644d8-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone propionate is agonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:1d9672c8-d20a-11ec-8377-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:4146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone propionate targets Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.25']} DrugCentral uuid:1d969f64-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4146 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone propionate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1d96e69a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1d96e69a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1d96e69a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1d96e69a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1d96e69a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1d96e69a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1d96e69a-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doripenem is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1d9751e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1d978028-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1d97ace2-d20a-11ec-8377-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:1d97d9b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q14330 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets GPCR (N-arachidonyl glycine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1d98070a-d20a-11ec-8377-0242ac110003 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:1d9833ce-d20a-11ec-8377-0242ac110003 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1d986128-d20a-11ec-8377-0242ac110003 UniProtKB:P47746 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1d988df6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant targets GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1d98bb78-d20a-11ec-8377-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:4150 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimonabant is antagonist of GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.72']} DrugCentral uuid:1d98e814-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4151 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silodosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1d9914b0-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4151 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silodosin targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:1d993da0-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4151 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silodosin is antagonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.44']} DrugCentral uuid:1d996a8c-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4151 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silodosin is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1d999746-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4151 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silodosin is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1d99c400-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4151 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 silodosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1d99f114-d20a-11ec-8377-0242ac110003 UniProtKB:Q2VKV7 biolink:molecularly_interacts_with DrugCentral:4152 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 permethrin is blocker of Ion channel (Sodium channel protein) DrugCentral uuid:1d9a3ba6-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d9a3ba6-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d9a3ba6-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d9a3ba6-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d9a3ba6-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d9a3ba6-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d9a3ba6-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d9a3ba6-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d9a3ba6-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4153 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabazitaxel is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1d9abc70-d20a-11ec-8377-0242ac110003 UniProtKB:P39654 biolink:molecularly_interacts_with DrugCentral:4156 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edaravone targets Enzyme (Polyunsaturated fatty acid lipoxygenase ALOX15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.47']} DrugCentral uuid:1d9aed8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4157 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lercanidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:1d9aed8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:4157 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lercanidipine is blocker of Ion channel (Voltage-gated L-type calcium channel) DrugCentral uuid:1d9b2174-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4161 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temsirolimus targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:1d9b49ba-d20a-11ec-8377-0242ac110003 UniProtKB:P62942 biolink:molecularly_interacts_with DrugCentral:4161 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temsirolimus is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP1A) DrugCentral uuid:1d9b71e2-d20a-11ec-8377-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:4161 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temsirolimus targets Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1d9b9e88-d20a-11ec-8377-0242ac110003 UniProtKB:Q00688 biolink:molecularly_interacts_with DrugCentral:4161 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 temsirolimus targets Enzyme (Peptidyl-prolyl cis-trans isomerase FKBP3) DrugCentral uuid:1d9bccbe-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexlansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:1d9bccbe-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexlansoprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:1d9bfffe-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:4162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexlansoprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1d9c2cb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:4162 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexlansoprazole targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9d032c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Voltage-gated potassium channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1d9f215c-d20a-11ec-8377-0242ac110003 UniProtKB:P15388 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:1d9f4df8-d20a-11ec-8377-0242ac110003 UniProtKB:P22462 biolink:molecularly_interacts_with DrugCentral:4163 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fampridine is blocker of Ion channel (Potassium voltage-gated channel subfamily C member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1d9f7b0c-d20a-11ec-8377-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 liraglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.2']} DrugCentral uuid:1d9fa78a-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alcaftadine is antagonist of GPCR (Histamine H1 receptor) DrugCentral uuid:1d9fcfda-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4166 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ulipristal is antagonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1d9ffdac-d20a-11ec-8377-0242ac110003 UniProtKB:O95470 biolink:molecularly_interacts_with DrugCentral:4167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fingolimod targets Enzyme (Sphingosine-1-phosphate lyase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1da02a7a-d20a-11ec-8377-0242ac110003 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:4167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1da05720-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:4167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1da083d0-d20a-11ec-8377-0242ac110003 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:4167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1da0b2f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:4167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fingolimod is agonist of GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1da0df92-d20a-11ec-8377-0242ac110003 UniProtKB:Q923J1 biolink:molecularly_interacts_with DrugCentral:4167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fingolimod is blocker of Ion channel (Transient receptor potential cation channel subfamily M member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1da10c38-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.39']} DrugCentral uuid:1da13956-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.195']} DrugCentral uuid:1da16610-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.305']} DrugCentral uuid:1da192b6-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.967']} DrugCentral uuid:1da1bf66-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:1da1ecca-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.17']} DrugCentral uuid:1da21970-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.69']} DrugCentral uuid:1da2463e-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.003']} DrugCentral uuid:1da2751e-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4168 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lurasidone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.328']} DrugCentral uuid:1da2bbbe-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1da2bbbe-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1da2bbbe-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1da2bbbe-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1da2bbbe-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1da2bbbe-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1da2bbbe-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftaroline fosamil is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1da325d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q02643 biolink:molecularly_interacts_with DrugCentral:4170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tesamorelin is agonist of GPCR (Growth hormone-releasing hormone receptor) DrugCentral uuid:1da37090-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1da37090-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1da37090-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1da37090-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1da37090-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1da37090-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1da37090-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1da37090-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1da37090-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4171 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eribulin is inhibitor of Tumour-associated antigen (Tubulin beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1da402f8-d20a-11ec-8377-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1da42fa8-d20a-11ec-8377-0242ac110003 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1da45d02-d20a-11ec-8377-0242ac110003 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1da48980-d20a-11ec-8377-0242ac110003 UniProtKB:P23946 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Chymase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:1da4b608-d20a-11ec-8377-0242ac110003 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir is inhibitor of Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1da4e312-d20a-11ec-8377-0242ac110003 UniProtKB:O60911 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Cathepsin L2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:1da50fa4-d20a-11ec-8377-0242ac110003 UniProtKB:P43235 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Cathepsin K) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1da53c54-d20a-11ec-8377-0242ac110003 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1da568dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBX1 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Enzyme (Cathepsin F) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1da59b9a-d20a-11ec-8377-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:1da59b9a-d20a-11ec-8377-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:1da5d4de-d20a-11ec-8377-0242ac110003 UniProtKB:A0A0K1CY61 biolink:molecularly_interacts_with DrugCentral:4172 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 boceprevir targets Unclassified (Nonstructural protein NS3-4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1da601a2-d20a-11ec-8377-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1da631a4-d20a-11ec-8377-0242ac110003 UniProtKB:P08246 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Neutrophil elastase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1da661a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNI1 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Chymotrypsin-like elastase family member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1da68e6a-d20a-11ec-8377-0242ac110003 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1da6bb60-d20a-11ec-8377-0242ac110003 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1da6e7fc-d20a-11ec-8377-0242ac110003 UniProtKB:P23946 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Chymase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1da71498-d20a-11ec-8377-0242ac110003 UniProtKB:P10619 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir is inhibitor of Enzyme (Lysosomal protective protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1da7415c-d20a-11ec-8377-0242ac110003 UniProtKB:O60911 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Cathepsin L2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:1da76eac-d20a-11ec-8377-0242ac110003 UniProtKB:P43235 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Cathepsin K) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1da79bca-d20a-11ec-8377-0242ac110003 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1da7ccbc-d20a-11ec-8377-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) DrugCentral uuid:1da7ccbc-d20a-11ec-8377-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) DrugCentral uuid:1da801dc-d20a-11ec-8377-0242ac110003 UniProtKB:C1KIQ2 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1da82e82-d20a-11ec-8377-0242ac110003 UniProtKB:Q0ZMF1 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1da85b32-d20a-11ec-8377-0242ac110003 UniProtKB:Q91RS4 biolink:molecularly_interacts_with DrugCentral:4173 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telaprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:1da88864-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilpivirine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1da8b532-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:4174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilpivirine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) DrugCentral uuid:1da8dd6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:4174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilpivirine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1da90a1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilpivirine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1da938c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WJQ2 biolink:molecularly_interacts_with DrugCentral:4174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilpivirine targets Unclassified (Reverse transcriptase protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1da9657c-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linagliptin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:1da9924a-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:1da9bfea-d20a-11ec-8377-0242ac110003 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:4175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1da9ed76-d20a-11ec-8377-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1daa1a30-d20a-11ec-8377-0242ac110003 UniProtKB:P97321 biolink:molecularly_interacts_with DrugCentral:4175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1daa46e0-d20a-11ec-8377-0242ac110003 UniProtKB:O31048 biolink:molecularly_interacts_with DrugCentral:4175 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linagliptin targets Unclassified (Dipeptidyl peptidase IV) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1daa7412-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1daaa0c2-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abiraterone acetate targets Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1daacd72-d20a-11ec-8377-0242ac110003 UniProtKB:P05093 biolink:molecularly_interacts_with DrugCentral:4176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abiraterone acetate is inhibitor of Enzyme (Steroid 17-alpha-hydroxylase/17,20 lyase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.54']} DrugCentral uuid:1daafa9a-d20a-11ec-8377-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:4176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1dab2768-d20a-11ec-8377-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:4176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:1dab5418-d20a-11ec-8377-0242ac110003 UniProtKB:P11715 biolink:molecularly_interacts_with DrugCentral:4176 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abiraterone acetate targets Enzyme (Cytochrome P450 17A1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1dab80e6-d20a-11ec-8377-0242ac110003 UniProtKB:P54289 biolink:molecularly_interacts_with DrugCentral:4177 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin enacarbil is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-1) DrugCentral uuid:1dabac38-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY47 biolink:molecularly_interacts_with DrugCentral:4177 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gabapentin enacarbil is modulator of Ion channel (Voltage-dependent calcium channel subunit alpha-2/delta-2) DrugCentral uuid:1dabd758-d20a-11ec-8377-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1dac0534-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1dac3252-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1dac5ef8-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.47']} DrugCentral uuid:1dac8bbc-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1dacb862-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1dace5da-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1dad1280-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1dad3f4e-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1dad6d8e-d20a-11ec-8377-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1dad9aca-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1dadc824-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1dadf4de-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1dae221a-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1dae501e-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1dae7cc4-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1daeaa14-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1daed6e2-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1daf03a6-d20a-11ec-8377-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1daf3042-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1daf6102-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1daf9050-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:1dafbe40-d20a-11ec-8377-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1dafeb5e-d20a-11ec-8377-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1db01836-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1db044fa-d20a-11ec-8377-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:1db07286-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1db09f4a-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1db0cbfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1db0f8aa-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1db12852-d20a-11ec-8377-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1db1550c-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1db181da-d20a-11ec-8377-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1db1af16-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1db1dbd0-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.16']} DrugCentral uuid:1db20880-d20a-11ec-8377-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1db2353a-d20a-11ec-8377-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1db262a8-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1db28f94-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1db2bd3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1db2eb74-d20a-11ec-8377-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1db31b62-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1db348a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1db37558-d20a-11ec-8377-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1db3a2b2-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1db3cf6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1db3fc3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1db429b2-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1db45676-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.34']} DrugCentral uuid:1db48330-d20a-11ec-8377-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1db4b008-d20a-11ec-8377-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1db4dde4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:1db50b52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1db537ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1db5652a-d20a-11ec-8377-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1db591e4-d20a-11ec-8377-0242ac110003 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1db5beb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1db5eb6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1db6189e-d20a-11ec-8377-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1db646b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1db67384-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1db6a1c4-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1db6cf3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:1db6fc46-d20a-11ec-8377-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1db72b12-d20a-11ec-8377-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1db757cc-d20a-11ec-8377-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1db7849a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1db7b15e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1db7deae-d20a-11ec-8377-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1db80b68-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1db83836-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1db866da-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1db893b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1db8c058-d20a-11ec-8377-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1db8ed1c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1db91a44-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1db94726-d20a-11ec-8377-0242ac110003 UniProtKB:Q6DT37 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase MRCK gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1db973fe-d20a-11ec-8377-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1db9a2d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1db9cfa2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1db9fd9c-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:1dba2a74-d20a-11ec-8377-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1dba59c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1dba8668-d20a-11ec-8377-0242ac110003 UniProtKB:Q5VT25 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase MRCK alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1dbab318-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1dbae036-d20a-11ec-8377-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1dbb0cfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1dbb39b4-d20a-11ec-8377-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1dbb666e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1dbb94a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1dbbc17c-d20a-11ec-8377-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1dbbee2c-d20a-11ec-8377-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:1dbc1c9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16659 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1dbc4944-d20a-11ec-8377-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1dbc76a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1dbca3b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1dbcd076-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1dbcfe66-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:1dbd2b3e-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:1dbd587a-d20a-11ec-8377-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1dbd8548-d20a-11ec-8377-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1dbdb202-d20a-11ec-8377-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1dbddfd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1dbe0c7a-d20a-11ec-8377-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1dbe3934-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:1dbe65da-d20a-11ec-8377-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1dbe9316-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1dbebfd0-d20a-11ec-8377-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1dbeec8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WU08 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Serine/threonine-protein kinase 32A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1dbf19ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4178 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vandetanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:1dbf5396-d20a-11ec-8377-0242ac110003 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:1dbf5396-d20a-11ec-8377-0242ac110003 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:1dbf5396-d20a-11ec-8377-0242ac110003 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:1dbf5396-d20a-11ec-8377-0242ac110003 UniProtKB:Q18CI5 biolink:molecularly_interacts_with DrugCentral:4180 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fidaxomicin is inhibitor of Enzyme (DNA-directed RNA polymerase) DrugCentral uuid:1dbf9c5c-d20a-11ec-8377-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1dbfcc90-d20a-11ec-8377-0242ac110003 UniProtKB:O43525 biolink:molecularly_interacts_with DrugCentral:4181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1dbff940-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:4181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1dc025fa-d20a-11ec-8377-0242ac110003 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:4181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retigabine is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1dc0530e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z351 biolink:molecularly_interacts_with DrugCentral:4181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 retigabine targets Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1dc07fc8-d20a-11ec-8377-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:4182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivaroxaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1dc0ac82-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y6 biolink:molecularly_interacts_with DrugCentral:4182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivaroxaban targets Enzyme (Suppressor of tumorigenicity 14 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1dc0d932-d20a-11ec-8377-0242ac110003 UniProtKB:O19045 biolink:molecularly_interacts_with DrugCentral:4182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rivaroxaban targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1dc10696-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indacaterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.04']} DrugCentral uuid:1dc13378-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indacaterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1dc16014-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indacaterol targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1dc18e36-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indacaterol targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.98']} DrugCentral uuid:1dc1bd8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 indacaterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1dc1ea70-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:4184 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticagrelor is negative allosteric modulator of GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1dc2172a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99808 biolink:molecularly_interacts_with DrugCentral:4184 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticagrelor is inhibitor of Transporter (Equilibrative nucleoside transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1dc2443e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9EPX4 biolink:molecularly_interacts_with DrugCentral:4184 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ticagrelor targets GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1dc270c6-d20a-11ec-8377-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:1dc29d9e-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1dc2cac6-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1dc2f78a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1dc32548-d20a-11ec-8377-0242ac110003 UniProtKB:P10398 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib targets Kinase (Serine/threonine-protein kinase A-Raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1dc35284-d20a-11ec-8377-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib targets Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.78']} DrugCentral uuid:1dc38236-d20a-11ec-8377-0242ac110003 UniProtKB:P22830 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib targets Enzyme (Ferrochelatase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1dc3aefa-d20a-11ec-8377-0242ac110003 UniProtKB:P28028 biolink:molecularly_interacts_with DrugCentral:4185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vemurafenib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1dc3dbbe-d20a-11ec-8377-0242ac110003 UniProtKB:P30411 biolink:molecularly_interacts_with DrugCentral:4186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icatibant is antagonist of GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.22']} DrugCentral uuid:1dc408fa-d20a-11ec-8377-0242ac110003 UniProtKB:P25023 biolink:molecularly_interacts_with DrugCentral:4186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icatibant targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.11']} DrugCentral uuid:1dc436ae-d20a-11ec-8377-0242ac110003 UniProtKB:O70526 biolink:molecularly_interacts_with DrugCentral:4186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icatibant targets GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.96']} DrugCentral uuid:1dc4637c-d20a-11ec-8377-0242ac110003 UniProtKB:P46663 biolink:molecularly_interacts_with DrugCentral:4186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icatibant is antagonist of GPCR (B1 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1dc49036-d20a-11ec-8377-0242ac110003 UniProtKB:P32299 biolink:molecularly_interacts_with DrugCentral:4186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icatibant is antagonist of GPCR (B2 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.6']} DrugCentral uuid:1dc4bda4-d20a-11ec-8377-0242ac110003 UniProtKB:P97583 biolink:molecularly_interacts_with DrugCentral:4186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icatibant is antagonist of GPCR (B1 bradykinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1dc4ea5e-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1dc51718-d20a-11ec-8377-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1dc54620-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:1dc57302-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1dc59fa8-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1dc5ccf8-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1dc5f994-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1dc62658-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1dc652ea-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1dc68058-d20a-11ec-8377-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1dc6ad08-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1dc6d9cc-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1dc7079e-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1dc734e4-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1dc76176-d20a-11ec-8377-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1dc78e30-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1dc7bb44-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1dc7e7ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1dc81490-d20a-11ec-8377-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1dc8421c-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1dc86ecc-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:1dc89c80-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1dc8c91c-d20a-11ec-8377-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1dc8f91e-d20a-11ec-8377-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1dc9266e-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1dc95364-d20a-11ec-8377-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1dc9806e-d20a-11ec-8377-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1dc9ad3c-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.26']} DrugCentral uuid:1dc9db18-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1dca07d2-d20a-11ec-8377-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1dca3536-d20a-11ec-8377-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:1dca6204-d20a-11ec-8377-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1dca8f36-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1dcabdd0-d20a-11ec-8377-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1dcaee04-d20a-11ec-8377-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1dcb1e42-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1dcb4dfe-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1dcb7ab8-d20a-11ec-8377-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1dcba75e-d20a-11ec-8377-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1dcbd404-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1dcc015e-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1dcc2e18-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1dcc5af0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.13']} DrugCentral uuid:1dcc88ea-d20a-11ec-8377-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1dccb59a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:1dcce240-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1dcd0ff4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1dcd3d44-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1dcd69f4-d20a-11ec-8377-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1dcd96ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1dcdc408-d20a-11ec-8377-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1dcdf0e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1dce1d86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1dce4a40-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1dce7952-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1dcea60c-d20a-11ec-8377-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1dced2a8-d20a-11ec-8377-0242ac110003 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1dceffa8-d20a-11ec-8377-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1dcf2c62-d20a-11ec-8377-0242ac110003 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1dcf591c-d20a-11ec-8377-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1dcf85b8-d20a-11ec-8377-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1dcfb33a-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1dcfdfe0-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:1dd00cae-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:1dd03b3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1dd06942-d20a-11ec-8377-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1dd095fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1dd0c2c0-d20a-11ec-8377-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1dd0eff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1dd11cb6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1dd1495c-d20a-11ec-8377-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1dd177f6-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1dd1a49c-d20a-11ec-8377-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1dd1d14c-d20a-11ec-8377-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1dd1fe7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1dd22c1e-d20a-11ec-8377-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1dd258ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1dd2857e-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1dd2b292-d20a-11ec-8377-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1dd2df56-d20a-11ec-8377-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1dd30bf2-d20a-11ec-8377-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1dd3392e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1dd365e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1dd392b6-d20a-11ec-8377-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1dd3bf52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1dd3eeaa-d20a-11ec-8377-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1dd41de4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1dd44ab2-d20a-11ec-8377-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1dd477c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1dd4a4a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1dd4d158-d20a-11ec-8377-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1dd4fe12-d20a-11ec-8377-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1dd52b6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1dd55808-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:1dd5849a-d20a-11ec-8377-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:1dd5b2c6-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1dd5e3f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:1dd61428-d20a-11ec-8377-0242ac110003 UniProtKB:P21127 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase 11B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1dd6443e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ88 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase 11A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1dd67166-d20a-11ec-8377-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1dd69e20-d20a-11ec-8377-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1dd6cad0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1dd6f820-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TD19 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase Nek9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1dd72606-d20a-11ec-8377-0242ac110003 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1dd752c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1dd78074-d20a-11ec-8377-0242ac110003 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1dd7ad7e-d20a-11ec-8377-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1dd7da38-d20a-11ec-8377-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1dd806e8-d20a-11ec-8377-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1dd833f2-d20a-11ec-8377-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1dd860a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1dd88d7a-d20a-11ec-8377-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1dd8bb06-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.39']} DrugCentral uuid:1dd8e7c0-d20a-11ec-8377-0242ac110003 UniProtKB:P00520 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:1dd91448-d20a-11ec-8377-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1dd9410c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1dd96f6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1dd99ca6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1dd9c94c-d20a-11ec-8377-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1dd9f69c-d20a-11ec-8377-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1dda234c-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:1dda5100-d20a-11ec-8377-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1dda7db0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1ddaab0a-d20a-11ec-8377-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:1ddad7ba-d20a-11ec-8377-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1ddb0582-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1ddb33ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1ddb607c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1ddb8d36-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1ddbb9dc-d20a-11ec-8377-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1ddbe6f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1ddc13aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:1ddc4078-d20a-11ec-8377-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1ddc6df0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1ddc9aa0-d20a-11ec-8377-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1ddcc750-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1ddcf414-d20a-11ec-8377-0242ac110003 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1ddd21c8-d20a-11ec-8377-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1ddd4ebe-d20a-11ec-8377-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1ddd7bf0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1dddaae4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1dddd7b2-d20a-11ec-8377-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1dde0476-d20a-11ec-8377-0242ac110003 UniProtKB:Q62190 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1dde3112-d20a-11ec-8377-0242ac110003 UniProtKB:Q02858 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1dde5e26-d20a-11ec-8377-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1dde8c02-d20a-11ec-8377-0242ac110003 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1ddeb8bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1ddee828-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1ddf183e-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1ddf4962-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:1ddf4962-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.29']} DrugCentral uuid:1ddf831e-d20a-11ec-8377-0242ac110003 UniProtKB:O15357 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Enzyme (Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1ddfafd8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1ddfdc92-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NB16 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Mixed lineage kinase domain-like protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1de009c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4187 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizotinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1de0369c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BU89 biolink:molecularly_interacts_with DrugCentral:4188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deferiprone targets Enzyme (Deoxyhypusine hydroxylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1de063d8-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.638']} DrugCentral uuid:1de0909c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.261']} DrugCentral uuid:1de0be8c-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.573']} DrugCentral uuid:1de0eb32-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1de11800-d20a-11ec-8377-0242ac110003 UniProtKB:P04278 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets Secreted (Sex hormone-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1de14582-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.501']} DrugCentral uuid:1de17322-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.307']} DrugCentral uuid:1de19ffa-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.81']} DrugCentral uuid:1de1cdfe-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4189 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydroxyprogesterone caproate is agonist of Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.664']} DrugCentral uuid:1de1fb30-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1de227ea-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1de25490-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1de28294-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1de2b02a-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1de2dcda-d20a-11ec-8377-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1de30980-d20a-11ec-8377-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1de336d0-d20a-11ec-8377-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1de36380-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1de3903a-d20a-11ec-8377-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1de3bd94-d20a-11ec-8377-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1de3ea6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1de4188e-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:1de44570-d20a-11ec-8377-0242ac110003 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1de475cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:1de4a506-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1de4d1d4-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.44']} DrugCentral uuid:1de4ff1a-d20a-11ec-8377-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:1de52bb6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1de5587a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1de58516-d20a-11ec-8377-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1de5b2a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1de5df3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1de60bee-d20a-11ec-8377-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1de639d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1de6668e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1de6933e-d20a-11ec-8377-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1de6c052-d20a-11ec-8377-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1de6ee06-d20a-11ec-8377-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1de71b42-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1de747d4-d20a-11ec-8377-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:1de77542-d20a-11ec-8377-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:1de7a21a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1de7cee8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1de7fcba-d20a-11ec-8377-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1de82c76-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1de85926-d20a-11ec-8377-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1de885ea-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1de8b2f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1de8dfa4-d20a-11ec-8377-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1de90c54-d20a-11ec-8377-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1de939e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1de96686-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1de99340-d20a-11ec-8377-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1de9bffa-d20a-11ec-8377-0242ac110003 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1de9ef70-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1dea1c16-d20a-11ec-8377-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1dea48da-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1dea75da-d20a-11ec-8377-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1deaa294-d20a-11ec-8377-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1dead07a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1deafd34-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1deb2ac0-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1deb58ba-d20a-11ec-8377-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1deb8556-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1debb42c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1debe136-d20a-11ec-8377-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1dec0dfa-d20a-11ec-8377-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1dec3a96-d20a-11ec-8377-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1dec67e6-d20a-11ec-8377-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1dec948c-d20a-11ec-8377-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1decc150-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1deceec8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1ded1b8c-d20a-11ec-8377-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1ded4846-d20a-11ec-8377-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1ded74f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1deda458-d20a-11ec-8377-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1dedd130-d20a-11ec-8377-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1dedfdd6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1dee2af4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1dee579a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1dee84ea-d20a-11ec-8377-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1deeb262-d20a-11ec-8377-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1deedf26-d20a-11ec-8377-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.17']} DrugCentral uuid:1def0bd6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1def38b8-d20a-11ec-8377-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1def67fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1def9722-d20a-11ec-8377-0242ac110003 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1defc4d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1deff1fe-d20a-11ec-8377-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1df01ea4-d20a-11ec-8377-0242ac110003 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1df04b4a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1df07822-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1df0a5ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1df0d268-d20a-11ec-8377-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1df0ff36-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1df12d12-d20a-11ec-8377-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1df15b02-d20a-11ec-8377-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1df187b2-d20a-11ec-8377-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1df1b46c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:1df1e176-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1df20e30-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1df23ad6-d20a-11ec-8377-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1df2683a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:1df294f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1df2c1a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1df2ee5e-d20a-11ec-8377-0242ac110003 UniProtKB:O95747 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase OSR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1df31ee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1df34bb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1df3787e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1df3a59c-d20a-11ec-8377-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1df3d26a-d20a-11ec-8377-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1df40014-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1df42cc4-d20a-11ec-8377-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1df45a0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1df486a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1df4b356-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1df4e27c-d20a-11ec-8377-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1df5129c-d20a-11ec-8377-0242ac110003 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1df5410e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1df56e36-d20a-11ec-8377-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1df59afa-d20a-11ec-8377-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1df5c854-d20a-11ec-8377-0242ac110003 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1df5f504-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1df62272-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1df64f22-d20a-11ec-8377-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1df67bbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1df6a954-d20a-11ec-8377-0242ac110003 UniProtKB:P51956 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase Nek3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1df6d5e6-d20a-11ec-8377-0242ac110003 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1df702a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q86Y07 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase VRK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1df72f32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1df75c78-d20a-11ec-8377-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1df7891e-d20a-11ec-8377-0242ac110003 UniProtKB:Q62120 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.73']} DrugCentral uuid:1df7b5c4-d20a-11ec-8377-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1df7e72e-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1df7e72e-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1df82630-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1df82630-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1df86532-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:1df86532-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:1df8a952-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:1df8a952-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:1df8a952-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:1df8f45c-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1df8f45c-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1df92e90-d20a-11ec-8377-0242ac110003 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1df95b4a-d20a-11ec-8377-0242ac110003 UniProtKB:P55055 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Nuclear other (Oxysterols receptor LXR-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1df9880e-d20a-11ec-8377-0242ac110003 UniProtKB:Q62120 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.73']} DrugCentral uuid:1df9b522-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4190 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ruxolitinib targets Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1df9e1d2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fesoterodine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.393']} DrugCentral uuid:1dfa0eb4-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fesoterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.401']} DrugCentral uuid:1dfa3b8c-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fesoterodine is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.271']} DrugCentral uuid:1dfa6abc-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fesoterodine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.187']} DrugCentral uuid:1dfa9780-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4191 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fesoterodine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.979']} DrugCentral uuid:1dfac44e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:4192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tafamidis is inhibitor of Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.936']} DrugCentral uuid:1dfaf1da-d20a-11ec-8377-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:4192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tafamidis is inhibitor of Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.538']} DrugCentral uuid:1dfb1e8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:4192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tafamidis is inhibitor of Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.627']} DrugCentral uuid:1dfb4b6c-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:4192 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tafamidis is binding agent of Secreted (Transthyretin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.812']} DrugCentral uuid:1dfb77fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q99707 biolink:molecularly_interacts_with DrugCentral:4196 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyanocobalamin targets Enzyme (Methionine synthase) DrugCentral uuid:1dfba080-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBK8 biolink:molecularly_interacts_with DrugCentral:4196 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyanocobalamin targets Enzyme (Methionine synthase reductase) DrugCentral uuid:1dfbc88a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BXJ7 biolink:molecularly_interacts_with DrugCentral:4196 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyanocobalamin targets Unclassified (Protein amnionless) DrugCentral uuid:1dfbf0b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q96EY8 biolink:molecularly_interacts_with DrugCentral:4196 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyanocobalamin targets Enzyme (Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial) DrugCentral uuid:1dfc18bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IVH4 biolink:molecularly_interacts_with DrugCentral:4196 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyanocobalamin targets Enzyme (Methylmalonic aciduria type A protein, mitochondrial) DrugCentral uuid:1dfc4378-d20a-11ec-8377-0242ac110003 UniProtKB:P20062 biolink:molecularly_interacts_with DrugCentral:4196 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyanocobalamin targets Secreted (Transcobalamin-2) DrugCentral uuid:1dfc6b8c-d20a-11ec-8377-0242ac110003 UniProtKB:P20061 biolink:molecularly_interacts_with DrugCentral:4196 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cyanocobalamin targets Secreted (Transcobalamin-1) DrugCentral uuid:1dfc93be-d20a-11ec-8377-0242ac110003 UniProtKB:P02753 biolink:molecularly_interacts_with DrugCentral:4197 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vitamin A palmitate targets Secreted (Retinol-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1dfcc136-d20a-11ec-8377-0242ac110003 UniProtKB:P02754 biolink:molecularly_interacts_with DrugCentral:4197 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vitamin A palmitate targets Unclassified (Beta-lactoglobulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:1dfcee04-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4199 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 potassium chloride targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1dfd1ad2-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium acetate targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.97']} DrugCentral uuid:1dfd4778-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium acetate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.44']} DrugCentral uuid:1dfd791e-d20a-11ec-8377-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lithium carbonate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:1dfd791e-d20a-11ec-8377-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lithium carbonate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:1dfdadbc-d20a-11ec-8377-0242ac110003 UniProtKB:P29218 biolink:molecularly_interacts_with DrugCentral:4207 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lithium carbonate is inhibitor of Enzyme (Inositol-1(or 4)-monophosphatase 1) DrugCentral uuid:1dfdd5da-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1dfe04b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1dfe3516-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.73']} DrugCentral uuid:1dfe63e2-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.582']} DrugCentral uuid:1dfe91aa-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin is inverse agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:1dfebe5a-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1dfeeb0a-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.48']} DrugCentral uuid:1dff17c4-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:1dff44f6-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:1dff719c-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1dff9e60-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin is inverse agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1dffcc82-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin is inverse agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.68']} DrugCentral uuid:1dfff964-d20a-11ec-8377-0242ac110003 UniProtKB:P16083 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Enzyme (Ribosyldihydronicotinamide dehydrogenase [quinone]) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:1e002600-d20a-11ec-8377-0242ac110003 UniProtKB:P14780 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Enzyme (Matrix metalloproteinase-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.157']} DrugCentral uuid:1e0052b0-d20a-11ec-8377-0242ac110003 UniProtKB:P03956 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Enzyme (Interstitial collagenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.394']} DrugCentral uuid:1e008014-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1e00adaa-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10']} DrugCentral uuid:1e00da8c-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:1e0107d2-d20a-11ec-8377-0242ac110003 UniProtKB:P23944 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1e0134a0-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1e016146-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1e018dec-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.63']} DrugCentral uuid:1e01bdbc-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1e01ea80-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.78']} DrugCentral uuid:1e021730-d20a-11ec-8377-0242ac110003 UniProtKB:P18130 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:1e0244a8-d20a-11ec-8377-0242ac110003 UniProtKB:P18871 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1e0271f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q28838 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:1e029ed0-d20a-11ec-8377-0242ac110003 UniProtKB:P18841 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:1e02cb94-d20a-11ec-8377-0242ac110003 UniProtKB:O15244 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Transporter (Solute carrier family 22 member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.87']} DrugCentral uuid:1e02f89e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96FL8 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Transporter (Multidrug and toxin extrusion protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1e03253a-d20a-11ec-8377-0242ac110003 UniProtKB:Q86VL8 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Transporter (Multidrug and toxin extrusion protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:1e035a82-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1e035a82-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1e035a82-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1e03ac80-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.99']} DrugCentral uuid:1e03ac80-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.99']} DrugCentral uuid:1e03ac80-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.99']} DrugCentral uuid:1e03fc62-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1e03fc62-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1e03fc62-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1e044b54-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:1e044b54-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:1e044b54-d20a-11ec-8377-0242ac110003 UniProtKB:P30994 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Serotonin 2 (5-HT2) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:1e049b2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1e049b2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1e049b2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01338 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets GPCR (Alpha-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1e04e136-d20a-11ec-8377-0242ac110003 UniProtKB:P02665 biolink:molecularly_interacts_with DrugCentral:4209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prazosin targets Unclassified (Beta-casein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:1e050dbe-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetic acid targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1e053a78-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetic acid targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1e056ad4-d20a-11ec-8377-0242ac110003 UniProtKB:O15552 biolink:molecularly_interacts_with DrugCentral:4211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetic acid is agonist of GPCR (Free fatty acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1e059ad6-d20a-11ec-8377-0242ac110003 UniProtKB:O14843 biolink:molecularly_interacts_with DrugCentral:4211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acetic acid targets GPCR (Free fatty acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1e05cb00-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4213 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1e05f45e-d20a-11ec-8377-0242ac110003 UniProtKB:P08185 biolink:molecularly_interacts_with DrugCentral:4213 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone acetate targets Secreted (Corticosteroid-binding globulin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:1e0629ce-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopate is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:1e0629ce-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopate is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:1e0629ce-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methyldopate is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:1e0667b8-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4219 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium phosphate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1e069526-d20a-11ec-8377-0242ac110003 UniProtKB:Q03732 biolink:molecularly_interacts_with DrugCentral:4220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telbivudine targets Unclassified (Capsid protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1e06c1f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9IF40 biolink:molecularly_interacts_with DrugCentral:4220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telbivudine is inhibitor of Polyprotein (Protein P) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.886']} DrugCentral uuid:1e06eeae-d20a-11ec-8377-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4221 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mequinol is inhibitor of Enzyme (Tyrosinase) DrugCentral uuid:1e0716d6-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1e07448a-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1e07714e-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1e079e3a-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1e07cb94-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1e07f84e-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone is agonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1e0824f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13639 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone is agonist of GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1e0851f4-d20a-11ec-8377-0242ac110003 UniProtKB:P28564 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1e087fda-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1e08ac8a-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1e08d926-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1e0908d8-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1e0938b2-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1e096580-d20a-11ec-8377-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.67']} DrugCentral uuid:1e09941a-d20a-11ec-8377-0242ac110003 UniProtKB:P08909 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1e09c0c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q62758 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1e09ed5c-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1e0a1a02-d20a-11ec-8377-0242ac110003 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1e0a4716-d20a-11ec-8377-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1e0a73bc-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1e0aa4e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1e0aa4e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JJ16 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets Ion channel (Serotonin 3 (5-HT3) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1e0aea0e-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1e0aea0e-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1e0aea0e-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1e0b3860-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1e0b3860-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1e0b3860-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1e0b7f1e-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilazodone targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1e0babe2-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1e0bd8a6-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:1e0c05ba-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1e0c3288-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.31']} DrugCentral uuid:1e0c6032-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1e0c8cc4-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1e0cbd20-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1e0cea5c-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1e0d170c-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1e0d4470-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1e0d712a-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.23']} DrugCentral uuid:1e0d9dee-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1e0dcaa8-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1e0df7e4-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.29']} DrugCentral uuid:1e0e2494-d20a-11ec-8377-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1e0e5144-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1e0e802e-d20a-11ec-8377-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1e0eafb8-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1e0edc72-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1e0f09b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1e0f3672-d20a-11ec-8377-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1e0f6322-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1e0f9126-d20a-11ec-8377-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1e0fbe58-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1e0feb1c-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1e1017f4-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1e1045ee-d20a-11ec-8377-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:1e1075c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1e10a2f0-d20a-11ec-8377-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1e10d090-d20a-11ec-8377-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1e10fdd6-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1e112a7c-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1e115740-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1e118440-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1e11b0e6-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1e11dd96-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1e120a50-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1e12389a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.25']} DrugCentral uuid:1e126536-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1e129204-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:1e12bf5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1e12ec18-d20a-11ec-8377-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1e1318c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1e13456e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1e1372aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1e139f3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1e13cbec-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1e13fa40-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1e142718-d20a-11ec-8377-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1e145396-d20a-11ec-8377-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1e148046-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1e14adaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1e14da50-d20a-11ec-8377-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1e1506f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1e15350e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1e1561aa-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1e158e64-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1e15bb14-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1e15e8aa-d20a-11ec-8377-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:1e16153c-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1e16437c-d20a-11ec-8377-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1e1670f4-d20a-11ec-8377-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1e169db8-d20a-11ec-8377-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1e16ca72-d20a-11ec-8377-0242ac110003 UniProtKB:Q13705 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Activin receptor type-2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1e16f740-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1e172440-d20a-11ec-8377-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1e1750d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1e177d78-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1e17ab5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1e17d7f0-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1e18048c-d20a-11ec-8377-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1e183272-d20a-11ec-8377-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1e185f36-d20a-11ec-8377-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1e188bf0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5S2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase MRCK beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1e18b882-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NEV4 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Myosin-IIIa) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1e18e5aa-d20a-11ec-8377-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1e191246-d20a-11ec-8377-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1e193f00-d20a-11ec-8377-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1e196cdc-d20a-11ec-8377-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1e199e28-d20a-11ec-8377-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1e19ce66-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1e19fbca-d20a-11ec-8377-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1e1a2924-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1e1a55ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1e1a8266-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1e1aaf70-d20a-11ec-8377-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1e1adc16-d20a-11ec-8377-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1e1b08c6-d20a-11ec-8377-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1e1b3562-d20a-11ec-8377-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1e1b65d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1e1b94c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:1e1bc180-d20a-11ec-8377-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1e1beef8-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1e1c1ba8-d20a-11ec-8377-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1e1c4844-d20a-11ec-8377-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1e1c74f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1e1ca1fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1e1cceae-d20a-11ec-8377-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1e1cfc94-d20a-11ec-8377-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4225 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 axitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1e1d2a98-d20a-11ec-8377-0242ac110003 UniProtKB:P05129 biolink:molecularly_interacts_with DrugCentral:4226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ingenol mebutate is activator of Kinase (Protein kinase C gamma type) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.79']} DrugCentral uuid:1e1d5748-d20a-11ec-8377-0242ac110003 UniProtKB:P05771 biolink:molecularly_interacts_with DrugCentral:4226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ingenol mebutate targets Kinase (Protein kinase C beta type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.836']} DrugCentral uuid:1e1d8402-d20a-11ec-8377-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:4226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ingenol mebutate targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.197']} DrugCentral uuid:1e1db116-d20a-11ec-8377-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:4226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ingenol mebutate targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.959']} DrugCentral uuid:1e1dddd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:4226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ingenol mebutate targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.523']} DrugCentral uuid:1e1e0b84-d20a-11ec-8377-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:4226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ingenol mebutate is activator of Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.328']} DrugCentral uuid:1e1e3802-d20a-11ec-8377-0242ac110003 UniProtKB:Q62226 biolink:molecularly_interacts_with DrugCentral:4227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vismodegib targets Enzyme (Sonic hedgehog protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1e1e652a-d20a-11ec-8377-0242ac110003 UniProtKB:Q15465 biolink:molecularly_interacts_with DrugCentral:4227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vismodegib targets Enzyme (Sonic hedgehog protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1e1e91ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:4227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vismodegib is inhibitor of GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.79']} DrugCentral uuid:1e1ebea8-d20a-11ec-8377-0242ac110003 UniProtKB:P56726 biolink:molecularly_interacts_with DrugCentral:4227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vismodegib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1e1eed88-d20a-11ec-8377-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:4228 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivacaftor is positive modulator of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1e1f1ca4-d20a-11ec-8377-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:4229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tafluprost is agonist of GPCR (Prostaglandin F2-alpha receptor) DrugCentral uuid:1e1f44e0-d20a-11ec-8377-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:4234 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peginesatide is agonist of Membrane receptor (Erythropoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.43']} DrugCentral uuid:1e1f719a-d20a-11ec-8377-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avobenzone is inhibitor of Enzyme (Tyrosinase) DrugCentral uuid:1e1f9a26-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:4247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neomycin targets Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1e1fc6d6-d20a-11ec-8377-0242ac110003 UniProtKB:P15917 biolink:molecularly_interacts_with DrugCentral:4247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neomycin targets Enzyme (Lethal factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1e1ff39a-d20a-11ec-8377-0242ac110003 UniProtKB:O95237 biolink:molecularly_interacts_with DrugCentral:4247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neomycin targets Enzyme (Lecithin retinol acyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.83']} DrugCentral uuid:1e202086-d20a-11ec-8377-0242ac110003 UniProtKB:O00255 biolink:molecularly_interacts_with DrugCentral:4247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neomycin targets Unclassified (Menin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.81']} DrugCentral uuid:1e204d36-d20a-11ec-8377-0242ac110003 UniProtKB:P48442 biolink:molecularly_interacts_with DrugCentral:4247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neomycin is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4']} DrugCentral uuid:1e2079f0-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1e20a6a0-d20a-11ec-8377-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1e20d63e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.76']} DrugCentral uuid:1e2106c2-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1e2135f2-d20a-11ec-8377-0242ac110003 UniProtKB:P51787 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1e2162f2-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1e218fd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.45']} DrugCentral uuid:1e21bc84-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1e21e92a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1e221652-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.79']} DrugCentral uuid:1e2242f8-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1e2270d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1e229f6e-d20a-11ec-8377-0242ac110003 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc is activator of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1e22cc46-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:4248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pyrithione zinc targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1e22fd74-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:4257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bismuth subsalicylate is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:1e22fd74-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:4257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bismuth subsalicylate is inhibitor of Enzyme (Cyclooxygenase) DrugCentral uuid:1e23312c-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thymol targets Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1e235f26-d20a-11ec-8377-0242ac110003 UniProtKB:Q8R455 biolink:molecularly_interacts_with DrugCentral:4258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thymol targets Ion channel (Transient receptor potential cation channel subfamily M member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1e238bd6-d20a-11ec-8377-0242ac110003 UniProtKB:Q4QYD9 biolink:molecularly_interacts_with DrugCentral:4258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thymol targets Unclassified (Heat sensitive channel TRPV3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1e23b87c-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfur targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1e23e5a4-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfur targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1e241272-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H255 biolink:molecularly_interacts_with DrugCentral:4264 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carbamide targets GPCR (Olfactory receptor 51E2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1e243efa-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentamicin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:1e246d1c-d20a-11ec-8377-0242ac110003 UniProtKB:P00376 biolink:molecularly_interacts_with DrugCentral:4265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentamicin targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1e249d0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BLA8 biolink:molecularly_interacts_with DrugCentral:4265 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gentamicin is gating inhibitor of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1e24c9d8-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1e24f714-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1e25243c-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1e255114-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1e257dce-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1e25aaec-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1e25d79c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.94']} DrugCentral uuid:1e26044c-d20a-11ec-8377-0242ac110003 UniProtKB:P00720 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Endolysin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1e2630f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.98']} DrugCentral uuid:1e265f64-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.76']} DrugCentral uuid:1e268c5a-d20a-11ec-8377-0242ac110003 UniProtKB:P96878 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1e26b914-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.59']} DrugCentral uuid:1e27087e-d20a-11ec-8377-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.86']} DrugCentral uuid:1e273c9a-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPJ7 biolink:molecularly_interacts_with DrugCentral:4266 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenol targets Enzyme (Beta-carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.19']} DrugCentral uuid:1e27694a-d20a-11ec-8377-0242ac110003 UniProtKB:P14679 biolink:molecularly_interacts_with DrugCentral:4267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arbutin targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1e27969a-d20a-11ec-8377-0242ac110003 UniProtKB:O42713 biolink:molecularly_interacts_with DrugCentral:4267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arbutin targets Enzyme (Polyphenol oxidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1e27c336-d20a-11ec-8377-0242ac110003 UniProtKB:P11344 biolink:molecularly_interacts_with DrugCentral:4267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arbutin targets Enzyme (Tyrosinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1e27f04a-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e28af80-d20a-11ec-8377-0242ac110003 UniProtKB:E0W4F7 biolink:molecularly_interacts_with DrugCentral:4276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piperonyl butoxide is inhibitor of Enzyme (Cytochrome P450) DrugCentral uuid:1e2a5114-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tapentadol is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.018']} DrugCentral uuid:1e2a7dec-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tapentadol is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.319']} DrugCentral uuid:1e2aab3c-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tapentadol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1e2ad7f6-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tapentadol targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1e2b0488-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:4285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 Florbetapir F-18 targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.54']} DrugCentral uuid:1e2b31ba-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:1e2b5e92-d20a-11ec-8377-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent targets Nuclear hormone receptor (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1e2b8b6a-d20a-11ec-8377-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent is agonist of GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1e2bb7f2-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1e2be57e-d20a-11ec-8377-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1e2c1242-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDS5 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent targets GPCR (Oxoeicosanoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1e2c3f10-d20a-11ec-8377-0242ac110003 UniProtKB:Q6RI86 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1e2c6d32-d20a-11ec-8377-0242ac110003 UniProtKB:P19793 biolink:molecularly_interacts_with DrugCentral:4289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doconexent targets Nuclear other (Retinoic acid receptor RXR-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1e2c9b2c-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4296 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 potassium iodide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1e2cc7e6-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:4298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apixaban targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1e2cf518-d20a-11ec-8377-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:4298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apixaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:1e2d21f0-d20a-11ec-8377-0242ac110003 UniProtKB:O19045 biolink:molecularly_interacts_with DrugCentral:4298 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apixaban targets Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:1e2d5bc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:1e2d5bc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:1e2d5bc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:1e2d5bc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HB55 biolink:molecularly_interacts_with DrugCentral:4299 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cobicistat is inhibitor of Enzyme (Cytochrome P450 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.027']} DrugCentral uuid:1e2db39a-d20a-11ec-8377-0242ac110003 UniProtKB:P03367 biolink:molecularly_interacts_with DrugCentral:4300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elvitegravir targets Polyprotein (Gag-Pol polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1e2de086-d20a-11ec-8377-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:4300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elvitegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:1e2e0d5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:4300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elvitegravir targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1e2e3a9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:4300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elvitegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:1e2e675e-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:4301 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 Flutemetamol (18F) targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:1e2e942c-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.69']} DrugCentral uuid:1e2ec118-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.25']} DrugCentral uuid:1e2eee72-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:1e2f1b5e-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:1e2f4854-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glycopyrronium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.91']} DrugCentral uuid:1e2f9cb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1e2f9cb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1e2f9cb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1e2f9cb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1e2f9cb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1e2f9cb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1e2f9cb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1e2f9cb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1e2f9cb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1e2f9cb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y9 biolink:molecularly_interacts_with DrugCentral:4303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eslicarbazepine acetate is blocker of Ion channel (Sodium channel alpha subunit) DrugCentral uuid:1e3027ec-d20a-11ec-8377-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4304 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1e3054ce-d20a-11ec-8377-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4304 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapagliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:1e30817e-d20a-11ec-8377-0242ac110003 UniProtKB:P53792 biolink:molecularly_interacts_with DrugCentral:4304 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapagliflozin targets Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1e30aea6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WWX8 biolink:molecularly_interacts_with DrugCentral:4304 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapagliflozin targets Transporter (Sodium/myo-inositol cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1e30dc3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY91 biolink:molecularly_interacts_with DrugCentral:4304 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapagliflozin targets Transporter (Low affinity sodium-glucose cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.87']} DrugCentral uuid:1e31091e-d20a-11ec-8377-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:4305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avanafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.284']} DrugCentral uuid:1e3135ce-d20a-11ec-8377-0242ac110003 UniProtKB:P51160 biolink:molecularly_interacts_with DrugCentral:4305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avanafil targets Enzyme (Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.201']} DrugCentral uuid:1e316332-d20a-11ec-8377-0242ac110003 UniProtKB:O77746 biolink:molecularly_interacts_with DrugCentral:4305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avanafil targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:1e31942e-d20a-11ec-8377-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:4308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lasofoxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:1e31942e-d20a-11ec-8377-0242ac110003 UniProtKB:Q62986 biolink:molecularly_interacts_with DrugCentral:4308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lasofoxifene targets Transcription factor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:1e31ceee-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lasofoxifene is agonist of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1e31fc8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lasofoxifene is agonist of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:1e322a06-d20a-11ec-8377-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide is blocker of Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1e3256c0-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1e328406-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1e32b0ca-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1e32dd84-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.45']} DrugCentral uuid:1e330a48-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1e333aea-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1e33679a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1e33947c-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1e33c1ea-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1e33eec2-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1e341b86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1e3448cc-d20a-11ec-8377-0242ac110003 UniProtKB:P04775 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide is blocker of Ion channel (Sodium channel protein type 2 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1e34755e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1e34a222-d20a-11ec-8377-0242ac110003 UniProtKB:Q99N23 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Carbonic anhydrase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1e34cef0-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Ion channel (Sodium channel protein type 3 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1e34fda8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16555 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Enzyme (Dihydropyrimidinase-related protein 2) DrugCentral uuid:1e3526de-d20a-11ec-8377-0242ac110003 UniProtKB:Q62968 biolink:molecularly_interacts_with DrugCentral:4310 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lacosamide targets Ion channel (Sodium channel protein type X alpha subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1e355398-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1e3580fc-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1e35ad98-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1e35da3e-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1e3606e4-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine is agonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1e363402-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1e3671ba-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1e3671ba-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1e3671ba-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1e3671ba-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1e3671ba-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aceclidine targets GPCR (Muscarinic acetylcholine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1e36d3bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:4317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 euflavine targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1e370382-d20a-11ec-8377-0242ac110003 UniProtKB:O40947 biolink:molecularly_interacts_with DrugCentral:4317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 euflavine targets Unclassified (ORF 73) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1e373028-d20a-11ec-8377-0242ac110003 UniProtKB:Q16665 biolink:molecularly_interacts_with DrugCentral:4317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 euflavine targets Transcription factor (Hypoxia-inducible factor 1-alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1e375d6e-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1e378a32-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:1e37b84a-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1e37e4fa-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1e381240-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1e383f2c-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1e386bc8-d20a-11ec-8377-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1e389a4e-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1e38c71c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1e38f3b8-d20a-11ec-8377-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1e392162-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1e394f34-d20a-11ec-8377-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1e397be4-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1e39a8a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1e39d616-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1e3a02d0-d20a-11ec-8377-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1e3a2f8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1e3a5c44-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1e3a89f8-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1e3ab6b2-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1e3ae36c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1e3b10da-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1e3b3d8a-d20a-11ec-8377-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1e3b6a76-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1e3b97b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1e3bc494-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1e3bf14e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1e3c1e08-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1e3c4c84-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1e3c7934-d20a-11ec-8377-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1e3ca5d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1e3cd2f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q92630 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1e3cffa8-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1e3d2c62-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1e3d5912-d20a-11ec-8377-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1e3d878e-d20a-11ec-8377-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1e3db434-d20a-11ec-8377-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1e3de0e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4318 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afatinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1e3e0ef2-d20a-11ec-8377-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:4322 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azilsartan medoxomil is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:1e3e3b8e-d20a-11ec-8377-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:4322 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 azilsartan medoxomil targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1e3e6992-d20a-11ec-8377-0242ac110003 UniProtKB:P34995 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant targets GPCR (Prostaglandin E2 receptor EP1 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:1e3e962e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5Y4 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant targets GPCR (Prostaglandin D2 receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.13']} DrugCentral uuid:1e3ec36a-d20a-11ec-8377-0242ac110003 UniProtKB:P43115 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant targets GPCR (Prostaglandin E2 receptor EP3 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1e3ef02e-d20a-11ec-8377-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant targets GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:1e3f1d06-d20a-11ec-8377-0242ac110003 UniProtKB:P21731 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant targets GPCR (Thromboxane A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.53']} DrugCentral uuid:1e3f4a92-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant targets GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:1e3f7756-d20a-11ec-8377-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1e3fa42e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:4326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laropiprant is antagonist of GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.52']} DrugCentral uuid:1e3fd124-d20a-11ec-8377-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:4329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1e40016c-d20a-11ec-8377-0242ac110003 UniProtKB:P32745 biolink:molecularly_interacts_with DrugCentral:4329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1e403092-d20a-11ec-8377-0242ac110003 UniProtKB:P35346 biolink:molecularly_interacts_with DrugCentral:4329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.8']} DrugCentral uuid:1e405d38-d20a-11ec-8377-0242ac110003 UniProtKB:P30872 biolink:molecularly_interacts_with DrugCentral:4329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1e408a56-d20a-11ec-8377-0242ac110003 UniProtKB:P30680 biolink:molecularly_interacts_with DrugCentral:4329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pasireotide is agonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.07']} DrugCentral uuid:1e40b7ba-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4334 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bazedoxifene is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1e40e49c-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4334 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bazedoxifene is modulator of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e41b9a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQ05 biolink:molecularly_interacts_with DrugCentral:4336 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 amifampridine is blocker of Ion channel (Voltage-gated potassium channel) DrugCentral uuid:1e439548-d20a-11ec-8377-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:4337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambrisentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.98']} DrugCentral uuid:1e43c496-d20a-11ec-8377-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ambrisentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.65']} DrugCentral uuid:1e43f18c-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4340 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alogliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1e441e64-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:4342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zucapsaicin is opener of Ion channel (Transient receptor potential cation channel subfamily V member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.71']} DrugCentral uuid:1e444b82-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.158']} DrugCentral uuid:1e447846-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.936']} DrugCentral uuid:1e44a500-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1e44d232-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.726']} DrugCentral uuid:1e44feec-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.363']} DrugCentral uuid:1e452bc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q08209 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets Enzyme (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.958']} DrugCentral uuid:1e45587e-d20a-11ec-8377-0242ac110003 UniProtKB:O43194 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets GPCR (G-protein coupled receptor 39) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.44']} DrugCentral uuid:1e4585d8-d20a-11ec-8377-0242ac110003 UniProtKB:A6QR73 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets GPCR (G protein-coupled receptor 39-1b) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1e45b26a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPD8 biolink:molecularly_interacts_with DrugCentral:4344 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zinc chloride targets Unclassified (Ubiquitin-conjugating enzyme E2 T) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1e45df06-d20a-11ec-8377-0242ac110003 UniProtKB:P62593 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin targets Enzyme (Beta-lactamase TEM) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1e4625d8-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1e4625d8-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1e4625d8-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1e4625d8-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1e4625d8-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1e4625d8-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1e4625d8-d20a-11ec-8377-0242ac110003 UniProtKB:P24228 biolink:molecularly_interacts_with DrugCentral:4347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzathine benzylpenicillin is inhibitor of Enzyme (Bacterial penicillin-binding protein) DrugCentral uuid:1e469068-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aurothioglucose targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.5']} DrugCentral uuid:1e46bdb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:4349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aurothioglucose targets Enzyme (Thioredoxin reductase 1, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.398']} DrugCentral uuid:1e46ea5e-d20a-11ec-8377-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:4349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aurothioglucose targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.85']} DrugCentral uuid:1e4717ea-d20a-11ec-8377-0242ac110003 UniProtKB:O95264 biolink:molecularly_interacts_with DrugCentral:4349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aurothioglucose targets Ion channel (5-hydroxytryptamine receptor 3B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.85']} DrugCentral uuid:1e47467a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6N5 biolink:molecularly_interacts_with DrugCentral:4349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aurothioglucose targets Unclassified (Sulfide:quinone oxidoreductase, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1e477320-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bilastine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.194']} DrugCentral uuid:1e479fd0-d20a-11ec-8377-0242ac110003 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:4357 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anidulafungin is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:1e47cca8-d20a-11ec-8377-0242ac110003 UniProtKB:P35228 biolink:molecularly_interacts_with DrugCentral:4358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arginine glutamate targets Enzyme (Nitric oxide synthase, inducible) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1e47f944-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1e4825d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1e4852ea-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1e488058-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.54']} DrugCentral uuid:1e48acf4-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1e48d990-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1e49073a-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:1e4933fe-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.23']} DrugCentral uuid:1e4960a4-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1e498d40-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1e49ba2c-d20a-11ec-8377-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1e49e6be-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1e4a1350-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1e4a40b4-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1e4a6d5a-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1e4a99ec-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1e4ac67e-d20a-11ec-8377-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1e4af4c8-d20a-11ec-8377-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1e4b216e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:1e4b4e1e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:1e4b7c2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1e4ba8dc-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib is inhibitor of Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.47']} DrugCentral uuid:1e4bd56e-d20a-11ec-8377-0242ac110003 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1e4c0200-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1e4c2f46-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1e4c5be2-d20a-11ec-8377-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1e4c8888-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1e4cb664-d20a-11ec-8377-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1e4ce436-d20a-11ec-8377-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1e4d1118-d20a-11ec-8377-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:1e4d3da0-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1e4d6ac8-d20a-11ec-8377-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1e4d975a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1e4dc414-d20a-11ec-8377-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1e4df15a-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1e4e1e28-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.38']} DrugCentral uuid:1e4e4ace-d20a-11ec-8377-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1e4e7788-d20a-11ec-8377-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1e4ea79e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1e4ed4c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1e4f0158-d20a-11ec-8377-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1e4f2e62-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1e4f5afe-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1e4f8844-d20a-11ec-8377-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1e4fb4e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1e4fe352-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1e500ff8-d20a-11ec-8377-0242ac110003 UniProtKB:P54756 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:1e503c9e-d20a-11ec-8377-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1e506a5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1e5096e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1e50c376-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1e50f044-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1e511d4e-d20a-11ec-8377-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1e5149f4-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1e517672-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1e51a3cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1e51d054-d20a-11ec-8377-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1e51fd04-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1e5229aa-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1e52574a-d20a-11ec-8377-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1e5283dc-d20a-11ec-8377-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1e52b082-d20a-11ec-8377-0242ac110003 UniProtKB:P49761 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1e52ddaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1e530a64-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1e5336f6-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1e53657c-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1e539240-d20a-11ec-8377-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1e53bedc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1e53eb78-d20a-11ec-8377-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1e541abc-d20a-11ec-8377-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1e544870-d20a-11ec-8377-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1e54750c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.33']} DrugCentral uuid:1e54a23e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1e54cef8-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1e54fb80-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1e55281c-d20a-11ec-8377-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.04']} DrugCentral uuid:1e55556c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1e558208-d20a-11ec-8377-0242ac110003 UniProtKB:Q96Q40 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1e55aeb8-d20a-11ec-8377-0242ac110003 UniProtKB:O14733 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1e55dc8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1e560912-d20a-11ec-8377-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:1e5635d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1e56625e-d20a-11ec-8377-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1e568f86-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1e56bc0e-d20a-11ec-8377-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1e56e8aa-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:1e571686-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1e574354-d20a-11ec-8377-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:1e576ffa-d20a-11ec-8377-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.08']} DrugCentral uuid:1e579c96-d20a-11ec-8377-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1e57cc8e-d20a-11ec-8377-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1e57fcd6-d20a-11ec-8377-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1e582d0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1e585a50-d20a-11ec-8377-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1e5886f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1e58b4be-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1e58e13c-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1e590e64-d20a-11ec-8377-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1e593af6-d20a-11ec-8377-0242ac110003 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1e5967ba-d20a-11ec-8377-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1e59964a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1e59c2fa-d20a-11ec-8377-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1e59ef78-d20a-11ec-8377-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1e5a1dd6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1e5a4a68-d20a-11ec-8377-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1e5a770e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1e5aa3b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N752 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Casein kinase I isoform alpha-like) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1e5ad0fa-d20a-11ec-8377-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1e5afd96-d20a-11ec-8377-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1e5b2a32-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1e5b57dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q86UE8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase tousled-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1e5b8482-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1e5bb128-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1e5bddec-d20a-11ec-8377-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:1e5c0aec-d20a-11ec-8377-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1e5c37a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:1e5c6424-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBE8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase NLK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1e5c91a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1e5cbe60-d20a-11ec-8377-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1e5ceb06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1e5d1888-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:1e5d4826-d20a-11ec-8377-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1e5d786e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1e5da8ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1e5dd7e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:1e5e0482-d20a-11ec-8377-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1e5e3128-d20a-11ec-8377-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1e5e5dd8-d20a-11ec-8377-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1e5e8b3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q99640 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1e5eb882-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.29']} DrugCentral uuid:1e5ee514-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.48']} DrugCentral uuid:1e5f1426-d20a-11ec-8377-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1e5f4360-d20a-11ec-8377-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.09']} DrugCentral uuid:1e5f7010-d20a-11ec-8377-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1e5f9d1a-d20a-11ec-8377-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1e5fc9ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1e5ff666-d20a-11ec-8377-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1e60232a-d20a-11ec-8377-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1e60508e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1e607d2a-d20a-11ec-8377-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1e60a9c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NEV4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Myosin-IIIa) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1e60d90a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1e610948-d20a-11ec-8377-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1e613918-d20a-11ec-8377-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1e6165aa-d20a-11ec-8377-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1e6193d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1e61c07c-d20a-11ec-8377-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1e61ed0e-d20a-11ec-8377-0242ac110003 UniProtKB:P54753 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1e621a40-d20a-11ec-8377-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1e6246f0-d20a-11ec-8377-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1e62738c-d20a-11ec-8377-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1e62a00a-d20a-11ec-8377-0242ac110003 UniProtKB:P48729 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Casein kinase I isoform alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1e62d08e-d20a-11ec-8377-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.51']} DrugCentral uuid:1e6300d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.49']} DrugCentral uuid:1e632da4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1e635acc-d20a-11ec-8377-0242ac110003 UniProtKB:P16277 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:1e638754-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1e63b418-d20a-11ec-8377-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1e63e172-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1e640e18-d20a-11ec-8377-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1e643ab4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1e64675a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1e64969e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1e64c3bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1e64f062-d20a-11ec-8377-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1e651d62-d20a-11ec-8377-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1e654a08-d20a-11ec-8377-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.32']} DrugCentral uuid:1e65769a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1e65a340-d20a-11ec-8377-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.27']} DrugCentral uuid:1e65d072-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1e65fe12-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1e662aa4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1e6658ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1e668594-d20a-11ec-8377-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1e66b23a-d20a-11ec-8377-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1e66dee0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1e670bf4-d20a-11ec-8377-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1e673886-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1e676522-d20a-11ec-8377-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1e6793da-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1e67c08a-d20a-11ec-8377-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1e67ed3a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1e6819ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1e684a14-d20a-11ec-8377-0242ac110003 UniProtKB:P42679 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Megakaryocyte-associated tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1e687a16-d20a-11ec-8377-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.11']} DrugCentral uuid:1e68aa04-d20a-11ec-8377-0242ac110003 UniProtKB:Q13233 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1e68d8c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1e690562-d20a-11ec-8377-0242ac110003 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:1e693212-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WU08 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase 32A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1e695f6c-d20a-11ec-8377-0242ac110003 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:1e698c08-d20a-11ec-8377-0242ac110003 UniProtKB:Q86Y07 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase VRK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1e69b8ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1e69e52c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BQI3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1e6a142a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1e6a43e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.09']} DrugCentral uuid:1e6a741a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NG66 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase Nek11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1e6aa124-d20a-11ec-8377-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1e6acdca-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1e6afa66-d20a-11ec-8377-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1e6b2b62-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1e6b2b62-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1e6b69c4-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:1e6b69c4-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Tyrosine-protein kinase ABL) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:1e6ba74a-d20a-11ec-8377-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1e6ba74a-d20a-11ec-8377-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bosutinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1e6be16a-d20a-11ec-8377-0242ac110003 UniProtKB:Q05193 biolink:molecularly_interacts_with DrugCentral:4360 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetrimide targets Structural (Dynamin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1e6c0dfc-d20a-11ec-8377-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:4361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chenodiol is antagonist of GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:1e6c3ad4-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:4361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chenodiol is agonist of Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1e6c677a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:4361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chenodiol is agonist of GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1e6c948e-d20a-11ec-8377-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:4362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chiniofon targets Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1e6cc120-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:4365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vernakalant targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.73']} DrugCentral uuid:1e6cedd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vernakalant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1e6d1b52-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZV8 biolink:molecularly_interacts_with DrugCentral:4365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vernakalant targets Ion channel (Potassium voltage-gated channel subfamily D member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1e6d4816-d20a-11ec-8377-0242ac110003 UniProtKB:P22460 biolink:molecularly_interacts_with DrugCentral:4365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vernakalant is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.875']} DrugCentral uuid:1e6d753e-d20a-11ec-8377-0242ac110003 UniProtKB:P62937 biolink:molecularly_interacts_with DrugCentral:4366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voclosporin is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1e6da20c-d20a-11ec-8377-0242ac110003 UniProtKB:P62937 biolink:molecularly_interacts_with DrugCentral:4366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voclosporin is inhibitor of Enzyme (Peptidyl-prolyl cis-trans isomerase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1e6dcf98-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium benzoate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1e6dfd7e-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium benzoate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.13']} DrugCentral uuid:1e6e2a38-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4373 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium benzoate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.61']} DrugCentral uuid:1e6e574c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcaserin targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.58']} DrugCentral uuid:1e6e850a-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcaserin targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.036']} DrugCentral uuid:1e6eb1ba-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcaserin targets GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.833']} DrugCentral uuid:1e6edf46-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4374 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorcaserin is agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:1e6f0c0a-d20a-11ec-8377-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:4376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dequalinium targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1e6f38a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UGI6 biolink:molecularly_interacts_with DrugCentral:4376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dequalinium targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1e6f6556-d20a-11ec-8377-0242ac110003 UniProtKB:P70605 biolink:molecularly_interacts_with DrugCentral:4376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dequalinium targets Ion channel (Small conductance calcium-activated potassium channel protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1e6f947c-d20a-11ec-8377-0242ac110003 UniProtKB:Q92952 biolink:molecularly_interacts_with DrugCentral:4376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dequalinium is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1e6fc136-d20a-11ec-8377-0242ac110003 UniProtKB:P70604 biolink:molecularly_interacts_with DrugCentral:4376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dequalinium is blocker of Ion channel (Small conductance calcium-activated potassium channel protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1e6fedd2-d20a-11ec-8377-0242ac110003 UniProtKB:P29973 biolink:molecularly_interacts_with DrugCentral:4376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dequalinium is blocker of Ion channel (cGMP-gated cation channel alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1e701ae6-d20a-11ec-8377-0242ac110003 UniProtKB:Q16280 biolink:molecularly_interacts_with DrugCentral:4376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dequalinium is blocker of Ion channel (Cyclic nucleotide-gated olfactory channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1e704782-d20a-11ec-8377-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:4379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 degarelix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:1e70743c-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desvenlafaxine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.325']} DrugCentral uuid:1e70a10a-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desvenlafaxine is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.275']} DrugCentral uuid:1e70ce82-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 desvenlafaxine targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1e70fb28-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dapoxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.95']} DrugCentral uuid:1e7127e2-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirabegron is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.65']} DrugCentral uuid:1e715618-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1e71869c-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1e71b3ba-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1e71e092-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1e720d88-d20a-11ec-8377-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:1e723a4c-d20a-11ec-8377-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1e7266d4-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1e729410-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1e72c1b0-d20a-11ec-8377-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1e72ee56-d20a-11ec-8377-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1e731b2e-d20a-11ec-8377-0242ac110003 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1e734900-d20a-11ec-8377-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1e737a10-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:1e737a10-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:1e73b854-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:1e73b854-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:1e73f904-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1e73f904-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1e73f904-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1e73f904-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1e744c9c-d20a-11ec-8377-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1e7486ee-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1e7486ee-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1e7486ee-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1e7486ee-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1e74ddb0-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1e74ddb0-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1e752202-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1e752202-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1e752202-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1e75679e-d20a-11ec-8377-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:4390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline theophyllinate targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1e7594a8-d20a-11ec-8377-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.026']} DrugCentral uuid:1e75c144-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.95']} DrugCentral uuid:1e75eed0-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1e761b8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q92887 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Transporter (Canalicular multispecific organic anion transporter 1) DrugCentral uuid:1e764448-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1e7670f8-d20a-11ec-8377-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:1e7698e4-d20a-11ec-8377-0242ac110003 UniProtKB:O15440 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Transporter (Multidrug resistance-associated protein 5) DrugCentral uuid:1e76c0d0-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.582']} DrugCentral uuid:1e76ee34-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.639']} DrugCentral uuid:1e771ada-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.321']} DrugCentral uuid:1e77478a-d20a-11ec-8377-0242ac110003 UniProtKB:P25025 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets GPCR (C-X-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.024']} DrugCentral uuid:1e7774bc-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.029']} DrugCentral uuid:1e77a14e-d20a-11ec-8377-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.154']} DrugCentral uuid:1e77ce08-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.335']} DrugCentral uuid:1e77fa90-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cisplatin targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.219']} DrugCentral uuid:1e7827ea-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clofenotane targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:1e78549a-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clopenthixol targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1e788154-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltrombopag targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1e78aefe-d20a-11ec-8377-0242ac110003 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:4399 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eltrombopag is agonist of Membrane receptor (Thrombopoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:1e78db90-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:4401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 casopitant targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.53']} DrugCentral uuid:1e79084a-d20a-11ec-8377-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:4401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 casopitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:1e793504-d20a-11ec-8377-0242ac110003 UniProtKB:Q7DHH4 biolink:molecularly_interacts_with DrugCentral:4402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceftobiprole medocaril targets Enzyme (MecA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1e79622c-d20a-11ec-8377-0242ac110003 UniProtKB:P61073 biolink:molecularly_interacts_with DrugCentral:4410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plerixafor is partial agonist of GPCR (C-X-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1e799012-d20a-11ec-8377-0242ac110003 UniProtKB:P41597 biolink:molecularly_interacts_with DrugCentral:4410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plerixafor targets GPCR (C-C chemokine receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.4']} DrugCentral uuid:1e79bc90-d20a-11ec-8377-0242ac110003 UniProtKB:P48061 biolink:molecularly_interacts_with DrugCentral:4410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plerixafor targets Cytokine (Stromal cell-derived factor 1) DrugCentral uuid:1e79e544-d20a-11ec-8377-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:4410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plerixafor is antagonist of GPCR (C-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1e7a11d6-d20a-11ec-8377-0242ac110003 UniProtKB:O08565 biolink:molecularly_interacts_with DrugCentral:4410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plerixafor targets GPCR (C-X-C chemokine receptor type 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:1e7a3e72-d20a-11ec-8377-0242ac110003 UniProtKB:P25106 biolink:molecularly_interacts_with DrugCentral:4410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plerixafor is agonist of GPCR (Atypical chemokine receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1e7a6ca8-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.118']} DrugCentral uuid:1e7a9ba6-d20a-11ec-8377-0242ac110003 UniProtKB:Q99720 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.157']} DrugCentral uuid:1e7ac856-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.886']} DrugCentral uuid:1e7af510-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.308']} DrugCentral uuid:1e7b2238-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.977']} DrugCentral uuid:1e7b4efc-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.915']} DrugCentral uuid:1e7b7ba2-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.677']} DrugCentral uuid:1e7ba87a-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:1e7bd5e8-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.085']} DrugCentral uuid:1e7c02a2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.478']} DrugCentral uuid:1e7c2f5c-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.604']} DrugCentral uuid:1e7c5d06-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.262']} DrugCentral uuid:1e7c89b6-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.559']} DrugCentral uuid:1e7cb67a-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.126']} DrugCentral uuid:1e7ce316-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.131']} DrugCentral uuid:1e7d1048-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.781']} DrugCentral uuid:1e7d3d0c-d20a-11ec-8377-0242ac110003 UniProtKB:P15823 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.065']} DrugCentral uuid:1e7d69d0-d20a-11ec-8377-0242ac110003 UniProtKB:P70580 biolink:molecularly_interacts_with DrugCentral:4411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexchlorpheniramine targets Membrane receptor (Membrane-associated progesterone receptor component 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.931']} DrugCentral uuid:1e7d9748-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:4412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diamorphine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1e7dc416-d20a-11ec-8377-0242ac110003 UniProtKB:P18901 biolink:molecularly_interacts_with DrugCentral:4412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diamorphine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1e7df0d0-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:4412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diamorphine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.44']} DrugCentral uuid:1e7e1d76-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dibutylphthalate is activator of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1e7e4e22-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:4420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocryptine is agonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:1e7e7e38-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:4420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocryptine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1e7eac32-d20a-11ec-8377-0242ac110003 UniProtKB:P32304 biolink:molecularly_interacts_with DrugCentral:4420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dihydroergocryptine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1e7ed964-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colistin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:1e7f0614-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colistin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.018']} DrugCentral uuid:1e7f32b0-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colistin targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.652']} DrugCentral uuid:1e7f6014-d20a-11ec-8377-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colistin targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.092']} DrugCentral uuid:1e7f8cba-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colistin targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.604']} DrugCentral uuid:1e7fb974-d20a-11ec-8377-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:4425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 colistin targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.775']} DrugCentral uuid:1e7fe624-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1e8017e8-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1e804574-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1e807242-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is antagonist of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1e809f56-d20a-11ec-8377-0242ac110003 UniProtKB:P05186 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets Enzyme (Alkaline phosphatase, tissue-nonspecific isozyme) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.09']} DrugCentral uuid:1e80cc1a-d20a-11ec-8377-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1e80f8ac-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1e812552-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1e81528e-d20a-11ec-8377-0242ac110003 UniProtKB:E1BN64 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets Enzyme (Uncharacterized protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1e817f3e-d20a-11ec-8377-0242ac110003 UniProtKB:P28647 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.07']} DrugCentral uuid:1e81abd0-d20a-11ec-8377-0242ac110003 UniProtKB:P28190 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1e81da9c-d20a-11ec-8377-0242ac110003 UniProtKB:P47745 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1e820f6c-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:1e820f6c-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.88']} DrugCentral uuid:1e824d42-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:1e824d42-d20a-11ec-8377-0242ac110003 UniProtKB:Q14432 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 3) DrugCentral uuid:1e828de8-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1e828de8-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1e828de8-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1e828de8-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1e82e194-d20a-11ec-8377-0242ac110003 UniProtKB:P29276 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine A2b receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.82']} DrugCentral uuid:1e831bc8-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1e831bc8-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1e831bc8-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1e831bc8-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1e83729e-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1e83729e-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline is antagonist of GPCR (Adenosine A2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.85']} DrugCentral uuid:1e83b4b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1e83b4b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1e83b4b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q01061 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets Enzyme (Heart phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1e83f322-d20a-11ec-8377-0242ac110003 UniProtKB:P46616 biolink:molecularly_interacts_with DrugCentral:4426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bufylline targets GPCR (Adenosine A2a receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1e841b68-d20a-11ec-8377-0242ac110003 UniProtKB:P30988 biolink:molecularly_interacts_with DrugCentral:4427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin human is agonist of GPCR (Calcitonin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:1e844804-d20a-11ec-8377-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:4427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.53']} DrugCentral uuid:1e844804-d20a-11ec-8377-0242ac110003 UniProtKB:O60894 biolink:molecularly_interacts_with DrugCentral:4427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.53']} DrugCentral uuid:1e847f72-d20a-11ec-8377-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:4427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.082']} DrugCentral uuid:1e847f72-d20a-11ec-8377-0242ac110003 UniProtKB:O60895 biolink:molecularly_interacts_with DrugCentral:4427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.082']} DrugCentral uuid:1e84b6fe-d20a-11ec-8377-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:4427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.706']} DrugCentral uuid:1e84b6fe-d20a-11ec-8377-0242ac110003 UniProtKB:O60896 biolink:molecularly_interacts_with DrugCentral:4427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 calcitonin human is agonist of GPCR (Amylin receptor AMY3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.706']} DrugCentral uuid:1e84eb06-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prednisolone sodium phosphate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1e851072-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.179']} DrugCentral uuid:1e8538a4-d20a-11ec-8377-0242ac110003 UniProtKB:P04083 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Cytosolic other (Annexin A1) DrugCentral uuid:1e855cb2-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1e858714-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.599']} DrugCentral uuid:1e85afa0-d20a-11ec-8377-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1e85d7be-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.818']} DrugCentral uuid:1e8600fe-d20a-11ec-8377-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:1e8629a8-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1e865284-d20a-11ec-8377-0242ac110003 UniProtKB:P20815 biolink:molecularly_interacts_with DrugCentral:4452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clobetasol propionate targets Enzyme (Cytochrome P450 3A5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1e867ab6-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4454 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone cypionate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:1e869ece-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4456 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone succinate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1e86c386-d20a-11ec-8377-0242ac110003 UniProtKB:P06537 biolink:molecularly_interacts_with DrugCentral:4456 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone succinate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1e86ec12-d20a-11ec-8377-0242ac110003 UniProtKB:P0AC13 biolink:molecularly_interacts_with DrugCentral:4458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfisoxazole acetyl is inhibitor of Enzyme (Dihydropteroate synthase) DrugCentral uuid:1e871034-d20a-11ec-8377-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfisoxazole acetyl targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1e873884-d20a-11ec-8377-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:4458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfisoxazole acetyl targets GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:1e87619c-d20a-11ec-8377-0242ac110003 UniProtKB:P26684 biolink:molecularly_interacts_with DrugCentral:4458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sulfisoxazole acetyl targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1e8789ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q99873 biolink:molecularly_interacts_with DrugCentral:4466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eosin targets Enzyme (Protein arginine N-methyltransferase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1e87b1f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q5VLE3 biolink:molecularly_interacts_with DrugCentral:4466 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eosin targets Enzyme (RmtA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:1e87f1d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:1e87f1d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:1e87f1d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:1e87f1d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:1e87f1d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:1e87f1d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:1e87f1d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4468 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esketamine is antagonist of Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.161']} DrugCentral uuid:1e885c8c-d20a-11ec-8377-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:4470 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosaprepitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:1e888586-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4474 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trisodium citrate dihydrate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1e88adb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4474 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trisodium citrate dihydrate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:1e88d608-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium citrate targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:1e88fe62-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4477 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium citrate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:1e892856-d20a-11ec-8377-0242ac110003 UniProtKB:P19111 biolink:molecularly_interacts_with DrugCentral:4480 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 potassium phosphate, monobasic targets Enzyme (Intestinal alkaline phosphatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1e895380-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1e8987ce-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:1e8987ce-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:1e8987ce-d20a-11ec-8377-0242ac110003 UniProtKB:P22909 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.69']} DrugCentral uuid:1e89d238-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1e89d238-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1e89d238-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1e8a19e6-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:1e8a19e6-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:1e8a19e6-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4482 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corbadrine is agonist of GPCR (Adrenergic receptor alpha-2) DrugCentral uuid:1e8a5172-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1e8a7a58-d20a-11ec-8377-0242ac110003 UniProtKB:P07858 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Enzyme (Cathepsin B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1e8aa280-d20a-11ec-8377-0242ac110003 UniProtKB:P28062 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1e8acad0-d20a-11ec-8377-0242ac110003 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.84']} DrugCentral uuid:1e8af424-d20a-11ec-8377-0242ac110003 UniProtKB:P49721 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.69']} DrugCentral uuid:1e8b1c88-d20a-11ec-8377-0242ac110003 UniProtKB:P78417 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Unclassified (Glutathione S-transferase omega-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1e8b44b0-d20a-11ec-8377-0242ac110003 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.84']} DrugCentral uuid:1e8b6cf6-d20a-11ec-8377-0242ac110003 UniProtKB:P28065 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1e8b958c-d20a-11ec-8377-0242ac110003 UniProtKB:P40306 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Enzyme (Proteasome subunit beta type-10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1e8bbdc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1e8be6ae-d20a-11ec-8377-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:4483 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 carfilzomib is inhibitor of Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:1e8c0ed6-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:1e8c379e-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:1e8c6002-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclidinium bromide is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.15']} DrugCentral uuid:1e8c8852-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1e8cb08e-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4484 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aclidinium bromide targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.8']} DrugCentral uuid:1e8cda78-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4485 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflorasone diacetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.536']} DrugCentral uuid:1e8d03ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4485 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diflorasone diacetate targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1e8d2bfe-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4493 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alclometasone dipropionate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1e8d502a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol decanoate is inverse agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.34']} DrugCentral uuid:1e8d78c0-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol decanoate targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:1e8da110-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:4496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol decanoate targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1e8dc942-d20a-11ec-8377-0242ac110003 UniProtKB:P50130 biolink:molecularly_interacts_with DrugCentral:4496 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 haloperidol decanoate targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1e8df19c-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4497 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estradiol acetate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:1e8e1668-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4498 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone palmitate targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1e8e3ea4-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4498 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone palmitate is antagonist of GPCR (D(2) dopamine receptor) DrugCentral uuid:1e8e62f8-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4498 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paliperidone palmitate is antagonist of GPCR (5-hydroxytryptamine receptor 2A) DrugCentral uuid:1e8e86fc-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 armodafinil targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.921']} DrugCentral uuid:1e8eb15e-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 armodafinil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.41']} DrugCentral uuid:1e8ed9d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 armodafinil is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.497']} DrugCentral uuid:1e8f01ea-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 armodafinil targets GPCR (Alpha-1B adrenergic receptor) DrugCentral uuid:1e8f2602-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:4501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 armodafinil targets Enzyme (Cytochrome P450 1A2) DrugCentral uuid:1e8f4ba0-d20a-11ec-8377-0242ac110003 UniProtKB:P33261 biolink:molecularly_interacts_with DrugCentral:4501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 armodafinil targets Enzyme (Cytochrome P450 2C19) DrugCentral uuid:1e8f6fea-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:4501 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 armodafinil targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1e8f984e-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4504 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone valerate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1e8fbcac-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline fenofibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.46']} DrugCentral uuid:1e8fe5b0-d20a-11ec-8377-0242ac110003 UniProtKB:P12104 biolink:molecularly_interacts_with DrugCentral:4505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline fenofibrate targets Cytosolic other (Fatty acid-binding protein, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:1e900e14-d20a-11ec-8377-0242ac110003 UniProtKB:P02692 biolink:molecularly_interacts_with DrugCentral:4505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline fenofibrate targets Unclassified (Fatty acid-binding protein, liver) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:1e903650-d20a-11ec-8377-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:4505 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choline fenofibrate targets Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1e905e96-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4507 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halcinonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.135']} DrugCentral uuid:1e908966-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4507 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halcinonide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.229']} DrugCentral uuid:1e90b1c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q690N0 biolink:molecularly_interacts_with DrugCentral:4507 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 halcinonide targets Transcription factor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.917']} DrugCentral uuid:1e90d9fc-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:4508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racepinefrine is agonist of GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1e910346-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:4508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racepinefrine is agonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6']} DrugCentral uuid:1e912c0e-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:4508 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 racepinefrine is agonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1e915904-d20a-11ec-8377-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4512 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lithium citrate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:1e915904-d20a-11ec-8377-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4512 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lithium citrate is inhibitor of Kinase (Glycogen synthase kinase-3) DrugCentral uuid:1e9186ea-d20a-11ec-8377-0242ac110003 UniProtKB:P29218 biolink:molecularly_interacts_with DrugCentral:4512 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lithium citrate is inhibitor of Enzyme (Inositol-1(or 4)-monophosphatase 1) DrugCentral uuid:1e91abe8-d20a-11ec-8377-0242ac110003 UniProtKB:Q03431 biolink:molecularly_interacts_with DrugCentral:4514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1e91d424-d20a-11ec-8377-0242ac110003 UniProtKB:P49190 biolink:molecularly_interacts_with DrugCentral:4514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1e91fc6a-d20a-11ec-8377-0242ac110003 UniProtKB:P70555 biolink:molecularly_interacts_with DrugCentral:4514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1e92249c-d20a-11ec-8377-0242ac110003 UniProtKB:P25961 biolink:molecularly_interacts_with DrugCentral:4514 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriparatide is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1e924e68-d20a-11ec-8377-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4516 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracosactide targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.19']} DrugCentral uuid:1e9278d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:4516 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tetracosactide is agonist of GPCR (Adrenocorticotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.268']} DrugCentral uuid:1e92a11a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) DrugCentral uuid:1e92c546-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1e92ede6-d20a-11ec-8377-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine targets Secreted (Hemoglobin subunit alpha) DrugCentral uuid:1e931212-d20a-11ec-8377-0242ac110003 UniProtKB:Q92953 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine is blocker of Ion channel (Potassium voltage-gated channel subfamily B member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1e933a58-d20a-11ec-8377-0242ac110003 UniProtKB:O15245 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine targets Transporter (Solute carrier family 22 member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:1e936a64-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1e936a64-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1e936a64-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY46 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1e93a9a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q7RTT9 biolink:molecularly_interacts_with DrugCentral:4523 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quinine is inhibitor of Transporter (Equilibrative nucleoside transporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.57']} DrugCentral uuid:1e93d1de-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:4536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenbendazole targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.496']} DrugCentral uuid:1e93f9fc-d20a-11ec-8377-0242ac110003 UniProtKB:P10424 biolink:molecularly_interacts_with DrugCentral:4536 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fenbendazole targets Enzyme (Beta-lactamase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.222']} DrugCentral uuid:1e942314-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4554 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone furoate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.12']} DrugCentral uuid:1e944b64-d20a-11ec-8377-0242ac110003 UniProtKB:P08235 biolink:molecularly_interacts_with DrugCentral:4554 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone furoate targets Nuclear hormone receptor (Mineralocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.83']} DrugCentral uuid:1e9473aa-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4554 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone furoate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1e949cea-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4554 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone furoate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:1e94c6c0-d20a-11ec-8377-0242ac110003 UniProtKB:P06536 biolink:molecularly_interacts_with DrugCentral:4554 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone furoate targets Transcription factor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1e94eefc-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:4554 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluticasone furoate targets Nuclear hormone receptor (Progesterone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1e951742-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1e953f9c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1e956896-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1e9590e6-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:1e95c4c6-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1e95c4c6-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1e95c4c6-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1e95c4c6-d20a-11ec-8377-0242ac110003 UniProtKB:P30940 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (Serotonin 1 (5-HT1) receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1e961890-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1e961890-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1e961890-d20a-11ec-8377-0242ac110003 UniProtKB:P43140 biolink:molecularly_interacts_with DrugCentral:4562 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gepirone targets GPCR (Adrenergic receptor alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1e965b02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium oxybate is agonist of GPCR (GABA-B receptor) DrugCentral uuid:1e965b02-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium oxybate is agonist of GPCR (GABA-B receptor) DrugCentral uuid:1e96892e-d20a-11ec-8377-0242ac110003 UniProtKB:Q6RY99 biolink:molecularly_interacts_with DrugCentral:4566 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium oxybate targets Unclassified (Gamma-hydroxybutyrate receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:1e96b156-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4568 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrochloric acid targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1e96d99c-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4569 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 hydrocortisone probutate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1e96fe4a-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4573 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1e972726-d20a-11ec-8377-0242ac110003 UniProtKB:P16184 biolink:molecularly_interacts_with DrugCentral:4573 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1e974f58-d20a-11ec-8377-0242ac110003 UniProtKB:B0BL08 biolink:molecularly_interacts_with DrugCentral:4573 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1e97776c-d20a-11ec-8377-0242ac110003 UniProtKB:P0A017 biolink:molecularly_interacts_with DrugCentral:4573 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iclaprim targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.1']} DrugCentral uuid:1e97ab56-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1e97ab56-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1e97ab56-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1e97ab56-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4586 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomethadone targets GPCR (Opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1e97fb88-d20a-11ec-8377-0242ac110003 UniProtKB:O43526 biolink:molecularly_interacts_with DrugCentral:4588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linopirdine is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1e9826b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NR82 biolink:molecularly_interacts_with DrugCentral:4588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linopirdine is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1e984f16-d20a-11ec-8377-0242ac110003 UniProtKB:P56696 biolink:molecularly_interacts_with DrugCentral:4588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linopirdine is blocker of Ion channel (Potassium voltage-gated channel subfamily KQT member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1e9877c0-d20a-11ec-8377-0242ac110003 UniProtKB:O88944 biolink:molecularly_interacts_with DrugCentral:4588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linopirdine is inhibitor of Ion channel (Potassium voltage-gated channel subfamily KQT member 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1e989fe8-d20a-11ec-8377-0242ac110003 UniProtKB:P97414 biolink:molecularly_interacts_with DrugCentral:4588 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linopirdine is inhibitor of Ion channel (Potassium voltage-gated channel subfamily KQT member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1e98c810-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:4601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmetin targets Transporter (Multidrug resistance-associated protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1e98f042-d20a-11ec-8377-0242ac110003 UniProtKB:Q16678 biolink:molecularly_interacts_with DrugCentral:4601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmetin targets Enzyme (Cytochrome P450 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1e99190a-d20a-11ec-8377-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:1e994150-d20a-11ec-8377-0242ac110003 UniProtKB:O60341 biolink:molecularly_interacts_with DrugCentral:4601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmetin targets Enzyme (Lysine-specific histone demethylase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.55']} DrugCentral uuid:1e996978-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NFU5 biolink:molecularly_interacts_with DrugCentral:4601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmetin targets Kinase (Inositol polyphosphate multikinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1e9991aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHH9 biolink:molecularly_interacts_with DrugCentral:4601 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diosmetin targets Kinase (Inositol hexakisphosphate kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1e99bd56-d20a-11ec-8377-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:4605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tonzonium targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:1e99e6f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q63470 biolink:molecularly_interacts_with DrugCentral:4605 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tonzonium targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.03']} DrugCentral uuid:1e9a0f22-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4606 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clocortolone pivalate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1e9a33bc-d20a-11ec-8377-0242ac110003 UniProtKB:P18031 biolink:molecularly_interacts_with DrugCentral:4608 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trypan blue targets Enzyme (Tyrosine-protein phosphatase non-receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1e9a5c02-d20a-11ec-8377-0242ac110003 UniProtKB:P25044 biolink:molecularly_interacts_with DrugCentral:4608 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trypan blue targets Enzyme (Tyrosine-protein phosphatase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1e9a8466-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4609 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 testosterone enantate is agonist of Nuclear hormone receptor (Androgen receptor) DrugCentral uuid:1e9aa87e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stearic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1e9ad178-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:4611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stearic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1e9af982-d20a-11ec-8377-0242ac110003 UniProtKB:P15090 biolink:molecularly_interacts_with DrugCentral:4611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stearic acid targets Cytosolic other (Fatty acid-binding protein, adipocyte) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1e9b21d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:4611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stearic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1e9b49fa-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:4611 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 stearic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1e9b7394-d20a-11ec-8377-0242ac110003 UniProtKB:P27471 biolink:molecularly_interacts_with DrugCentral:4615 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 N-Acetylglucosamine targets Unclassified (Killer cell lectin-like receptor subfamily B member 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1e9b9d10-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylnaltrexone is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.55']} DrugCentral uuid:1e9bc560-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylnaltrexone targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1e9bed88-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:4616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylnaltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.65']} DrugCentral uuid:1e9c165a-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:4616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylnaltrexone targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1e9c3e82-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:4616 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylnaltrexone targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1e9c677c-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1e9c8fcc-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1e9cb8bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.1']} DrugCentral uuid:1e9ce0f8-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1e9d0934-d20a-11ec-8377-0242ac110003 UniProtKB:P05413 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Cytosolic other (Fatty acid-binding protein, heart) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.56']} DrugCentral uuid:1e9d317a-d20a-11ec-8377-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1e9d5aec-d20a-11ec-8377-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1e9d8314-d20a-11ec-8377-0242ac110003 UniProtKB:P13726 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Membrane receptor (Tissue factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1e9dab5a-d20a-11ec-8377-0242ac110003 UniProtKB:P79208 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.92']} DrugCentral uuid:1e9dd378-d20a-11ec-8377-0242ac110003 UniProtKB:O62664 biolink:molecularly_interacts_with DrugCentral:4618 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linolenic acid targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.03']} DrugCentral uuid:1e9dfce0-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:4619 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenol targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1e9e251c-d20a-11ec-8377-0242ac110003 UniProtKB:P40763 biolink:molecularly_interacts_with DrugCentral:4619 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenol targets Transcription factor (Signal transducer and activator of transcription 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:1e9e4d4e-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:4619 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomenol targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1e9e756c-d20a-11ec-8377-0242ac110003 UniProtKB:P04818 biolink:molecularly_interacts_with DrugCentral:4621 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomefolic acid targets Enzyme (Thymidylate synthase) DrugCentral uuid:1e9e9a24-d20a-11ec-8377-0242ac110003 UniProtKB:P23897 biolink:molecularly_interacts_with DrugCentral:4622 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linaclotide is agonist of Enzyme (Heat-stable enterotoxin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.38']} DrugCentral uuid:1e9ec26a-d20a-11ec-8377-0242ac110003 UniProtKB:P25092 biolink:molecularly_interacts_with DrugCentral:4622 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 linaclotide is agonist of Enzyme (Heat-stable enterotoxin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.907']} DrugCentral uuid:1e9efe1a-d20a-11ec-8377-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:1e9efe1a-d20a-11ec-8377-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:1e9efe1a-d20a-11ec-8377-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:1e9efe1a-d20a-11ec-8377-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:1e9efe1a-d20a-11ec-8377-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:1e9efe1a-d20a-11ec-8377-0242ac110003 UniProtKB:E0VP62 biolink:molecularly_interacts_with DrugCentral:4623 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 spinosad is agonist of Ion channel (Nicotinic acetylcholine receptor) DrugCentral uuid:1e9f5964-d20a-11ec-8377-0242ac110003 UniProtKB:P15121 biolink:molecularly_interacts_with DrugCentral:4624 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenylacetic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.02']} DrugCentral uuid:1e9f81aa-d20a-11ec-8377-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:1e9faa18-d20a-11ec-8377-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:1e9fd2c2-d20a-11ec-8377-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:1e9ffb1c-d20a-11ec-8377-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:1ea0238a-d20a-11ec-8377-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1ea04c48-d20a-11ec-8377-0242ac110003 UniProtKB:Q63931 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:1ea07880-d20a-11ec-8377-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1ea07880-d20a-11ec-8377-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4627 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sincalide targets GPCR (Cholecystokinin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1ea0ac06-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:4628 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enzalutamide is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.31']} DrugCentral uuid:1ea0d442-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:4628 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enzalutamide targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.53']} DrugCentral uuid:1ea0fe90-d20a-11ec-8377-0242ac110003 UniProtKB:P14324 biolink:molecularly_interacts_with DrugCentral:4630 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium pyrophosphate targets Enzyme (Farnesyl pyrophosphate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1ea12956-d20a-11ec-8377-0242ac110003 UniProtKB:P16066 biolink:molecularly_interacts_with DrugCentral:4631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroprusside targets Enzyme (Atrial natriuretic peptide receptor 1) DrugCentral uuid:1ea15930-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:1ea15930-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:1ea15930-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:1ea15930-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4631 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nitroprusside is activator of Enzyme (Soluble guanylate cyclase) DrugCentral uuid:1ea19ada-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trabectedin targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1ea1c316-d20a-11ec-8377-0242ac110003 UniProtKB:O54915 biolink:molecularly_interacts_with DrugCentral:4633 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trabectedin is antagonist of Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1ea1ec42-d20a-11ec-8377-0242ac110003 UniProtKB:Q02127 biolink:molecularly_interacts_with DrugCentral:4634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriflunomide is inhibitor of Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1ea214a6-d20a-11ec-8377-0242ac110003 UniProtKB:P00374 biolink:molecularly_interacts_with DrugCentral:4634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriflunomide targets Enzyme (Dihydrofolate reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1ea23da0-d20a-11ec-8377-0242ac110003 UniProtKB:Q63707 biolink:molecularly_interacts_with DrugCentral:4634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1ea265e6-d20a-11ec-8377-0242ac110003 UniProtKB:O35435 biolink:molecularly_interacts_with DrugCentral:4634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriflunomide targets Enzyme (Dihydroorotate dehydrogenase (quinone), mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.16']} DrugCentral uuid:1ea28e18-d20a-11ec-8377-0242ac110003 UniProtKB:Q54A96 biolink:molecularly_interacts_with DrugCentral:4634 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teriflunomide targets Enzyme (Dihydroorotate dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1ea2b65e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8BGY9 biolink:molecularly_interacts_with DrugCentral:4635 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 Choline C-11 targets Transporter (High affinity choline transporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1ea2e32c-d20a-11ec-8377-0242ac110003 UniProtKB:P00811 biolink:molecularly_interacts_with DrugCentral:4637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rose bengal targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1ea30e74-d20a-11ec-8377-0242ac110003 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:4637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rose bengal targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1ea336e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q99895 biolink:molecularly_interacts_with DrugCentral:4637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rose bengal targets Enzyme (Chymotrypsin C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1ea35f8c-d20a-11ec-8377-0242ac110003 UniProtKB:P16278 biolink:molecularly_interacts_with DrugCentral:4637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rose bengal targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1ea387dc-d20a-11ec-8377-0242ac110003 UniProtKB:O06446 biolink:molecularly_interacts_with DrugCentral:4637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rose bengal targets Unclassified (Protein translocase subunit SecA 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1ea3b036-d20a-11ec-8377-0242ac110003 UniProtKB:Q2FUW6 biolink:molecularly_interacts_with DrugCentral:4637 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rose bengal targets Unclassified (Protein translocase subunit SecA 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1ea3d868-d20a-11ec-8377-0242ac110003 UniProtKB:Q8HZ64 biolink:molecularly_interacts_with DrugCentral:4641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levmetamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1ea40144-d20a-11ec-8377-0242ac110003 UniProtKB:Q923Y9 biolink:molecularly_interacts_with DrugCentral:4641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levmetamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.63']} DrugCentral uuid:1ea42980-d20a-11ec-8377-0242ac110003 UniProtKB:Q923Y8 biolink:molecularly_interacts_with DrugCentral:4641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levmetamfetamine targets GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1ea451c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RJ0 biolink:molecularly_interacts_with DrugCentral:4641 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levmetamfetamine is agonist of GPCR (Trace amine-associated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1ea479f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:4642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dodecanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1ea4a57c-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:4642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dodecanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1ea4cfa2-d20a-11ec-8377-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:4642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dodecanoic acid targets Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1ea4f7de-d20a-11ec-8377-0242ac110003 UniProtKB:O14842 biolink:molecularly_interacts_with DrugCentral:4642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dodecanoic acid targets GPCR (Free fatty acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1ea51ffc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NQS5 biolink:molecularly_interacts_with DrugCentral:4642 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dodecanoic acid is agonist of GPCR (G-protein coupled receptor 84) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1ea548a6-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4647 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluorometholone acetate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.347']} DrugCentral uuid:1ea570ec-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:4648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eugenol targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1ea5991e-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:4648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eugenol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:1ea5c150-d20a-11ec-8377-0242ac110003 UniProtKB:P09917 biolink:molecularly_interacts_with DrugCentral:4648 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eugenol targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.58']} DrugCentral uuid:1ea5ea18-d20a-11ec-8377-0242ac110003 UniProtKB:P23415 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Ion channel (Glycine receptor subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1ea61240-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ea63a68-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.21']} DrugCentral uuid:1ea662a4-d20a-11ec-8377-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ea68ea0-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:1ea6b8a8-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1ea6e0ee-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ea709c0-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1ea731de-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ea75a06-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ea78256-d20a-11ec-8377-0242ac110003 UniProtKB:P34913 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib is inhibitor of Enzyme (Bifunctional epoxide hydrolase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1ea7ab32-d20a-11ec-8377-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ea7d350-d20a-11ec-8377-0242ac110003 UniProtKB:P35917 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ea7fb96-d20a-11ec-8377-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ea823be-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ea84da8-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ea875e4-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ea89e02-d20a-11ec-8377-0242ac110003 UniProtKB:P35917 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ea8c62a-d20a-11ec-8377-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ea8eee8-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1ea91706-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4654 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 regorafenib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ea93f42-d20a-11ec-8377-0242ac110003 UniProtKB:Q17ST2 biolink:molecularly_interacts_with DrugCentral:4655 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tedisamil is blocker of Ion channel (Potassium voltage-gated channel subfamily A member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.7']} DrugCentral uuid:1ea9679c-d20a-11ec-8377-0242ac110003 UniProtKB:O75762 biolink:molecularly_interacts_with DrugCentral:4659 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metamizole is blocker of Ion channel (Transient receptor potential cation channel subfamily A member 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.041']} DrugCentral uuid:1ea990a0-d20a-11ec-8377-0242ac110003 UniProtKB:P10980 biolink:molecularly_interacts_with DrugCentral:4660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.57']} DrugCentral uuid:1ea9b8e6-d20a-11ec-8377-0242ac110003 UniProtKB:P08482 biolink:molecularly_interacts_with DrugCentral:4660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1ea9e118-d20a-11ec-8377-0242ac110003 UniProtKB:P08483 biolink:molecularly_interacts_with DrugCentral:4660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.59']} DrugCentral uuid:1eaa0954-d20a-11ec-8377-0242ac110003 UniProtKB:P16395 biolink:molecularly_interacts_with DrugCentral:4660 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methylatropine targets GPCR (Muscarinic acetylcholine receptor DM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:1eaa347e-d20a-11ec-8377-0242ac110003 UniProtKB:P23141 biolink:molecularly_interacts_with DrugCentral:4663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzoin targets Enzyme (Liver carboxylesterase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1eaa5ca6-d20a-11ec-8377-0242ac110003 UniProtKB:O00748 biolink:molecularly_interacts_with DrugCentral:4663 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzoin targets Enzyme (Cocaine esterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.65']} DrugCentral uuid:1eaa86ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:4664 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzoic acid targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.86']} DrugCentral uuid:1eaaafa8-d20a-11ec-8377-0242ac110003 UniProtKB:P14920 biolink:molecularly_interacts_with DrugCentral:4664 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzoic acid targets Enzyme (D-amino-acid oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1eaad7f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XQN6 biolink:molecularly_interacts_with DrugCentral:4664 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benzoic acid targets Enzyme (Nicotinate phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.72']} DrugCentral uuid:1eab0034-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone phosphate targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.932']} DrugCentral uuid:1eab287a-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.776']} DrugCentral uuid:1eab516a-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.866']} DrugCentral uuid:1eab79ba-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.779']} DrugCentral uuid:1eaba1f6-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone phosphate targets GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.248']} DrugCentral uuid:1eabca46-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4667 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betamethasone phosphate is agonist of Nuclear hormone receptor (Glucocorticoid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.428']} DrugCentral uuid:1eabf412-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2I1 biolink:molecularly_interacts_with DrugCentral:4671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metizoline targets Membrane receptor (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.2']} DrugCentral uuid:1eac1cf8-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:4671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metizoline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:1eac452a-d20a-11ec-8377-0242ac110003 UniProtKB:P21396 biolink:molecularly_interacts_with DrugCentral:4671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metizoline targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.86']} DrugCentral uuid:1eac6d48-d20a-11ec-8377-0242ac110003 UniProtKB:Q4G017 biolink:molecularly_interacts_with DrugCentral:4671 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metizoline targets Unclassified (Nischarin) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1eac95f2-d20a-11ec-8377-0242ac110003 UniProtKB:O43613 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1eacbe1a-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.14']} DrugCentral uuid:1eace62e-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.13']} DrugCentral uuid:1ead0e42-d20a-11ec-8377-0242ac110003 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.833']} DrugCentral uuid:1ead371e-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:1ead5f3c-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:1ead875a-d20a-11ec-8377-0242ac110003 UniProtKB:P42866 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.37']} DrugCentral uuid:1eadaf8c-d20a-11ec-8377-0242ac110003 UniProtKB:P97266 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:1eadd980-d20a-11ec-8377-0242ac110003 UniProtKB:P32300 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:1eae01c6-d20a-11ec-8377-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.43']} DrugCentral uuid:1eae2a02-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:1eae5248-d20a-11ec-8377-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1eae7bb0-d20a-11ec-8377-0242ac110003 UniProtKB:P33534 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:1eaea3f6-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:1eaecc1e-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.26']} DrugCentral uuid:1eaef504-d20a-11ec-8377-0242ac110003 UniProtKB:P34975 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine targets GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1eaf1d36-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:4673 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nalfurafine is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:1eaf4586-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4676 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 obidoxime targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.67']} DrugCentral uuid:1eaf6db8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XYC7 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:1eaf96ee-d20a-11ec-8377-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1eafbf20-d20a-11ec-8377-0242ac110003 UniProtKB:A5H660 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat targets Unclassified (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1eafe766-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:1eb00fc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.19']} DrugCentral uuid:1eb03874-d20a-11ec-8377-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1eb0620e-d20a-11ec-8377-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.96']} DrugCentral uuid:1eb08a68-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.15']} DrugCentral uuid:1eb0b2d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:1eb0dbd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1eb10448-d20a-11ec-8377-0242ac110003 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.22']} DrugCentral uuid:1eb12cca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.92']} DrugCentral uuid:1eb1552e-d20a-11ec-8377-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1eb17fae-d20a-11ec-8377-0242ac110003 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4682 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panobinostat is inhibitor of Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.46']} DrugCentral uuid:1eb1a7ea-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:1eb1d012-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1eb1f844-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1eb220d0-d20a-11ec-8377-0242ac110003 UniProtKB:P06276 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1eb24916-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:1eb2722e-d20a-11ec-8377-0242ac110003 UniProtKB:P21836 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1eb29a4c-d20a-11ec-8377-0242ac110003 UniProtKB:P47746 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1eb2c300-d20a-11ec-8377-0242ac110003 UniProtKB:O35678 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Monoglyceride lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1eb2eb14-d20a-11ec-8377-0242ac110003 UniProtKB:O08914 biolink:molecularly_interacts_with DrugCentral:4683 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 paraoxon targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.27']} DrugCentral uuid:1eb31ef4-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:1eb31ef4-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:1eb31ef4-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:1eb31ef4-d20a-11ec-8377-0242ac110003 UniProtKB:P48058 biolink:molecularly_interacts_with DrugCentral:4684 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 perampanel is antagonist of Ion channel (Glutamate receptor ionotropic AMPA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:1eb36d50-d20a-11ec-8377-0242ac110003 UniProtKB:O75469 biolink:molecularly_interacts_with DrugCentral:4690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pleconaril targets Nuclear hormone receptor (Nuclear receptor subfamily 1 group I member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1eb3956e-d20a-11ec-8377-0242ac110003 UniProtKB:Q4U254 biolink:molecularly_interacts_with DrugCentral:4690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pleconaril targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1eb3bd96-d20a-11ec-8377-0242ac110003 UniProtKB:Q7T664 biolink:molecularly_interacts_with DrugCentral:4690 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pleconaril targets Unclassified (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:1eb3e640-d20a-11ec-8377-0242ac110003 UniProtKB:P00797 biolink:molecularly_interacts_with DrugCentral:4696 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remikiren is inhibitor of Enzyme (Renin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:1eb40e54-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esatenolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1eb43686-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esatenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1eb45ecc-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esatenolol targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.75']} DrugCentral uuid:1eb487a8-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:4702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esatenolol targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5']} DrugCentral uuid:1eb4afe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esatenolol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.93']} DrugCentral uuid:1eb4d83e-d20a-11ec-8377-0242ac110003 UniProtKB:B0FL73 biolink:molecularly_interacts_with DrugCentral:4702 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esatenolol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:1eb50066-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4704 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 semustine targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.744']} DrugCentral uuid:1eb52a50-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium aurothiomalate targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.074']} DrugCentral uuid:1eb5526e-d20a-11ec-8377-0242ac110003 UniProtKB:Q16881 biolink:molecularly_interacts_with DrugCentral:4706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium aurothiomalate targets Enzyme (Thioredoxin reductase 1, cytoplasmic) DrugCentral uuid:1eb57686-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium aurothiomalate targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.624']} DrugCentral uuid:1eb59e90-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium aurothiomalate targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.091']} DrugCentral uuid:1eb5c71c-d20a-11ec-8377-0242ac110003 UniProtKB:P07711 biolink:molecularly_interacts_with DrugCentral:4706 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium aurothiomalate targets Enzyme (Cathepsin L1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1eb5f084-d20a-11ec-8377-0242ac110003 UniProtKB:P32241 biolink:molecularly_interacts_with DrugCentral:4710 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatorelin is agonist of GPCR (Vasoactive intestinal polypeptide receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1eb619b0-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:1eb641e2-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1eb66adc-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1eb69318-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1eb6bb5e-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1eb6e480-d20a-11ec-8377-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1eb70cbc-d20a-11ec-8377-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1eb7357a-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.17']} DrugCentral uuid:1eb75db6-d20a-11ec-8377-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1eb7864c-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:1eb7ae88-d20a-11ec-8377-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1eb7d6b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1eb7fee2-d20a-11ec-8377-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1eb827dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1eb85018-d20a-11ec-8377-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1eb87840-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1eb8a086-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1eb8caca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1eb8f630-d20a-11ec-8377-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1eb92182-d20a-11ec-8377-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.35']} DrugCentral uuid:1eb949f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1eb97286-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:1eb99aa4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1eb9c2c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1eb9eb1c-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.36']} DrugCentral uuid:1eba151a-d20a-11ec-8377-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1eba3d56-d20a-11ec-8377-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1eba659c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1eba8ee6-d20a-11ec-8377-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1ebab9fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1ebae49a-d20a-11ec-8377-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1ebb0ce0-d20a-11ec-8377-0242ac110003 UniProtKB:Q62137 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:1ebb3562-d20a-11ec-8377-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1ebbde40-d20a-11ec-8377-0242ac110003 UniProtKB:Q62120 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:1ebc0bcc-d20a-11ec-8377-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1ebc382c-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:1ebc382c-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:1ebc779c-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:1ebc779c-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:1ebc779c-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK1/JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.12']} DrugCentral uuid:1ebcbba8-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1ebcbba8-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1ebcef2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q63272 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1ebd1bde-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.391']} DrugCentral uuid:1ebd1bde-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK2/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.391']} DrugCentral uuid:1ebd53e2-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.252']} DrugCentral uuid:1ebd53e2-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4713 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofacitinib is inhibitor of Kinase (JAK3/JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.252']} DrugCentral uuid:1ebd8736-d20a-11ec-8377-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib is inhibitor of Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.907']} DrugCentral uuid:1ebdb04e-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.65']} DrugCentral uuid:1ebdd880-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1ebe01ac-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1ebe29e8-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:1ebe5558-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.95']} DrugCentral uuid:1ebe7dda-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1ebea62a-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:1ebece52-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:1ebef706-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.337']} DrugCentral uuid:1ebf1f4c-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.947']} DrugCentral uuid:1ebf47a6-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.284']} DrugCentral uuid:1ebf70a0-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.456']} DrugCentral uuid:1ebf98f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib is inhibitor of Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.845']} DrugCentral uuid:1ebfc118-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4715 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabozantinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.886']} DrugCentral uuid:1ebfe968-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:1ec0130c-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.432']} DrugCentral uuid:1ec03ba2-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.903']} DrugCentral uuid:1ec063e8-d20a-11ec-8377-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Breakpoint cluster region protein) DrugCentral uuid:1ec0880a-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1ec12364-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1ec15cc6-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1ec18606-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.824']} DrugCentral uuid:1ec1af32-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.959']} DrugCentral uuid:1ec1d7fa-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.03']} DrugCentral uuid:1ec20266-d20a-11ec-8377-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.268']} DrugCentral uuid:1ec22b38-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:1ec256b2-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.658']} DrugCentral uuid:1ec27fa2-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1ec2a874-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:1ec2d128-d20a-11ec-8377-0242ac110003 UniProtKB:P00523 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.05']} DrugCentral uuid:1ec2f9e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1ec322cc-d20a-11ec-8377-0242ac110003 UniProtKB:P49336 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Cyclin-dependent kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.17']} DrugCentral uuid:1ec34b9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1ec373ee-d20a-11ec-8377-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1ec3a06c-d20a-11ec-8377-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1ec3a06c-d20a-11ec-8377-0242ac110003 UniProtKB:P11274 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib targets Kinase (Bcr/Abl fusion protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1ec3d546-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4716 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponatinib is inhibitor of Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1ec3fef4-d20a-11ec-8377-0242ac110003 UniProtKB:O95838 biolink:molecularly_interacts_with DrugCentral:4718 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teduglutide is agonist of GPCR (Glucagon-like peptide 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:1ec42758-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z0W0 biolink:molecularly_interacts_with DrugCentral:4718 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teduglutide targets GPCR (Glucagon-like peptide 2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.1']} DrugCentral uuid:1ec45048-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicinol targets Transporter (Multidrug resistance protein 1) DrugCentral uuid:1ec474a6-d20a-11ec-8377-0242ac110003 UniProtKB:P11388 biolink:molecularly_interacts_with DrugCentral:4719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicinol targets Enzyme (DNA topoisomerase 2-alpha) DrugCentral uuid:1ec498fa-d20a-11ec-8377-0242ac110003 UniProtKB:P33527 biolink:molecularly_interacts_with DrugCentral:4719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicinol targets Transporter (Multidrug resistance-associated protein 1) DrugCentral uuid:1ec4bd30-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:4719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicinol targets Transporter (ATP-binding cassette sub-family G member 2) DrugCentral uuid:1ec4e1ac-d20a-11ec-8377-0242ac110003 UniProtKB:O95255 biolink:molecularly_interacts_with DrugCentral:4719 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daunorubicinol targets Transporter (Multidrug resistance-associated protein 6) DrugCentral uuid:1ec5068c-d20a-11ec-8377-0242ac110003 UniProtKB:P55157 biolink:molecularly_interacts_with DrugCentral:4721 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lomitapide is inhibitor of Cytosolic other (Microsomal triglyceride transfer protein large subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.097']} DrugCentral uuid:1ec52f36-d20a-11ec-8377-0242ac110003 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:4723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 succinimide targets Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.58']} DrugCentral uuid:1ec557ae-d20a-11ec-8377-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:4723 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 succinimide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1ec58076-d20a-11ec-8377-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:4727 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tacalcitol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.5']} DrugCentral uuid:1ec5aa42-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.573']} DrugCentral uuid:1ec5d2ce-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1ec5fb28-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.155']} DrugCentral uuid:1ec6242c-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1ec64d76-d20a-11ec-8377-0242ac110003 UniProtKB:P12527 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Arachidonate 5-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1ec67602-d20a-11ec-8377-0242ac110003 UniProtKB:O97554 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1ec69e66-d20a-11ec-8377-0242ac110003 UniProtKB:O02768 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1ec6cb5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1ec6cb5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap targets Enzyme (Cyclooxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1ec6feec-d20a-11ec-8377-0242ac110003 UniProtKB:P48050 biolink:molecularly_interacts_with DrugCentral:4728 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenidap is activator of Ion channel (Inward rectifier potassium channel 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec76256-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ES14 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside targets Ion channel (GABA-A receptor; anion channel) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ec83ce4-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:1ec83ce4-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:1ec83ce4-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.699']} DrugCentral uuid:1ec884ba-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:1ec884ba-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:1ec884ba-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.886']} DrugCentral uuid:1ec8cb82-d20a-11ec-8377-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.824']} DrugCentral uuid:1ec8cb82-d20a-11ec-8377-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.824']} DrugCentral uuid:1ec8cb82-d20a-11ec-8377-0242ac110003 UniProtKB:P18507 biolink:molecularly_interacts_with DrugCentral:4731 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiocolchicoside is negative modulator of Ion channel (GABA A receptor alpha-1/beta-1/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.824']} DrugCentral uuid:1ec909d0-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioctic acid targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1ec93734-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:4732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioctic acid targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1ec93734-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBT2 biolink:molecularly_interacts_with DrugCentral:4732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioctic acid targets Enzyme (SUMO-activating enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1ec96dc6-d20a-11ec-8377-0242ac110003 UniProtKB:P9WMN3 biolink:molecularly_interacts_with DrugCentral:4732 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thioctic acid targets Enzyme (Bifunctional protein GlmU) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1ec99616-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.699']} DrugCentral uuid:1ec9be70-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.971']} DrugCentral uuid:1ec9e760-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.035']} DrugCentral uuid:1eca0fba-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.56']} DrugCentral uuid:1eca3882-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.071']} DrugCentral uuid:1eca60c8-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.538']} DrugCentral uuid:1eca897c-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.135']} DrugCentral uuid:1ecab1d6-d20a-11ec-8377-0242ac110003 UniProtKB:P10635 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Cytochrome P450 2D6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:1ecada12-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.718']} DrugCentral uuid:1ecb0262-d20a-11ec-8377-0242ac110003 UniProtKB:P22748 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.25']} DrugCentral uuid:1ecb2b98-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1ecb5410-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1ecb7c88-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2D0 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 5B, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1ecba6ae-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1ecbd034-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NR96 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Membrane receptor (Toll-like receptor 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1ecbf87a-d20a-11ec-8377-0242ac110003 UniProtKB:P07451 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1ecc20fc-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1ecc49ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.18']} DrugCentral uuid:1ecc721e-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.111']} DrugCentral uuid:1ecc9a50-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N1Q1 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1eccc296-d20a-11ec-8377-0242ac110003 UniProtKB:Q932Y6 biolink:molecularly_interacts_with DrugCentral:4733 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thiomersal targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.77']} DrugCentral uuid:1eccec1c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1ecd2f42-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:1ecd2f42-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:1ecd2f42-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:1ecd2f42-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:1ecd2f42-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:1ecd2f42-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:1ecd2f42-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:1ecd2f42-d20a-11ec-8377-0242ac110003 UniProtKB:P9WPV7 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline is inhibitor of Enzyme (ATP synthase) DrugCentral uuid:1ecd9766-d20a-11ec-8377-0242ac110003 UniProtKB:Q5TIX5 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline targets Enzyme (ATP synthase subunit c) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1ecdbfac-d20a-11ec-8377-0242ac110003 UniProtKB:P00845 biolink:molecularly_interacts_with DrugCentral:4741 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bedaquiline targets Enzyme (ATP synthase subunit c) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1ecde810-d20a-11ec-8377-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:4744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crofelemer is inhibitor of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.155']} DrugCentral uuid:1ece1060-d20a-11ec-8377-0242ac110003 UniProtKB:Q5XXA6 biolink:molecularly_interacts_with DrugCentral:4744 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crofelemer is inhibitor of Ion channel (Anoctamin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:1ece391e-d20a-11ec-8377-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:4746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pomalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1ece6164-d20a-11ec-8377-0242ac110003 UniProtKB:A4TVL0 biolink:molecularly_interacts_with DrugCentral:4746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pomalidomide targets Unclassified (Cereblon isoform 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1ece89e6-d20a-11ec-8377-0242ac110003 UniProtKB:Q96SW2 biolink:molecularly_interacts_with DrugCentral:4746 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pomalidomide is modulator of Cytosolic other (Protein cereblon) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.577']} DrugCentral uuid:1eceb326-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4749 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ospemifene is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.082']} DrugCentral uuid:1ecedb6c-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobetaxolol is antagonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1ecf03a8-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4752 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levobetaxolol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:1ecf2bee-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDS4 biolink:molecularly_interacts_with DrugCentral:4757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimethyl fumarate targets GPCR (Hydroxycarboxylic acid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1ecf55ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q14145 biolink:molecularly_interacts_with DrugCentral:4757 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dimethyl fumarate is inhibitor of Cytosolic other (Kelch-like ECH-associated protein 1) DrugCentral uuid:1ecf79fa-d20a-11ec-8377-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 canagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.658']} DrugCentral uuid:1ecfa2ae-d20a-11ec-8377-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 canagliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ecfcb12-d20a-11ec-8377-0242ac110003 UniProtKB:Q9YQ12 biolink:molecularly_interacts_with DrugCentral:4758 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 canagliflozin targets Enzyme (Protease) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1ecff3a8-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1ed01c16-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.42']} DrugCentral uuid:1ed04448-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1ed06cac-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.73']} DrugCentral uuid:1ed095c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16790 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1ed0bf5e-d20a-11ec-8377-0242ac110003 UniProtKB:O43570 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1ed0e7c2-d20a-11ec-8377-0242ac110003 UniProtKB:P43166 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1ed11030-d20a-11ec-8377-0242ac110003 UniProtKB:Q9ULX7 biolink:molecularly_interacts_with DrugCentral:4773 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ethyl hydroxybenzoate targets Enzyme (Carbonic anhydrase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1ed1393e-d20a-11ec-8377-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:4778 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ridaforolimus is inhibitor of Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.699']} DrugCentral uuid:1ed16170-d20a-11ec-8377-0242ac110003 UniProtKB:D2WKD8 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets Ion channel (Sodium/potassium-transporting ATPase subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.289']} DrugCentral uuid:1ed1898e-d20a-11ec-8377-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.736']} DrugCentral uuid:1ed1b1f2-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.961']} DrugCentral uuid:1ed1da9c-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.477']} DrugCentral uuid:1ed202d8-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.111']} DrugCentral uuid:1ed22b0a-d20a-11ec-8377-0242ac110003 UniProtKB:P21452 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets GPCR (Substance-K receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.818']} DrugCentral uuid:1ed25350-d20a-11ec-8377-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.497']} DrugCentral uuid:1ed27e98-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4794 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gramicidin targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.724']} DrugCentral uuid:1ed2a6f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q5AJ71 biolink:molecularly_interacts_with DrugCentral:4796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium propionate targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.29']} DrugCentral uuid:1ed2cf42-d20a-11ec-8377-0242ac110003 UniProtKB:B2GV46 biolink:molecularly_interacts_with DrugCentral:4796 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium propionate targets GPCR (Free fatty acid receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1ed2f88c-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium nitrite targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['1.2']} DrugCentral uuid:1ed320dc-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium nitrite targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['2.08']} DrugCentral uuid:1ed34a4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9D6N1 biolink:molecularly_interacts_with DrugCentral:4797 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sodium nitrite targets Enzyme (Carbonic anhydrase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['1.9']} DrugCentral uuid:1ed3728a-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilanterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1ed39b34-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilanterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1ed3c3c0-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4799 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vilanterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1ed3ebfc-d20a-11ec-8377-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1ed41456-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:1ed43fe4-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:1ed468ca-d20a-11ec-8377-0242ac110003 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1ed49110-d20a-11ec-8377-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:1ed4b94c-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1ed4e264-d20a-11ec-8377-0242ac110003 UniProtKB:P10398 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Serine/threonine-protein kinase A-Raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1ed50b0e-d20a-11ec-8377-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1ed53340-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1ed55b72-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:1ed5849e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:1ed5acee-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1ed5d534-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y572 biolink:molecularly_interacts_with DrugCentral:4801 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dabrafenib targets Kinase (Receptor-interacting serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1ed5fd7a-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trametinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:1ed627b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trametinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:1ed6500e-d20a-11ec-8377-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trametinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.036']} DrugCentral uuid:1ed67868-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4802 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trametinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.61']} DrugCentral uuid:1ed6a2b6-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4804 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palifermin is agonist of Kinase (Fibroblast growth factor receptor 2) DrugCentral uuid:1ed6c732-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolutegravir targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1ed6ef82-d20a-11ec-8377-0242ac110003 UniProtKB:Q60492 biolink:molecularly_interacts_with DrugCentral:4805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolutegravir targets Membrane other (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1ed718ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q62666 biolink:molecularly_interacts_with DrugCentral:4805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolutegravir targets Transporter (Vesicular acetylcholine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1ed7423e-d20a-11ec-8377-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:4805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolutegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.57']} DrugCentral uuid:1ed76a70-d20a-11ec-8377-0242ac110003 UniProtKB:Q5U3Y7 biolink:molecularly_interacts_with DrugCentral:4805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolutegravir targets Unclassified (Sigma intracellular receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:1ed792ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:4805 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dolutegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.131']} DrugCentral uuid:1ed7bb24-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1ed7e554-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1ed80fac-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1ed839d2-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1ed863bc-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1ed88c70-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1ed8b4e8-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1ed8dd42-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1ed905a6-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:1ed92e64-d20a-11ec-8377-0242ac110003 UniProtKB:P23977 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1ed956c8-d20a-11ec-8377-0242ac110003 UniProtKB:P35563 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1ed97f22-d20a-11ec-8377-0242ac110003 UniProtKB:P28565 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1ed9a790-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.699']} DrugCentral uuid:1ed9d396-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.796']} DrugCentral uuid:1ed9fc36-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1eda24b8-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:1eda4d9e-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.481']} DrugCentral uuid:1eda777e-d20a-11ec-8377-0242ac110003 UniProtKB:P46098 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine is antagonist of Ion channel (5-hydroxytryptamine receptor 3A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.432']} DrugCentral uuid:1edaa000-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:4806 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vortioxetine is antagonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.268']} DrugCentral uuid:1edac864-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NP56 biolink:molecularly_interacts_with DrugCentral:4807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riociguat targets Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 7B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.538']} DrugCentral uuid:1edaf140-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:4807 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 riociguat is positive allosteric modulator of Enzyme (Guanylate cyclase soluble subunit beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'MEC', 'has_quantitative_value': ['7.523']} DrugCentral uuid:1edb1a94-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipidacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1edb42da-d20a-11ec-8377-0242ac110003 UniProtKB:O42275 biolink:molecularly_interacts_with DrugCentral:4808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipidacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1edb6af8-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:4808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipidacrine targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1edb951e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JKC1 biolink:molecularly_interacts_with DrugCentral:4808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipidacrine targets Enzyme (Butyrylcholinesterase; Protein Bche) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.658']} DrugCentral uuid:1edbbd3c-d20a-11ec-8377-0242ac110003 UniProtKB:P37136 biolink:molecularly_interacts_with DrugCentral:4808 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipidacrine targets Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.569']} DrugCentral uuid:1edbe5c8-d20a-11ec-8377-0242ac110003 UniProtKB:P25101 biolink:molecularly_interacts_with DrugCentral:4809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 macitentan is antagonist of GPCR (Endothelin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.301']} DrugCentral uuid:1edc0e40-d20a-11ec-8377-0242ac110003 UniProtKB:P24530 biolink:molecularly_interacts_with DrugCentral:4809 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 macitentan is antagonist of GPCR (Endothelin B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.408']} DrugCentral uuid:1edc3730-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1edc602a-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1edc8866-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:1edcb1ba-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:1edcdadc-d20a-11ec-8377-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:1edd0336-d20a-11ec-8377-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1edd2bcc-d20a-11ec-8377-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1edd541c-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1edd7d84-d20a-11ec-8377-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.48']} DrugCentral uuid:1edda5d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BRX8 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Unclassified (Redox-regulatory protein FAM213A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1eddce38-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.854']} DrugCentral uuid:1eddf76e-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.495']} DrugCentral uuid:1ede1fd2-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.721']} DrugCentral uuid:1ede482c-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.201']} DrugCentral uuid:1ede7072-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.387']} DrugCentral uuid:1ede9930-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:1edec18a-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.194']} DrugCentral uuid:1edeeac0-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:1edf1400-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.469']} DrugCentral uuid:1edf3e80-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:1edf66d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:1edf8f16-d20a-11ec-8377-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.155']} DrugCentral uuid:1edfb784-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1edfe092-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:1ee00900-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4810 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrutinib is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.143']} DrugCentral uuid:1ee03182-d20a-11ec-8377-0242ac110003 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:4811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sofosbuvir is inhibitor of Enzyme (NS5B protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1ee059f0-d20a-11ec-8377-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4811 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sofosbuvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC90', 'has_quantitative_value': ['6.959']} DrugCentral uuid:1ee08290-d20a-11ec-8377-0242ac110003 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simeprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1ee0afa4-d20a-11ec-8377-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simeprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1ee0afa4-d20a-11ec-8377-0242ac110003 UniProtKB:D2K2A8 biolink:molecularly_interacts_with DrugCentral:4812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simeprevir is inhibitor of Enzyme (Hepatitis C virus serine protease, NS3/NS4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1ee0e348-d20a-11ec-8377-0242ac110003 UniProtKB:A0A0K1CY61 biolink:molecularly_interacts_with DrugCentral:4812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simeprevir targets Unclassified (Nonstructural protein NS3-4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:1ee10d14-d20a-11ec-8377-0242ac110003 UniProtKB:Q6GYR8 biolink:molecularly_interacts_with DrugCentral:4812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simeprevir is inhibitor of Polyprotein (Polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.44']} DrugCentral uuid:1ee135a0-d20a-11ec-8377-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4812 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 simeprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.444']} DrugCentral uuid:1ee15e18-d20a-11ec-8377-0242ac110003 UniProtKB:P10613 biolink:molecularly_interacts_with DrugCentral:4813 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 luliconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:1ee1826c-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olodaterol targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:1ee1ab98-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olodaterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1ee1d42e-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4814 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olodaterol is antagonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.14']} DrugCentral uuid:1ee1fcd8-d20a-11ec-8377-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4815 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lixisenatide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.845']} DrugCentral uuid:1ee2251e-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:4816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umeclidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:1ee24df0-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:4816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umeclidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.9']} DrugCentral uuid:1ee277a8-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umeclidinium targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.796']} DrugCentral uuid:1ee2a020-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:4816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umeclidinium targets GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.824']} DrugCentral uuid:1ee2c8b6-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4816 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umeclidinium is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.222']} DrugCentral uuid:1ee2f37c-d20a-11ec-8377-0242ac110003 UniProtKB:O95342 biolink:molecularly_interacts_with DrugCentral:4817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifamycin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1ee31bcc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6L6 biolink:molecularly_interacts_with DrugCentral:4817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifamycin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1B1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1ee34458-d20a-11ec-8377-0242ac110003 UniProtKB:P46721 biolink:molecularly_interacts_with DrugCentral:4817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifamycin is inhibitor of Transporter (Solute carrier organic anion transporter family member 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1ee36d52-d20a-11ec-8377-0242ac110003 UniProtKB:O70127 biolink:molecularly_interacts_with DrugCentral:4817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifamycin targets Transporter (Bile salt export pump) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1ee39660-d20a-11ec-8377-0242ac110003 UniProtKB:P0A8V2 biolink:molecularly_interacts_with DrugCentral:4817 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rifamycin is inhibitor of Enzyme (DNA-directed RNA polymerase subunit beta) DrugCentral uuid:1ee3ba82-d20a-11ec-8377-0242ac110003 UniProtKB:P05067 biolink:molecularly_interacts_with DrugCentral:4818 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 florbetaben F18 targets Unclassified (Amyloid beta A4 protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.65']} DrugCentral uuid:1ee3e322-d20a-11ec-8377-0242ac110003 UniProtKB:P48039 biolink:molecularly_interacts_with DrugCentral:4820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tasimelteon is agonist of GPCR (Melatonin receptor type 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.45']} DrugCentral uuid:1ee40be0-d20a-11ec-8377-0242ac110003 UniProtKB:P49286 biolink:molecularly_interacts_with DrugCentral:4820 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tasimelteon is agonist of GPCR (Melatonin receptor type 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:1ee4346c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:4821 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 seractide is agonist of GPCR (Adrenocorticotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.009']} DrugCentral uuid:1ee45cd0-d20a-11ec-8377-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:4822 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laninamivir octanoate hydrate targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1ee48520-d20a-11ec-8377-0242ac110003 UniProtKB:Q194T1 biolink:molecularly_interacts_with DrugCentral:4822 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 laninamivir octanoate hydrate targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1ee4ae6a-d20a-11ec-8377-0242ac110003 UniProtKB:B4URF0 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:1ee4d6d8-d20a-11ec-8377-0242ac110003 UniProtKB:P10481 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir targets Enzyme (Sialidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.4']} DrugCentral uuid:1ee4ff5a-d20a-11ec-8377-0242ac110003 UniProtKB:A5Z252 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1ee527c8-d20a-11ec-8377-0242ac110003 UniProtKB:P03470 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1ee550b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y3R4 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir targets Enzyme (Sialidase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.25']} DrugCentral uuid:1ee5794e-d20a-11ec-8377-0242ac110003 UniProtKB:D5F1R0 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:1ee5a19e-d20a-11ec-8377-0242ac110003 UniProtKB:P03471 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir targets Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1ee5ca20-d20a-11ec-8377-0242ac110003 UniProtKB:P03468 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.85']} DrugCentral uuid:1ee5f2f2-d20a-11ec-8377-0242ac110003 UniProtKB:P03474 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1ee61b7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9IGQ6 biolink:molecularly_interacts_with DrugCentral:4823 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peramivir is inhibitor of Enzyme (Neuraminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.08']} DrugCentral uuid:1ee643f6-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4824 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etilefrine pivalate is agonist of GPCR (Beta-1 adrenergic receptor) DrugCentral uuid:1ee6685e-d20a-11ec-8377-0242ac110003 UniProtKB:P48357 biolink:molecularly_interacts_with DrugCentral:4826 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 metreleptin is agonist of Membrane receptor (Leptin receptor) DrugCentral uuid:1ee68e88-d20a-11ec-8377-0242ac110003 UniProtKB:Q07343 biolink:molecularly_interacts_with DrugCentral:4829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:1ee6b9e4-d20a-11ec-8377-0242ac110003 UniProtKB:P27815 biolink:molecularly_interacts_with DrugCentral:4829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1ee6e22a-d20a-11ec-8377-0242ac110003 UniProtKB:Q08493 biolink:molecularly_interacts_with DrugCentral:4829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.93']} DrugCentral uuid:1ee70b92-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:4829 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apremilast is inhibitor of Enzyme (cAMP-specific 3',5'-cyclic phosphodiesterase 4D) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.131']} DrugCentral uuid:1ee73496-d20a-11ec-8377-0242ac110003 UniProtKB:Q2M3M2 biolink:molecularly_interacts_with DrugCentral:4830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 empagliflozin targets Transporter (Sodium/glucose cotransporter 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.959']} DrugCentral uuid:1ee75ce6-d20a-11ec-8377-0242ac110003 UniProtKB:A0PJK1 biolink:molecularly_interacts_with DrugCentral:4830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 empagliflozin targets Transporter (Sodium/glucose cotransporter 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.959']} DrugCentral uuid:1ee78540-d20a-11ec-8377-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 empagliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.081']} DrugCentral uuid:1ee7adc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WWX8 biolink:molecularly_interacts_with DrugCentral:4830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 empagliflozin targets Transporter (Sodium/myo-inositol cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:1ee7d73e-d20a-11ec-8377-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4830 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 empagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.244']} DrugCentral uuid:1ee7ffd4-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:4832 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naloxegol is antagonist of GPCR (Mu-type opioid receptor) DrugCentral uuid:1ee8241e-d20a-11ec-8377-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4833 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemigliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.328']} DrugCentral uuid:1ee84dae-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4833 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemigliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:1ee879d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q16739 biolink:molecularly_interacts_with DrugCentral:4834 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eliglustat is inhibitor of Enzyme (Ceramide glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.827']} DrugCentral uuid:1ee8a452-d20a-11ec-8377-0242ac110003 UniProtKB:P00813 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide targets Enzyme (Adenosine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1ee8ccac-d20a-11ec-8377-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1ee8f5d8-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1ee91e32-d20a-11ec-8377-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.9']} DrugCentral uuid:1ee946a0-d20a-11ec-8377-0242ac110003 UniProtKB:P33033 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide targets GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:1ee96edc-d20a-11ec-8377-0242ac110003 UniProtKB:P41149 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide targets GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:1ee9979a-d20a-11ec-8377-0242ac110003 UniProtKB:P56450 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide targets GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:1ee9bfea-d20a-11ec-8377-0242ac110003 UniProtKB:Q01727 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide targets GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:1ee9e830-d20a-11ec-8377-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:4836 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 afamelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:1eea1080-d20a-11ec-8377-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:4839 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprotinin is inhibitor of Enzyme (Plasminogen) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1eea39de-d20a-11ec-8377-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:4839 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aprotinin is inhibitor of Enzyme (Plasma kallikrein) DrugCentral uuid:1eea5e46-d20a-11ec-8377-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:4846 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ecallantide is inhibitor of Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.602']} DrugCentral uuid:1eea86dc-d20a-11ec-8377-0242ac110003 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:4848 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatropin is agonist of GPCR (Growth hormone receptor) DrugCentral uuid:1eeaaafe-d20a-11ec-8377-0242ac110003 UniProtKB:P00761 biolink:molecularly_interacts_with DrugCentral:4853 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cridanimod targets Enzyme (Trypsin) {'has_attribute_type': 'IAO:0000004', 'name': 'AC50', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1eead402-d20a-11ec-8377-0242ac110003 UniProtKB:Q3TBT3 biolink:molecularly_interacts_with DrugCentral:4853 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cridanimod targets Unclassified (Stimulator of interferon genes protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1eeafc98-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 conjugated estrogens is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:1eeb2204-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4855 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 conjugated estrogens is agonist of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:1eeb4644-d20a-11ec-8377-0242ac110003 UniProtKB:P08842 biolink:molecularly_interacts_with DrugCentral:4857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone sulphate targets Enzyme (Steryl-sulfatase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.22']} DrugCentral uuid:1eeb6f34-d20a-11ec-8377-0242ac110003 UniProtKB:Q80UJ1 biolink:molecularly_interacts_with DrugCentral:4857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone sulphate targets Transporter (Solute carrier family 22 member 20) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.24']} DrugCentral uuid:1eeb97b6-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:4857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone sulphate is agonist of Nuclear hormone receptor (Estrogen receptor) DrugCentral uuid:1eebbc28-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:4857 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estrone sulphate is agonist of Nuclear hormone receptor (Estrogen receptor beta) DrugCentral uuid:1eebe068-d20a-11ec-8377-0242ac110003 UniProtKB:Q60748 biolink:molecularly_interacts_with DrugCentral:4858 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1eec0a66-d20a-11ec-8377-0242ac110003 UniProtKB:P47866 biolink:molecularly_interacts_with DrugCentral:4858 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1eec34aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q13324 biolink:molecularly_interacts_with DrugCentral:4858 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1eec5d2c-d20a-11ec-8377-0242ac110003 UniProtKB:P34998 biolink:molecularly_interacts_with DrugCentral:4858 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticorelin is agonist of GPCR (Corticotropin-releasing factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.481']} DrugCentral uuid:1eec8996-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenibut is agonist of GPCR (GABA-B receptor) DrugCentral uuid:1eec8996-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBS5 biolink:molecularly_interacts_with DrugCentral:4863 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 phenibut is agonist of GPCR (GABA-B receptor) DrugCentral uuid:1eecbbf0-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1eece454-d20a-11ec-8377-0242ac110003 UniProtKB:P31652 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.07']} DrugCentral uuid:1eed248c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1eed248c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1eed248c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1eed248c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1eed248c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1eed248c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1eed248c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R1M7 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran targets Ion channel (Glutamate NMDA receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1eed91b0-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.951']} DrugCentral uuid:1eedba46-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:4864 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 levomilnacipran is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.035']} DrugCentral uuid:1eede408-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebanazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) DrugCentral uuid:1eee083e-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:4865 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mebanazine is inhibitor of Enzyme (Amine oxidase [flavin-containing] A) DrugCentral uuid:1eee2c74-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1eee54b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1eee7efe-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1eeea776-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1eeecfd0-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1eeef820-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1eef2110-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1eef496a-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1eef71a6-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1eef99f6-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1eefc4ee-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1eefed48-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.94']} DrugCentral uuid:1ef015ac-d20a-11ec-8377-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1ef03df2-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1ef066b0-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1ef08f14-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.56']} DrugCentral uuid:1ef0b746-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1ef0e07c-d20a-11ec-8377-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1ef108d6-d20a-11ec-8377-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1ef1313a-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.87']} DrugCentral uuid:1ef1598a-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:1ef18338-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1ef1ad9a-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.71']} DrugCentral uuid:1ef1d5f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.65']} DrugCentral uuid:1ef1fe44-d20a-11ec-8377-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1ef227d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:1ef2501a-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1ef2796e-d20a-11ec-8377-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1ef2a1c8-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1ef2cb30-d20a-11ec-8377-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1ef2f39e-d20a-11ec-8377-0242ac110003 UniProtKB:P41212 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Transcription factor (Transcription factor ETV6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1ef31bf8-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1ef344d4-d20a-11ec-8377-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.097']} DrugCentral uuid:1ef371ca-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.155']} DrugCentral uuid:1ef39c54-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.638']} DrugCentral uuid:1ef3c4e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4866 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ceritinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.699']} DrugCentral uuid:1ef3ee16-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1ef41698-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1ef43ee8-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1ef4674c-d20a-11ec-8377-0242ac110003 UniProtKB:P49327 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets Enzyme (Fatty acid synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1ef4906e-d20a-11ec-8377-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1ef4b8be-d20a-11ec-8377-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1ef4e10e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NFI3 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets Enzyme (Cytosolic endo-beta-N-acetylglucosaminidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1ef50954-d20a-11ec-8377-0242ac110003 UniProtKB:O94760 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets Enzyme (N(G),N(G)-dimethylarginine dimethylaminohydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.28']} DrugCentral uuid:1ef532da-d20a-11ec-8377-0242ac110003 UniProtKB:P14735 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets Enzyme (Insulin-degrading enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1ef55b2a-d20a-11ec-8377-0242ac110003 UniProtKB:Q6SZW1 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole targets Unclassified (Sterile alpha and TIR motif-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:1ef58794-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:1ef58794-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4867 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dexrabeprazole is inhibitor of Transporter (Potassium-transporting ATPase) DrugCentral uuid:1ef5b5a2-d20a-11ec-8377-0242ac110003 UniProtKB:P25116 biolink:molecularly_interacts_with DrugCentral:4870 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vorapaxar is antagonist of GPCR (Proteinase-activated receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.092']} DrugCentral uuid:1ef5de4c-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tedizolid phosphate targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1ef60692-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:4873 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tedizolid phosphate targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1ef62ece-d20a-11ec-8377-0242ac110003 UniProtKB:F2SHH3 biolink:molecularly_interacts_with DrugCentral:4874 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efinaconazole is inhibitor of Enzyme (Lanosterol 14-alpha demethylase) DrugCentral uuid:1ef6541c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclatasvir targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.53']} DrugCentral uuid:1ef67d34-d20a-11ec-8377-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.64']} DrugCentral uuid:1ef6a584-d20a-11ec-8377-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.64']} DrugCentral uuid:1ef6cdd4-d20a-11ec-8377-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.046']} DrugCentral uuid:1ef6f638-d20a-11ec-8377-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4875 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.301']} DrugCentral uuid:1ef72180-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQL6 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1ef749e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:1ef77234-d20a-11ec-8377-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:1ef79b1a-d20a-11ec-8377-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1ef7c374-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBN7 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1ef7ec6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WUI4 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.29']} DrugCentral uuid:1ef814dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1ef83de0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKV0 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.62']} DrugCentral uuid:1ef8663a-d20a-11ec-8377-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.23']} DrugCentral uuid:1ef88ea8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9XYC7 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat targets Enzyme (Histone deacetylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.67']} DrugCentral uuid:1ef8b6f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:1ef8e0b0-d20a-11ec-8377-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.57']} DrugCentral uuid:1ef908f6-d20a-11ec-8377-0242ac110003 UniProtKB:P56524 biolink:molecularly_interacts_with DrugCentral:4876 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belinostat is inhibitor of Enzyme (Histone deacetylase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.569']} DrugCentral uuid:1ef9325e-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:4877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1ef95ad6-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:4877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1ef983c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTL6 biolink:molecularly_interacts_with DrugCentral:4877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1ef9ac2a-d20a-11ec-8377-0242ac110003 UniProtKB:Q3I4V7 biolink:molecularly_interacts_with DrugCentral:4877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tavaborole targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.05']} DrugCentral uuid:1ef9d48e-d20a-11ec-8377-0242ac110003 UniProtKB:P26637 biolink:molecularly_interacts_with DrugCentral:4877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tavaborole targets Enzyme (Leucine--tRNA ligase, cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.73']} DrugCentral uuid:1ef9fcd4-d20a-11ec-8377-0242ac110003 UniProtKB:F2SF18 biolink:molecularly_interacts_with DrugCentral:4877 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tavaborole is inhibitor of Enzyme (Leucine-tRNA ligase) DrugCentral uuid:1efa21aa-d20a-11ec-8377-0242ac110003 UniProtKB:P78527 biolink:molecularly_interacts_with DrugCentral:4878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idelalisib targets Kinase (DNA-dependent protein kinase catalytic subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1efa4af4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NEB9 biolink:molecularly_interacts_with DrugCentral:4878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 3-kinase catalytic subunit type 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1efa734e-d20a-11ec-8377-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:4878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.086']} DrugCentral uuid:1efa9b8a-d20a-11ec-8377-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:4878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.248']} DrugCentral uuid:1efac786-d20a-11ec-8377-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:4878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idelalisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.051']} DrugCentral uuid:1efaf206-d20a-11ec-8377-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:4878 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 idelalisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.602']} DrugCentral uuid:1efb1a56-d20a-11ec-8377-0242ac110003 UniProtKB:P01008 biolink:molecularly_interacts_with DrugCentral:4879 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enoxaparin sodium is activator of Secreted (Antithrombin-III) DrugCentral uuid:1efb3f22-d20a-11ec-8377-0242ac110003 UniProtKB:P58308 biolink:molecularly_interacts_with DrugCentral:4881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suvorexant targets GPCR (Orexin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.06']} DrugCentral uuid:1efb679a-d20a-11ec-8377-0242ac110003 UniProtKB:P58307 biolink:molecularly_interacts_with DrugCentral:4881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suvorexant targets GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:1efb8ffe-d20a-11ec-8377-0242ac110003 UniProtKB:O43613 biolink:molecularly_interacts_with DrugCentral:4881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suvorexant is antagonist of GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:1efbb862-d20a-11ec-8377-0242ac110003 UniProtKB:O43614 biolink:molecularly_interacts_with DrugCentral:4881 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 suvorexant is antagonist of GPCR (Orexin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.456']} DrugCentral uuid:1efbe134-d20a-11ec-8377-0242ac110003 UniProtKB:P30542 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.08']} DrugCentral uuid:1efc0998-d20a-11ec-8377-0242ac110003 UniProtKB:P29275 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline targets GPCR (Adenosine receptor A2b) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1efc31f2-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline targets GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1efc5a6a-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:1efc83fa-d20a-11ec-8377-0242ac110003 UniProtKB:P25099 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline targets GPCR (Adenosine receptor A1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1efcac5e-d20a-11ec-8377-0242ac110003 UniProtKB:P30543 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline targets GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1efcd4a4-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.57']} DrugCentral uuid:1efcfd08-d20a-11ec-8377-0242ac110003 UniProtKB:P29274 biolink:molecularly_interacts_with DrugCentral:4882 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 istradefylline is antagonist of GPCR (Adenosine receptor A2a) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.66']} DrugCentral uuid:1efd2602-d20a-11ec-8377-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4885 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dulaglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) DrugCentral uuid:1efd4a2e-d20a-11ec-8377-0242ac110003 UniProtKB:P16233 biolink:molecularly_interacts_with DrugCentral:4886 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetilistat is inhibitor of Enzyme (Pancreatic triacylglycerol lipase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.225']} DrugCentral uuid:1efd7274-d20a-11ec-8377-0242ac110003 UniProtKB:P80457 biolink:molecularly_interacts_with DrugCentral:4888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiroxostat targets Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1efd9ae2-d20a-11ec-8377-0242ac110003 UniProtKB:P47989 biolink:molecularly_interacts_with DrugCentral:4888 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 topiroxostat is inhibitor of Enzyme (Xanthine dehydrogenase/oxidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.276']} DrugCentral uuid:1efdc3a0-d20a-11ec-8377-0242ac110003 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:4889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asunaprevir targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:1efdebb4-d20a-11ec-8377-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4889 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 asunaprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.398']} DrugCentral uuid:1efe140e-d20a-11ec-8377-0242ac110003 UniProtKB:P53792 biolink:molecularly_interacts_with DrugCentral:4890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1efe3d6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8C3K6 biolink:molecularly_interacts_with DrugCentral:4890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:1efe68b4-d20a-11ec-8377-0242ac110003 UniProtKB:P53790 biolink:molecularly_interacts_with DrugCentral:4890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.93']} DrugCentral uuid:1efe92b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q923I7 biolink:molecularly_interacts_with DrugCentral:4890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.25']} DrugCentral uuid:1efebd00-d20a-11ec-8377-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipragliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.727']} DrugCentral uuid:1efee62c-d20a-11ec-8377-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4890 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipragliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.132']} DrugCentral uuid:1eff1002-d20a-11ec-8377-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 luseogliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.399']} DrugCentral uuid:1eff3870-d20a-11ec-8377-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4891 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 luseogliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.646']} DrugCentral uuid:1eff60ca-d20a-11ec-8377-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:4892 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofogliflozin targets Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.073']} DrugCentral uuid:1eff89c4-d20a-11ec-8377-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:4892 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tofogliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.538']} DrugCentral uuid:1effb23c-d20a-11ec-8377-0242ac110003 UniProtKB:P07650 biolink:molecularly_interacts_with DrugCentral:4893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipiracil targets Enzyme (Thymidine phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1effdabe-d20a-11ec-8377-0242ac110003 UniProtKB:P19971 biolink:molecularly_interacts_with DrugCentral:4893 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tipiracil is inhibitor of Enzyme (Thymidine phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:1f000318-d20a-11ec-8377-0242ac110003 UniProtKB:P14174 biolink:molecularly_interacts_with DrugCentral:4894 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 iguratimod targets Unclassified (Macrophage migration inhibitory factor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1f002cd0-d20a-11ec-8377-0242ac110003 UniProtKB:P14740 biolink:molecularly_interacts_with DrugCentral:4895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teneligliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.54']} DrugCentral uuid:1f00550c-d20a-11ec-8377-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:4895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teneligliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.585']} DrugCentral uuid:1f007df2-d20a-11ec-8377-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teneligliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.268']} DrugCentral uuid:1f00a642-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4895 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teneligliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.432']} DrugCentral uuid:1f00cf0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12884 biolink:molecularly_interacts_with DrugCentral:4896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anagliptin targets Enzyme (Prolyl endopeptidase FAP) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:1f00f746-d20a-11ec-8377-0242ac110003 UniProtKB:Q6V1X1 biolink:molecularly_interacts_with DrugCentral:4896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anagliptin targets Enzyme (Dipeptidyl peptidase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.167']} DrugCentral uuid:1f011f8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q86TI2 biolink:molecularly_interacts_with DrugCentral:4896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anagliptin targets Enzyme (Dipeptidyl peptidase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:1f0147e6-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:4896 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1f017158-d20a-11ec-8377-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:4897 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 edoxaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.252']} DrugCentral uuid:1f0199da-d20a-11ec-8377-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:4898 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 netupitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.022']} DrugCentral uuid:1f01c248-d20a-11ec-8377-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ledipasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.51']} DrugCentral uuid:1f01ea98-d20a-11ec-8377-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ledipasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.51']} DrugCentral uuid:1f02159a-d20a-11ec-8377-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ledipasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:1f023eda-d20a-11ec-8377-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4899 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ledipasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.509']} DrugCentral uuid:1f026734-d20a-11ec-8377-0242ac110003 UniProtKB:P51582 biolink:molecularly_interacts_with DrugCentral:4900 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diquafosol is agonist of GPCR (P2Y purinoceptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1f028f8e-d20a-11ec-8377-0242ac110003 UniProtKB:P41231 biolink:molecularly_interacts_with DrugCentral:4900 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 diquafosol is agonist of GPCR (P2Y purinoceptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.469']} DrugCentral uuid:1f02b874-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4901 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin glargine is agonist of Kinase (Insulin receptor) DrugCentral uuid:1f02dcc8-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:4902 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imidafenacin targets GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kb', 'has_quantitative_value': ['8.384']} DrugCentral uuid:1f030554-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:4902 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imidafenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kb', 'has_quantitative_value': ['9.499']} DrugCentral uuid:1f032e3a-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.09']} DrugCentral uuid:1f0356b2-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.59']} DrugCentral uuid:1f037f0c-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:1f03a77a-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1f03d13c-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:1f03fbc6-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.57']} DrugCentral uuid:1f042420-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1f044c98-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.21']} DrugCentral uuid:1f0475b0-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1f049e28-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1f04c696-d20a-11ec-8377-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1f04f030-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.38']} DrugCentral uuid:1f0518ee-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.02']} DrugCentral uuid:1f05415c-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:1f0569ca-d20a-11ec-8377-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1f059238-d20a-11ec-8377-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1f05bdc6-d20a-11ec-8377-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1f05e94a-d20a-11ec-8377-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:1f0611c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1f063bc0-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is agonist of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.62']} DrugCentral uuid:1f06642e-d20a-11ec-8377-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1f068ca6-d20a-11ec-8377-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1f06b4f6-d20a-11ec-8377-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1f06ddf0-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:1f070636-d20a-11ec-8377-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1f072f4e-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1f075794-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.32']} DrugCentral uuid:1f0780de-d20a-11ec-8377-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1f07a924-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.49']} DrugCentral uuid:1f07d17e-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.35']} DrugCentral uuid:1f07f9ec-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1f0822dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1f084b2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1f087390-d20a-11ec-8377-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1f089bf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1f08c4c6-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1f08ed20-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1f09158e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1f093de8-d20a-11ec-8377-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1f0968a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1f0990f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1f09b94e-d20a-11ec-8377-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1f09e1c6-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1f0a0ad4-d20a-11ec-8377-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1f0a340a-d20a-11ec-8377-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:1f0a5c8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1f0a8554-d20a-11ec-8377-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1f0aadb8-d20a-11ec-8377-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1f0ad5fe-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1f0affa2-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1f0b29a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:1f0b5222-d20a-11ec-8377-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1f0b7a7c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1f0ba2e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1f0bcbd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:1f0bf42a-d20a-11ec-8377-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1f0c1c66-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1f0c44b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.51']} DrugCentral uuid:1f0c6d56-d20a-11ec-8377-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1f0c95c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.66']} DrugCentral uuid:1f0cbe00-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1f0ce650-d20a-11ec-8377-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.06']} DrugCentral uuid:1f0d11ac-d20a-11ec-8377-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:1f0d3b64-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1f0d63b4-d20a-11ec-8377-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:1f0d8c18-d20a-11ec-8377-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1f0db4fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1f0ddd6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1f0e062a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1f0e2ff6-d20a-11ec-8377-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1f0e5850-d20a-11ec-8377-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1f0e80aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.29']} DrugCentral uuid:1f0ea918-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1f0ed30c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1f0efe5e-d20a-11ec-8377-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1f0f29ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1f0f5520-d20a-11ec-8377-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1f0f7f00-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1f0fa746-d20a-11ec-8377-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1f0fcf96-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1f0ff7f0-d20a-11ec-8377-0242ac110003 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1f1020c2-d20a-11ec-8377-0242ac110003 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1f10493a-d20a-11ec-8377-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1f10718a-d20a-11ec-8377-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1f109a84-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:1f10c540-d20a-11ec-8377-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:1f10eebc-d20a-11ec-8377-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1f1117c0-d20a-11ec-8377-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1f1142a4-d20a-11ec-8377-0242ac110003 UniProtKB:P49840 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Glycogen synthase kinase-3 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1f116b12-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1f1194c0-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1f11bf04-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1f11e998-d20a-11ec-8377-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1f1211de-d20a-11ec-8377-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1f123b6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1f1263aa-d20a-11ec-8377-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1f128e84-d20a-11ec-8377-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1f12b6ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1f12def2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:1f1307b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1f1331fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1f135b16-d20a-11ec-8377-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1f13835c-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:1f13ac7e-d20a-11ec-8377-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1f13d4ba-d20a-11ec-8377-0242ac110003 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1f13fd00-d20a-11ec-8377-0242ac110003 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:1f142564-d20a-11ec-8377-0242ac110003 UniProtKB:Q07002 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 18) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1f144f12-d20a-11ec-8377-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1f14774e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:1f149fa8-d20a-11ec-8377-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1f14c884-d20a-11ec-8377-0242ac110003 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1f14f1ba-d20a-11ec-8377-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1f1519ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1f154232-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.64']} DrugCentral uuid:1f156a5a-d20a-11ec-8377-0242ac110003 UniProtKB:P48730 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Casein kinase I isoform delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1f159390-d20a-11ec-8377-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1f15bbc2-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.49']} DrugCentral uuid:1f15e3f4-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1f160c4e-d20a-11ec-8377-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1f16375a-d20a-11ec-8377-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1f165fc8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1f168818-d20a-11ec-8377-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1f16b054-d20a-11ec-8377-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.74']} DrugCentral uuid:1f16d976-d20a-11ec-8377-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1f1702e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.31']} DrugCentral uuid:1f172b42-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:1f175446-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1f177cf0-d20a-11ec-8377-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1f17a518-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1f17cd68-d20a-11ec-8377-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:1f17f752-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1f181f98-d20a-11ec-8377-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:1f1847c0-d20a-11ec-8377-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:1f187010-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1f189892-d20a-11ec-8377-0242ac110003 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:1f18c0e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:1f18e932-d20a-11ec-8377-0242ac110003 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1f191164-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1f1939fa-d20a-11ec-8377-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1f196240-d20a-11ec-8377-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:1f198a9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1f19b2ea-d20a-11ec-8377-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1f19dd24-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1f1a0678-d20a-11ec-8377-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1f1a2ec8-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1f1a5718-d20a-11ec-8377-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.25']} DrugCentral uuid:1f1a7fcc-d20a-11ec-8377-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1f1aa808-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1f1ad04e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1f1af8b2-d20a-11ec-8377-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1f1b217a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.07']} DrugCentral uuid:1f1b49b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q16566 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium/calmodulin-dependent protein kinase type IV) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1f1b7274-d20a-11ec-8377-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1f1b9bbe-d20a-11ec-8377-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1f1bc404-d20a-11ec-8377-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.15']} DrugCentral uuid:1f1bec54-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1f1c1486-d20a-11ec-8377-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1f1c3d3a-d20a-11ec-8377-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:1f1c656c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WXR4 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Myosin-IIIb) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1f1c8da8-d20a-11ec-8377-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1f1cb60c-d20a-11ec-8377-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1f1ce046-d20a-11ec-8377-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1f1d088c-d20a-11ec-8377-0242ac110003 UniProtKB:P36897 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (TGF-beta receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1f1d30c8-d20a-11ec-8377-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1f1d5918-d20a-11ec-8377-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1f1d824e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1f1daa94-d20a-11ec-8377-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1f1dd2c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1f1dfbf2-d20a-11ec-8377-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1f1e24b0-d20a-11ec-8377-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1f1e4d14-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1f1e755a-d20a-11ec-8377-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:1f1e9d96-d20a-11ec-8377-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1f1ec686-d20a-11ec-8377-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1f1eeec2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1f1f16fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1f1f3f4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1f1f6a3c-d20a-11ec-8377-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1f1f9282-d20a-11ec-8377-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1f1fbac8-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1f1fe37c-d20a-11ec-8377-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1f200bd6-d20a-11ec-8377-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1f203408-d20a-11ec-8377-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1f205c4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1f208534-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1f20ad84-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1f20d5ca-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1f20fe1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1f212854-d20a-11ec-8377-0242ac110003 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1f21536a-d20a-11ec-8377-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1f217bec-d20a-11ec-8377-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1f21a450-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.03']} DrugCentral uuid:1f21ccfa-d20a-11ec-8377-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.47']} DrugCentral uuid:1f21f63a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1f221eee-d20a-11ec-8377-0242ac110003 UniProtKB:O95747 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase OSR1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1f224734-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1f227038-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1f229888-d20a-11ec-8377-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.39']} DrugCentral uuid:1f22c0b0-d20a-11ec-8377-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1f22ead6-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1f23165a-d20a-11ec-8377-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.22']} DrugCentral uuid:1f233f0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.28']} DrugCentral uuid:1f23674a-d20a-11ec-8377-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1f238fe0-d20a-11ec-8377-0242ac110003 UniProtKB:Q6ZN16 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1f23b81c-d20a-11ec-8377-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1f23e06c-d20a-11ec-8377-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1f2408a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1f24317a-d20a-11ec-8377-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1f2459a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.08']} DrugCentral uuid:1f2481fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1f24aa4c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1f24d4b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.74']} DrugCentral uuid:1f24fd12-d20a-11ec-8377-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1f252580-d20a-11ec-8377-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.43']} DrugCentral uuid:1f254dd0-d20a-11ec-8377-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1f25768e-d20a-11ec-8377-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1f259ec0-d20a-11ec-8377-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.44']} DrugCentral uuid:1f25c7e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13976 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Kinase (cGMP-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1f25f01e-d20a-11ec-8377-0242ac110003 UniProtKB:P08183 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib targets Transporter (Multidrug resistance protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:1f261940-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.983']} DrugCentral uuid:1f2641a4-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:1f266a12-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:1f26926c-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:1f26bcf6-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4903 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nintedanib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.42']} DrugCentral uuid:1f26e53c-d20a-11ec-8377-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4904 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 adalimumab is antibody binding of Cytokine (Tumor necrosis factor) DrugCentral uuid:1f27097c-d20a-11ec-8377-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4905 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pegaptanib is antagonist of Secreted (Vascular endothelial growth factor A) DrugCentral uuid:1f272dbc-d20a-11ec-8377-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:4906 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fimasartan is antagonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.377']} DrugCentral uuid:1f275670-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:1f277ec0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKK3 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1f27a792-d20a-11ec-8377-0242ac110003 UniProtKB:Q53GL7 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1f27d0aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0J9 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1f27f904-d20a-11ec-8377-0242ac110003 UniProtKB:Q460N3 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Enzyme (Poly [ADP-ribose] polymerase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1f28214a-d20a-11ec-8377-0242ac110003 UniProtKB:Q2NL67 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Unclassified (Poly [ADP-ribose] polymerase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1f2849c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N5Y8 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Unclassified (Mono [ADP-ribose] polymerase PARP16) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1f287384-d20a-11ec-8377-0242ac110003 UniProtKB:O95271 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib targets Enzyme (Tankyrase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.824']} DrugCentral uuid:1f289be8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1f28c73a-d20a-11ec-8377-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:1f28efa8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6F1 biolink:molecularly_interacts_with DrugCentral:4907 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1f291988-d20a-11ec-8377-0242ac110003 UniProtKB:P22303 biolink:molecularly_interacts_with DrugCentral:4908 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acotiamide is inhibitor of Enzyme (Acetylcholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.523']} DrugCentral uuid:1f2943f4-d20a-11ec-8377-0242ac110003 UniProtKB:P31358 biolink:molecularly_interacts_with DrugCentral:4909 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alemtuzumab is antibody binding of Surface antigen (CAMPATH-1 antigen) DrugCentral uuid:1f2969a6-d20a-11ec-8377-0242ac110003 UniProtKB:P37288 biolink:molecularly_interacts_with DrugCentral:4910 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 felypressin is agonist of GPCR (Vasopressin V1a receptor) DrugCentral uuid:1f298f30-d20a-11ec-8377-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:4912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ombitasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.85']} DrugCentral uuid:1f29b852-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WMX2 biolink:molecularly_interacts_with DrugCentral:4912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ombitasvir targets Unclassified (Genome polyprotein [Cleaved into: Core protein p21) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.92']} DrugCentral uuid:1f29e192-d20a-11ec-8377-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ombitasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.301']} DrugCentral uuid:1f2a09ce-d20a-11ec-8377-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:4912 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ombitasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.854']} DrugCentral uuid:1f2a3228-d20a-11ec-8377-0242ac110003 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:4914 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasabuvir targets Enzyme (NS5B protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:1f2a5c12-d20a-11ec-8377-0242ac110003 UniProtKB:Q8JXU8 biolink:molecularly_interacts_with DrugCentral:4914 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasabuvir targets Unclassified (NS5B protein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:1f2a846c-d20a-11ec-8377-0242ac110003 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:4915 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blinatumomab is antibody binding of Surface antigen (B-lymphocyte antigen CD19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:1f2ab4a0-d20a-11ec-8377-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:4915 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blinatumomab is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1f2ab4a0-d20a-11ec-8377-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:4915 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blinatumomab is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1f2ab4a0-d20a-11ec-8377-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:4915 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 blinatumomab is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1f2af442-d20a-11ec-8377-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aflibercept is inhibitor of Secreted (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['12.301']} DrugCentral uuid:1f2b1ca6-d20a-11ec-8377-0242ac110003 UniProtKB:P49763 biolink:molecularly_interacts_with DrugCentral:4916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aflibercept is inhibitor of Secreted (Placenta growth factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.409']} DrugCentral uuid:1f2b4514-d20a-11ec-8377-0242ac110003 UniProtKB:P49765 biolink:molecularly_interacts_with DrugCentral:4916 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aflibercept is inhibitor of Secreted (Vascular endothelial growth factor B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.717']} DrugCentral uuid:1f2b6d78-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4917 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ramucirumab is antibody binding of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.3']} DrugCentral uuid:1f2b985c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15858 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide targets Ion channel (Sodium channel protein type 9 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:1f2bc08e-d20a-11ec-8377-0242ac110003 UniProtKB:P21397 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide targets Enzyme (Amine oxidase [flavin-containing] A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1f2be906-d20a-11ec-8377-0242ac110003 UniProtKB:Q9R0C9 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide targets Membrane receptor (Sigma non-opioid intracellular receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.71']} DrugCentral uuid:1f2c130e-d20a-11ec-8377-0242ac110003 UniProtKB:P19643 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide targets Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1f2c4342-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1f2c4342-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1f2c4342-d20a-11ec-8377-0242ac110003 UniProtKB:P08104 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide targets Ion channel (Sodium channel alpha subunits; brain (Types I, II, III)) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1f2c82c6-d20a-11ec-8377-0242ac110003 UniProtKB:P27338 biolink:molecularly_interacts_with DrugCentral:4921 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 safinamide is inhibitor of Enzyme (Amine oxidase [flavin-containing] B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.347']} DrugCentral uuid:1f2cab8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:4923 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 nivolumab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.14']} DrugCentral uuid:1f2cd514-d20a-11ec-8377-0242ac110003 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:4924 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pembrolizumab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:1f2d0192-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 becaplermin is agonist of Kinase (Platelet-derived growth factor receptor) DrugCentral uuid:1f2d0192-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4925 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 becaplermin is agonist of Kinase (Platelet-derived growth factor receptor) DrugCentral uuid:1f2d2f78-d20a-11ec-8377-0242ac110003 UniProtKB:P32301 biolink:molecularly_interacts_with DrugCentral:4927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albiglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1f2d59a8-d20a-11ec-8377-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:4927 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 albiglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.699']} DrugCentral uuid:1f2d820c-d20a-11ec-8377-0242ac110003 UniProtKB:P23945 biolink:molecularly_interacts_with DrugCentral:4928 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 follitropin is agonist of GPCR (Follicle-stimulating hormone receptor) DrugCentral uuid:1f2da674-d20a-11ec-8377-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:4929 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lutropin alfa is agonist of GPCR (Lutropin-choriogonadotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.9']} DrugCentral uuid:1f2dcee2-d20a-11ec-8377-0242ac110003 UniProtKB:P16473 biolink:molecularly_interacts_with DrugCentral:4930 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 thyrotropin alfa is agonist of GPCR (Thyrotropin receptor) DrugCentral uuid:1f2df426-d20a-11ec-8377-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:4931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticotropin is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1f2e1c94-d20a-11ec-8377-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:4931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticotropin is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1f2e461a-d20a-11ec-8377-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:4931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticotropin is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1f2e6e88-d20a-11ec-8377-0242ac110003 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:4931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticotropin is agonist of GPCR (Adrenocorticotropic hormone receptor) DrugCentral uuid:1f2e93ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q64326 biolink:molecularly_interacts_with DrugCentral:4931 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corticotropin is agonist of GPCR (Adrenocorticotropic hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.8']} DrugCentral uuid:1f2ec04a-d20a-11ec-8377-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:4933 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocilizumab is antibody binding of Membrane receptor (Interleukin-6 receptor) DrugCentral uuid:1f2ec04a-d20a-11ec-8377-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:4933 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tocilizumab is antibody binding of Membrane receptor (Interleukin-6 receptor) DrugCentral uuid:1f2eee76-d20a-11ec-8377-0242ac110003 UniProtKB:Q16552 biolink:molecularly_interacts_with DrugCentral:4934 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 secukinumab is antibody binding of Cytokine (Interleukin-17A) DrugCentral uuid:1f2f12c0-d20a-11ec-8377-0242ac110003 UniProtKB:P03420 biolink:molecularly_interacts_with DrugCentral:4935 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palivizumab is antibody binding of Surface antigen (Fusion glycoprotein F0) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.357']} DrugCentral uuid:1f2f3c0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q03431 biolink:molecularly_interacts_with DrugCentral:4936 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 parathyroid hormone is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) DrugCentral uuid:1f2f6040-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alectinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1f2f88b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alectinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:1f2fb11c-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:4937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alectinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1f2fdb1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:4937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alectinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:1f300388-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:4937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alectinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.721']} DrugCentral uuid:1f302c1e-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4937 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alectinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.319']} DrugCentral uuid:1f30545a-d20a-11ec-8377-0242ac110003 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:4938 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripasudil is inhibitor of Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1f307d36-d20a-11ec-8377-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:4938 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripasudil is inhibitor of Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.292']} DrugCentral uuid:1f30a59a-d20a-11ec-8377-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:4938 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripasudil is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.721']} DrugCentral uuid:1f30cde0-d20a-11ec-8377-0242ac110003 UniProtKB:P25774 biolink:molecularly_interacts_with DrugCentral:4939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vaniprevir targets Enzyme (Cathepsin S) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.11']} DrugCentral uuid:1f30f716-d20a-11ec-8377-0242ac110003 UniProtKB:A0A0K1CY61 biolink:molecularly_interacts_with DrugCentral:4939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vaniprevir targets Unclassified (Nonstructural protein NS3-4A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.3']} DrugCentral uuid:1f311f70-d20a-11ec-8377-0242ac110003 UniProtKB:K7XJL6 biolink:molecularly_interacts_with DrugCentral:4939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vaniprevir targets Unclassified (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1f3148ce-d20a-11ec-8377-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:4939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vaniprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.301']} DrugCentral uuid:1f317146-d20a-11ec-8377-0242ac110003 UniProtKB:Q99IB8 biolink:molecularly_interacts_with DrugCentral:4939 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vaniprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.046']} DrugCentral uuid:1f319b94-d20a-11ec-8377-0242ac110003 UniProtKB:P01589 biolink:molecularly_interacts_with DrugCentral:4940 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 basiliximab is antibody binding of Membrane receptor (Interleukin-2 receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:1f31c5ce-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1f31ee0a-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1f321646-d20a-11ec-8377-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1f3242e2-d20a-11ec-8377-0242ac110003 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1f3242e2-d20a-11ec-8377-0242ac110003 UniProtKB:P24385 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (Cyclin-dependent kinase 4/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1f327a32-d20a-11ec-8377-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (CDK2/Cyclin A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1f327a32-d20a-11ec-8377-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (CDK2/Cyclin A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1f32b178-d20a-11ec-8377-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (CDK6/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1f32b178-d20a-11ec-8377-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib targets Kinase (CDK6/cyclin D1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1f32e56c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib is inhibitor of Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.097']} DrugCentral uuid:1f330de4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib is inhibitor of Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.699']} DrugCentral uuid:1f333648-d20a-11ec-8377-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1f335eb6-d20a-11ec-8377-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:4941 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 palbociclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.959']} DrugCentral uuid:1f338af8-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:1f33b488-d20a-11ec-8377-0242ac110003 UniProtKB:P35218 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib targets Enzyme (Carbonic anhydrase 5A, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.88']} DrugCentral uuid:1f33dd00-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.409']} DrugCentral uuid:1f3405d2-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.187']} DrugCentral uuid:1f342e40-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1f3456b8-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1f347f12-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.658']} DrugCentral uuid:1f34a7da-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.398']} DrugCentral uuid:1f34d048-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.284']} DrugCentral uuid:1f34f992-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.292']} DrugCentral uuid:1f3521f6-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:4942 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenvatinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.337']} DrugCentral uuid:1f354c58-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:4943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arformoterol targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.6']} DrugCentral uuid:1f357476-d20a-11ec-8377-0242ac110003 UniProtKB:Q8K4Z4 biolink:molecularly_interacts_with DrugCentral:4943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arformoterol targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.9']} DrugCentral uuid:1f359d66-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:4943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arformoterol is agonist of GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.947']} DrugCentral uuid:1f35c5d4-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:4943 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 arformoterol is agonist of GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.538']} DrugCentral uuid:1f35ee9c-d20a-11ec-8377-0242ac110003 UniProtKB:P32238 biolink:molecularly_interacts_with DrugCentral:4945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancreozymin targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10']} DrugCentral uuid:1f3616c4-d20a-11ec-8377-0242ac110003 UniProtKB:P32239 biolink:molecularly_interacts_with DrugCentral:4945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancreozymin is agonist of GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1f363f0a-d20a-11ec-8377-0242ac110003 UniProtKB:P30551 biolink:molecularly_interacts_with DrugCentral:4945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancreozymin is agonist of GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1f366778-d20a-11ec-8377-0242ac110003 UniProtKB:P30553 biolink:molecularly_interacts_with DrugCentral:4945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancreozymin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.39']} DrugCentral uuid:1f369040-d20a-11ec-8377-0242ac110003 UniProtKB:P56481 biolink:molecularly_interacts_with DrugCentral:4945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancreozymin targets GPCR (Gastrin/cholecystokinin type B receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1f36b89a-d20a-11ec-8377-0242ac110003 UniProtKB:Q63931 biolink:molecularly_interacts_with DrugCentral:4945 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pancreozymin targets GPCR (Cholecystokinin receptor type A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.55']} DrugCentral uuid:1f36e108-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:4946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avibactam targets Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1f370976-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD65 biolink:molecularly_interacts_with DrugCentral:4946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avibactam targets Enzyme (Penicillin-binding protein 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1f3735ae-d20a-11ec-8377-0242ac110003 UniProtKB:P05364 biolink:molecularly_interacts_with DrugCentral:4946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avibactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.155']} DrugCentral uuid:1f375e30-d20a-11ec-8377-0242ac110003 UniProtKB:P24735 biolink:molecularly_interacts_with DrugCentral:4946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avibactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1f378694-d20a-11ec-8377-0242ac110003 UniProtKB:Q9EXV5 biolink:molecularly_interacts_with DrugCentral:4946 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avibactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1f37af66-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y275 biolink:molecularly_interacts_with DrugCentral:4949 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belimumab is antibody binding of Cytokine (Tumor necrosis factor ligand superfamily member 13B) DrugCentral uuid:1f37d7ac-d20a-11ec-8377-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:4950 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abciximab is antibody binding of Adhesion (Integrin alpha-IIb/beta-3) DrugCentral uuid:1f37d7ac-d20a-11ec-8377-0242ac110003 UniProtKB:P08514 biolink:molecularly_interacts_with DrugCentral:4950 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abciximab is antibody binding of Adhesion (Integrin alpha-IIb/beta-3) DrugCentral uuid:1f3805ce-d20a-11ec-8377-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4951 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ofatumumab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.92']} DrugCentral uuid:1f382e3c-d20a-11ec-8377-0242ac110003 UniProtKB:P01584 biolink:molecularly_interacts_with DrugCentral:4952 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 canakinumab is antibody binding of Cytokine (Interleukin-1 beta) DrugCentral uuid:1f385ab0-d20a-11ec-8377-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:4953 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclizumab is antibody binding of Membrane receptor (Interleukin-2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:1f385ab0-d20a-11ec-8377-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:4953 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclizumab is antibody binding of Membrane receptor (Interleukin-2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:1f385ab0-d20a-11ec-8377-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:4953 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daclizumab is antibody binding of Membrane receptor (Interleukin-2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:1f38994e-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4954 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cetuximab is antibody binding of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.41']} DrugCentral uuid:1f38c2ac-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:4955 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 panitumumab is agonist of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.3']} DrugCentral uuid:1f38ecc8-d20a-11ec-8377-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4956 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bevacizumab is antibody binding of Secreted (Vascular endothelial growth factor A) DrugCentral uuid:1f391310-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4957 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pertuzumab is antibody binding of Kinase (Receptor tyrosine-protein kinase erbB-2) DrugCentral uuid:1f393750-d20a-11ec-8377-0242ac110003 UniProtKB:P16410 biolink:molecularly_interacts_with DrugCentral:4958 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ipilimumab is antibody binding of Surface antigen (Cytotoxic T-lymphocyte protein 4) DrugCentral uuid:1f395ce4-d20a-11ec-8377-0242ac110003 UniProtKB:P20701 biolink:molecularly_interacts_with DrugCentral:4959 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 efalizumab is antibody binding of Adhesion (Leukocyte adhesion glycoprotein LFA-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.4']} DrugCentral uuid:1f3985d4-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4960 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin degludec is agonist of Kinase (Insulin receptor) DrugCentral uuid:1f39aa14-d20a-11ec-8377-0242ac110003 UniProtKB:P13423 biolink:molecularly_interacts_with DrugCentral:4961 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 raxibacumab is antibody binding of Secreted (Protective antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.556']} DrugCentral uuid:1f39d336-d20a-11ec-8377-0242ac110003 UniProtKB:P28908 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is binding agent of Membrane receptor (Tumor necrosis factor receptor superfamily member 8) DrugCentral uuid:1f3a1706-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f3a1706-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f3a1706-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f3a1706-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f3a1706-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f3a1706-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f3a1706-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f3a1706-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f3a1706-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4964 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brentuximab vedotin is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f3a8ab0-d20a-11ec-8377-0242ac110003 UniProtKB:O14788 biolink:molecularly_interacts_with DrugCentral:4965 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 denosumab is antibody binding of Cytokine (Tumor necrosis factor ligand superfamily member 11) DrugCentral uuid:1f3ab2ec-d20a-11ec-8377-0242ac110003 UniProtKB:P29460 biolink:molecularly_interacts_with DrugCentral:4966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-12) DrugCentral uuid:1f3ab2ec-d20a-11ec-8377-0242ac110003 UniProtKB:P29460 biolink:molecularly_interacts_with DrugCentral:4966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-12) DrugCentral uuid:1f3ae82a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:4966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:1f3ae82a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:4966 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ustekinumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:1f3b162e-d20a-11ec-8377-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4967 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 golimumab is antibody binding of Cytokine (Tumor necrosis factor) DrugCentral uuid:1f3b3a78-d20a-11ec-8377-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4968 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 certolizumab pegol is antibody binding of Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.046']} DrugCentral uuid:1f3b6340-d20a-11ec-8377-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:4969 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eculizumab is antibody binding of Secreted (Complement C5) DrugCentral uuid:1f3b8b72-d20a-11ec-8377-0242ac110003 UniProtKB:P05556 biolink:molecularly_interacts_with DrugCentral:4970 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-1) DrugCentral uuid:1f3b8b72-d20a-11ec-8377-0242ac110003 UniProtKB:P05556 biolink:molecularly_interacts_with DrugCentral:4970 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-1) DrugCentral uuid:1f3bbd7c-d20a-11ec-8377-0242ac110003 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4970 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) DrugCentral uuid:1f3bbd7c-d20a-11ec-8377-0242ac110003 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4970 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 natalizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) DrugCentral uuid:1f3beb8a-d20a-11ec-8377-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:4971 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ranibizumab is antibody binding of Secreted (Vascular endothelial growth factor A) DrugCentral uuid:1f3c1092-d20a-11ec-8377-0242ac110003 UniProtKB:P01854 biolink:molecularly_interacts_with DrugCentral:4972 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omalizumab is antibody binding of Antibody (Ig epsilon chain C region) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.16']} DrugCentral uuid:1f3c39e6-d20a-11ec-8377-0242ac110003 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide targets Enzyme (Nicotinamide phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1f3c6222-d20a-11ec-8377-0242ac110003 UniProtKB:P43490 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide targets Cytokine (Nicotinamide phosphoribosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1f3c8a68-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BY41 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.135']} DrugCentral uuid:1f3cb538-d20a-11ec-8377-0242ac110003 UniProtKB:Q96DB2 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.365']} DrugCentral uuid:1f3cdd9c-d20a-11ec-8377-0242ac110003 UniProtKB:Q92769 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.796']} DrugCentral uuid:1f3d05e2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13547 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.022']} DrugCentral uuid:1f3d2ebe-d20a-11ec-8377-0242ac110003 UniProtKB:O15379 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.174']} DrugCentral uuid:1f3d5722-d20a-11ec-8377-0242ac110003 UniProtKB:Q969S8 biolink:molecularly_interacts_with DrugCentral:4973 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chidamide is inhibitor of Enzyme (Histone deacetylase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.108']} DrugCentral uuid:1f3d7f68-d20a-11ec-8377-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4974 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infliximab is antibody binding of Cytokine (Tumor necrosis factor) DrugCentral uuid:1f3da3a8-d20a-11ec-8377-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4975 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rituximab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.51']} DrugCentral uuid:1f3dcea0-d20a-11ec-8377-0242ac110003 UniProtKB:P04150 biolink:molecularly_interacts_with DrugCentral:4976 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 triamcinolone hexacetonide is agonist of Nuclear hormone receptor (Glucocorticoid receptor) DrugCentral uuid:1f3df2f4-d20a-11ec-8377-0242ac110003 UniProtKB:P05231 biolink:molecularly_interacts_with DrugCentral:4977 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 siltuximab is antibody binding of Cytokine (Interleukin-6) DrugCentral uuid:1f3e172a-d20a-11ec-8377-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:4978 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etanercept is inhibitor of Cytokine (Tumor necrosis factor) DrugCentral uuid:1f3e3b74-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4979 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab is antibody binding of Kinase (Receptor tyrosine-protein kinase erbB-2) DrugCentral uuid:1f3e5fbe-d20a-11ec-8377-0242ac110003 UniProtKB:P20138 biolink:molecularly_interacts_with DrugCentral:4980 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gemtuzumab ozogamicin is antibody binding of Surface antigen (Myeloid cell surface antigen CD33) DrugCentral uuid:1f3e8714-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4981 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin aspart is agonist of Kinase (Insulin receptor) DrugCentral uuid:1f3eaf3c-d20a-11ec-8377-0242ac110003 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vedolizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1f3eaf3c-d20a-11ec-8377-0242ac110003 UniProtKB:P26010 biolink:molecularly_interacts_with DrugCentral:4982 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vedolizumab is antibody binding of Adhesion (Integrin alpha-4/beta-7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1f3ee2cc-d20a-11ec-8377-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4983 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 obinutuzumab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) DrugCentral uuid:1f3f0784-d20a-11ec-8377-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:4984 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibritumomab tiuxetan is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.854']} DrugCentral uuid:1f3f2fd4-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:4985 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin detemir is agonist of Kinase (Insulin receptor) DrugCentral uuid:1f3f5414-d20a-11ec-8377-0242ac110003 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:4986 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pegfilgrastim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:1f3f785e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:4987 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgrastim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:1f3f9d48-d20a-11ec-8377-0242ac110003 UniProtKB:P21462 biolink:molecularly_interacts_with DrugCentral:4988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deoxycholic acid is antagonist of GPCR (fMet-Leu-Phe receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4']} DrugCentral uuid:1f3fc5a2-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:4988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deoxycholic acid targets Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.35']} DrugCentral uuid:1f3fedde-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:4988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deoxycholic acid is agonist of GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.2']} DrugCentral uuid:1f401624-d20a-11ec-8377-0242ac110003 UniProtKB:P07445 biolink:molecularly_interacts_with DrugCentral:4988 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deoxycholic acid targets Unclassified (Steroid Delta-isomerase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.8']} DrugCentral uuid:1f40402c-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is antibody binding of Kinase (Receptor tyrosine-protein kinase erbB-2) DrugCentral uuid:1f40837a-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f40837a-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f40837a-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f40837a-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f40837a-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f40837a-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f40837a-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f40837a-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f40837a-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:4990 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab emtansine is inhibitor of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1f40f5bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:4991 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lipegfilgrastim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:1f411dda-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4993 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vonoprazan is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1f411dda-d20a-11ec-8377-0242ac110003 UniProtKB:P51164 biolink:molecularly_interacts_with DrugCentral:4993 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vonoprazan is inhibitor of Transporter (Potassium-transporting ATPase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:1f41516a-d20a-11ec-8377-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:4995 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoetin alfa is agonist of Membrane receptor (Erythropoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11.15']} DrugCentral uuid:1f417a78-d20a-11ec-8377-0242ac110003 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:4996 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romiplostim is agonist of Membrane receptor (Thrombopoietin receptor) DrugCentral uuid:1f419ec2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NBP7 biolink:molecularly_interacts_with DrugCentral:5000 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evolocumab is inhibitor of Enzyme (Proprotein convertase subtilisin/kexin type 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.72']} DrugCentral uuid:1f41c6ea-d20a-11ec-8377-0242ac110003 UniProtKB:P33535 biolink:molecularly_interacts_with DrugCentral:5001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eluxadoline targets GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:1f41ef44-d20a-11ec-8377-0242ac110003 UniProtKB:P33533 biolink:molecularly_interacts_with DrugCentral:5001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eluxadoline targets GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.89']} DrugCentral uuid:1f4219ec-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:5001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eluxadoline is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1f4244ee-d20a-11ec-8377-0242ac110003 UniProtKB:P41144 biolink:molecularly_interacts_with DrugCentral:5001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eluxadoline is agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1f426d70-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eluxadoline is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:1f4295d4-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:5001 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eluxadoline is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.886']} DrugCentral uuid:1f42beba-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5002 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin lispro is agonist of Kinase (Insulin receptor) DrugCentral uuid:1f42e2e6-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5003 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin human targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.74']} DrugCentral uuid:1f430b22-d20a-11ec-8377-0242ac110003 UniProtKB:P15127 biolink:molecularly_interacts_with DrugCentral:5003 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin human targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.71']} DrugCentral uuid:1f433354-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5003 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin human is agonist of Kinase (Insulin receptor) DrugCentral uuid:1f435848-d20a-11ec-8377-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:5005 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mirodenafil is inhibitor of Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.469']} DrugCentral uuid:1f43808e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BPV8 biolink:molecularly_interacts_with DrugCentral:5006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cangrelor is antagonist of GPCR (P2Y purinoceptor 13) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1f43aa0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q6NS65 biolink:molecularly_interacts_with DrugCentral:5006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cangrelor is antagonist of GPCR (Uracil nucleotide/cysteinyl leukotriene receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.92']} DrugCentral uuid:1f43d25a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H244 biolink:molecularly_interacts_with DrugCentral:5006 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cangrelor is antagonist of GPCR (P2Y purinoceptor 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.627']} DrugCentral uuid:1f43fd98-d20a-11ec-8377-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5007 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoetin theta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:1f4421d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q62226 biolink:molecularly_interacts_with DrugCentral:5008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sonidegib targets Enzyme (Sonic hedgehog protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:1f444a46-d20a-11ec-8377-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5008 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sonidegib is antagonist of GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.222']} DrugCentral uuid:1f44728c-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecasermin targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.854']} DrugCentral uuid:1f449b40-d20a-11ec-8377-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5009 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mecasermin is agonist of Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.31']} DrugCentral uuid:1f44c39a-d20a-11ec-8377-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:5010 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumacaftor is pharmacological chaperone of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.456']} DrugCentral uuid:1f44f3c4-d20a-11ec-8377-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5011 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldesleukin is agonist of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:1f44f3c4-d20a-11ec-8377-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5011 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldesleukin is agonist of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:1f44f3c4-d20a-11ec-8377-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5011 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aldesleukin is agonist of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:1f452be6-d20a-11ec-8377-0242ac110003 UniProtKB:P08473 biolink:molecularly_interacts_with DrugCentral:5012 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sacubitril is inhibitor of Enzyme (Neprilysin) DrugCentral uuid:1f455030-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:5013 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trelagliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.398']} DrugCentral uuid:1f457952-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1f45a1c0-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:1f45cc04-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.64']} DrugCentral uuid:1f45f4fe-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.05']} DrugCentral uuid:1f461d4e-d20a-11ec-8377-0242ac110003 UniProtKB:P08588 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (Beta-1 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.229']} DrugCentral uuid:1f464594-d20a-11ec-8377-0242ac110003 UniProtKB:P07550 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (Beta-2 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.174']} DrugCentral uuid:1f466e52-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is agonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.796']} DrugCentral uuid:1f4696b6-d20a-11ec-8377-0242ac110003 UniProtKB:P08913 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (Alpha-2A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1f46bf1a-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.538']} DrugCentral uuid:1f46e74c-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.857']} DrugCentral uuid:1f4710b4-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.721']} DrugCentral uuid:1f473918-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.469']} DrugCentral uuid:1f476172-d20a-11ec-8377-0242ac110003 UniProtKB:P50406 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.237']} DrugCentral uuid:1f478bde-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.432']} DrugCentral uuid:1f47b6e0-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1f47e066-d20a-11ec-8377-0242ac110003 UniProtKB:P18089 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (Alpha-2B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1f4808c0-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.959']} DrugCentral uuid:1f48317e-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.721']} DrugCentral uuid:1f4859e2-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.495']} DrugCentral uuid:1f488250-d20a-11ec-8377-0242ac110003 UniProtKB:P18825 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is antagonist of GPCR (Alpha-2C adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.229']} DrugCentral uuid:1f48aaa0-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.025']} DrugCentral uuid:1f48d39a-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is agonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.201']} DrugCentral uuid:1f48fbea-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is antagonist of GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.585']} DrugCentral uuid:1f492458-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is antagonist of GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.77']} DrugCentral uuid:1f494c94-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.854']} DrugCentral uuid:1f49778c-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.523']} DrugCentral uuid:1f49a2f2-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.921']} DrugCentral uuid:1f49ce76-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5014 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexpiprazole is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.328']} DrugCentral uuid:1f49f8ce-d20a-11ec-8377-0242ac110003 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:5015 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pegvisomant is antagonist of GPCR (Growth hormone receptor) DrugCentral uuid:1f4a1d7c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NBP7 biolink:molecularly_interacts_with DrugCentral:5016 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alirocumab is inhibitor of Enzyme (Proprotein convertase subtilisin/kexin type 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.42']} DrugCentral uuid:1f4a49aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPH3 biolink:molecularly_interacts_with DrugCentral:5017 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anakinra is antagonist of Membrane receptor (Interleukin-1 receptor, type I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1f4a49aa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPH3 biolink:molecularly_interacts_with DrugCentral:5017 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 anakinra is antagonist of Membrane receptor (Interleukin-1 receptor, type I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1f4a7d3a-d20a-11ec-8377-0242ac110003 UniProtKB:P19327 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.93']} DrugCentral uuid:1f4aa62a-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.516']} DrugCentral uuid:1f4ace66-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.439']} DrugCentral uuid:1f4af6c0-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.398']} DrugCentral uuid:1f4b1f10-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.049']} DrugCentral uuid:1f4b4828-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.054']} DrugCentral uuid:1f4b7154-d20a-11ec-8377-0242ac110003 UniProtKB:P47898 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin targets GPCR (5-hydroxytryptamine receptor 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.093']} DrugCentral uuid:1f4b99d6-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin is agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1f4bc2f8-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5022 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flibanserin is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.31']} DrugCentral uuid:1f4befda-d20a-11ec-8377-0242ac110003 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5025 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sargramostim is agonist of Membrane receptor (Granulocyte macrophage colony-stimulating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.301']} DrugCentral uuid:1f4befda-d20a-11ec-8377-0242ac110003 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5025 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sargramostim is agonist of Membrane receptor (Granulocyte macrophage colony-stimulating factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.301']} DrugCentral uuid:1f4c275c-d20a-11ec-8377-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5026 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oprelvekin is agonist of Membrane receptor (Interleukin-11 receptor) DrugCentral uuid:1f4c275c-d20a-11ec-8377-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5026 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oprelvekin is agonist of Membrane receptor (Interleukin-11 receptor) DrugCentral uuid:1f4c5556-d20a-11ec-8377-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:5027 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rolapitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.18']} DrugCentral uuid:1f4c7e28-d20a-11ec-8377-0242ac110003 UniProtKB:P51679 biolink:molecularly_interacts_with DrugCentral:5031 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mogamulizumab is antibody binding of GPCR (C-C chemokine receptor type 4) DrugCentral uuid:1f4ca254-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1f4ccacc-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.68']} DrugCentral uuid:1f4cf31c-d20a-11ec-8377-0242ac110003 UniProtKB:P21918 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets GPCR (D(1B) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1f4d1c3e-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1f4d4498-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1f4d6dec-d20a-11ec-8377-0242ac110003 UniProtKB:P19020 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1f4d9650-d20a-11ec-8377-0242ac110003 UniProtKB:P41595 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine is antagonist of GPCR (5-hydroxytryptamine receptor 2B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.24']} DrugCentral uuid:1f4dbf72-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine is antagonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.87']} DrugCentral uuid:1f4de7c2-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.95']} DrugCentral uuid:1f4e1026-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine is partial agonist of GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.07']} DrugCentral uuid:1f4e38a8-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine is antagonist of GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.63']} DrugCentral uuid:1f4e617a-d20a-11ec-8377-0242ac110003 UniProtKB:P25100 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine targets GPCR (Alpha-1D adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1f4e89de-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine is partial agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.31']} DrugCentral uuid:1f4eb24c-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:1f4edaa6-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5037 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cariprazine is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.73']} DrugCentral uuid:1f4f06de-d20a-11ec-8377-0242ac110003 UniProtKB:P00918 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.48']} DrugCentral uuid:1f4f326c-d20a-11ec-8377-0242ac110003 UniProtKB:P00915 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1f4f5e22-d20a-11ec-8377-0242ac110003 UniProtKB:P04035 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (3-hydroxy-3-methylglutaryl-coenzyme A reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:1f4f8708-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1f4faf58-d20a-11ec-8377-0242ac110003 UniProtKB:P05177 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Cytochrome P450 1A2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1f4fd794-d20a-11ec-8377-0242ac110003 UniProtKB:O76074 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (cGMP-specific 3',5'-cyclic phosphodiesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1f4fffda-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1f502866-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:1f5050ac-d20a-11ec-8377-0242ac110003 UniProtKB:P24557 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Thromboxane-A synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:1f5078d4-d20a-11ec-8377-0242ac110003 UniProtKB:P23280 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1f50a12e-d20a-11ec-8377-0242ac110003 UniProtKB:P27361 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Kinase (Mitogen-activated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1f50cb68-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1f50f390-d20a-11ec-8377-0242ac110003 UniProtKB:P07943 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Aldose reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1f511c3a-d20a-11ec-8377-0242ac110003 UniProtKB:P12530 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Arachidonate 15-lipoxygenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1f514480-d20a-11ec-8377-0242ac110003 UniProtKB:P28482 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Kinase (Mitogen-activated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.73']} DrugCentral uuid:1f516d16-d20a-11ec-8377-0242ac110003 UniProtKB:Q2PCB5 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Enzyme (Carbonic anhydrase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.03']} DrugCentral uuid:1f519570-d20a-11ec-8377-0242ac110003 UniProtKB:A6XA80 biolink:molecularly_interacts_with DrugCentral:5039 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tannic acid targets Unclassified (Leukotriene C4 synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1f51bdc0-d20a-11ec-8377-0242ac110003 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:5042 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somatrem is agonist of GPCR (Growth hormone receptor) DrugCentral uuid:1f51e214-d20a-11ec-8377-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5044 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reteplase is activator of Enzyme (Plasminogen) DrugCentral uuid:1f520686-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cobimetinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.74']} DrugCentral uuid:1f522ec2-d20a-11ec-8377-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cobimetinib is allosteric modulator of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1f525712-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5046 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cobimetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.046']} DrugCentral uuid:1f527f62-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:5047 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saroglitazar is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.187']} DrugCentral uuid:1f52aab4-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:5047 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 saroglitazar is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:1f52d2f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1f52fb36-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.94']} DrugCentral uuid:1f532412-d20a-11ec-8377-0242ac110003 UniProtKB:P25021 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant is antagonist of GPCR (Histamine H2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1f534d3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9QYN8 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1f5376ba-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1f539ef6-d20a-11ec-8377-0242ac110003 UniProtKB:P58406 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1f53c78c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JI35 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:1f53efdc-d20a-11ec-8377-0242ac110003 UniProtKB:P81908 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets Enzyme (Cholinesterase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1f54182c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1f544072-d20a-11ec-8377-0242ac110003 UniProtKB:Q9JI35 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant targets GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.8']} DrugCentral uuid:1f5469ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5N1 biolink:molecularly_interacts_with DrugCentral:5048 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pitolisant is inverse agonist of GPCR (Histamine H3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.796']} DrugCentral uuid:1f54923e-d20a-11ec-8377-0242ac110003 UniProtKB:P28222 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1f54baac-d20a-11ec-8377-0242ac110003 UniProtKB:P28221 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1f54e2de-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1f550b7e-d20a-11ec-8377-0242ac110003 UniProtKB:P14842 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1f5533ba-d20a-11ec-8377-0242ac110003 UniProtKB:P32305 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1f555c1e-d20a-11ec-8377-0242ac110003 UniProtKB:P30729 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is antagonist of GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.3']} DrugCentral uuid:1f55846e-d20a-11ec-8377-0242ac110003 UniProtKB:P31388 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is agonist of GPCR (5-hydroxytryptamine receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1f55ad22-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1f55d55e-d20a-11ec-8377-0242ac110003 UniProtKB:P34969 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil targets GPCR (5-hydroxytryptamine receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.409']} DrugCentral uuid:1f55fdd6-d20a-11ec-8377-0242ac110003 UniProtKB:P35462 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil targets GPCR (D(3) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:1f56261c-d20a-11ec-8377-0242ac110003 UniProtKB:P35367 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil targets GPCR (Histamine H1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.215']} DrugCentral uuid:1f5651aa-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.357']} DrugCentral uuid:1f567a0e-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is partial agonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.469']} DrugCentral uuid:1f56a286-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is partial agonist of GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.77']} DrugCentral uuid:1f56cbc6-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5052 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 aripiprazole lauroxil is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.469']} DrugCentral uuid:1f56f420-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omarigliptin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.41']} DrugCentral uuid:1f571c3e-d20a-11ec-8377-0242ac110003 UniProtKB:P28843 biolink:molecularly_interacts_with DrugCentral:5054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omarigliptin targets Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.36']} DrugCentral uuid:1f57459c-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:5054 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omarigliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.097']} DrugCentral uuid:1f576e6e-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5057 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 insulin glulisine is agonist of Kinase (Insulin receptor) DrugCentral uuid:1f5792c2-d20a-11ec-8377-0242ac110003 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:5059 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lusutrombopag is agonist of Membrane receptor (Thrombopoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.076']} DrugCentral uuid:1f57baf4-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:5060 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esflurbiprofen targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1f57e34e-d20a-11ec-8377-0242ac110003 UniProtKB:Q63921 biolink:molecularly_interacts_with DrugCentral:5060 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 esflurbiprofen targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:1f580d6a-d20a-11ec-8377-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:5061 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mepolizumab is antibody binding of Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10']} DrugCentral uuid:1f5838e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osimertinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.79']} DrugCentral uuid:1f586422-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osimertinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1f588ee8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osimertinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1f58b792-d20a-11ec-8377-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osimertinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:1f58dfc4-d20a-11ec-8377-0242ac110003 UniProtKB:P53634 biolink:molecularly_interacts_with DrugCentral:5062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osimertinib targets Enzyme (Dipeptidyl peptidase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.48']} DrugCentral uuid:1f59081e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osimertinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1f5931a4-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5062 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osimertinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1f595a58-d20a-11ec-8377-0242ac110003 UniProtKB:P28907 biolink:molecularly_interacts_with DrugCentral:5063 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daratumumab is antibody binding of Tumour-associated antigen (Lymphocyte differentiation antigen CD38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.22']} DrugCentral uuid:1f59830c-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:5064 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 climbazole targets Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1f59ab3e-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:5065 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trenbolone hexahydrobenzylcarbonate targets Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:1f59d38e-d20a-11ec-8377-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:5065 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trenbolone hexahydrobenzylcarbonate targets Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['4.04']} DrugCentral uuid:1f59ffb2-d20a-11ec-8377-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5066 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenecteplase is activator of Enzyme (Plasminogen) DrugCentral uuid:1f5a2672-d20a-11ec-8377-0242ac110003 UniProtKB:P20618 biolink:molecularly_interacts_with DrugCentral:5067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixazomib is inhibitor of Enzyme (Proteasome subunit beta type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.509']} DrugCentral uuid:1f5a516a-d20a-11ec-8377-0242ac110003 UniProtKB:P49721 biolink:molecularly_interacts_with DrugCentral:5067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixazomib is inhibitor of Enzyme (Proteasome subunit beta type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.456']} DrugCentral uuid:1f5a7c62-d20a-11ec-8377-0242ac110003 UniProtKB:P28074 biolink:molecularly_interacts_with DrugCentral:5067 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixazomib is inhibitor of Enzyme (Proteasome subunit beta type-5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.469']} DrugCentral uuid:1f5aa4e4-d20a-11ec-8377-0242ac110003 UniProtKB:Q02563 biolink:molecularly_interacts_with DrugCentral:5068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brivaracetam is inhibitor of Unclassified (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1f5acd3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q7L0J3 biolink:molecularly_interacts_with DrugCentral:5068 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brivaracetam is modulator of Transporter (Synaptic vesicle glycoprotein 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1f5af58e-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5071 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 necitumumab is antibody binding of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.49']} DrugCentral uuid:1f5b1e56-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NQ25 biolink:molecularly_interacts_with DrugCentral:5072 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elotuzumab is antibody binding of Membrane receptor (SLAM family member 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.05']} DrugCentral uuid:1f5b4796-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSA0 biolink:molecularly_interacts_with DrugCentral:5075 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lesinurad is inhibitor of Transporter (Solute carrier family 22 member 11) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.432']} DrugCentral uuid:1f5b7072-d20a-11ec-8377-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:5075 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lesinurad is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.137']} DrugCentral uuid:1f5b9890-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:5077 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1f5bc2e8-d20a-11ec-8377-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:5077 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1f5bee12-d20a-11ec-8377-0242ac110003 UniProtKB:Q13258 biolink:molecularly_interacts_with DrugCentral:5077 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selexipag targets GPCR (Prostaglandin D2 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1f5c1662-d20a-11ec-8377-0242ac110003 UniProtKB:P43253 biolink:molecularly_interacts_with DrugCentral:5077 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selexipag is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1f5c3e9e-d20a-11ec-8377-0242ac110003 UniProtKB:P35408 biolink:molecularly_interacts_with DrugCentral:5077 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP4 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.31']} DrugCentral uuid:1f5c678e-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:5077 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selexipag is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1f5c8fd4-d20a-11ec-8377-0242ac110003 UniProtKB:P43119 biolink:molecularly_interacts_with DrugCentral:5077 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selexipag is agonist of GPCR (Prostacyclin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.699']} DrugCentral uuid:1f5cb838-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:5078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lobeglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.699']} DrugCentral uuid:1f5ce09c-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:5078 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lobeglitazone is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.745']} DrugCentral uuid:1f5d093c-d20a-11ec-8377-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elbasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:1f5d315a-d20a-11ec-8377-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elbasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.7']} DrugCentral uuid:1f5d59a0-d20a-11ec-8377-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elbasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.523']} DrugCentral uuid:1f5d825e-d20a-11ec-8377-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:5080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elbasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:1f5daad6-d20a-11ec-8377-0242ac110003 UniProtKB:O39929 biolink:molecularly_interacts_with DrugCentral:5080 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elbasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.523']} DrugCentral uuid:1f5dd2fe-d20a-11ec-8377-0242ac110003 UniProtKB:A3EZI9 biolink:molecularly_interacts_with DrugCentral:5081 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grazoprevir targets Enzyme (NS3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.4']} DrugCentral uuid:1f5dfb30-d20a-11ec-8377-0242ac110003 UniProtKB:K7XJL6 biolink:molecularly_interacts_with DrugCentral:5081 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grazoprevir targets Unclassified (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.85']} DrugCentral uuid:1f5e2416-d20a-11ec-8377-0242ac110003 UniProtKB:Q0ZMF1 biolink:molecularly_interacts_with DrugCentral:5081 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grazoprevir targets Unclassified (NS3 protease) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.15']} DrugCentral uuid:1f5e4c7a-d20a-11ec-8377-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5081 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grazoprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.301']} DrugCentral uuid:1f5e74c0-d20a-11ec-8377-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:5081 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grazoprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.398']} DrugCentral uuid:1f5e9cf2-d20a-11ec-8377-0242ac110003 UniProtKB:O39929 biolink:molecularly_interacts_with DrugCentral:5081 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 grazoprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['12.523']} DrugCentral uuid:1f5ec5d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16552 biolink:molecularly_interacts_with DrugCentral:5083 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ixekizumab is antibody binding of Cytokine (Interleukin-17A) DrugCentral uuid:1f5ef1de-d20a-11ec-8377-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5087 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 denileukin diftitox is antibody binding of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:1f5ef1de-d20a-11ec-8377-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5087 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 denileukin diftitox is antibody binding of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:1f5ef1de-d20a-11ec-8377-0242ac110003 UniProtKB:P31785 biolink:molecularly_interacts_with DrugCentral:5087 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 denileukin diftitox is antibody binding of Membrane receptor (Interleukin-2 receptor) DrugCentral uuid:1f5f2c4e-d20a-11ec-8377-0242ac110003 UniProtKB:P06729 biolink:molecularly_interacts_with DrugCentral:5088 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alefacept is inhibitor of Surface antigen (T-cell surface antigen CD2) DrugCentral uuid:1f5f508e-d20a-11ec-8377-0242ac110003 UniProtKB:P33681 biolink:molecularly_interacts_with DrugCentral:5089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD80) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1f5f7b9a-d20a-11ec-8377-0242ac110003 UniProtKB:P42081 biolink:molecularly_interacts_with DrugCentral:5089 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD86) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1f5fa3fe-d20a-11ec-8377-0242ac110003 UniProtKB:P33681 biolink:molecularly_interacts_with DrugCentral:5091 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD80) DrugCentral uuid:1f5fc834-d20a-11ec-8377-0242ac110003 UniProtKB:P42081 biolink:molecularly_interacts_with DrugCentral:5091 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belatacept is inhibitor of Surface antigen (T-lymphocyte activation antigen CD86) DrugCentral uuid:1f5fed0a-d20a-11ec-8377-0242ac110003 UniProtKB:P05113 biolink:molecularly_interacts_with DrugCentral:5093 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 reslizumab is antibody binding of Cytokine (Interleukin-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.092']} DrugCentral uuid:1f6015e6-d20a-11ec-8377-0242ac110003 UniProtKB:P13423 biolink:molecularly_interacts_with DrugCentral:5094 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 obiltoxaximab is antibody binding of Secreted (Protective antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.481']} DrugCentral uuid:1f603e72-d20a-11ec-8377-0242ac110003 UniProtKB:P01583 biolink:molecularly_interacts_with DrugCentral:5105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilonacept is inhibitor of Cytokine (Interleukin-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.854']} DrugCentral uuid:1f6066b8-d20a-11ec-8377-0242ac110003 UniProtKB:P18510 biolink:molecularly_interacts_with DrugCentral:5105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilonacept is inhibitor of Unclassified (Interleukin-1 receptor antagonist protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.215']} DrugCentral uuid:1f608f9e-d20a-11ec-8377-0242ac110003 UniProtKB:P01584 biolink:molecularly_interacts_with DrugCentral:5105 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rilonacept is inhibitor of Cytokine (Interleukin-1 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['12.301']} DrugCentral uuid:1f60b820-d20a-11ec-8377-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5109 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 urokinase is activator of Enzyme (Plasminogen) DrugCentral uuid:1f60dc2e-d20a-11ec-8377-0242ac110003 UniProtKB:O43451 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Maltase-glucoamylase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1f610474-d20a-11ec-8377-0242ac110003 UniProtKB:P10253 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Lysosomal alpha-glucosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1f612da0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HCG7 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Non-lysosomal glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1f615604-d20a-11ec-8377-0242ac110003 UniProtKB:P14410 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Sucrase-isomaltase, intestinal) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1f617e4a-d20a-11ec-8377-0242ac110003 UniProtKB:P35573 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Glycogen debranching enzyme) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5']} DrugCentral uuid:1f61a668-d20a-11ec-8377-0242ac110003 UniProtKB:P09848 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Lactase-phlorizin hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.3']} DrugCentral uuid:1f61cf1c-d20a-11ec-8377-0242ac110003 UniProtKB:P16278 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.05']} DrugCentral uuid:1f61f744-d20a-11ec-8377-0242ac110003 UniProtKB:Q59750 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.9']} DrugCentral uuid:1f621f6c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02401 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Lactase-phlorizin hydrolase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.14']} DrugCentral uuid:1f6247a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UUZ4 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Alpha-galactosidase C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.74']} DrugCentral uuid:1f62707a-d20a-11ec-8377-0242ac110003 UniProtKB:Q42656 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Alpha-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1f6298a2-d20a-11ec-8377-0242ac110003 UniProtKB:D3ZUM4 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.62']} DrugCentral uuid:1f62c0d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8VNN2 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat targets Enzyme (Beta-galactosidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.89']} DrugCentral uuid:1f62e938-d20a-11ec-8377-0242ac110003 UniProtKB:P06280 biolink:molecularly_interacts_with DrugCentral:5110 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 migalastat is pharmacological chaperone of Enzyme (Alpha-galactosidase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1f631480-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chromic chloride targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:1f633cf8-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5118 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 chromic chloride targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:1f636534-d20a-11ec-8377-0242ac110003 UniProtKB:Q07817 biolink:molecularly_interacts_with DrugCentral:5133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venetoclax is inhibitor of Cytosolic other (Bcl-2-like protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.319']} DrugCentral uuid:1f638d98-d20a-11ec-8377-0242ac110003 UniProtKB:Q92843 biolink:molecularly_interacts_with DrugCentral:5133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venetoclax is inhibitor of Cytosolic other (Apoptosis regulator Bcl-W) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.611']} DrugCentral uuid:1f63b67e-d20a-11ec-8377-0242ac110003 UniProtKB:P10415 biolink:molecularly_interacts_with DrugCentral:5133 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 venetoclax is inhibitor of Cytosolic other (Apoptosis regulator Bcl-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['11']} DrugCentral uuid:1f63e2e8-d20a-11ec-8377-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peginterferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:1f63e2e8-d20a-11ec-8377-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5137 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peginterferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:1f6414ca-d20a-11ec-8377-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5139 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 interferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:1f6414ca-d20a-11ec-8377-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5139 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 interferon beta-1a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:1f644756-d20a-11ec-8377-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5140 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 interferon beta-1b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:1f644756-d20a-11ec-8377-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5140 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 interferon beta-1b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:1f6476ae-d20a-11ec-8377-0242ac110003 UniProtKB:P00747 biolink:molecularly_interacts_with DrugCentral:5141 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alteplase is activator of Enzyme (Plasminogen) DrugCentral uuid:1f649ada-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimavanserin is inverse agonist of GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1f64c348-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5142 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pimavanserin is inverse agonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1f64ec60-d20a-11ec-8377-0242ac110003 UniProtKB:P22734 biolink:molecularly_interacts_with DrugCentral:5143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 opicapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1f6514ba-d20a-11ec-8377-0242ac110003 UniProtKB:O88587 biolink:molecularly_interacts_with DrugCentral:5143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 opicapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1f653d1e-d20a-11ec-8377-0242ac110003 UniProtKB:P21964 biolink:molecularly_interacts_with DrugCentral:5143 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 opicapone is inhibitor of Enzyme (Catechol O-methyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9']} DrugCentral uuid:1f65655a-d20a-11ec-8377-0242ac110003 UniProtKB:P04062 biolink:molecularly_interacts_with DrugCentral:5144 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gluconolactone targets Enzyme (Glucosylceramidase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.52']} DrugCentral uuid:1f658e18-d20a-11ec-8377-0242ac110003 UniProtKB:P22888 biolink:molecularly_interacts_with DrugCentral:5149 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 choriogonadotropin alfa is agonist of GPCR (Lutropin-choriogonadotropic hormone receptor) DrugCentral uuid:1f65b262-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZQ7 biolink:molecularly_interacts_with DrugCentral:5151 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atezolizumab is antibody binding of CD molecules (Programmed cell death 1 ligand 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.39']} DrugCentral uuid:1f65dad0-d20a-11ec-8377-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:1f660398-d20a-11ec-8377-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:1f662c7e-d20a-11ec-8377-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.796']} DrugCentral uuid:1f6654c4-d20a-11ec-8377-0242ac110003 UniProtKB:P27958 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.854']} DrugCentral uuid:1f667d0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99IB8 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.979']} DrugCentral uuid:1f66a564-d20a-11ec-8377-0242ac110003 UniProtKB:O39929 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.046']} DrugCentral uuid:1f66d1b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q81495 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:1f66f9f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9DHD6 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.398']} DrugCentral uuid:1f672250-d20a-11ec-8377-0242ac110003 UniProtKB:O91936 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.426']} DrugCentral uuid:1f674b0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q5I2N3 biolink:molecularly_interacts_with DrugCentral:5154 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 velpatasvir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11.097']} DrugCentral uuid:1f677340-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDU6 biolink:molecularly_interacts_with DrugCentral:5155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 obeticholic acid targets GPCR (G-protein coupled bile acid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1f679b90-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RI1 biolink:molecularly_interacts_with DrugCentral:5155 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 obeticholic acid is agonist of Nuclear hormone receptor (Bile acid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.004']} DrugCentral uuid:1f67c3cc-d20a-11ec-8377-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5157 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darbepoetin alfa is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:1f67eca8-d20a-11ec-8377-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peginterferon alfa-2a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:1f67eca8-d20a-11ec-8377-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5158 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peginterferon alfa-2a is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:1f681ac0-d20a-11ec-8377-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5160 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoetin beta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:1f6842f2-d20a-11ec-8377-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peginterferon alfa-2b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:1f6842f2-d20a-11ec-8377-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5164 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 peginterferon alfa-2b is agonist of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:1f687100-d20a-11ec-8377-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5165 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 methoxy polyethylene glycol-epoetin beta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:1f6895e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q99062 biolink:molecularly_interacts_with DrugCentral:5167 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lenograstim is activator of Membrane receptor (Granulocyte colony-stimulating factor receptor) DrugCentral uuid:1f68ba0c-d20a-11ec-8377-0242ac110003 UniProtKB:P11473 biolink:molecularly_interacts_with DrugCentral:5169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eldecalcitol is agonist of Nuclear hormone receptor (Vitamin D3 receptor) DrugCentral uuid:1f68de42-d20a-11ec-8377-0242ac110003 UniProtKB:P13053 biolink:molecularly_interacts_with DrugCentral:5169 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eldecalcitol is agonist of Transcription factor (Vitamin D3 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:1f6906a6-d20a-11ec-8377-0242ac110003 UniProtKB:P19235 biolink:molecularly_interacts_with DrugCentral:5170 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 epoetin zeta is agonist of Membrane receptor (Erythropoietin receptor) DrugCentral uuid:1f692b22-d20a-11ec-8377-0242ac110003 UniProtKB:P05362 biolink:molecularly_interacts_with DrugCentral:5174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lifitegrast targets Unclassified (Intercellular adhesion molecule 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.53']} DrugCentral uuid:1f695796-d20a-11ec-8377-0242ac110003 UniProtKB:P05107 biolink:molecularly_interacts_with DrugCentral:5174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lifitegrast is antagonist of Adhesion (Integrin alpha-L/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.046']} DrugCentral uuid:1f695796-d20a-11ec-8377-0242ac110003 UniProtKB:P05107 biolink:molecularly_interacts_with DrugCentral:5174 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lifitegrast is antagonist of Adhesion (Integrin alpha-L/beta-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.046']} DrugCentral uuid:1f6992ce-d20a-11ec-8377-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:5177 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 muromonab-CD3 is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) DrugCentral uuid:1f6992ce-d20a-11ec-8377-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:5177 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 muromonab-CD3 is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) DrugCentral uuid:1f6992ce-d20a-11ec-8377-0242ac110003 UniProtKB:P04234 biolink:molecularly_interacts_with DrugCentral:5177 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 muromonab-CD3 is antibody binding of Surface antigen (T-cell surface glycoprotein CD3) DrugCentral uuid:1f69d072-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NAC3 biolink:molecularly_interacts_with DrugCentral:5179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodalumab is antibody binding of Membrane receptor (Interleukin-17 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:1f69d072-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NAC3 biolink:molecularly_interacts_with DrugCentral:5179 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brodalumab is antibody binding of Membrane receptor (Interleukin-17 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.2']} DrugCentral uuid:1f6a040c-d20a-11ec-8377-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:5181 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etelcalcetide is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.6']} DrugCentral uuid:1f6a2c5c-d20a-11ec-8377-0242ac110003 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5182 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eteplirsen is binding agent of RNA (exon 51 of dystrophin pre-mRNA) DrugCentral uuid:1f6a5196-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5183 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olaratumab is antibody binding of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.4']} DrugCentral uuid:1f6a7d92-d20a-11ec-8377-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:5185 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallium (68Ga) edotreotide is antagonist of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1f6aa8d0-d20a-11ec-8377-0242ac110003 UniProtKB:P18177 biolink:molecularly_interacts_with DrugCentral:5186 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bezlotoxumab is antibody binding of Enzyme (Toxin B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:1f6ad134-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5188 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 radotinib is inhibitor of Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.514']} DrugCentral uuid:1f6af9b6-d20a-11ec-8377-0242ac110003 UniProtKB:P54750 biolink:molecularly_interacts_with DrugCentral:5201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crisaborole targets Enzyme (Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1f6b21fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q13946 biolink:molecularly_interacts_with DrugCentral:5201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crisaborole targets Enzyme (High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1f6b55f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:1f6b55f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:1f6b55f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:1f6b55f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q08499 biolink:molecularly_interacts_with DrugCentral:5201 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crisaborole is inhibitor of Enzyme (Phosphodiesterase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:1f6ba050-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baricitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1f6bc8a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:5202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baricitinib is inhibitor of Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1f6bf0fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:5202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baricitinib is inhibitor of Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1f6c195e-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baricitinib is inhibitor of Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.87']} DrugCentral uuid:1f6c444c-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baricitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.276']} DrugCentral uuid:1f6c6cce-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baricitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.229']} DrugCentral uuid:1f6c9546-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5202 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baricitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.244']} DrugCentral uuid:1f6cbd82-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1f6ce62c-d20a-11ec-8377-0242ac110003 UniProtKB:O95271 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Tankyrase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.84']} DrugCentral uuid:1f6d0e5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKK3 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.08']} DrugCentral uuid:1f6d369a-d20a-11ec-8377-0242ac110003 UniProtKB:Q53GL7 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1f6d5eb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0J9 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:1f6d8794-d20a-11ec-8377-0242ac110003 UniProtKB:Q460N5 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1f6dafbc-d20a-11ec-8377-0242ac110003 UniProtKB:Q460N3 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.49']} DrugCentral uuid:1f6dd802-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:1f6e0264-d20a-11ec-8377-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.5']} DrugCentral uuid:1f6e2aaa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6F1 biolink:molecularly_interacts_with DrugCentral:5203 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rucaparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1f6e5318-d20a-11ec-8377-0242ac110003 UniProtKB:P01375 biolink:molecularly_interacts_with DrugCentral:5208 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plecanatide targets Cytokine (Tumor necrosis factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1f6e7b68-d20a-11ec-8377-0242ac110003 UniProtKB:P19438 biolink:molecularly_interacts_with DrugCentral:5208 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plecanatide targets Unclassified (Tumor necrosis factor receptor superfamily member 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.66']} DrugCentral uuid:1f6ea41c-d20a-11ec-8377-0242ac110003 UniProtKB:P25092 biolink:molecularly_interacts_with DrugCentral:5208 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 plecanatide is agonist of Enzyme (Heat-stable enterotoxin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.721']} DrugCentral uuid:1f6ecc6c-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5209 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 icotinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.699']} DrugCentral uuid:1f6ef4a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olmutinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1f6f1e38-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5210 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 olmutinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.036']} DrugCentral uuid:1f6f4746-d20a-11ec-8377-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apatinib is inhibitor of Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1f6f6f8c-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apatinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.368']} DrugCentral uuid:1f6f97f0-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.276']} DrugCentral uuid:1f6fc04a-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.886']} DrugCentral uuid:1f6fe9b2-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5211 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apatinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1f7012d4-d20a-11ec-8377-0242ac110003 UniProtKB:P17752 biolink:molecularly_interacts_with DrugCentral:5214 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 telotristat ethyl is inhibitor of Enzyme (Tryptophan 5-hydroxylase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:1f703afc-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclabuvir targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.61']} DrugCentral uuid:1f706356-d20a-11ec-8377-0242ac110003 UniProtKB:O39930 biolink:molecularly_interacts_with DrugCentral:5215 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 beclabuvir targets Unclassified (RNA-directed RNA polymerase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1f708c0a-d20a-11ec-8377-0242ac110003 UniProtKB:P36544 biolink:molecularly_interacts_with DrugCentral:5217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytisine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1f70b464-d20a-11ec-8377-0242ac110003 UniProtKB:P02718 biolink:molecularly_interacts_with DrugCentral:5217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytisine targets Ion channel (Acetylcholine receptor subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1f70dc8c-d20a-11ec-8377-0242ac110003 UniProtKB:P09483 biolink:molecularly_interacts_with DrugCentral:5217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytisine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.47']} DrugCentral uuid:1f7104f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q05941 biolink:molecularly_interacts_with DrugCentral:5217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytisine targets Ion channel (Neuronal acetylcholine receptor subunit alpha-7) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.05']} DrugCentral uuid:1f712df4-d20a-11ec-8377-0242ac110003 UniProtKB:P02710 biolink:molecularly_interacts_with DrugCentral:5217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytisine targets Ion channel (Acetylcholine receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:1f71563a-d20a-11ec-8377-0242ac110003 UniProtKB:A9XFY4 biolink:molecularly_interacts_with DrugCentral:5217 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cytisine targets Ion channel (Nicotinic acetylcholine receptor alpha 5 subunit) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.91']} DrugCentral uuid:1f717f98-d20a-11ec-8377-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:5218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribociclib targets Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.12']} DrugCentral uuid:1f71a914-d20a-11ec-8377-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:5218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribociclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.409']} DrugCentral uuid:1f71d272-d20a-11ec-8377-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5218 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ribociclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:1f71faae-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:5220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naldemedine is antagonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.04']} DrugCentral uuid:1f722312-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5220 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 naldemedine is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.95']} DrugCentral uuid:1f724bd0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZQ7 biolink:molecularly_interacts_with DrugCentral:5221 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avelumab is antibody binding of CD molecules (Programmed cell death 1 ligand 1) DrugCentral uuid:1f72701a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1f729856-d20a-11ec-8377-0242ac110003 UniProtKB:O95271 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Tankyrase-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1f72c0ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6F1 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1f72e9b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKK3 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1f731222-d20a-11ec-8377-0242ac110003 UniProtKB:Q53GL7 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1f733a86-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0J9 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1f7362f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q460N5 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.76']} DrugCentral uuid:1f738c7a-d20a-11ec-8377-0242ac110003 UniProtKB:Q460N3 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib targets Enzyme (Poly [ADP-ribose] polymerase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:1f73b4d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.68']} DrugCentral uuid:1f73dd38-d20a-11ec-8377-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5222 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 niraparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.42']} DrugCentral uuid:1f7405a6-d20a-11ec-8377-0242ac110003 UniProtKB:P11836 biolink:molecularly_interacts_with DrugCentral:5223 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ocrelizumab is antibody binding of Surface antigen (B-lymphocyte antigen CD20) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.08']} DrugCentral uuid:1f742f4a-d20a-11ec-8377-0242ac110003 UniProtKB:P24394 biolink:molecularly_interacts_with DrugCentral:5224 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dupilumab is antibody binding of Membrane receptor (Interleukin-4 receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['11.06']} DrugCentral uuid:1f7457b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:5226 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 deutetrabenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) DrugCentral uuid:1f747bf8-d20a-11ec-8377-0242ac110003 UniProtKB:Q01827 biolink:molecularly_interacts_with DrugCentral:5227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valbenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.73']} DrugCentral uuid:1f74a470-d20a-11ec-8377-0242ac110003 UniProtKB:Q05940 biolink:molecularly_interacts_with DrugCentral:5227 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 valbenazine is inhibitor of Transporter (Synaptic vesicular amine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.523']} DrugCentral uuid:1f74cd7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8T9Z7 biolink:molecularly_interacts_with DrugCentral:5229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 forodesine targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.07']} DrugCentral uuid:1f74f722-d20a-11ec-8377-0242ac110003 UniProtKB:P55859 biolink:molecularly_interacts_with DrugCentral:5229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 forodesine targets Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.64']} DrugCentral uuid:1f751f86-d20a-11ec-8377-0242ac110003 UniProtKB:P00491 biolink:molecularly_interacts_with DrugCentral:5229 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 forodesine is inhibitor of Enzyme (Purine nucleoside phosphorylase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.143']} DrugCentral uuid:1f7547d6-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1f75721a-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1f759a74-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1f75c3be-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:1f75ec4a-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.06']} DrugCentral uuid:1f7614a4-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1f763cf4-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1f76653a-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1f768e48-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1f76b68e-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1f76ded4-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1f770724-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1f773064-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1f7758aa-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1f7780e6-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1f77a918-d20a-11ec-8377-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:1f77d1d6-d20a-11ec-8377-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1f77fa08-d20a-11ec-8377-0242ac110003 UniProtKB:P11309 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase pim-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1f78223a-d20a-11ec-8377-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1f784a80-d20a-11ec-8377-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1f7873ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1f789be8-d20a-11ec-8377-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1f78c438-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1f78ec88-d20a-11ec-8377-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1f791762-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1f793f9e-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1f7967f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1f799034-d20a-11ec-8377-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1f79b9ce-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1f79e214-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1f7a0a6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q05655 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Protein kinase C delta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1f7a335e-d20a-11ec-8377-0242ac110003 UniProtKB:P22694 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1f7a5c4e-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:1f7a849e-d20a-11ec-8377-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1f7aacf8-d20a-11ec-8377-0242ac110003 UniProtKB:P17252 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Protein kinase C alpha type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1f7ad69c-d20a-11ec-8377-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1f7b022a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.44']} DrugCentral uuid:1f7b2a70-d20a-11ec-8377-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1f7b52c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1f7b7b92-d20a-11ec-8377-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1f7ba3d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:1f7bcc3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1f7bf48c-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1f7c1d86-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1f7c45d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1f7c6e1c-d20a-11ec-8377-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1f7c9676-d20a-11ec-8377-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1f7cc06a-d20a-11ec-8377-0242ac110003 UniProtKB:P24723 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Protein kinase C eta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1f7ce8a6-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1f7d10f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1f7d395a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1f7d61fa-d20a-11ec-8377-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1f7d8b30-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1f7db362-d20a-11ec-8377-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1f7ddc5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:1f7e0498-d20a-11ec-8377-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:1f7e2cd4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1f7e5510-d20a-11ec-8377-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1f7e7eb4-d20a-11ec-8377-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1f7ea920-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1f7ed166-d20a-11ec-8377-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.03']} DrugCentral uuid:1f7ef9ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q04759 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Protein kinase C theta type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1f7f2274-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1f7f4ab0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1f7f730a-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1f7f9b50-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1f7fc422-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1f7fec7c-d20a-11ec-8377-0242ac110003 UniProtKB:P31749 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (RAC-alpha serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1f8014b8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1f803d08-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P1W9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase pim-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1f806800-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1f809082-d20a-11ec-8377-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1f80b8dc-d20a-11ec-8377-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1f80e258-d20a-11ec-8377-0242ac110003 UniProtKB:P49761 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.44']} DrugCentral uuid:1f810ba2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1f8133e8-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1f815c2e-d20a-11ec-8377-0242ac110003 UniProtKB:P49841 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Glycogen synthase kinase-3 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1f818622-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1f81ae72-d20a-11ec-8377-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1f81d6cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1f81ff26-d20a-11ec-8377-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1f8228d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1f8253cc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1f827c30-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1f82a49e-d20a-11ec-8377-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1f82cd5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1f82f5b6-d20a-11ec-8377-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.68']} DrugCentral uuid:1f831dfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1f834656-d20a-11ec-8377-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1f836f50-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1f8397a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1f83bfe6-d20a-11ec-8377-0242ac110003 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1f83e82c-d20a-11ec-8377-0242ac110003 UniProtKB:O15530 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (3-phosphoinositide-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1f841112-d20a-11ec-8377-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.59']} DrugCentral uuid:1f84396c-d20a-11ec-8377-0242ac110003 UniProtKB:P49840 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Glycogen synthase kinase-3 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1f8461a8-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1f8489f8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1f84b2ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1f84db10-d20a-11ec-8377-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1f850360-d20a-11ec-8377-0242ac110003 UniProtKB:Q16513 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase N2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1f852ba6-d20a-11ec-8377-0242ac110003 UniProtKB:P31751 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (RAC-beta serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.11']} DrugCentral uuid:1f85559a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1f857dd6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1f85a612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1f85cf7a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.08']} DrugCentral uuid:1f85f806-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1f862056-d20a-11ec-8377-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1f8648a6-d20a-11ec-8377-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1f86716e-d20a-11ec-8377-0242ac110003 UniProtKB:O75914 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PAK 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1f8699be-d20a-11ec-8377-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1f86c20e-d20a-11ec-8377-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1f86eb80-d20a-11ec-8377-0242ac110003 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1f8714a2-d20a-11ec-8377-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1f873cf2-d20a-11ec-8377-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1f876556-d20a-11ec-8377-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.18']} DrugCentral uuid:1f878dba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1f87b8da-d20a-11ec-8377-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1f87e364-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1f880bb4-d20a-11ec-8377-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1f8833f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1f885cb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1f8884ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1f88ad30-d20a-11ec-8377-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1f88d56c-d20a-11ec-8377-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1f88fe70-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1f89279c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1f895000-d20a-11ec-8377-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1f897972-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1f89a1c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:1f89ca08-d20a-11ec-8377-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1f89f262-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1f8a1b02-d20a-11ec-8377-0242ac110003 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1f8a435c-d20a-11ec-8377-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1f8a6ba2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y243 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (RAC-gamma serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1f8a93fc-d20a-11ec-8377-0242ac110003 UniProtKB:O95835 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase LATS1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1f8abcf6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1f8ae546-d20a-11ec-8377-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1f8b0d8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1f8b35e6-d20a-11ec-8377-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:1f8b5f80-d20a-11ec-8377-0242ac110003 UniProtKB:Q86V86 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase pim-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.25']} DrugCentral uuid:1f8b87d0-d20a-11ec-8377-0242ac110003 UniProtKB:P17612 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1f8bb016-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1f8bd85c-d20a-11ec-8377-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.21']} DrugCentral uuid:1f8c00fc-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1f8c2956-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDC3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase BRSK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1f8c51a6-d20a-11ec-8377-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1f8c7a0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1f8ca2fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1f8ccc9e-d20a-11ec-8377-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1f8cf4f8-d20a-11ec-8377-0242ac110003 UniProtKB:P52564 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity mitogen-activated protein kinase kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1f8d1f0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1f8d475a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1f8d6fb4-d20a-11ec-8377-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1f8d97fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1f8dc0d6-d20a-11ec-8377-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1f8de8fe-d20a-11ec-8377-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1f8e1158-d20a-11ec-8377-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1f8e3a16-d20a-11ec-8377-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1f8e62fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IWQ3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase BRSK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1f8e8b38-d20a-11ec-8377-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1f8eb37e-d20a-11ec-8377-0242ac110003 UniProtKB:P68370 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Structural (Tubulin alpha-1A chain) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1f8edbb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1f8f0522-d20a-11ec-8377-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:1f8f2d5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.13']} DrugCentral uuid:1f8f55cc-d20a-11ec-8377-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1f8f7dfe-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.37']} DrugCentral uuid:1f8fa6c6-d20a-11ec-8377-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1f8fcf0c-d20a-11ec-8377-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1f8ff766-d20a-11ec-8377-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1f901fc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1f90489c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.03']} DrugCentral uuid:1f9070d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q13627 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1f909928-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1f90c178-d20a-11ec-8377-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1f90ea9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q15835 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Rhodopsin kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1f9113c6-d20a-11ec-8377-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1f913c0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.32']} DrugCentral uuid:1f9164de-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1f918d1a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1f91b54c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1f91dd88-d20a-11ec-8377-0242ac110003 UniProtKB:P57058 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Hormonally up-regulated neu tumor-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1f920664-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1f922eb4-d20a-11ec-8377-0242ac110003 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1f92570e-d20a-11ec-8377-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1f927f7c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1f92a92a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1f92d594-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1f92fe0c-d20a-11ec-8377-0242ac110003 UniProtKB:O43172 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Nuclear other (U4/U6 small nuclear ribonucleoprotein Prp4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1f932666-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:1f934f56-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1f9377d8-d20a-11ec-8377-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1f93a028-d20a-11ec-8377-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1f93c864-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.82']} DrugCentral uuid:1f93f118-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Enzyme (Tankyrase-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1f94197c-d20a-11ec-8377-0242ac110003 UniProtKB:O00750 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1f9441b8-d20a-11ec-8377-0242ac110003 UniProtKB:O75747 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1f9469f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:1f949578-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WU08 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase 32A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1f94bdb4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.26']} DrugCentral uuid:1f94e6ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:1f950fe4-d20a-11ec-8377-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1f9538b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.75']} DrugCentral uuid:1f956110-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1f958956-d20a-11ec-8377-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1f95b20a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13976 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (cGMP-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1f95da3c-d20a-11ec-8377-0242ac110003 UniProtKB:P51817 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (cAMP-dependent protein kinase catalytic subunit PRKX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1f960296-d20a-11ec-8377-0242ac110003 UniProtKB:Q06418 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin targets Kinase (Tyrosine-protein kinase receptor TYRO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1f962ae6-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5231 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 midostaurin is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1f96541c-d20a-11ec-8377-0242ac110003 UniProtKB:Q03431 biolink:molecularly_interacts_with DrugCentral:5232 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abaloparatide is agonist of GPCR (Parathyroid hormone/parathyroid hormone-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1f967c58-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brigatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.174']} DrugCentral uuid:1f96a4a8-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brigatinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:1f96cce4-d20a-11ec-8377-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brigatinib is inhibitor of Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.137']} DrugCentral uuid:1f96f5e8-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brigatinib is inhibitor of Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.796']} DrugCentral uuid:1f971e24-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brigatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.721']} DrugCentral uuid:1f97467e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5233 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brigatinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.222']} DrugCentral uuid:1f976ece-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZQ7 biolink:molecularly_interacts_with DrugCentral:5234 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 durvalumab is antibody binding of CD molecules (Programmed cell death 1 ligand 1) DrugCentral uuid:1f979386-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5235 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cenegermin is agonist of Kinase (High affinity nerve growth factor receptor) DrugCentral uuid:1f97b7bc-d20a-11ec-8377-0242ac110003 UniProtKB:P08138 biolink:molecularly_interacts_with DrugCentral:5235 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cenegermin is agonist of Membrane receptor (Tumor necrosis factor receptor superfamily member 16) DrugCentral uuid:1f97dff8-d20a-11ec-8377-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarilumab is antibody binding of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.1']} DrugCentral uuid:1f97dff8-d20a-11ec-8377-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5237 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sarilumab is antibody binding of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.1']} DrugCentral uuid:1f981392-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evogliptin targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.1']} DrugCentral uuid:1f983db8-d20a-11ec-8377-0242ac110003 UniProtKB:P27487 biolink:molecularly_interacts_with DrugCentral:5239 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evogliptin is inhibitor of Enzyme (Dipeptidyl peptidase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.046']} DrugCentral uuid:1f986608-d20a-11ec-8377-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:5240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polmacoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1f988f7a-d20a-11ec-8377-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:5240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polmacoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1f98b978-d20a-11ec-8377-0242ac110003 UniProtKB:P23219 biolink:molecularly_interacts_with DrugCentral:5240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polmacoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.081']} DrugCentral uuid:1f98e1d2-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:5240 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polmacoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.081']} DrugCentral uuid:1f990a18-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betrixaban targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1f993290-d20a-11ec-8377-0242ac110003 UniProtKB:P00734 biolink:molecularly_interacts_with DrugCentral:5241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betrixaban targets Enzyme (Prothrombin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.75']} DrugCentral uuid:1f995b44-d20a-11ec-8377-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:5241 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 betrixaban is inhibitor of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.824']} DrugCentral uuid:1f9983b2-d20a-11ec-8377-0242ac110003 UniProtKB:P26663 biolink:molecularly_interacts_with DrugCentral:5242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voxilaprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.42']} DrugCentral uuid:1f99ac20-d20a-11ec-8377-0242ac110003 UniProtKB:Q81495 biolink:molecularly_interacts_with DrugCentral:5242 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voxilaprevir is inhibitor of Polyprotein (Genome polyprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.18']} DrugCentral uuid:1f99d484-d20a-11ec-8377-0242ac110003 UniProtKB:Q5L478 biolink:molecularly_interacts_with DrugCentral:5244 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pibrentasvir targets Unclassified (Nonstructural protein 5A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.19']} DrugCentral uuid:1f99fdb0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WMX2 biolink:molecularly_interacts_with DrugCentral:5244 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pibrentasvir targets Unclassified (Genome polyprotein [Cleaved into: Core protein p21) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1f9a260a-d20a-11ec-8377-0242ac110003 UniProtKB:P23945 biolink:molecularly_interacts_with DrugCentral:5245 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 corifollitropin alfa is agonist of GPCR (Follicle-stimulating hormone receptor) DrugCentral uuid:1f9a4ed2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5246 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guselkumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:1f9a4ed2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5246 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 guselkumab is antibody binding of Cytokine (Interleukin-23) DrugCentral uuid:1f9a7d12-d20a-11ec-8377-0242ac110003 UniProtKB:P20273 biolink:molecularly_interacts_with DrugCentral:5247 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 inotuzumab ozogamicin is antibody binding of Membrane receptor (B-cell receptor CD22) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1f9aa62a-d20a-11ec-8377-0242ac110003 UniProtKB:P37231 biolink:molecularly_interacts_with DrugCentral:5248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.959']} DrugCentral uuid:1f9ace7a-d20a-11ec-8377-0242ac110003 UniProtKB:Q03181 biolink:molecularly_interacts_with DrugCentral:5248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.801']} DrugCentral uuid:1f9af6c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q07869 biolink:molecularly_interacts_with DrugCentral:5248 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemafibrate is agonist of Nuclear hormone receptor (Peroxisome proliferator-activated receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1f9b1efc-d20a-11ec-8377-0242ac110003 UniProtKB:Q05769 biolink:molecularly_interacts_with DrugCentral:5250 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imrecoxib targets Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.75']} DrugCentral uuid:1f9b479c-d20a-11ec-8377-0242ac110003 UniProtKB:P22437 biolink:molecularly_interacts_with DrugCentral:5250 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imrecoxib targets Enzyme (Prostaglandin G/H synthase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:1f9b6fe2-d20a-11ec-8377-0242ac110003 UniProtKB:P35354 biolink:molecularly_interacts_with DrugCentral:5250 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imrecoxib is inhibitor of Enzyme (Prostaglandin G/H synthase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.824']} DrugCentral uuid:1f9b983c-d20a-11ec-8377-0242ac110003 UniProtKB:O75874 biolink:molecularly_interacts_with DrugCentral:5251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enasidenib targets Enzyme (Isocitrate dehydrogenase [NADP] cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1f9bc0a0-d20a-11ec-8377-0242ac110003 UniProtKB:O75874 biolink:molecularly_interacts_with DrugCentral:5251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enasidenib targets Enzyme (Isocitrate dehydrogenase [NADP] cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1f9bebde-d20a-11ec-8377-0242ac110003 UniProtKB:P48735 biolink:molecularly_interacts_with DrugCentral:5251 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enasidenib is inhibitor of Enzyme (Isocitrate dehydrogenase [NADP], mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:1f9c1438-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1f9c3c74-d20a-11ec-8377-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.08']} DrugCentral uuid:1f9c6582-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1f9c8ecc-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1f9cb6fe-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1f9cdf58-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1f9d07ee-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1f9d3034-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1f9d588e-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1f9d80d4-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1f9daa82-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1f9dd2d2-d20a-11ec-8377-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1f9dfb22-d20a-11ec-8377-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1f9e2372-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:1f9e4c76-d20a-11ec-8377-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1f9e75de-d20a-11ec-8377-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1f9e9e42-d20a-11ec-8377-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1f9ec67e-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1f9eef50-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1f9f17a0-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1f9f400e-d20a-11ec-8377-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1f9f6854-d20a-11ec-8377-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1f9f9176-d20a-11ec-8377-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1f9fb9bc-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1f9fe216-d20a-11ec-8377-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1fa00b2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1fa03388-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1fa05c46-d20a-11ec-8377-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1fa0857c-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1fa0ae26-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1fa0d66c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.19']} DrugCentral uuid:1fa0fea8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1fa12716-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1fa14ff2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.25']} DrugCentral uuid:1fa17842-d20a-11ec-8377-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1fa1a07e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13043 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1fa1c8ec-d20a-11ec-8377-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1fa1f196-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:1fa219f0-d20a-11ec-8377-0242ac110003 UniProtKB:O14733 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1fa2422c-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.85']} DrugCentral uuid:1fa26a9a-d20a-11ec-8377-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.59']} DrugCentral uuid:1fa2939e-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1fa2bc0c-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1fa2e43e-d20a-11ec-8377-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1fa30c8e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15139 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase D1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1fa33826-d20a-11ec-8377-0242ac110003 UniProtKB:Q13188 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1fa36080-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1fa388d0-d20a-11ec-8377-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1fa3b116-d20a-11ec-8377-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1fa3d9a2-d20a-11ec-8377-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1fa401fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1fa42a38-d20a-11ec-8377-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1fa45472-d20a-11ec-8377-0242ac110003 UniProtKB:P78368 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Casein kinase I isoform gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.18']} DrugCentral uuid:1fa47dda-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6M4 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Casein kinase I isoform gamma-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1fa4a63e-d20a-11ec-8377-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1fa4cea2-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.32']} DrugCentral uuid:1fa4f882-d20a-11ec-8377-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1fa523d4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:1fa54e2c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:1fa5765e-d20a-11ec-8377-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1fa59f08-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.48']} DrugCentral uuid:1fa5c758-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1fa5efa8-d20a-11ec-8377-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.03']} DrugCentral uuid:1fa617ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1fa640e8-d20a-11ec-8377-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1fa6694c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:1fa691b0-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1fa6ba0a-d20a-11ec-8377-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1fa6e520-d20a-11ec-8377-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1fa70d66-d20a-11ec-8377-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.27']} DrugCentral uuid:1fa73642-d20a-11ec-8377-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1fa75f00-d20a-11ec-8377-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1fa7875a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6E0 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 24) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.19']} DrugCentral uuid:1fa7af96-d20a-11ec-8377-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1fa7d80e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1fa800fe-d20a-11ec-8377-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1fa82958-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BZL6 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase D2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1fa85194-d20a-11ec-8377-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1fa87aca-d20a-11ec-8377-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1fa8a4f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.13']} DrugCentral uuid:1fa8cd68-d20a-11ec-8377-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1fa8f5ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1fa91e08-d20a-11ec-8377-0242ac110003 UniProtKB:O96017 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Chk2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1fa946c6-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1fa96f0c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1fa99766-d20a-11ec-8377-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1fa9bfb6-d20a-11ec-8377-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.13']} DrugCentral uuid:1fa9e8b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1faa110a-d20a-11ec-8377-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1faa3964-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2H9 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Microtubule-associated serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.26']} DrugCentral uuid:1faa6326-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.38']} DrugCentral uuid:1faa8d2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1faab592-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDR2 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 35) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.35']} DrugCentral uuid:1faadde2-d20a-11ec-8377-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Receptor tyrosine-protein kinase erbB-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:1fab06a0-d20a-11ec-8377-0242ac110003 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1fab2ef0-d20a-11ec-8377-0242ac110003 UniProtKB:P51956 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase Nek3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1fab5772-d20a-11ec-8377-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.43']} DrugCentral uuid:1fab7fae-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.2']} DrugCentral uuid:1faba8d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1fabd10c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY57 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib targets Kinase (Serine/threonine-protein kinase 32B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1fabf9de-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.62']} DrugCentral uuid:1fac221a-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.036']} DrugCentral uuid:1fac4b0a-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5252 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 neratinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.229']} DrugCentral uuid:1fac7418-d20a-11ec-8377-0242ac110003 UniProtKB:P42345 biolink:molecularly_interacts_with DrugCentral:5256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 copanlisib is inhibitor of Kinase (Serine/threonine-protein kinase mTOR) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.35']} DrugCentral uuid:1fac9c5e-d20a-11ec-8377-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.432']} DrugCentral uuid:1facc49a-d20a-11ec-8377-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.194']} DrugCentral uuid:1faced76-d20a-11ec-8377-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.155']} DrugCentral uuid:1fad15d0-d20a-11ec-8377-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5256 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 copanlisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.301']} DrugCentral uuid:1fad3ec0-d20a-11ec-8377-0242ac110003 UniProtKB:O95069 biolink:molecularly_interacts_with DrugCentral:5257 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 butylphthalide is blocker of Ion channel (Potassium channel subfamily K member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:1fad66de-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.65']} DrugCentral uuid:1fad8fd8-d20a-11ec-8377-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.76']} DrugCentral uuid:1fadb828-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.764']} DrugCentral uuid:1fade082-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.788']} DrugCentral uuid:1fae08dc-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.375']} DrugCentral uuid:1fae3456-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.866']} DrugCentral uuid:1fae5ea4-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.524']} DrugCentral uuid:1fae8708-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.678']} DrugCentral uuid:1faeafe4-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.796']} DrugCentral uuid:1faed82a-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5258 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tivozanib is inhibitor of Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:1faf005c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.96']} DrugCentral uuid:1faf28b6-d20a-11ec-8377-0242ac110003 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1faf51b0-d20a-11ec-8377-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1faf79e2-d20a-11ec-8377-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1fafa20a-d20a-11ec-8377-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1fafca3c-d20a-11ec-8377-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:1faff408-d20a-11ec-8377-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.62']} DrugCentral uuid:1fb01c9e-d20a-11ec-8377-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5259 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abemaciclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.222']} DrugCentral uuid:1fb045de-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:1fb06f50-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:1fb097f0-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:1fb0c04a-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:1fb0e890-d20a-11ec-8377-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib is inhibitor of Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.337']} DrugCentral uuid:1fb110b8-d20a-11ec-8377-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.032']} DrugCentral uuid:1fb13994-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.434']} DrugCentral uuid:1fb161d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5260 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 acalabrutinib is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.292']} DrugCentral uuid:1fb18a20-d20a-11ec-8377-0242ac110003 UniProtKB:P37289 biolink:molecularly_interacts_with DrugCentral:5261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latanoprostene bunod targets GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.01']} DrugCentral uuid:1fb1b266-d20a-11ec-8377-0242ac110003 UniProtKB:P43088 biolink:molecularly_interacts_with DrugCentral:5261 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 latanoprostene bunod is agonist of GPCR (Prostaglandin F2-alpha receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.6']} DrugCentral uuid:1fb1e506-d20a-11ec-8377-0242ac110003 UniProtKB:F5HCU8 biolink:molecularly_interacts_with DrugCentral:5262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 letermovir is inhibitor of Enzyme (DNA terminase complex) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:1fb1e506-d20a-11ec-8377-0242ac110003 UniProtKB:F5HCU8 biolink:molecularly_interacts_with DrugCentral:5262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 letermovir is inhibitor of Enzyme (DNA terminase complex) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:1fb1e506-d20a-11ec-8377-0242ac110003 UniProtKB:F5HCU8 biolink:molecularly_interacts_with DrugCentral:5262 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 letermovir is inhibitor of Enzyme (DNA terminase complex) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.678']} DrugCentral uuid:1fb223c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q01344 biolink:molecularly_interacts_with DrugCentral:5263 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 benralizumab is antibody binding of Membrane receptor (Interleukin-5 receptor subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.959']} DrugCentral uuid:1fb24c26-d20a-11ec-8377-0242ac110003 UniProtKB:P43220 biolink:molecularly_interacts_with DrugCentral:5267 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 semaglutide is agonist of GPCR (Glucagon-like peptide 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.42']} DrugCentral uuid:1fb27584-d20a-11ec-8377-0242ac110003 UniProtKB:P00742 biolink:molecularly_interacts_with DrugCentral:5268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emicizumab is antibody binding of Enzyme (Coagulation factor X) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.73']} DrugCentral uuid:1fb29dd4-d20a-11ec-8377-0242ac110003 UniProtKB:P00740 biolink:molecularly_interacts_with DrugCentral:5268 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emicizumab is antibody binding of Enzyme (Coagulation factor IX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1fb2c624-d20a-11ec-8377-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:5269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 netarsudil is inhibitor of Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.49']} DrugCentral uuid:1fb2ee7e-d20a-11ec-8377-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5269 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 netarsudil is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.377']} DrugCentral uuid:1fb31764-d20a-11ec-8377-0242ac110003 UniProtKB:P53792 biolink:molecularly_interacts_with DrugCentral:5270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertugliflozin targets Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.94']} DrugCentral uuid:1fb33faa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NY91 biolink:molecularly_interacts_with DrugCentral:5270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertugliflozin targets Transporter (Low affinity sodium-glucose cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.06']} DrugCentral uuid:1fb367e6-d20a-11ec-8377-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:5270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertugliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.708']} DrugCentral uuid:1fb39036-d20a-11ec-8377-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:5270 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ertugliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.057']} DrugCentral uuid:1fb3b994-d20a-11ec-8377-0242ac110003 UniProtKB:Q92847 biolink:molecularly_interacts_with DrugCentral:5271 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 macimorelin is agonist of GPCR (Growth hormone secretagogue receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:1fb3e2c0-d20a-11ec-8377-0242ac110003 UniProtKB:P50052 biolink:molecularly_interacts_with DrugCentral:5272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 angiotensin II is agonist of GPCR (Type-2 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.2']} DrugCentral uuid:1fb40b06-d20a-11ec-8377-0242ac110003 UniProtKB:P29089 biolink:molecularly_interacts_with DrugCentral:5272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 angiotensin II targets GPCR (Type-1B angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.51']} DrugCentral uuid:1fb433e2-d20a-11ec-8377-0242ac110003 UniProtKB:P25104 biolink:molecularly_interacts_with DrugCentral:5272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 angiotensin II targets GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.24']} DrugCentral uuid:1fb45c46-d20a-11ec-8377-0242ac110003 UniProtKB:P25095 biolink:molecularly_interacts_with DrugCentral:5272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 angiotensin II targets GPCR (Type-1A angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:1fb4848c-d20a-11ec-8377-0242ac110003 UniProtKB:P30556 biolink:molecularly_interacts_with DrugCentral:5272 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 angiotensin II is agonist of GPCR (Type-1 angiotensin II receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:1fb4acd2-d20a-11ec-8377-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bictegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:1fb4d5a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bictegravir targets Unclassified (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:1fb4fdf4-d20a-11ec-8377-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:5274 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bictegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.125']} DrugCentral uuid:1fb52662-d20a-11ec-8377-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:5275 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lutetium (177Lu) oxodotreotide is agonist of GPCR (Somatostatin receptor type 2) DrugCentral uuid:1fb54ae8-d20a-11ec-8377-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:5276 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tezacaftor is pharmacological chaperone of Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1fb5745a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12908 biolink:molecularly_interacts_with DrugCentral:5277 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elobixibat is inhibitor of Transporter (Ileal sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.276']} DrugCentral uuid:1fb59cd2-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:5278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apalutamide is antagonist of Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.03']} DrugCentral uuid:1fb5c55e-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:5278 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 apalutamide is inhibitor of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.796']} DrugCentral uuid:1fb5eda4-d20a-11ec-8377-0242ac110003 UniProtKB:P01730 biolink:molecularly_interacts_with DrugCentral:5279 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibalizumab is antibody binding of Membrane receptor (T-cell surface glycoprotein CD4) DrugCentral uuid:1fb61392-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fostamatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1fb63be2-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fostamatinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.16']} DrugCentral uuid:1fb6643c-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fostamatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1fb68c96-d20a-11ec-8377-0242ac110003 UniProtKB:P0DMS8 biolink:molecularly_interacts_with DrugCentral:5280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fostamatinib is inhibitor of GPCR (Adenosine receptor A3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.092']} DrugCentral uuid:1fb6b5ae-d20a-11ec-8377-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5280 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fostamatinib is inhibitor of Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.387']} DrugCentral uuid:1fb6e1dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tildrakizumab is antibody binding of Cytokine (Interleukin-23) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.5']} DrugCentral uuid:1fb6e1dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5281 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tildrakizumab is antibody binding of Cytokine (Interleukin-23) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.5']} DrugCentral uuid:1fb7156c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GZV9 biolink:molecularly_interacts_with DrugCentral:5282 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 burosumab is antibody binding of Secreted (Fibroblast growth factor 23) DrugCentral uuid:1fb739c0-d20a-11ec-8377-0242ac110003 UniProtKB:P25103 biolink:molecularly_interacts_with DrugCentral:5283 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosnetupitant is antagonist of GPCR (Substance-P receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.022']} DrugCentral uuid:1fb76ad0-d20a-11ec-8377-0242ac110003 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erenumab is antibody binding of GPCR (Calcitonin-gene-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.699']} DrugCentral uuid:1fb76ad0-d20a-11ec-8377-0242ac110003 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5284 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erenumab is antibody binding of GPCR (Calcitonin-gene-related peptide receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.699']} DrugCentral uuid:1fb7a3d8-d20a-11ec-8377-0242ac110003 UniProtKB:P40238 biolink:molecularly_interacts_with DrugCentral:5285 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avatrombopag is agonist of Membrane receptor (Thrombopoietin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:1fb7cf3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q25634 biolink:molecularly_interacts_with DrugCentral:5286 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxidectin is inhibitor of Ion channel (Glutamate-gated chloride channel) DrugCentral uuid:1fb7f400-d20a-11ec-8377-0242ac110003 UniProtKB:P21554 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1fb81c46-d20a-11ec-8377-0242ac110003 UniProtKB:P34972 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1fb844a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q14330 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol is agonist of GPCR (N-arachidonyl glycine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.29']} DrugCentral uuid:1fb86ce6-d20a-11ec-8377-0242ac110003 UniProtKB:P20272 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.9']} DrugCentral uuid:1fb895fe-d20a-11ec-8377-0242ac110003 UniProtKB:P47936 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol targets GPCR (Cannabinoid receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1fb8be6c-d20a-11ec-8377-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:1fb8e6bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WUD2 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1fb90fc0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5S1 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol is activator of Ion channel (Transient receptor potential cation channel subfamily V member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.5']} DrugCentral uuid:1fb93afe-d20a-11ec-8377-0242ac110003 UniProtKB:P97612 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol targets Enzyme (Fatty-acid amide hydrolase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.27']} DrugCentral uuid:1fb9663c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NER1 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol is inhibitor of Ion channel (Transient receptor potential cation channel subfamily V member 1) DrugCentral uuid:1fb98ab8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2T6 biolink:molecularly_interacts_with DrugCentral:5288 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cannabidiol is antagonist of GPCR (G-protein coupled receptor 55) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1fb9b380-d20a-11ec-8377-0242ac110003 UniProtKB:Q16539 biolink:molecularly_interacts_with DrugCentral:5289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encorafenib targets Kinase (Mitogen-activated protein kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1fb9dbee-d20a-11ec-8377-0242ac110003 UniProtKB:P04049 biolink:molecularly_interacts_with DrugCentral:5289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encorafenib is inhibitor of Kinase (RAF proto-oncogene serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.523']} DrugCentral uuid:1fba0452-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5289 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 encorafenib is inhibitor of Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.328']} DrugCentral uuid:1fba2ca2-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 binimetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1fba5588-d20a-11ec-8377-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5290 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 binimetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.9']} DrugCentral uuid:1fba7df6-d20a-11ec-8377-0242ac110003 UniProtKB:P33815 biolink:molecularly_interacts_with DrugCentral:5291 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tecovirimat is inhibitor of Viral envelope protein (Envelope protein F13) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.382']} DrugCentral uuid:1fbaa65a-d20a-11ec-8377-0242ac110003 UniProtKB:O75874 biolink:molecularly_interacts_with DrugCentral:5292 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ivosidenib is inhibitor of Enzyme (Isocitrate dehydrogenase [NADP] cytoplasmic) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.149']} DrugCentral uuid:1fbaceaa-d20a-11ec-8377-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:5293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elagolix targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1fbaf902-d20a-11ec-8377-0242ac110003 UniProtKB:Q8SPZ1 biolink:molecularly_interacts_with DrugCentral:5293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elagolix targets GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.48']} DrugCentral uuid:1fbb2486-d20a-11ec-8377-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:5293 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elagolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.824']} DrugCentral uuid:1fbb4d1c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:5295 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doravirine targets Enzyme (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1fbb7562-d20a-11ec-8377-0242ac110003 UniProtKB:Q9WKE8 biolink:molecularly_interacts_with DrugCentral:5295 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doravirine targets Unclassified (Reverse transcriptase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1fbb9f2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q72547 biolink:molecularly_interacts_with DrugCentral:5295 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 doravirine is inhibitor of Enzyme (Reverse transcriptase/RNaseH) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.921']} DrugCentral uuid:1fbbc88c-d20a-11ec-8377-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5296 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1fbbf0d2-d20a-11ec-8377-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5296 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1fbc19d6-d20a-11ec-8377-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5296 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.638']} DrugCentral uuid:1fbc430c-d20a-11ec-8377-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5296 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 duvelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.62']} DrugCentral uuid:1fbc6bac-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacomitinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.45']} DrugCentral uuid:1fbc93f2-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacomitinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:1fbcbd3c-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacomitinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:1fbce5a0-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacomitinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:1fbd0e0e-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacomitinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1fbd3672-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5297 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dacomitinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.133']} DrugCentral uuid:1fbd5f12-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talazoparib tosylate is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.06']} DrugCentral uuid:1fbd878a-d20a-11ec-8377-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5300 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 talazoparib tosylate is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.921']} DrugCentral uuid:1fbdb05c-d20a-11ec-8377-0242ac110003 UniProtKB:P03433 biolink:molecularly_interacts_with DrugCentral:5301 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 baloxavir marboxil is inhibitor of Enzyme (Polymerase acidic protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.854']} DrugCentral uuid:1fbdd8a2-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.28']} DrugCentral uuid:1fbe01b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.959']} DrugCentral uuid:1fbe2a28-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.301']} DrugCentral uuid:1fbe528c-d20a-11ec-8377-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1fbe7ae6-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.62']} DrugCentral uuid:1fbea5a2-d20a-11ec-8377-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.481']} DrugCentral uuid:1fbece60-d20a-11ec-8377-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1fbef6b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.638']} DrugCentral uuid:1fbf1ef6-d20a-11ec-8377-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.854']} DrugCentral uuid:1fbf47c8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.337']} DrugCentral uuid:1fbf7108-d20a-11ec-8377-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.569']} DrugCentral uuid:1fbf996c-d20a-11ec-8377-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:5302 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lorlatinib is inhibitor of Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.222']} DrugCentral uuid:1fbfc1b2-d20a-11ec-8377-0242ac110003 UniProtKB:P11229 biolink:molecularly_interacts_with DrugCentral:5303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.38']} DrugCentral uuid:1fbfeb06-d20a-11ec-8377-0242ac110003 UniProtKB:P08172 biolink:molecularly_interacts_with DrugCentral:5303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.52']} DrugCentral uuid:1fc01374-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:5303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.75']} DrugCentral uuid:1fc03be2-d20a-11ec-8377-0242ac110003 UniProtKB:P08173 biolink:molecularly_interacts_with DrugCentral:5303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:1fc06608-d20a-11ec-8377-0242ac110003 UniProtKB:P08912 biolink:molecularly_interacts_with DrugCentral:5303 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 revefenacin is antagonist of GPCR (Muscarinic acetylcholine receptor M5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1fc0916e-d20a-11ec-8377-0242ac110003 UniProtKB:P56726 biolink:molecularly_interacts_with DrugCentral:5304 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glasdegib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1fc0bc20-d20a-11ec-8377-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5304 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 glasdegib is antagonist of GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:1fc0e48e-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 larotrectinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.187']} DrugCentral uuid:1fc10d4c-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 larotrectinib is inhibitor of Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.092']} DrugCentral uuid:1fc135a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5305 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 larotrectinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.975']} DrugCentral uuid:1fc15e8c-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:1fc186e6-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.96']} DrugCentral uuid:1fc1b06c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.82']} DrugCentral uuid:1fc1d9e8-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib is inhibitor of Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1fc2022e-d20a-11ec-8377-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib is inhibitor of Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.7']} DrugCentral uuid:1fc22a6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib is inhibitor of Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1fc25594-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:1fc27de4-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5306 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gilteritinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.301']} DrugCentral uuid:1fc2a620-d20a-11ec-8377-0242ac110003 UniProtKB:P41180 biolink:molecularly_interacts_with DrugCentral:5307 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evocalcet is agonist of GPCR (Extracellular calcium-sensing receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.032']} DrugCentral uuid:1fc2ce52-d20a-11ec-8377-0242ac110003 UniProtKB:P04275 biolink:molecularly_interacts_with DrugCentral:5308 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 caplacizumab is antibody binding of Unclassified (von Willebrand factor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.509']} DrugCentral uuid:1fc2f706-d20a-11ec-8377-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:5309 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lanadelumab is antibody binding of Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.05']} DrugCentral uuid:1fc31f42-d20a-11ec-8377-0242ac110003 UniProtKB:P26255 biolink:molecularly_interacts_with DrugCentral:5311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vibegron targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.07']} DrugCentral uuid:1fc34882-d20a-11ec-8377-0242ac110003 UniProtKB:O02662 biolink:molecularly_interacts_with DrugCentral:5311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vibegron targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1fc37172-d20a-11ec-8377-0242ac110003 UniProtKB:Q28524 biolink:molecularly_interacts_with DrugCentral:5311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vibegron targets GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.24']} DrugCentral uuid:1fc399e0-d20a-11ec-8377-0242ac110003 UniProtKB:P13945 biolink:molecularly_interacts_with DrugCentral:5311 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vibegron is agonist of GPCR (Beta-3 adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.959']} DrugCentral uuid:1fc3c29e-d20a-11ec-8377-0242ac110003 UniProtKB:P43116 biolink:molecularly_interacts_with DrugCentral:5312 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 omidenepag isopropyl is agonist of GPCR (Prostaglandin E2 receptor EP2 subtype) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.081']} DrugCentral uuid:1fc3eb02-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:5313 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 patisiran is antisense inhibitor of RNA (transthyretin (TTR) mRNA) DrugCentral uuid:1fc41078-d20a-11ec-8377-0242ac110003 UniProtKB:P20273 biolink:molecularly_interacts_with DrugCentral:5314 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 moxetumomab pasudotox is binding agent of Membrane receptor (B-cell receptor CD22) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.2']} DrugCentral uuid:1fc43b52-d20a-11ec-8377-0242ac110003 UniProtKB:P06881 biolink:molecularly_interacts_with DrugCentral:5315 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fremanezumab is antibody binding of GPCR (Calcitonin gene-related peptide 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.3']} DrugCentral uuid:1fc463b6-d20a-11ec-8377-0242ac110003 UniProtKB:P06881 biolink:molecularly_interacts_with DrugCentral:5316 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 galcanezumab is antibody binding of GPCR (Calcitonin gene-related peptide 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.7']} DrugCentral uuid:1fc48c2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:5317 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cemiplimab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.102']} DrugCentral uuid:1fc4b4c4-d20a-11ec-8377-0242ac110003 UniProtKB:P02766 biolink:molecularly_interacts_with DrugCentral:5319 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 inotersen is antisense inhibitor of RNA (transthyretin (TTR) mRNA) DrugCentral uuid:1fc4d918-d20a-11ec-8377-0242ac110003 UniProtKB:P01579 biolink:molecularly_interacts_with DrugCentral:5320 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 emapalumab is antibody binding of Cytokine (Interferon gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.1']} DrugCentral uuid:1fc50168-d20a-11ec-8377-0242ac110003 UniProtKB:P01031 biolink:molecularly_interacts_with DrugCentral:5322 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ravulizumab is antibody binding of Secreted (Complement C5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.357']} DrugCentral uuid:1fc52dbe-d20a-11ec-8377-0242ac110003 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tagraxofusp is binding agent of Membrane receptor (Interleukin-3 receptor) DrugCentral uuid:1fc52dbe-d20a-11ec-8377-0242ac110003 UniProtKB:P32927 biolink:molecularly_interacts_with DrugCentral:5323 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tagraxofusp is binding agent of Membrane receptor (Interleukin-3 receptor) DrugCentral uuid:1fc55c44-d20a-11ec-8377-0242ac110003 UniProtKB:P11413 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone targets Enzyme (Glucose-6-phosphate 1-dehydrogenase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.18']} DrugCentral uuid:1fc58c78-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:1fc58c78-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:1fc58c78-d20a-11ec-8377-0242ac110003 UniProtKB:P47870 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.222']} DrugCentral uuid:1fc5d2dc-d20a-11ec-8377-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:1fc5d2dc-d20a-11ec-8377-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:1fc5d2dc-d20a-11ec-8377-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA A receptor alpha-4/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.097']} DrugCentral uuid:1fc61f12-d20a-11ec-8377-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:1fc61f12-d20a-11ec-8377-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:1fc61f12-d20a-11ec-8377-0242ac110003 UniProtKB:O14764 biolink:molecularly_interacts_with DrugCentral:5324 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brexanolone is positive allosteric modulator of Ion channel (GABA-A receptor alpha-6/beta-3/delta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.81']} DrugCentral uuid:1fc6612a-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:5325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solriamfetol is inhibitor of Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.088']} DrugCentral uuid:1fc68ae2-d20a-11ec-8377-0242ac110003 UniProtKB:P23975 biolink:molecularly_interacts_with DrugCentral:5325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solriamfetol is inhibitor of Transporter (Sodium-dependent noradrenaline transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.432']} DrugCentral uuid:1fc6b332-d20a-11ec-8377-0242ac110003 UniProtKB:Q01959 biolink:molecularly_interacts_with DrugCentral:5325 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 solriamfetol is inhibitor of Transporter (Sodium-dependent dopamine transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['4.848']} DrugCentral uuid:1fc6dba0-d20a-11ec-8377-0242ac110003 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:5326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.125']} DrugCentral uuid:1fc70512-d20a-11ec-8377-0242ac110003 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:5326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['3']} DrugCentral uuid:1fc72dee-d20a-11ec-8377-0242ac110003 UniProtKB:O95136 biolink:molecularly_interacts_with DrugCentral:5326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4']} DrugCentral uuid:1fc75620-d20a-11ec-8377-0242ac110003 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:5326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.409']} DrugCentral uuid:1fc77e66-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:5326 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 siponimod is modulator of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.009']} DrugCentral uuid:1fc7a67a-d20a-11ec-8377-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:5327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erdafitinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:1fc7d064-d20a-11ec-8377-0242ac110003 UniProtKB:P35918 biolink:molecularly_interacts_with DrugCentral:5327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erdafitinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10']} DrugCentral uuid:1fc7f8aa-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erdafitinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.434']} DrugCentral uuid:1fc820fa-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.523']} DrugCentral uuid:1fc8492c-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.921']} DrugCentral uuid:1fc871cc-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.602']} DrugCentral uuid:1fc89af8-d20a-11ec-8377-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5327 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 erdafitinib is inhibitor of Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.244']} DrugCentral uuid:1fc8c334-d20a-11ec-8377-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1fc8eb7a-d20a-11ec-8377-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1fc9146a-d20a-11ec-8377-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:1fc93cc4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Z1L0 biolink:molecularly_interacts_with DrugCentral:5328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpelisib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1fc96532-d20a-11ec-8377-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5328 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 alpelisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.337']} DrugCentral uuid:1fc98e9a-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:5329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bremelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.77']} DrugCentral uuid:1fc9ba0a-d20a-11ec-8377-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:5329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bremelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.62']} DrugCentral uuid:1fc9e28c-d20a-11ec-8377-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:5329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bremelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['10.02']} DrugCentral uuid:1fca0adc-d20a-11ec-8377-0242ac110003 UniProtKB:Q01718 biolink:molecularly_interacts_with DrugCentral:5329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bremelanotide is agonist of GPCR (Adrenocorticotropic hormone receptor) DrugCentral uuid:1fca2fbc-d20a-11ec-8377-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:5329 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bremelanotide is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8']} DrugCentral uuid:1fca5bc2-d20a-11ec-8377-0242ac110003 UniProtKB:O14980 biolink:molecularly_interacts_with DrugCentral:5330 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selinexor is inhibitor of Nuclear other (Exportin-1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.7']} DrugCentral uuid:1fca8458-d20a-11ec-8377-0242ac110003 UniProtKB:P60880 biolink:molecularly_interacts_with DrugCentral:5331 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 prabotulinumtoxinA is blocker of Cytosolic other (Synaptosomal-associated protein 25) DrugCentral uuid:1fcac864-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1fcac864-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1fcac864-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1fcac864-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1fcac864-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1fcac864-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1fcac864-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1fcac864-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1fcac864-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:1fcb39fc-d20a-11ec-8377-0242ac110003 UniProtKB:P40259 biolink:molecularly_interacts_with DrugCentral:5333 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 polatuzumab vedotin is antibody binding of Tumour-associated antigen (B-cell antigen receptor complex-associated protein beta chain) DrugCentral uuid:1fcb5e32-d20a-11ec-8377-0242ac110003 UniProtKB:P15207 biolink:molecularly_interacts_with DrugCentral:5334 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darolutamide is antagonist of Transcription factor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.96']} DrugCentral uuid:1fcb8a88-d20a-11ec-8377-0242ac110003 UniProtKB:P06401 biolink:molecularly_interacts_with DrugCentral:5334 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darolutamide is antagonist of Nuclear hormone receptor (Progesterone receptor) DrugCentral uuid:1fcbaf0e-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:5334 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 darolutamide is inhibitor of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.187']} DrugCentral uuid:1fcbd772-d20a-11ec-8377-0242ac110003 UniProtKB:P02656 biolink:molecularly_interacts_with DrugCentral:5335 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 volanesorsen is antisense inhibitor of RNA (apolipoprotein C-III (apoC-III) mRNA) DrugCentral uuid:1fcbfd4c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NPF7 biolink:molecularly_interacts_with DrugCentral:5337 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 risankizumab is inhibitor of Cytokine (Interleukin-23 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11']} DrugCentral uuid:1fcc29d4-d20a-11ec-8377-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropeginterferon alfa-2b is binding agent of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:1fcc29d4-d20a-11ec-8377-0242ac110003 UniProtKB:P48551 biolink:molecularly_interacts_with DrugCentral:5338 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ropeginterferon alfa-2b is binding agent of Membrane receptor (Interferon alpha/beta receptor) DrugCentral uuid:1fcc57e2-d20a-11ec-8377-0242ac110003 UniProtKB:P31639 biolink:molecularly_interacts_with DrugCentral:5339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.745']} DrugCentral uuid:1fcc805a-d20a-11ec-8377-0242ac110003 UniProtKB:P13866 biolink:molecularly_interacts_with DrugCentral:5339 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotagliflozin is inhibitor of Transporter (Sodium/glucose cotransporter 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.444']} DrugCentral uuid:1fccaad0-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1fccd348-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1fccfb8e-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1fcd23f2-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1fcd4d64-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1fcd75be-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:1fcd9dfa-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.06']} DrugCentral uuid:1fcdc76c-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.39']} DrugCentral uuid:1fcdf002-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1fce185c-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:1fce40c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1fce691a-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1fce9214-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1fceba64-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1fcee2a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.04']} DrugCentral uuid:1fcf0c08-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKE5 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (TRAF2 and NCK-interacting protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:1fcf3494-d20a-11ec-8377-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1fcf5ce4-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1fcf853e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y4K4 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1fcfae06-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1fcfd638-d20a-11ec-8377-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.43']} DrugCentral uuid:1fcffe92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.34']} DrugCentral uuid:1fd026f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:1fd04ffa-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1fd0784a-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1fd0a0a4-d20a-11ec-8377-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:1fd0c8ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.26']} DrugCentral uuid:1fd0f298-d20a-11ec-8377-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1fd11ade-d20a-11ec-8377-0242ac110003 UniProtKB:O95819 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1fd1432e-d20a-11ec-8377-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1fd16b7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1fd19450-d20a-11ec-8377-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1fd1be76-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1fd1e6da-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.5']} DrugCentral uuid:1fd20f20-d20a-11ec-8377-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1fd237f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1fd26042-d20a-11ec-8377-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:1fd288ba-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5341 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 quizartinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.796']} DrugCentral uuid:1fd2b10a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8RL90 biolink:molecularly_interacts_with DrugCentral:5342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relebactam targets Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1fd2dce8-d20a-11ec-8377-0242ac110003 UniProtKB:Q2PUH3 biolink:molecularly_interacts_with DrugCentral:5342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.4']} DrugCentral uuid:1fd3081c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9X5A7 biolink:molecularly_interacts_with DrugCentral:5342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1fd33148-d20a-11ec-8377-0242ac110003 UniProtKB:Q93LQ9 biolink:molecularly_interacts_with DrugCentral:5342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.64']} DrugCentral uuid:1fd35a2e-d20a-11ec-8377-0242ac110003 UniProtKB:Q93DC4 biolink:molecularly_interacts_with DrugCentral:5342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.59']} DrugCentral uuid:1fd38288-d20a-11ec-8377-0242ac110003 UniProtKB:B1PL86 biolink:molecularly_interacts_with DrugCentral:5342 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relebactam is inhibitor of Enzyme (Beta-lactamase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1fd3aace-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1fd3d31e-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.06']} DrugCentral uuid:1fd3fbd2-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.36']} DrugCentral uuid:1fd42436-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.05']} DrugCentral uuid:1fd44c72-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BWU1 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (Cyclin-dependent kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1fd474e0-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.56']} DrugCentral uuid:1fd49fc4-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:1fd4cb02-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5343 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pexidartinib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.88']} DrugCentral uuid:1fd4f32a-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1fd51b70-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.79']} DrugCentral uuid:1fd5446a-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1fd56cb0-d20a-11ec-8377-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:1fd594e2-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:1fd5be4a-d20a-11ec-8377-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1fd5e6d6-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.95']} DrugCentral uuid:1fd60f26-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.67']} DrugCentral uuid:1fd63762-d20a-11ec-8377-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.71']} DrugCentral uuid:1fd66142-d20a-11ec-8377-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:1fd689c4-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1fd6b214-d20a-11ec-8377-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib is inhibitor of Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:1fd6da6e-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:1fd7034a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib is inhibitor of Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.92']} DrugCentral uuid:1fd72ba4-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib is inhibitor of Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:1fd75412-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.3']} DrugCentral uuid:1fd77c62-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5345 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 entrectinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.15']} DrugCentral uuid:1fd7a520-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 upadacitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1fd7ce7e-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 upadacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.63']} DrugCentral uuid:1fd7f6d8-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 upadacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.33']} DrugCentral uuid:1fd81fbe-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5346 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 upadacitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1fd84a48-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:1fd872fc-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.4']} DrugCentral uuid:1fd89b4c-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.34']} DrugCentral uuid:1fd8c374-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1fd8ec6e-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.12']} DrugCentral uuid:1fd914a0-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.14']} DrugCentral uuid:1fd93ce6-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1fd96522-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.42']} DrugCentral uuid:1fd98dd6-d20a-11ec-8377-0242ac110003 UniProtKB:P29317 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1fd9b70c-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.03']} DrugCentral uuid:1fd9df70-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:1fda08c4-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1fda3394-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1fda5bbc-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1fda8416-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1fdaacca-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1fdad51a-d20a-11ec-8377-0242ac110003 UniProtKB:P51812 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1fdafd4c-d20a-11ec-8377-0242ac110003 UniProtKB:P15735 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, liver/testis isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1fdb2588-d20a-11ec-8377-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1fdb4e46-d20a-11ec-8377-0242ac110003 UniProtKB:Q15746 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Myosin light chain kinase, smooth muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1fdb768c-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1fdb9ebe-d20a-11ec-8377-0242ac110003 UniProtKB:O43293 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Death-associated protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.92']} DrugCentral uuid:1fdbc740-d20a-11ec-8377-0242ac110003 UniProtKB:Q14012 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1fdbf15c-d20a-11ec-8377-0242ac110003 UniProtKB:P45983 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.58']} DrugCentral uuid:1fdc19c0-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1fdc41f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13464 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Rho-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1fdc6a4c-d20a-11ec-8377-0242ac110003 UniProtKB:Q05397 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Focal adhesion kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.38']} DrugCentral uuid:1fdc9346-d20a-11ec-8377-0242ac110003 UniProtKB:P08631 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase HCK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1fdcbbaa-d20a-11ec-8377-0242ac110003 UniProtKB:P53350 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1fdce3f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1fdd0c54-d20a-11ec-8377-0242ac110003 UniProtKB:P53779 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1fdd3508-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UIK4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Death-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.54']} DrugCentral uuid:1fdd5d62-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:1fdd85b2-d20a-11ec-8377-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1fddb0d2-d20a-11ec-8377-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1fddd918-d20a-11ec-8377-0242ac110003 UniProtKB:Q13557 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit delta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1fde0186-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H1R3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Myosin light chain kinase 2, skeletal/cardiac muscle) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.52']} DrugCentral uuid:1fde29e0-d20a-11ec-8377-0242ac110003 UniProtKB:P41240 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase CSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.23']} DrugCentral uuid:1fde5302-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1fde7b52-d20a-11ec-8377-0242ac110003 UniProtKB:P29322 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.11']} DrugCentral uuid:1fdea3b6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13555 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.27']} DrugCentral uuid:1fdecc6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q2M2I8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (AP2-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.46']} DrugCentral uuid:1fdef532-d20a-11ec-8377-0242ac110003 UniProtKB:Q7KZI7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase MARK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1fdf1d82-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1fdf45f0-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.3']} DrugCentral uuid:1fdf6e2c-d20a-11ec-8377-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1fdf9898-d20a-11ec-8377-0242ac110003 UniProtKB:P51955 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1fdfc124-d20a-11ec-8377-0242ac110003 UniProtKB:P53667 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (LIM domain kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.03']} DrugCentral uuid:1fdfe96a-d20a-11ec-8377-0242ac110003 UniProtKB:Q15349 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1fe011ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1fe03ab4-d20a-11ec-8377-0242ac110003 UniProtKB:Q13554 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1fe062e6-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.55']} DrugCentral uuid:1fe08b36-d20a-11ec-8377-0242ac110003 UniProtKB:Q16816 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.48']} DrugCentral uuid:1fe0b386-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQM7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1fe0dc44-d20a-11ec-8377-0242ac110003 UniProtKB:O94768 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 17B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.35']} DrugCentral uuid:1fe1048a-d20a-11ec-8377-0242ac110003 UniProtKB:O94804 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1fe12cc6-d20a-11ec-8377-0242ac110003 UniProtKB:P16591 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1fe15520-d20a-11ec-8377-0242ac110003 UniProtKB:Q02156 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Protein kinase C epsilon type) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.09']} DrugCentral uuid:1fe17f3c-d20a-11ec-8377-0242ac110003 UniProtKB:O00444 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.02']} DrugCentral uuid:1fe1a886-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UQB9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Aurora kinase C) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1fe1d0e0-d20a-11ec-8377-0242ac110003 UniProtKB:O75716 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.18']} DrugCentral uuid:1fe1f9da-d20a-11ec-8377-0242ac110003 UniProtKB:P33981 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase TTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.35']} DrugCentral uuid:1fe2222a-d20a-11ec-8377-0242ac110003 UniProtKB:P42684 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Abelson tyrosine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1fe24a70-d20a-11ec-8377-0242ac110003 UniProtKB:P54764 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1fe272ca-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.33']} DrugCentral uuid:1fe29ba6-d20a-11ec-8377-0242ac110003 UniProtKB:Q16512 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase N1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1fe2c3f6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEE5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 17A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:1fe2ec3c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UF33 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1fe3148c-d20a-11ec-8377-0242ac110003 UniProtKB:P09769 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fgr) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.09']} DrugCentral uuid:1fe33dcc-d20a-11ec-8377-0242ac110003 UniProtKB:O14965 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Aurora kinase A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1fe36612-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1fe38e58-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRP7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 36) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:1fe3b7de-d20a-11ec-8377-0242ac110003 UniProtKB:P29320 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.15']} DrugCentral uuid:1fe3e09c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NSY1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (BMP-2-inducible protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.5']} DrugCentral uuid:1fe408ec-d20a-11ec-8377-0242ac110003 UniProtKB:P42685 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase FRK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.7']} DrugCentral uuid:1fe4313c-d20a-11ec-8377-0242ac110003 UniProtKB:P49759 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase CLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:1fe459a0-d20a-11ec-8377-0242ac110003 UniProtKB:P49760 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase CLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.64']} DrugCentral uuid:1fe48254-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y6R4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:1fe4aaa4-d20a-11ec-8377-0242ac110003 UniProtKB:O14976 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-G-associated kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.96']} DrugCentral uuid:1fe4d2f4-d20a-11ec-8377-0242ac110003 UniProtKB:O43353 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.21']} DrugCentral uuid:1fe4fb4e-d20a-11ec-8377-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1fe52772-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IU85 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1D) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.34']} DrugCentral uuid:1fe552d8-d20a-11ec-8377-0242ac110003 UniProtKB:Q00536 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 16) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1fe57d9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07912 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Activated CDC42 kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.19']} DrugCentral uuid:1fe5a742-d20a-11ec-8377-0242ac110003 UniProtKB:Q15375 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.19']} DrugCentral uuid:1fe5d014-d20a-11ec-8377-0242ac110003 UniProtKB:O75582 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:1fe5f88c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2G2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (STE20-like serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.17']} DrugCentral uuid:1fe620be-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HAZ1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity protein kinase CLK4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1fe649ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HBH9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.42']} DrugCentral uuid:1fe6723a-d20a-11ec-8377-0242ac110003 UniProtKB:P45984 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.62']} DrugCentral uuid:1fe69a94-d20a-11ec-8377-0242ac110003 UniProtKB:Q96RR4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.4']} DrugCentral uuid:1fe6c2e4-d20a-11ec-8377-0242ac110003 UniProtKB:P27448 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (MAP/microtubule affinity-regulating kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1fe6edd2-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N5S9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1fe71816-d20a-11ec-8377-0242ac110003 UniProtKB:Q96NX5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium/calmodulin-dependent protein kinase type 1G) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:1fe7407a-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1fe768c0-d20a-11ec-8377-0242ac110003 UniProtKB:P54760 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1fe79188-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BXA7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Testis-specific serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1fe7b9e2-d20a-11ec-8377-0242ac110003 UniProtKB:P36896 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Activin receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.17']} DrugCentral uuid:1fe7e232-d20a-11ec-8377-0242ac110003 UniProtKB:P37023 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase receptor R3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1fe80a82-d20a-11ec-8377-0242ac110003 UniProtKB:Q04771 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Activin receptor type-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1fe8335e-d20a-11ec-8377-0242ac110003 UniProtKB:Q96Q40 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1fe85ba4-d20a-11ec-8377-0242ac110003 UniProtKB:O14920 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1fe88408-d20a-11ec-8377-0242ac110003 UniProtKB:P37173 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (TGF-beta receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1fe8ad98-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.29']} DrugCentral uuid:1fe8d908-d20a-11ec-8377-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1fe9016c-d20a-11ec-8377-0242ac110003 UniProtKB:Q08881 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase ITK/TSK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:1fe929d0-d20a-11ec-8377-0242ac110003 UniProtKB:P43403 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase ZAP-70) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1fe9527a-d20a-11ec-8377-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.06']} DrugCentral uuid:1fe97afc-d20a-11ec-8377-0242ac110003 UniProtKB:Q13882 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Protein-tyrosine kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1fe9a572-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1fe9cdd6-d20a-11ec-8377-0242ac110003 UniProtKB:P30530 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase receptor UFO) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1fe9f694-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1fea1ee4-d20a-11ec-8377-0242ac110003 UniProtKB:P29323 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1fea473e-d20a-11ec-8377-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1fea6f84-d20a-11ec-8377-0242ac110003 UniProtKB:P23443 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1fea9a4a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9C098 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase DCLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.89']} DrugCentral uuid:1feac57e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UK32 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1feaeffe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.31']} DrugCentral uuid:1feb183a-d20a-11ec-8377-0242ac110003 UniProtKB:Q13470 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Non-receptor tyrosine-protein kinase TNK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1feb413e-d20a-11ec-8377-0242ac110003 UniProtKB:O14757 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Chk1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1feb6984-d20a-11ec-8377-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.41']} DrugCentral uuid:1feb91c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q00537 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.46']} DrugCentral uuid:1febba7e-d20a-11ec-8377-0242ac110003 UniProtKB:Q07002 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 18) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.57']} DrugCentral uuid:1febe2c4-d20a-11ec-8377-0242ac110003 UniProtKB:O94921 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 14) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:1fec0b28-d20a-11ec-8377-0242ac110003 UniProtKB:Q99755 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:1fec3378-d20a-11ec-8377-0242ac110003 UniProtKB:P78356 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1fec5d30-d20a-11ec-8377-0242ac110003 UniProtKB:Q86YV6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Myosin light chain kinase family member 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.89']} DrugCentral uuid:1fec892c-d20a-11ec-8377-0242ac110003 UniProtKB:P30291 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Wee1-like protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:1fecb19a-d20a-11ec-8377-0242ac110003 UniProtKB:O00506 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 25) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1fecd9fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYL2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase MLT) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1fed0316-d20a-11ec-8377-0242ac110003 UniProtKB:Q14289 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Protein-tyrosine kinase 2-beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1fed2b5c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BRS2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase RIO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1fed53b6-d20a-11ec-8377-0242ac110003 UniProtKB:P35590 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase receptor Tie-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1fed7bfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UKI8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase tousled-like 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1feda5b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q86UE8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase tousled-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1fedcdf0-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.07']} DrugCentral uuid:1fedf640-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.82']} DrugCentral uuid:1fee1e86-d20a-11ec-8377-0242ac110003 UniProtKB:P68400 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Casein kinase II subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.04']} DrugCentral uuid:1fee4a00-d20a-11ec-8377-0242ac110003 UniProtKB:P19784 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Casein kinase II subunit alpha') {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1fee72b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y463 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity tyrosine-phosphorylation-regulated kinase 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1fee9b04-d20a-11ec-8377-0242ac110003 UniProtKB:Q14164 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:1feec354-d20a-11ec-8377-0242ac110003 UniProtKB:P53671 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (LIM domain kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1feeec44-d20a-11ec-8377-0242ac110003 UniProtKB:Q15831 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase STK11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.51']} DrugCentral uuid:1fef149e-d20a-11ec-8377-0242ac110003 UniProtKB:P46734 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.46']} DrugCentral uuid:1fef3cee-d20a-11ec-8377-0242ac110003 UniProtKB:Q14680 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Maternal embryonic leucine zipper kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:1fef65ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BUB5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (MAP kinase-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1fef8e06-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P289 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 26) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1fefb782-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TDX7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1fefdfe6-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P2K8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1ff009c6-d20a-11ec-8377-0242ac110003 UniProtKB:P14616 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Insulin receptor-related protein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1ff034a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y616 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Interleukin-1 receptor-associated kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:1ff05cf0-d20a-11ec-8377-0242ac110003 UniProtKB:O14730 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase RIO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:1ff08540-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H0K1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SIK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.01']} DrugCentral uuid:1ff0ae26-d20a-11ec-8377-0242ac110003 UniProtKB:Q96SB4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (SRSF protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.8']} DrugCentral uuid:1ff0d66c-d20a-11ec-8377-0242ac110003 UniProtKB:P78362 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (SRSF protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:1ff0feb2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BYT3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 33) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1ff12702-d20a-11ec-8377-0242ac110003 UniProtKB:Q59H18 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TNNI3K) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1ff14fb6-d20a-11ec-8377-0242ac110003 UniProtKB:P54646 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.33']} DrugCentral uuid:1ff177fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NFD2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ankyrin repeat and protein kinase domain-containing protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.37']} DrugCentral uuid:1ff1a164-d20a-11ec-8377-0242ac110003 UniProtKB:Q16832 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Discoidin domain-containing receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.02']} DrugCentral uuid:1ff1c9a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q09013 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Myotonin-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1ff1f43e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NI60 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Chaperone activity of bc1 complex-like, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1ff21d92-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRM7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase LATS2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.1']} DrugCentral uuid:1ff245d8-d20a-11ec-8377-0242ac110003 UniProtKB:P29376 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Leukocyte tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:1ff26e32-d20a-11ec-8377-0242ac110003 UniProtKB:Q92918 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1ff29754-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NQU5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1ff2bfa4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P286 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1ff2e7e0-d20a-11ec-8377-0242ac110003 UniProtKB:O60285 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (NUAK family SNF1-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.47']} DrugCentral uuid:1ff3110c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IVH8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.75']} DrugCentral uuid:1ff339f2-d20a-11ec-8377-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.31']} DrugCentral uuid:1ff36242-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:1ff38a92-d20a-11ec-8377-0242ac110003 UniProtKB:Q13873 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Bone morphogenetic protein receptor type-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1ff3b4a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9P0L2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase MARK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.16']} DrugCentral uuid:1ff3dcd6-d20a-11ec-8377-0242ac110003 UniProtKB:Q96L34 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (MAP/microtubule affinity-regulating kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.01']} DrugCentral uuid:1ff40530-d20a-11ec-8377-0242ac110003 UniProtKB:P45985 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:1ff42d76-d20a-11ec-8377-0242ac110003 UniProtKB:Q12866 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Mer) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.09']} DrugCentral uuid:1ff477a4-d20a-11ec-8377-0242ac110003 UniProtKB:P80192 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:1ff4a4ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q02779 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.16']} DrugCentral uuid:1ff4ccfe-d20a-11ec-8377-0242ac110003 UniProtKB:Q16584 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1ff4f634-d20a-11ec-8377-0242ac110003 UniProtKB:O15146 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Muscle, skeletal receptor tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:1ff51e70-d20a-11ec-8377-0242ac110003 UniProtKB:O14578 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Citron Rho-interacting kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1ff546b6-d20a-11ec-8377-0242ac110003 UniProtKB:P53355 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Death-associated protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.8']} DrugCentral uuid:1ff56f10-d20a-11ec-8377-0242ac110003 UniProtKB:O15075 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase DCLK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.72']} DrugCentral uuid:1ff59a9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N568 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase DCLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:1ff5c6fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q6P3R8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1ff5f14c-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TD19 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek9) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.82']} DrugCentral uuid:1ff61afa-d20a-11ec-8377-0242ac110003 UniProtKB:Q13153 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1ff6435e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13177 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1ff66bcc-d20a-11ec-8377-0242ac110003 UniProtKB:O96013 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PAK 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:1ff69444-d20a-11ec-8377-0242ac110003 UniProtKB:Q96D53 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (AarF domain-containing protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1ff6bd16-d20a-11ec-8377-0242ac110003 UniProtKB:P57059 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SIK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.41']} DrugCentral uuid:1ff6e584-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H3Y6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Srms) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.3']} DrugCentral uuid:1ff70dde-d20a-11ec-8377-0242ac110003 UniProtKB:Q15569 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity testis-specific protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.5']} DrugCentral uuid:1ff73656-d20a-11ec-8377-0242ac110003 UniProtKB:P21709 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-A receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.14']} DrugCentral uuid:1ff760e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H4B4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1ff78bce-d20a-11ec-8377-0242ac110003 UniProtKB:Q16659 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1ff7b41e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13164 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.18']} DrugCentral uuid:1ff7dc82-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TD08 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase 15) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.29']} DrugCentral uuid:1ff80568-d20a-11ec-8377-0242ac110003 UniProtKB:O94806 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase D3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.02']} DrugCentral uuid:1ff82dd6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13237 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (cGMP-dependent protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1ff85630-d20a-11ec-8377-0242ac110003 UniProtKB:P19525 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Interferon-induced, double-stranded RNA-activated protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.96']} DrugCentral uuid:1ff87e9e-d20a-11ec-8377-0242ac110003 UniProtKB:Q13546 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.28']} DrugCentral uuid:1ff8a766-d20a-11ec-8377-0242ac110003 UniProtKB:P07332 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Tyrosine-protein kinase Fes/Fps) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.28']} DrugCentral uuid:1ff8cfca-d20a-11ec-8377-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.7']} DrugCentral uuid:1ff8f842-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.22']} DrugCentral uuid:1ff9209c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15418 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.38']} DrugCentral uuid:1ff94a2c-d20a-11ec-8377-0242ac110003 UniProtKB:O75676 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ribosomal protein S6 kinase alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.85']} DrugCentral uuid:1ff972a4-d20a-11ec-8377-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.12']} DrugCentral uuid:1ff99b1c-d20a-11ec-8377-0242ac110003 UniProtKB:Q12851 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.68']} DrugCentral uuid:1ff9c4fc-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N4C8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Misshapen-like kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.05']} DrugCentral uuid:1ff9ed6a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UHD2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.04']} DrugCentral uuid:1ffa16be-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1ffa3f22-d20a-11ec-8377-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:1ffa67e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q92772 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase-like 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1ffa906c-d20a-11ec-8377-0242ac110003 UniProtKB:O15197 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Ephrin type-B receptor 6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.52']} DrugCentral uuid:1ffab8c6-d20a-11ec-8377-0242ac110003 UniProtKB:O75460 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase/endoribonuclease IRE1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:1ffae12a-d20a-11ec-8377-0242ac110003 UniProtKB:P32298 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (G protein-coupled receptor kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1ffb0ace-d20a-11ec-8377-0242ac110003 UniProtKB:Q8WTQ7 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (G protein-coupled receptor kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:1ffb335a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2X6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:1ffb5bd2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H422 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1ffb8440-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NE63 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1ffbad30-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPZ9 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ICK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ffbd6b6-d20a-11ec-8377-0242ac110003 UniProtKB:O15111 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Inhibitor of nuclear factor kappa-B kinase subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.08']} DrugCentral uuid:1ffbff06-d20a-11ec-8377-0242ac110003 UniProtKB:P51617 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Interleukin-1 receptor-associated kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.66']} DrugCentral uuid:1ffc2788-d20a-11ec-8377-0242ac110003 UniProtKB:O43283 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 13) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.23']} DrugCentral uuid:1ffc5064-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2U5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.24']} DrugCentral uuid:1ffc78dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q99759 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1ffca140-d20a-11ec-8377-0242ac110003 UniProtKB:Q15208 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase 38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.24']} DrugCentral uuid:1ffcc9a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IY84 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase NIM1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.36']} DrugCentral uuid:1ffcf5d2-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BVS4 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase RIO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.58']} DrugCentral uuid:1ffd2034-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UPE1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (SRSF protein kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.77']} DrugCentral uuid:1ffd488e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UEW8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (STE20/SPS1-related proline-alanine-rich protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:1ffd7160-d20a-11ec-8377-0242ac110003 UniProtKB:O43318 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.51']} DrugCentral uuid:1ffd99b0-d20a-11ec-8377-0242ac110003 UniProtKB:Q7L7X3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TAO1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.89']} DrugCentral uuid:1ffdc30e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H2K8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TAO3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1ffdeb86-d20a-11ec-8377-0242ac110003 UniProtKB:O75385 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ULK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.57']} DrugCentral uuid:1ffe1444-d20a-11ec-8377-0242ac110003 UniProtKB:Q8IYT8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ULK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.1']} DrugCentral uuid:1ffe3ca8-d20a-11ec-8377-0242ac110003 UniProtKB:Q6PHR2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase ULK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.54']} DrugCentral uuid:1ffe6502-d20a-11ec-8377-0242ac110003 UniProtKB:Q56UN5 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.72']} DrugCentral uuid:1ffe8d66-d20a-11ec-8377-0242ac110003 UniProtKB:Q86Z02 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Homeodomain-interacting protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.07']} DrugCentral uuid:1ffeb80e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NYY3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PLK2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.62']} DrugCentral uuid:1ffee298-d20a-11ec-8377-0242ac110003 UniProtKB:P57078 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Receptor-interacting serine/threonine-protein kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:1fff0afc-d20a-11ec-8377-0242ac110003 UniProtKB:P0C264 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Uncharacterized serine/threonine-protein kinase SBK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.54']} DrugCentral uuid:1fff3356-d20a-11ec-8377-0242ac110003 UniProtKB:O76039 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Cyclin-dependent kinase-like 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.14']} DrugCentral uuid:1fff5c46-d20a-11ec-8377-0242ac110003 UniProtKB:P42679 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Megakaryocyte-associated tyrosine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1fff84a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UBF8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 4-kinase beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:1fffad04-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y2K2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SIK3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.72']} DrugCentral uuid:1fffd55e-d20a-11ec-8377-0242ac110003 UniProtKB:P0C1S8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Wee1-like protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.22']} DrugCentral uuid:1ffffe30-d20a-11ec-8377-0242ac110003 UniProtKB:O00238 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Bone morphogenetic protein receptor type-1B) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.39']} DrugCentral uuid:2000268a-d20a-11ec-8377-0242ac110003 UniProtKB:Q52WX2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase SBK1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.1']} DrugCentral uuid:20004f02-d20a-11ec-8377-0242ac110003 UniProtKB:P51956 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.19']} DrugCentral uuid:20007752-d20a-11ec-8377-0242ac110003 UniProtKB:O14936 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Peripheral plasma membrane protein CASK) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.55']} DrugCentral uuid:2000a3d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13523 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PRP4 homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.41']} DrugCentral uuid:2000cd38-d20a-11ec-8377-0242ac110003 UniProtKB:Q12852 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Mitogen-activated protein kinase kinase kinase 12) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.2']} DrugCentral uuid:2000f5a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q96BR1 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Sgk3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.6']} DrugCentral uuid:20011e78-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BQI3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Eukaryotic translation initiation factor 2-alpha kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6']} DrugCentral uuid:200146dc-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UL54 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase TAO2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.12']} DrugCentral uuid:20016f5e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NRH2 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (SNF-related serine/threonine-protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.64']} DrugCentral uuid:200197ea-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TBX8 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.39']} DrugCentral uuid:2001c2a6-d20a-11ec-8377-0242ac110003 UniProtKB:Q13163 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual specificity mitogen-activated protein kinase kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.44']} DrugCentral uuid:2001eb0a-d20a-11ec-8377-0242ac110003 UniProtKB:Q8NG66 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:20021382-d20a-11ec-8377-0242ac110003 UniProtKB:Q32MK0 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Myosin light chain kinase 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.01']} DrugCentral uuid:20023bdc-d20a-11ec-8377-0242ac110003 UniProtKB:Q5S007 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Leucine-rich repeat serine/threonine-protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.06']} DrugCentral uuid:20026634-d20a-11ec-8377-0242ac110003 UniProtKB:Q6XUX3 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Dual serine/threonine and tyrosine protein kinase) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.77']} DrugCentral uuid:20028eb6-d20a-11ec-8377-0242ac110003 UniProtKB:P62344 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Calcium-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.92']} DrugCentral uuid:2002b710-d20a-11ec-8377-0242ac110003 UniProtKB:O60885 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Unclassified (Bromodomain-containing protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.79']} DrugCentral uuid:2002df88-d20a-11ec-8377-0242ac110003 UniProtKB:P9WI81 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase PknB) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7']} DrugCentral uuid:2003085a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9HC98 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek6) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.92']} DrugCentral uuid:200330be-d20a-11ec-8377-0242ac110003 UniProtKB:Q13976 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (cGMP-dependent protein kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.42']} DrugCentral uuid:20035922-d20a-11ec-8377-0242ac110003 UniProtKB:P51957 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.8']} DrugCentral uuid:200381ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q58F21 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Unclassified (Bromodomain testis-specific protein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:2003aa62-d20a-11ec-8377-0242ac110003 UniProtKB:Q96PY6 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib targets Kinase (Serine/threonine-protein kinase Nek1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.47']} DrugCentral uuid:2003d2da-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.99']} DrugCentral uuid:2003fb3e-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.97']} DrugCentral uuid:200424e2-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:20044fb2-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.82']} DrugCentral uuid:20047834-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5347 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fedratinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:2004a0a2-d20a-11ec-8377-0242ac110003 UniProtKB:P26433 biolink:molecularly_interacts_with DrugCentral:5349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenapanor targets Transporter (Sodium/hydrogen exchanger 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.2']} DrugCentral uuid:2004c99c-d20a-11ec-8377-0242ac110003 UniProtKB:P48764 biolink:molecularly_interacts_with DrugCentral:5349 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tenapanor is inhibitor of Transporter (Sodium/hydrogen exchanger 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.06']} DrugCentral uuid:2004f1f6-d20a-11ec-8377-0242ac110003 UniProtKB:P10276 biolink:molecularly_interacts_with DrugCentral:5350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:20051a3c-d20a-11ec-8377-0242ac110003 UniProtKB:P10826 biolink:molecularly_interacts_with DrugCentral:5350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.9']} DrugCentral uuid:20054278-d20a-11ec-8377-0242ac110003 UniProtKB:P13631 biolink:molecularly_interacts_with DrugCentral:5350 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trifarotene is agonist of Nuclear hormone receptor (Retinoic acid receptor gamma) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.11']} DrugCentral uuid:20056b90-d20a-11ec-8377-0242ac110003 UniProtKB:P30939 biolink:molecularly_interacts_with DrugCentral:5351 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lasmiditan is agonist of GPCR (5-hydroxytryptamine receptor 1F) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.65']} DrugCentral uuid:200594ee-d20a-11ec-8377-0242ac110003 UniProtKB:P0AD68 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan synthase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:2005bd84-d20a-11ec-8377-0242ac110003 UniProtKB:Q07806 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:2005e5fc-d20a-11ec-8377-0242ac110003 UniProtKB:P02918 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:200611bc-d20a-11ec-8377-0242ac110003 UniProtKB:P02919 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:20063a7a-d20a-11ec-8377-0242ac110003 UniProtKB:G1C775 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.98']} DrugCentral uuid:20066310-d20a-11ec-8377-0242ac110003 UniProtKB:A6T4V3 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 1B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.46']} DrugCentral uuid:20068b7e-d20a-11ec-8377-0242ac110003 UniProtKB:H4I819 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase MrdA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.66']} DrugCentral uuid:2006b478-d20a-11ec-8377-0242ac110003 UniProtKB:A0A0W8ASI8 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase MrdA) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.2']} DrugCentral uuid:2006dcf0-d20a-11ec-8377-0242ac110003 UniProtKB:A6T4M7 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.21']} DrugCentral uuid:20070590-d20a-11ec-8377-0242ac110003 UniProtKB:G3XD46 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.22']} DrugCentral uuid:20072dfe-d20a-11ec-8377-0242ac110003 UniProtKB:D0CCM7 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Peptidoglycan D,D-transpeptidase FtsI) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.17']} DrugCentral uuid:200756ee-d20a-11ec-8377-0242ac110003 UniProtKB:A0A5E6DR09 biolink:molecularly_interacts_with DrugCentral:5352 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cefiderocol is inhibitor of Enzyme (Penicillin-binding protein 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.44']} DrugCentral uuid:20077f52-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5353 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 zanubrutinib is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.52']} DrugCentral uuid:2007a7ca-d20a-11ec-8377-0242ac110003 UniProtKB:P13196 biolink:molecularly_interacts_with DrugCentral:5354 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 givosiran is antisense inhibitor of RNA (aminolevulinate synthase1 (ALAS1) mRNA) DrugCentral uuid:2007ce44-d20a-11ec-8377-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:5355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:2007f6d0-d20a-11ec-8377-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:5355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:20081f52-d20a-11ec-8377-0242ac110003 UniProtKB:P48169 biolink:molecularly_interacts_with DrugCentral:5355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.38']} DrugCentral uuid:200847e8-d20a-11ec-8377-0242ac110003 UniProtKB:Q16445 biolink:molecularly_interacts_with DrugCentral:5355 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cenobamate is allosteric modulator of Ion channel (Gamma-aminobutyric acid receptor subunit alpha-6) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.24']} DrugCentral uuid:20087100-d20a-11ec-8377-0242ac110003 UniProtKB:P08684 biolink:molecularly_interacts_with DrugCentral:5356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voxelotor is inhibitor of Enzyme (Cytochrome P450 3A4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.9']} DrugCentral uuid:2008996e-d20a-11ec-8377-0242ac110003 UniProtKB:P10632 biolink:molecularly_interacts_with DrugCentral:5356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voxelotor is inhibitor of Enzyme (Cytochrome P450 2C8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.1']} DrugCentral uuid:2008c1d2-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:5356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voxelotor is inhibitor of Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.07']} DrugCentral uuid:2008ea7c-d20a-11ec-8377-0242ac110003 UniProtKB:P69905 biolink:molecularly_interacts_with DrugCentral:5356 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 voxelotor is inhibitor of Transporter (hemoglobin subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.09']} DrugCentral uuid:20091330-d20a-11ec-8377-0242ac110003 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5357 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 golodirsen is antisense inhibitor of RNA (exon 53 of dystrophin pre-mRNA) DrugCentral uuid:2009377a-d20a-11ec-8377-0242ac110003 UniProtKB:P08908 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone targets GPCR (5-hydroxytryptamine receptor 1A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.83']} DrugCentral uuid:20095fd4-d20a-11ec-8377-0242ac110003 UniProtKB:P28335 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone targets GPCR (5-hydroxytryptamine receptor 2C) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.76']} DrugCentral uuid:20098928-d20a-11ec-8377-0242ac110003 UniProtKB:P35348 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone targets GPCR (Alpha-1A adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.14']} DrugCentral uuid:2009b2b8-d20a-11ec-8377-0242ac110003 UniProtKB:P21917 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone targets GPCR (D(4) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.97']} DrugCentral uuid:2009db26-d20a-11ec-8377-0242ac110003 UniProtKB:P35368 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone targets GPCR (Alpha-1B adrenergic receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.51']} DrugCentral uuid:200a03a8-d20a-11ec-8377-0242ac110003 UniProtKB:P61169 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone targets GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.5']} DrugCentral uuid:200a2c34-d20a-11ec-8377-0242ac110003 UniProtKB:P21728 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone is antagonist of GPCR (D(1A) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.38']} DrugCentral uuid:200a551a-d20a-11ec-8377-0242ac110003 UniProtKB:P31645 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone targets Transporter (Sodium-dependent serotonin transporter) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.48']} DrugCentral uuid:200a7e46-d20a-11ec-8377-0242ac110003 UniProtKB:P14416 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone is antagonist of GPCR (D(2) dopamine receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.49']} DrugCentral uuid:200aa6b4-d20a-11ec-8377-0242ac110003 UniProtKB:P28223 biolink:molecularly_interacts_with DrugCentral:5358 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumateperone is antagonist of GPCR (5-hydroxytryptamine receptor 2A) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.26']} DrugCentral uuid:200acf22-d20a-11ec-8377-0242ac110003 UniProtKB:Q99572 biolink:molecularly_interacts_with DrugCentral:5359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brilliant Blue G is antagonist of Ion channel (P2X purinoceptor 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:200af826-d20a-11ec-8377-0242ac110003 UniProtKB:P37840 biolink:molecularly_interacts_with DrugCentral:5359 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brilliant Blue G targets Transporter (Alpha-synuclein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:200b2076-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5360 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lemborexant targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:200b48da-d20a-11ec-8377-0242ac110003 UniProtKB:O43613 biolink:molecularly_interacts_with DrugCentral:5360 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lemborexant is antagonist of GPCR (Orexin receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:200b7166-d20a-11ec-8377-0242ac110003 UniProtKB:O43614 biolink:molecularly_interacts_with DrugCentral:5360 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lemborexant is antagonist of GPCR (Orexin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.52']} DrugCentral uuid:200b9b82-d20a-11ec-8377-0242ac110003 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5361 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ubrogepant is antagonist of GPCR (Calcitonin gene-related peptide type 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.2']} DrugCentral uuid:200bc3f0-d20a-11ec-8377-0242ac110003 UniProtKB:Q9BQB4 biolink:molecularly_interacts_with DrugCentral:5362 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 romosozumab is binding agent of Glycoprotein (Sclerostin) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['11.7']} DrugCentral uuid:200bec68-d20a-11ec-8377-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:5363 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 brolucizumab is inhibitor of Secreted (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.8']} DrugCentral uuid:200c156c-d20a-11ec-8377-0242ac110003 UniProtKB:O95390 biolink:molecularly_interacts_with DrugCentral:5364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 luspatercept is binding agent of Cytokine (Growth/differentiation factor 11) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.13']} DrugCentral uuid:200c3dee-d20a-11ec-8377-0242ac110003 UniProtKB:O14793 biolink:molecularly_interacts_with DrugCentral:5364 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 luspatercept is binding agent of Cytokine (Growth/differentiation factor 8) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.69']} DrugCentral uuid:200c6684-d20a-11ec-8377-0242ac110003 UniProtKB:P16109 biolink:molecularly_interacts_with DrugCentral:5365 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 crizanlizumab is inhibitor of Adhesion (P-selectin) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.59']} DrugCentral uuid:200cae8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:200cae8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:200cae8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:200cae8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:200cae8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:200cae8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:200cae8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:200cae8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:200cae8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q3ZCM7 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Tubulin beta) DrugCentral uuid:200d22e0-d20a-11ec-8377-0242ac110003 UniProtKB:Q96NY8 biolink:molecularly_interacts_with DrugCentral:5366 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enfortumab vedotin is binding agent of Tumour-associated antigen (Nectin-4) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.24']} DrugCentral uuid:200d4c52-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab deruxtecan is binding agent of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.13']} DrugCentral uuid:200d74f2-d20a-11ec-8377-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:5367 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trastuzumab deruxtecan is inhibitor of Enzyme (DNA topoisomerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.51']} DrugCentral uuid:200d9d38-d20a-11ec-8377-0242ac110003 UniProtKB:P60880 biolink:molecularly_interacts_with DrugCentral:5368 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 botulinum toxin type A is blocker of Cytosolic other (Synaptosomal-associated protein 25) DrugCentral uuid:200dc196-d20a-11ec-8377-0242ac110003 UniProtKB:Q9C0B1 biolink:molecularly_interacts_with DrugCentral:5371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxadustat targets Unclassified (Alpha-ketoglutarate-dependent dioxygenase FTO) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.01']} DrugCentral uuid:200dea68-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxadustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:200e12f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxadustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:200e3b4e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5371 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 roxadustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.18']} DrugCentral uuid:200e63bc-d20a-11ec-8377-0242ac110003 UniProtKB:P13569 biolink:molecularly_interacts_with DrugCentral:5372 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 elexacaftor targets Ion channel (Cystic fibrosis transmembrane conductance regulator) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.15']} DrugCentral uuid:200e8c48-d20a-11ec-8377-0242ac110003 UniProtKB:P28593 biolink:molecularly_interacts_with DrugCentral:5375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cepharanthine targets Enzyme (Trypanothione reductase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.12']} DrugCentral uuid:200eb4c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q13131 biolink:molecularly_interacts_with DrugCentral:5375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cepharanthine is inhibitor of Kinase (5'-AMP-activated protein kinase catalytic subunit alpha-1) DrugCentral uuid:200ed914-d20a-11ec-8377-0242ac110003 UniProtKB:P19838 biolink:molecularly_interacts_with DrugCentral:5375 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cepharanthine is inhibitor of Cytosolic other (Nuclear factor NF-kappa-B p105 subunit) DrugCentral uuid:200efe12-d20a-11ec-8377-0242ac110003 UniProtKB:P0DTD1 biolink:molecularly_interacts_with DrugCentral:5376 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remdesivir is inhibitor of Enzyme (Replicase polyprotein 1ab) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:200f281a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UGN5 biolink:molecularly_interacts_with DrugCentral:5378 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefuparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:200f5290-d20a-11ec-8377-0242ac110003 UniProtKB:P09874 biolink:molecularly_interacts_with DrugCentral:5378 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 mefuparib is inhibitor of Enzyme (Poly [ADP-ribose] polymerase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.49']} DrugCentral uuid:200f7cde-d20a-11ec-8377-0242ac110003 UniProtKB:P05532 biolink:molecularly_interacts_with DrugCentral:5379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avapritinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.66']} DrugCentral uuid:200fa6aa-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avapritinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.57']} DrugCentral uuid:200fcf4a-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5379 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 avapritinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.62']} DrugCentral uuid:200ff79a-d20a-11ec-8377-0242ac110003 UniProtKB:O75530 biolink:molecularly_interacts_with DrugCentral:5380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazemetostat targets Unclassified (Polycomb protein EED) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:20101fcc-d20a-11ec-8377-0242ac110003 UniProtKB:Q92800 biolink:molecularly_interacts_with DrugCentral:5380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazemetostat is inhibitor of Enzyme (Histone-lysine N-methyltransferase EZH1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.41']} DrugCentral uuid:20104826-d20a-11ec-8377-0242ac110003 UniProtKB:Q15910 biolink:molecularly_interacts_with DrugCentral:5380 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tazemetostat is inhibitor of Enzyme (Histone-lysine N-methyltransferase EZH2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:201070ee-d20a-11ec-8377-0242ac110003 UniProtKB:Q16602 biolink:molecularly_interacts_with DrugCentral:5381 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 rimegepant is antagonist of GPCR (Calcitonin gene-related peptide type 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.56']} DrugCentral uuid:20109952-d20a-11ec-8377-0242ac110003 UniProtKB:P53396 biolink:molecularly_interacts_with DrugCentral:5382 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bempedoic acid is inhibitor of Enzyme (ATP-citrate synthase) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['5.69']} DrugCentral uuid:2010c29c-d20a-11ec-8377-0242ac110003 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:5383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ozanimod targets GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:2010eace-d20a-11ec-8377-0242ac110003 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:5383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ozanimod targets GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5']} DrugCentral uuid:201113fa-d20a-11ec-8377-0242ac110003 UniProtKB:O95136 biolink:molecularly_interacts_with DrugCentral:5383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ozanimod targets GPCR (Sphingosine 1-phosphate receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.02']} DrugCentral uuid:20113c4a-d20a-11ec-8377-0242ac110003 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:5383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ozanimod is agonist of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['9.39']} DrugCentral uuid:2011647c-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:5383 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ozanimod is agonist of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:20118c86-d20a-11ec-8377-0242ac110003 UniProtKB:P11511 biolink:molecularly_interacts_with DrugCentral:5384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osilodrostat targets Enzyme (Aromatase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.07']} DrugCentral uuid:2011b512-d20a-11ec-8377-0242ac110003 UniProtKB:P15539 biolink:molecularly_interacts_with DrugCentral:5384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osilodrostat targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.68']} DrugCentral uuid:2011dd4e-d20a-11ec-8377-0242ac110003 UniProtKB:P15393 biolink:molecularly_interacts_with DrugCentral:5384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osilodrostat targets Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.3']} DrugCentral uuid:2012058a-d20a-11ec-8377-0242ac110003 UniProtKB:P30099 biolink:molecularly_interacts_with DrugCentral:5384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osilodrostat targets Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.96']} DrugCentral uuid:20122e84-d20a-11ec-8377-0242ac110003 UniProtKB:P19099 biolink:molecularly_interacts_with DrugCentral:5384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osilodrostat is inhibitor of Enzyme (Cytochrome P450 11B2, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.15']} DrugCentral uuid:201256c0-d20a-11ec-8377-0242ac110003 UniProtKB:P15538 biolink:molecularly_interacts_with DrugCentral:5384 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 osilodrostat is inhibitor of Enzyme (Cytochrome P450 11B1, mitochondrial) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.6']} DrugCentral uuid:20127f06-d20a-11ec-8377-0242ac110003 UniProtKB:P28907 biolink:molecularly_interacts_with DrugCentral:5385 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 isatuximab is binding agent of Tumour-associated antigen (Lymphocyte differentiation antigen CD38) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:2012a882-d20a-11ec-8377-0242ac110003 UniProtKB:P06881 biolink:molecularly_interacts_with DrugCentral:5386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eptinezumab is binding agent of GPCR (Calcitonin gene-related peptide 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.82']} DrugCentral uuid:2012d258-d20a-11ec-8377-0242ac110003 UniProtKB:P10092 biolink:molecularly_interacts_with DrugCentral:5386 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 eptinezumab is binding agent of GPCR (Calcitonin gene-related peptide 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.24']} DrugCentral uuid:2012fb20-d20a-11ec-8377-0242ac110003 UniProtKB:P08069 biolink:molecularly_interacts_with DrugCentral:5387 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 teprotumumab is antagonist of Kinase (Insulin-like growth factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:20132348-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selumetinib targets Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.66']} DrugCentral uuid:20134c38-d20a-11ec-8377-0242ac110003 UniProtKB:Q02750 biolink:molecularly_interacts_with DrugCentral:5388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selumetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:201374f6-d20a-11ec-8377-0242ac110003 UniProtKB:P36507 biolink:molecularly_interacts_with DrugCentral:5388 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selumetinib is inhibitor of Kinase (Dual specificity mitogen-activated protein kinase kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.85']} DrugCentral uuid:20139d3c-d20a-11ec-8377-0242ac110003 UniProtKB:P00533 biolink:molecularly_interacts_with DrugCentral:5389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tucatinib is inhibitor of Kinase (Epidermal growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.35']} DrugCentral uuid:2013c58c-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tucatinib is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.5']} DrugCentral uuid:2013f1ba-d20a-11ec-8377-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tucatinib is inhibitor of Kinase (ERBB2/ERBB3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.16']} DrugCentral uuid:2013f1ba-d20a-11ec-8377-0242ac110003 UniProtKB:P21860 biolink:molecularly_interacts_with DrugCentral:5389 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tucatinib is inhibitor of Kinase (ERBB2/ERBB3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.16']} DrugCentral uuid:201425cc-d20a-11ec-8377-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.52']} DrugCentral uuid:20144e08-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:20147752-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.4']} DrugCentral uuid:2014a0ce-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5390 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pemigatinib is inhibitor of Kinase (Fibroblast growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.3']} DrugCentral uuid:2014c928-d20a-11ec-8377-0242ac110003 UniProtKB:P55899 biolink:molecularly_interacts_with DrugCentral:5391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sacituzumab govitecan is antibody binding of Membrane receptor (IgG receptor FcRn large subunit p51) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.71']} DrugCentral uuid:2014f196-d20a-11ec-8377-0242ac110003 UniProtKB:P11387 biolink:molecularly_interacts_with DrugCentral:5391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sacituzumab govitecan is binding agent of Enzyme (DNA topoisomerase 1) DrugCentral uuid:201515f4-d20a-11ec-8377-0242ac110003 UniProtKB:P09758 biolink:molecularly_interacts_with DrugCentral:5391 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sacituzumab govitecan is antibody binding of Tumour-associated antigen (Tumor-associated calcium signal transducer 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.58']} DrugCentral uuid:20153ec6-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5392 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 capmatinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.88']} DrugCentral uuid:20156720-d20a-11ec-8377-0242ac110003 UniProtKB:Q96GD4 biolink:molecularly_interacts_with DrugCentral:5393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selpercatinib is inhibitor of Kinase (Aurora kinase B) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.1']} DrugCentral uuid:20158f70-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5393 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 selpercatinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.76']} DrugCentral uuid:2015b7de-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripretinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:2015e0d8-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripretinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.47']} DrugCentral uuid:20160932-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripretinib is inhibitor of Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.91']} DrugCentral uuid:201631b4-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripretinib is inhibitor of Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.27']} DrugCentral uuid:20165a18-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripretinib is inhibitor of Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:20168380-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5394 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ripretinib is inhibitor of Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.44']} DrugCentral uuid:2016abe4-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:5395 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fluoroestradiol F 18 is binding agent of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['10.07']} DrugCentral uuid:2016d45c-d20a-11ec-8377-0242ac110003 UniProtKB:P10636 biolink:molecularly_interacts_with DrugCentral:5396 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 flortaucipir F 18 is binding agent of Structural (Microtubule-associated protein tau) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.24']} DrugCentral uuid:2016fcb6-d20a-11ec-8377-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 inebilizumab is antibody binding of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.11']} DrugCentral uuid:2017256a-d20a-11ec-8377-0242ac110003 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:5397 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 inebilizumab is antibody binding of Surface antigen (B-lymphocyte antigen CD19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.8']} DrugCentral uuid:2017559e-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:2017559e-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:2017559e-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-3/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.04']} DrugCentral uuid:20179c98-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:20179c98-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:20179c98-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; alpha-1/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.44']} DrugCentral uuid:2017e4e6-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:2017e4e6-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:2017e4e6-d20a-11ec-8377-0242ac110003 UniProtKB:P63138 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-2/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.18']} DrugCentral uuid:20182c8a-d20a-11ec-8377-0242ac110003 UniProtKB:P18508 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:20182c8a-d20a-11ec-8377-0242ac110003 UniProtKB:P18508 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:20182c8a-d20a-11ec-8377-0242ac110003 UniProtKB:P18508 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA A receptor alpha-5/beta-2/gamma-2) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.86']} DrugCentral uuid:20188374-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:20188374-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:20188374-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:20188374-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:20188374-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:20188374-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:20188374-d20a-11ec-8377-0242ac110003 UniProtKB:Q99928 biolink:molecularly_interacts_with DrugCentral:5400 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 remimazolam is modulator of Ion channel (GABA-A receptor; benzodiazepine binding site) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.53']} DrugCentral uuid:2018ee90-d20a-11ec-8377-0242ac110003 UniProtKB:Q75760 biolink:molecularly_interacts_with DrugCentral:5401 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fostemsavir is inhibitor of Viral envelope protein (Envelope glycoprotein gp160) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.08']} DrugCentral uuid:20191712-d20a-11ec-8377-0242ac110003 UniProtKB:P32320 biolink:molecularly_interacts_with DrugCentral:5402 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 inqovi is inhibitor of Enzyme (Cytidine deaminase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.39']} DrugCentral uuid:20193f76-d20a-11ec-8377-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:5403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:201967c6-d20a-11ec-8377-0242ac110003 UniProtKB:P32246 biolink:molecularly_interacts_with DrugCentral:5403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:201990c0-d20a-11ec-8377-0242ac110003 UniProtKB:P32246 biolink:molecularly_interacts_with DrugCentral:5403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['4.8']} DrugCentral uuid:2019b8f2-d20a-11ec-8377-0242ac110003 UniProtKB:P51681 biolink:molecularly_interacts_with DrugCentral:5403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:2019e12e-d20a-11ec-8377-0242ac110003 UniProtKB:P51685 biolink:molecularly_interacts_with DrugCentral:5403 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 abametapir targets GPCR (C-C chemokine receptor type 8) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:201a09b0-d20a-11ec-8377-0242ac110003 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:5404 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tafasitamab is antibody binding of Surface antigen (B-lymphocyte antigen CD19) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.39']} DrugCentral uuid:201a34d0-d20a-11ec-8377-0242ac110003 UniProtKB:P55899 biolink:molecularly_interacts_with DrugCentral:5405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belantamab mafodotin is binding agent of Membrane receptor (IgG receptor FcRn large subunit p51) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.28']} DrugCentral uuid:201a5d8e-d20a-11ec-8377-0242ac110003 UniProtKB:P12314 biolink:molecularly_interacts_with DrugCentral:5405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belantamab mafodotin is binding agent of Membrane receptor (High affinity immunoglobulin gamma Fc receptor I) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.15']} DrugCentral uuid:201a8606-d20a-11ec-8377-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belantamab mafodotin is binding agent of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.55']} DrugCentral uuid:201aaf96-d20a-11ec-8377-0242ac110003 UniProtKB:Q02223 biolink:molecularly_interacts_with DrugCentral:5405 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 belantamab mafodotin is binding agent of Tumour-associated antigen (Tumor necrosis factor receptor superfamily member 17) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9']} DrugCentral uuid:201ad912-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:201b0162-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:201b29bc-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:201b5202-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.21']} DrugCentral uuid:201b7af2-d20a-11ec-8377-0242ac110003 UniProtKB:Q13936 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine targets Ion channel (Voltage-dependent L-type calcium channel subunit alpha-1C) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.44']} DrugCentral uuid:201ba338-d20a-11ec-8377-0242ac110003 UniProtKB:Q14524 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine targets Ion channel (Sodium channel protein type 5 subunit alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:201bcb74-d20a-11ec-8377-0242ac110003 UniProtKB:P41146 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine is agonist of GPCR (Nociceptin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.4']} DrugCentral uuid:201bf478-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5406 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 oliceridine is agonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.22']} DrugCentral uuid:201c1cf0-d20a-11ec-8377-0242ac110003 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5408 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 viltolarsen is binding agent of RNA (exon 53 of dystrophin pre-mRNA) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.33']} DrugCentral uuid:201c4a22-d20a-11ec-8377-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5409 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 satralizumab is antagonist of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:201c4a22-d20a-11ec-8377-0242ac110003 UniProtKB:P40189 biolink:molecularly_interacts_with DrugCentral:5409 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 satralizumab is antagonist of Membrane receptor (Interleukin-6 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:201c7db2-d20a-11ec-8377-0242ac110003 UniProtKB:P10275 biolink:molecularly_interacts_with DrugCentral:5410 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 clascoterone is antagonist of Nuclear hormone receptor (Androgen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:201ca684-d20a-11ec-8377-0242ac110003 UniProtKB:P30874 biolink:molecularly_interacts_with DrugCentral:5411 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 copper dotatate Cu-64 is binding agent of GPCR (Somatostatin receptor type 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.69']} DrugCentral uuid:201ccff6-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.46']} DrugCentral uuid:201cf850-d20a-11ec-8377-0242ac110003 UniProtKB:P09619 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Platelet-derived growth factor receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:201d20be-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:201d49c2-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.66']} DrugCentral uuid:201d721c-d20a-11ec-8377-0242ac110003 UniProtKB:P04629 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (High affinity nerve growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:201d9a62-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.72']} DrugCentral uuid:201dc2c6-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.96']} DrugCentral uuid:201dee18-d20a-11ec-8377-0242ac110003 UniProtKB:Q08345 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Epithelial discoidin domain-containing receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.7']} DrugCentral uuid:201e1672-d20a-11ec-8377-0242ac110003 UniProtKB:Q16288 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (NT-3 growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.05']} DrugCentral uuid:201e3eea-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5412 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pralsetinib is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.39']} DrugCentral uuid:201e68a2-d20a-11ec-8377-0242ac110003 UniProtKB:P10912 biolink:molecularly_interacts_with DrugCentral:5413 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 somapacitan targets GPCR (Growth hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.04']} DrugCentral uuid:201e9106-d20a-11ec-8377-0242ac110003 UniProtKB:P01112 biolink:molecularly_interacts_with DrugCentral:5414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonafarnib is inhibitor of Cytosolic other (GTPase HRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:201eb974-d20a-11ec-8377-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:5414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:201ee1ba-d20a-11ec-8377-0242ac110003 UniProtKB:P01111 biolink:molecularly_interacts_with DrugCentral:5414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase NRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:201f0aa0-d20a-11ec-8377-0242ac110003 UniProtKB:P01112 biolink:molecularly_interacts_with DrugCentral:5414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase HRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:201f32dc-d20a-11ec-8377-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:5414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonafarnib is inhibitor of Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.28']} DrugCentral uuid:201f5f1e-d20a-11ec-8377-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:5414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonafarnib is inhibitor of Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:201f5f1e-d20a-11ec-8377-0242ac110003 UniProtKB:P49356 biolink:molecularly_interacts_with DrugCentral:5414 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lonafarnib is inhibitor of Enzyme (Protein farnesyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.72']} DrugCentral uuid:201f92a4-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UJM8 biolink:molecularly_interacts_with DrugCentral:5415 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 lumasiran is antisense inhibitor of RNA (Hydroxyacid oxidase 1 (HAO1) mRNA) DrugCentral uuid:201fba0e-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:5416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:201fe59c-d20a-11ec-8377-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:5416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:2020112a-d20a-11ec-8377-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:5416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setmelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:20203c9a-d20a-11ec-8377-0242ac110003 UniProtKB:P33032 biolink:molecularly_interacts_with DrugCentral:5416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['6.37']} DrugCentral uuid:20206508-d20a-11ec-8377-0242ac110003 UniProtKB:P41968 biolink:molecularly_interacts_with DrugCentral:5416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8']} DrugCentral uuid:20208d62-d20a-11ec-8377-0242ac110003 UniProtKB:Q01726 biolink:molecularly_interacts_with DrugCentral:5416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setmelanotide is agonist of GPCR (Melanocyte-stimulating hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.41']} DrugCentral uuid:2020b5da-d20a-11ec-8377-0242ac110003 UniProtKB:P32245 biolink:molecularly_interacts_with DrugCentral:5416 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 setmelanotide is agonist of GPCR (Melanocortin receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.68']} DrugCentral uuid:2020dee8-d20a-11ec-8377-0242ac110003 UniProtKB:Q14973 biolink:molecularly_interacts_with DrugCentral:5417 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bulevirtide is inhibitor of Transporter (Sodium/bile acid cotransporter) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.49']} DrugCentral uuid:202112f0-d20a-11ec-8377-0242ac110003 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:202112f0-d20a-11ec-8377-0242ac110003 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:202112f0-d20a-11ec-8377-0242ac110003 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:202112f0-d20a-11ec-8377-0242ac110003 UniProtKB:P01861 biolink:molecularly_interacts_with DrugCentral:5418 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imlifidase is inhibitor of Antibody (Immunoglobulin gamma (IgG), heavy chain) DrugCentral uuid:202154f4-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:20217e48-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:2021a68e-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:2021ceca-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:2021f706-d20a-11ec-8377-0242ac110003 UniProtKB:P07333 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Kinase (Macrophage colony-stimulating factor 1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.31']} DrugCentral uuid:202220c8-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.56']} DrugCentral uuid:20224a44-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.47']} DrugCentral uuid:202272a8-d20a-11ec-8377-0242ac110003 UniProtKB:Q12809 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib targets Ion channel (Potassium voltage-gated channel subfamily H member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.07']} DrugCentral uuid:20229af8-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.09']} DrugCentral uuid:2022c410-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.55']} DrugCentral uuid:2022ec60-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:202314b0-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5419 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 filgotinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8']} DrugCentral uuid:20233d32-d20a-11ec-8377-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat targets Secreted (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:20236924-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NWT6 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat targets Enzyme (Hypoxia-inducible factor 1-alpha inhibitor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:2023921e-d20a-11ec-8377-0242ac110003 UniProtKB:P15692 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat targets Unclassified (Vascular endothelial growth factor A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.12']} DrugCentral uuid:2023ba6e-d20a-11ec-8377-0242ac110003 UniProtKB:Q8N543 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat targets Unclassified (Prolyl 3-hydroxylase OGFOD1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.85']} DrugCentral uuid:2023e336-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NWT6 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat targets Unclassified (Hypoxia-inducible factor 1-alpha inhibitor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.54']} DrugCentral uuid:20240b9a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.81']} DrugCentral uuid:202433fe-d20a-11ec-8377-0242ac110003 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.93']} DrugCentral uuid:20245c80-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5420 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vadadustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.12']} DrugCentral uuid:20248598-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5421 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daprodustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.46']} DrugCentral uuid:2024adfc-d20a-11ec-8377-0242ac110003 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5421 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daprodustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.14']} DrugCentral uuid:2024d688-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5421 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 daprodustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.26']} DrugCentral uuid:2024fed8-d20a-11ec-8377-0242ac110003 UniProtKB:Q63016 biolink:molecularly_interacts_with DrugCentral:5422 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 borofalan (10B) is substrate of Transporter (L-type amino acid transporter 1) DrugCentral uuid:20252520-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:202550b8-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:202578fe-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride targets Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.21']} DrugCentral uuid:2025a1bc-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.43']} DrugCentral uuid:2025ca98-d20a-11ec-8377-0242ac110003 UniProtKB:Q15303 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Receptor tyrosine-protein kinase erbB-4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.11']} DrugCentral uuid:2025f2de-d20a-11ec-8377-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.22']} DrugCentral uuid:20261c28-d20a-11ec-8377-0242ac110003 UniProtKB:P42680 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase Tec) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.32']} DrugCentral uuid:20264464-d20a-11ec-8377-0242ac110003 UniProtKB:P42681 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase TXK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.04']} DrugCentral uuid:20266d68-d20a-11ec-8377-0242ac110003 UniProtKB:P51451 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase Blk) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:202695c2-d20a-11ec-8377-0242ac110003 UniProtKB:Q06187 biolink:molecularly_interacts_with DrugCentral:5423 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirabrutinib hydrochloride is inhibitor of Kinase (Tyrosine-protein kinase BTK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.17']} DrugCentral uuid:2026be08-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NWZ3 biolink:molecularly_interacts_with DrugCentral:5424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tepotinib is inhibitor of Kinase (Interleukin-1 receptor-associated kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.21']} DrugCentral uuid:2026e644-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5424 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tepotinib is inhibitor of Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.77']} DrugCentral uuid:2027110a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UNQ0 biolink:molecularly_interacts_with DrugCentral:5425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dotinurad is inhibitor of Transporter (ATP-binding cassette sub-family G member 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:2027395a-d20a-11ec-8377-0242ac110003 UniProtKB:Q4U2R8 biolink:molecularly_interacts_with DrugCentral:5425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dotinurad is inhibitor of Transporter (Solute carrier family 22 member 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.39']} DrugCentral uuid:202761a0-d20a-11ec-8377-0242ac110003 UniProtKB:Q8TCC7 biolink:molecularly_interacts_with DrugCentral:5425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dotinurad is inhibitor of Transporter (Solute carrier family 22 member 8) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.88']} DrugCentral uuid:20278a54-d20a-11ec-8377-0242ac110003 UniProtKB:P11712 biolink:molecularly_interacts_with DrugCentral:5425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dotinurad is inhibitor of Enzyme (Cytochrome P450 2C9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.24']} DrugCentral uuid:2027b2ae-d20a-11ec-8377-0242ac110003 UniProtKB:Q96S37 biolink:molecularly_interacts_with DrugCentral:5425 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dotinurad is inhibitor of Transporter (Solute carrier family 22 member 12) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.43']} DrugCentral uuid:2027dafe-d20a-11ec-8377-0242ac110003 UniProtKB:O75116 biolink:molecularly_interacts_with DrugCentral:5426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delgocitinib is inhibitor of Kinase (Rho-associated protein kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.58']} DrugCentral uuid:20280358-d20a-11ec-8377-0242ac110003 UniProtKB:P52333 biolink:molecularly_interacts_with DrugCentral:5426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delgocitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.89']} DrugCentral uuid:20282d7e-d20a-11ec-8377-0242ac110003 UniProtKB:P23458 biolink:molecularly_interacts_with DrugCentral:5426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delgocitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.55']} DrugCentral uuid:2028560a-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delgocitinib is inhibitor of Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.58']} DrugCentral uuid:20287e96-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5426 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 delgocitinib is inhibitor of Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.24']} DrugCentral uuid:2028a6fa-d20a-11ec-8377-0242ac110003 UniProtKB:Q9GZT9 biolink:molecularly_interacts_with DrugCentral:5427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enarodustat is inhibitor of Enzyme (Egl nine homolog 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.8']} DrugCentral uuid:2028d030-d20a-11ec-8377-0242ac110003 UniProtKB:Q96KS0 biolink:molecularly_interacts_with DrugCentral:5427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enarodustat is inhibitor of Enzyme (Egl nine homolog 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.21']} DrugCentral uuid:2028f89e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H6Z9 biolink:molecularly_interacts_with DrugCentral:5427 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 enarodustat is inhibitor of Enzyme (Egl nine homolog 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7']} DrugCentral uuid:2029210c-d20a-11ec-8377-0242ac110003 UniProtKB:P20309 biolink:molecularly_interacts_with DrugCentral:5428 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sofpironium bromide is inhibitor of GPCR (Muscarinic acetylcholine receptor M3) DrugCentral uuid:20294646-d20a-11ec-8377-0242ac110003 UniProtKB:P07288 biolink:molecularly_interacts_with DrugCentral:5429 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 gallium (68Ga) gozetotide is binding agent of Surface antigen (Prostate-specific antigen) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.57']} DrugCentral uuid:20296f0e-d20a-11ec-8377-0242ac110003 UniProtKB:P03952 biolink:molecularly_interacts_with DrugCentral:5430 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 berotralstat is inhibitor of Enzyme (Plasma kallikrein) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.8']} DrugCentral uuid:20299768-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirbanibulin is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:2029bf86-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirbanibulin targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:2029e7f4-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirbanibulin is inhibitor of Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['4.34']} DrugCentral uuid:202a11ca-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5431 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 tirbanibulin targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7']} DrugCentral uuid:202a3a24-d20a-11ec-8377-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:5432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relugolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:202a627e-d20a-11ec-8377-0242ac110003 UniProtKB:P30969 biolink:molecularly_interacts_with DrugCentral:5432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relugolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.48']} DrugCentral uuid:202a8ae2-d20a-11ec-8377-0242ac110003 UniProtKB:P30968 biolink:molecularly_interacts_with DrugCentral:5432 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 relugolix is antagonist of GPCR (Gonadotropin-releasing hormone receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9.92']} DrugCentral uuid:202ab62a-d20a-11ec-8377-0242ac110003 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5433 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ansuvimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.7']} DrugCentral uuid:202adee8-d20a-11ec-8377-0242ac110003 UniProtKB:P04626 biolink:molecularly_interacts_with DrugCentral:5434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 margetuximab is antagonist of Kinase (Receptor tyrosine-protein kinase erbB-2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.55']} DrugCentral uuid:202b074c-d20a-11ec-8377-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5434 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 margetuximab is antagonist of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['7.05']} DrugCentral uuid:202b2fec-d20a-11ec-8377-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atoltivimab is antibody binding of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.64']} DrugCentral uuid:202b58be-d20a-11ec-8377-0242ac110003 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5436 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 atoltivimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.11']} DrugCentral uuid:202b8140-d20a-11ec-8377-0242ac110003 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5437 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 maftivimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.48']} DrugCentral uuid:202ba9e0-d20a-11ec-8377-0242ac110003 UniProtKB:P08637 biolink:molecularly_interacts_with DrugCentral:5438 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 odesivimab is antibody binding of Membrane receptor (Low affinity immunoglobulin gamma Fc region receptor III-A) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.8']} DrugCentral uuid:202bd316-d20a-11ec-8377-0242ac110003 UniProtKB:P87666 biolink:molecularly_interacts_with DrugCentral:5438 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 odesivimab is antibody binding of Glycoprotein (Envelope glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.08']} DrugCentral uuid:202bfb5c-d20a-11ec-8377-0242ac110003 UniProtKB:P20595 biolink:molecularly_interacts_with DrugCentral:5439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vericiguat is activator of Enzyme (Guanylate cyclase soluble subunit beta-1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6']} DrugCentral uuid:202c23c0-d20a-11ec-8377-0242ac110003 UniProtKB:Q02153 biolink:molecularly_interacts_with DrugCentral:5439 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 vericiguat is activator of Enzyme (Guanylate cyclase soluble subunit beta-1) DrugCentral uuid:202c4800-d20a-11ec-8377-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabotegravir targets Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:202c7190-d20a-11ec-8377-0242ac110003 UniProtKB:Q76353 biolink:molecularly_interacts_with DrugCentral:5440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabotegravir targets Unclassified (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:202c9a1c-d20a-11ec-8377-0242ac110003 UniProtKB:Q7ZJM1 biolink:molecularly_interacts_with DrugCentral:5440 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 cabotegravir is inhibitor of Enzyme (Integrase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.52']} DrugCentral uuid:202cc26c-d20a-11ec-8377-0242ac110003 UniProtKB:P42336 biolink:molecularly_interacts_with DrugCentral:5441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:202cead0-d20a-11ec-8377-0242ac110003 UniProtKB:P42338 biolink:molecularly_interacts_with DrugCentral:5441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5']} DrugCentral uuid:202d137a-d20a-11ec-8377-0242ac110003 UniProtKB:P48736 biolink:molecularly_interacts_with DrugCentral:5441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['5.85']} DrugCentral uuid:202d3c74-d20a-11ec-8377-0242ac110003 UniProtKB:O00329 biolink:molecularly_interacts_with DrugCentral:5441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umbralisib is inhibitor of Kinase (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.21']} DrugCentral uuid:202d64d8-d20a-11ec-8377-0242ac110003 UniProtKB:P49674 biolink:molecularly_interacts_with DrugCentral:5441 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 umbralisib is inhibitor of Kinase (Casein kinase I isoform epsilon) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['6.74']} DrugCentral uuid:202d8d50-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:202db672-d20a-11ec-8377-0242ac110003 UniProtKB:P06493 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:202ddfc6-d20a-11ec-8377-0242ac110003 UniProtKB:P24941 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:202e0956-d20a-11ec-8377-0242ac110003 UniProtKB:Q00535 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent-like kinase 5) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.83']} DrugCentral uuid:202e319c-d20a-11ec-8377-0242ac110003 UniProtKB:P50750 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 9) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.3']} DrugCentral uuid:202e5c8a-d20a-11ec-8377-0242ac110003 UniProtKB:P50613 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 7) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.33']} DrugCentral uuid:202e84da-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H093 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (NUAK family SNF1-like kinase 2) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.15']} DrugCentral uuid:202ead3e-d20a-11ec-8377-0242ac110003 UniProtKB:Q6ZWH5 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Serine/threonine-protein kinase Nek10) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.57']} DrugCentral uuid:202ed5ac-d20a-11ec-8377-0242ac110003 UniProtKB:Q00534 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 6) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.4']} DrugCentral uuid:202efe88-d20a-11ec-8377-0242ac110003 UniProtKB:P11802 biolink:molecularly_interacts_with DrugCentral:5442 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 trilaciclib is inhibitor of Kinase (Cyclin-dependent kinase 4) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['9']} DrugCentral uuid:202f26d8-d20a-11ec-8377-0242ac110003 UniProtKB:P11532 biolink:molecularly_interacts_with DrugCentral:5443 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 casimersen is antisense inhibitor of RNA (exon 53 of dystrophin pre-mRNA) DrugCentral uuid:202f4b0e-d20a-11ec-8377-0242ac110003 UniProtKB:Q9NZB8 biolink:molecularly_interacts_with DrugCentral:5444 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 fosdenopterin targets Enzyme (Molybdenum cofactor biosynthesis protein 1) DrugCentral uuid:202f6f26-d20a-11ec-8377-0242ac110003 UniProtKB:Q9H228 biolink:molecularly_interacts_with DrugCentral:5446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 5) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['7.23']} DrugCentral uuid:202f97ee-d20a-11ec-8377-0242ac110003 UniProtKB:O95977 biolink:molecularly_interacts_with DrugCentral:5446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 4) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:202fbff8-d20a-11ec-8377-0242ac110003 UniProtKB:Q99500 biolink:molecularly_interacts_with DrugCentral:5446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['6.94']} DrugCentral uuid:202fe848-d20a-11ec-8377-0242ac110003 UniProtKB:P21453 biolink:molecularly_interacts_with DrugCentral:5446 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ponesimod is agonist of GPCR (Sphingosine 1-phosphate receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['8.13']} DrugCentral uuid:20301084-d20a-11ec-8377-0242ac110003 UniProtKB:P47871 biolink:molecularly_interacts_with DrugCentral:5447 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dasiglucagon is agonist of GPCR (Glucagon receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'EC50', 'has_quantitative_value': ['11']} DrugCentral uuid:203039ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q9Y5C1 biolink:molecularly_interacts_with DrugCentral:5449 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 evinacumab is inhibitor of Secreted (Angiopoietin-related protein 3) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['9.04']} DrugCentral uuid:20306228-d20a-11ec-8377-0242ac110003 UniProtKB:P03372 biolink:molecularly_interacts_with DrugCentral:5450 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estetrol is modulator of Nuclear hormone receptor (Estrogen receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.31']} DrugCentral uuid:20308a8c-d20a-11ec-8377-0242ac110003 UniProtKB:Q92731 biolink:molecularly_interacts_with DrugCentral:5450 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 estetrol is modulator of Nuclear hormone receptor (Estrogen receptor beta) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.72']} DrugCentral uuid:2030b35e-d20a-11ec-8377-0242ac110003 UniProtKB:Q15116 biolink:molecularly_interacts_with DrugCentral:5451 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 dostarlimab is antibody binding of Membrane receptor (Programmed cell death protein 1) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.82']} DrugCentral uuid:2030dbcc-d20a-11ec-8377-0242ac110003 UniProtKB:P15391 biolink:molecularly_interacts_with DrugCentral:5452 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 loncastuximab tesirine is antibody binding of Surface antigen (B-lymphocyte antigen CD19) DrugCentral uuid:20310034-d20a-11ec-8377-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5453 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 bamlanivimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.15']} DrugCentral uuid:203128a2-d20a-11ec-8377-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5454 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 etesevimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['8.19']} DrugCentral uuid:203151ba-d20a-11ec-8377-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5455 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 casirivimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.34']} DrugCentral uuid:20317a28-d20a-11ec-8377-0242ac110003 UniProtKB:P0DTC2 biolink:molecularly_interacts_with DrugCentral:5456 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 imdevimab targets Glycoprotein (Spike glycoprotein) {'has_attribute_type': 'IAO:0000004', 'name': 'Kd', 'has_quantitative_value': ['10.33']} DrugCentral uuid:2031a2aa-d20a-11ec-8377-0242ac110003 UniProtKB:P01024 biolink:molecularly_interacts_with DrugCentral:5457 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 pegcetacoplan is inhibitor of Unclassified (Complement C3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.6']} DrugCentral uuid:2031cc8a-d20a-11ec-8377-0242ac110003 UniProtKB:Q04609 biolink:molecularly_interacts_with DrugCentral:5458 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 piflufolastat F-18 is binding agent of Enzyme (Glutamate carboxypeptidase 2) DrugCentral uuid:2031f228-d20a-11ec-8377-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:20321d7a-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:20324822-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:2032707c-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:20329912-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:2032c14e-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:2032e994-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:203311d0-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:20333aca-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:2033631a-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:20338b74-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:2033b3b0-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:2033de62-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:203406b2-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:20342f02-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:20345752-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:20348010-d20a-11ec-8377-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:2034a8c4-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:2034d114-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:2034f9e6-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:20352222-d20a-11ec-8377-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:20354a4a-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:20357290-d20a-11ec-8377-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:20359bda-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:2035c52e-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:2035ed88-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:203615ba-d20a-11ec-8377-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:20363e78-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:203666aa-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:20368ed2-d20a-11ec-8377-0242ac110003 UniProtKB:P35968 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib is inhibitor of Kinase (Vascular endothelial growth factor receptor 2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.74']} DrugCentral uuid:2036b722-d20a-11ec-8377-0242ac110003 UniProtKB:O60674 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase JAK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:2036e008-d20a-11ec-8377-0242ac110003 UniProtKB:P00519 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase ABL1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.64']} DrugCentral uuid:20370844-d20a-11ec-8377-0242ac110003 UniProtKB:P06213 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Insulin receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:20373076-d20a-11ec-8377-0242ac110003 UniProtKB:P06239 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lck) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.6']} DrugCentral uuid:2037593e-d20a-11ec-8377-0242ac110003 UniProtKB:P06241 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Fyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.72']} DrugCentral uuid:2037845e-d20a-11ec-8377-0242ac110003 UniProtKB:P07947 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Yes) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.96']} DrugCentral uuid:2037accc-d20a-11ec-8377-0242ac110003 UniProtKB:P07948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase Lyn) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.52']} DrugCentral uuid:2037d508-d20a-11ec-8377-0242ac110003 UniProtKB:P07949 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase receptor Ret) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:2037fd4e-d20a-11ec-8377-0242ac110003 UniProtKB:P08581 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Hepatocyte growth factor receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:203825ee-d20a-11ec-8377-0242ac110003 UniProtKB:P08922 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase ROS) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:20384e34-d20a-11ec-8377-0242ac110003 UniProtKB:P10721 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Mast/stem cell growth factor receptor Kit) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['6.12']} DrugCentral uuid:2038765c-d20a-11ec-8377-0242ac110003 UniProtKB:P12931 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Proto-oncogene tyrosine-protein kinase Src) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.53']} DrugCentral uuid:20389ea2-d20a-11ec-8377-0242ac110003 UniProtKB:P15056 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Serine/threonine-protein kinase B-raf) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.38']} DrugCentral uuid:2038c760-d20a-11ec-8377-0242ac110003 UniProtKB:P16234 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Platelet-derived growth factor receptor alpha) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.57']} DrugCentral uuid:2038ef9c-d20a-11ec-8377-0242ac110003 UniProtKB:P17948 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.82']} DrugCentral uuid:203917ec-d20a-11ec-8377-0242ac110003 UniProtKB:P29597 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Non-receptor tyrosine-protein kinase TYK2) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.48']} DrugCentral uuid:2039414a-d20a-11ec-8377-0242ac110003 UniProtKB:P35916 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Vascular endothelial growth factor receptor 3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.68']} DrugCentral uuid:2039697c-d20a-11ec-8377-0242ac110003 UniProtKB:P36888 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Receptor-type tyrosine-protein kinase FLT3) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.49']} DrugCentral uuid:2039929e-d20a-11ec-8377-0242ac110003 UniProtKB:P43405 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Tyrosine-protein kinase SYK) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.27']} DrugCentral uuid:2039bbf2-d20a-11ec-8377-0242ac110003 UniProtKB:P51813 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Cytoplasmic tyrosine-protein kinase BMX) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.47']} DrugCentral uuid:2039e492-d20a-11ec-8377-0242ac110003 UniProtKB:P54762 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Ephrin type-B receptor 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.52']} DrugCentral uuid:203a0cce-d20a-11ec-8377-0242ac110003 UniProtKB:Q02763 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Angiopoietin-1 receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.69']} DrugCentral uuid:203a3514-d20a-11ec-8377-0242ac110003 UniProtKB:Q04912 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (Macrophage-stimulating protein receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.54']} DrugCentral uuid:203a5d5a-d20a-11ec-8377-0242ac110003 UniProtKB:Q16620 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (BDNF/NT-3 growth factors receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.5']} DrugCentral uuid:203a865e-d20a-11ec-8377-0242ac110003 UniProtKB:Q99835 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets GPCR (Smoothened homolog) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['7.33']} DrugCentral uuid:203aaeb8-d20a-11ec-8377-0242ac110003 UniProtKB:Q9UM73 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib targets Kinase (ALK tyrosine kinase receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['5.51']} DrugCentral uuid:203ad6fe-d20a-11ec-8377-0242ac110003 UniProtKB:P22607 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 3) DrugCentral uuid:203afb2a-d20a-11ec-8377-0242ac110003 UniProtKB:P21802 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 2) DrugCentral uuid:203b2122-d20a-11ec-8377-0242ac110003 UniProtKB:P22455 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 4) DrugCentral uuid:203b4788-d20a-11ec-8377-0242ac110003 UniProtKB:P11362 biolink:molecularly_interacts_with DrugCentral:5459 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 infigratinib is inhibitor of Kinase (Fibroblast growth factor receptor 1) DrugCentral uuid:203b6bd2-d20a-11ec-8377-0242ac110003 UniProtKB:P35372 biolink:molecularly_interacts_with DrugCentral:5460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 samidorphan is antagonist of GPCR (Mu-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['10.28']} DrugCentral uuid:203b9422-d20a-11ec-8377-0242ac110003 UniProtKB:P41145 biolink:molecularly_interacts_with DrugCentral:5460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 samidorphan is partial agonist of GPCR (Kappa-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['9.64']} DrugCentral uuid:203bbce0-d20a-11ec-8377-0242ac110003 UniProtKB:P41143 biolink:molecularly_interacts_with DrugCentral:5460 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 samidorphan is partial agonist of GPCR (Delta-type opioid receptor) {'has_attribute_type': 'IAO:0000004', 'name': 'Ki', 'has_quantitative_value': ['8.59']} DrugCentral uuid:203be530-d20a-11ec-8377-0242ac110003 UniProtKB:P01116 biolink:molecularly_interacts_with DrugCentral:5461 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 sotorasib is inhibitor of Enzyme (GTPase KRas) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.03']} DrugCentral uuid:203c0d94-d20a-11ec-8377-0242ac110003 UniProtKB:O13428 biolink:molecularly_interacts_with DrugCentral:5462 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrexafungerp is inhibitor of Enzyme (Beta-1,3-glucan synthase catalytic subunit 1) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.35']} DrugCentral uuid:203c365c-d20a-11ec-8377-0242ac110003 UniProtKB:Q6FTN8 biolink:molecularly_interacts_with DrugCentral:5462 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrexafungerp is inhibitor of Enzyme (1,3-Beta-D-glucan-UDP glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['7.83']} DrugCentral uuid:203c5f6a-d20a-11ec-8377-0242ac110003 UniProtKB:P87204 biolink:molecularly_interacts_with DrugCentral:5462 biolink:DrugToGeneAssociation|biolink:Association RO:0002436 ibrexafungerp is inhibitor of Enzyme (1,3-Beta-D-glucan-UDP glucosyltransferase) {'has_attribute_type': 'IAO:0000004', 'name': 'IC50', 'has_quantitative_value': ['8.97']} DrugCentral